Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.962887656175497,2.7406892203898754,0.0,0.0,0.0,77/87,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;SEC61B;RPL10;RPS6;RPL10A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.9523042977573288,2.7120739948519126,0.0,0.0,0.0,77/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;SSR2;RPS6;RPL10A
prerank,cytoplasmic translation (GO:0002181),0.9556649531039274,2.7051578952433584,0.0,0.0,0.0,75/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,protein targeting to ER (GO:0045047),0.9445048773483584,2.7036694019222662,0.0,0.0,0.0,76/99,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.9336136672004048,2.7026625447109462,0.0,0.0,0.0,78/110,2.78%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH
prerank,peptide biosynthetic process (GO:0043043),0.8966293678681272,2.6257747864201053,0.0,0.0,0.0,82/153,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.8700591242732592,2.5616723028686517,0.0,0.0,0.0,79/168,2.90%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D
prerank,rRNA metabolic process (GO:0016072),0.8505729885633497,2.509072449319299,0.0,0.0,0.0,59/160,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,translation (GO:0006412),0.8454599736825705,2.496371686302532,0.0,0.0,0.0,87/208,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;LARS2;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;MRPS34;RPS6;RPL10A;EEF1G
prerank,rRNA processing (GO:0006364),0.8338591764673676,2.456861769322687,0.0,0.0,0.0,59/172,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ribosome biogenesis (GO:0042254),0.8089929445041967,2.393774898598054,0.0,0.0,0.0,59/187,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ncRNA processing (GO:0034470),0.8014313140829322,2.368230581080504,0.0,0.0,0.0,59/200,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.7931094595926259,2.3536817756959314,0.0,0.0,0.0,94/306,3.75%,RPLP1;RPL41;APOE;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;PTMS;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;EEF1G;EIF4G2;POLR2D;MRPL43;POLR2F;EEF1D
prerank,ribosome assembly (GO:0042255),0.8479142378937035,2.248183645449312,0.0,0.0,0.0,18/47,3.10%,RPSA;RPL11;RPS15;RPS14;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPS28;RPL10;NPM1;RPS27L
prerank,cellular protein metabolic process (GO:0044267),0.7512437098965851,2.247592533643289,0.0,0.0,0.0,127/396,7.48%,RPLP1;RPL41;APOE;CST3;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;SFTPA1;SFTPA2;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;IGFBP6;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;SPARCL1;RPL7A;RPL14;RPL31;SPP1;RPL36A;LGALS1;RPS28;MRPL34;RPL35;RPL4;RPL10;C3;LAMC1;LAMB2;RPS6;LGMN;RPL10A;PNPLA2;CKAP4;RPN1;IGFBP3;MFGE8;MRPL43;IGFBP4;HSP90B1;IGFBP5;CHEK2;RPN2;SHISA5;MRPL35;UBE2G2;UBL5;PDIA6;MRPL55;PSENEN;EEF1A2;CPE;LOX;CDC34;MRPL28;PENK;FN1;OMA1;SFTPB;UBA52;SPCS1;MRPL41;MRPL27;P4HB;MRPS11
prerank,gene expression (GO:0010467),0.7454385708701602,2.243201232644611,0.0,0.0,0.0,91/348,3.45%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;MRPL23;RPL17;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;MRPL43;POLR2F
prerank,response to copper ion (GO:0046688),0.927229599613886,2.2038294731757797,0.0,0.0,0.0,12/20,2.47%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;ATP5F1D;MT3;MT2A;PRNP
prerank,response to cadmium ion (GO:0046686),0.8867184156662743,2.195408478428888,0.0,0.0,0.0,12/26,2.16%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;MT2A;MAPK3;AKT1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.837631237414938,2.1841641553350746,0.0,0.0,0.0,19/39,7.48%,RPS24;RPSA;RPS15;RPS16;RPS14;RPS5;RPS7;RPS19;RPS27;RPS25;RPS17;RPS28;RPS6;NPM1;RPS27L;LSM6;EMG1;SRFBP1;MRPS11
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.6531489542581814,-2.171122238313292,0.0,0.03497520993554435,0.028,16/26,19.27%,SETD5;TET2;SETD2;OGT;TET3;KMT2A;KMT5C;KMT5B;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3;VCPKMT;BEND3
prerank,cellular response to cadmium ion (GO:0071276),0.8870815475483523,2.157082256894719,0.0,0.0,0.0,12/24,2.16%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;MT2A;MAPK3;AKT1
prerank,cellular response to copper ion (GO:0071280),0.9349755039010698,2.1326924790557276,0.0,0.0,0.0,11/16,2.47%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;MT2A;PRNP
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.7860028351696459,2.1299378792450896,0.0,0.0,0.0,19/57,4.99%,RPL26;RPS24;RPL35A;RPL11;RPS15;RPS16;RPL38;RPS7;RPS19;RPL5;RPS25;RPL7;RPS17;RPL14;RPS28;RPS6;NPM1;EMG1;LTO1
prerank,response to zinc ion (GO:0010043),0.8679078636781157,2.1243664281267733,0.0,0.0,0.0,11/25,1.87%,CRIP1;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;MT2A
prerank,ribosomal large subunit assembly (GO:0000027),0.8715833486123894,2.101664167225529,0.0,0.0,0.0,10/24,4.50%,RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPL10;DDX28
prerank,ribosomal large subunit biogenesis (GO:0042273),0.7759271754848437,2.0886263228564443,0.0,0.0,0.0,16/54,3.04%,RPL26;RPL35A;RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL7;RPL23A;RPL7A;RPL14;RPL10;RPL10A;NPM1
prerank,aerobic electron transport chain (GO:0019646),0.751638806989647,2.080289960627569,0.0,0.0,0.0,45/68,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.7492710736351574,2.0759901547796975,0.0,0.0,0.0,45/69,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,cellular zinc ion homeostasis (GO:0006882),0.8419321173446459,2.0459983904431076,0.0,0.0,0.0,11/26,1.87%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;SLC30A1;MT2A
prerank,negative regulation of peptidase activity (GO:0010466),0.7725488546856528,2.0322828263699875,0.0,0.0,0.0,20/47,12.85%,CST3;GAPDH;VTN;PARK7;UBXN1;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;ECM1;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,retina homeostasis (GO:0001895),0.8409800569639249,2.0268249139045436,0.0,0.0,0.0,6/23,1.79%,POTEF;ACTB;ACTG1;B2M;HSPB1;SOD1
prerank,zinc ion homeostasis (GO:0055069),0.8260848648070408,2.0245174669299857,0.0,0.0,0.0,11/28,1.87%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;SLC30A1;MT2A
prerank,androgen receptor signaling pathway (GO:0030521),-0.7839767450045353,-2.021408625497456,0.003472222222222222,0.20026128269545557,0.273,8/11,13.24%,ZMIZ1;ARID1A;KDM3A;PMEPA1;DDX17;RNF14;AR;PLPP1
prerank,cellular response to zinc ion (GO:0071294),0.8978700702791456,2.0070453143364198,0.0,9.111439900075244e-05,0.003,10/15,1.87%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT3;MT2A
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6151242884324796,-2.003821659110119,0.0,0.16885880925870342,0.334,12/24,16.29%,SMAD6;PARVA;ACVR1;BMPR1A;ROBO1;NRP1;ZFPM2;FGFR2;NRP2;SMAD4;BMP4;BMPR2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.8974983129158761,2.0036967986637113,0.0,8.835335660679023e-05,0.003,11/16,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,ATP synthesis coupled proton transport (GO:0015986),0.8866789375821806,2.0024419311566932,0.0,8.575472847129641e-05,0.003,11/17,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,embryonic limb morphogenesis (GO:0030326),-0.5680293238284465,-1.9987135621604046,0.0,0.13510585128327213,0.357,10/34,5.80%,CACNA1C;AFF3;CREBBP;GLI3;FBXW4;NIPBL;SKI;LRP6;RARG;WDPCP
prerank,ribosomal small subunit assembly (GO:0000028),0.892488047920728,1.9962111750442189,0.0,0.000111072791162822,0.004,8/16,3.10%,RPSA;RPS15;RPS14;RPS5;RPS19;RPS27;RPS28;RPS27L
prerank,negative regulation of hippo signaling (GO:0035331),-0.7429438789933063,-1.9834830460737192,0.0,0.12658769531509925,0.409,6/12,17.31%,WWC2;VGLL4;DLG5;MARK3;LIMD1;MAPK14
prerank,cristae formation (GO:0042407),0.8019412178239895,1.980918930963886,0.0,0.00026996858963185906,0.01,12/27,3.31%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A;MICOS13
prerank,inner mitochondrial membrane organization (GO:0007007),0.7484055543740977,1.9739771337711172,0.0,0.00034147378364245953,0.013,18/47,5.54%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;TIMM8B;ATP5MC1;TIMM13;ATP5MG;NDUFA13;ATP5PF;ATP5ME;ATP5F1A;MICOS13;ROMO1;GHITM;TIMM10B
prerank,limb morphogenesis (GO:0035108),-0.6489662280432383,-1.9682053092404483,0.0,0.12692616508866905,0.455,7/20,7.84%,GLI3;FBXW4;NIPBL;SKI;LRP6;PCSK5;IQCE
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.7579655658401181,1.9575962500856008,0.0,0.0004347915180386782,0.016,30/38,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.8627593774150831,1.9552446520123086,0.0,0.0005482439050985445,0.021,9/17,3.20%,COX4I1;COX6C;COX6B1;COX7C;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L
prerank,negative regulation of viral life cycle (GO:1903901),0.8987254920349249,1.9542540490490812,0.0,0.000534537807471081,0.021,6/15,0.98%,IFITM3;PPIA;LY6E;IFITM2;GSN;IFITM1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.6968364495000766,1.9526399709099616,0.0,0.0005215002999717862,0.021,26/91,7.01%,FTH1;FTL;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;ATOX1;MT3;BOLA2;SLC30A1;HMOX1;SOD1;MT2A;TMPRSS6;PRNP;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;SLC39A10;TFRC;SLC39A7
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7439732088145757,-1.9450473218429638,0.003401360544217687,0.1415126005687002,0.542,3/11,6.50%,AFDN;RAPGEF2;RAPGEF6
prerank,ribonucleoprotein complex assembly (GO:0022618),0.6660201188332222,1.940708697827496,0.0,0.0006479246151164616,0.025,33/132,7.48%,RPSA;RPL11;RPS15;RPS14;RPL38;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;HSP90AA1;HSP90AB1;SNRPG;RPS28;RPL10;GEMIN7;POLR2D;RPS27L;DDX39B;SNRPD2;LSM4;SNRPE;PUF60;SNRPF;SRSF9;STRAP;XAB2;MRPS11
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.7769180760167623,1.9379822210035702,0.0,0.0006780606437265296,0.026,5/29,0.50%,RPS8;RPS16;RPS14;RPS21;RPS19
prerank,regulation of complement activation (GO:0030449),0.7542923515600202,1.927692143249763,0.0,0.0008393568877645072,0.033,9/40,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,glycolytic process (GO:0006096),0.7891962212901594,1.9239891602314119,0.0,0.0009502894355041437,0.036,11/28,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;PGK1
prerank,regulation of humoral immune response (GO:0002920),0.7424718488356025,1.9238331682877219,0.0,0.0009296309695149233,0.036,9/44,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,regulation of viral entry into host cell (GO:0046596),0.7793355780237573,1.917090356578441,0.0,0.0010339222581645666,0.042,7/30,1.44%,IFITM3;CD74;LY6E;IFITM2;GSN;IFITM1;LGALS1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8020300975189574,1.9135319101586006,0.0,0.0010731251437866396,0.044,7/22,3.46%,RPL23;RPS15;RPL37;RPS7;RPS20;UBB;EIF5A
prerank,regulation of immune effector process (GO:0002697),0.7474969119255149,1.911622228428069,0.0,0.001150396765614942,0.049,9/41,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7505717276570376,-1.9075440992962738,0.0035211267605633804,0.19010718948836205,0.703,10/11,22.76%,TET2;OGT;TET3;KMT2A;KMT2D;WDR82;PRDM9;SETD1B;BEND3;CTR9
prerank,negative regulation of cell activation (GO:0050866),0.8708838718470777,1.906443462825798,0.0,0.001302328476384088,0.057,6/14,4.06%,APOE;THBD;TREM2;GPER1;PDGFB;NR1D1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.8472481890937802,1.9062798058948314,0.0,0.0012767926239059687,0.057,4/16,1.69%,TPT1;RPS3;CLU;CXCL12
prerank,substantia nigra development (GO:0021762),0.747100151793648,1.905695520280629,0.0,0.001270929052728444,0.058,15/37,5.43%,ACTB;CALM1;S100A1;MBP;PLP1;COX6B1;CKB;DYNLL1;ATP5PF;HSPA5;CNP;CALM3;NDRG2;YWHAH;YWHAE
prerank,negative regulation of endopeptidase activity (GO:0010951),0.724418304827126,1.9031976542496685,0.0,0.0012836242374948768,0.06,17/47,12.85%,GAPDH;VTN;MT3;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;SORL1;SPOCK1;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.698262398441024,-1.9003286095859246,0.0,0.18553157958640015,0.732,8/13,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,translational elongation (GO:0006414),0.6694989429896439,1.9000329893791876,0.0,0.0013858387601102097,0.064,54/101,21.67%,EEF1A1;MRPL23;MRPL13;MRPS12;EEF2;RACK1;EEF1B2;MRPL34;AURKAIP1;MRPS34;EEF1G;MRPL43;EEF1D;MRPL35;MRPL55;MRPL4;EEF1A2;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.6145143948768004,-1.8808053345797024,0.0,0.204322919978293,0.802,11/18,18.12%,ASH1L;SETD2;EHMT1;KMT2A;KMT2D;SETD7;EHMT2;SETD4;PRDM9;SETD1B;SETD3
prerank,catecholamine metabolic process (GO:0006584),-0.6927781086137762,-1.8807986087210056,0.00411522633744856,0.18574810907117545,0.802,3/14,6.77%,SNCAIP;PRKN;ATP7A
prerank,pyruvate metabolic process (GO:0006090),0.7035122485842735,1.8803236125541902,0.0,0.0022971872717765457,0.114,14/52,6.70%,BSG;ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;GLO1;PKM;ENO1;LDHA;PGK1;SDS
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8279215018912,1.8707829219604668,0.0,0.003175987622311941,0.149,7/17,7.41%,PPIA;HSPB1;SOD1;AKT1;TREM2;BAG5;P4HB
prerank,negative regulation of viral entry into host cell (GO:0046597),0.9129069606135072,1.8702177983877732,0.0,0.003154369836751195,0.15,5/12,0.98%,IFITM3;LY6E;IFITM2;GSN;IFITM1
prerank,cellular response to interleukin-12 (GO:0071349),0.6914290976504776,1.8631015438505825,0.0,0.0037199809798927883,0.179,15/48,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;SIRPA;AIP;MSN;GSTO1;P4HB;LCP1
prerank,mitochondrial translational elongation (GO:0070125),0.6616213620000096,1.8613306773142022,0.0,0.0039040203504051205,0.189,49/88,22.71%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,aggrephagy (GO:0035973),0.7550697761958016,1.8595982548805856,0.0,0.004065726959855797,0.2,7/27,1.79%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6872798186937366,1.857428676785701,0.0,0.004110603705738863,0.205,14/56,6.79%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;HSP90B1;S100A8;S100A9;UBA52
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7425538025540056,1.8574184178980457,0.0,0.004044303645968882,0.205,9/32,8.39%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1;ROMO1;ANG;S100A9;CXCL10
prerank,negative regulation of lipid catabolic process (GO:0050995),0.8034521388261414,1.8555680583640166,0.0,0.004134376115505041,0.214,7/17,8.69%,AKT1;APOC1;TNF;SORL1;BSCL2;PDE3B;MFSD2A
prerank,regulation of membrane depolarization (GO:0003254),-0.6153103297190993,-1.8546003887756732,0.0,0.22132162416201992,0.872,5/18,8.88%,LRRK2;CAMK2D;FHL1;PTPN3;SMAD7
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8769320618025129,1.8512287455351237,0.0,0.004570905683204413,0.238,6/12,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,regulation of glucose import (GO:0046324),-0.5416560202608757,-1.8451439392260358,0.0,0.22321647631320116,0.889,15/30,16.96%,PRKAG2;SORBS1;PID1;OSBPL8;APPL2;IRS1;GRB10;INSR;IGF1;ENPP1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6830121779788004,1.8447410079886308,0.0,0.0051244946831938325,0.268,38/56,22.69%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.6830121779788004,1.8447410079886308,0.0,0.0051244946831938325,0.268,38/56,22.69%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,reverse cholesterol transport (GO:0043691),0.8566416222087866,1.8433833081407964,0.0,0.00522207898750581,0.276,4/13,6.66%,APOE;CLU;ABCG1;LIPG
prerank,mitochondrial translational termination (GO:0070126),0.6532870687643662,1.843041013070012,0.0,0.0051595761630229995,0.276,47/88,22.71%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.7617529429430232,1.8412798822940781,0.0,0.005451017957610231,0.291,7/24,5.15%,APOE;UBB;GPX1;PSME1;PSME2;PINK1;ATP5IF1
prerank,response to interferon-beta (GO:0035456),0.7893489346702539,1.8379442949441653,0.0,0.005748016942676039,0.308,7/22,6.19%,IFITM3;IFITM2;IFITM1;NDUFA13;SHFL;UBE2G2;CDC34
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6855273841248813,1.8368327229974601,0.0,0.0057902558914280965,0.314,14/46,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;AIP;MSN;GSTO1;P4HB;LCP1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8412725260570573,1.8356609910008266,0.0,0.005925810542419307,0.322,5/15,6.66%,APOE;PLTP;APOC1;ABCG1;LIPG
prerank,negative regulation of lipid metabolic process (GO:0045833),0.7611512993336046,1.8347823543603197,0.0,0.00593782969195771,0.325,6/22,5.48%,APOD;APOC1;GPER1;TNF;BSCL2;PDE3B
prerank,neutrophil activation involved in immune response (GO:0002283),0.6096164583672661,1.834400385850078,0.0,0.005896989571364013,0.326,160/428,18.28%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SYK;SLC2A3;CTSC;LAMP2
prerank,neutrophil degranulation (GO:0043312),0.6093698087520035,1.8338183774868133,0.0,0.005857238520652813,0.328,159/425,18.28%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,negative regulation of hemostasis (GO:1900047),0.8822280318658392,1.8322409089982477,0.0,0.005959201394294824,0.336,5/12,2.99%,APOE;VTN;THBD;SERPINE2;CD34
prerank,amyloid fibril formation (GO:1990000),0.6864832664161177,1.8301844465893207,0.0011086474501108647,0.006222600686735368,0.349,16/51,8.71%,CST3;RPS27A;UBC;B2M;UBB;GSN;H3-3A;ITM2B;MFGE8;FKBP1A;SORL1;PSENEN;TTR;UBA52;CALB1;MAPT
prerank,eye morphogenesis (GO:0048592),-0.6255321823847944,-1.8285563651062269,0.0,0.24748587491257307,0.921,14/19,19.10%,COL5A2;FBN1;COL5A1;NIPBL;SHROOM2;SKI;RARG;EFEMP1;STAT3;IFT122;MFAP5;NF1;NKD1;AGTPBP1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7682137775777039,1.8277408101265364,0.0,0.006429405796155658,0.362,4/21,0.52%,RPL23;RPL11;RPS7;RPL5
prerank,eye development (GO:0001654),-0.480365943215313,-1.826595700872173,0.0,0.23549974689933198,0.926,14/54,7.79%,PBX1;CACNA1C;COL5A2;FBN1;COL5A1;SMOC1;PBX3;NIPBL;SHROOM2;SKI;LAMA1;EFEMP1;SIPA1L3;CEP290
prerank,neutrophil mediated immunity (GO:0002446),0.6064026937478628,1.826229312093461,0.0,0.006643277699295366,0.375,160/432,18.28%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;ADAM17;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,regulation of amyloid fibril formation (GO:1905906),0.8300745410180228,1.8258746920238902,0.0,0.006633128247254776,0.379,6/15,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,modulation by symbiont of host process (GO:0044003),0.9009762952497502,1.8236308290204608,0.0,0.0068991972905919526,0.4,8/10,6.79%,RPS27A;UBC;B2M;UBB;MRC1;ENO1;PGK1;UBA52
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.7300328124800735,1.822993319928481,0.0,0.006909878974626167,0.405,7/30,4.88%,TPT1;RPS3;CD74;CLU;CXCL12;DDX39B;MIF
prerank,protein localization to vacuole (GO:0072665),0.8335959956077704,1.821229342535227,0.0,0.007131073926613105,0.415,8/13,10.01%,CD81;LAMTOR4;LAMTOR5;GLMP;RTN4;ATP13A2;RNF128;MFSD1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5934673519166822,-1.8208182755188518,0.004975124378109453,0.23417877458859435,0.935,10/21,15.76%,SAMD4A;CNOT4;PAN3;CNOT1;PARN;TUT7;CNOT10;CNOT7;TNKS1BP1;TUT4
prerank,platelet aggregation (GO:0070527),0.7237933516371211,1.8195898359924376,0.0,0.007335432249711369,0.429,13/33,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,regulation of hippo signaling (GO:0035330),-0.6186882239263208,-1.8183428231931609,0.009259259259259259,0.22544741584638364,0.938,8/17,17.31%,WWC2;VGLL4;DLG5;MOB3B;MARK3;NF2;LIMD1;MAPK14
prerank,regulation of endopeptidase activity (GO:0052548),0.6687624572730546,1.8181098959539503,0.0,0.007592151960658774,0.444,22/59,12.85%,GAPDH;VTN;PSME1;TIMP2;SERPINH1;AKT1;SPOCK2;PSME2;SERPINF1;PSMB8;SERPINE2;AGT;PSENEN;SPOCK1;VSIR;SPOCK3;TIMP1;ATP13A2;SERPING1;PSMB9;TIMP3;SERPINA9
prerank,postsynaptic membrane organization (GO:0001941),0.7956834261375436,1.8177416704043472,0.0,0.00754907516682203,0.445,8/17,6.40%,APOE;NRXN1;NLGN1;SHISA7;LRP4;LHFPL4;MUSK;GPHN
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7951398779282409,1.8134745505105168,0.0,0.008143742145170699,0.467,8/18,10.02%,LAPTM5;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5809009803839104,-1.8072414583687524,0.005128205128205128,0.2327919887107737,0.952,8/21,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,cellular glucan metabolic process (GO:0006073),-0.6999752197050755,-1.8061534188616808,0.0,0.22261810194967024,0.954,5/11,13.55%,PRKAG2;PHKB;PHKA1;GBE1;GSK3B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6489630126301157,1.8057880552000698,0.0,0.009685736718019379,0.519,29/67,16.22%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,translational termination (GO:0006415),0.6367028966245453,1.8037653180966857,0.0,0.010024631404667052,0.533,49/95,22.90%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;TRMT112;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38;ETF1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.6456423258005094,1.7997477562055055,0.0,0.010820341072444908,0.565,30/70,16.22%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;FCER1G;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,glucose catabolic process to pyruvate (GO:0061718),0.7543822775814731,1.794477749934374,0.0,0.011673207060386251,0.607,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,canonical glycolysis (GO:0061621),0.7543822775814731,1.794477749934374,0.0,0.011673207060386251,0.607,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,alcohol catabolic process (GO:0046164),0.8809138856634471,1.7941124931274561,0.0,0.011579039895952251,0.608,3/10,2.26%,APOE;MT3;SNX17
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.6987309706637952,1.7925995805983395,0.0,0.01180739218823935,0.616,12/35,9.28%,CLU;B2M;VTN;C3;CCL19;APOC1;HNRNPK;RAC1;FLOT1;SNAP91;LRPAP1;ARF6
prerank,platelet degranulation (GO:0002576),0.6247234355336443,1.7904066636463472,0.0,0.012307157557659527,0.635,38/118,15.48%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;ANXA5;PDGFB;TUBA4A;LGALS3BP;ECM1;FLNA;RARRES2;MANF;ENDOD1;FN1;LEFTY2;APLP2;CLEC3B;TIMP1;SERPING1;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;IGF2;PDGFA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.748864492438142,1.789834207164231,0.0,0.012330815331435159,0.639,9/25,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.88578844454916,1.7846761029408755,0.001402524544179523,0.01356633910620138,0.671,6/10,9.30%,CLU;HSP90AA1;HSP90AB1;C5AR1;SORL1;EGR1
prerank,regulation of peptidase activity (GO:0052547),0.7601953959585973,1.7819993958136318,0.0025220680958385876,0.01426095300822661,0.692,8/19,9.60%,CST3;NDUFA13;RCN3;PSMB8;PINK1;ECM1;CSTB;ATP13A2
prerank,neuron cell-cell adhesion (GO:0007158),0.7985134592605828,1.7792614918664074,0.0,0.014813912791071828,0.713,8/14,12.53%,NRXN1;NLGN1;CNTN4;NINJ2;NRXN3;CDK5R1;NCAM2;NRXN2
prerank,microglial cell activation (GO:0001774),0.757362896270374,1.7788921079745135,0.002512562814070352,0.014801837832335565,0.715,12/21,14.99%,CLU;C1QA;TYROBP;GRN;ITGB2;TREM2;TNF;C5AR1;MAPT;AIF1;CX3CR1;IFNGR1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.806715162434801,1.778772136797747,0.0013175230566534915,0.01467453026810798,0.715,6/15,5.97%,RPL23;RPL11;RPS7;RPL5;PARK7;BAG5
prerank,pre-replicative complex assembly (GO:0036388),0.6412489808674229,1.7775867933747191,0.0,0.014873681238188186,0.722,24/64,16.22%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,extracellular matrix disassembly (GO:0022617),0.6671497485112935,1.777479068531431,0.0,0.014767019747435862,0.722,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.7351422188984273,1.777154458574534,0.0012345679012345679,0.014690444638890543,0.723,7/25,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;GABARAPL2;HIPK2
prerank,carbohydrate catabolic process (GO:0016052),0.6990246503953665,1.7760097622658384,0.0,0.014893010081748384,0.727,12/38,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;MAN2B2;PGK1
prerank,positive regulation of peptidase activity (GO:0010952),0.7519844391451561,1.7759035716743616,0.0,0.014770847475744616,0.727,13/20,19.20%,GRN;NDUFA13;PSME1;RCN3;PSME2;PINK1;PSENEN;VCP;VSIR;CTSH;APH1B;PRELID1;DDRGK1
prerank,cellular component disassembly (GO:0022411),0.669156155560723,1.7749477256199733,0.0,0.014887127722091784,0.732,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,immunoglobulin mediated immune response (GO:0016064),0.8557625034627775,1.7725630819072766,0.001394700139470014,0.015568188668770539,0.748,3/10,4.09%,CD74;CD81;FCER1G
prerank,mitochondrial translation (GO:0032543),0.6228723295431118,1.7716834360244176,0.0,0.015683936669585175,0.752,51/104,22.71%,MRPL23;MRPL13;MRPS12;LARS2;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL2;MRPL37;MRPL44;NDUFA7;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.7213623298609364,1.7702348633011413,0.0,0.016053804895453782,0.763,9/26,5.97%,PPIA;HSPB1;PARK7;ATF4;AKT1;TXN;PINK1;GPR37L1;BAG5
prerank,negative regulation of coagulation (GO:0050819),0.8149294474262521,1.7675545120172855,0.00267379679144385,0.0167847498267332,0.778,7/14,10.55%,APOE;VTN;THBD;SERPINE2;CD34;HS3ST5;PROCR
prerank,regulation of phagocytosis (GO:0050764),0.6596963556107318,1.7674857288068182,0.0,0.016643563550804107,0.779,20/53,13.55%,RACK1;CALR;CYBA;TREM2;DOCK2;TGM2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;SYT11;GATA2;HCK;IL2RG;SLC11A1;GAS6
prerank,negative regulation of platelet activation (GO:0010544),0.7974305922076349,1.7664930759250659,0.0,0.016891910762239788,0.782,4/16,3.89%,APOE;THBD;SERPINE2;PDGFB
prerank,positive regulation of lipid transport (GO:0032370),0.8356162035942937,1.7653894203169809,0.0013812154696132596,0.017246730215534238,0.792,3/12,1.34%,APOE;DBI;SPP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6566810557683438,1.7589598263104231,0.0,0.019209556306431095,0.827,14/54,9.82%,TMSB4X;APOE;ATP5F1B;HSPB1;AKT1;ATP5F1A;CSNK2B;TNF;PDGFB;ACVRL1;VASH1;KDR;GATA2;HMGB1
prerank,gluconeogenesis (GO:0006094),0.6789972536850228,1.75759733820194,0.0,0.019454495124574447,0.829,12/39,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,maturation of SSU-rRNA (GO:0030490),0.6972346844792452,1.753588354404283,0.0,0.020982789458771564,0.859,9/34,10.07%,RPS8;RPS16;RPS14;RPS19;RPS28;LSM6;SRFBP1;MRPS11;WDR3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6806950670236381,-1.7534631292362237,0.020066889632107024,0.33322349207945245,0.992,5/11,6.98%,PARP4;PARP9;PARP12;PARP16;PARP3
prerank,toll-like receptor signaling pathway (GO:0002224),0.6214639884480944,1.7534208174124595,0.0,0.020912041497212243,0.859,26/84,15.58%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;ITGB2;HSP90B1;S100A8;S100A9;TIRAP;UBA52;HSPD1;TICAM2;HMGB1;RIPK2;TLR6;TRAF3;TRIL;UNC93B1;TLR5;TLR1
prerank,regulation of tube diameter (GO:0035296),-0.6632874337188979,-1.7523342058988036,0.0,0.30626386178162884,0.992,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.6632874337188979,-1.7523342058988036,0.0,0.30626386178162884,0.992,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6220783656896507,-1.751248707442262,0.016194331983805668,0.2953516676324159,0.992,10/16,24.58%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;KDM4D;SMCHD1;SHLD2;SHLD3;PRKDC
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7252055478741415,1.7501684323107625,0.0012484394506866417,0.022108385711599936,0.88,5/24,4.88%,TPT1;CD74;CLU;CXCL12;MIF
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6860959464356065,1.74600576857621,0.0,0.02364924845175085,0.897,17/37,17.17%,RPS3;RPS7;RACK1;UBB;SOD1;EIF5A;S100A8;S100A9;NUPR1;BAX;MSX1;PMAIP1;BBC3;BAD;CAV1;BCAP31;DNM1L
prerank,positive regulation of cellular component movement (GO:0051272),0.7267079760608994,1.7449742095292093,0.0,0.02391163114712859,0.9,12/24,17.49%,RPS19;CAVIN1;CCL19;SPOCK2;TUBB2B;NTN1;PHPT1;CSF1R;STK11;TRIM32;TWIST1;ADAM17
prerank,response to metal ion (GO:0010038),0.6236885258993364,1.7447933117270016,0.0,0.02383512846428426,0.9,14/67,8.71%,CRIP1;MT1A;MT1X;CALM1;ATP5F1D;PPP1CA;MT3;MT2A;CALM3;SLC25A13;GPHN;NDRG1;HVCN1;MAPT
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8330301589193119,1.7438123994759183,0.0013623978201634877,0.02413124115323993,0.905,2/12,0.25%,ACTB;ACTG1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7464189472676069,1.7437857602427647,0.0038412291933418692,0.023952309965273068,0.905,6/18,5.97%,PPIA;HSPB1;PARK7;AKT1;PINK1;BAG5
prerank,negative regulation of blood coagulation (GO:0030195),0.6756022818861428,1.7434962915192698,0.002331002331002331,0.023908418297797437,0.906,7/38,3.89%,APOE;VTN;THBD;A2M;SERPINE2;CD34;PDGFB
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.6054961420900711,1.7413256362886764,0.0,0.024860250410956616,0.917,23/107,9.60%,TPT1;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;CALR;MT3;SLC30A1;CXCL12;MT2A;CCL19;SLC24A4;SLC24A2;SLC39A10;DRD5;SLC39A7;TMCO1;HTR2C;ATP13A2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.6738946317691985,1.73939021605493,0.001152073732718894,0.02562108202452654,0.922,10/37,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;HIPK2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.854367502894801,1.7347997734264848,0.0,0.02771396302939553,0.94,7/10,8.07%,ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5F1A;ATP5MC2
prerank,mitochondrial transport (GO:0006839),0.6373312620958669,1.7347523356232817,0.0,0.027521728128144584,0.94,20/53,16.84%,TSPO;HSP90AA1;TIMM8B;TIMM13;TOMM5;SLC25A5;TOMM7;SLC25A4;SLC25A13;AIP;TIMM10B;TMEM14A;GDAP1;PMAIP1;TMEM14C;SPG7;ABCB10;BAD;MFF;BCAP31
prerank,DNA alkylation (GO:0006305),-0.5792497051076578,-1.7343544370436832,0.013452914798206279,0.31197887262505564,0.996,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),-0.5792497051076578,-1.7343544370436832,0.013452914798206279,0.31197887262505564,0.996,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7057982707431949,-1.7329424648805782,0.006430868167202572,0.3033209893913834,0.996,5/10,15.41%,RAPGEF2;RAPGEF1;NGF;KIDINS220;BDNF
prerank,regulation of protein-containing complex assembly (GO:0043254),0.6052259366261818,1.731567925431189,0.0,0.028962230295705833,0.95,28/110,11.61%,APOE;RPS3;HSPA8;GFAP;CLU;RACK1;GSN;HSP90AA1;PARK7;HSPA5;NRG1;CRYAB;PINK1;TNF;RHOC;LGALS3;SORL1;TIRAP;VCP;TFRC;SAR1A;MTLN;HCK;PIH1D1;MMP3;BAX;SVIP;WARS1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.7667922961914407,1.7313520265500137,0.0012836970474967907,0.02884501034625347,0.954,7/17,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,neutrophil chemotaxis (GO:0030593),0.6507527420688373,1.7279507197939765,0.0,0.030452456910473696,0.961,18/53,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,protein localization to lysosome (GO:0061462),0.6956486920725216,1.7275438028930672,0.0012062726176115801,0.030413484001293758,0.961,14/28,19.10%,CD81;LAPTM5;LAMTOR4;LAMTOR5;GLMP;RTN4;SORL1;ATP13A2;RNF128;MFSD1;M6PR;NCOA4;VPS4A;SNX16
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6825092690037988,-1.725861656672711,0.023255813953488372,0.3077567755977111,0.997,5/11,7.78%,MLLT3;DAB2;PLEKHA4;WNT5B;RSPO3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6641885454026333,1.7223827405381327,0.0023148148148148147,0.03305140825842219,0.971,7/40,3.00%,CLU;CD63;B2M;VTN;C3;CCL19;HNRNPK
prerank,cellular response to metal ion (GO:0071248),0.5888550177425595,1.720890122236315,0.0,0.03377127077234802,0.972,41/123,16.41%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;B2M;MT3;MT2A;MAPK3;LGMN;AKT1;NLGN1;PRNP;ANK3;DLG2;SYT1;AQP1;HVCN1;SYT12;SYT11;JUN;ATP13A2;SYT6;SYT4;SMPD1;WNT5A;GLRA2;TRPM2;GLRA1;ALOX5AP;CPNE5;SYT10;CPNE6;NCF1;KCNA1;DMTN;ADCY8;SYT2
prerank,homotypic cell-cell adhesion (GO:0034109),0.6658067637502465,1.7199537716302764,0.0011312217194570137,0.03403748097573206,0.972,13/39,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,positive regulation of phospholipid transport (GO:2001140),0.8259147217639616,1.7194392194652721,0.005532503457814661,0.03407279481464633,0.972,3/10,3.73%,APOE;DBI;TMEM30A
prerank,neutrophil migration (GO:1990266),0.6376908969981717,1.719282561668684,0.0,0.033889274434134926,0.972,19/58,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;PECAM1;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6017886507944884,1.7175872679332609,0.0,0.03466629757281385,0.974,32/86,16.58%,RPS27A;UBC;UBB;PSMB4;ELOB;HMOX1;PSME1;ATF4;KLF2;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;HSPA1A;PSMB10;EGLN2;DNAJB1;PSMB1;PSMB5;VHL
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.6451991311970734,1.716337540080994,0.0011185682326621924,0.03525172709530063,0.975,18/46,16.84%,TSPO;TIMM8B;TIMM13;AKT1;TOMM5;TOMM7;PINK1;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;GDAP1;TIMM50;TOMM20L;MFF;BCAP31
prerank,hydrogen peroxide metabolic process (GO:0042743),0.7445426219326856,1.7158642353764646,0.0013192612137203166,0.035270534633520575,0.975,9/19,9.70%,GPX1;PARK7;SOD1;CYBA;PRDX5;PRDX4;PRDX2;GPX3;PRDX1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7971281066246583,1.713837533370512,0.001394700139470014,0.036281497021820736,0.979,5/13,12.50%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.5454522789300751,-1.7106579103145196,0.015384615384615385,0.33379566717286796,0.997,10/20,19.22%,TNRC6B;TNRC6A;TNRC6C;CNOT1;MOV10;CNOT7;LIMD1;AGO2;CELF1;AGO4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.7049849441557988,1.7097615775676223,0.0012135922330097086,0.038488081420327155,0.984,5/26,3.71%,APOE;S100A1;PARK7;AKT1;TNF
prerank,regulated exocytosis (GO:0045055),0.5837684073562358,1.7071739346739376,0.0,0.03956389681054894,0.986,65/173,20.17%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;SNAP25;ANXA5;PDGFB;TUBA4A;LGALS3BP;DNAJC5;ECM1;SYNGR2;FLNA;RARRES2;MANF;ENDOD1;SYT1;FN1;RIMS2;LEFTY2;SYNGR1;RIMS1;APLP2;SDF4;SYT12;SYT11;CLEC3B;TIMP1;VAMP2;SERPING1;SYT6;SYT4;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;RAB26;IGF2;SYT10;PDGFA;CDK5;SYT2;SCCPDH;SCG3;SCIN;LAMP2;SNCA;RAB31;HGF;TGFB1;CYB5R1;QSOX1
prerank,negative regulation of protein binding (GO:0032091),0.6176325961540171,1.7069574372768972,0.0,0.039438501055295797,0.986,21/71,12.09%,ACTB;RACK1;B2M;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;ADAM15;PDGFB;PIN1;SORL1;TLE5;LRPAP1;IFIT1;MAP2;CAMK1;BAX;DNAJB2;DDX11
prerank,cholesterol efflux (GO:0033344),0.7343811617033872,1.7066060205753206,0.0038461538461538464,0.03938804740730244,0.986,4/20,5.55%,APOE;NPC2;APOC1;ABCG1
prerank,positive regulation of locomotion (GO:0040017),0.6965642218203021,1.7060305553546482,0.0,0.03947712119245298,0.986,17/27,21.84%,CAVIN1;CCL19;SPOCK2;TREM2;PDGFB;RARRES2;NTN1;P2RY12;PHPT1;CSF1R;AIF1;F2RL1;TRIM32;TWIST1;STX4;TGFB1;PPM1F
prerank,regulation of plasminogen activation (GO:0010755),0.7893410320675232,1.7043666895037497,0.00684931506849315,0.04024137204155753,0.986,4/12,8.76%,CTSZ;SERPINE2;ENO1;CLEC3B
prerank,hexose biosynthetic process (GO:0019319),0.6479697460119276,1.704213802655274,0.001128668171557562,0.040095227608599564,0.986,12/42,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.6051581795147177,1.7041596956881913,0.0010416666666666667,0.03984736382966239,0.986,38/87,18.07%,UQCC2;NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;COX17;NDUFA3;COA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;OMA1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.6295301269590314,1.7004942189132908,0.0011013215859030838,0.042344662677329815,0.99,15/53,10.18%,APOE;UBB;GPX1;HSP90AB1;PSME1;PSME2;TREM2;PINK1;GABARAPL2;PSMC3;FOXF2;NUPR1;XPO1;ALAD;ECSCR
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6622494381642754,1.698542686989925,0.0,0.04338963590309515,0.992,8/33,9.86%,RPS3;CD81;LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6724058909232706,-1.6968502981688387,0.029605263157894735,0.35885576912732053,0.999,3/10,5.44%,HDAC4;PIAS1;SAE1
prerank,positive regulation of endocytosis (GO:0045807),0.6459773645403163,1.695396762003147,0.0011148272017837235,0.04532296204760739,0.993,11/45,5.06%,APOE;CLU;B2M;VTN;CD151;C3;CCL19;NLGN1;TREM2;HNRNPK;FLOT1
prerank,protein targeting to mitochondrion (GO:0006626),0.6298171319144801,1.6940296996192066,0.0011389521640091116,0.04603840974618104,0.994,19/52,15.14%,TSPO;HSP90AA1;TIMM8B;TIMM13;NDUFA13;TOMM5;TOMM7;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;PMPCB;GDAP1;TIMM50;TOMM20L;TIMM29;MFF
prerank,granulocyte chemotaxis (GO:0071621),0.6344138705191376,1.6918045006860956,0.0011074197120708748,0.047359109206206146,0.994,18/55,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,histone H3-K9 demethylation (GO:0033169),-0.6695699190541172,-1.6884745554119955,0.010638297872340425,0.3694209539751098,1.0,7/11,14.05%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,positive regulation of glycolytic process (GO:0045821),-0.5590959786579248,-1.6873817990873545,0.008928571428571428,0.34876489584919834,1.0,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5590959786579248,-1.6873817990873545,0.008928571428571428,0.34876489584919834,1.0,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.7048150463444011,1.6864030862609418,0.0049504950495049506,0.051379175969860184,0.997,9/23,10.13%,RPS27A;UBC;UBB;COPS7A;COPS6;PARP1;UBA52;RBX1;DDB1
prerank,negative regulation of secretion by cell (GO:1903531),0.6622556243835456,1.6862356838776598,0.0,0.05118810804838874,0.997,18/38,21.22%,APOE;SLC30A1;TRH;IL1RAPL1;GRM7;SYT11;VAMP3;DPH3;SYT4;CHGA;IL11;VAMP8;LILRB1;TNFRSF1A;SNCA;NOTCH1;ERP29;RSAD2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4444254055680288,-1.6859605454853746,0.0,0.3417177158414133,1.0,13/50,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;ADAP2;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;TNFAIP8L3;NGF
prerank,response to interferon-alpha (GO:0035455),0.7607882604973989,1.6848040602974348,0.0026455026455026454,0.05214357875641372,0.997,7/16,14.08%,IFITM3;IFITM2;IFITM1;BST2;GAS6;PDE12;RO60
prerank,lipoprotein catabolic process (GO:0042159),0.8101581431807516,1.6843984478669474,0.007194244604316547,0.05212736903503004,0.997,3/11,3.56%,APOE;CTSD;LYPLA2
prerank,skeletal system morphogenesis (GO:0048705),-0.46803237185615904,-1.682080221759309,0.0,0.3409253385937217,1.0,11/42,8.39%,WWOX;HOXB3;ANKRD11;HOXA3;LRP5;SKI;LRP6;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.6658752833739465,1.6809840612645943,0.001160092807424594,0.05445603913611636,0.998,14/33,13.09%,CLU;GPX1;AKT1;VAT1;SLC25A5;PINK1;FZD9;GHITM;TMEM14A;TFRC;OMA1;MAPT;ACAA2;HSPA1A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5735335482623534,-1.6808307611756546,0.016129032258064516,0.3340213136885812,1.0,6/17,11.61%,PBX1;CREBBP;MAML2;KAT2B;MAML1;RBPJ
prerank,glucose metabolic process (GO:0006006),0.6182020397266393,1.6765573716649929,0.0,0.05781821705203854,0.999,23/58,20.39%,ALDOA;APOD;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;OMA1;SLC25A11;GAA;DCXR;SLC25A1;ENO3;PPARGC1A;G6PC3;AKR1A1;TFAP2B;GOT1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.749736009738453,1.6752307711682835,0.007802340702210663,0.058625179064056135,0.999,5/16,6.51%,APOE;CLU;TREM2;TNF;LRPAP1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7991900536021612,1.6739888988992084,0.006963788300835654,0.059320877261905,0.999,3/11,1.42%,ITM2A;ITM2C;ITM2B
prerank,response to unfolded protein (GO:0006986),0.6335995000768249,1.6733529291544136,0.0011337868480725624,0.059563630852459346,0.999,24/48,21.15%,HSPA8;HSP90AA1;HSPB1;HSP90AB1;HSPA5;SERPINH1;TMBIM6;HSPE1;HSPA1B;HSPD1;HSPB8;HSPB2;DNAJA1;BAX;DNAJB2;HSPA1A;DNAJB1;DAB2IP;HERPUD1;HSPA4L;HSPA2;HSPA9;BAK1;DDIT3
prerank,regulation of B cell proliferation (GO:0030888),0.6346491666718196,1.6725469052484627,0.001148105625717566,0.059856453989213486,1.0,15/44,20.07%,CD74;CD81;TYROBP;PTPRC;MIF;TIRAP;TFRC;IL2;CD22;CTLA4;VAV3;IKZF3;CD300A;GPR183;MEF2C
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7314619651924638,1.6724187211900405,0.003978779840848806,0.05957783930805826,1.0,7/18,9.92%,APOE;CD81;HSP90AA1;ATP5IF1;MSN;PTTG1IP;RNF128
prerank,regulation of oxidative phosphorylation (GO:0002082),0.7374441977031575,1.6711065429086271,0.008985879332477536,0.060518874903557646,1.0,9/16,13.84%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;NUPR1;MLXIPL;AK4;PDE12
prerank,regulation of neuron death (GO:1901214),0.5909717914165932,1.671071608204317,0.002109704641350211,0.06018178367014777,1.0,34/82,20.07%,CLU;UBB;C1QA;CTSZ;TYROBP;GPNMB;PARK7;DCC;AKT1;PRNP;ITGB2;CD34;GRID2;NENF;SORL1;MAPT;FAIM2;DHCR24;TRIM2;EGR1;ATP13A2;CHGA;WNT5A;EGLN2;EPHB1;CDK5;PPARGC1A;GRM4;GRIN2B;AKT1S1;NSMF;SNCA;DDIT4;MEF2C
prerank,regulation of leukocyte migration (GO:0002685),0.7543087229109982,1.6708720849489547,0.005361930294906166,0.06005571084906398,1.0,4/16,6.43%,CD81;HMOX1;RAC1;RHOG
prerank,glutamate receptor signaling pathway (GO:0007215),0.6377790744675715,1.6702636211666848,0.0023612750885478157,0.06021697033254433,1.0,13/37,10.00%,GRM5;GRIA2;GRID2;HOMER2;GRIK2;GRIN1;GRIN3A;GRM8;GRM7;GRIA4;GRIN2A;CDK5R1;GRM1
prerank,positive regulation of transport (GO:0051050),0.6004591698233479,1.6699235486303647,0.0,0.060211520811787676,1.0,26/85,13.79%,APOE;ACTB;CHCHD10;CALR;CD151;CCL19;CYBA;TREM2;DOCK2;TNF;FCER1G;LMAN2;CAMK1D;FLOT1;SIRPA;IL2RB;MLC1;SPACA3;SGK1;GATA2;SMPD1;BAX;IL2RG;SLC11A1;GAS6;CLIP3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7638192545650965,1.6695892068124207,0.005532503457814661,0.06011007606635685,1.0,4/15,8.38%,TMSB4X;HSPB1;LGMN;KDR
prerank,response to interferon-gamma (GO:0034341),0.607127451908781,1.6683044403034988,0.0021436227224008574,0.060964837484773195,1.0,22/67,19.11%,IFITM3;CD74;IFITM2;GAPDH;IFITM1;RPL13A;CCL19;AQP4;SHFL;SIRPA;CXCL16;IRF8;WNT5A;AIF1;SLC11A1;BST2;PDE12;CCL2;CCL3;CCL8;EPRS1;SNCA
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6168777002728102,1.667051741370898,0.004415011037527594,0.061658964019574304,1.0,24/53,20.35%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;BCKDK;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.8189984432776685,1.6669417684583578,0.005479452054794521,0.06137882439657544,1.0,6/10,8.96%,RPS27A;UBC;UBB;UBA52;ISG15;NEDD8
prerank,negative regulation of lymphocyte migration (GO:2000402),0.820284888665674,1.6664432299901715,0.0,0.06143319326565883,1.0,2/10,2.16%,APOD;AKT1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6360859434858371,-1.6661157143885303,0.0199203187250996,0.361003085347254,1.0,3/12,3.12%,FBXW4;SKI;LRP6
prerank,positive regulation of B cell proliferation (GO:0030890),0.6715359499895962,1.6648955765073878,0.002457002457002457,0.062486289152757064,1.0,7/29,8.64%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2
prerank,response to reactive oxygen species (GO:0000302),0.6076215011377608,1.6642417901263467,0.002190580503833516,0.06269216655140909,1.0,19/54,15.91%,APOE;RPS3;APOD;GPX1;HMOX1;SOD1;MAPK3;AKT1;PTPRN;PRDX5;ROMO1;HYAL2;MAPT;JUN;PJVK;CAT;HP;GLRX2;NCF1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.7270501846008116,1.6626436310526218,0.002583979328165375,0.06402508710715069,1.0,7/19,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,intermediate filament organization (GO:0045109),0.7429620292511359,1.661712244692175,0.005115089514066497,0.06459268475531858,1.0,6/17,13.89%,GFAP;VIM;NEFL;KRT9;EPPK1;DES
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7999928113544527,1.66080624446117,0.00725689404934688,0.06499292437599159,1.0,5/11,12.50%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.7433348353101515,1.6586793345330544,0.007731958762886598,0.06655289405106975,1.0,4/16,3.71%,APOE;S100A1;AKT1;TNF
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6150085511304203,1.657495548762285,0.0022099447513812156,0.0674319576896206,1.0,28/50,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;PSMD10
prerank,maintenance of blood-brain barrier (GO:0035633),0.6635167268197257,1.6547493675775622,0.0024067388688327317,0.06964837479558965,1.0,12/30,14.81%,ACTB;ACTG1;CLDN5;MBP;LAMC1;ESAM;MFSD2A;PECAM1;SLC1A1;LSR;GJA1;JAM3
prerank,DNA methylation (GO:0006306),-0.5217592568561773,-1.6521457937638921,0.014563106796116505,0.3846663237462005,1.0,8/23,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6390885507749946,1.6520767635796698,0.005668934240362812,0.07211926310528743,1.0,8/40,5.68%,RPL39;MBL2;MPEG1;PGLYRP1;ROMO1;ANG;TIRAP;RARRES2
prerank,histone lysine demethylation (GO:0070076),-0.5125295692369195,-1.6504370360759062,0.02197802197802198,0.3789080044120688,1.0,10/25,14.05%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;KDM3A;KDM5C;KDM4C;PHF8;KDM4D
prerank,positive regulation of phagocytosis (GO:0050766),0.6279418288364673,1.6473276670708907,0.001142857142857143,0.07670591411217466,1.0,21/47,15.66%,CALR;C4B;C3;CYBA;TREM2;DOCK2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;GATA2;IL2RG;SLC11A1;GAS6;CCL2;F2RL1;CD300LF
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5939582039215965,1.6464844681273378,0.0021551724137931034,0.07724681995568959,1.0,21/62,17.04%,TPT1;PPIA;CLU;HSPB1;CXCL12;NDUFA13;PARK7;AKT1;TMBIM6;PINK1;ENO1;BAG5;CREB3;PTTG1IP;DNAJA1;SYVN1;HSPA1A;YBX3;HERPUD1;TRIM32;NDUFS3
prerank,nuclear migration (GO:0007097),-0.6118133746559066,-1.6443580814781948,0.033962264150943396,0.38461159312908366,1.0,7/13,11.78%,SYNE2;SYNE3;PAFAH1B1;DOCK7;PCM1;FBXW11;CLMN
prerank,defense response to fungus (GO:0050832),0.7112904512999985,1.642801195099499,0.008974358974358974,0.0811939149336634,1.0,7/17,14.23%,GAPDH;S100A8;S100A9;RARRES2;CLEC6A;CLEC4D;CX3CR1
prerank,protein targeting to lysosome (GO:0006622),0.7088462939043633,1.642600952641686,0.0039011703511053317,0.0809545810776068,1.0,9/20,19.10%,HSPA8;CLU;LAPTM5;SORL1;M6PR;LAMP2;NCOA4;VPS4A;SNX16
prerank,positive regulation of cation channel activity (GO:2001259),0.6307644516227742,1.6424526654773435,0.006795016987542469,0.0806768449706592,1.0,15/40,19.60%,TMSB4X;CALM1;CTSS;AKAP6;CALM3;ANK3;GSTO1;P2RY6;HAP1;GSTM2;CCL2;LRRC55;CCR2;CALM2;STAC3
prerank,chemical synaptic transmission (GO:0007268),0.5499310465624041,1.6411420652912263,0.0,0.08168429722354366,1.0,121/284,23.37%,APOE;HSPA8;CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;SLC17A8;ASIC2;NRXN1;CNP;GABRB1;NLGN1;NSG1;SNAP25;CHRNA9;DLGAP2;GRM5;GRIA2;SLC1A4;SLC1A2;DLGAP1;GRID2;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;DNAJC5;GRIK5;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;RIMS1;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;ERC2;SYN2;HTR2C;SLC6A2;SLC6A5;CRH;VAMP2;PTPRN2;CAMK1;KIF5A;GRID1;GRM1;SLC17A7;PRKAR1B;HAP1;CHRM3;GLRA2;SLC17A6;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;CHAT;HCRT;CBLN2;SDCBP;LIN7C;NAAA;PPFIA3;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;NAPA;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;STAC3;GABBR2;UTS2;GAD1;SST;CACNB4;RIMBP2;NPY5R;GRIA3;GRIK1;CHRNA3;SLC32A1;CACNA1E;HTR3B;SYT5;SLC5A7
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6318680262287372,1.6399985163332338,0.0,0.08254458358362608,1.0,8/40,6.83%,RPL23;RPL11;RPS7;RPL5;CLU;LAPTM5;HIPK2;FOXF2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.754966186466543,1.6391960752624022,0.011857707509881422,0.08300317174324848,1.0,5/13,9.64%,BGN;HEXB;BCAN;HEXA;DCN
prerank,cellular response to interferon-beta (GO:0035458),0.7629806273695147,1.6388131063362639,0.00922266139657444,0.08304623462463082,1.0,4/14,6.19%,IFITM2;NDUFA13;UBE2G2;CDC34
prerank,B cell mediated immunity (GO:0019724),0.802433505275948,1.6384697839921416,0.00860832137733142,0.08303403144492501,1.0,2/10,4.09%,CD74;FCER1G
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.49327191769169054,-1.6364350519707993,0.0,0.39615066414896816,1.0,13/29,19.40%,FER;GHR;STAT5B;IL31RA;PIAS1;IL15;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,aerobic respiration (GO:0009060),0.6908496821953745,1.6358150773109086,0.014925373134328358,0.08561530411684307,1.0,9/20,14.10%,ATP5F1D;UQCR10;NDUFS7;UQCRH;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.582891777008196,1.634977166511967,0.0,0.0861032612255909,1.0,33/74,21.65%,RPS27A;UBC;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;EGLN2;PSMB1;PSMB5;VHL;PSMA6;NOTCH1;CITED2;PSMA4;SIRT2;ELOC
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.7920731716898989,1.6349570646716702,0.011126564673157162,0.08568312182934056,1.0,8/11,14.56%,UQCR11;UQCR10;CYC1;UQCRH;UQCRQ;UQCRC1;UQCRB;UQCRFS1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7249887041608537,1.6333562284323202,0.003861003861003861,0.0870937662917477,1.0,6/17,9.86%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4680665652783071,-1.6321643468020863,0.007142857142857143,0.39678013537420453,1.0,15/29,19.58%,SMAD3;DICER1;DROSHA;SMAD1;ZC3H7A;TUT7;ZC3H7B;SMAD2;PUM2;SRRT;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,regulation of neuron apoptotic process (GO:0043523),0.5738968154100518,1.6314974475738848,0.0,0.08882560529785352,1.0,43/96,21.81%,APOE;MDK;GRN;MT3;PARK7;SOD1;ATF4;LGMN;PRNP;FOXQ1;TREM2;PINK1;GRID2;TNF;FZD9;NTRK2;CTNNB1;FAIM2;NUPR1;TRIM2;CDK5R1;SET;BAX;WFS1;EGLN2;CCL2;PTPRZ1;CDK5;TYRO3;CCL3;BACE1;PPARGC1A;GRM4;AGAP2;ERBB3;AKT1S1;NSMF;TFAP2B;POU4F1;MEF2C;CRLF1;DDIT3;MAG
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4930606336076853,-1.6311742116216723,0.02197802197802198,0.3901804334207232,1.0,11/28,15.34%,PID1;APPL2;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,regulation of protein neddylation (GO:2000434),0.7970907596387805,1.6309639976520576,0.011428571428571429,0.08906545828690465,1.0,4/10,4.55%,RPL11;RPL5;COPS9;EPAS1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4967656608244582,-1.6309454479715568,0.005813953488372093,0.3815000393569504,1.0,8/27,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;PRKN;ARHGEF18;PPFIA1;MET
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8004345614639007,1.6296765369254185,0.012569832402234637,0.09028444605935942,1.0,1/10,0.03%,APOE
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7879684611702721,1.6296152359476714,0.007173601147776184,0.08990672177787216,1.0,7/11,13.89%,GPX1;PRDX5;PRDX4;PRDX2;GPX3;PRDX1;CAT
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6471652706766733,1.6273318004591537,0.0034965034965034965,0.09213869159082624,1.0,17/32,21.19%,PPIA;CALM1;HSP90AB1;CALM3;PPP1R15B;PIN1;DUSP26;SMPD1;DLC1;CDH5;CD300A;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.6683308414882738,1.6273007638390853,0.011306532663316583,0.09170345729412964,1.0,13/25,20.87%,HSPA8;HSPA5;SDF2L1;HSPE1;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A;HSPA2;HSPA9
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5812697514100847,1.626985545683088,0.0010570824524312897,0.09162157300166276,1.0,16/84,4.82%,APOE;MRPL13;RPS3;CLU;RACK1;GAPDH;RPL13A;CALR;PRNP;IGFBP5;NTRK2;NCL;ORMDL3;RTN4;PIN1;SORL1
prerank,defense response to bacterium (GO:0042742),0.5668467670483496,1.6268586932891598,0.0,0.09128694414282147,1.0,23/105,12.89%,RPL30;RPL39;RPS19;MBL2;MPEG1;PGLYRP1;TREM2;ROMO1;FCER1G;ANG;S100A8;S100A9;TIRAP;RARRES2;ISG15;CEBPB;AQP1;ADGRB1;STAB1;CHGA;LYZL4;LCN2;SLC11A1
prerank,regulation of interleukin-2 production (GO:0032663),0.6214333098899536,1.6263258709396682,0.002320185614849188,0.09145549393034498,1.0,11/43,11.49%,RPS3;LAPTM5;PDE4B;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36;PNP
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7274694196257556,1.6260341760975312,0.01092896174863388,0.09137132126141165,1.0,2/14,1.05%,RPS3;CD81
prerank,neurotransmitter transport (GO:0006836),0.580479992384514,1.6258213993416089,0.002145922746781116,0.0912277858083978,1.0,30/73,15.30%,HSPA8;SLC17A8;NRXN1;SNAP25;SLC1A2;DNAJC5;SYT1;GLUL;GABRA2;RIMS1;PPFIA4;PPFIA2;SYN2;SLC6A2;VAMP2;PTPRN2;SLC6A16;SLC17A7;SLC29A1;SLC17A6;SYN1;SLC1A1;NRXN2;CHAT;GLS2;GLS;SLC29A2;LIN7C;NAAA;PPFIA3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5796876982743164,1.6245543631005916,0.0010559662090813093,0.09189832666007963,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5796876982743164,1.6245543631005916,0.0010559662090813093,0.09189832666007963,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6969896392918978,1.623808598543802,0.00788436268068331,0.09244332888915151,1.0,8/18,19.90%,GNA11;CDK5R1;RGS10;CHRM3;CHRM2;CHRM5;GRK2;AGRN
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6960171427832401,1.623060791632625,0.01125,0.09290603166895411,1.0,9/20,14.87%,CLU;HSP90AA1;HSP90AB1;PFDN6;CCT2;HSPD1;PSMG3;HSPA1A;PTGES3
prerank,error-prone translesion synthesis (GO:0042276),0.6919089347571787,1.6219766644904936,0.008695652173913044,0.09401536845482909,1.0,7/21,13.26%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2
prerank,heme biosynthetic process (GO:0006783),0.674142126154342,1.6219729028500383,0.012626262626262626,0.09359361054887166,1.0,10/22,16.27%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,iron ion homeostasis (GO:0055072),0.6047097142686995,1.620797766889354,0.00322234156820623,0.09477912929788868,1.0,18/58,12.89%,FTH1;FTL;B2M;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,negative regulation of RNA splicing (GO:0033119),0.6941721646320235,1.6199032363900334,0.014102564102564103,0.09541432990405399,1.0,5/19,7.06%,RPS13;RPS26;TMBIM6;PCBP4;SRSF9
prerank,'de novo' posttranslational protein folding (GO:0051084),0.6458394191487986,1.6197081774184534,0.01090909090909091,0.09524491842211985,1.0,12/30,16.17%,HSPA8;HSPA5;SDF2L1;HSPE1;CCT2;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A
prerank,positive regulation of neuron death (GO:1901216),0.6036443832157297,1.6195687831424828,0.003367003367003367,0.09501519969494221,1.0,25/46,22.12%,CLU;C1QA;TYROBP;GRN;ATF4;PRNP;ITGB2;TNF;CTNNB1;MAPT;NUPR1;EGR1;CDK5R1;WNT5A;BAX;TLR6;CDK5;CCL3;BACE1;GRIN2B;SNCA;TFAP2B;DDIT4;DDIT3;REST
prerank,keratan sulfate catabolic process (GO:0042340),0.778489906320716,1.6195396798458872,0.015299026425591099,0.09462484577009665,1.0,4/11,2.91%,HEXB;FMOD;LUM;HEXA
prerank,selective autophagy (GO:0061912),0.5901100660339753,1.6188808930117342,0.002178649237472767,0.09496911267379325,1.0,11/56,7.70%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1;MAP1LC3B;AUP1;UBA52;UFC1
prerank,negative regulation of wound healing (GO:0061045),0.65524201480984,1.6174882586939339,0.00954653937947494,0.09634319422711547,1.0,8/28,9.80%,APOE;VTN;THBD;SERPINE2;CD34;TNF;CLASP1;EPPK1
prerank,ATP transport (GO:0015867),0.7888707858755784,1.6174513017270993,0.014285714285714285,0.09594346214779229,1.0,2/10,4.33%,SLC25A5;SLC25A4
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5455085255812264,1.6172340951398818,0.0,0.0957891750988177,1.0,95/224,23.29%,CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;ASIC2;NRXN1;CNP;GABRB1;NLGN1;SNAP25;CHRNA9;GRM5;GRIA2;SLC1A2;DLGAP1;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;SYN2;HTR2C;SLC6A2;SLC6A5;CRH;CAMK1;KIF5A;GRM1;PRKAR1B;HAP1;CHRM3;GLRA2;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;HCRT;SDCBP;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;GABBR2;UTS2;GAD1;SST;CACNB4;NPY5R;GRIA3;GRIK1;CHRNA3;CACNA1E;HTR3B;SYT5
prerank,kinetochore organization (GO:0051383),-0.5992331697669164,-1.6172141656797496,0.031496062992125984,0.40931765117382296,1.0,8/13,26.50%,POGZ;CENPC;CENPT;CENPE;CENPH;NDC80;MIS12;NUF2
prerank,negative regulation of transposition (GO:0010529),-0.5707020078321456,-1.617099045688008,0.0273972602739726,0.40039720621551494,1.0,7/16,16.08%,UBR2;TUT7;MOV10;MYBL1;TEX15;TUT4;SIRT7
prerank,negative regulation of viral process (GO:0048525),0.6033039004065056,1.6168962839217254,0.0054466230936819175,0.0958125691911157,1.0,22/57,22.30%,IFITM3;PPIA;IFITM2;IFITM1;MBL2;SHFL;TNF;ISG15;TRIM28;PROX1;IFIT1;ZFP36;BANF1;BST2;HEXIM1;TRIM32;OAS3;TRIM13;FAM111A;RSAD2;ISG20;TNIP1
prerank,regulation of lipid catabolic process (GO:0050994),0.6921897527466094,1.615188149494897,0.006631299734748011,0.0974412972385609,1.0,5/19,5.68%,APOC1;TNF;BSCL2;PDE3B;RARRES2
prerank,cellular response to hypoxia (GO:0071456),0.5545415124001544,1.6150233597235624,0.0,0.09721426823911858,1.0,54/126,21.65%,RPS27A;UBC;UBB;PSMB4;ELOB;MT3;HMOX1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCND2;PSMD1;ZFP36L1;EPAS1;PSMC3;PSMD6;PGK1;HIPK2;UBA52;PSMA7;NDRG1;BNIP3L;P4HB;FMN2;AQP1;PSMD5;RBX1;AK4;PSMB9;PSMD13;PSMB3;ACAA2;PMAIP1;PSMB11;PSMB10;EGLN2;BAD;PSMB1;PSMB5;VHL;LMNA;TWIST1;NOP53;PSMA6;SFRP1;PSMA4;MYC;SIRT2;HYOU1;STUB1;ELOC
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6867128064539944,1.614644734349621,0.006361323155216285,0.09729479345990097,1.0,11/20,22.37%,GNA11;LY6H;CDK5R1;RGS10;CHRM3;CHRM2;LYPD1;CHRM5;GRK2;AGRN;CHRNA3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4409407179770086,-1.6145368462134022,0.0,0.39794725189635843,1.0,13/39,14.26%,TSPAN5;ZMIZ1;CREBBP;MAML2;ROBO1;YAP1;KAT2B;STAT3;MAML1;AAK1;RBPJ;JAG1;PRKCI
prerank,regulation of cholesterol esterification (GO:0010872),0.7908069129017787,1.6139361291013388,0.013313609467455622,0.09777605001639005,1.0,5/10,9.19%,APOE;APOC1;AGT;ABCG1;STARD4
prerank,negative regulation of protein metabolic process (GO:0051248),0.6118619799476019,1.6134521389100038,0.0044742729306487695,0.0979796651742348,1.0,11/48,5.34%,APOE;CLU;PFDN5;HSP90AB1;PRNP;TREM2;CRYAB;PFDN6;CD84;PIN1;FLNA
prerank,cellular iron ion homeostasis (GO:0006879),0.6091934053895516,1.611266392463628,0.0032967032967032967,0.10030962225623065,1.0,17/55,12.89%,FTH1;FTL;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5733491435217767,1.6105011068414017,0.0,0.100738373688912,1.0,22/79,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,regulation of platelet activation (GO:0010543),0.6858161562238358,1.608603643630606,0.007444168734491315,0.10282065238348155,1.0,4/21,4.09%,APOE;THBD;PDGFB;FCER1G
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7005736891952044,1.6070932847646429,0.008860759493670886,0.1043475699830007,1.0,5/17,4.03%,CALM1;HSP90AB1;CALM3;PPP1R15B;PTPRC
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5668303812646882,1.6049994583997935,0.0010438413361169101,0.10685402535017055,1.0,24/84,13.59%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ECRG4;PSMD6;UBA52;PSMA7;PSMD5;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXO5;FBXO31;PSMB10
prerank,regulation of blood coagulation (GO:0030193),0.6513502215983553,1.6049144426202337,0.009535160905840286,0.10651388577870237,1.0,5/27,2.99%,APOE;VTN;THBD;SERPINE2;CD34
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.6781844585731627,1.6040183135233825,0.005108556832694764,0.1072546639666,1.0,10/23,15.08%,HSP90AA1;TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B;BAX;PMAIP1;BAD;TIMM29
prerank,cellular respiration (GO:0045333),0.6094495500655869,1.603208764207721,0.011560693641618497,0.10800550906376497,1.0,20/41,23.79%,ATP5F1D;UQCR10;NDUFS7;UQCRH;ETFB;SLC25A13;NDUFA5;MTLN;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8;UQCRFS1;PPARGC1A;CYCS;SDHA;COQ10A;MTFR1L;SLC25A14
prerank,regulation of mRNA catabolic process (GO:0061013),0.551998691959429,1.6009225682939074,0.0,0.11061288038691344,1.0,37/121,13.60%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;YWHAB;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PRR5L;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;HSPA1A;PSMB10;YWHAZ
prerank,positive regulation of translation (GO:0045727),0.5608957544745882,1.5982414902160407,0.0010438413361169101,0.11365834451727606,1.0,17/94,6.54%,RPL26;RPS9;RPS4X;RPL5;EEF2;VIM;UQCC2;EIF3D;POLR2D;NPM1;RPS27L;EIF5A;EIF5AL1;COA3;PKM;UHMK1;EIF3C
prerank,negative regulation of receptor binding (GO:1900121),0.7861877037796079,1.5981566902655497,0.013062409288824383,0.11334129227985607,1.0,2/10,3.42%,B2M;ADAM15
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.6516439560421494,1.596459022439379,0.016270337922403004,0.11537857590666474,1.0,7/24,7.53%,B2M;CALR;CANX;FCER1G;TAPBP;TAP2;PDIA3
prerank,macrophage migration (GO:1905517),0.7268035147419902,1.5964010938348872,0.015810276679841896,0.11500130832567097,1.0,6/13,19.16%,LGALS3;P2RY12;CCL2;CCL3;CCR2;CXCL17
prerank,actin filament bundle organization (GO:0061572),-0.4667934499153068,-1.5963596171694483,0.024539877300613498,0.43950660172263667,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,protein stabilization (GO:0050821),0.5455978396158607,1.5958939682483249,0.0,0.11526578902921852,1.0,56/168,18.28%,RPL23;RPL11;RPS7;RPL5;CLU;GAPDH;LAMP1;TYROBP;HSP90AA1;HSP90AB1;GRN;CALR;MT3;PPIB;PARK7;CRYAB;PINK1;CCT2;CHEK2;GLMP;RTN4;PIN1;HSPA1B;FLOT1;FLNA;BAG5;PFN1;BAG1;DNLZ;CCT7;ATP1B2;HSPD1;TSPAN1;CCT8;MFSD1;TAF9;MTMR9;CDC37;SOX17;MSX1;WFS1;SYVN1;NCLN;HSPA1A;FBXW7;WNT10B;PTGES3;ATP1B1;GOLGA7;PEX6;VHL;PFN2;PPARGC1A;ATP1B3;NOP53;LAMP2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4893406613573878,-1.5948186514064462,0.005076142131979695,0.43422851367556886,1.0,7/24,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ARHGEF18;PPFIA1;MET
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.699555880539187,1.5940874764101944,0.017264276228419653,0.11743633648985868,1.0,2/16,7.11%,CLDN5;CLDN11
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7718823914958494,1.5919260699318258,0.009735744089012517,0.11957736157892294,1.0,8/11,19.11%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7718823914958494,1.5919260699318258,0.009735744089012517,0.11957736157892294,1.0,8/11,19.11%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,zymogen activation (GO:0031638),0.6172498499486448,1.5917912075313396,0.010404624277456647,0.1193000955484015,1.0,18/39,18.83%,CTSL;LGMN;CD5L;PGK1;OMA1;F9;KLK1;GRIN2A;VSIR;PLAT;RIPK2;CTSH;BAD;HPR;HP;PLAU;MMP14;PRSS12
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7308365583215068,1.5914694692640023,0.017955801104972375,0.11930106353216385,1.0,3/15,2.14%,TMSB4X;HSPB1;LGMN
prerank,positive regulation of chemokine production (GO:0032722),0.6051748746166403,1.590440077859256,0.011350737797956867,0.12025455042831844,1.0,23/44,25.86%,CD74;MBP;HMOX1;TNF;TIRAP;LPL;EGR1;HMGB1;CSF1R;WNT5A;AIF1;F2RL1;TWIST1;ADCYAP1;ADAM17;SYK;OAS3;IL6;PYCARD;APP;AGER;IL33;TLR7
prerank,cellular response to heat (GO:0034605),0.6252422835169791,1.5898988618939824,0.005924170616113744,0.12057954221200103,1.0,11/35,13.09%,HSP90AA1;HSP90AB1;HSBP1;HMOX1;POLR2D;HSPA1B;YWHAE;VCP;MAPT;PDCD6;HSPA1A
prerank,protein-containing complex disassembly (GO:0032984),0.5850072092291984,1.5898693360170268,0.006535947712418301,0.1201375162835112,1.0,10/54,5.80%,RPL23;HSPA8;GABARAP;PPP1CA;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;CTNNB1;VCP
prerank,lipid catabolic process (GO:0016042),0.6979516925670888,1.588321513299997,0.0064516129032258064,0.1220368563456167,1.0,5/18,8.93%,MT3;PLAAT3;LIPG;LIPE;LPL
prerank,cell-cell junction assembly (GO:0007043),0.5826258596547084,1.5882927522806918,0.001081081081081081,0.12161926157862525,1.0,22/63,16.81%,ACTB;ACTG1;CLDN5;RAMP2;GJA4;GJB2;RHOC;CDH20;CTNNB1;CLDN11;CDH18;RHOA;CDH12;GJA1;CDH19;DCHS1;JAM3;CDH7;CDH24;EPB41L3;CDH10;CDH5
prerank,positive regulation of leukocyte migration (GO:0002687),0.6430410793290217,1.5881489123115824,0.00850546780072904,0.12133780443596033,1.0,11/27,19.67%,MDK;TNF;LGALS3;THY1;AIF1;F2RL1;JAM3;ADAM17;PLVAP;EDN3;IL6
prerank,cholesterol transport (GO:0030301),0.5932233944325759,1.5880831912591522,0.011135857461024499,0.12095265110827769,1.0,8/45,9.19%,APOE;CLU;NPC2;APOC1;ABCG1;LIPG;TSPO2;STARD4
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6339628636958659,-1.5879696521758948,0.039735099337748346,0.44406313286169086,1.0,4/10,5.46%,ROCK2;ROCK1;IL18;IL15
prerank,error-free translesion synthesis (GO:0070987),0.6705477756667027,1.586662802005672,0.012437810945273632,0.12272897651450186,1.0,8/22,13.26%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;PCNA;RFC2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6082411707685423,1.5862917477771772,0.010428736964078795,0.12282174079561915,1.0,20/38,19.76%,PRNP;GRM5;AGT;PDGFB;PTPRC;HYAL2;PTK6;THY1;LILRA5;FCGR1A;CSF1R;DOK7;SRCIN1;GAS6;LRP8;CAV1;CASS4;ERBB3;UNC119;EFNA1
prerank,proton transmembrane transport (GO:1902600),0.6091279824667392,1.586037142066495,0.006984866123399301,0.12271567609418262,1.0,11/36,13.03%,ATP5MF;ATP6V0C;ATP5F1B;ATP6V1F;UCP2;ATP6V0E2;ATP1A3;HVCN1;ATP1A4;ATP1A1;SLC25A27
prerank,negative regulation of neuron death (GO:1901215),0.5606907853630442,1.5858326389387754,0.0010504201680672268,0.12258808192097144,1.0,17/93,4.82%,APOE;MDK;GRN;GPNMB;MT3;PARK7;SOD1;ATF4;LGMN;AKT1;FOXQ1;CD34;PINK1;FZD9;NTRK2;NENF;SORL1
prerank,response to ethanol (GO:0045471),0.7228898507088816,1.5858025906837978,0.01813110181311018,0.12214615492302396,1.0,7/14,11.81%,SOD1;GRIN1;GRIN3A;GRIN2A;SDF4;GLRA2;GLRA1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7303971185078526,1.5848731757430887,0.026525198938992044,0.12303792810058513,1.0,3/14,5.28%,TYROBP;TNF;ATP6AP1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7698276365954297,1.5831895914084528,0.017341040462427744,0.12501263681889094,1.0,4/11,3.08%,RACK1;PARK7;ATF4;PINK1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6925119306274584,1.5831083200640927,0.01576872536136662,0.12464358095857396,1.0,6/18,12.23%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,epithelial cell differentiation (GO:0030855),0.5604414880805137,1.5817250838657437,0.0010427528675703858,0.12627953316346888,1.0,18/88,11.93%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;AKT1;ERBB4;TOLLIP;LGALS3;PGK1;EDF1;PROX1;BASP1;KDR;DNPH1;PIH1D1;KDM6B;PCNA
prerank,sulfur compound catabolic process (GO:0044273),0.6088122196437705,1.5815935794706315,0.006920415224913495,0.12599949748458605,1.0,22/38,30.61%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;MPST;DCN;ACAT1;TXN2;TST;VCAN;ACAN;PRELP;ADO;CSPG5;CHAC2;GLB1;GGT5;GGT7;IDS;GNS
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6003846415578338,1.581511389285864,0.011299435028248588,0.12564902274937592,1.0,10/42,12.89%,RPL30;RPS19;MPEG1;TREM2;ROMO1;RARRES2;AQP1;ADGRB1;CHGA;SLC11A1
prerank,triglyceride catabolic process (GO:0019433),0.6866202741290057,1.5813084320195543,0.015544041450777202,0.12547096301355656,1.0,7/19,23.46%,PNPLA2;FABP5;LIPG;LPL;FABP7;FABP4;FABP3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.6765635774408881,1.5798942406570666,0.01288659793814433,0.12714800655421543,1.0,5/18,10.12%,LAPTM5;GPNMB;AKT1;DUSP3;FGL1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6938546132298936,1.579345810124912,0.015748031496062992,0.12752160589102107,1.0,10/18,17.77%,APOE;NSG1;PSENEN;ABCG1;KLK6;ACHE;BACE1;PSEN2;ADAM17;APH1B
prerank,negative regulation of axonogenesis (GO:0050771),0.6433381648248082,1.5792696582475672,0.015873015873015872,0.12718855477767776,1.0,10/27,15.85%,ARHGDIA;MT3;DCC;RTN4;LRP4;THY1;MAP2;GDI1;RHOA;FGF13
prerank,T cell activation involved in immune response (GO:0002286),0.7560150402120986,1.5790487242994382,0.015492957746478873,0.12706798509533992,1.0,7/12,14.62%,CD74;MDK;FCER1G;LCP1;SLC11A1;LILRB1;F2RL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.75959349726928,1.5790024582141298,0.022535211267605635,0.12666807991108006,1.0,4/11,10.04%,GSN;PARK7;ST18;PIH1D1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.6470587369306459,1.5788604737022518,0.02132998745294856,0.12637003888755993,1.0,10/24,16.27%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,regulation of cellular component biogenesis (GO:0044087),0.6067823581583064,1.578762976277849,0.009070294784580499,0.12607063625217152,1.0,9/39,6.44%,APOE;HSPA8;GFAP;HSP90AA1;CCL19;PINK1;AGT;BAG5;MSN
prerank,acylglycerol homeostasis (GO:0055090),0.6817529582032276,1.5768584001805857,0.020278833967046894,0.12854871145471258,1.0,4/20,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6384827944023201,1.576736600465434,0.008254716981132075,0.12828208180080997,1.0,15/32,20.40%,CALM1;AKAP6;CALM3;GPER1;APLNR;GSTO1;P2RY6;THY1;CXCL10;HAP1;GSTM2;TRPC1;CALM2;SNCA;CAPN3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6569146704779615,1.5762605428059253,0.021383647798742137,0.12859910223792695,1.0,13/22,20.35%,PSMB4;PSMB6;PSMB8;PSMA7;PSMB9;PSMB3;PSMB11;PSMB10;PSMB1;ENC1;PSMB5;PSMA6;PSMA4
prerank,positive regulation of cellular component organization (GO:0051130),0.5481494590099646,1.576023224398024,0.0,0.1285077483506612,1.0,30/107,11.61%,APOE;RPS3;CLU;RACK1;GPX1;CD151;PARK7;CCL19;NRXN1;NRG1;TREM2;TNF;TMEM30A;RHOC;LGALS3;LRP4;FLOT1;TIRAP;VCP;TFRC;LMAN1;SURF4;MTLN;CAMK1;PIH1D1;SMPD1;TMED9;MMP3;BAX;WARS1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6900952339695366,1.5752197510740331,0.021108179419525065,0.12927825407734753,1.0,5/17,8.35%,APOE;SOD1;RAN;ABCG1;SEC14L2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5504442781171336,1.5751704169096903,0.001026694045174538,0.1288956415178493,1.0,36/94,20.79%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;PSMD1;PSMC3;ST18;PSMD6;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;RIPK2;PSMB10;UBE2V1;PSMB1;PSMB5;SQSTM1;TAB1;PSMA6;SKP1;IL1RAP;PSMA4;NFKBIA
prerank,neuron maturation (GO:0042551),0.68458523838722,1.5743301720541716,0.024081115335868188,0.12969023939182717,1.0,6/18,12.93%,MTCH1;C1QA;C3;ADGRB3;B4GALT6;CLN5
prerank,actin filament bundle assembly (GO:0051017),-0.4590898814111514,-1.573732065759099,0.012987012987012988,0.476994169566111,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,positive regulation of chemotaxis (GO:0050921),0.6056744208256472,1.5728341122632432,0.005707762557077625,0.13158801391087066,1.0,19/43,19.84%,TMSB4X;MDK;HSPB1;LGMN;CCL19;TREM2;PDGFB;DSCAM;RARRES2;KDR;P2RY12;AIF1;F2RL1;ADAM17;CCR2;STX4;EDN3;IL6;TGFB1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.7461004147128845,1.5717008484953365,0.019635343618513323,0.13292684998547197,1.0,4/12,10.15%,RPL26;CD74;MIF;TAF9
prerank,natural killer cell mediated immunity (GO:0002228),0.6979242457851098,1.5714937067391332,0.03713527851458886,0.13281548421614572,1.0,2/15,1.46%,TUBB;TUBB4B
prerank,negative regulation of translational initiation (GO:0045947),-0.5875385434078552,-1.5712033290678105,0.047619047619047616,0.4753177486876066,1.0,7/13,21.61%,EIF2AK4;LARP1;RBM4;PAIP2;AGO2;FMR1;TPR
prerank,positive regulation of phosphatase activity (GO:0010922),0.6737260872477295,1.5710446082098906,0.00984009840098401,0.1330164401486478,1.0,10/21,20.07%,CALM1;HSP90AB1;CALM3;PPP1R15B;MTMR9;BMP2;CD300A;PPP1R15A;CALM2;MEF2C
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6388627578587219,1.5678841112270234,0.018094089264173704,0.13740051369313466,1.0,5/27,6.79%,RPS27A;UBC;UBB;MAPK3;UBA52
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5914497801350078,1.567823786325022,0.0054466230936819175,0.1370158785139619,1.0,11/48,9.82%,TMSB4X;ATP5F1B;HSPB1;HMOX1;AKT1;ATP5F1A;PDGFB;KDR;JCAD;GATA2;HMGB1
prerank,muscle filament sliding (GO:0030049),0.6070061573084018,1.565486397857899,0.007058823529411765,0.13982480379621537,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,actin-myosin filament sliding (GO:0033275),0.6070061573084018,1.565486397857899,0.007058823529411765,0.13982480379621537,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.7247211238724574,1.565236780006006,0.0273972602739726,0.1397786411118027,1.0,7/13,19.84%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.55464447139196,-1.5651693931281987,0.034934497816593885,0.4837080212797927,1.0,4/16,8.26%,PDS5A;NIPBL;PDS5B;POGZ
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.71396674933287,1.563338038967071,0.0160857908847185,0.1423366543989547,1.0,5/14,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,regulation of calcium ion import (GO:0090279),0.6655949749950173,1.5626184933180156,0.01910828025477707,0.14308555633010675,1.0,11/21,20.24%,SLC30A1;CXCL12;PRNP;PDGFB;LGALS3;CTNNB1;PLN;CCL2;CCL3;PSEN2;SPHK2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.7034326260241354,1.56085689710974,0.017834394904458598,0.14557877742084513,1.0,8/16,9.83%,TMSB4X;TREM2;PINK1;ENO1;PARP1;VCP;AK4;DNAJC30
prerank,regulation of aerobic respiration (GO:1903715),0.7050338703633638,1.5604319880975133,0.028683181225554105,0.14580273881179862,1.0,6/15,9.44%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;AK4
prerank,ganglioside metabolic process (GO:0001573),0.6749450582780301,1.5598467856845237,0.02258469259723965,0.14620517110499187,1.0,9/20,16.06%,GM2A;HEXB;HEXA;B4GALNT1;CLN6;ST8SIA4;ST6GALNAC3;ABCA2;NEU1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4064213928358171,-1.559221407728825,0.030612244897959183,0.4922500027690369,1.0,16/51,11.55%,FBN1;SMAD6;BMPR1A;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;CHRDL1
prerank,digestive tract development (GO:0048565),-0.45386112540848755,-1.558349991545973,0.014084507042253521,0.48543251352594835,1.0,10/33,10.39%,RARB;SMO;GLI3;GLI2;NIPBL;COBL;CLMP;PCSK5;FGFR2;PKD1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5511279595745235,1.5577286277149087,0.0031446540880503146,0.149152028975442,1.0,26/88,17.56%,APOE;CST3;MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;AKT1;SERPINE2;IGFBP5;NCL;CSTB;NELL1;YBX1;PCIF1;ATRAID;PLAT;CAMK2N1;CDK5;ENC1;EIF4A3;DAB2IP;EIF4ENIF1;CLN8;NANOS2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6097379718163521,1.557459442053467,0.010309278350515464,0.14914726236430856,1.0,8/36,8.89%,APOE;CALM1;S100A1;HSP90AA1;AKT1;TNF;CYGB;SPR
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6549903110787276,1.5540890950916957,0.01893939393939394,0.15430324708998536,1.0,8/24,16.33%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2;POLD4
prerank,peptide cross-linking (GO:0018149),0.6432822321607987,1.5524414427071642,0.018270401948842874,0.15665138186207767,1.0,6/25,13.69%,F13A1;TGM2;FN1;EPB42;COL3A1;EVPL
prerank,regulation of superoxide anion generation (GO:0032928),0.7114202114775657,1.5521016267260344,0.03155006858710562,0.15670872085974885,1.0,7/14,19.84%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,regulation of leukocyte activation (GO:0002694),0.7148000514210275,1.5519589843909296,0.025537634408602152,0.1564513417174284,1.0,4/14,9.11%,CD74;GPER1;MIF;GPR137B
prerank,positive regulation of dephosphorylation (GO:0035306),0.6292938317606823,1.5507259313802062,0.015834348355663823,0.15800835284958553,1.0,14/27,21.19%,PPIA;CALM1;CALM3;PIN1;SMPD1;MTMR9;BMP2;DLC1;CDH5;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7513293775089065,1.550334330775363,0.030985915492957747,0.15813078209092335,1.0,5/10,13.40%,TYROBP;HSP90AB1;FN1;CD24;LILRB1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6463143506156669,1.5501071886550533,0.02418379685610641,0.15802690796627228,1.0,10/25,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF;KLF4;DDAH1;TLR6;DDAH2
prerank,dendrite self-avoidance (GO:0070593),0.6985994552893762,1.5496199665426837,0.018494055482166448,0.158474551994047,1.0,8/16,15.44%,BSG;DSCAM;CNTN4;ROBO4;EMB;TNN;IGSF9;DSCAML1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6019331237009076,-1.5495790427210145,0.04827586206896552,0.5025763304521037,1.0,5/11,18.78%,PDK1;STK24;PRODH;GSKIP;MAP3K5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4590611964923341,-1.5495489565440448,0.02158273381294964,0.49368234116392784,1.0,14/35,13.79%,NR3C2;RBFOX2;ZMIZ1;UBR5;YAP1;ARID1A;KDM3A;PMEPA1;ESR1;DDX17;RNF14;AR;PLPP1;PPARGC1B
prerank,myelin maintenance (GO:0043217),0.7551711559228687,1.5494057795763974,0.023743016759776536,0.1583702362406498,1.0,7/10,16.65%,CLU;SOD1;MYRF;CXCR4;DEGS1;EPB41L3;PRX
prerank,cellular response to peptide (GO:1901653),0.5758986053110547,1.5493326583420353,0.006659267480577136,0.1579866670742712,1.0,20/56,16.62%,RPL23;VIM;LGMN;PRNP;TREM2;GRM5;GPER1;ZFP36L1;GRIN1;CACNA1A;ATP1A3;GRIN2A;CHMP5;DDX11;GJA1;RIPK2;TLR6;CDK5;CAV1;VCAM1
prerank,gene silencing by miRNA (GO:0035195),-0.43845072832641585,-1.549195825613735,0.03937007874015748,0.4859515444977643,1.0,16/32,19.58%,TNRC6B;TNRC6A;TNRC6C;CNOT1;DICER1;ZC3H7A;MOV10;RBM4;ZC3H7B;CNOT7;PUM2;TARBP2;LIMD1;AGO2;AGO4;ADAR
prerank,histone H3-K36 demethylation (GO:0070544),-0.6295449173321754,-1.5484334335205183,0.07011070110701106,0.47944048903301545,1.0,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,mitochondrion localization (GO:0051646),-0.5127693811612949,-1.546110364060614,0.02643171806167401,0.4779499164182589,1.0,6/19,8.33%,LRRK2;TRAK1;MFN1;MARK1;BRAT1;MEF2A
prerank,protein catabolic process (GO:0030163),0.5708523311448855,1.545783046578495,0.0054288816503800215,0.1636500821828912,1.0,15/59,12.97%,APOE;HSPA8;CTSD;HSP90AA1;USE1;NR1D1;CHEK2;UBE2G2;VCP;PRPF19;FBXO27;DDB1;PMAIP1;CLN5;CLN6
prerank,protein insertion into ER membrane (GO:0045048),0.5965835917091419,1.5452593142417324,0.013528748590755355,0.16408951297685773,1.0,17/37,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;EMC6;SEC61G;EMC3;EMC10;VAMP2;EMC4;SERP1;SGTA;TRAM1L1;EMC8;VAPA;TRAM1;CYB5A
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6138705673814868,1.5444555023532216,0.013872832369942197,0.16515536138874848,1.0,8/33,6.09%,APOD;HMOX1;IGFBP3;GPER1;IGFBP5;ANG;NDRG4;TNFAIP3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.753397529906623,1.5444408079588048,0.02510460251046025,0.16464323382716578,1.0,3/10,2.58%,CALM1;PDE4B;CALM3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.4240104146292485,-1.5443763235610208,0.017543859649122806,0.474741465184241,1.0,13/41,11.10%,UBE2E2;HECTD1;RNF152;PRKN;TRAF3IP2;ARIH2;TRAF5;RNF135;TRIM5;RNF8;ZFP91;ITCH;RNF115
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5616772472216427,1.5437075234130908,0.0032292787944025836,0.16550862871396124,1.0,24/69,20.75%,APOE;MDK;GRN;MT3;PARK7;SOD1;LGMN;FOXQ1;PINK1;FZD9;NTRK2;SET;WFS1;CX3CR1;CCL2;PTPRZ1;NONO;TYRO3;PPARGC1A;AGAP2;ERBB3;POU4F1;MEF2C;CRLF1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5673356252697477,-1.5431312270501083,0.04980842911877394,0.4699181167807379,1.0,8/14,22.36%,GHR;STAT5B;PXN;STAT3;PTK2;STAT5A;STAT6;PIK3R1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7297454311059739,1.5429448364795506,0.027624309392265192,0.1663253340557058,1.0,3/12,1.67%,CTSB;CTSL;CTSS
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.531075063350046,-1.5425131516947084,0.0390625,0.46397654928541854,1.0,5/17,9.60%,PRKAG2;PPARA;NCOR1;PRKAA2;PPARG
prerank,gastrulation (GO:0007369),-0.5477219703571137,-1.542000367441697,0.06607929515418502,0.45797288462963426,1.0,5/15,13.79%,LRP5;GPC3;TASOR;NPHP3;SMAD2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.7490515674700408,1.541983456692617,0.03276353276353276,0.16747826103584715,1.0,5/11,5.54%,TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6555815337942972,1.5417628595376291,0.01717791411042945,0.16731784516734594,1.0,8/24,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6314844506086941,1.5415691143535335,0.022332506203473945,0.16714621321094,1.0,12/26,16.42%,CYBA;RTN4;FLOT1;TIRAP;SLC15A4;TICAM2;HMGB1;NINJ1;F2RL1;TLR5;TLR1;CAV1
prerank,mitochondrial gene expression (GO:0140053),0.602946888705402,1.5413558029727383,0.010380622837370242,0.1670518240036867,1.0,16/42,19.37%,MRPL23;MRPS12;LARS2;MRPS34;MRPS11;MRPS14;MRPL51;MRPL57;MRPL2;NDUFA7;MRPS24;MRPL12;MRPS2;MRPS6;MRPS16;MRPS21
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5664396384101102,-1.5412602708634504,0.022222222222222223,0.45286197985594706,1.0,4/15,3.12%,EDA;ANKRD11;GLI2;LRP6
prerank,protein autoubiquitination (GO:0051865),-0.3838155727491433,-1.5401259405897374,0.016129032258064516,0.4487241326321056,1.0,19/61,15.26%,RNF220;CNOT4;PRKN;SH3RF1;SH3RF3;RNF146;RNF213;RNF8;UHRF2;DDB2;RNF41;SH3RF2;NFX1;ITCH;RNF115;ERCC8;WWP2;RNF185;MDM2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6419330615102156,1.5399680390862747,0.018518518518518517,0.16906580449252948,1.0,11/24,16.81%,CLU;RACK1;PARK7;UBXN1;TMBIM6;CREB3;WFS1;SYVN1;HSPA1A;NR1H2;HERPUD1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6606047725809899,1.5393606777457525,0.034210526315789476,0.16962605870046618,1.0,6/19,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,embryonic eye morphogenesis (GO:0048048),-0.6144133380813849,-1.5392258836439234,0.04946996466431095,0.44421593616082866,1.0,4/11,5.77%,FBN1;LRP6;RARG;EFEMP1
prerank,neurotransmitter secretion (GO:0007269),0.5855958353741247,1.538065012373099,0.009009009009009009,0.17133581693339003,1.0,27/44,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6339098184867085,1.5372073037930634,0.016786570743405275,0.17233089697321255,1.0,9/28,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;OTULIN;AAMP;RIPK2;UBE2V1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5894872071922361,-1.5367590067384929,0.06293706293706294,0.443850064266287,1.0,8/11,39.05%,SMAD7;RC3H2;SOCS5;ANXA1;JAK3;IL4;FOXP3;TBX21
prerank,negative regulation of growth (GO:0045926),0.536900530299737,1.5363421284194552,0.0010214504596527069,0.17330183663767804,1.0,44/121,20.24%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;RACK1;MT3;NDUFA13;MT2A;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;NOTCH1;TGFB1;ING5;OSGIN1;SFRP1;SPHK2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.7093233154583842,1.535857015256312,0.02699055330634278,0.17368964997781997,1.0,4/13,3.67%,RACK1;PARK7;TXN;GPR37L1
prerank,regulation of B cell activation (GO:0050864),0.6320532880297928,1.5357318362807564,0.02197802197802198,0.17338939700233164,1.0,9/25,21.40%,LAPTM5;ZFP36L1;ZFP36L2;TNFAIP3;CD22;IKZF3;SH3KBP1;IL6;BANK1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5724215187755743,1.5348563428840163,0.012114537444933921,0.17448193786709632,1.0,14/53,17.09%,MTNR1A;MTNR1B;NPY1R;AGT;SSTR4;HTR2C;VIPR1;MC1R;CHRM3;CHRM2;CCL2;HTR7;PTGIR;CHRM5
prerank,response to thyroid hormone (GO:0097066),0.7182500297370825,1.5346252924199117,0.027434842249657063,0.1742788814968213,1.0,3/13,1.67%,CTSB;CTSL;CTSS
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6892930390986466,1.5337944144488156,0.022871664548919948,0.17530004184000486,1.0,7/16,21.10%,APOE;AGT;DDAH1;MAFA;DDAH2;NOS2;KCNC2
prerank,cellular response to purine-containing compound (GO:0071415),0.746122389859995,1.533790566927638,0.032716927453769556,0.17477766492766553,1.0,6/10,15.89%,P2RY6;P2RY1;GSTM2;TRPM2;SLC8A1;RYR2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6890197041545796,1.5319264861092476,0.020969855832241154,0.1775381957085356,1.0,6/16,13.45%,IGFBP6;IGFBP3;IGFBP4;IGFBP5;IGFBP2;BMP2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6195906837343294,1.5315027964408865,0.020190023752969122,0.17778797733374127,1.0,11/28,14.57%,RPS3;RAC1;HSPA1B;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;HSPA1A;ARL2
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4572896661759819,-1.5299399283746344,0.03289473684210526,0.45565663684053825,1.0,9/31,10.62%,RANBP3L;SMAD6;CRIM1;SUFU;LRP5;SKI;CDK6;PPARG;TRPM4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.6440907204776718,1.5297561765364596,0.02586206896551724,0.18047910968275563,1.0,7/22,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.666233685410312,1.5290379066754485,0.03337783711615487,0.18145187043158226,1.0,6/17,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4810921330032427,-1.528792935448723,0.010471204188481676,0.4518489721172663,1.0,11/25,19.40%,GHR;STAT5B;IL31RA;PIAS1;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,regulation of fibroblast proliferation (GO:0048145),0.5772172965586361,1.5277831504096444,0.014722536806342015,0.18330947823641924,1.0,18/45,20.52%,FTH1;CD74;S100A6;AGT;PDGFB;MIF;CTNNB1;FN1;AQP1;WNT5A;GAS6;PDGFA;DAB2IP;TRIM32;CD300A;DDR2;SFRP1;MYC
prerank,anterograde axonal transport (GO:0008089),0.6022476363399106,1.5265601226237027,0.026932084309133488,0.18497380005394018,1.0,12/37,12.70%,HSPB1;SOD1;BLOC1S4;MAP1A;DLG2;NEFL;AP3B2;KIF5A;BLOC1S1;BLOC1S3;HAP1;BLOC1S5
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7282037460104673,1.5259296070487234,0.043115438108484005,0.18560444679376217,1.0,7/11,15.58%,CYBA;TREM2;TIRAP;TNFAIP3;TLR6;F2RL1;TLR1
prerank,positive regulation of response to wounding (GO:1903036),0.6437466420397477,1.5252659299332598,0.023661270236612703,0.1862716175674238,1.0,4/24,1.29%,ACTG1;VTN;MDK;GRN
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5470358687345772,1.5250825259334173,0.010741138560687433,0.18608050915375687,1.0,30/68,25.86%,CD74;MBP;TYROBP;CYBA;TNF;TIRAP;HYAL2;HSPD1;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PYCARD;APP;AGER;LBP;IL33;TLR7;POU2F2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4574800052182354,-1.5248815177628146,0.03208556149732621,0.45566090326625547,1.0,10/27,15.34%,PID1;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,autophagosome maturation (GO:0097352),0.6071436626263371,1.5248012050413329,0.024764150943396228,0.18609347776461127,1.0,7/32,5.80%,CALM1;GABARAP;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;VCP
prerank,regulation of protein binding (GO:0043393),0.524087170435986,1.5234990633753933,0.003061224489795918,0.18802164307580488,1.0,31/114,14.55%,ACTB;RPL11;RACK1;CLDN5;B2M;VTN;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;RAN;PDGFB;FKBP1A;PIN1;SORL1;FLOT1;TLE5;ADD2;HIPK2;LRPAP1;IFIT1;CAMK1;BAX;DNAJB2;DDX11;BMP2;RIPK2;HDAC5;TIAM1
prerank,axon development (GO:0061564),0.5470844280539797,1.5228878070047467,0.008456659619450317,0.18859437316756128,1.0,25/78,16.85%,ACTB;S100A6;PLP1;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;RTN4;NEFH;NRCAM;GRM7;MAPT;CDK5R1;PAK3;ADGRB1;APBB1;SHTN1;CCK;DSCAML1;SPTBN4;CDK5;GAP43;BRSK2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5980247734578544,1.5222212172877312,0.01650943396226415,0.18939894335960486,1.0,13/34,20.24%,LAPTM5;RBP4;SLC7A5;PTPRC;IL2;VAMP3;WNT5A;F2RL1;DNAJB9;STX4;CD86;IL6;SPHK2
prerank,regulation of receptor binding (GO:1900120),0.7382720219238841,1.5219386079974802,0.04329004329004329,0.18937103678209097,1.0,2/10,3.42%,B2M;ADAM15
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5663201584036032,1.5219199524290734,0.014301430143014302,0.18885593998872865,1.0,20/54,16.87%,RPS3;RPL11;RPL5;PARK7;UBXN1;AKT1;COPS9;HSPA1B;CTNNB1;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;ARRB2;CAV1;SQSTM1
prerank,water transport (GO:0006833),0.7105615418713107,1.521762867393185,0.036011080332409975,0.18860505035546887,1.0,2/12,8.41%,AQP4;AQP1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7150064257657164,1.5206749471501486,0.034106412005457026,0.1902769740023859,1.0,5/13,5.80%,TMSB4X;TREM2;PINK1;ENO1;VCP
prerank,positive regulation of neutrophil migration (GO:1902624),0.6574624110072949,1.5205035738882209,0.036193029490616625,0.19005137061763075,1.0,6/18,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,signal release from synapse (GO:0099643),0.5803386189669744,1.5203722863052596,0.010101010101010102,0.18980756665496953,1.0,26/43,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,negative regulation of macrophage activation (GO:0043031),0.6748551202862287,1.519974058728117,0.03042328042328042,0.19001500066201868,1.0,5/16,8.58%,GRN;PTPRC;NR1D1;LRFN5;SYT11
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6540824385510626,1.5199394397034542,0.02349869451697128,0.18955671464212756,1.0,4/20,8.35%,APOE;ACADVL;RAN;SEC14L2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5338215509159367,1.5198606217102506,0.012605042016806723,0.1891424481559862,1.0,43/85,26.32%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,negative regulation of axon extension (GO:0030517),0.6134900126746412,1.5198088128799605,0.028402366863905324,0.1886864772568405,1.0,9/30,13.41%,MT3;SEMA3F;SEMA7A;RTN4;SEMA4C;SEMA6D;MAP2;SEMA4A;SEMA4G
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6141928453812084,-1.519487840595129,0.052083333333333336,0.4632268717996608,1.0,5/10,17.24%,RAPGEF2;ATP7A;GIPC1;APPL1;CTNS
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6292939589777672,1.5194356539439124,0.031363088057901084,0.18880688011090754,1.0,6/26,3.71%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6393553578053681,1.5193877997019651,0.029639175257731958,0.1883681118722034,1.0,5/21,5.60%,RPS3;CD81;NFAM1;PTPRC;SLC39A10
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5802219558400675,1.5192426455221693,0.016317016317016316,0.18813929010147873,1.0,22/41,23.07%,PRNP;GRM5;AGT;PDGFB;NTRK2;DOCK3;LILRA5;FCGR1A;CSF1R;DOK7;FBXW7;SRCIN1;GAS6;LRP8;NCF1;CASS4;ADAM17;ERBB3;UNC119;EFNA1;TGFA;PTPN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6555821707913475,1.5191969283878244,0.035443037974683546,0.18768851571417738,1.0,9/18,11.36%,SLC17A8;GRIA2;SLC1A4;GRID2;GRIK5;GRIK2;GRID1;SLC17A7;SLC17A6
prerank,transition metal ion transport (GO:0000041),0.6035239418294864,1.5188078218520276,0.018518518518518517,0.1879352402122931,1.0,12/35,15.53%,FTH1;ATOX1;MT3;SLC30A1;COX17;TFRC;TTYH1;TRPC7;SLC11A1;TRPC1;SLC31A1;HEPH
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6684963604426202,1.5187025241786258,0.04806408544726302,0.18757959048804115,1.0,4/16,9.25%,TUBB;TUBB4B;CORO1A;VAMP2
prerank,glycine transport (GO:0015816),0.7581748253303774,1.5186567782178169,0.030683403068340307,0.1871638238199752,1.0,3/10,9.08%,SLC38A5;SLC6A17;SLC6A5
prerank,negative regulation of proteolysis (GO:0045861),0.5977144156674271,1.5184039448925717,0.011876484560570071,0.18710842417144355,1.0,13/34,12.45%,CST3;TIMP2;AKT1;PRNP;SERPINE2;TMEM59;ECM1;CSTB;TIMP1;GAS1;PLAT;CAMK2N1;TIMP3
prerank,phospholipid transport (GO:0015914),0.5662159046899558,1.518391095725815,0.00782122905027933,0.18662913685858723,1.0,11/52,10.95%,APOE;PLTP;NPC2;APOC1;TMEM30A;SCP2;ATP8B4;ABCG1;ATP8A2;MFSD2A;ATP8A1
prerank,transition metal ion homeostasis (GO:0055076),0.6245251383881186,1.5181844927864885,0.023474178403755867,0.18650322629916363,1.0,5/28,1.88%,FTL;B2M;MT3;HMOX1;TMPRSS6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4875918063648415,-1.5180590438806065,0.01990049751243781,0.4605539405087743,1.0,8/23,11.38%,ZBTB20;ARNT;NFKB1;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5643633005873221,-1.5176750193302144,0.040145985401459854,0.455543222647004,1.0,7/13,22.20%,RANBP2;CBLB;KPNA4;KPNA2;NUP35;KPNA3;KPNA6
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.6349020823923158,1.5170740954914548,0.03176620076238882,0.18807079961362633,1.0,6/22,12.23%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5457167369358802,1.5164308517985807,0.010869565217391304,0.18886825017051675,1.0,18/71,10.13%,RPS27A;CTSB;UBC;UBB;CTSL;CTSZ;CTSS;LGMN;NR1D1;VCP;TNFAIP3;OMA1;UBA52;ISG15;PRPF19;NEDD8;OTUD7A;DDB1
prerank,dopamine metabolic process (GO:0042417),-0.5118725860051727,-1.5155786711982304,0.03225806451612903,0.4547692074792576,1.0,4/18,6.77%,SNCAIP;MOXD1;PRKN;ATP7A
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6453901486365273,1.5149272378563607,0.033582089552238806,0.19113510603060568,1.0,5/22,6.25%,TMSB4X;TMSB10;GSN;MYADM;PFN1
prerank,lipoprotein biosynthetic process (GO:0042158),0.7275876053524405,1.5143054211650038,0.04310344827586207,0.19179539611638857,1.0,1/11,0.03%,APOE
prerank,intraciliary retrograde transport (GO:0035721),-0.5734838837930768,-1.514234844916209,0.05802047781569966,0.4523761347018021,1.0,7/12,17.04%,DYNC2H1;WDR35;IFT140;IFT122;WDR19;DYNC2I2;DYNC2LI1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5811337403260792,1.513491139055873,0.012850467289719626,0.19280335027973708,1.0,13/41,16.91%,GPX4;SCD5;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;SCD;FADS3;DEGS1;FAAH
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5604077570797764,-1.5132250375545602,0.04779411764705882,0.44905141143475436,1.0,5/12,10.73%,NFIB;PAFAH1B1;GLI2;EPHA4;EPHB2
prerank,synaptic vesicle cycle (GO:0099504),0.6069537785644892,1.511419562870368,0.02364066193853428,0.1964607518949268,1.0,17/30,28.13%,SLC17A8;NLGN1;SNAP25;DNAJC5;RIMS1;VAMP2;SLC17A7;SLC17A6;SYNDIG1;SYT10;CDK5;SNCA;SLC32A1;WNT7A;PIP5K1C;CPLX1;PCLO
prerank,cellular response to interleukin-1 (GO:0071347),0.5171340780073059,1.5102484690342997,0.0,0.19803378074132544,1.0,48/143,20.94%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;NR1D1;PSMD1;PSMC3;SIRPA;ST18;PSMD6;HYAL2;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;RIPK2;PSMB10;UBE2V1;CCL2;MAPK11;PSMB1;PSMB5;DAB2IP;CCL3;SQSTM1;CCL8;TAB1;PSMA6;SKP1;SFRP1;IL1RAP;PSMA4;NFKBIA;PYCARD
prerank,acylglycerol metabolic process (GO:0006639),0.582699354924854,1.5102460734062628,0.023310023310023312,0.19750523624834437,1.0,8/37,9.18%,APOE;PNPLA2;APOC1;LYPLA2;PLAAT3;DGKH;LPL;DGKI
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6420769727205993,1.509994667959334,0.027227722772277228,0.19751772883884974,1.0,7/22,9.86%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;CD22;PHPT1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7426344245812637,1.509247965105815,0.03687943262411347,0.19832486090987725,1.0,8/10,20.71%,SORL1;HSPA1B;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,negative regulation of T cell activation (GO:0050868),0.5841838327795889,1.509173639349053,0.028935185185185185,0.19789852565853264,1.0,8/35,13.40%,LAPTM5;GPNMB;LGALS3;DUSP3;CEBPB;FGL1;SDC4;LILRB1
prerank,dendritic cell differentiation (GO:0097028),0.6356497913313893,1.5077536582736206,0.030112923462986198,0.2001361385140936,1.0,10/22,19.96%,CCL19;TREM2;IRF8;TRPM2;LILRB1;GAS6;F2RL1;BATF3;FLT3;BATF2
prerank,spliceosomal snRNP assembly (GO:0000387),0.5848313646987158,1.5074341471301114,0.02619047619047619,0.20018802762582336,1.0,13/38,18.56%,SNRPG;GEMIN7;SNRPD2;LSM4;SNRPE;SNRPF;STRAP;CD2BP2;PRPF19;PRPF8;SNRPB;PRPF31;SNRPD3
prerank,regulation of mRNA stability (GO:0043488),0.5158045128761526,1.5073184656603347,0.0,0.19989419624455082,1.0,55/145,20.35%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;YWHAB;PSMD1;ZFP36L1;MEX3D;PSMC3;ZFP36L2;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;YBX1;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;SLC11A1;HSPA1A;PSMB10;YWHAZ;HNRNPU;PDE12;CIRBP;YTHDF1;PSMB1;PSMB5;PCID2;EIF4ENIF1;TBRG4;ANP32A;EXOSC9;PSMA6;CARHSP1;SERBP1;PSMA4
prerank,pulmonary valve morphogenesis (GO:0003184),-0.5271577555893467,-1.5071718305039852,0.0794979079497908,0.4583115172073279,1.0,8/17,14.92%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2
prerank,response to axon injury (GO:0048678),0.6558826050015633,1.5064486342553671,0.039141414141414144,0.20107774781665874,1.0,4/18,2.84%,APOD;TYROBP;SOD1;TREM2
prerank,heart process (GO:0003015),0.6837028679567068,1.5063113293221317,0.04217687074829932,0.20084209939526274,1.0,6/14,20.41%,GPX1;SOD1;SGCZ;RAMP3;SGCG;PPCS
prerank,acylglycerol catabolic process (GO:0046464),0.6016130906535188,1.5055745402348946,0.02491103202846975,0.20179697391041027,1.0,12/30,25.29%,PNPLA2;LYPLA2;FABP5;LIPG;LIPE;LPL;FAAH;FABP7;FABP4;FABP3;ABHD16A;ABHD12
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6221749551391813,1.5053518779986637,0.03329223181257707,0.20169076985595777,1.0,11/24,19.11%,CALM1;AKAP6;CALM3;FKBP1A;GSTO1;GSTM2;JPH4;SRI;FKBP1B;SELENON;CALM2
prerank,negative regulation of immune system process (GO:0002683),0.667708667457072,1.505308993694237,0.038510911424903725,0.20123402133234242,1.0,4/16,13.00%,HMOX1;GPER1;COL3A1;SOX9
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6199177624486069,1.5051841178891696,0.02875,0.20099281327492005,1.0,11/26,19.11%,CALM1;CALM3;FKBP1A;YWHAE;GSTO1;PLN;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,positive regulation of inflammatory response (GO:0050729),0.5311920265312741,1.5048667058238208,0.005246589716684155,0.20113250483863315,1.0,36/86,26.22%,RPS19;CD81;MDK;GRN;AGT;TNF;S100A8;S100A9;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;NUPR1;LILRA5;KARS1;NINJ1;PLA2G7;WNT5A;VAMP8;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;IL6;NFKBIA;TNIP1;APP;PLA2G3;LBP;PDE2A;IL33;TLR7;CX3CL1
prerank,hemidesmosome assembly (GO:0031581),0.7277685736296627,1.504721052563352,0.04477611940298507,0.20093572797677964,1.0,4/11,9.48%,CD151;LAMC1;PLEC;LAMC2
prerank,positive regulation of ATPase activity (GO:0032781),0.5799930869382922,1.50346837275858,0.027906976744186046,0.20292797518106093,1.0,16/41,18.89%,DYNLL2;DYNLL1;GABARAPL2;PFN1;ATP1B2;DNAJB2;VMP1;HNRNPU;DNAJB1;ATP1B1;RYR2;PFN2;DNAJB11;ATP1B3;AHSA1;DNAJC10
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.630788386708808,1.503008772296381,0.025735294117647058,0.2033302963678462,1.0,8/26,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6158302920943788,1.5029142376411098,0.030303030303030304,0.20297657991004733,1.0,10/27,15.48%,CD74;S100A6;AGT;PDGFB;MIF;FN1;AQP1;WNT5A;GAS6;PDGFA
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6369099524663542,1.5028234115629768,0.046019900497512436,0.20262218362189602,1.0,3/21,2.84%,APOE;PLTP;TREM2
prerank,negative regulation of neuron projection development (GO:0010977),0.5569572797995893,1.5025426382890026,0.014460511679644048,0.2026658355729283,1.0,12/56,8.34%,APOE;ARHGDIA;ITM2C;MT3;DCC;NLGN1;RTN4;LRP4;SPOCK1;BAG5;CRMP1;THY1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6989892461359734,1.5021346659440635,0.04227212681638045,0.20295285738206814,1.0,8/13,19.11%,CALM1;CALM3;ANK3;IRX3;SLC8A1;CAV1;SRI;CALM2
prerank,response to hydrogen peroxide (GO:0042542),0.570327123345579,1.50201198510756,0.0257847533632287,0.20267313362491177,1.0,14/45,15.71%,RPS3;GPX1;HMOX1;PARK7;SOD1;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2;CAT;HP;GLRX2
prerank,negative regulation of bone remodeling (GO:0046851),0.7235732385908435,1.5008532308376819,0.052486187845303865,0.20457106874680894,1.0,6/11,20.17%,TNFAIP3;P2RX7;GPR137B;TMEM119;IL6;SFRP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6111381404640215,1.5003465091204153,0.029150823827629912,0.20511254160976147,1.0,5/24,7.08%,MT3;HSPA5;ATF4;KLF2;CEBPB
prerank,regulation of microtubule-based movement (GO:0060632),0.720266273179627,1.500113400495389,0.051209103840682786,0.20505337784502833,1.0,4/11,11.11%,LAMP1;NEFH;MAP2;HAP1
prerank,regulation of interleukin-8 production (GO:0032677),0.5425892076020108,1.499930450947064,0.010683760683760684,0.20488407119142932,1.0,22/69,21.15%,TMSB4X;CD74;PARK7;TNF;LAMTOR5;PTPRC;HSPA1B;TIRAP;HYAL2;HMGB1;KLF4;HSPA1A;TLR6;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,limb development (GO:0060173),-0.44177160452245656,-1.4991161794404189,0.03164556962025317,0.4736841087548414,1.0,8/28,13.22%,SMOC1;GLI3;KREMEN1;KAT2B;PCSK5;IQCE;INTU;IFT122
prerank,negative regulation of binding (GO:0051100),0.531086486535033,1.4974242156625,0.008368200836820083,0.2094257193301056,1.0,21/81,12.09%,ACTB;RACK1;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;PDGFB;PIN1;SORL1;TLE5;LRPAP1;PLN;IFIT1;JUN;CAMK1;SUMO3;BAX;DNAJB2;DDX11
prerank,positive regulation of DNA replication (GO:0045740),-0.521045077374002,-1.4973315478716749,0.05286343612334802,0.47168690639083666,1.0,7/16,13.83%,EGFR;GLI2;KAT7;BRPF3;BCAR3;ATAD5;STN1
prerank,energy reserve metabolic process (GO:0006112),-0.4997691597346056,-1.4970980725946013,0.04736842105263158,0.46652417123701906,1.0,5/19,4.38%,PRKAG2;PID1;PHKB;PHKA1;LEPR
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5388291731842192,1.496886961321818,0.008528784648187633,0.20997641383656146,1.0,29/73,20.94%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;CD86;IL6;SPHK2;TMEM106A;PYCARD
prerank,long-term memory (GO:0007616),0.659434732271812,1.4968667658863,0.03354838709677419,0.20948913006945927,1.0,4/19,7.77%,APOE;PRNP;CALB1;SGK1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7192882514461314,1.4966237502900337,0.04261363636363636,0.2094076157941026,1.0,6/11,14.42%,CXCL12;CCL19;HCLS1;LILRB1;GAS6;IRF7
prerank,regulation of T cell migration (GO:2000404),0.6504264529606518,1.4961229588554024,0.03553299492385787,0.2098791021345079,1.0,9/18,24.38%,APOD;CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,positive regulation of macrophage activation (GO:0043032),0.6595460440327408,1.4961172392907984,0.03626943005181347,0.2093618500740871,1.0,8/17,16.37%,TREM2;SPACA3;HSPD1;CEBPA;KARS1;WNT5A;TLR6;CCL3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6895263205405604,1.4959512584685621,0.04223433242506812,0.20917514671243706,1.0,5/14,13.40%,CD74;LAPTM5;SEMA7A;WNT5A;LILRB1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.542561656838372,1.4957867287063886,0.008528784648187633,0.2089749336606564,1.0,28/69,20.94%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PYCARD
prerank,innate immune response (GO:0045087),0.5066827592786259,1.4952907629678596,0.0,0.20943803225520113,1.0,55/217,18.49%,IFITM3;RPL39;CD74;IFITM2;B2M;IFITM1;MBL2;TYROBP;C3;PGLYRP1;S100B;CYBA;TREM2;SHFL;ADAM15;FCER1G;SERINC3;ANG;RARRES2;CYBB;RNF187;PPP1R14B;MFAP4;ISG15;CXCL16;CORO1A;TRIM28;CLEC6A;PTK6;CAPZA2;OTULIN;CXCL10;IFIT1;TRIM59;HMGB1;HCK;SMPD1;CHGA;LCN2;SLC11A1;BST2;MSRB1;RIPK2;CLEC4D;CX3CR1;IRF7;SERINC5;NCF1;ATAD3A;PIK3CD;TRIM32;NOS2;SYK;SRMS;SLA
prerank,lipid droplet organization (GO:0034389),0.6292718433699965,1.49515013387,0.04621309370988447,0.20922140130219408,1.0,6/22,7.35%,PPIA;CDS1;AUP1;BSCL2;TSPO2;HSD17B13
prerank,regulation of translation (GO:0006417),0.5108992757601335,1.4947432168355936,0.0010090817356205853,0.2095669980856356,1.0,24/173,4.47%,RPL26;MRPL13;RPS3;RPS4X;RPL5;EEF2;VIM;RACK1;GAPDH;RPL13A;HSPB1;CALR;EIF1;RPL10;EIF4G2;EIF3D;GRM5;SHFL;NPM1;RPS27L;EIF1B;METAP1;IGFBP5;NCL
prerank,regulation of stress fiber assembly (GO:0051492),-0.37537863993569764,-1.492324443905935,0.01694915254237288,0.4736069646469052,1.0,20/74,6.21%,ROCK2;PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ABL1;ASAP3;ALMS1;SLC9A1;LPAR1;ROCK1;PPM1E;NRP1;SORBS3;ARHGEF18;ARHGEF10L;CARMIL1;TGFBR1;PPFIA1;PXN
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6717100405766345,1.4922102328553002,0.05570652173913043,0.21424389663078885,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6740969763645617,1.4915223356524987,0.048209366391184574,0.2151339426512305,1.0,9/15,18.68%,TYROBP;TREM2;FLOT1;CD53;CAMK1;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,response to UV-B (GO:0010224),0.7074996098538954,1.4908856515810243,0.05138888888888889,0.21584423324650437,1.0,4/12,14.18%,CRIP1;HYAL2;MFAP4;STK11
prerank,cellular protein-containing complex assembly (GO:0034622),0.5035353662953931,1.490355804394389,0.0,0.21637135112325315,1.0,46/160,15.73%,RPL38;CLU;GPX4;HSP90AA1;HSP90AB1;FMOD;NSG1;CYBA;NRG1;HIGD2A;COX7A2L;CSNK2B;PFDN6;CCT2;MID1IP1;FKBP1A;RTN4;COX7A2;POMP;AP2M1;EID2;OMA1;DNAAF3;HSPD1;CLTC;MAPT;VAMP3;VAMP2;AP2S1;HIGD1B;PSMG3;PSMD13;FCHO1;VAMP8;ANLN;HSPA1A;NSG2;VBP1;OTUD6B;TIAM1;ARL2;PTGES3;CLTA;PDE4DIP;MAPK8IP2;TBCA
prerank,receptor-mediated endocytosis (GO:0006898),0.5133024902765191,1.489801218439204,0.0010183299389002036,0.21693365335682055,1.0,45/132,20.32%,APOE;SPARC;CTSL;CD81;RAMP2;HSP90AA1;CALR;MRC1;ITGB2;LRP1B;CANX;HSP90B1;FCER1G;SORL1;CAV2;DNM3;SNAP91;AP2M1;TFRC;CD163;CXCL16;CLTC;AP2S1;FCGR1A;STAB1;LRP3;FNBP1L;FCHO1;RAMP3;MSR1;LILRB1;CLTA;M6PR;HPR;HP;ARRB2;DLL1;CAV1;TMEM108;SYK;SNCA;GRK2;RAB31;HSPG2;CTTN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5872804170466523,1.4879512578788843,0.02883506343713956,0.22018768905768918,1.0,15/38,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;CD34;TNF;RAC1;SIRPA;KLF4;DDAH1;CX3CR1;TLR6;CAV1;DDAH2
prerank,protein-DNA complex assembly (GO:0065004),0.5142884959005773,1.4875880959923866,0.003051881993896236,0.2204164418931696,1.0,34/116,16.77%,RPS27A;UBC;UBB;PSMB4;H3-3A;PSME1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;PSMD1;PSMC3;MCM5;PARP1;PSMD6;RPA2;UBA52;BRD2;PSMA7;GMNN;PSMD5;RBX1;DDB1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;PSMB10;PSMB1;PSMB5;NAP1L2;CETN2
prerank,respiratory electron transport chain (GO:0022904),0.6866977128130787,1.4865557394740352,0.04450625869262865,0.22208435846786448,1.0,11/14,27.44%,ETFB;SLC25A13;NDUFA5;SDHB;SLC25A22;UQCRFS1;PPARGC1A;SLC25A18;SDHA;GPD2;SLC25A12
prerank,neuron remodeling (GO:0016322),0.7329627260218794,1.48646058409447,0.04985754985754986,0.22177011090119034,1.0,3/10,4.22%,C1QA;C3;ADGRB3
prerank,regulation of interleukin-6 production (GO:0032675),0.5150208073990362,1.4863745681299358,0.007216494845360825,0.2214177492276766,1.0,38/96,26.22%,CD74;MBP;TYROBP;CYBA;TREM2;TNF;TIRAP;SIRPA;HYAL2;TNFAIP3;HSPD1;SYT11;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;GAS6;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS;APP;AGER;LBP;IL33;TLR7;POU2F2;CX3CL1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6253249595633512,1.4862487288449728,0.047865459249676584,0.22114380141013246,1.0,10/23,25.31%,LAPTM5;PRNP;VSIR;HMGB1;LILRB1;GAS6;INHBA;DDIT3;C1QBP;INHA
prerank,response to nitric oxide (GO:0071731),0.6921989280441134,1.4855197574717938,0.027816411682892908,0.2222141744132654,1.0,5/13,11.31%,MT3;CCL19;TXN;AQP1;MMP3
prerank,regulation of steroid metabolic process (GO:0019218),0.6171423229396964,1.485514062408033,0.035897435897435895,0.22168972107857993,1.0,3/23,5.55%,APOE;ACADVL;ABCG1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.6190764906887226,1.48478979599477,0.03201970443349754,0.22270985057291118,1.0,19/25,32.42%,TMEM50A;CHMP2B;VCP;LEPROT;CHMP5;CHMP6;SORT1;UBXN6;CHMP1B;CHMP7;LYST;CHMP1A;LAPTM4B;CHMP4C;LEPROTL1;MVB12A;TMEM50B;CHMP4A;CHMP4B
prerank,cellular response to chemical stress (GO:0062197),0.5240150028425288,1.4844274848504095,0.004153686396677051,0.22296053286980963,1.0,35/96,21.52%,PPIA;GPX1;MT3;CHCHD2;PARK7;SOD1;ATF4;CYBA;PRDX5;PRDX6;PINK1;PRDX2;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT;NCF1;ERO1A;CAV1;PPARGC1A;STX4;SNCA;SOD3;SIRT2;SELENOS;CYCS
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5500872132881275,-1.4839333678184063,0.06716417910447761,0.490753653808417,1.0,10/13,25.91%,RNF152;SESN1;ATM;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2;SESN3
prerank,regulation of transport (GO:0051049),0.5805254273660613,1.483658957887556,0.019406392694063926,0.2239751323786628,1.0,15/36,20.22%,ACTB;ACTG1;PINK1;REEP5;REEP6;VAMP2;DNAJA1;RSC1A1;CDK5;EPB41;ICA1;TMEM102;ICA1L;SNCA;TRAT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5976794113603017,1.4835466205254295,0.03341288782816229,0.22369444524486612,1.0,13/30,19.20%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;TAF9;SVIP;SDCBP;SGTA;NOP53;CCAR2;DDRGK1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5589129697299806,-1.4828786426845748,0.08,0.4762867013727279,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5589129697299806,-1.4828786426845748,0.08,0.4762867013727279,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5589129697299806,-1.4828786426845748,0.08,0.4762867013727279,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5518113026855774,1.48195152951218,0.023204419889502764,0.22653197752253576,1.0,24/55,21.42%,RPS3;RACK1;AGT;GPER1;TNF;S100A8;S100A9;HYAL2;TNFSF12;NUPR1;BAX;PMAIP1;BBC3;BAD;DAB2IP;CAV1;BCAP31;DNM1L;LTBR;TNFRSF12A;ING5;PYCARD;DDIT3;FIS1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.677475509134575,1.4817197199861536,0.0398936170212766,0.22656600564296017,1.0,4/15,5.38%,CLU;GPX1;AKT1;GHITM
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5242389546641465,1.4812746538704002,0.009473684210526316,0.22688893676792515,1.0,22/84,11.65%,TMSB4X;SPARC;ATP5F1B;HSPB1;GRN;CALR;RHOB;LGMN;AKT1;ATP5F1A;AGT;PDGFB;RAC1;EMC10;PROX1;KDR;GATA2;HMGB1;PDCD6;WNT5A;AAMP;FLT4
prerank,protein localization to cell-cell junction (GO:0150105),0.6687625068296565,1.4812284663068398,0.04479578392621871,0.22643829916401317,1.0,2/15,0.25%,ACTB;ACTG1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.577761821744151,1.4810268877504316,0.024676850763807285,0.22630239738885866,1.0,13/35,17.61%,NLGN1;PCDHGB4;CDH20;SELL;CDH18;CDH12;CDH19;DCHS1;CDH7;CDH24;CDH10;CDH5;PCDHB14
prerank,regulation of proteolysis (GO:0030162),0.5491545773914089,1.4809647944843174,0.029768467475192944,0.22593658709611694,1.0,21/48,21.57%,CST3;AURKAIP1;AKT1;SERPINE2;LTBP4;PRSS37;CSTB;GSAP;NEDD8;PLAT;CAMK2N1;CLN6;TRAF3;BAD;CDK5;CAV1;TRIM32;CLN8;CAPN3;BAK1;STUB1
prerank,cell junction maintenance (GO:0034331),0.6828832842649335,1.4804583075844575,0.03888888888888889,0.22647445752183312,1.0,6/14,14.62%,CHCHD10;MYADM;CSF1R;DCTN1;CBLN2;F2RL1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.456332857077914,-1.4803133637170998,0.0374331550802139,0.47712430988215027,1.0,7/26,5.50%,FOXP1;STRN3;DAB2;KANK2;PIAS2;CNOT1;NCOR1
prerank,cellular copper ion homeostasis (GO:0006878),0.6809760297594096,1.4797995938568083,0.04871447902571042,0.227455285979582,1.0,6/14,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,macrophage chemotaxis (GO:0048246),0.7141212443350539,1.47975981881001,0.0546218487394958,0.22700629953475834,1.0,4/10,19.16%,LGALS3;CCL2;CCL3;CXCL17
prerank,morphogenesis of an epithelium (GO:0002009),0.6178199918496408,1.4787214637321557,0.03717472118959108,0.22862408201987874,1.0,2/25,0.25%,ACTB;ACTG1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6774171610743042,1.4786873133363656,0.05383580080753701,0.22817223877028883,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,negative regulation of viral genome replication (GO:0045071),0.5720251558725402,1.4785803821626637,0.02413793103448276,0.22787627598896434,1.0,10/40,13.02%,IFITM3;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;BANF1;BST2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6028963385102607,1.4777024168399353,0.04390243902439024,0.22917849795831058,1.0,9/26,14.57%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;ARL2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5952191582137664,1.477350704918948,0.04702970297029703,0.22938972187029003,1.0,11/29,13.55%,CALR;CXCL12;LGMN;TNF;LGALS3;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;GAS6
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6145955375784259,1.4769876196368237,0.04218362282878412,0.22964647466052052,1.0,13/24,16.61%,TYROBP;GRN;ATF4;PRNP;TNF;CTNNB1;NUPR1;CDK5R1;BAX;FBXW7;CDK5;CCL3;BACE1
prerank,regulation of dendritic spine development (GO:0060998),0.6490169853443654,1.4765279650733678,0.042746113989637305,0.23012073495021546,1.0,6/19,9.69%,APOE;NLGN1;GRIN3A;PPFIA2;ARF6;CAMK1
prerank,epiboly involved in wound healing (GO:0090505),0.6753200772673611,1.476311703041332,0.04569190600522193,0.23008816842387436,1.0,7/16,17.95%,CD151;RHOC;MRTFA;FLNA;LCP1;RHOA;TMEFF2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6242874940649816,1.4756695991245767,0.03522012578616352,0.23089790466775292,1.0,6/21,10.71%,MDK;MAPK3;MIF;DDT;RARRES2;CSF1R
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6570423105058119,1.4737470084324318,0.043596730245231606,0.23444194205612412,1.0,2/15,3.71%,APOE;TNF
prerank,triglyceride homeostasis (GO:0070328),0.5988081369952616,1.4737385688916138,0.0462085308056872,0.23393143114019005,1.0,4/26,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,carbohydrate derivative transport (GO:1901264),0.6370417050209438,1.4735438941623153,0.04292929292929293,0.23381852147107843,1.0,9/18,15.78%,PLTP;NPC2;ABCG1;MFSD2A;SLC15A4;SLC29A1;SLC29A2;SLC15A2;SLC25A19
prerank,heart contraction (GO:0060047),0.5578337299655005,1.4732736846705443,0.02857142857142857,0.23391967175210213,1.0,12/41,19.18%,GPX1;SOD1;SGCZ;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;SGCG;GRK2
prerank,apoptotic cell clearance (GO:0043277),0.5897682736206565,1.47297119418424,0.036991368680641186,0.2340529831142848,1.0,12/30,20.24%,TYROBP;TREM2;TGM2;RAC1;RHOG;XKR4;HMGB1;ADGRB1;GAS6;TYRO3;RAC2;XKR6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.45224900856298517,-1.472898420367374,0.046875,0.4904050941499983,1.0,12/25,16.73%,SULF1;ZNF423;BMPR1A;FOXD1;SMAD4;RBPJ;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,actin cytoskeleton reorganization (GO:0031532),-0.36819313544580423,-1.4723795993503899,0.0,0.48603746651630736,1.0,16/63,9.64%,AUTS2;MCU;SIPA1L1;PHACTR1;FER;PARVA;GAB1;NRP1;PTK7;RICTOR;MYH9;MKLN1;CDC42BPB;PDLIM4;NRK;PIP5K1A
prerank,regulation of establishment of planar polarity (GO:0090175),0.5157150616441085,1.472359261538559,0.015806111696522657,0.23485604098624896,1.0,43/88,26.32%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.522469817536289,1.4716913198437886,0.011603375527426161,0.23574643323462383,1.0,22/80,16.13%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;RACK1;EIF3D;NPM1;RPS27L;TNF;ABCG1;EIF3C;GSAP;PCIF1;ZCCHC4;TNFRSF1A;IFNGR1;CIRBP;YTHDF1;ABCA2;EIF4A3
prerank,hexose metabolic process (GO:0019318),0.5726237235777958,1.4715356358042935,0.03218390804597701,0.2355054793538144,1.0,11/39,10.95%,ALDOA;APOD;ALDOC;OMA1;GALT;PMM1;FUOM;CHST1;GAA;DCXR;FUCA1
prerank,copper ion homeostasis (GO:0055070),0.6557598103763376,1.4715255790934079,0.045871559633027525,0.2350026888947241,1.0,6/17,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5755776162281729,1.4714770693774488,0.03751465416178194,0.2345752297106097,1.0,9/36,10.15%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;GABARAPL2;BAG5;ALAD;TAF9
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7152365833531212,1.4711355774913317,0.046153846153846156,0.2347997278243731,1.0,4/10,14.25%,AKT1;TREM2;CD68;TLR6
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.508659317529263,-1.4706872780637117,0.06910569105691057,0.48511465524226577,1.0,9/18,21.30%,BIRC2;BIRC3;SEC14L1;ANKRD17;DDX60;NPLOC4;PUM2;DHX58;GPATCH3
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5824394889135789,1.4706308612569883,0.044063647490820076,0.23527156049056547,1.0,9/31,18.00%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;HMGB1;RIPK2;MAPK11;SYK
prerank,positive regulation of leukocyte activation (GO:0002696),0.6409257938426447,1.4705151530695384,0.034210526315789476,0.2349915778266673,1.0,10/18,25.78%,SPACA3;HSPD1;CEBPA;KARS1;WNT5A;CLEC4D;TLR6;CRLF2;LBP;IL33
prerank,positive regulation of cholesterol transport (GO:0032376),0.5984275460968137,1.469956454840755,0.05017921146953405,0.23570815472026227,1.0,5/27,6.66%,APOE;PLTP;TREM2;SCP2;LIPG
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6682309485451783,1.4698890862776197,0.05320600272851296,0.235326361988114,1.0,10/15,27.18%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,gas transport (GO:0015669),0.7229077424757722,1.4698735415907225,0.059490084985835696,0.23484862337609946,1.0,6/10,22.18%,CA2;IPCEF1;CYGB;AQP1;MYC;MB
prerank,fatty acid transport (GO:0015908),0.6474146710623438,1.4691947438448576,0.047936085219707054,0.23584879470379802,1.0,3/17,8.69%,APOE;FABP5;MFSD2A
prerank,protein kinase B signaling (GO:0043491),0.6172903864250694,1.468509553193181,0.062111801242236024,0.2367981359120308,1.0,12/23,21.37%,MT3;AKT1;TNF;ZFP36L1;KDR;GAS6;CCL2;TYRO3;CCL3;TGFB1;THEM4;SIRT2
prerank,regulation of macrophage migration (GO:1905521),0.7085200540820712,1.467966220133757,0.059574468085106386,0.2374671823929603,1.0,3/10,14.23%,CD81;P2RY12;CX3CR1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.609068298219213,1.467399651673997,0.04020100502512563,0.23812281431203858,1.0,6/21,10.12%,LAPTM5;GPNMB;LGALS3;DUSP3;TNFAIP3;FGL1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5843531473442343,1.4673314670465325,0.03348729792147806,0.23778693434252518,1.0,8/35,4.63%,CALM1;HSP90AB1;CALM3;CSNK2B;PPP1R15B;HSP90B1;FKBP1A;PPP1R1B
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5621539973701274,1.4673014125687838,0.029850746268656716,0.2373498675211324,1.0,16/40,20.94%,CLU;GPX1;AKT1;PINK1;GPER1;GHITM;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PRELID1;HGF;PYCARD
prerank,activation of protein kinase B activity (GO:0032148),0.5849722457670461,1.4672973413213406,0.038686987104337635,0.23684988809552435,1.0,9/29,4.35%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;PDGFB;ANG
prerank,positive regulation of T cell migration (GO:2000406),0.6233973346947186,1.466929606502213,0.062420382165605096,0.23714249472687962,1.0,12/20,26.20%,CXCL12;CXCL10;WNT5A;AIF1;RHOA;DOCK8;TMEM102;ADAM17;CCR2;PYCARD;APP;OXSR1
prerank,central nervous system myelination (GO:0022010),0.7061662202385464,1.4666782068619668,0.06647807637906648,0.23714665251756722,1.0,6/11,16.01%,CLU;PLP1;B4GALT6;MYRF;TENM4;ABCA2
prerank,glutathione derivative metabolic process (GO:1901685),0.6314707915017063,1.4665352712687338,0.05361596009975062,0.2364275539057591,1.0,9/20,20.13%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6314707915017063,1.4665352712687338,0.05361596009975062,0.2364275539057591,1.0,9/20,20.13%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5940680038480898,1.4665241488348413,0.04142011834319527,0.23593692362412141,1.0,9/29,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,regulation of supramolecular fiber organization (GO:1902903),0.6189641660824825,1.4664556432198943,0.03783102143757881,0.23557837431210538,1.0,8/22,10.83%,APOE;HSPA8;GPX1;PARK7;MAP1A;MAPT;MAP2;AEBP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.681873324686409,1.4663313231331108,0.043701799485861184,0.23534694830709604,1.0,2/13,1.79%,APOE;SOD1
prerank,positive regulation of cellular respiration (GO:1901857),0.7157481277799593,1.4656737681776444,0.05352112676056338,0.23623221881587608,1.0,7/11,20.10%,PARK7;PINK1;VCP;NUPR1;ISCU;PRELID1;IL10RB
prerank,regulation of tissue remodeling (GO:0034103),0.6445869075115811,1.4650029971572252,0.05412371134020619,0.23711375400605372,1.0,3/18,1.42%,CST3;MDK;GPNMB
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5307992093727775,1.4642801704466704,0.02176278563656148,0.23814298722127883,1.0,22/61,16.42%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;NCOR2;ODC1;PSMB10;PSMB1;PSMB5;CAV1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5900221784111984,1.464245816648831,0.043478260869565216,0.23772844155642814,1.0,9/30,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,steroid catabolic process (GO:0006706),0.7191907089498862,1.463861702767237,0.046742209631728045,0.23804505859524044,1.0,3/10,6.58%,SPP1;YWHAH;HSD17B6
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.40727492482999306,-1.4635115349857846,0.026490066225165563,0.49861612013845047,1.0,11/36,11.01%,AFDN;GOLGA4;VAMP5;MACF1;SPTBN1;GORASP2;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,fatty acid biosynthetic process (GO:0006633),0.5292177646415372,1.4629440975248957,0.022702702702702703,0.23945016550115725,1.0,25/63,28.16%,GPX4;SCD5;FADS1;LIPG;ELOVL1;ELOVL2;TECRL;LPL;OXSM;ELOVL7;SCD;ACOT7;FADS3;DEGS1;LTC4S;ASAH2;ACSM5;NDUFAB1;CYP2E1;ELOVL6;ACLY;HACD4;XBP1;GSTM4;HSD17B8
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5827680839812721,-1.4627838946553764,0.0661764705882353,0.4951453240680024,1.0,4/11,8.88%,TGFBR3;ACVR1;TGFBR1;SMAD7
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6862525284957776,1.4608878417852902,0.06056338028169014,0.24333289115350837,1.0,4/13,3.73%,TYROBP;HSP90AB1;TNF;MAP1A
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7255789162070994,1.4606383631890445,0.05346820809248555,0.24284645626283982,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7255789162070994,1.4606383631890445,0.05346820809248555,0.24284645626283982,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,global genome nucleotide-excision repair (GO:0070911),0.5996177094940005,1.460270420758723,0.033373063170441,0.24308061426581928,1.0,7/26,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5895555841956291,1.4599320836480343,0.04410011918951132,0.24326349796430008,1.0,9/30,15.42%,RPS3;PRNP;IL2;PRKAR1A;CD24;ICOSLG;HMGB1;IGFBP2;IGF2
prerank,myeloid cell differentiation (GO:0030099),0.5525716856414109,1.4595941381707802,0.02249718785151856,0.24341751351337101,1.0,11/47,11.15%,RPS14;RPS19;SLC25A5;HCLS1;SPI1;ATP5IF1;TIRAP;HIPK2;CEBPA;IKZF1;IL11
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5891789520654989,-1.4581899916409253,0.08135593220338982,0.49645872916832523,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,DNA dealkylation (GO:0035510),-0.5891789520654989,-1.4581899916409253,0.08135593220338982,0.49645872916832523,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,positive regulation of nervous system development (GO:0051962),0.5552237756292007,1.4580141487448386,0.037714285714285714,0.24627614620576707,1.0,19/42,20.88%,NRXN1;NLGN1;SERPINF1;TGM2;GPER1;GRID2;IL1RAPL1;PTPRD;SNW1;SYNDIG1;LRRC4B;CX3CR1;EPHB1;CLSTN2;CLSTN1;TRIM32;SOX11;IL1RAP;CLSTN3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.656051573587523,1.4579112715909062,0.05186170212765957,0.2459573832932684,1.0,1/17,0.01%,TMSB4X
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5844478374911455,-1.4576350686776782,0.08358208955223881,0.49256954033795636,1.0,5/10,16.18%,CAMK2D;PRKCE;ATP1A2;HECW2;STK39
prerank,regulation of protein metabolic process (GO:0051246),0.5539330834339717,1.4574378150308527,0.0447427293064877,0.2465659161876405,1.0,12/44,12.78%,APOE;HSP90AB1;KLF2;LTBP4;FKBP1A;CHEK2;GSAP;NEDD8;CHMP6;WFS1;ODC1;KLF4
prerank,cell junction assembly (GO:0034329),0.5127756315104591,1.456760384511108,0.00932642487046632,0.2476240418395093,1.0,33/100,19.08%,ACTB;ACTG1;CLDN5;GJA4;NRXN1;SPOCK2;NLGN1;DSCAM;CDH20;FLNA;ADGRL3;DNM3;FN1;KIRREL3;CDH18;NRCAM;DNER;NRXN2;RHOA;CDH12;VMP1;CDH19;DCHS1;CDH7;ACHE;CDH24;CDK5;CDH10;CDH5;PCDHB14;GPM6A;CTNND2;FBLIM1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.4111817379529039,-1.4565986090373306,0.031496062992125984,0.49003297533461154,1.0,10/36,14.96%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,cellular response to oxidative stress (GO:0034599),0.5036947375904909,1.4563347940275635,0.003067484662576687,0.24813326510259168,1.0,32/118,13.89%,RPS3;PPIA;GPX1;MT3;CHCHD2;HMOX1;PARK7;SOD1;MAPK3;ATF4;AKT1;CYBA;PRDX5;PRDX6;PINK1;PRDX2;ROMO1;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;MAPT;JUN;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT
prerank,macrophage activation involved in immune response (GO:0002281),0.6860688482947599,1.4562481734956048,0.056708160442600276,0.24779943019885722,1.0,3/13,2.84%,TYROBP;GRN;TREM2
prerank,histone modification (GO:0016570),-0.339893618577909,-1.4556595605355682,0.0,0.48754925543550326,1.0,32/109,14.96%,EYA2;NSD1;EYA1;PRDM5;KAT6B;CREBBP;USP3;MIDEAS;BAZ2A;HDAC4;MTA3;EHMT1;TBL1X;HUWE1;RCOR1;UFL1;EYA4;BAZ1B;USP16;NSD3;MIER1;USP36;TBL1XR1;EYA3;RCOR3;BRD8;PHF20L1;KAT6A;SIRT1;EHMT2;CARM1;EZH2
prerank,positive regulation of ERAD pathway (GO:1904294),0.6902077636192385,1.4547394953945483,0.05509641873278237,0.25065973231361915,1.0,8/13,21.25%,UBQLN2;RNFT1;SGTA;CAV1;HERPUD1;BCAP31;TMEM259;USP13
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6292786408834095,1.4542591482268896,0.05972045743329098,0.2512782032496631,1.0,4/19,15.63%,APOE;RAPSN;CHRNA4;ACHE
prerank,regulation of autophagosome maturation (GO:1901096),-0.5346232520691333,-1.454192040498312,0.06766917293233082,0.4867334919097853,1.0,7/13,22.92%,CLEC16A;UVRAG;CLN3;TMEM39A;RUBCN;ADRB2;PHF23
prerank,negative regulation of MAPK cascade (GO:0043409),0.5159779254470535,1.45401041741052,0.00946372239747634,0.2512850108977181,1.0,21/87,13.41%,APOE;PPIA;AGT;PEBP1;GPER1;PTPRC;PIN1;SORL1;UCHL1;DUSP3;SIRPA;RGS2;HYAL2;DUSP26;P2RX7;SMPD1;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1
prerank,regulation of telomere maintenance (GO:0032204),-0.4403357179802747,-1.4539806103911712,0.06857142857142857,0.4823654776462715,1.0,8/26,13.31%,SMG6;DHX36;SMG1;HDAC8;PML;YLPM1;TERF2;TINF2
prerank,negative regulation of cartilage development (GO:0061037),-0.5364213780755895,-1.4538663252201864,0.07835820895522388,0.47778940258966995,1.0,8/13,21.57%,ADAMTS12;TGFBR1;EFEMP1;WNT11;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5328642303123959,1.4537763697496717,0.03618421052631579,0.251295725749314,1.0,19/51,19.67%,MDK;CALR;CXCL12;MAPK3;LGMN;RARRES2;CXCL10;CREB3;HMGB1;PLA2G7;CSF1R;AIF1;GAS6;F2RL1;ADAM17;CCR2;EDN3;CXCL17;IL6
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6290513134888646,1.4534650820555763,0.059050064184852376,0.25148703083764307,1.0,11/19,21.42%,PRNP;GRM5;PTPRC;KDR;TRPM2;RYR2;DMTN;VCAM1;BCAP31;FKBP1B;FIS1
prerank,DNA-dependent DNA replication (GO:0006261),0.5015418614612644,1.453316992660559,0.006134969325153374,0.25134641757897885,1.0,47/128,26.19%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;RPA2;CDC34;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;POLE4;PSMB11;RFC2;PSMB10;RECQL5;PSMB1;PSMB5;POLD4;PSMA6;RFC4;PSMA4;GINS3;POLG;BLM;CDC45;PSMC1;PSMD9;POLD1;PNKP;RPA3;RPAIN;PSMB2;PSMD4;RAD51;PSMD10
prerank,muscle organ development (GO:0007517),-0.37541349740189656,-1.4529716217923758,0.020833333333333332,0.4751438681372629,1.0,11/54,8.33%,LAMA2;LARGE1;TCF12;VAMP5;MRAS;ITGA11;CHD2;FHL1;UTRN;IGF1;MEF2A
prerank,regulation of microglial cell activation (GO:1903978),0.663411509866151,1.4525370788500704,0.05548216644649934,0.2525595809340132,1.0,5/15,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5339333797584231,1.4523889708273756,0.025219298245614034,0.25240371761101604,1.0,16/57,18.04%,PSAP;MTNR1A;GNAI2;NPY1R;GPR37L1;FLNA;GRM8;GRM7;P2RY12;GNAI1;CHRM3;CHRM2;ADCY4;ADCY8;CHRM5;GRM4
prerank,positive regulation of cellular senescence (GO:2000774),0.7101863940862003,1.4510369015770952,0.05923836389280677,0.2548271929899574,1.0,2/10,2.35%,B2M;YPEL3
prerank,protein O-linked glycosylation (GO:0006493),-0.34323577992179577,-1.4508940149718563,0.0,0.4755556171753415,1.0,18/96,7.40%,TMTC1;GXYLT2;LARGE1;ST3GAL4;TMTC4;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;GALNT11;TET3;B3GNT2;PGM3;ST6GAL1;GALNT12;CRPPA
prerank,endothelial cell differentiation (GO:0045446),0.6833248707869659,1.4506979230836285,0.05858310626702997,0.25509893568980796,1.0,7/12,13.18%,SOX18;ACVRL1;EDF1;PROX1;KDR;KDM6B;TIE1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5802734297258074,1.4506185629194168,0.036231884057971016,0.25474688759608904,1.0,7/28,7.56%,APOE;TYROBP;LGMN;NSG1;SHISA7;FAM107A;CALB1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5274061689577888,1.450412933546277,0.02062975027144408,0.254684710513657,1.0,19/72,13.26%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6707480342677806,1.4503550762048152,0.054945054945054944,0.254305903011436,1.0,5/13,14.84%,RPS15;NPM1;RAN;XPO1;NUP88
prerank,positive regulation of protein binding (GO:0032092),0.5283980353489244,1.4502760833343604,0.03594771241830065,0.2539729506961714,1.0,11/56,6.46%,APOE;RPL11;CLDN5;B2M;VTN;RAN;FKBP1A;PIN1;FLOT1;ADD2;HIPK2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5333602363002264,1.449969866494202,0.02826086956521739,0.25417826047210823,1.0,21/55,16.22%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;ATF5;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,positive regulation of synaptic transmission (GO:0050806),0.5152949977659783,1.4495328055884409,0.018162393162393164,0.2546017214133278,1.0,35/72,24.49%,LGMN;NRXN1;NLGN1;GPER1;SLC24A2;TNF;MPP2;SHISA7;GRIK2;FLOT1;SYT1;LGI1;RIMS2;RIMS1;GRIN2A;VAMP2;HAP1;CCL2;ADRA1A;ADCY8;CACNG8;CLSTN2;SQSTM1;CLSTN1;GRIN2B;CCR2;KCTD13;CACNG5;STX4;ZDHHC12;CLSTN3;STX1B;CACNG2;APP;AGER
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5488435420847417,1.44881913024906,0.03125,0.2556676026388398,1.0,22/50,27.26%,ACTB;HSP90AB1;CCNI;CCND2;SERTAD1;CDKN1C;CCND1;CDK5R1;CDC37;CAMK2N1;CCNG1;CDK5R2;CCNJL;CDC25A;GADD45A;BLM;CCNA2;CDKN2B;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.538561173039964,1.448797885107955,0.034140969162995596,0.2552159753637874,1.0,20/51,21.29%,TYROBP;HSPB1;CCL19;S100A13;TNF;P2RX7;LPL;EGR1;LILRA5;HMGB1;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;TMED10
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5817123047308911,1.4486678723557056,0.04929577464788732,0.25499143239409,1.0,8/29,10.13%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1
prerank,regulation of viral genome replication (GO:0045069),0.5368722413635928,1.4481894023633992,0.024498886414253896,0.2556176946272403,1.0,23/56,24.08%,IFITM3;PPIA;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;DDB1;BANF1;PABPC1;BST2;PDE12;OAS3;RAD23A;FAM111A;RSAD2;ISG20;TNIP1;VAPB;CD28;BTBD17
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3904470531705473,-1.4474094593889664,0.038461538461538464,0.4796868846536218,1.0,15/47,11.35%,GOLGA4;VAMP5;MACF1;EXOC4;SPTBN1;RABEP1;EXOC2;BLZF1;RAB10;ARL3;ARFGEF2;GGA2;OPTN;KIF13A;EXOC6B
prerank,cellular response to unfolded protein (GO:0034620),0.5981976851505715,1.4466033283108715,0.044902912621359224,0.25855045040180114,1.0,16/26,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPD1;HSPB8;BAX;HSPA1A;ABCB10;DAB2IP;HSPA2;HSPA9;BAK1;PTPN1;HSPA14;TM7SF3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6734984082819772,1.4463607753391425,0.07053941908713693,0.2585522928978018,1.0,9/12,18.14%,CD74;MBP;TNF;TIRAP;LPL;HMGB1;KLF4;F2RL1;OAS3
prerank,macrophage activation (GO:0042116),0.5636131146676184,1.4461418713763186,0.05841121495327103,0.25853518304639744,1.0,18/34,24.75%,CLU;C1QA;ITGB2;TREM2;TNF;C5AR1;CD93;MAPT;AIF1;SLC11A1;IFNGR1;TLR1;SYK;SNCA;TMEM106A;APP;AGER;LBP
prerank,negative regulation of neurogenesis (GO:0050768),0.5629539010841436,1.4458823341315554,0.041469194312796206,0.2585881005020783,1.0,16/34,23.15%,ARHGDIA;B2M;TNF;RTN4;SORL1;YWHAH;LRP4;THY1;GDI1;RHOA;NOTCH1;IL6;MAG;REST;WNT7A;PTN
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6739157285571651,1.4457883904560265,0.055710306406685235,0.25829546234268963,1.0,5/12,9.00%,SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4
prerank,myoblast fusion (GO:0007520),0.6582556133004869,1.4453411996868135,0.07225433526011561,0.25876300966034876,1.0,3/12,5.56%,CD81;ADGRB3;ADAM12
prerank,release of cytochrome c from mitochondria (GO:0001836),0.6420830815567904,1.4451688641823355,0.07040417209908735,0.25867418998221603,1.0,10/17,21.42%,CLU;FZD9;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;BAK1;FIS1
prerank,phospholipid homeostasis (GO:0055091),0.7014787662190494,1.4450418869727302,0.05286343612334802,0.258429986182026,1.0,3/11,6.66%,RCN3;ABCG1;LIPG
prerank,cellular response to superoxide (GO:0071451),0.7064691916555421,1.4450023168652846,0.0754985754985755,0.25802380597591623,1.0,4/10,9.70%,MT3;SOD1;PRDX2;PRDX1
prerank,regulation of macrophage activation (GO:0043030),0.5848926531587527,1.444007610373504,0.04420549581839905,0.25981154061732503,1.0,10/30,14.25%,CD74;LRFN5;MIF;SPACA3;HSPD1;CEBPA;GPR137B;KARS1;WNT5A;TLR6
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5834428122322136,-1.443781656193345,0.07876712328767123,0.48400082249043624,1.0,5/10,15.34%,PID1;APPL2;GRB10;ENPP1;PRKCB
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.6170184511656575,1.4437062826719214,0.051964512040557666,0.2599713573986817,1.0,13/21,31.55%,MDK;NES;FZD9;CTNNB1;PROX1;CX3CR1;TOX;NAP1L1;CX3CL1;FZD3;DLL4;DRD2;DISP3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6000353744320776,1.4437061875715387,0.061957868649318466,0.2594733279783777,1.0,7/23,18.48%,TUBB;TUBA1A;TUBA1B;KIF5A;CCDC88A;HOOK1;KIF5C
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.48892844681993625,-1.443514566465751,0.0593607305936073,0.475555404401635,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,cellular response to interleukin-7 (GO:0098761),-0.48892844681993625,-1.443514566465751,0.0593607305936073,0.475555404401635,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,positive regulation of binding (GO:0051099),0.5093013946729869,1.4434205619787346,0.009404388714733543,0.2596666295468938,1.0,26/84,16.42%,APOE;RPL11;CLDN5;B2M;VTN;TXN;NME1;RAN;FKBP1A;PIN1;FLOT1;HES1;ADD2;HIPK2;GMNN;EDF1;HMGB1;DPH3;DDX11;CLN5;BMP2;RIPK2;STMN1;TIAM1;EPB41;CAV1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5328408898676611,-1.4428348333393681,0.0851063829787234,0.47269751930841764,1.0,2/12,1.11%,PLEKHH2;LIMA1
prerank,leukocyte tethering or rolling (GO:0050901),0.6308986842104675,1.4422625839494145,0.0655307994757536,0.26173434156519443,1.0,8/17,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,type I interferon signaling pathway (GO:0060337),0.5569229671460777,1.4418300466197191,0.034129692832764506,0.26169256393966167,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,cellular response to type I interferon (GO:0071357),0.5569229671460777,1.4418300466197191,0.034129692832764506,0.26169256393966167,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6046887222443078,1.4410855098800022,0.04932182490752158,0.26278015085168804,1.0,12/22,19.60%,CALM1;AKAP6;CALM3;GSTO1;P2RY6;HAP1;GSTM2;VMP1;ATP1B1;RYR2;CALM2;STAC3
prerank,antibacterial humoral response (GO:0019731),0.6534876149638529,1.4399234108795405,0.05774278215223097,0.26489072588687435,1.0,2/16,4.35%,RPL39;ANG
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5607669315087153,1.4398159080556516,0.053003533568904596,0.2646086159018297,1.0,12/33,15.50%,NRG3;NLGN1;GRID2;GRIK5;GRIK2;FABP5;LRRC4C;CACNA1A;GRID1;ABR;CX3CR1;LRP8
prerank,histone mRNA catabolic process (GO:0071044),-0.5104529609057393,-1.4393822922935329,0.056179775280898875,0.47631448851924785,1.0,8/15,21.79%,TENT4B;XRN1;TUT7;TUT1;ATM;TUT4;TENT2;LSM1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6900124944690854,1.4363944655104097,0.07365439093484419,0.2720348171544678,1.0,7/11,24.77%,TERF1;CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,receptor clustering (GO:0043113),0.5787287880826405,1.4358467964441368,0.06748466257668712,0.2726664452326547,1.0,10/27,14.33%,NRXN1;NLGN1;ITGB2;DLG2;LRP4;FLNA;MUSK;THY1;NRXN2;LRRC7
prerank,maintenance of protein localization in organelle (GO:0072595),0.6224720898999511,1.4357242265077608,0.0741687979539642,0.2724462111394127,1.0,5/19,4.30%,CHCHD10;HSPA5;AKT1;PINK1;ARL2BP
prerank,negative regulation of secretion (GO:0051048),0.6901360260202847,1.435279175345111,0.0603448275862069,0.27291058879887153,1.0,4/10,11.89%,CD74;NRG1;VAMP3;VAMP8
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6895932909866129,1.4352177405752877,0.07044198895027624,0.272539661278735,1.0,5/11,18.78%,TYROBP;ITGB2;SPI1;F2RL1;STX4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5376976959171672,1.4345409774859257,0.030837004405286344,0.2736397587595033,1.0,14/50,13.55%,GPX1;MT3;PARK7;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;PIH1D1;KLF4;GAS6
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3470511343988293,-1.4342836564103145,0.028985507246376812,0.48468035847357105,1.0,25/73,16.73%,SULF1;SMAD6;ZNF423;BMPR1A;FOXD1;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;RBPJ;ITGA3;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,dendritic cell chemotaxis (GO:0002407),0.6462365768915591,1.4333404723210625,0.07692307692307693,0.2759796216021994,1.0,7/14,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6298786685892612,1.4332240431087164,0.06832298136645963,0.2756919237320544,1.0,8/18,16.70%,CHCHD10;SLC25A5;FZD9;TMEM14A;BAX;ACAA2;HSPA1A;TMEM102
prerank,monocyte chemotaxis (GO:0002548),0.5686440367391424,1.4326769647369582,0.057919621749408984,0.2764711193193785,1.0,11/32,21.09%,RPS19;CCL19;PDGFB;LGALS3;CCL2;FOLR2;FLT1;CCL3;CCL8;IL6;PTPRO
prerank,negative regulation of leukocyte activation (GO:0002695),0.6482591927455564,1.432666794963439,0.06512890094979647,0.2759726109261726,1.0,4/15,4.44%,GRN;GPER1;CD84;LRFN5
prerank,detection of calcium ion (GO:0005513),0.6593001001900074,1.43234919264586,0.0863013698630137,0.27619226551817216,1.0,5/13,19.11%,CALM1;CALM3;SYT1;RYR2;CALM2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5886131717018054,1.4320183529726833,0.05134474327628362,0.27643625857178616,1.0,11/27,19.32%,RPS27A;UBC;UBB;TIRAP;UBA52;HSPD1;TLR6;TLR5;TLR1;TAB1;CD14
prerank,regulation of immune response (GO:0050776),0.4927955992072259,1.4317914463461534,0.0020408163265306124,0.2764623802162658,1.0,33/135,18.00%,B2M;IFITM1;CD81;TYROBP;COL1A1;C3;ITGB2;TREM2;CD34;FKBP1A;TIRAP;SPPL2B;SELL;CD3D;COL3A1;CD22;FGL1;FCGR1A;NPDC1;CD300LG;ELMOD2;COL1A2;LILRB1;IRF7;NCR1;TRAF3;LRP8;PIANP;CD300LF;VCAM1;OSCAR;CD300A;SYK
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6450679167480737,1.4314994225384223,0.07208387942332896,0.27671750606482165,1.0,9/15,22.12%,GPER1;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HNRNPU;SSTR2;REST
prerank,regulation of immunoglobulin production (GO:0002637),0.5983757416024256,1.431497805895847,0.06909547738693467,0.27621240729235935,1.0,9/23,19.67%,RBP4;PTPRC;IL2;CD22;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,positive regulation of synapse assembly (GO:0051965),0.5856108807541802,1.4310039905242866,0.05166051660516605,0.2767648631176372,1.0,15/27,23.04%,NRXN1;NLGN1;GRID2;IL1RAPL1;SEMA4A;PTPRD;SYNDIG1;LRRC4B;EPHB1;CLSTN2;CLSTN1;AGRN;IL1RAP;CLSTN3;WNT7A
prerank,negative regulation of protein processing (GO:0010955),0.6724426553348526,1.4305117800317204,0.07894736842105263,0.2773900558277168,1.0,5/12,10.76%,CTSZ;PRNP;SERPINE2;TMEM59;GAS1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5982822957332283,1.4305014923636374,0.05979643765903308,0.27691137234496555,1.0,7/22,17.01%,MBP;TNF;FLOT1;MYADM;THY1;KLF4;SKAP1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5522373874817926,1.4300531676663453,0.046857142857142854,0.2773992287397701,1.0,10/39,13.26%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4640642408333725,-1.4297169188199146,0.07172995780590717,0.4915781800115041,1.0,7/19,16.99%,NFAT5;PLCE1;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,negative regulation of chemokine production (GO:0032682),0.6578779921801682,1.429590310743365,0.07506702412868632,0.2779348758832909,1.0,7/14,19.67%,APOD;SIRPA;KLF4;F2RL1;SIGIRR;OAS3;IL6
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4994039667454846,1.4293640953820617,0.010256410256410256,0.2779031137367337,1.0,41/112,21.40%,CLU;TYROBP;HSPB1;CCL19;CYBA;CD34;POMC;PTPRC;MIF;TIRAP;SIRPA;DDT;TNFAIP3;SYT11;VSIR;LPL;LILRA5;HMGB1;ZFP36;MC1R;WNT5A;C1QTNF4;LILRB1;GAS6;CX3CR1;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.44852656877945174,-1.4282988307998057,0.07027027027027027,0.49064783509872,1.0,9/23,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.5932464587352657,1.4271758726816925,0.07044025157232704,0.2823710740294437,1.0,9/23,23.36%,GPX4;GSTM1;FADS1;GSTM2;ACOT7;LTC4S;ASAH2;CYP2E1;ELOVL6
prerank,translesion synthesis (GO:0019985),0.5497693775079546,1.4269959222738566,0.048478015783540024,0.28226272444839856,1.0,11/42,16.33%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15;PCNA;RFC2;POLDIP2;POLD4
prerank,cellular response to ATP (GO:0071318),0.6657135608446842,1.4261563750322326,0.0673076923076923,0.2836714727216578,1.0,4/14,9.32%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,amide transport (GO:0042886),0.5887669992824829,1.4260273645816313,0.05861244019138756,0.283459417109845,1.0,7/26,15.31%,SLC38A5;PLTP;TAP2;GLTP;SLC14A1;SLC19A1;FOLR2
prerank,cardiac conduction system development (GO:0003161),-0.44672368208133384,-1.4260140905987808,0.08866995073891626,0.49167562633306794,1.0,9/24,14.92%,NOTCH2;BMPR1A;SMAD1;MAML1;SMAD4;GJB6;CACNA1G;BMP4;HEY2
prerank,cellular response to BMP stimulus (GO:0071773),-0.3504138878625917,-1.425981479366589,0.014925373134328358,0.487356179919826,1.0,23/66,16.73%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5614149829724375,1.4258620814458767,0.049586776859504134,0.283330429599995,1.0,15/34,22.37%,AKT1;GRID2;MPP2;GABRG3;GRIN1;GABRA2;GRIN2A;GLRA1;GABRA3;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.595376115854935,1.425165695397435,0.06483790523690773,0.28442026072346144,1.0,9/22,20.24%,LAPTM5;SLC7A5;TNF;WNT5A;LILRB1;F2RL1;TRIL;CCR2;SPHK2
prerank,postreplication repair (GO:0006301),0.5461243426365832,1.4242328323512663,0.039149888143176735,0.2861064104091418,1.0,11/45,14.04%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15;PCNA;NSMCE1;RFC2;UBE2V1
prerank,pulmonary valve development (GO:0003177),-0.47733512033653325,-1.4242119950639958,0.06224066390041494,0.48750630189061495,1.0,9/18,16.29%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2;BMPR2
prerank,lipoxygenase pathway (GO:0019372),0.6514093603747939,1.424173090072419,0.08276797829036635,0.28574172219770494,1.0,2/14,1.19%,GPX4;GPX1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.49494264528743404,1.424051063737376,0.013541666666666667,0.2854896102643969,1.0,28/113,11.61%,RPS3;CLU;RACK1;HSP90AA1;PARK7;TPPP3;NRG1;TERF1;IL5;RASIP1;TNF;RHOC;LGALS3;PSMC3;PARP1;TIRAP;VCP;RPA2;TFRC;ISG15;MTLN;RBX1;LCP1;PIH1D1;DDB1;MMP3;BAX;WARS1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6740943245360844,1.4235112684491085,0.07113543091655267,0.28624326038840187,1.0,7/12,24.77%,CCT2;CCT7;CCT8;DKC1;GNL3L;CCT4;CCT3
prerank,central nervous system neuron differentiation (GO:0021953),0.5668448140736602,1.4231568722679464,0.05778301886792453,0.2865784432010166,1.0,10/33,8.81%,MDGA2;GRID2;NTRK2;KNDC1;CTNNB1;SPOCK1;PROX1;MAPT;MAP2;FAIM2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.5559769633070973,1.422867040858685,0.04487917146144994,0.28673431156761575,1.0,10/37,13.26%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,positive regulation of T cell proliferation (GO:0042102),0.5297390927140554,1.4223202434186872,0.025136612021857924,0.28739024293748755,1.0,22/55,24.67%,RPS3;CCL19;PTPRC;TFRC;IL2;CD24;ICOSLG;HMGB1;PNP;AIF1;IGFBP2;IGF2;VCAM1;SYK;CCR2;CD86;IL6;PYCARD;IL12RB1;CD28;AGER;CD276
prerank,peptidyl-proline modification (GO:0018208),0.5834036589887422,1.4221097999410028,0.04836759371221282,0.28733388835898743,1.0,6/25,5.50%,PPIA;PPIB;FKBP1A;PIN1;FKBP10;FKBP7
prerank,insulin secretion (GO:0030073),0.6062243611101067,1.4208852396292577,0.07233502538071065,0.2896412246493582,1.0,6/19,17.30%,PARK7;PTPRN;RIMS2;PTPRN2;MAFA;ADCYAP1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.47044950763752846,-1.4198352145886628,0.06666666666666667,0.49418566296589467,1.0,9/20,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5142231168434203,1.419557792622001,0.03739316239316239,0.29241948281048075,1.0,17/71,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,relaxation of cardiac muscle (GO:0055119),0.6658795981613026,1.4194675231155878,0.05748663101604278,0.2921077280679548,1.0,8/13,15.38%,GSN;RGS2;PLN;CHGA;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3941134945168435,-1.4194132831136241,0.03571428571428571,0.4907909823942614,1.0,22/43,27.58%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;PABIR1;ATM;RAD17;ORC1;NAE1;TAOK1;CHFR;CLSPN;INTS3;CDC14B;ABRAXAS1;HUS1B;PLK1;CDK1;BRCC3;TICRR
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.673081981879188,1.4185307804620824,0.07142857142857142,0.29378362161189087,1.0,7/12,24.00%,APOC1;P4HB;MFSD2A;SOAT2;ACSL3;DGAT1;MTTP
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5982926226019321,1.4185235814955364,0.07274969173859433,0.29329121879168973,1.0,10/21,20.52%,MT3;MAPK3;ZFP36L1;ZFP36L2;KDR;KARS1;SOX9;CTSH;MAP2K2;MYC
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4944958474515855,-1.418280200436602,0.06477732793522267,0.4894973208109223,1.0,8/17,14.92%,NOTCH2;ACVR1;BMPR1A;GALNT11;RBPJ;JAG1;BMP4;HEY2
prerank,regulation of B cell differentiation (GO:0045577),0.6273242863829877,1.4180228602289593,0.07057256990679095,0.2939582826840088,1.0,11/17,27.82%,ZFP36L1;ZFP36L2;IKZF3;MMP14;SYK;INHBA;SFRP1;ID2;PPP2R3C;INHA;XBP1
prerank,regulation of interferon-gamma production (GO:0032649),0.5089806685708498,1.4179787813308768,0.03787878787878788,0.29353367974918876,1.0,28/71,28.32%,LAPTM5;PDE4B;PRNP;SLC7A5;SIRPA;ISG15;HSPD1;VSIR;HMGB1;SLC11A1;LILRB1;GAS6;F2RL1;RASGRP1;CCR2;CD14;INHBA;PYCARD;DDIT3;IL12RB1;C1QBP;CD276;INHA;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5573546441721648,1.4176622819154563,0.055619930475086905,0.29371034480313407,1.0,13/33,20.95%,APOE;CSNK2B;TNF;ACVRL1;VASH1;HMGB1;KLF4;RHOA;HDAC5;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6123848546501729,1.4172380918227585,0.07934508816120907,0.2942086593949508,1.0,6/20,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,negative regulation of cytokine production (GO:0001818),0.48033613582304524,1.417205152155995,0.0030272452068617556,0.2937756803461194,1.0,37/163,16.39%,TMSB4X;APOD;TYROBP;LAPTM5;GPNMB;PRNP;TREM2;CD34;CD84;TNF;HOMER2;PTPRC;RAC1;PIN1;SIRPA;TNFAIP3;FN1;CUEDC2;ISG15;NAV3;SYT11;VSIR;SARS1;LILRA5;HMGB1;ZFP36;SRGN;ATP2B1;KLF4;SLC11A1;LILRB1;GAS6;TLR6;F2RL1;SIGIRR;DLL1;HDAC9
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5050224244325038,1.417186995252576,0.028907922912205567,0.29330533183446383,1.0,22/72,16.81%,APOE;HSPA8;CLU;PFDN5;TREM2;CRYAB;PFDN6;MID1IP1;MYADM;PFN1;CORO1A;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;VBP1;PFDN1;FGF13;PFN2;CDH5
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6731629216834746,1.4159196422497777,0.06990014265335236,0.2953121366222145,1.0,6/10,23.51%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6731629216834746,1.4159196422497777,0.06990014265335236,0.2953121366222145,1.0,6/10,23.51%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5685767191054298,1.4157270610808201,0.053864168618266976,0.2952770706403715,1.0,15/31,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPB8;BAX;HSPA1A;DAB2IP;HSPA2;HSPA9;BAK1;STUB1;PTPN1;HSPA14;TM7SF3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.53030285453698,-1.415393147142397,0.09342560553633218,0.4924783420507819,1.0,4/12,5.50%,FOXP1;DAB2;PIAS2;NCOR1
prerank,spermatid development (GO:0007286),-0.40756413335666924,-1.4146551553599225,0.028735632183908046,0.49012144245651695,1.0,18/32,32.43%,CDYL;RNF8;ING2;NECTIN2;RFX2;SYCP3;JAM2;ZMYND15;CIB1;YTHDC2;MKKS;ACRBP;DPY19L2;TDRD5;CCDC63;RSPH1;SOX30;TTC21A
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5785844084041085,-1.414150649776949,0.08108108108108109,0.4873490692102972,1.0,5/10,13.42%,CREBBP;KAT7;KAT2B;ESCO1;SIRT1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6537526950507018,1.4140359484088838,0.08665749656121045,0.29884096095244594,1.0,1/13,0.01%,TMSB4X
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.38185699823212443,-1.4137759402506722,0.048,0.48425622659681383,1.0,13/43,13.42%,SORBS1;PID1;SIK2;TNS2;OGT;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;SIRT1
prerank,cellular response to lectin (GO:1990858),0.49069436832718966,1.4134997856377516,0.015416238437821172,0.29911200091288204,1.0,40/104,25.43%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.49069436832718966,1.4134997856377516,0.015416238437821172,0.29911200091288204,1.0,40/104,25.43%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,fluid transport (GO:0042044),0.6676891285186297,1.4127509773834097,0.078125,0.30036315637053534,1.0,2/12,8.41%,AQP4;AQP1
prerank,diol metabolic process (GO:0034311),0.6101849152539925,1.411876909119887,0.08600770218228498,0.30196343312611623,1.0,9/19,21.12%,CALM1;HSP90AA1;AKT1;SPR;NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.510435301197136,1.4116079048009094,0.03739316239316239,0.30209374233809283,1.0,17/73,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4895713030770442,1.4113988207740242,0.01641025641025641,0.30208405305446495,1.0,40/105,25.43%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,regulation of amyloid-beta formation (GO:1902003),0.5600133391519221,1.4110682773073042,0.04964539007092199,0.30236297759867437,1.0,10/34,7.89%,APOE;CLU;PRNP;TNF;NTRK2;RTN4;PIN1;SORL1;ABCG1;GSAP
prerank,positive regulation of cell communication (GO:0010647),0.5706993506548858,1.4109432526109102,0.05703883495145631,0.30213100091414063,1.0,15/28,20.88%,ANK3;TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;CLSTN3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.5432497384622301,1.410810877659171,0.04081632653061224,0.3019427878577678,1.0,7/42,6.97%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,negative regulation of immune effector process (GO:0002698),0.6653971288067159,1.410731855830527,0.0702247191011236,0.3016116584411913,1.0,3/13,4.08%,RPS19;GRN;LGALS3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.662963543343011,1.4105766460220404,0.07713884992987377,0.3015023851372785,1.0,8/12,24.38%,CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5243639224084794,1.410541034148333,0.04927211646136618,0.30109747545523774,1.0,21/52,25.07%,CXXC1;ACADVL;HSPA5;CTDSP2;SSR1;PDIA6;WFS1;SYVN1;SERP1;DDX11;KLHDC3;DCTN1;DNAJB11;LMNA;DNAJB9;YIF1A;HYOU1;MYDGF;TLN1;VAPB;DNAJC3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5828919381278473,1.4101931676778985,0.06733167082294264,0.30136703107329943,1.0,12/25,22.37%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;GLRA1;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,peptide hormone secretion (GO:0030072),0.5860841339062128,1.410133694307963,0.06991260923845194,0.3010128832481024,1.0,8/26,19.67%,PARK7;PTPRN;LTBP4;RIMS2;MAFA;ADCYAP1;EDN3;IL6
prerank,activin receptor signaling pathway (GO:0032924),-0.5096741419290399,-1.4099843216897452,0.13178294573643412,0.4892706454139747,1.0,6/15,16.73%,SMAD3;ACVR1;TGFBR1;SMAD2;ACVR2A;ACVR2B
prerank,positive regulation of calcium ion import (GO:0090280),0.6678511540828653,1.409839854430109,0.08926080892608089,0.30121459057852334,1.0,7/12,20.24%,CXCL12;PDGFB;LGALS3;RAMP3;CCL2;CCL3;SPHK2
prerank,action potential (GO:0001508),0.5332494844267025,1.4096620887800264,0.045351473922902494,0.3011020026084159,1.0,19/44,27.61%,AKAP6;ANK3;GPER1;SCN1A;KCND2;GNA11;YWHAH;KCNE4;KCNA2;CHRNA4;KCNE5;KCNA1;SRI;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4;KCNQ1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5573164969325081,1.4093831967727475,0.06904761904761905,0.301307775587741,1.0,10/31,19.97%,TYROBP;GPNMB;CEBPB;SDC4;CTLA4;LILRB1;CD300A;SOX11;CD86;LST1
prerank,cellular response to dsRNA (GO:0071359),0.6277598224717228,1.409164458411162,0.08083441981747067,0.3013093652985686,1.0,7/15,21.33%,NPM1;FLOT1;PQBP1;IFIT1;PDE12;CAV1;RALB
prerank,vasodilation (GO:0042311),0.6516964225887304,1.4090760446436021,0.0913978494623656,0.3009550245487149,1.0,5/13,18.34%,SOD1;KLF2;GPER1;F2RL1;KCNMA1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6085970089902532,1.4085477576750587,0.0978120978120978,0.301773323264088,1.0,8/18,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5297365656544367,1.4084775007126495,0.04820627802690583,0.3013950932137245,1.0,21/49,21.74%,RACK1;NDUFA13;PINK1;S100A8;S100A9;P4HB;NUPR1;BAX;PMAIP1;BBC3;BAD;CAV1;HERPUD1;BCAP31;NDUFS3;DNM1L;RTKN2;PYCARD;DDIT3;FIS1;PTPMT1
prerank,iron ion transport (GO:0006826),0.534946317462705,1.4084594183183206,0.04671857619577308,0.30094050024790725,1.0,12/47,12.89%,FTH1;ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;TTYH1;CLTC;ATP6V0D2;SLC40A1;SLC11A1
prerank,adherens junction organization (GO:0034332),0.5319273416864124,1.4080350695709711,0.04138702460850112,0.30137696854508894,1.0,16/48,16.81%,ACTB;RAMP2;CADM2;ANG;CDH20;CTNNB1;CDH18;CADM3;CDH12;CDH19;DCHS1;JAM3;CDH7;CDH24;CDH10;CDH5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.525198097144723,1.4080061546769145,0.04525386313465784,0.30094808969940506,1.0,18/49,21.15%,CD74;PARK7;TNF;LAMTOR5;HSPA1B;TIRAP;HYAL2;HMGB1;HSPA1A;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,histone H3 deacetylation (GO:0070932),-0.5047974115510587,-1.4079345724572054,0.07936507936507936,0.4903465246991984,1.0,6/15,16.08%,HDAC4;PER2;HDAC8;SMARCAD1;SIRT1;SIRT7
prerank,regulation of cholesterol efflux (GO:0010874),0.5579986565523607,1.4076126204967057,0.08206330597889801,0.30142010911111605,1.0,3/30,2.84%,APOE;PLTP;TREM2
prerank,negative regulation of neuron differentiation (GO:0045665),0.5828980043157236,1.407127289220296,0.08020050125313283,0.3020512105946354,1.0,7/22,15.99%,B2M;CALR;CNTN4;HES1;SOX9;HEY1;DLL1
prerank,positive regulation of macrophage migration (GO:1905523),0.605165517893405,1.4070741111586176,0.07496823379923762,0.3016810781577036,1.0,8/19,19.16%,MDK;MAPK3;TREM2;RARRES2;P2RY12;CSF1R;CCL3;CXCL17
prerank,camera-type eye development (GO:0043010),-0.44566147005959356,-1.4070145481512621,0.06666666666666667,0.48865312323531457,1.0,7/25,7.79%,CACNA1C;FBN1;SHROOM2;SKI;LAMA1;EFEMP1;CEP290
prerank,adenine nucleotide transport (GO:0051503),0.6157235610554443,1.40675710060804,0.09174311926605505,0.30195902246152045,1.0,4/17,13.31%,SLC25A5;LRRC8A;SLC25A4;SLC19A1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.47770918333814083,-1.4067256118731122,0.07906976744186046,0.48547665882696156,1.0,6/17,4.47%,ABL1;BAIAP2L1;BCAS3;NRP1;BAIAP2;NTRK3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5027004907396416,1.405666817057915,0.030851063829787233,0.3039864080346156,1.0,22/72,16.22%,PSMB4;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;TIRAP;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;TLR6;COPS8;PSMB1;PSMB5
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5565451845387767,1.4056344819057847,0.06519208381839348,0.3035494904351898,1.0,8/33,11.56%,RPS3;PARK7;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2
prerank,protein deneddylation (GO:0000338),0.6839902403394758,1.405561754646759,0.09206798866855524,0.3032478389615075,1.0,3/10,14.73%,COPS7A;COPS6;COPS8
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.587153981153865,1.405423714556147,0.07197943444730077,0.30310464920352426,1.0,8/23,11.75%,SEC61B;HSP90B1;AUP1;VCP;LMAN1;SURF4;TMED9;SYVN1
prerank,phospholipid catabolic process (GO:0009395),0.5838623618008469,1.405244042553819,0.09488139825218476,0.30299368839647156,1.0,11/24,18.52%,PRDX6;LIPG;ENPP2;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2;GPCPD1;GDPD1;ENPP6
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6289572330104949,1.4051902498186433,0.0901749663526245,0.30260246321144285,1.0,5/15,10.00%,GRM5;HOMER2;GRM8;GRM7;GRM1
prerank,innate immune response in mucosa (GO:0002227),0.6897560415451169,1.4050790299179627,0.08866279069767442,0.3024135378465277,1.0,1/10,0.48%,RPL39
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.632047218059651,1.4049376316595488,0.08026315789473684,0.3022647344715259,1.0,4/16,10.70%,C3;GPER1;KLK6;CHGA
prerank,T cell migration (GO:0072678),0.6554609991602084,1.4049375571522664,0.08839779005524862,0.30177404496751364,1.0,8/13,24.39%,S1PR1;MSN;CXCL16;CXCL10;CCL3;PIK3CD;GPR183;MYO1G
prerank,glycosphingolipid metabolic process (GO:0006687),0.5355418657984168,1.4049334764103516,0.04805491990846682,0.3012896715733492,1.0,13/42,16.06%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;B4GALT6;SMPD1;CTSA;GLTP;CLN6;ST6GALNAC3;ABCA2;NEU1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5704674997083349,1.404889445866668,0.05411764705882353,0.3009043689494018,1.0,12/32,20.40%,AKAP6;GPER1;APLNR;GRIN1;P2RX7;THY1;CXCL10;RAMP3;TRPC1;CAV1;SNCA;CAPN3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.48726724734692445,1.4045909950649849,0.007231404958677686,0.3011310770171642,1.0,41/114,24.18%,TMSB4X;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;EIF5A;TNF;PSMD1;PSMC3;ST18;PSMD6;PSMA7;TNFSF12;PSMD5;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;TRAF3;PSMB1;PSMB5;ADAM17;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;PSMA4;NFKBIA;PYCARD;TNFRSF9;PSMC1;PSMD9;RELA;TNFRSF13B;TNFRSF11A
prerank,positive regulation of viral life cycle (GO:1903902),0.5957141151795753,1.4040162376578897,0.06607369758576874,0.30194018592218375,1.0,5/22,10.13%,CD74;LGALS1;CHMP2B;P4HB;DDB1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5315775648534735,1.4038531646774244,0.042175360710321866,0.30184053356144047,1.0,18/48,20.40%,CALM1;AKAP6;CALM3;GPER1;FKBP1A;APLNR;GSTO1;THY1;CXCL10;GSTM2;JPH4;TRPC1;SRI;FKBP1B;SELENON;CALM2;SNCA;CAPN3
prerank,central nervous system neuron development (GO:0021954),0.6330013438610039,1.4035171068207215,0.0731070496083551,0.30209589347749577,1.0,6/15,10.09%,HSP90AA1;HSP90AB1;NTRK2;MAPT;MAP2;B4GALT6
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.511883364727774,-1.4026079733429806,0.12133891213389121,0.49136785261704113,1.0,6/15,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,regulation of mononuclear cell migration (GO:0071675),0.5886278044648999,1.4022777919209921,0.06540880503144654,0.30438000807504006,1.0,8/23,12.35%,MDK;MAPK3;TNF;LGALS3;RARRES2;MSN;CSF1R;AIF1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.5658196472712562,1.4020989941496151,0.078125,0.30428315488516233,1.0,10/29,19.75%,PPIA;HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,cellular response to fatty acid (GO:0071398),-0.5316385450145831,-1.4019421541527428,0.12454212454212454,0.48902614322063986,1.0,2/12,4.54%,PID1;IRS1
prerank,glycolipid metabolic process (GO:0006664),0.5280589278323907,1.401633392141477,0.06097560975609756,0.3048661549618264,1.0,13/47,16.60%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;SMPD1;FUCA1;CTSA;GLTP;ST6GALNAC3;ABCA2;NEU1;SCCPDH
prerank,regulation of interleukin-4 production (GO:0032673),0.6030172703557669,1.4015212388704636,0.07623888182973317,0.3046446318129694,1.0,11/21,27.86%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;DDIT3;CD28;PRKCQ;LEF1;ZFPM1
prerank,ceramide catabolic process (GO:0046514),0.6401968665987695,1.4012915894313405,0.095112285336856,0.30470127581795053,1.0,3/14,2.91%,GM2A;HEXB;HEXA
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4745362749657493,1.4011103480721478,0.004024144869215292,0.3046617888082569,1.0,51/175,20.94%,TMSB4X;RPS3;PSMB4;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;GPER1;EIF5A;TNF;NR1D1;PSMD1;ZFP36L1;PSMC3;ZFP36L2;ST18;PSMD6;HYAL2;PSMA7;TNFSF12;PSMD5;ZFP36;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;ERBIN;CCL2;TRAF3;YBX3;PSMB1;PSMB5;DAB2IP;CCL3;ADAM17;CCL8;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;SFRP1;PSMA4;NFKBIA;PYCARD
prerank,Rap protein signal transduction (GO:0032486),-0.5676314587576266,-1.4007848129228593,0.11246200607902736,0.48801833441686393,1.0,5/10,18.41%,RAPGEF2;RAPGEF1;RAPGEF3;SGSM3;PLK2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4989899291659148,1.4003679705069514,0.024210526315789474,0.305897159803692,1.0,32/88,20.90%,RPS3;CLU;RACK1;PARK7;NRG1;TNF;RHOC;LGALS3;FLOT1;TIRAP;VCP;PFN1;TFRC;MTLN;ATP13A2;PIH1D1;SDC4;CHGA;MMP3;BAX;WARS1;SDCBP;DAB2IP;PFN2;CDH5;CRB3;SYK;VPS4A;TGFB1;CDC42EP2;ERCC1;BAK1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5677263283893759,1.400149178444041,0.07116104868913857,0.305943832547373,1.0,14/27,25.44%,BGN;BCAN;DCN;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;CSGALNACT2;CHSY3;B3GAT1;CHST9;CSPG5
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4796711876328907,1.3998365043333525,0.009174311926605505,0.30623371414730644,1.0,37/152,17.30%,PSAP;MTNR1A;RAMP2;GNAI2;NPY1R;GPER1;GPR37L1;ADGRB3;GNA11;SCTR;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;GRM8;ADGRG1;RXFP1;CXCL10;VIPR1;P2RY12;ADGRB1;MC1R;GNAI1;GNAO1;ADGRB2;CALCB;RAMP3;CHRM2;ADCY4;PF4;ADGRL4;ADRA1D;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6090878408201756,1.39922376891567,0.08578745198463508,0.30717162821269695,1.0,10/18,24.49%,RPS3;IL2;CD24;ICOSLG;HMGB1;IGFBP2;IGF2;PYCARD;IL12RB1;AGER
prerank,regulation of macrophage cytokine production (GO:0010935),0.6576406759643292,1.3990972387358733,0.075,0.3069412357971382,1.0,6/13,13.40%,CD74;LAPTM5;SEMA7A;CUEDC2;WNT5A;LILRB1
prerank,stem cell differentiation (GO:0048863),-0.3835434524328463,-1.3989294483372414,0.021897810218978103,0.48891253646793703,1.0,13/39,18.13%,MLLT3;FBXL17;SETD2;LRP6;HOXB4;JARID2;UFL1;FGFR2;KIT;BATF;TP53;PSMD11;METTL5
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.579698679573728,-1.3989277816018628,0.12264150943396226,0.485131262794376,1.0,5/10,16.27%,MLLT3;HOXB4;UFL1;BATF;TP53
prerank,cellular response to leucine (GO:0071233),-0.5640717005664134,-1.3988734761063468,0.11607142857142858,0.4778710904909171,1.0,8/10,25.91%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,response to leucine (GO:0043201),-0.5640717005664134,-1.3988734761063468,0.11607142857142858,0.4778710904909171,1.0,8/10,25.91%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6370575299513614,1.3988612024636975,0.10013531799729364,0.3070273567741695,1.0,4/13,8.93%,CD81;ITGB2;FCER1G;LPL
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.527479951663164,1.3988511805590298,0.052455357142857144,0.30657139867627026,1.0,20/45,25.54%,TYROBP;HSPB1;CCL19;TNF;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;APP;AGER;CASP1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6053878233045058,1.3982373633930274,0.10677083333333333,0.3075899860338021,1.0,4/18,3.71%,RPS13;RPS26;TMBIM6;TNF
prerank,response to glucocorticoid (GO:0051384),0.576718944475368,1.397877032272528,0.07990314769975787,0.30793100479708396,1.0,14/26,22.12%,TNF;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HSD3B2;HNRNPU;PDCD7;SLIT3;IL6;GOT1;SSTR2;REST
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5390812157586158,1.3966826851044407,0.06356413166855845,0.31033202507894303,1.0,12/40,11.72%,UBB;PARK7;SOD1;AKT1;PINK1;ATP5IF1;VCP;MTLN;MAPT;TUSC2;BAX;PMAIP1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5041098126943961,1.3964055349098374,0.03582718651211802,0.3105019018216565,1.0,25/75,16.88%,ACTB;S100A6;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;LRP4;NEFH;NRCAM;MFSD2A;MAP2;PAK3;ADGRB1;APBB1;TMEM106B;SHTN1;CCK;MAPK8IP2;DSCAML1;SPTBN4;CDK5;BRSK2;CDHR1
prerank,"phagocytosis, engulfment (GO:0006911)",0.5433635127902429,1.39631964508461,0.07647740440324449,0.31021871285117847,1.0,11/36,12.35%,GSN;ITGB2;ARHGAP25;RAC1;ELMO1;RHOG;XKR4;ADGRB1;FCGR1A;MSR1;AIF1
prerank,BMP signaling pathway (GO:0030509),-0.3526212361418089,-1.3962996461106143,0.0136986301369863,0.4807210978506405,1.0,22/62,16.73%,BMP6;TGFBR3;SMAD3;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,positive regulation of telomerase activity (GO:0051973),0.5510281504117666,1.3960785208607487,0.07217694994179279,0.31027148860433856,1.0,16/33,23.98%,HSP90AA1;HSP90AB1;MAPK3;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.47636031979108645,1.3956670546645207,0.0060790273556231,0.31075857276139485,1.0,43/151,17.62%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;NDRG4;TIRAP;ATP6AP1;DDT;P2RY6;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;FBXW7;BMP2;GAS6;CCL2;F2RL1;PDGFA;RASGRP1;ARRB2;ADRA1A;CCL3;GATA4;ADCYAP1;CCL8
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.38006540235728214,-1.3951639912670621,0.03508771929824561,0.47984664691098755,1.0,22/50,15.34%,FBXL17;CREBBP;SMO;DCDC2;GLI3;SUFU;GPC3;TTC23;HERC4;DLG5;FGFR2;BTRC;ZIC1;TULP3;INTU;IFT122;RORA;WDR11;GAS8;EVC;UCHL5;KIF7
prerank,atrial septum development (GO:0003283),-0.524893557075162,-1.3948646631907775,0.11372549019607843,0.47709082710343886,1.0,7/13,19.43%,NOTCH2;ANK2;MDM4;NPHP3;HEY2;BMPR2;DAND5
prerank,triglyceride metabolic process (GO:0006641),0.5225819984562813,1.394749963348925,0.049217002237136466,0.31244879799008046,1.0,8/48,11.20%,APOE;PNPLA2;APOC1;FABP5;PLAAT3;LIPG;LPL;MOGAT2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5821295313790082,1.3940011486950792,0.09113300492610837,0.3137564887760237,1.0,7/24,13.41%,SEMA3F;DSCAM;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4854533402857493,1.392792141844935,0.02405857740585774,0.31617214416252826,1.0,37/101,23.89%,RPL26;RPS4X;RPL5;EEF2;VIM;HSP90AA1;AURKAIP1;AKT1;EIF3D;NPM1;RPS27L;AGT;MSN;EIF3C;PTTG1IP;PCIF1;ZCCHC4;KLF4;CLN6;BAD;NR1H2;CIRBP;YTHDF1;EIF4A3;ASPSCR1;TRIM32;INHBA;IL6;TGFB1;CAPN3;NFKBIA;BAK1;STUB1;WNT7A;ELAVL1;PLXNB2;CD28
prerank,glutathione metabolic process (GO:0006749),0.5429443359315467,1.392791457476363,0.05542986425339366,0.3156827135988092,1.0,8/38,15.71%,GPX1;PARK7;SOD1;GSTM1;GSTM5;GSTM2;HPGDS;GLRX2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6125758705969698,1.3927663421247096,0.07953063885267275,0.3152518774155987,1.0,4/18,9.73%,TYROBP;DOCK2;FCER1G;KARS1
prerank,positive regulation of cell death (GO:0010942),0.5102508068132197,1.3925833687287665,0.033261802575107295,0.31524682158961564,1.0,20/59,19.99%,CLU;C1QA;TYROBP;MT3;PRNP;ITGB2;TNF;SLC6A6;MAPT;EGR1;WNT5A;MMP3;RAMP3;RIPK2;HPR;HP;GRIN2B;SNCA;TRIM13;DDIT4
prerank,positive regulation of cellular process (GO:0048522),0.4605055430496795,1.392474265442694,0.0,0.31502464173876993,1.0,168/565,20.96%,RPL23;RPS9;RPS4X;RPS15A;RPS19;CLDN5;CD81;MDK;HSP90AB1;GRN;CALR;H3-3A;GNAI2;MT3;CAPNS1;CXCL12;RPS6;LGMN;AKT1;TSPAN31;S100B;AKAP6;SLC25A5;CYBA;NRG1;EIF4G2;CCND2;TREM2;DOCK2;TGM2;ERBB4;NPM1;COPS9;S100A13;GPER1;COX17;TNF;MAP1A;EMP2;PDGFB;ROMO1;HCLS1;FCER1G;LMAN2;RAC1;NTRK2;ZFP36L1;S100A8;S100A9;CAMK1D;FLOT1;SSR1;SIRPA;IL2RB;GRIN1;SERTAD1;HES1;FN1;FRMD5;MATK;LGI1;RHOG;RNF187;MLC1;SPACA3;ADGRG1;CCND1;CXCL16;P4HB;NAMPT;PTK6;SLC6A6;PAK1;DUSP26;P2RX7;DDX49;MTLN;PROX1;KDR;CCN2;IL2;MFSD2A;MAPT;VIPR1;NUPR1;MLXIPL;TIMP1;LAMC2;GATA2;LILRA5;HCK;DNPH1;ZFP36;KITLG;EXOSC2;FASN;CSF1R;MYRF;TENM4;WNT5A;IL11;RAMP3;CEP131;FLT4;IL2RG;HRAS;NSMCE1;AIF1;SLC11A1;PRMT1;SOX9;FBXO5;RIPK2;GAS6;CTSH;SDCBP;TIAM1;PDF;FOLR2;IGF2;PDGFA;HPR;HP;RYR2;DLL1;IER5;ADRA1D;FLT1;CAV1;CCKBR;EPB41L4B;VHL;TMEM102;CIAO1;TRIM32;LMNA;MMP14;ADAM17;FKBP1B;CNBP;TBRG4;ERBB3;EXOSC9;MAZ;STX4;HMGN5;EDN3;SOX11;PPP3CA;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;TRIM13;IL6;RAD23A;MAPK15;TGFB1;CITED2;THPO;SFRP1;MYC;CRLF1;PTPN6;PYCARD;CRLF2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.4169009451980183,-1.3918061600388916,0.049723756906077346,0.4811285151706783,1.0,7/27,14.03%,UBE2E2;ANAPC5;ANAPC1;PRKN;ANAPC7;CDC26;CDC27
prerank,regulation of cation channel activity (GO:2001257),0.488601005230727,1.3914462451915053,0.024210526315789474,0.3169248494309659,1.0,39/89,25.12%,CALM1;CTSS;NLGN1;GRIA2;ANK3;FKBP1A;DLG2;SHISA7;NEFL;FGF14;AHNAK;GRIN1;GRIA4;GRIN2A;CRH;VAMP2;FGF11;FGF12;GRIA1;JPH4;LRRC7;KCNE5;MAPK8IP2;FGF13;CACNG8;FKBP1B;GRIN2B;CACNG5;SELENON;CALM2;MEF2C;CACNB4;GRIA3;KCNAB1;CACNG2;APP;SHISA6;PRRT1;PRKACA
prerank,apoptotic mitochondrial changes (GO:0008637),0.5533799829333222,1.3899922338803743,0.08,0.3199851850359491,1.0,14/32,21.42%,CLU;ERBB4;FZD9;HSPD1;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;CCAR2;BAK1;THEM4;FIS1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5175034619692311,1.3893613777296354,0.06544202066590127,0.3210849061424797,1.0,12/49,14.81%,CLU;RPL13A;PARK7;HSPA5;TREM2;CRYAB;SORL1;HMGB1;SVIP;THRA;NLRP2B;JAM3
prerank,negative regulation of cell projection organization (GO:0031345),0.5241299667573287,1.3891053311333352,0.052690582959641255,0.32119448870085354,1.0,9/48,6.93%,APOE;ITM2C;MT3;DCC;PRNP;YWHAH;SPOCK1;BAG5;CRMP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5035974845561056,1.3889022395397062,0.05032119914346895,0.32120862794398586,1.0,16/70,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,regulation of protein targeting to membrane (GO:0090313),0.5656566086097101,1.388701493645396,0.06272617611580217,0.3211900804836295,1.0,11/28,21.42%,PRNP;ITGB2;ANK3;GDI1;HRAS;MTCL1;MIEF2;MFF;DMTN;C2CD5;FIS1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5671958962718547,1.388627476192763,0.07701711491442542,0.32085898569741383,1.0,10/27,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC25A29;SLC6A5;SLC3A2;SLC1A1;SLC25A22
prerank,regulation of mitochondrial translation (GO:0070129),0.5907385671686645,1.3886246292054456,0.09517601043024772,0.32037653297594243,1.0,10/21,27.39%,UQCC2;COA3;TRUB2;TSFM;SHMT2;RPUSD4;MTG2;C1QBP;TRMT10C;RCC1L
prerank,retrograde axonal transport (GO:0008090),0.6218481552519053,1.3880189242312286,0.09549795361527967,0.32138882582326594,1.0,6/16,11.11%,SOD1;MAP1A;DLG2;NEFL;KIF5A;HAP1
prerank,protein targeting (GO:0006605),0.48156504661622,1.3874253350365828,0.018499486125385406,0.32228596238558505,1.0,29/118,15.91%,RPL11;GABARAP;TSPO;NACA;TIMM8B;TIMM13;TOMM5;NLGN1;AKAP6;TOMM7;SRP14;SEC61G;SORL1;AIP;TIMM10B;SPCS1;ICMT;HAP1;CDC37;GDAP1;GOLGA7B;SEC61A1;YIF1B;SPCS2;SDCBP;MFF;GOLGA7;PEX6;NCF1
prerank,positive regulation of immune response (GO:0050778),0.5033606461125991,1.3871917330370995,0.045064377682403435,0.3223410234644962,1.0,20/64,23.32%,CD74;CD81;GRN;CYBA;ITGB2;PTPRC;IL2;SLC15A4;KARS1;LILRB1;F2RL1;SKAP1;STX4;NLRP3;SPHK2;PYCARD;RSAD2;POLR3D;AKIRIN2;IL12RB1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6449280985018734,1.386914109484954,0.10796221322537113,0.32253559912055757,1.0,2/13,1.13%,LAMP1;TYROBP
prerank,negative regulation of B cell activation (GO:0050869),0.5867939512254943,1.3862457287872982,0.08875,0.3236706436076195,1.0,11/21,25.31%,TYROBP;LAPTM5;TNFAIP3;CTLA4;CD300A;INHBA;SFRP1;ID2;BANK1;TNFRSF13B;INHA
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4856498488038736,1.3861888290183781,0.02171664943123061,0.3233173147287031,1.0,23/108,11.72%,RPS3;MTCH1;CTSD;RACK1;GSN;LAPTM5;NDUFA13;RPS27L;HSPE1;GPER1;TNF;S100A8;S100A9;ST18;VCP;BEX3;FOXL2;HSPD1;MAPT;HMGB1;PDCD6;BAX;PMAIP1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.593355332879016,1.3861292596943984,0.0907911802853437,0.32297529588926954,1.0,4/22,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,prostaglandin metabolic process (GO:0006693),0.5732566416902278,1.3860437332694944,0.10324129651860744,0.3227205332394851,1.0,7/26,14.87%,CD74;PTGDS;GSTM1;MIF;PRXL2B;HPGDS;PTGES3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.6087821060565586,1.385947151796222,0.07866666666666666,0.32246069848400816,1.0,6/17,17.60%,EMC6;EMC3;EMC10;EMC4;SGTA;EMC8
prerank,carbohydrate biosynthetic process (GO:0016051),-0.44993634651228326,-1.3855554990787138,0.07655502392344497,0.492664324583058,1.0,9/21,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,regulation of chemokine production (GO:0032642),0.5356180038812237,1.3851041858031963,0.0775462962962963,0.32404050535660694,1.0,19/36,26.11%,CD74;HMOX1;TREM2;TNF;LPL;EGR1;CSF1R;WNT5A;AIF1;F2RL1;SIGIRR;ADAM17;IL6;PYCARD;APP;AGER;IL33;TLR7;ACKR1
prerank,regulation of protein dephosphorylation (GO:0035304),0.5383931681778875,1.3851041403913997,0.06984866123399301,0.3235554147797258,1.0,16/37,21.19%,PPIA;CALM1;CALM3;HSP90B1;YWHAB;PIN1;SMPD1;ARPP19;DLC1;CDH5;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,cellular response to organonitrogen compound (GO:0071417),0.4803903145268095,1.3850173283792893,0.032753326509723645,0.32328968626495974,1.0,31/99,20.17%,ACTB;GABRB1;AKAP6;LAMTOR2;LAMTOR4;HSP90B1;LAMTOR5;IGFBP5;ZFP36L1;CTNNB1;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GLRA2;TRPM2;GLRA1;GABRB3;SOX9;LAMTOR3;RRAGC;HCN1;RRAGD;DMTN;GABRB2;HCN3;NSMF;MEF2C;SFRP1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6388092347360754,1.3843696512173742,0.10869565217391304,0.324324468406531,1.0,8/13,21.20%,GLUL;DDAH1;GLS2;GLS;NOS2;GLUD1;GAD1;ALDH4A1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6143956684845555,1.38398343218519,0.09825033647375504,0.32479707779633543,1.0,11/17,23.15%,MDK;SERPINE2;HES1;TENM4;BMP2;CXCR4;PTPRZ1;NOTCH1;TGFB1;ID2;PTN
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4234774685780003,-1.3839526072724173,0.042682926829268296,0.4929552840903578,1.0,12/27,17.61%,EGFR;TNRC6B;DDX6;STAT3;RIPK1;EIF4G1;BMP4;PUM2;LIMD1;TP53;AGO2;FMR1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5842409048027825,1.3837443850006055,0.06341463414634146,0.32490960805577834,1.0,12/25,19.56%,MT3;ANK3;TMTC2;GRIN1;ATP13A2;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.6032218143959085,1.3834098136683095,0.10065359477124183,0.32520520603982866,1.0,9/18,20.91%,SLC25A5;SLC25A4;ALKBH7;PMAIP1;SPG7;BAD;TMEM102;BAK1;THEM4
prerank,protein processing (GO:0016485),0.48195706904916763,1.3832101089086868,0.02688728024819028,0.32524181447621303,1.0,35/102,18.83%,CTSL;CTSS;LGMN;CD5L;RCE1;CPXM1;CPD;PSENEN;CPE;OMA1;F9;SPCS1;KLK1;KLK6;VSIR;METAP2;PCSK2;SRGN;AEBP1;MYRF;CPXM2;TMEM208;CLN5;SPCS2;CTSH;SPG7;HPR;HP;BACE1;PSEN2;MMP14;ADAM17;APH1B;SEC11C;PRSS12
prerank,positive regulation of cell division (GO:0051781),-0.3866898387068967,-1.3827309782211143,0.05982905982905983,0.4923999401584772,1.0,9/38,12.16%,SVIL;FGF1;PRKCE;CDC14A;FGFR2;CSPP1;CDC25B;PKP4;GIPC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.6417393506651061,1.3827122674254242,0.10921985815602837,0.32596655436765776,1.0,4/13,13.55%,CD74;TAF9;WNT5A;GAS6
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6162226058132981,1.3826704614295053,0.09031413612565445,0.32557349288073195,1.0,8/17,25.95%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;CD28;PRKCQ
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4685410963964818,1.3823694057955085,0.005025125628140704,0.32577161551225986,1.0,47/185,16.89%,RPS27A;TUBB;UBC;UBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;ZFP36L1;DCTN3;PSMC3;PPP2R1A;ZFP36L2;YWHAE;PSMD6;UBA52;PSMA7;CLASP1;YWHAG;TUBB4A;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;CEP131;PSMB11;DCTN1;ANLN;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6708603829006483,1.3822040144151937,0.11482558139534883,0.3256838948652106,1.0,2/10,4.96%,ACADVL;ETFB
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.572609796847914,1.3817084813257658,0.09113924050632911,0.3264008515257273,1.0,6/23,5.25%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5067091875658113,1.3816939401602935,0.055741360089186176,0.32595943990129567,1.0,25/57,22.12%,CTSD;NDUFA13;LGMN;GPER1;TNF;GRIN1;FOXL2;GRIN2A;HMGB1;PDCD6;PMAIP1;RIPK2;BAD;BCAP31;PDCD5;SYK;GRIN2B;NLRP3;MYC;BAK1;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,regulation of transmembrane transport (GO:0034762),0.5580038436071579,1.3812320169656649,0.07227488151658767,0.32658112180655396,1.0,3/31,5.63%,ACTB;SLC2A1;KCNJ10
prerank,erythrocyte differentiation (GO:0030218),0.5235171829684625,1.3810664650764513,0.06561085972850679,0.32652122977350384,1.0,8/44,9.02%,RPS14;RPS19;SLC25A5;HCLS1;ATP5IF1;HIPK2;TSPO2;IKZF1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4560316464900156,1.3806085488189703,0.0,0.3272071481819583,1.0,155/532,21.23%,TMSB4X;RPS27A;IFITM3;HSPA8;PPIA;UBC;VIM;IFITM2;B2M;UBB;RPLP0;IFITM1;PSMB4;HSP90AA1;F13A1;MT3;BOLA2;CFL1;CXCL12;HMOX1;SOD1;MT2A;MAPK3;TALDO1;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;ITGB2;PSMD2;IL5;POMC;CNN2;CSNK2B;EIF5A;CANX;TNF;HSP90B1;PDGFB;TOLLIP;FCER1G;PSMD1;SPI1;JUNB;MIF;PSMC3;ST18;AIP;PSMD6;IL2RB;CSF3R;S1PR1;FN1;MSN;UBA52;PSMA7;ISG15;CCND1;CCR5;GSTO1;P4HB;CEBPA;CXCL10;TNFSF12;IL2;IFIT1;PSMD5;RBX1;LCP1;TIMP1;EGR1;HCK;FCGR1A;PSMB9;IRF8;CSF1R;PSMD13;TXNDC17;IL11;MMP3;PSMB3;LCN2;IL2RG;IL3RA;MAOA;PSMB11;COL1A2;BST2;VAV1;RIPK2;PSMB10;YWHAZ;TNFRSF1A;RHOU;UBE2V1;NDN;CCL2;PTPRZ1;IRF7;ARF1;PF4;IFNGR1;TRAF3;LRP8;CSF2RB;CD300LF;IL17RB;PSMB1;PSMB5;CCL3;VCAM1;SQSTM1;PIK3CD;TWIST1;ADAM17;NCAM1;NOS2;CCL8;SYK;OAS3;COMMD7;CCR2;SLA;PLVAP;LTBR;TNFRSF12A;STX4;TAB1;IL20RA;PSMA6;MUC1;CD86;SOS1;FLT3;IL6;HGF;IFNGR2;TGFB1;CSF2RA;IL10RB;SKP1;IL1RAP;PSMA4;MYC;CRLF1;NFKBIA;HSPA9;PTPN6;PYCARD;CRLF2;RSAD2;HNRNPF;IRF9
prerank,regulation of feeding behavior (GO:0060259),-0.5235819865296719,-1.3799910662243615,0.13559322033898305,0.49548078795668826,1.0,4/11,6.91%,AGRP;LEPR;EIF2AK4;STAT3
prerank,cGMP-mediated signaling (GO:0019934),0.6515746192370833,1.3791022304136664,0.0942622950819672,0.33039750620266606,1.0,3/13,8.96%,APOE;AQP1;HTR2C
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4983886828807522,-1.3790640179796447,0.128,0.4941981046284152,1.0,7/13,22.30%,SNX6;CBLB;ERRFI1;SOCS5;GPRC5A;CBL;TSG101
prerank,connective tissue development (GO:0061448),-0.39528463310422757,-1.378796223283825,0.07142857142857142,0.4913652920892033,1.0,11/35,11.14%,SULF1;SOX5;ZBTB16;LRP5;SLC39A13;ATP7A;ITGB8;ARID5B;PKD1;SPTLC2;CREB3L2
prerank,regulation of viral transcription (GO:0046782),0.5384861843293725,1.378481831606334,0.05658198614318707,0.33133256828959945,1.0,15/39,21.24%,IFITM3;POLR2E;POLR2D;POLR2F;NELFCD;ZFP36;POLR2G;SUPT4H1;POLR2K;HEXIM1;NELFE;TRIM32;TRIM13;POLR2H;CDK9
prerank,positive regulation of cell junction assembly (GO:1901890),0.5053825478723082,1.3778562772681597,0.057649667405764965,0.33233007450812047,1.0,28/56,23.80%,CLDN5;NRXN1;NLGN1;S100A10;AGT;GRID2;CNTNAP2;RAC1;FLOT1;IL1RAPL1;THY1;KDR;PTPRD;SYNDIG1;IRX3;LRRC4B;EPHB1;CAV1;CLSTN2;CLSTN1;CRB3;SFRP1;IL1RAP;CLSTN3;COL16A1;PPM1F;WNT7A;TEK
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6000772116386166,1.3769800671210257,0.09431524547803617,0.3340122125053647,1.0,9/18,22.12%,ZFP36L1;ZFP36L2;FAM107A;SSTR4;AQP1;ZFP36;HNRNPU;SSTR2;REST
prerank,response to nutrient levels (GO:0031667),0.5959854771333901,1.376423268494555,0.10561497326203209,0.33485601102532336,1.0,4/17,9.67%,ATF4;SCTR;FAM107A;CD68
prerank,activation of GTPase activity (GO:0090630),-0.3227484006902857,-1.3757324060821845,0.0,0.4955404062857714,1.0,23/89,12.35%,ARHGAP29;SIPA1L1;ARHGAP42;BCAS3;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;DOCK7;SIPA1L3;TBC1D2B;RABGAP1;TBC1D9B;BCR;TBC1D4;SYDE2;PIP5K1A;TBC1D8B;TBCK;SIPA1;RALGAPA1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6803994850402711,1.3756285978160174,0.12142857142857143,0.33628839158238033,1.0,2/10,2.58%,CALM1;CALM3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5041626044766436,1.3751810529866901,0.04643628509719223,0.33684755620841644,1.0,16/63,20.07%,CD74;CD81;CCL19;PTPRC;MIF;TIRAP;TFRC;IL2;PNP;AIF1;VAV3;VCAM1;CD86;GPR183;IL6;MEF2C
prerank,positive regulation of ruffle assembly (GO:1900029),0.6370388127270987,1.3749660670867336,0.10231923601637108,0.33691142323805473,1.0,5/13,12.02%,NLGN1;PFN1;P2RY12;DEF8;HRAS
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6700260350619668,1.3747513110595755,0.12039660056657224,0.33695544322870935,1.0,5/10,17.60%,EMC6;EMC3;EMC10;EMC4;EMC8
prerank,protein K48-linked ubiquitination (GO:0070936),-0.3472317290712692,-1.3746529879453329,0.047619047619047616,0.494678702402142,1.0,15/54,11.10%,UBE2E2;TTC3;RNF216;RNF152;UBR5;PRKN;RNF146;ARIH2;UBE2R2;UBE2Q2;RNF8;ZNRF1;TOPORS;ITCH;RNF115
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5770003484528887,1.3742578429176127,0.09923664122137404,0.33773140684657155,1.0,9/22,16.24%,TREM2;NR1D1;FLOT1;TIRAP;TNFAIP3;TICAM2;NINJ1;F2RL1;DAB2IP
prerank,membrane repolarization during action potential (GO:0086011),0.6350131399347115,1.3741511367417198,0.11506849315068493,0.3375052390667026,1.0,5/13,15.24%,YWHAE;KCNE4;ATP1A1;KCNE5;ATP1B1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.401017403386662,-1.374014878627618,0.07317073170731707,0.49272423889482825,1.0,10/28,16.08%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;MRNIP;CYREN;KDM4D;SMCHD1;SIRT7
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48507934718661727,1.3740117910109526,0.035343035343035345,0.3373594308410094,1.0,29/87,16.22%,PSMB4;GPNMB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PSMD6;GPR132;FAM107A;PSMA7;JADE1;PSMD5;RBX1;CDK2AP2;PSMB9;PSMD13;PSMB3;PSMB11;KLF4;FBXO5;PSMB10;CCL2;PSMB1;PSMB5
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3802758305174347,-1.3737894930850292,0.05737704918032787,0.48987858561333414,1.0,10/38,14.96%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,ceramide transport (GO:0035627),0.6458887476088243,1.3728793645590678,0.10957004160887657,0.3395962816764289,1.0,2/12,1.44%,PSAP;PLTP
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5214342985847351,1.3724588547690035,0.0779816513761468,0.3401046475029903,1.0,13/44,19.48%,APOE;AGT;SORL1;UCHL1;RGS2;HYAL2;SMPD1;DNAJA1;MAPK8IP1;SPRY1;DAB2IP;CD300A;SPRY3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5059691741673832,-1.3723577275571255,0.11895910780669144,0.4897611257832369,1.0,6/13,2.52%,ROCK2;AKAP13;ASAP3;ALMS1;SLC9A1;ROCK1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.42243201797943497,-1.3719944449801487,0.058823529411764705,0.4872583230125014,1.0,12/25,22.06%,SF3B1;TRA2B;MPHOSPH10;SRRM1;SCAF11;PRPF3;SF3B3;PRPF4;SLU7;DDX23;LSM1;PRPF6
prerank,prostanoid biosynthetic process (GO:0046457),0.6231477892622971,1.371735437916585,0.10263157894736842,0.3413871168886874,1.0,4/15,9.20%,CD74;PTGDS;MIF;PRXL2B
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5480450578967376,1.3715594847326817,0.07535885167464115,0.34133252690726507,1.0,11/31,15.07%,CHCHD10;YWHAB;YWHAH;YWHAE;YWHAG;BAX;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5591581528792484,1.3710223994539248,0.08476658476658476,0.342193055014422,1.0,9/28,20.94%,TYROBP;SIRPA;HSPD1;THY1;CCL2;SH3KBP1;CCR2;IL6;PYCARD
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6307015522813714,1.3706988304111212,0.10204081632653061,0.3425076477008902,1.0,3/13,11.72%,RPL26;MSX1;PMAIP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5868859378042943,1.370678109185345,0.08567774936061381,0.34207235433245825,1.0,7/19,19.16%,MDK;MAPK3;CAMK1D;RARRES2;CSF1R;JAM3;CXCL17
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6115422356862998,1.370657435412101,0.1295060080106809,0.3416369168670336,1.0,8/15,27.66%,RACK1;TNF;ORMDL3;TNFRSF1A;SPHK2;ORMDL2;PLA2G6;SAMD8
prerank,positive regulation of signaling (GO:0023056),0.5316076727951025,1.370546311273161,0.06496519721577726,0.3414429271281378,1.0,17/37,20.88%,TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;VAMP3;RAMP3;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;SNCA;CLSTN3
prerank,negative regulation of viral transcription (GO:0032897),0.6529055408255944,1.3704382930768273,0.1232876712328767,0.3411860738162416,1.0,5/13,19.65%,IFITM3;ZFP36;HEXIM1;TRIM32;TRIM13
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4954535923159193,1.370341266049726,0.05913978494623656,0.34092581830300794,1.0,26/65,21.57%,MT3;HMOX1;PINK1;KCND2;ZFP36L1;EPAS1;PGK1;HIPK2;NDRG1;BNIP3L;P4HB;FMN2;AQP1;AK4;ACAA2;PMAIP1;EGLN2;BAD;LMNA;TWIST1;NOP53;SFRP1;MYC;SIRT2;HYOU1;STUB1
prerank,presynapse organization (GO:0099172),0.6608094687200772,1.3702857494880936,0.11061946902654868,0.34058794320905866,1.0,6/10,23.04%,NLGN1;C5AR1;WNT5A;LRRTM3;FZD1;WNT7A
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5243265897685042,1.3702075251428028,0.07046979865771812,0.34033201314141687,1.0,11/46,6.09%,APOD;HMOX1;AKT1;IGFBP3;TNF;PDGFB;IGFBP5;ANG;NDRG4;CTNNB1;TNFAIP3
prerank,regulation of histone methylation (GO:0031060),-0.5027683120789228,-1.3693983542932686,0.12062256809338522,0.49028566412478963,1.0,3/13,5.61%,NSD1;JARID2;MTHFR
prerank,response to alcohol (GO:0097305),0.5571611777356648,1.3693653830411718,0.09316770186335403,0.34196300587453055,1.0,14/27,19.84%,SOD1;CCL19;GRIN1;GRIN3A;CCR5;GRIN2A;SDF4;GLRA1;HSD3B2;ABCA2;CCL3;SLIT3;GRIN2B;TGFB1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4868354600825967,-1.3692469948935957,0.10317460317460317,0.4874873383092326,1.0,6/16,13.79%,RBFOX2;ARID1A;ESR1;DDX17;AR;PPARGC1B
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4783496120213428,1.3683204426650126,0.03423236514522822,0.3441040936744885,1.0,28/98,20.95%,APOE;CD63;MT3;CHCHD2;AKT1;APOC1;AGT;SLCO1C1;PDGFB;ROMO1;GHITM;VAMP3;STARD4;FASN;DCXR;RAMP3;KLF4;SFRP4;NR1H2;ARRB2;SNCA;PRELID1;CBR1;INHBA;TGFB1;IL10RB;NFKBIA;GADD45A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4946623149760176,-1.3681064796003235,0.0875,0.4869075731564438,1.0,9/16,23.30%,SHLD1;FBH1;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5910905837950787,1.3680202452028571,0.10353535353535354,0.3443295581177989,1.0,7/20,5.04%,VTN;S100A11;IGFBP3;PDGFB;IGFBP5;SORL1;NDRG4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.41708000241677445,-1.367875814393187,0.07103825136612021,0.48428075880630367,1.0,9/23,19.80%,HDAC4;CLK2;PPARA;NCOR1;SIK1;C1QTNF3;CRY1;TIGAR;PFKFB1
prerank,regulation of protein ubiquitination (GO:0031396),0.4787578911071467,1.3675407011957244,0.02889576883384933,0.3449966523842272,1.0,32/108,16.87%,RPS3;UBB;HSP90AA1;HSP90AB1;LAPTM5;PARK7;UBXN1;AKT1;PINK1;FKBP1A;HSPA1B;BAG5;TNFAIP3;FAM107A;FOXF2;ISG15;CENPX;PTTG1IP;ADGRB1;DNAJA1;WFS1;VPS28;DNAJB2;NSMCE3;HSPA1A;FBXW7;IVNS1ABP;RIPK2;HSPBP1;ARRB2;CAV1;SQSTM1
prerank,cAMP biosynthetic process (GO:0006171),-0.5550111091011247,-1.367192920835525,0.1353135313531353,0.4825940628988301,1.0,4/10,10.19%,ADCY9;ADCY1;ADCY5;ADCY7
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6294419745180522,1.3670813773700246,0.11351351351351352,0.3456659647042813,1.0,8/14,26.23%,TIRAP;HNRNPA0;ZFP36;TARDBP;ELAVL4;YBX3;ELAVL1;HNRNPC
prerank,interstrand cross-link repair (GO:0036297),0.5127353357543755,1.3664393790627176,0.058165548098434,0.3467662594007646,1.0,8/53,7.60%,RPS27A;UBC;UBB;VCP;NUCKS1;RPA2;UBA52;CENPX
prerank,angiogenesis involved in wound healing (GO:0060055),0.6629687278614219,1.366018542138689,0.09787234042553192,0.34737413468248446,1.0,7/11,24.84%,CD34;KDR;GATA2;MCAM;HPSE;PRCP;SRF
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6460067519166691,1.365954143758473,0.11263736263736264,0.3470342153613164,1.0,6/12,19.11%,CALM1;CALM3;IRX3;CAV1;SRI;CALM2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4869166955447738,1.3657884916905283,0.032873806998939555,0.3469582094315588,1.0,32/80,22.12%,CTSD;GPX1;MT3;NDUFA13;AKT1;ARL6IP1;GPER1;TNF;LAMTOR5;YWHAE;BEX3;FOXL2;AQP1;DHCR24;HMGB1;PDCD6;PMAIP1;KLF4;GAS6;BAD;BCAP31;PDCD5;SYK;SNCA;NLRP3;HGF;MYC;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,mitochondrion disassembly (GO:0061726),0.536623727617955,1.3654083714022371,0.09378663540445487,0.3473494082374311,1.0,7/34,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,regulation of primary metabolic process (GO:0080090),0.47096731144771337,1.365364271023679,0.026449643947100712,0.3469812037592529,1.0,28/126,12.63%,APOE;PSAP;PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;CERS2;NR1D1;PSMD1;PSMC3;PSMD6;PSMA7;EDF1;LSS;PSMD5;SIN3B;PSMB9;FASN;PSMD13;SCD;PSMB3;SC5D;PSMB11;NCOR2;ODC1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6413471180532331,1.3651366555438802,0.10674157303370786,0.3470662194589253,1.0,7/13,19.20%,RACK1;HSPA5;PPP1R15B;WFS1;PPP1R15A;DNAJB9;DDRGK1
prerank,T cell proliferation (GO:0042098),0.6272718463981379,1.3645449316216227,0.12549019607843137,0.34803661612503034,1.0,5/13,15.62%,MSN;SLC11A1;LILRB1;DOCK8;RASGRP1
prerank,positive regulation of cell aging (GO:0090343),0.6537409568230691,1.3641955649101625,0.1262002743484225,0.3484389611279005,1.0,2/11,2.35%,B2M;YPEL3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5449836943076313,-1.363687704216587,0.15017064846416384,0.48748496277018055,1.0,5/10,19.08%,GHR;STAT5B;STAT3;STAT5A;STAT6
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.537234362348642,1.3634805259207956,0.07126696832579185,0.34977309704962334,1.0,14/36,21.74%,RPS3;PPIA;TMBIM6;TNF;CX3CR1;MAPK8IP2;DAB2IP;GATA4;MAZ;QARS1;ING5;PYCARD;ASAH2;PTPMT1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5934248756479659,1.3632621325419918,0.10981912144702842,0.3497893523509843,1.0,5/17,14.60%,AKAP6;ANK3;VAMP2;KCNE4;KCNE5
prerank,cellular response to gamma radiation (GO:0071480),0.5938195754449864,1.3631108104123617,0.1266490765171504,0.3496768715762356,1.0,4/17,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,UV protection (GO:0009650),0.6696511258205508,1.3629100453497909,0.09781021897810219,0.34968116645413466,1.0,5/10,13.89%,GPX1;MFAP4;SDF4;MC1R;CAT
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6189725819577029,1.3618401320137947,0.11543624161073826,0.3517428552580867,1.0,8/15,17.45%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2
prerank,negative regulation of phagocytosis (GO:0050765),0.6007743200150282,1.360855594538491,0.1303780964797914,0.35373346461585886,1.0,6/17,17.78%,RACK1;SIRPA;SYT11;HMGB1;CD300LF;CD300A
prerank,prostaglandin biosynthetic process (GO:0001516),0.5996135841427631,1.3599973520415012,0.10335917312661498,0.3554133149557873,1.0,6/18,14.87%,CD74;PTGDS;MIF;PRXL2B;HPGDS;PTGES3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6704558841071596,1.3595504270980163,0.11884057971014493,0.3559382748821941,1.0,6/10,24.77%,CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6214802718193966,1.3590104427679968,0.11668928086838534,0.3568154536890095,1.0,2/14,1.61%,RPL7;RPL35
prerank,positive regulation of cytokinesis (GO:0032467),-0.39493498559007745,-1.3588881098896064,0.06338028169014084,0.496239179929639,1.0,11/32,21.39%,SVIL;PRKCE;CDC14A;CSPP1;CDC25B;PKP4;GIPC1;CDC14B;RACGAP1;PKN2;KIF23
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5245047939169085,1.358149742197169,0.0984936268829664,0.35852138503131764,1.0,11/36,17.49%,CD74;LAPTM5;HSPA1B;TICAM2;WNT5A;C1QTNF4;HSPA1A;GAS6;CXCR4;CD300LF;ADAM17
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5922570849350541,1.3579120362803878,0.12179487179487179,0.3586488148185106,1.0,6/19,12.78%,KLF2;SLCO1C1;TNF;PDGFB;WFS1;KLF4
prerank,calcium-ion regulated exocytosis (GO:0017156),0.556203731216062,1.357825431891805,0.08098159509202454,0.3583985298474792,1.0,16/27,25.63%,SYT1;RIMS2;RIMS1;SDF4;SYT12;SYT11;VAMP2;SYT6;SYT4;SYT10;SYT2;DOC2B;SCIN;SYT3;SYT5;SYT17
prerank,protein autoprocessing (GO:0016540),0.6020704949444204,1.3577435139982494,0.10353866317169069,0.358135702972659,1.0,4/17,10.97%,CTSL;OMA1;KLK6;MYRF
prerank,peptidyl-amino acid modification (GO:0018193),0.6733067651198061,1.357523420383344,0.12236286919831224,0.358220881416335,1.0,5/10,15.29%,METAP1;FKBP10;FKBP7;METAP2;PDF
prerank,regulation of chemotaxis (GO:0050920),0.550107647609078,1.3573264372918397,0.08066429418742586,0.35824648690423383,1.0,15/30,21.84%,CCL19;TREM2;PDGFB;DUSP3;RARRES2;P2RY12;AIF1;ZSWIM8;CXCR4;F2RL1;YTHDF1;STX4;GPR183;TGFB1;PPM1F
prerank,negative regulation of T cell proliferation (GO:0042130),0.551198507586015,1.3571937423158653,0.11191335740072202,0.35807316808820355,1.0,6/28,13.40%,GPNMB;PRNP;CEBPB;PRKAR1A;SDC4;LILRB1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.536330956955187,1.356870652060155,0.08352668213457076,0.35838954964141156,1.0,6/35,7.58%,APOE;SPARC;ATP5F1A;CAV2;ATP5IF1;VASH1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5110859994977957,-1.356011473127387,0.13307984790874525,0.499843426904023,1.0,7/13,19.30%,LARGE1;OGA;PGM3;MGAT3;RENBP;CHST3;NAGK
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5108162983859419,1.35526580906536,0.08114285714285714,0.36201211836784714,1.0,10/47,13.19%,APOE;RPL10;AKT1;GRM5;AGT;METAP1;PCIF1;RBM4B;KLF4;METTL18
prerank,regulation of intracellular transport (GO:0032386),0.5262868677807716,1.3551652658074784,0.08967082860385925,0.3617531009496288,1.0,12/38,11.11%,LAMP1;CRYAB;NEFH;REEP5;MLC1;REEP6;MAP2;LCP1;ATP13A2;DNAJC30;GAS1;HAP1
prerank,protein localization to chromatin (GO:0071168),-0.46529266665830354,-1.3545029491130258,0.12345679012345678,0.5002120388713791,1.0,7/18,12.25%,NIPBL;WAPL;TASOR;ESR1;PPHLN1;MRNIP;LRWD1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4644772007004734,1.354371175835715,0.026236125126135216,0.3631595637383592,1.0,41/146,16.89%,TUBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;DCTN3;PSMC3;PPP2R1A;YWHAE;PSMD6;GPR132;PSMA7;CCND1;CLASP1;YWHAG;TUBB4A;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;CEP131;PSMB11;DCTN1;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6679575709632395,1.3540541856141681,0.1199400299850075,0.36299845931937036,1.0,4/10,20.24%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6679575709632395,1.3540541856141681,0.1199400299850075,0.36299845931937036,1.0,4/10,20.24%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,endothelial tube morphogenesis (GO:0061154),0.6664019497496373,1.3535296845903515,0.11095305832147938,0.36381315017777305,1.0,5/10,13.17%,RHOB;CSNK2B;ACVRL1;CTNNB1;RHOA
prerank,positive regulation of angiogenesis (GO:0045766),0.47123038239589643,1.3527556162993875,0.032224532224532226,0.3652145213409105,1.0,32/108,17.06%,S100A1;RAMP2;MDK;HSPB1;GRN;HMOX1;RHOB;CD34;PKM;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;KLF4;TIE1;CTSH;RRAS;DLL1;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5435506299903398,1.3526829248107426,0.10340632603406326,0.3648986531205287,1.0,11/28,19.20%,CLU;LAPTM5;TREM2;PSMC3;ATP5IF1;NUPR1;ECSCR;FBXW7;DAB2IP;CTSC;DDRGK1
prerank,regulation of axon extension (GO:0030516),0.5232109900462019,1.3525304981626083,0.09741784037558686,0.3648291998263853,1.0,8/37,9.09%,APOE;MT3;SEMA7A;RTN4;NRCAM;MAPT;MAP2;NTN1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.561136274278196,1.352523657487408,0.11528822055137844,0.36387446384940486,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.561136274278196,1.352523657487408,0.11528822055137844,0.36387446384940486,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,maturation of LSU-rRNA (GO:0000470),0.5546504118822067,1.35242631691092,0.09517923362175525,0.3636190038247232,1.0,4/26,2.38%,RPL7;RPL7A;RPL35;RPL10A
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5323735204118681,1.3522642229721158,0.10281517747858017,0.3635710076666336,1.0,11/29,23.49%,SCD5;ELOVL1;ELOVL2;FASN;ELOVL7;SCD;SLC25A1;ACSL3;ELOVL6;ACSL4;ACLY
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5427094519901445,1.3520923869572727,0.09014423076923077,0.3635257203613481,1.0,3/29,4.50%,LAMP1;TYROBP;SPI1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6306354620819679,1.3511539134487953,0.10419485791610285,0.3654861978124187,1.0,5/13,15.47%,CLU;MANF;NUPR1;WFS1;NR1H2
prerank,relaxation of muscle (GO:0090075),0.6372636039195814,1.351134575085639,0.10225763612217796,0.36506261170321774,1.0,7/13,15.38%,GSN;RGS2;PLN;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3062079275279497,-1.3498363786946808,0.03571428571428571,0.5081286458459844,1.0,33/108,13.39%,SULF1;NXN;WWOX;TRABD2B;WLS;DCDC2;LRRK2;VGLL4;MACF1;KREMEN1;GPC3;SKI;PTK7;PRKN;NFATC1;AXIN1;TLE1;GRB10;MDFIC;RSPO3;FGFR2;BTRC;KANK1;ESR1;TERT;PSEN1;LRP1;ITGA3;CSNK2A1;NLK;RNF43;ZRANB1;CBFB
prerank,MAPK cascade (GO:0000165),0.4518147881921384,1.3493568203161421,0.002002002002002002,0.3691036268741027,1.0,94/295,20.68%,RPS27A;UBC;CALM1;UBB;MBP;PSMB4;MT3;MAPK3;PSME1;PSMB6;PSME2;PSMB8;NRG1;PSMD2;ERBB4;IL5;RCE1;LAMTOR2;PEBP1;TNF;PDGFB;YWHAB;DLG2;PSMD1;ZFP36L1;NEFL;PSMC3;ZFP36L2;YWHAE;PSMD6;IL2RB;GRIN1;SHC3;UBA52;PSMA7;CCR5;PAK1;KDR;IL2;PSMD5;RBX1;ABHD17A;KARS1;ZFP36;KITLG;ICMT;PSMB9;RASGRP3;PSMD13;PSMB3;IL2RG;IL3RA;HRAS;GFRA1;PSMB11;SOX9;LAMTOR3;PSMB10;KBTBD7;CTSH;CCL2;LRRC7;ARL2;MAPK11;GOLGA7;PDGFA;CSF2RB;RASGRP1;SPTBN4;FGF13;PSMB1;GFRA2;PSMB5;DAB2IP;CCL3;SPTBN2;NCAM1;RASGRF1;ERBB3;GRIN2B;PLVAP;MAP2K2;KLB;PSMA6;SOS1;FLT3;HGF;TGFB1;CSF2RA;MEF2C;SKP1;PSMA4;MYC;BRAP
prerank,anterior/posterior pattern specification (GO:0009952),-0.346638714721297,-1.349130330729131,0.02127659574468085,0.5066335534762907,1.0,19/53,16.73%,WLS;HOXB6;HOXB3;HOXA3;LRP5;SKI;HOXB4;HOXA5;HOXC4;TGFBR1;HOXB5;PCSK5;HOXC6;HOXA6;HOXC5;SMAD2;HEY2;BMPR2;ACVR2B
prerank,positive regulation of type 2 immune response (GO:0002830),0.6275986083335804,1.3491025836757917,0.11615487316421896,0.36923999862779594,1.0,2/14,1.05%,CD74;CD81
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.63582465915754,1.3488553007761486,0.11081081081081082,0.3693708818706738,1.0,1/13,0.38%,RPS21
prerank,cholesterol metabolic process (GO:0008203),0.4886479092149425,1.3486434760831374,0.06587473002159827,0.369436115575288,1.0,18/68,23.49%,APOE;MT3;SNX17;ABCG1;LSS;DHCR24;PIP4P1;ACAA2;CLN6;SOAT2;CLN8;CH25H;PLPP6;OSBPL1A;FDPS;NSDHL;PMVK;ACLY
prerank,positive regulation of B cell activation (GO:0050871),0.5025086903169437,1.3483805283238697,0.07838745800671892,0.369609875491768,1.0,14/50,20.07%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2;VAV3;SH3KBP1;MMP14;SYK;GPR183;IL6;MEF2C
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4896817640650392,1.348093904199426,0.05806451612903226,0.3698751312539769,1.0,30/65,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;VPS4A;PSMA6;SKP1;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;CHMP4C;PSMD10
prerank,glutamate metabolic process (GO:0006536),0.577008750229537,1.3479860640331514,0.11471321695760599,0.36967925618861364,1.0,8/19,21.67%,OAT;GLUL;GLS2;GLS;GLUD1;GOT1;GAD1;MTHFS
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.466284302286128,1.3479703252920072,0.03567787971457696,0.3692355093017682,1.0,42/124,20.32%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;RAC1;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;ATP1B2;PRDM12;MAPT;MAP2;STMN4;CDK5R1;HMGB1;BLOC1S1;CSF1R;BLOC1S3;BLOC1S5;PRMT1;STMN1;GPRIN2;EHD1;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;IL6;VAPA;POU4F1;CTTN
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.655399760819425,1.3474914608204085,0.13333333333333333,0.36947329478826413,1.0,7/11,24.77%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.655399760819425,1.3474914608204085,0.13333333333333333,0.36947329478826413,1.0,7/11,24.77%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,aminoglycan metabolic process (GO:0006022),0.6528597959924644,1.3472461922249983,0.13486370157819225,0.3695733245568274,1.0,6/10,25.19%,B3GAT3;CLN6;XYLT1;B3GAT1;GAL3ST3;CHST9
prerank,epithelium development (GO:0060429),0.47170407184154006,1.3469910633604352,0.029743589743589743,0.36974531976874825,1.0,22/107,13.45%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;RCN3;SOX18;CD34;TOLLIP;LGALS3;NDRG4;PGK1;PROX1;KDR;MFSD2A;DNPH1;PIH1D1;SOX17;PCNA;SOX8;SOX9;BMP2
prerank,cellular potassium ion homeostasis (GO:0030007),0.6215346468241701,1.3469776501009367,0.13043478260869565,0.3692917210611051,1.0,7/13,18.34%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,autophagy of mitochondrion (GO:0000422),0.5228018737043145,1.3465648012532119,0.09248554913294797,0.3698175081474354,1.0,7/38,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4607319214225158,-1.3464646380820657,0.11864406779661017,0.509698580823714,1.0,7/17,14.17%,CACNA1C;ANK2;ATP1A2;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,positive regulation of proteolysis (GO:0045862),0.49690924746090487,1.3462305107874086,0.08657047724750278,0.37019677761002506,1.0,18/55,22.30%,APOE;AURKAIP1;NDUFA13;RCN3;PINK1;TNF;ATP5IF1;CLN6;CTSH;BAD;SNX33;TRIM32;CTSC;WDR48;CAPN3;BAK1;STUB1;TNIP1
prerank,negative regulation of inflammatory response (GO:0050728),0.4568151524681679,1.3457505633500877,0.012145748987854251,0.3709444054765298,1.0,45/182,19.88%,APOE;RPS19;RAMP2;MDK;GRN;TREM2;POMC;GPER1;NR1D1;LRFN5;SCTR;SIRPA;TNFAIP3;DRD5;CD163;FEM1A;RXFP1;OTULIN;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;KLF4;ADCY4;TNFRSF1A;FNDC4;TYRO3;ADCY8;HTR7;CDH5;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;CXCL17;NLRP3;IL6;GIT1
prerank,negative regulation of cation channel activity (GO:2001258),0.5611937471268861,1.3457248288392167,0.10579345088161209,0.37053944279503226,1.0,9/26,19.11%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,organic substance transport (GO:0071702),0.46631759618748553,1.3452045995782222,0.03169734151329243,0.37136767430445866,1.0,31/121,17.52%,RAMP2;PLTP;GM2A;RCN3;SLC18A1;LRP1B;TXNIP;HSP90B1;ABCB6;ABCG1;CHMP2B;TAP2;RD3;ARRDC1;SCAMP3;MFSD2A;SLC6A2;VAMP2;SLC50A1;ATP8A1;SLC48A1;RAMP3;CMTM6;NME4;SLC19A1;SCAMP2;ARRDC3;CHMP1B;ABCA2;MFSD2B;CLN8
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.46341293001622114,1.345130872418371,0.03160040774719674,0.3710699429472021,1.0,60/124,28.47%,CALM1;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;RAC1;PSMD1;PSMC3;CTNNB1;PSMD6;AP2M1;SFRP5;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;GNAO1;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;SFRP4;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;AGO1;ARHGEF19;PPP3CA;PSMA6;SFRP1;PSMA4;FZD2;FZD1;AP2A1;PPP3R1;PSMC1;PARD6A;WNT7A;PSMD9;PDE6G;CELSR3;PSMB2;PSMD4;PSMD10;FZD3;LEF1;PSMC5;VANGL2;FZD5;MAP3K7;CCDC88C
prerank,regulation of mitochondrial depolarization (GO:0051900),0.661671247784809,1.3447413327097517,0.1347517730496454,0.37151663018073333,1.0,4/10,9.64%,RACK1;FZD9;KDR;DCN
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6439747171970291,1.3446593470963368,0.13278008298755187,0.37125328987212425,1.0,2/11,2.84%,AKAP6;TREM2
prerank,artery morphogenesis (GO:0048844),-0.39770762737378007,-1.3446474580889838,0.06790123456790123,0.5110611522759099,1.0,12/30,16.91%,BMPR1A;NRP1;ADAMTS9;TGFBR1;SMAD7;PDGFRB;LRP1;JAG1;BMP4;HEY2;BMPR2;NF1
prerank,calcium ion homeostasis (GO:0055074),0.472289071834667,1.3442509473669817,0.042708333333333334,0.37184118481195266,1.0,28/95,19.56%,TPT1;CALR;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;TMTC2;GRIN1;DRD5;TMCO1;HTR2C;ATP13A2;CALCB;WFS1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;CCR2;SELENON;EDN3;SNCA;TFAP2B
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3455273873477677,-1.3440033420554154,0.024096385542168676,0.5093935053946412,1.0,13/56,10.55%,BMP6;LDLRAD4;RBPMS;SMAD6;ACVR1;BMPR1A;DAB2;BMPER;TGFBR1;PMEPA1;SMAD7;GDF1;SMAD4
prerank,receptor internalization (GO:0031623),0.5132131982674735,1.3438245824860497,0.08967082860385925,0.3724450574214955,1.0,16/44,19.28%,CD81;RAMP2;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31
prerank,nitric oxide metabolic process (GO:0046209),0.6125966882475704,1.3433584987251461,0.12813738441215325,0.37311225528746966,1.0,5/14,17.56%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,histone H4-K16 acetylation (GO:0043984),-0.4345234697736713,-1.3432901230524583,0.10204081632653061,0.507983236300001,1.0,6/19,18.15%,OGT;KMT2A;KAT7;KANSL3;JADE2;KAT8
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.666368774950038,1.343271346314672,0.13920454545454544,0.3728606798575201,1.0,6/10,25.02%,APLNR;PDE3B;CDC34;PDE11A;PDE2A;RNF157
prerank,excitatory postsynaptic potential (GO:0060079),0.5818928495664171,1.343159663201533,0.11795543905635648,0.37266823610007455,1.0,10/19,22.37%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,cellular response to virus (GO:0098586),0.5345620999103865,1.3424324668756595,0.09026128266033254,0.37399377037344816,1.0,8/30,15.22%,HSP90AA1;CCL19;EIF5A;CXCL10;RRP1B;BAX;ARF1;MAPK11
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6016119003225969,1.3423511676853628,0.11963589076723016,0.373706037204605,1.0,9/17,19.16%,CXCL12;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6234387726467628,1.3420456649199983,0.13095238095238096,0.3740549793644223,1.0,4/14,9.22%,CD63;EMP2;FLNA;TIMP1
prerank,positive regulation of biosynthetic process (GO:0009891),0.5126559999339693,1.3418510457263344,0.10148232611174458,0.3740576102685123,1.0,8/40,10.10%,APOE;VIM;AKT1;CYBA;GRIN1;HSD17B13;MLXIPL;ADGRB1
prerank,regulation of programmed cell death (GO:0043067),0.456831155065009,1.3414922229438884,0.012060301507537688,0.3744113997276042,1.0,38/161,14.37%,TPT1;RPS3;CLU;CTSB;HSP90AA1;CALR;LGALS1;AKT1;NME1;TGM2;PINK1;AGT;IGFBP3;BEX2;MAGED1;TNF;PRDX2;RTN4;VCP;ALPK2;OMA1;NDRG1;BNIP3L;SGK1;CXCL10;TARDBP;GAS1;APEX1;BAX;ZBTB7A;WFS1;PMAIP1;ACTN1;PHLPP1;SOX9;NME2;GLS2;IKZF3
prerank,ovarian follicle development (GO:0001541),0.6215464370066398,1.3404628065336088,0.1272475795297372,0.3765635775823998,1.0,8/13,25.31%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;INHA
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4731295684509673,1.3404462140457623,0.04455958549222798,0.3761227057931838,1.0,20/88,13.45%,APOE;SPARC;AKT1;ATP5F1A;PDGFB;ACVRL1;ANG;ECM1;CAV2;ATP5IF1;EMC10;VASH1;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;TIE1;BMP2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6300707925861352,1.340040616649331,0.13261163734776726,0.3766597656557543,1.0,4/12,13.46%,RPS27L;RPA2;CCND1;FBXO31
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6091539065422141,1.3397792819331418,0.12672176308539945,0.37685469033186136,1.0,7/14,27.39%,UQCC2;COA3;TRUB2;RPUSD4;C1QBP;TRMT10C;RCC1L
prerank,mononuclear cell differentiation (GO:1903131),0.5549398964025075,1.3397302241940297,0.11013767209011265,0.376482700063967,1.0,11/24,20.16%,MT1G;TREM2;IKZF1;IRF8;CSF1R;TRPM2;LILRB1;GAS6;BATF3;FLT3;PDE1B
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6116260670049761,1.3394030370901073,0.13994565217391305,0.3767632551704109,1.0,6/12,19.94%,TRH;MAOA;ODC1;SMS;SRM;OAZ2
prerank,transferrin transport (GO:0033572),0.5285542725323565,1.339295505473539,0.0996523754345307,0.3765516441151835,1.0,8/33,11.17%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;CLTC;ATP6V0D2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5605442466183781,1.3392273203324554,0.12839506172839507,0.37624386700859486,1.0,8/24,10.88%,PEX5L;SCTR;APLNR;PDE3B;CDC34;PRKAR1A;GNAI1;PRKAR1B
prerank,protein localization to cilium (GO:0061512),-0.3824838928439636,-1.338752160175441,0.07065217391304347,0.5162529255971849,1.0,11/32,14.54%,ZNF423;RABEP1;BBS9;INVS;ARL3;WDR35;TULP3;IFT140;IFT122;TULP2;WDR19
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4717795382533989,-1.3387515725594592,0.13114754098360656,0.5131119213714617,1.0,6/16,15.43%,FTO;RREB1;SIX1;SIRT1;NAPEPLD;SOX13
prerank,entry into host (GO:0044409),0.6139216099079264,1.3386160548991524,0.13351134846461948,0.3773121758670655,1.0,4/13,13.70%,PPIA;CTNNB1;CCR5;CXCR4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6151550480768058,1.3378183241278132,0.12849162011173185,0.37887229073805667,1.0,8/13,32.37%,ELOVL1;ELOVL2;TECRL;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,defense response to symbiont (GO:0140546),0.4725363067629708,1.3376247693988261,0.043933054393305436,0.3788932263551088,1.0,30/92,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5319815880830242,-1.337437375077716,0.13257575757575757,0.5129355568553,1.0,6/11,21.61%,SETD2;IWS1;AKAP8L;CPSF6;KHDRBS1;TPR
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.45674931455108375,1.3372214668327964,0.021233569261880688,0.3794207573212819,1.0,41/166,16.45%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;HSP90AA1;HSP90AB1;PARK7;AKT1;KLF2;CCL19;EIF3D;NPM1;RPS27L;TNF;PDGFB;NR1D1;MID1IP1;CTDNEP1;EIF3C;MFSD2A;MLXIPL;STARD4;EGR1;DDB1;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;DDAH1;TLR6;ABCB10;ARPP19;IGF2;NR1H2;CIRBP;YTHDF1;EIF4A3;DDAH2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6036790943875235,1.3369916278707832,0.14859437751004015,0.3795309661479218,1.0,4/14,10.71%,MDK;MAPK3;RARRES2;CSF1R
prerank,positive regulation of secretion (GO:0051047),0.638137163379182,1.3369720883552099,0.13753581661891118,0.37909542791714385,1.0,4/11,18.55%,TRH;AQP1;SCIN;ACSL3
prerank,C4-dicarboxylate transport (GO:0015740),0.6103600069318054,1.3367063023462864,0.15319148936170213,0.37930283507782225,1.0,10/14,30.05%,SLC1A2;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,histone H4 deacetylation (GO:0070933),-0.5336017468077574,-1.3364798483570028,0.1465798045602606,0.5119933034695865,1.0,4/10,7.12%,HDAC4;HDAC8;SMARCAD1;RCOR1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5765873522289682,1.33635840237093,0.1134020618556701,0.3797375488808217,1.0,6/20,16.01%,ACADVL;APOC1;GPER1;FBXW7;BMP2;ABCA2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6397317294996121,1.3362047334431741,0.12898936170212766,0.37963500822012125,1.0,5/12,15.67%,HSP90AA1;HSP90AB1;B4GALT6;SPTBN4;EPHB1
prerank,regulation of cell motility (GO:2000145),0.461655444359969,1.3358475398087235,0.030800821355236138,0.3800791068260508,1.0,24/121,10.78%,TMSB4X;TMSB10;CAVIN1;RHOB;AKT1;CCL19;SPOCK2;SERPINE2;NRG1;ERBB4;RAC1;PIN1;FLNA;FRMD5;ENPP2;SGK1;PKN1;ROBO4;SPOCK3;NTN1;CADM4;PHPT1;CSF1R;DOCK10
prerank,nitric oxide biosynthetic process (GO:0006809),0.6199997911126394,1.3357221388328617,0.14035087719298245,0.3799232748594852,1.0,5/13,17.56%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,monocarboxylic acid transport (GO:0015718),-0.354774185193434,-1.3356803916543751,0.04807692307692308,0.5107312962540627,1.0,12/51,12.66%,SLCO3A1;SLC6A13;SLC16A12;NCOA1;SLC6A12;SLC16A9;ABCG2;SLCO2A1;ABCB4;SLC16A6;SLC16A13;ATP8B1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.48795928595116395,1.3355674460665388,0.08830022075055188,0.3798341493999671,1.0,27/57,25.00%,NLGN1;DLGAP2;GRIA2;DLGAP1;DLG2;SHISA7;NEFL;GRIN1;GRIA4;LYNX1;GRIN2A;CRH;GRIA1;BEGAIN;LRRC7;MAPK8IP2;CACNG8;NPTXR;GRIN2B;CACNG5;MEF2C;GRIA3;CACNG2;APP;NPTX1;SHISA6;PRRT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5057454794716039,1.3348613301849346,0.09561304836895389,0.3811290094733762,1.0,12/44,13.55%,GPX1;MT3;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;KLF4;GAS6
prerank,negative regulation of endocytosis (GO:0045806),0.5523507581475621,1.3346535858107629,0.1342534504391468,0.38119257466040196,1.0,11/24,19.38%,APOC1;LGALS3;RAC1;SYT11;ARF6;LILRB1;NR1H2;SNX33;CAV1;CD300A;UNC119
prerank,negative regulation of locomotion (GO:0040013),0.629967015673934,1.3345979197830542,0.1375166889185581,0.38086554605231865,1.0,4/12,8.70%,PIN1;DUSP3;FRMD5;SPOCK3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5442940211471,1.3337789571143475,0.11288343558282209,0.38245190239727184,1.0,12/27,20.94%,MDK;ITGB2;TNF;SIRPA;HSPD1;THY1;RHOA;CCL2;SKAP1;CCR2;IL6;PYCARD
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4195343411509197,-1.3337266240513628,0.12209302325581395,0.5127011189168967,1.0,7/27,13.32%,KAT6B;CREBBP;KAT7;KAT2B;BRD8;PHF20L1;KAT6A
prerank,synapse organization (GO:0050808),0.461962735342203,1.3337137714400997,0.03556910569105691,0.38212892098668544,1.0,44/125,19.95%,C1QB;C1QA;CHCHD10;C1QC;NRXN1;SPOCK2;NLGN1;GRM5;ANK3;LRFN5;C5AR1;DSCAM;PIN1;LRP4;ADGRL3;DNM3;LRRC4C;MUSK;GPHN;KIRREL3;NRCAM;PPFIA4;PPFIA2;MAPT;PAK3;DNER;PTPRD;DOK7;NRXN2;DCTN1;CBLN2;LRRC4B;CX3CR1;ELFN1;PPFIA3;ACHE;CDK5;RAB39B;PCDHB14;GPM6A;CTNND2;SNCA;AGRN;POU4F1
prerank,positive regulation of embryonic development (GO:0040019),0.5711528366837441,1.3336344932425057,0.13554987212276215,0.38185580820497933,1.0,4/19,11.04%,RACK1;CFL1;OTX2;TENM4
prerank,negative regulation of catabolic process (GO:0009895),0.5050014803686927,1.3330744182064027,0.09433962264150944,0.3827991225154301,1.0,10/47,10.10%,CST3;APOC1;TNF;PIN1;BSCL2;FLNA;PDE3B;FMN2;NUPR1;ADGRB1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6176055989580476,1.3330491376416018,0.10612244897959183,0.3823945213584666,1.0,1/14,0.01%,TMSB4X
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5880637459610727,1.3329479797737227,0.11936339522546419,0.38216263298577186,1.0,10/18,27.18%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,neural crest cell migration (GO:0001755),0.5217806671545302,1.3329071577975715,0.11578947368421053,0.3817836242678979,1.0,10/36,13.41%,ERBB4;SEMA3F;SEMA7A;SEMA4C;FN1;CORO1C;SEMA6D;SEMA4A;SOX8;SEMA4G
prerank,regulation of ion transport (GO:0043269),0.4760453851150711,1.3326841109261678,0.07278481012658228,0.38184925672455683,1.0,21/76,16.41%,B2M;NKAIN2;ANK3;CA2;YWHAH;KCNJ10;SYT1;NKAIN3;P2RX7;SYT12;SYT11;VAMP3;VAMP2;SYT6;SYT4;KCNA2;ATP1A1;CHRNA4;SYT10;SPTBN4;SYT2
prerank,regulation of cellular response to heat (GO:1900034),0.4724445825341835,1.3326509284124681,0.0617678381256656,0.3814691815272838,1.0,23/77,19.00%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;MAPK3;CRYAB;CD34;HSPA1B;YWHAE;RPA2;BAG5;BAG1;MAPT;HSPB8;HSPA1A;NUP85;NUP88;PTGES3;DNAJB1;IER5;NUP50;AKT1S1;CCAR2
prerank,cellular metal ion homeostasis (GO:0006875),0.466977488413302,1.3323115419376943,0.04559585492227979,0.38186968002792515,1.0,29/102,18.94%,TPT1;CALR;MT3;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;DRD5;ATP1A3;ATP1B2;TMCO1;HTR2C;ATP13A2;CALCB;ATP1A4;ATP1A1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;ATP1B3;CCR2;KCNMA1;EDN3
prerank,myeloid dendritic cell activation (GO:0001773),0.6228763503773156,1.3318534133005187,0.11901504787961696,0.382500321154079,1.0,5/12,20.94%,DOCK2;HMGB1;BATF3;BATF2;PYCARD
prerank,regulation of T cell activation (GO:0050863),0.5069106747706879,1.3317911674593856,0.0967741935483871,0.3821906850427989,1.0,12/42,20.94%,LAPTM5;GPNMB;LGALS3;DUSP3;SIRPA;HSPD1;THY1;FGL1;CCL2;CCR2;PRELID1;PYCARD
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4585334121590058,1.3312458178556617,0.059548254620123205,0.3831055285388068,1.0,52/107,28.08%,NRG3;NLGN1;DLGAP2;GRM5;DLGAP1;GRID2;TNF;GRIK5;GRIK2;LRRC4C;CACNA1A;SYT1;LGI1;RIMS2;GRM8;RIMS1;TPRG1L;GRM7;DGKI;GRID1;GRM1;BEGAIN;SYN1;HCRT;ABR;CX3CR1;MAPK8IP2;LRP8;CDK5;CLSTN2;CLSTN1;TMEM108;NPTXR;GRM4;KCTD13;CACNG5;MEF2C;CLSTN3;GRIK1;STX1B;UNC13A;APP;AGER;NPTX1;CACNA1B;SLC4A8;ITGB1;KCNMB4;PSMC5;CPLX1;CHRNA7;HOMER1
prerank,non-motile cilium assembly (GO:1905515),-0.38801952666084744,-1.3306687761785838,0.08522727272727272,0.5170442898068285,1.0,14/30,22.09%,PCM1;PIBF1;CEP290;IFT88;RPGRIP1L;CEP89;TMEM80;IFT122;C2CD3;IFT57;TBC1D32;RPGRIP1;GORAB;BBS10
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6486691305602226,1.3300517797872369,0.11527377521613832,0.38571275119282955,1.0,3/11,7.08%,HSPA5;ATF4;CEBPB
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4731715310433119,1.329823202677696,0.06910994764397906,0.38582613408322497,1.0,22/83,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NPM1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;ATF5;CEP131;DCTN1;NEK10;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B
prerank,regulation of monooxygenase activity (GO:0032768),0.5583969962610329,1.329100448741153,0.11473429951690821,0.3871255331740478,1.0,9/23,19.11%,CALM1;HSP90AA1;AKT1;CYGB;SPR;DDAH1;CAV1;DDAH2;SNCA
prerank,mesonephric tubule development (GO:0072164),-0.4868744882131365,-1.3283591865727695,0.11063829787234042,0.5195112824562573,1.0,7/15,19.40%,SLIT2;FGFR2;PKD1;SIX1;WNT11;BMP4;PKD2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5845002078337495,1.3274966023265204,0.1303763440860215,0.39075619722419863,1.0,7/16,23.49%,SCD5;FASN;SCD;ACAT1;SLC25A1;PPCS;ACLY
prerank,negative regulation of apoptotic process (GO:0043066),0.4411713045222602,1.3271159299076505,0.001,0.39118742436605186,1.0,125/444,20.87%,APOE;TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;UBB;GPX1;MDK;HSPB1;GRN;MT3;CFL1;PARK7;SOD1;RPL10;MAPK3;HSPA5;LGMN;AKT1;FOXQ1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;TNF;HSP90B1;FZD9;PRDX2;LAMTOR5;HCLS1;GLO1;NTRK2;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;YWHAE;IL2RB;LTK;TMEM14A;BEX3;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;SET;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;KLF4;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;CX3CR1;CCL2;PTPRZ1;MAPK8IP2;ARF4;DLL1;TYRO3;ATAD3A;CAV1;DDAH2;VHL;GATA4;PIM3;SQSTM1;PSEN2;PCID2;PPARGC1A;ASNS;CIAPIN1;AGAP2;ERBB3;MAZ;QARS1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;NOTCH1;IL6;HGF;POU4F1;CITED2;MEF2C;SFRP1;CAPN3;MYC;CRLF1;NFKBIA;HSPA9
prerank,positive regulation of defense response (GO:0031349),0.46765030060051094,1.3269157389558968,0.06334371754932502,0.39126665072992994,1.0,33/89,26.22%,MDK;GRN;CYBA;AGT;TNF;S100A8;S100A9;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;LILRA5;NINJ1;PLA2G7;WNT5A;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;MEF2C;NFKBIA;POLR3D;TNIP1;AKIRIN2;APP;PDE2A;IL33;TLR7;CX3CL1
prerank,positive regulation of cytokine production (GO:0001819),0.4435292829112117,1.3265617102455647,0.005005005005005005,0.3917466332757465,1.0,86/292,22.13%,RPS3;CD74;GAPDH;MBP;TYROBP;MDK;LAPTM5;POLR2E;HMOX1;PARK7;SOD1;C3;ATF4;PDE4B;CCL19;CYBA;CD34;SLC7A5;AGT;S100A13;NFAM1;POLR2F;TNF;LAMTOR5;PTPRC;FCER1G;SORL1;MIF;HSPA1B;FLOT1;TIRAP;CTNNB1;HYAL2;ISG15;CEBPB;PQBP1;CLEC6A;HSPD1;IL2;LPL;EGR1;LILRA5;HMGB1;CSF1R;WNT5A;PNP;FLT4;C1QTNF4;AIF1;POLR2K;SLC11A1;HSPA1A;LILRB1;RIPK2;TLR6;IRF7;F2RL1;G3BP1;TLR5;MAPK11;TLR1;RASGRP1;HPSE;GATA4;PIK3CD;TWIST1;ADAM17;NOS2;SYK;CCR2;CXCL17;CD14;CD86;NLRP3;IL6;TGFB1;SPHK2;TMEM106A;PYCARD;CRLF2;POLR2H;DDIT3;TMED10;POLR3K;IRF5;POLR3D
prerank,neuron development (GO:0048666),0.45303137093226403,1.3265574375153504,0.037525354969574036,0.3912840169650304,1.0,51/141,20.64%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;NTRK2;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;TENM2;TENM3;MANF;LGI1;ATP8A2;PQBP1;PRDM12;MAPT;MAP2;STMN4;CDK5R1;EPHA5;HMGB1;B4GALT6;BLOC1S1;BLOC1S3;TENM4;BLOC1S5;PRMT1;CLN5;STMN1;GPRIN2;EHD1;UGDH;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;MYT1L;ATCAY;DCX;IL6;VAPA;POU4F1;MEF2C;SRRM4
prerank,positive regulation of cell development (GO:0010720),0.529289683442745,1.3259886094792286,0.125,0.39224701257301375,1.0,10/31,18.98%,TYROBP;SERPINF1;TGM2;GPER1;ATP6AP1;SNW1;CX3CR1;BAD;TRIM32;SOX11
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5413287906515031,1.3254199552110801,0.1111111111111111,0.393228719687478,1.0,5/30,8.81%,GPX1;HMOX1;PARK7;TNFAIP3;FAIM2
prerank,positive regulation of bone resorption (GO:0045780),0.6450922527215645,1.3253941243592529,0.13168724279835392,0.3928196598725164,1.0,6/11,25.11%,SPP1;ATP6AP1;DEF8;SYK;TNFRSF11A;PRKCA
prerank,regulation of cytokine production (GO:0001817),0.45429436265022055,1.3252663237297937,0.03487179487179487,0.3927250553355277,1.0,32/126,18.31%,GAPDH;GPNMB;SOD1;TREM2;AGT;S100A13;NFAM1;TNF;PLD3;PTPRC;BTN3A3;MIF;FLOT1;SIRPA;ISG15;CLEC6A;SYT11;BCL6B;MOG;ICOSLG;IRF8;SRGN;ATP2B1;SLC11A1;IRF7;TRAF3;TRIL;HDAC9;PIK3CD;TRIM32;NOS2;CCR2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4476988372871418,1.3249402912018975,0.019095477386934675,0.39309974377927176,1.0,65/214,20.04%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;PIN1;MIF;NDRG4;DUSP3;TIRAP;ATP6AP1;SIRPA;DDT;FN1;P2RY6;DUSP26;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;CAMK2N1;PTPRR;TIMP3;FBXW7;CNKSR3;SPRY1;NEK10;BMP2;GAS6;YWHAZ;CCL2;RRAS;F2RL1;PDGFA;RASGRP1;EPHB1;ARRB2;ADRA1A;DAB2IP;CCL3;GATA4;ADCYAP1;CCL8;SYK;FAM83D;SPRY3;GPR183;NOTCH1;TGFB1;THPO
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6520738491607148,1.3238031320583987,0.15121255349500715,0.39545799873033427,1.0,8/10,32.99%,GABRG3;GABRA2;GABRA3;GABRB2;GABRA4;GABRG2;GABRA1;GABRG1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5939312059700824,1.3236707035500392,0.15535248041775457,0.3953315522598764,1.0,5/15,16.27%,SLC30A1;TMBIM6;PLN;LILRB1;CBARP
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5486257878744011,1.3235908934314937,0.1285892634207241,0.3950511582145081,1.0,5/25,14.62%,B2M;LAPTM5;SLC7A5;WNT5A;F2RL1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.48693123488099355,1.3234605028553363,0.07700534759358289,0.39491275581712215,1.0,16/63,12.45%,CST3;MT3;TIMP2;AKT1;EIF4G2;TREM2;APOC1;RASIP1;SORL1;NELL1;MFSD2A;NUPR1;TIMP1;MTMR9;ATRAID;TIMP3
prerank,cellular response to reactive oxygen species (GO:0034614),0.48360783351783515,1.3223558628343903,0.09230769230769231,0.39720902828890553,1.0,14/59,11.56%,RPS3;PARK7;RHOB;MAPK3;AKT1;PRDX5;ROMO1;SIRPA;TNFAIP3;AQP1;MAPT;NET1;JUN;TRPM2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5625575964358267,1.3219477360988496,0.13358778625954199,0.39775136799142574,1.0,11/20,28.16%,SCD5;HSD17B4;FASN;SCD;SLC25A1;ACSL3;DGAT1;ACSL4;ACLY;FAR2;HSD17B8
prerank,regulation of cell cycle phase transition (GO:1901987),0.46564511622368937,1.3219345475591133,0.06256517205422316,0.39730898995341873,1.0,40/91,28.26%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXW7;NEK10;FBXO5;PSMB10;PSMB1;PSMB5;PSMA6;SKP1;PSMA4;TFAP4;PSMC1;FZR1;PSMD9;CDC20;PSMB2;XPC;PSMD4;PSMD10;ERCC2;CDKN1A;PSMC5;TRIM39;ATP2B4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5703423269388539,1.3215014159129543,0.12643678160919541,0.39799749440686744,1.0,5/18,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,rRNA transcription (GO:0009303),0.5876869866476998,1.3213682760221328,0.14030612244897958,0.39782878441428055,1.0,3/17,4.76%,CAVIN1;ANG;GTF3C6
prerank,myelination (GO:0042552),0.49820359189371666,1.3212981208480061,0.1017897091722595,0.3975259047767612,1.0,16/46,15.94%,MBP;PLP1;MPZ;PLLP;PMP22;MAL;KLK6;GAL3ST1;B4GALT6;MYRF;MALL;CXCR4;BCAS1;NFASC;DEGS1;EPB41L3
prerank,neural crest cell development (GO:0014032),0.4995966463522896,1.321031865274932,0.11818181818181818,0.39771427983812746,1.0,11/44,13.41%,NRG1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;SEMA4A;PDCD6;SOX8;SEMA4G
prerank,positive regulation of glucose import (GO:0046326),-0.44055842765101955,-1.3210080240633355,0.10526315789473684,0.534650285213526,1.0,10/21,16.96%,SORBS1;OSBPL8;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.635295799964117,1.32080210434676,0.1591549295774648,0.39779549759851207,1.0,3/11,10.15%,CD74;MIF;TAF9
prerank,B cell proliferation (GO:0042100),0.5839036871959881,1.3207565142407203,0.12484076433121019,0.397446738906628,1.0,5/17,20.07%,PTPRC;CD180;HSPD1;RASGRP1;MEF2C
prerank,cellular protein catabolic process (GO:0044257),0.4828241986633864,1.3207199065959927,0.08546059933407325,0.39705988052335744,1.0,11/59,9.52%,CTSB;CTSL;CTSZ;CTSS;LGMN;CHEK2;UBE2G2;AP2M1;BNIP3L;CLTC;AP2S1
prerank,metal ion transport (GO:0030001),0.46641151856455976,1.320652628129701,0.06763787721123829,0.39678255505116994,1.0,24/86,18.53%,TPT1;RAMP2;MT3;SLC30A1;CACNA1A;GRIN3A;CCR5;SELENOK;SLC3A2;NIPAL4;RAMP3;TRPM2;CHRNA4;SLC11A1;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;PSEN2;CCL8;MAGT1;NIPA1
prerank,positive regulation of calcium ion transport (GO:0051928),0.5221602769534719,1.3205312135815102,0.10660486674391657,0.3966155184103821,1.0,12/36,16.89%,CXCL12;PDGFB;LGALS3;GRIN1;P2RX7;LILRA5;WFS1;ATP2B1;CCL2;CCL3;CAV1;ORAI1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6573269222028685,1.320495125500126,0.13872832369942195,0.39622415354132523,1.0,1/10,1.05%,CD81
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5619364038446609,1.3202578894123516,0.1475826972010178,0.3963111044405435,1.0,11/21,25.44%,BGN;BCAN;DCN;CHPF2;CHPF;UGDH;VCAN;CSGALNACT2;CHSY3;CHST9;CSPG5
prerank,negative regulation of vascular permeability (GO:0043116),0.6275483960733116,1.3200148065827089,0.15446071904127828,0.39651165579698555,1.0,3/12,5.39%,CLDN5;RAMP2;SH3GL2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.45746513816104106,1.3200128056015963,0.05165289256198347,0.3960513096039692,1.0,47/109,27.72%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,microtubule-based transport (GO:0099111),-0.49431074825683397,-1.319979571075635,0.12941176470588237,0.5344214701947871,1.0,8/13,30.04%,SPAG17;SPA17;DNAAF2;DYNC1I2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,androgen metabolic process (GO:0008209),0.5815722881159042,1.319526471887005,0.11855670103092783,0.3968034914937565,1.0,4/18,12.81%,SPP1;HSD17B6;HSD17B4;HSD3B2
prerank,T cell receptor signaling pathway (GO:0050852),0.4507238174486618,1.3192580138482615,0.03556910569105691,0.3970084365415531,1.0,61/138,30.42%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;EIF2B5;PSMA6;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;CD276;RFTN1;PSMB2;PSMD4;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E;MAP3K7;PSME3;TXK;EIF2B1;ZAP70;PSMC2
prerank,positive regulation of sodium ion transport (GO:0010765),0.6106742770426354,1.3179165100252208,0.16142270861833105,0.39998923818303267,1.0,4/12,15.00%,ANK3;SCN4B;CNKSR3;PRSS8
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.617366137447538,1.3173438525543617,0.1502808988764045,0.40100688022895065,1.0,4/12,17.01%,MDK;AKT1;FUT9;SKAP1
prerank,autophagosome organization (GO:1905037),0.4871593776746043,1.3173144625368571,0.10825892857142858,0.40062083033509127,1.0,12/50,14.91%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A;ATP13A2;ULK3;UBQLN2;VMP1;ATG101
prerank,positive regulation of gene expression (GO:0010628),0.4381460924845561,1.3170495959621356,0.002,0.40081248812680037,1.0,117/442,20.24%,ACTB;RPL26;RPL23;RPS3;ACTG1;RPL11;RPS4X;RPS7;RPL5;CD74;CLU;EEF2;VIM;CLDN5;GSN;GAPDH;RAMP2;TYROBP;ACTA2;MT3;POLR2E;PARK7;SOD1;MAPK3;ATF4;AKT1;EIF3D;TREM2;CD34;NPM1;RPS27L;ANK3;AGT;S100A13;NFAM1;GPER1;POLR2F;TNF;PDGFB;LAMTOR5;NTRK2;AMH;MIF;HSPA1B;FLOT1;POLR1B;FN1;MUSK;TFRC;MSN;RIMS2;EIF3C;RIMS1;CLEC6A;P2RX7;VSIR;EGR1;GATA2;ATP13A2;DEK;LRP3;WNT5A;PCIF1;RAMP3;POU3F1;ELAVL4;WARS1;WBP2;TMEM119;CAMK2N1;ZCCHC4;KLF4;POLR2K;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;CIRBP;HEY1;YTHDF1;EIF4A3;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;ERCC6;AGO1;MAP2K2;MAZ;HMGN5;SOX11;TBP;DDRGK1;POLR1H;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SPHK2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5628357211264767,1.3166927698476052,0.13308457711442787,0.4012077749410394,1.0,5/20,8.05%,HSP90AB1;C3;TXN;TXNIP;P2RX7
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6230776499341184,1.3160955412545103,0.1573187414500684,0.4022778492175916,1.0,3/12,13.00%,RBP4;STRAP;SOX9
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4340282292065085,-1.3158423832990782,0.13168724279835392,0.5413559904436951,1.0,4/17,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4478055111278856,-1.3157749904957246,0.14473684210526316,0.5384457560729586,1.0,7/15,10.33%,TNRC6B;TNRC6A;TNRC6C;TENT4B;CNOT1;CPEB3;CNOT7
prerank,protein localization to organelle (GO:0033365),0.45325371806222153,1.3157210365868561,0.0255885363357216,0.4028178828514499,1.0,28/133,11.98%,RPL11;LAMP1;CALR;COL1A1;HMOX1;SEC61B;PRNP;WDR83OS;TMEM30A;GABARAPL2;TOLLIP;AUP1;SEC61G;SORL1;IFT20;YWHAE;CTDNEP1;RPA2;ISG15;YBX1;VAMP2;ARF6;CD68;DNAJA1;MSX1;ZBTB7A;SERP1;ARL1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5891027327456725,1.3156930652979866,0.14524421593830333,0.4024286001091267,1.0,5/17,4.18%,VTN;MDK;S100A11;PDGFB;IGFBP5
prerank,L-amino acid transport (GO:0015807),0.53522938702561,1.3156219762460046,0.13892215568862276,0.40214122081775655,1.0,8/28,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC3A2;SLC1A1;SLC25A22
prerank,receptor metabolic process (GO:0043112),0.4871467491832264,1.3155940193059892,0.09944134078212291,0.4017468906774891,1.0,19/53,19.84%,CD81;RAMP2;LGMN;NSG1;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31;TGFB1
prerank,bone morphogenesis (GO:0060349),-0.4722503752226722,-1.3155185564759015,0.11904761904761904,0.5359556041219674,1.0,4/14,8.39%,LRP5;SKI;LRP6;FGFR2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5259619786971775,1.3152938587896812,0.12142857142857143,0.4020353575374398,1.0,18/29,31.71%,APOE;SHISA7;GRIK2;SYNGR1;SYP;PPFIA3;NCDN;NSMF;APP;SHISA6;ZDHHC2;NETO1;ACP4;CAMK2B;MCTP1;DRD2;RAB3A;DBN1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5238940449858555,1.3151028339163005,0.1354534746760895,0.4020592188191729,1.0,9/30,16.40%,BGN;HEXB;BCAN;HEXA;DCN;CHPF2;CHPF;UGDH;VCAN
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4997630811443813,1.3145696941292295,0.10113636363636364,0.40292644435844155,1.0,17/47,20.95%,TYROBP;SOD1;CYBA;ITGB2;AGT;PDGFB;ROMO1;GRIN1;MAPT;ADGRB1;DCXR;TLR6;F2RL1;SYK;CBR1;TGFB1;GADD45A
prerank,mammary gland epithelium development (GO:0061180),0.6022271780443693,1.3141366641494037,0.15281501340482573,0.40354173290372886,1.0,3/14,10.71%,AKT1;ERBB4;CSF1R
prerank,endoplasmic reticulum organization (GO:0007029),0.46906261577831415,1.31390208088437,0.07052631578947369,0.4037220505889119,1.0,27/72,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;LMAN2;SEC61G;RTN4;CAV2;REEP5;LMAN1;REEP6;VAMP2;REEP2;SERP1;SEC61A1;SHTN1;SGTA;TRAM1L1;DNM1L;LNPK;RAB18;MAPK15;VAPA;TMEM33;TRAM1;RTN3;CYB5A
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5632531379195792,1.3136665748116214,0.1329987452948557,0.40381957300760196,1.0,8/20,13.09%,HSP90AA1;HSP90AB1;PINK1;EPAS1;HSPA1B;EGR1;DNAJB2;HSPA1A
prerank,defense response to virus (GO:0051607),0.4604440611403442,1.3135975989983144,0.04573804573804574,0.4035310086905879,1.0,32/100,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;CXCL10;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;ATAD3A;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5488975361633187,1.313316154258836,0.1214017521902378,0.40383956483769984,1.0,5/22,12.45%,APOE;TIMP2;TNF;TIMP1;TIMP3
prerank,anion transmembrane transport (GO:0098656),0.4759856387696817,1.312987007675114,0.07601713062098502,0.4042328449354416,1.0,32/67,28.03%,SLC38A5;SLC25A5;LRRC8A;SLC7A5;SLC1A2;SLC25A4;SLC25A13;SLC25A29;SLC6A5;SLC25A11;SLC3A2;SLC1A1;SLC25A21;SLC25A22;SLC19A1;SLC35A3;SLC25A19;SLC25A1;SLC35A1;SLC25A18;SLC35B4;MFSD12;SLC25A14;SFXN1;SLC35B1;SLC6A8;ABCC5;SLC6A9;SLC25A12;SLC35A2;SLC16A7;SLC13A5
prerank,positive regulation of vascular permeability (GO:0043117),-0.49551681968241396,-1.3125144510641065,0.16725978647686832,0.5399041617304531,1.0,2/12,6.03%,BMP6;ANGPT1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5381823346062283,-1.3121250193283567,0.1498371335504886,0.5378227334265636,1.0,1/10,0.23%,BMP6
prerank,basement membrane organization (GO:0071711),0.5978146551567038,1.312001469328482,0.14577656675749318,0.4062675729912318,1.0,4/14,8.25%,RAMP2;CTSS;LAMB2;COL4A1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.500892523857184,-1.3119594439756117,0.12903225806451613,0.5351878988977208,1.0,4/13,5.44%,ATG10;SENP6;UBA3;SAE1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4599291305470925,-1.3118900151400894,0.1422924901185771,0.5323808086512442,1.0,6/16,14.10%,CREBBP;NAA40;KAT2B;NAA16;NAA15;NAA35
prerank,T cell homeostasis (GO:0043029),0.6346517058980196,1.3118223592079246,0.15373563218390804,0.40623766435088393,1.0,4/10,23.45%,AKT1;PMAIP1;ZC3H8;PPP2R3C
prerank,neutrophil activation (GO:0042119),0.6273350615527559,1.3115508421792719,0.14685314685314685,0.4064986158674691,1.0,4/12,18.00%,TYROBP;FCER1G;F2RL1;SYK
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5878343180455635,1.31126242292588,0.15025906735751296,0.4067711228989591,1.0,13/16,32.42%,TMEM50A;LEPROT;CHMP5;CHMP6;VPS28;CHMP7;VPS36;CHMP4C;SNF8;LEPROTL1;TMEM50B;CHMP4A;CHMP4B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6199703915389289,1.310847506860803,0.15384615384615385,0.40742249949609843,1.0,6/13,21.18%,BOLA2;GLRX5;LTO1;CIAO1;CIAO2A;CIAO2B
prerank,cell differentiation in hindbrain (GO:0021533),0.6283378749038776,1.3102776239953149,0.14769647696476965,0.40852418321920425,1.0,4/11,8.81%,GRID2;KNDC1;PROX1;FAIM2
prerank,anion transport (GO:0006820),0.5130674263440832,1.3102407137101095,0.12853773584905662,0.40814738027101555,1.0,10/33,19.97%,TSPO;SLC17A8;LRRC8A;SLC26A4;SLC17A7;SLC17A6;SLC19A1;SLC4A2;VDAC2;SLCO1B1
prerank,Fc receptor signaling pathway (GO:0038093),0.4541729731356621,1.3101404456612658,0.05595854922279793,0.40797372302380946,1.0,47/110,27.72%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.450561514159361,-1.3096543042371396,0.13513513513513514,0.535007888755972,1.0,7/18,15.01%,SARNP;DDX19A;IWS1;PABPN1;DDX19B;MCM3AP;THOC2
prerank,negative regulation by host of viral transcription (GO:0043922),0.6172954311674816,1.309224518943817,0.14606741573033707,0.4098924860050662,1.0,9/12,34.41%,PSMC3;JUN;TARDBP;CCL3;TFAP4;REST;POU2F3;CCL5;HMGA2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.48703918918184547,1.3086594915315457,0.11630558722919042,0.4108021226351576,1.0,21/46,24.20%,NRXN1;NLGN1;GRM5;TNF;SYT1;GRM8;TPRG1L;GRM7;DGKI;GRM1;CCL2;MAPK8IP2;CDK5;CACNG8;GRM4;CCR2;CACNG5;MEF2C;GRIK1;UNC13A;CACNG2
prerank,neuron projection organization (GO:0106027),0.5894931963562481,1.3085627806868314,0.16578249336870027,0.4105614134160684,1.0,6/15,14.51%,LGMN;PRNP;MAP1A;ATP1A3;DCTN1;ARF1
prerank,positive regulation of cell population proliferation (GO:0008284),0.43425711158942043,1.3081719762108068,0.002,0.41104578365784483,1.0,121/423,21.15%,RPL23;RPS9;RPS4X;RPS15A;CD74;S100A6;CLDN5;CD81;MDK;GRN;CALR;GNAI2;CAPNS1;HMOX1;LAMC1;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;S100A13;NES;GPER1;COX17;TNF;EMP2;PDGFB;FZD9;ROMO1;PTPRC;HCLS1;NTRK2;C5AR1;MIF;SSR1;SERTAD1;HES1;FN1;MATK;RHOG;RNF187;NAMPT;PAK1;PROX1;KDR;AQP1;IL2;VIPR1;MLXIPL;TIMP1;LAMC2;HCK;KITLG;CSF1R;WNT5A;IL11;CEP131;FLT4;HRAS;TMEM119;SOX8;AIF1;PRMT1;SOX9;BST2;GJA1;BMP2;FBXO5;GAS6;NME2;HNRNPU;CTSH;SDCBP;TIAM1;BAD;PDF;FOLR2;IGF2;PDGFA;DLL1;ADRA1D;HPSE;FLT1;CCKBR;CIAO1;ADAM17;CNBP;TBRG4;DDR2;ERBB3;MAZ;STX4;HMGN5;EDN3;SOX11;TOX;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;MAPK15;TGFB1;THPO;MEF2C;SFRP1;MYC;CRLF1;PTPN6;CRLF2;ID2
prerank,neuronal action potential (GO:0019228),0.5478784466559503,1.3080303981521326,0.14393939393939395,0.41093980992683715,1.0,10/22,26.89%,ANK3;GPER1;SCN1A;KCNA2;KCNA1;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4
prerank,negative regulation of catalytic activity (GO:0043086),0.5438231687556779,1.3077730906083342,0.13857677902621723,0.4112042649758841,1.0,11/24,19.64%,MT3;NES;ATP5IF1;PLN;IFIT1;TIMP1;PHPT1;HP;TMBIM1;CCAR2;NOTCH1
prerank,regulation of NMDA receptor activity (GO:2000310),0.5138721665134574,1.3074620739216063,0.11813842482100238,0.41152921021300254,1.0,16/32,21.61%,NLGN1;GRIA2;DLG2;NEFL;GRIN1;GRIA4;GRIN2A;CRH;GRIA1;CCL2;LRRC7;MAPK8IP2;GRIN2B;CCR2;MEF2C;GRIA3
prerank,positive regulation of cell motility (GO:2000147),0.4406865084442307,1.3069197050427301,0.026156941649899398,0.41251369982755,1.0,62/205,19.84%,ACTG1;RACK1;CAVIN1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;HSPA5;CCL19;SPOCK2;GPER1;RHOC;SEMA3F;PDGFB;SEMA7A;SEMA4C;MYADM;FAM107A;CXCL16;SEMA6D;PAK1;PODXL;KDR;VSIR;NTN1;LGR6;LAMC2;PHPT1;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;TWIST1;F10;MMP14;ADAM17;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.46805058146235595,1.3067171950435421,0.09168443496801706,0.41255239443516795,1.0,33/73,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;SPI1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;KITLG;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;METTL14;PSMB2;PSMD4;PSMD10
prerank,regulation of cellular response to stress (GO:0080135),0.4506705581929959,1.3066901255418653,0.05641025641025641,0.4121637635955528,1.0,23/115,9.17%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;CHCHD2;MAPK3;ATF4;CRYAB;NPM1;PINK1;IER3;HSPA1B;YWHAE;MANF;RPA2;BAG5;BAG1;USP51;CEBPB;VASH1;MAPT;NUPR1;HSPB8
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4789966782112564,1.3064712289835312,0.09891304347826087,0.41227226078425216,1.0,25/60,24.77%,HSP90AA1;HSP90AB1;MAPK3;CCT2;PDGFB;CTNNB1;CCT7;CCT8;PCNA;KLF4;RFC2;HNRNPA1;PTGES3;PARM1;HGF;DKC1;MAPK15;RFC4;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP;CCT3
prerank,regulation of exit from mitosis (GO:0007096),0.507411473229682,1.3061772717489633,0.12763466042154567,0.4125692527610855,1.0,3/38,0.82%,RPS27A;UBC;UBB
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6149959730134469,1.3058669323723195,0.13559322033898305,0.41285041374475157,1.0,3/13,8.53%,CD74;MIF;PTTG1IP
prerank,epithelial tube morphogenesis (GO:0060562),0.5162728298648858,1.3052660647690337,0.1380952380952381,0.4139253416318428,1.0,11/32,11.29%,RHOB;CSNK2B;RASIP1;ACVRL1;CTNNB1;HES1;PAK1;PODXL;COL4A1;CSF1R;SOX17
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.46224818510925275,1.304854193487969,0.09453781512605042,0.414489772623015,1.0,27/75,23.15%,APOE;AKT1;AGT;RASIP1;SORL1;UCHL1;RGS2;HYAL2;CDKN1C;CEBPA;PRKAR1A;SMPD1;PRKAR1B;SPRY1;HEXIM1;SLC8A1;DAB2IP;PRKAR2B;CD300A;SPRY3;TFAP4;PYCARD;GADD45A;MEN1;DUSP1;PTPN1;TESK1
prerank,negative regulation of cellular component organization (GO:0051129),0.4681990442207264,1.3043290580981983,0.08751334044823907,0.4153747518819368,1.0,19/74,18.24%,HSPA8;CLU;HSPA5;CRYAB;TNF;LGALS3;SORL1;HSPA1B;SYT11;SVIP;DNAJB2;HSPA1A;LILRB1;SACS;DNAJB1;DNAJA4;SNX33;TMEFF2;NOP53
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5416246450586807,1.3042378361505205,0.14074074074074075,0.415149966625759,1.0,2/23,4.50%,TMSB4X;SPI1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.632793996493701,1.3042290357574504,0.1492753623188406,0.4147112612730182,1.0,5/10,23.48%,ANK3;KCNE4;KCNE5;CAV1;KCNAB1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.5296063280862708,-1.3035501807301166,0.18456375838926176,0.5441862467550089,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),-0.5296063280862708,-1.3035501807301166,0.18456375838926176,0.5441862467550089,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,neuron projection development (GO:0031175),0.4440029583296963,1.3032884429198823,0.034378159757330634,0.4166661129964803,1.0,55/168,20.32%,APOE;UBB;PLP1;NBL1;NLGN1;BLOC1S4;CNTNAP2;PACSIN1;CNTN4;NEFH;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;PRDM12;KLK8;SGK1;PAK1;GRM7;MAPT;MAP2;STMN4;CDK5R1;HMGB1;PAK3;BLOC1S1;DOCK10;BLOC1S3;NYAP2;BLOC1S5;PRMT1;SHTN1;STMN1;GPRIN2;EHD1;EPHB1;CDK5;NCDN;EPB41L3;DAB2IP;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;CTNND2;IL6;VAPA;POU4F1;CTTN
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5882794829845018,1.303035860494646,0.15625,0.4168502568467108,1.0,4/16,9.52%,HMOX1;APLNR;JCAD;GATA2
prerank,ESCRT III complex disassembly (GO:1904903),0.6329531788457652,1.3026744397469496,0.18091168091168092,0.41688263551518945,1.0,6/10,24.80%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,ESCRT complex disassembly (GO:1904896),0.6329531788457652,1.3026744397469496,0.18091168091168092,0.41688263551518945,1.0,6/10,24.80%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,response to amino acid (GO:0043200),0.5195518118482348,1.3023789311536556,0.1324736225087925,0.4171977310053533,1.0,12/31,18.84%,TMBIM6;LAMTOR2;LAMTOR4;LAMTOR5;GRIN1;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF;GLRA3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4420371843731835,1.301875324125387,0.03943377148634985,0.4180537346363686,1.0,62/163,27.90%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;NFAM1;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;VAV3;SH2B2;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;SYK;EIF2B5;PSMA6;MEF2C;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;PLEKHA1;CD276;RFTN1;PSMB2;PSMD4;BLNK;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6149875701306879,1.3018557806302251,0.15517241379310345,0.4176301817438874,1.0,5/12,17.70%,FXYD1;ANK3;ATP1B2;ATP1B1;ATP1B3
prerank,regulation of neutrophil migration (GO:1902622),0.6300200150140461,1.3017645011107317,0.19558823529411765,0.41739552907577504,1.0,5/10,25.39%,RAC1;RHOG;JAM3;RAC2;MPP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6393493399037969,1.3010687823480456,0.17714285714285713,0.4187211047131365,1.0,4/10,15.91%,PTPRC;LILRB1;CX3CR1;ARRB2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5451940884182738,1.301000813041113,0.12298136645962733,0.4184356841689291,1.0,9/24,21.42%,PRNP;ITGB2;ANK3;HRAS;MTCL1;MIEF2;MFF;C2CD5;FIS1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.39270113233932,-1.3007796849692241,0.11931818181818182,0.548092920585198,1.0,10/29,15.71%,TCF7L2;CREBBP;TLE1;PYGO1;BCL9L;ASH2L;TERT;KMT2D;TLE3;CDC73
prerank,primary miRNA processing (GO:0031053),-0.524540454659147,-1.30076563294394,0.15357142857142858,0.5451509449052317,1.0,5/10,15.02%,SMAD3;DROSHA;SMAD1;SMAD2;SRRT
prerank,sphingolipid metabolic process (GO:0006665),0.45031976989320477,1.3004607982023202,0.06653019447287616,0.4193133209748303,1.0,37/108,23.79%,PSAP;GM2A;HEXB;SERINC1;HEXA;CERS2;ORMDL3;B4GALNT1;PPP2R1A;ELOVL1;ENPP2;ELOVL2;GAL3ST1;SMPD1;ELOVL7;CTSA;GLTP;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;NEU1;FA2H;CSNK1G2;CLN8;CERKL;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ORMDL2;ELOVL6;ALDH3B1;VAPB
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3220524828035067,-1.3004436587853998,0.08,0.5430518821134234,1.0,19/79,10.55%,SULF1;ADAMTS12;SMAD6;BMPR1A;CRIM1;SMURF2;SLIT2;SKI;NIBAN2;BMPER;SMAD9;CASK;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4
prerank,membrane organization (GO:0061024),0.4375928829105254,1.2996078531941542,0.023046092184368736,0.4210024875643577,1.0,52/227,16.41%,ACTB;MTCH1;RPS27A;ACTG1;HSPA8;UBC;UBB;ANK3;SGCZ;SYNGR2;SH3GL2;CHMP2B;CTDNEP1;DNM3;AP2M1;MYADM;SYT1;TFRC;UBA52;SYNGR1;SAR1A;CORO1C;AMPH;CD3D;RIMS1;CLTC;VAMP3;VAMP2;EPN1;AP2S1;CHMP5;CHMP6;FNBP1L;FCHO1;WNT5A;ARPC3;VAMP8;SERP1;CHRM2;GLTP;ARPC5;TIMM50;CCDC88A;SYP;ARPC4;CLTA;M6PR;ARRB2;CHMP1B;SH3KBP1;NAPA;SYT2
prerank,dendritic cell migration (GO:0036336),0.5713606218234832,1.2994519888064773,0.1716514954486346,0.4209268816391598,1.0,7/16,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,intracellular protein transmembrane transport (GO:0065002),0.49801449191182645,1.2991809740148481,0.12643678160919541,0.4211867205604854,1.0,11/42,15.80%,SEC61B;HSPA5;ROMO1;SEC61G;DNLZ;HSPD1;TOMM40L;SEC61A1;TIMM50;TOMM20L;PEX6
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.46249673491862847,1.299165273695722,0.07172995780590717,0.4207602666608588,1.0,14/86,9.84%,APOE;RPS3;CLU;GPX1;RAC1;PFN1;NAV3;PAK1;PROX1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,regulation of protein localization to cell surface (GO:2000008),0.5138326921344765,1.2986583474681803,0.12891566265060242,0.4216390606877404,1.0,7/33,7.82%,TYROBP;HSP90AB1;TNF;MAP1A;CTNNB1;GPM6B;LEPROT
prerank,"wound healing, spreading of cells (GO:0044319)",0.5481960191042348,1.2984618906882988,0.14002478314745972,0.42171643567044814,1.0,9/24,17.95%,CD151;RHOC;ACVRL1;MRTFA;FLNA;LCP1;RHOA;ADAM17;TMEFF2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5763619934301811,1.2974383278777069,0.16822429906542055,0.4239170040929499,1.0,4/16,6.77%,APOD;TREM2;SIRPA;CUEDC2
prerank,regulation of hormone secretion (GO:0046883),0.5716273200027681,1.297395379358448,0.16688741721854305,0.4235622502256041,1.0,7/15,18.98%,SCG5;VAMP3;VAMP2;IL11;NMB;EDN3;SOX11
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6453351109615235,1.2971252105795286,0.16165951359084407,0.42378802489969636,1.0,3/10,3.67%,PARK7;TXN;GPR37L1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5261623715264853,1.2971172242240703,0.132858837485172,0.42334888928391207,1.0,13/30,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,regulation of cell development (GO:0060284),0.506151084036109,1.2970504654833304,0.13225058004640372,0.42306742620352833,1.0,11/36,16.39%,RPS19;GRN;AKT1;CTNNB1;HES1;HES6;BHLHE41;CX3CR1;HEY1;DLL1;HDAC9
prerank,positive regulation of response to external stimulus (GO:0032103),0.4462362338185867,1.2966074177427727,0.05583756345177665,0.42375635723751165,1.0,48/128,26.54%,MDK;GRN;THBD;CCL19;CYBA;TREM2;AGT;TNF;PDGFB;S100A8;S100A9;LY86;CD180;DDT;RARRES2;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;P2RY12;LILRA5;NINJ1;PLA2G7;WNT5A;AIF1;TNFRSF1A;F2RL1;GPSM3;CCL3;CCR2;STX4;SNCA;TGFB1;NFKBIA;PPM1F;POLR3D;TNIP1;AKIRIN2;PTN;APP;PDE2A;PRKCA;IL33;TLR7;CX3CL1;STX3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5980931072953537,1.2958559368056568,0.15416098226466576,0.42532122737007816,1.0,7/13,29.63%,NAMPT;KDR;CCL2;SELENOS;IL33;TLR2;NOD2
prerank,T cell differentiation in thymus (GO:0033077),0.5814812810169152,1.2954904209070268,0.1588785046728972,0.4258458322310261,1.0,3/14,5.16%,PTPRC;ZFP36L1;ZFP36L2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5281949846181287,1.2947991274030857,0.1702127659574468,0.42710345812976835,1.0,3/25,4.03%,RPS3;PDE4B;PTPRC
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4417962284153552,1.2947716434480465,0.027411167512690356,0.42672112893078906,1.0,41/159,16.81%,BSG;CLDN5;MPZ;NLGN1;ITGB2;UNC5D;CD84;GRID2;LRFN5;DSCAM;CNTN4;PCDHGB4;CDH20;ADGRL3;LRRC4C;TENM2;TENM3;SELL;CLDN11;KIRREL3;CDH18;ROBO4;IL1RAPL1;EMB;PECAM1;TENM4;FGFRL1;CADM3;PTPRD;CDH12;LRRC4B;CDH19;DCHS1;IGSF9;DSCAML1;ROBO2;CDH7;CDH24;VCAM1;CDH10;CDH5
prerank,L-serine metabolic process (GO:0006563),0.6281363796276217,1.2944214169852455,0.18142235123367198,0.4271829689844939,1.0,5/10,20.45%,SERINC3;SDS;PHGDH;SERINC5;SHMT2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5520578207171415,1.293967319708711,0.14412136536030343,0.4278463368393713,1.0,4/20,4.81%,PPIA;PPIB;FKBP1A;PIN1
prerank,fatty acid elongation (GO:0030497),0.5925849565661968,1.2938902473275413,0.16022099447513813,0.4275874912946441,1.0,7/13,32.37%,ELOVL1;ELOVL2;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,cAMP metabolic process (GO:0046058),-0.4973284402319103,-1.2934452020083207,0.17843866171003717,0.5578321551356922,1.0,3/13,2.23%,ADCY9;ADCY1;ADCY5
prerank,linoleic acid metabolic process (GO:0043651),0.5589101453970811,1.2930037963450547,0.18758256274768825,0.4294833937104534,1.0,4/17,11.13%,FADS1;ELOVL1;ELOVL2;GSTM2
prerank,regulation of astrocyte differentiation (GO:0048710),0.6075084225735514,1.2923376312980404,0.16598079561042525,0.43071759983080027,1.0,6/12,21.15%,SERPINE2;HES1;BMP2;NOTCH1;IL6;ID2
prerank,regulation of ERAD pathway (GO:1904292),0.6240964030181805,1.2920245119234528,0.1647887323943662,0.43109993426337606,1.0,5/11,21.25%,UBXN1;RNFT1;HERPUD1;TMEM259;USP13
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5484156578807583,1.2919841867139508,0.13216957605985039,0.4307369614390898,1.0,12/24,22.49%,CXCL12;NBL1;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17;CCN3;DUSP1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6301685105097183,1.2919246496931651,0.18114874815905743,0.4304380345570999,1.0,2/10,8.66%,PRNP;VSIR
prerank,cellular response to amyloid-beta (GO:1904646),0.5079723789370765,1.2913118140734094,0.11966824644549763,0.43161104507805464,1.0,12/35,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;GJA1;TLR6;CDK5;VCAM1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.47826646888814905,1.2909982053665259,0.1137855579868709,0.431950433426539,1.0,14/59,13.82%,RPS27A;UBC;UBB;AKT1;TNF;PRDX4;UBA52;TICAM2;NKIRAS1;RBCK1;TBKBP1;RIPK2;TNFRSF1A;NKIRAS2
prerank,cellular calcium ion homeostasis (GO:0006874),0.4458807482311468,1.290949640452815,0.05344295991778006,0.43161498235983087,1.0,40/133,18.94%,TPT1;CALR;SLC30A1;CXCL12;SMDT1;CCL19;GPER1;SLC24A4;SLC24A2;FZD9;CAV2;YWHAE;DRD5;CALB1;TMCO1;KCTD17;PLN;SELENOK;HTR2C;ATP13A2;CALCB;BAX;TRPC7;WFS1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ADCY8;CCL3;CAV1;CDH5;HERPUD1;HCRTR1;CCL8;FKBP1B;CCR2;ANXA6;EDN3
prerank,central nervous system development (GO:0007417),0.4327932437215645,1.2907966142944276,0.018090452261306532,0.43152089213809264,1.0,82/250,22.42%,C1QA;APOD;GSN;MBP;BCAN;C3;MARCKS;ASIC2;S100B;SLC2A1;NES;CNTNAP2;ADAM23;CNTN4;SCTR;NDRG4;MAL;ECRG4;ABCB6;ADGRL3;SH3GL2;SPOCK1;GRIN1;TAGLN3;HAPLN2;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;NRCAM;KLK6;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;MOG;SLC6A17;CDK5R1;DNAJC30;MARCKSL1;DNER;AATK;MYRF;HAP1;ATP6AP2;ELP3;SOX8;LSR;CLN5;SOX9;CXCR4;CAPG;CX3CR1;PTPRZ1;IER3IP1;DSCAML1;ROBO2;CDK5;COX7B;DLL1;VCAN;GLIS2;SCIN;GRIN2B;EIF2B5;QARS1;SOX11;RAB18;DCX;NNAT;HSPG2;DDIT4;SOX10;HAPLN4;GRIK1;ROGDI;SNTG2;POU6F2;GRHL2;ACAN
prerank,cellular response to leucine starvation (GO:1990253),-0.5280173476614232,-1.2905663091712107,0.1724137931034483,0.5623485237989103,1.0,6/10,25.91%,EIF2AK4;RRAGB;SESN1;LARS1;SESN2;SESN3
prerank,negative regulation of innate immune response (GO:0045824),0.5112106234564198,1.2905108989107594,0.13752913752913754,0.43177572544109705,1.0,6/34,9.66%,RPS19;GRN;A2M;TNFAIP3;ISG15;SERPING1
prerank,lipid homeostasis (GO:0055088),0.4716532676287334,1.290119309640516,0.10144927536231885,0.4323495145017082,1.0,13/57,13.10%,APOE;RCN3;PNPLA2;TREM2;ORMDL3;ABCG1;LIPG;RBP1;CEBPA;MLXIPL;ATP13A2;ABHD8;FBXW7
prerank,vesicle organization (GO:0016050),0.48993362384426703,1.2900010433481575,0.11574074074074074,0.4322065567515353,1.0,14/46,17.51%,CD34;CAV2;CHMP2B;SAR1A;CORO1A;SRGN;FNBP1L;SNX11;SORT1;SNX33;CAV1;USP8;SQSTM1;HOOK1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.4415322729268683,1.2899692535135223,0.04536290322580645,0.4318242722950313,1.0,29/148,15.70%,RPL23;RPL11;RPS15;RPL37;RPL5;RPS20;AKT1;CSNK2B;MBD3;CHEK2;PIN1;RPA2;HIPK2;TTC5;BRPF1;SGK1;TAF10;CDK5R1;PIP4P1;TAF9;SSRP1;CCNG1;RFC2;STK11;PRR5;HEXIM1;L3MBTL1;MAPK11;CDK5
prerank,regulation of cation transmembrane transport (GO:1904062),0.5184090451915383,1.2891168835372626,0.13713592233009708,0.4335375924941791,1.0,8/29,15.36%,CD63;KCNIP4;DPP10;DPP6;FGF12;KCNN2;KCNE5;KCNIP1
prerank,membrane assembly (GO:0071709),0.5045765138321845,1.2887654845459602,0.13379469434832755,0.4339962592623463,1.0,10/34,12.53%,NRXN1;NLGN1;S100A10;ANK3;EMP2;LRP4;FLOT1;IL1RAPL1;PTPRD;NRXN2
prerank,histone H3-K4 methylation (GO:0051568),-0.39444540015266194,-1.2883878467718186,0.10160427807486631,0.5647524204176968,1.0,15/26,22.76%,KMT2C;TET2;OGT;TET3;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;WDR5B;BEND3;KDM6A;CTR9
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4830611374772862,1.288350845486722,0.12555555555555556,0.4346231159131137,1.0,17/50,16.87%,RPS3;PARK7;UBXN1;AKT1;HSPA1B;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;FBXO5;ARRB2;CAV1;SQSTM1
prerank,negative regulation of transferase activity (GO:0051348),0.5231194981217334,1.2877417646013922,0.145933014354067,0.4357883610727831,1.0,9/28,13.74%,PARK7;TERF1;BAG5;CDKN1C;MAPT;PHPT1;ZFP36;FBXO5;HNRNPU
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4430315022592696,1.2877339603540252,0.06481481481481481,0.43534600510403576,1.0,40/121,19.84%,CD74;VTN;CD81;PRNP;TREM2;GRM5;ERBB4;IL5;AGT;TNF;PDGFB;PTPRC;HCLS1;ARL2BP;MIF;HES1;CLEC6A;ENPP2;PTK6;IL2;LILRA5;FCGR1A;CSF1R;PECAM1;IL11;DOK7;SRCIN1;RIPK2;GAS6;TNFRSF1A;IGF2;LRP8;CASS4;ERBB3;UNC119;FLT3;IL6;HGF;EFNA1;TGFB1
prerank,cholesterol homeostasis (GO:0042632),0.46678409802640114,1.2875476777394563,0.10307017543859649,0.4353501553500346,1.0,16/64,17.91%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,actin nucleation (GO:0045010),0.5490420964237154,1.2873813254575464,0.1685823754789272,0.43534612976003206,1.0,9/21,17.69%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2;SCIN
prerank,epithelial cell migration (GO:0010631),-0.3631178614092733,-1.2871103210644324,0.09433962264150944,0.5653101861915089,1.0,9/37,6.62%,ABL1;KANK2;ROCK1;NRP1;ADGRA2;STARD13;DPP4;PXN;FAP
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5788088032232517,1.2869205305374622,0.15833333333333333,0.43611207550035413,1.0,7/15,21.40%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1;SELENOS
prerank,regulation of regulated secretory pathway (GO:1903305),0.5109811891503445,1.2868951124178312,0.12945368171021376,0.43572420991884625,1.0,18/34,25.63%,SYT1;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYT6;RAB3D;SYT4;SYN1;SYT10;DOC2A;SYT2;PREPL;SYT3;SYT5;UNC13D;SYT17
prerank,sterol homeostasis (GO:0055092),0.4659420515140386,1.2866677252357916,0.10208562019758508,0.43585108635525854,1.0,16/65,17.91%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,regulation of embryonic development (GO:0045995),-0.3662969851064005,-1.2863789866036188,0.10273972602739725,0.5642469267394389,1.0,11/34,9.93%,PHLDB2;TRIP12;NIPBL;DHX36;NIBAN2;EHMT1;WDPCP;INSR;NPHP3;TDG;NR2C2
prerank,negative regulation of cell death (GO:0060548),0.460890552387467,1.2861759249190552,0.09139213602550478,0.43668323033504264,1.0,25/88,19.95%,CLU;GPNMB;MT3;PARK7;AKT1;CD34;PINK1;NENF;SORL1;HSPA1B;LRPAP1;BNIP3L;CCN2;ATP13A2;CHGA;TMEM109;WFS1;HSPA1A;PDE12;CDK5;GATA4;PPARGC1A;SOX11;SNCA;POU4F1
prerank,regulation of axon regeneration (GO:0048679),0.6174887343880093,1.28596463015948,0.1619047619047619,0.4367956372800404,1.0,3/12,7.62%,GRN;CERS2;KLK8
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.45750620687856136,1.2858816057417877,0.08829568788501027,0.43656490999356196,1.0,41/95,29.64%,VIM;PDE4B;NR1D1;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SIRT2;SELENOS;NUGGC;RELA;LBP;CASP1;XBP1;TNFRSF1B;FZD5;PPBP;TLR2;NOD2;ACOD1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5126867267575799,1.2855869502207582,0.15967365967365968,0.43688800097022584,1.0,4/33,4.40%,CD74;TNF;HCLS1;ZFP36L1
prerank,mRNA polyadenylation (GO:0006378),-0.38742954995232265,-1.2850659462316516,0.12365591397849462,0.5617834333783346,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,RNA polyadenylation (GO:0043631),-0.38742954995232265,-1.2850659462316516,0.12365591397849462,0.5617834333783346,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,cartilage development (GO:0051216),-0.3349453209205786,-1.2847300807001796,0.09375,0.5595916674393981,1.0,20/49,23.96%,SULF1;NFIB;SOX5;ZBTB16;WNT5B;ATP7A;ITGB8;PKD1;CREB3L2;BMP4;RUNX2;TRIP11;GPLD1;FGF2;SULF2;HOXD3;WNT2B;COL11A2;TRPV4;HYAL3
prerank,regulation of microtubule nucleation (GO:0010968),0.6309411605040801,1.2844667439794666,0.1844380403458213,0.4393637558037394,1.0,6/10,19.88%,HSPA1B;PAK1;ARHGEF7;DCTN1;HSPA1A;GIT1
prerank,positive regulation of dendritic spine development (GO:0060999),0.5455187436560395,1.2843887312363664,0.16539440203562342,0.4391381557511782,1.0,2/20,2.44%,APOE;NLGN1
prerank,positive regulation of vasculature development (GO:1904018),0.451807457410357,1.2839105708313996,0.09643605870020965,0.43988087053440456,1.0,27/94,17.06%,RAMP2;HSPB1;GRN;HMOX1;RHOB;CD34;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;TIE1;CTSH;RRAS;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,cell junction organization (GO:0034330),0.4641873520313712,1.2836509475133921,0.09523809523809523,0.44007806872273136,1.0,23/71,19.90%,ACTB;ACTG1;C1QA;GRM5;PIN1;LRP4;FLNA;PPFIA4;PPFIA2;MAPT;PAK3;CBLN2;RHOA;VMP1;ELFN1;PPFIA3;RAB39B;CTNND2;FBLIM1;SNCA;TGFB1;MARVELD2;AGRN
prerank,cellular response to cytokine stimulus (GO:0071345),0.42672987512332095,1.283323120831496,0.002,0.44053597678304596,1.0,120/416,21.24%,RPS3;RPS27A;HSPA8;MT1X;UBC;VIM;IFITM2;UBB;GAPDH;RPL13A;HSP90AA1;F13A1;CXCL12;HMOX1;NDUFA13;MT2A;AKT1;CCL19;AQP4;AKAP6;ITGB2;IL5;POMC;GPER1;TNF;HSP90B1;NR1D1;HCLS1;ZFP36L1;UBE2G2;JUNB;ZFP36L2;SIRPA;IL2RB;CSF3R;S1PR1;HYAL2;CDC34;FN1;UBA52;CCND1;CCR5;IL1RAPL1;CEBPA;CXCL10;IL2;IFIT1;TIMP1;EGR1;HCK;ZFP36;IRF8;CSF1R;WNT5A;IL11;MMP3;LCN2;IL2RG;IL3RA;MAOA;AIF1;SELPLG;COL1A2;SOX9;VAV1;RHOA;GAS6;DOCK8;YWHAZ;CXCR4;HNRNPU;TNFRSF1A;PDE12;RHOU;ERBIN;RO60;NDN;CCL2;PTPRZ1;PF4;IFNGR1;MAPK11;LRP8;CSF2RB;YBX3;SIGIRR;DAB2IP;CCL3;VCAM1;PIK3CD;TWIST1;NOS2;CCL8;SYK;CCR2;SLA;STX4;EPRS1;IL20RA;MUC1;CD86;SOS1;FLT3;IL6;HGF;IFNGR2;TGFB1;CSF2RA;POU4F1;IL10RB;PDE1B;SFRP1;IL1RAP;MYC;CRLF1;PTPN6;PYCARD;CRLF2;ASAH2;CDK9
prerank,nucleotide-excision repair (GO:0006289),0.450345485629506,1.2832615643048384,0.08004158004158005,0.4402265047767532,1.0,38/101,26.91%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;PARP1;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2;COPS8;POLD4;CETN2;BRCA2;ERCC6;RAD23A;RFC4;ERCC1;POLR2H;POLD1;PNKP;RPA3;PPIE;XPC;LIG1;GTF2H5;ERCC2;CCNH
prerank,epithelial structure maintenance (GO:0010669),0.6163150896174119,1.2832314445196735,0.1791044776119403,0.43985127128714363,1.0,2/11,7.22%,RBP4;STRAP
prerank,response to amyloid-beta (GO:1904645),0.49076841682942973,1.2831412983975865,0.11534025374855825,0.4396446578420697,1.0,14/44,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;MMP3;RAMP3;GJA1;TLR6;CDK5;VCAM1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.45073176300159495,-1.282575748820647,0.15413533834586465,0.5618423772302967,1.0,4/16,4.58%,PRKAG2;APPL2;LONP2;PPARA
prerank,neutral amino acid transport (GO:0015804),0.5286930736424653,1.2818425977854935,0.16403402187120292,0.44267140092375473,1.0,7/28,12.43%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC6A17;SLC3A2;SLC1A1
prerank,ameboidal-type cell migration (GO:0001667),0.4833491775630979,1.2817316229721223,0.13072625698324022,0.44249239295332865,1.0,16/51,21.71%,AKT1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;PKN1;SEMA4A;SOX8;SEMA4G;AMOT;ANXA6;SOX10;SGPL1;CCN3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6160036632854308,1.281662605679656,0.1910569105691057,0.4421875089660818,1.0,6/11,22.12%,PARK7;PINK1;P4HB;MMP3;GATA4;REST
prerank,negative regulation of protein kinase activity (GO:0006469),0.4590641650635664,1.2814438635367313,0.08924731182795699,0.4422605973143888,1.0,36/88,23.15%,PPIA;HSPB1;PARK7;AKT1;NPM1;CAMK2N2;PTPRC;SORL1;DUSP3;HYAL2;CDKN1C;DBNDD2;CORO1C;PTK6;DUSP26;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;PTPRB;SRCIN1;SLC8A1;DAB2IP;CAV1;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA;PYCARD;GADD45A;PTPRO;PPM1F;PTPN1;TESK1
prerank,chromatin organization (GO:0006325),-0.2860066713479951,-1.281146062061774,0.0,0.5624789055920291,1.0,37/132,15.01%,BAZ2B;BRWD1;SETD5;BAZ2A;SETD2;HDAC4;HMG20A;EHMT1;NUDT5;KDM5B;HDAC8;ARID1A;KAT2B;JARID2;MYSM1;SMARCAD1;SMARCE1;CHD1;SMARCA5;BAZ1B;TOP1;ZBTB1;CDAN1;INO80;SETDB1;KDM5C;ESR1;MCM3AP;KDM4C;PBRM1;LRWD1;SETD7;SIRT1;KDM4D;RSF1;EZH2;EZH1
prerank,Golgi to lysosome transport (GO:0090160),0.6110304383121158,1.2810867729980582,0.19013062409288825,0.4427414878105917,1.0,2/11,1.38%,LAMP1;LAPTM5
prerank,rRNA pseudouridine synthesis (GO:0031118),0.6301387543380674,1.2808267545925176,0.17198335644937587,0.44296768040406914,1.0,6/10,22.31%,NOP10;NHP2;GAR1;DKC1;RPUSD4;NAF1
prerank,supramolecular fiber organization (GO:0097435),0.42751083510194987,1.2807397094048252,0.007007007007007007,0.44276134792290067,1.0,67/334,14.18%,CST3;RPS27A;GFAP;ALDOA;UBC;VIM;B2M;UBB;GSN;HSP90AB1;COL1A1;H3-3A;ITM2B;CD151;PPIB;RHOB;TPPP3;SERPINH1;MARCKS;LUM;TPM2;MFGE8;RHOC;ARHGAP25;EMP2;RAC1;FKBP1A;PLEC;NEFL;PIN1;SORL1;PSENEN;LOX;STMN3;ELMO1;RHOG;TTR;UBA52;MFAP4;CORO1C;P4HB;CORO1A;CALB1;MYO5A;COL6A1;COL4A1;MYO7B;MAPT;COL3A1;STMN4;LAMC2;KRT9;EPPK1;COL9A1;MYO1F;MARCKSL1;MYH11;ACTN1;DCTN1;COL1A2;RHOA;DPT;FLII;CLIP3;DES;STMN1;CCDC88A
prerank,B cell receptor signaling pathway (GO:0050853),0.509919856243217,1.280638396517905,0.14903846153846154,0.44254846103814616,1.0,13/32,26.69%,NFAM1;PTPRC;BAX;CTLA4;VAV3;SH2B2;PIK3CD;SYK;MEF2C;PLEKHA1;RFTN1;BLNK;ITK
prerank,nitrogen compound transport (GO:0071705),0.44149964661862573,1.280464428286552,0.0541922290388548,0.4425202307665724,1.0,34/141,18.57%,SLC38A5;RAMP2;RCN3;SLC18A1;LRP1B;SLC7A5;SLC1A4;TXNIP;TMEM30A;HSP90B1;ABCB6;CHMP2B;RD3;ARRDC1;SLC25A29;SCAMP3;SLC6A6;AQP1;SLC6A2;SLC15A4;VAMP2;SLC3A2;SLC48A1;SLC7A14;RAMP3;CMTM6;SLC11A1;SCAMP2;ARRDC3;SLC15A2;CHMP1B;ATP11B;SLC52A1;SLC19A2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5097885719746822,-1.2799515334938807,0.16838487972508592,0.5627405362917629,1.0,3/10,9.60%,RARB;RARG;PPARG
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4592875554508011,1.2789023918961566,0.11324786324786325,0.44614384630224724,1.0,30/70,26.19%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;PSMB2;PSMD4;PSMD10
prerank,regulation of DNA repair (GO:0006282),-0.3447381497060541,-1.2788101845346405,0.09243697478991597,0.5627532468784116,1.0,15/44,13.42%,EYA2;EGFR;EYA1;BABAM2;TRIP12;UBR5;KAT7;UIMC1;RNF8;PML;EYA4;PARG;EYA3;ERCC8;SIRT1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6032207779093073,1.2786386953500863,0.1936813186813187,0.4463902473329514,1.0,5/12,14.96%,SEC61B;HSPA5;SEC61G;SEC61A1;SGTA
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6272730593516255,1.2784424849842628,0.17360114777618366,0.4465011331199937,1.0,6/10,29.63%,NAMPT;KDR;CCL2;IL33;TLR2;NOD2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4509764395073626,1.2784178839417806,0.102803738317757,0.4461119650492785,1.0,23/88,16.34%,FTH1;FTL;HSPA8;BLOC1S4;SORL1;SH3GL2;SORCS1;RAB14;SCAMP3;MYO5A;CLVS1;CLTC;VAMP2;CLVS2;BLOC1S1;BLOC1S3;VAMP8;SCAMP2;SORT1;ARF1;CLTA;GOLGA7;NAPA
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4644359282734351,1.2778457221062136,0.11194029850746269,0.44713535273896393,1.0,22/66,20.94%,TYROBP;HSPB1;CCL19;TNF;SIRPA;TNFAIP3;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;NLRP2B;CX3CR1;TLR6;F2RL1;CCL3;NLRP3;IL6;GIT1;TMEM106A;PYCARD
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6276958110434023,1.27751199354649,0.17690058479532164,0.447584608639764,1.0,1/10,0.06%,CST3
prerank,positive regulation of cellular protein localization (GO:1903829),0.46225950149124895,1.27734598667614,0.12593383137673425,0.44755244484959616,1.0,23/69,23.15%,TYROBP;HSP90AB1;PARK7;AKT1;TNF;MAP1A;LAMTOR5;ORMDL3;RTN4;TFRC;SYT11;MAPT;GPR137B;VPS28;CCDC88A;SNX33;STX4;DDRGK1;TGFB1;GNL3L;TMEM35A;PARD6A;TESK1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.54291226102553,1.2771385059577127,0.1712846347607053,0.4476793645168785,1.0,6/20,8.17%,HSP90AB1;AKT1;CCND2;PDGFB;CCND1;PROX1
prerank,ventricular septum development (GO:0003281),-0.36530852037155304,-1.27667822059173,0.13286713286713286,0.5656092030990556,1.0,11/37,10.55%,TGFBR3;HECTD1;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;MDM4;SMAD7;SMAD4
prerank,positive regulation of hormone secretion (GO:0046887),0.5620716580466818,1.276198486643905,0.17623497997329773,0.449631397856865,1.0,6/17,18.98%,SPP1;RASL10B;VAMP8;NMB;EDN3;SOX11
prerank,peptidyl-asparagine modification (GO:0018196),0.5138980862336453,1.2761550552254375,0.14487632508833923,0.449289721878339,1.0,13/31,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5956608708362249,1.2758214451764278,0.17587209302325582,0.44967839196025783,1.0,4/12,17.01%,TNF;FLOT1;THY1;SKAP1
prerank,regulation of microtubule polymerization (GO:0031113),0.4921157884698499,1.2758120102664137,0.14726027397260275,0.44925079524150746,1.0,15/40,16.81%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;TUBB4A;MAP2;CDK5R1;DCTN1;CLIP3;STMN1;ARL2;MAPRE3;CDH5
prerank,copper ion transport (GO:0006825),0.6105371802311592,1.2757707461951682,0.18041958041958042,0.44889776547183513,1.0,4/11,15.43%,ATOX1;COX17;STEAP4;SLC31A1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.41165008059259234,-1.275106899384577,0.13333333333333333,0.5669226969532758,1.0,4/20,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5145199206469633,1.2748321597538594,0.16883116883116883,0.4509368797457736,1.0,13/30,23.59%,PTPRC;PPP2R1A;HYAL2;PTK6;THY1;CADM4;SRCIN1;DMTN;CAV1;CD300A;SFRP1;PTPN6;SOCS3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6309397768662415,1.2745054815369243,0.18355359765051396,0.45135174031153213,1.0,4/10,13.55%,CXCL12;CCL19;LILRB1;GAS6
prerank,negative chemotaxis (GO:0050919),0.5094792439742322,1.2744308029044065,0.1413551401869159,0.4510985719302413,1.0,14/33,16.96%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;NTN1;LGR6;UNC5C;SEMA4A;LRTM2;RHOA;SEMA4G;PDGFA;SLIT3;SLIT1
prerank,positive regulation of cell killing (GO:0031343),0.6007907238450809,1.2742798369890092,0.1945578231292517,0.45102404378730826,1.0,5/13,18.00%,CYBA;RAC1;WNT5A;NOS2;SYK
prerank,negative regulation of kinase activity (GO:0033673),0.46899770294834014,1.273981852695639,0.12541620421753608,0.45135641103282453,1.0,20/62,19.11%,PPIA;HSPB1;PARK7;AKT1;CAMK2N2;PTPRC;CDKN1C;DBNDD2;THY1;YWHAG;MAPT;RTRAF;WARS1;CAMK2N1;HNRNPU;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA
prerank,purine nucleotide catabolic process (GO:0006195),0.5947560907712102,1.273776293626277,0.1928374655647383,0.4514341498015705,1.0,5/13,17.45%,GPX1;HINT1;DNPH1;PNP;NT5C
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5896705597810861,1.2737327102342342,0.1794871794871795,0.45064749173232593,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5896705597810861,1.2737327102342342,0.1794871794871795,0.45064749173232593,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,peptidyl-arginine modification (GO:0018195),0.5793786730421807,1.2733459141451178,0.1778975741239892,0.45120385994198114,1.0,3/15,12.90%,PARK7;KRTCAP2;PRMT1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4969660101379447,1.2731818881675636,0.14153132250580047,0.4511929099079769,1.0,14/36,20.95%,APOE;CSNK2B;TNF;ACVRL1;VASH1;DCN;HMGB1;ADGRB1;DAB2IP;DNAJA4;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6219847752829012,1.2729232932122112,0.19166666666666668,0.45141815029625043,1.0,5/10,19.11%,MT3;DRD5;AOC3;HP;SNCA
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6064466663438604,1.2728594129632047,0.19382022471910113,0.45115651173443755,1.0,2/12,2.92%,ACADVL;APOC1
prerank,mesoderm development (GO:0007498),0.5593701161985098,1.2723590791886388,0.17721518987341772,0.4519759163951629,1.0,9/18,31.74%,IKZF1;HCK;TIE1;IKZF3;GDF11;MESD;MEST;TCF15;BTK
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5471085777739562,1.271477605808531,0.17493796526054592,0.45389735534861503,1.0,10/20,19.56%,ATP6AP1;ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;KCNMA1;TFAP2B
prerank,sensory perception (GO:0007600),0.4805759962300734,1.2714339570345092,0.14835787089467722,0.45353529173154344,1.0,14/45,22.52%,C5AR1;PCDH15;PENK;PRDM12;P2RX7;PDYN;TMEM150C;KCNA2;CHRNA4;CCL2;CCR2;NTSR2;SCN9A;USH2A
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5523910940500778,1.271408691411132,0.1969111969111969,0.45315170645080277,1.0,4/16,15.99%,TYROBP;VSIR;LILRB1;DLL1
prerank,negative regulation of TOR signaling (GO:0032007),-0.36816345405472606,-1.2713611247345455,0.109375,0.5738585775988904,1.0,16/36,23.14%,RNF152;FNIP1;UBR1;UBR2;PRKAA2;SESN1;ATM;DEPTOR;SIRT1;TSC1;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.49603509872931595,-1.2713108758123048,0.20066889632107024,0.571110208650601,1.0,5/11,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.46938636540217205,1.2712688765549713,0.12157721796276014,0.4530732022348773,1.0,22/55,20.60%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;HYAL2;GUSB;DCN;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;VCAN;SDC3;HPSE2;HSPG2;TGFB1;AGRN;LYVE1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6347567144797549,1.2712548188290855,0.2145922746781116,0.45266960478706547,1.0,2/10,8.68%,PRNP;PRKAR1A
prerank,protein import (GO:0017038),0.4501856859846548,1.2710442339853096,0.08773784355179703,0.4528125303483107,1.0,18/84,18.28%,APOE;CLU;HSP90AA1;AKT1;RAN;PXMP2;FAM53C;PTTG1IP;GDAP1;IPO4;NUP85;NUP88;SNX33;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4576593051565936,1.271041205757067,0.09433962264150944,0.45237338895968676,1.0,17/72,16.77%,RPS27A;UBC;UBB;RNASE1;RNASE4;PARP1;RPA2;UBA52;PNRC2;RBX1;DDB1;EDC4;PCNA;RFC2;PDE12;POLD4;MUS81
prerank,cellular response to UV (GO:0034644),0.45129274269052067,1.2707059240142917,0.11550802139037433,0.4527761361385826,1.0,16/76,12.08%,RPL26;CRIP1;ATF4;NPM1;COPS9;PARP1;HYAL2;MFAP4;AQP1;TIMP1;DDB1;SMPD1;MC1R;MMP3;PCNA;NSMCE3
prerank,embryonic organ morphogenesis (GO:0048562),-0.3457198527681319,-1.270306939584636,0.11627906976744186,0.5708745141347794,1.0,9/42,5.77%,FBN1;HOXB3;ACVR1;HOXA3;NIPBL;HOXB4;HOXC4;RARG;EFEMP1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4908423626893024,1.2702389461863994,0.15028248587570622,0.45357126339365655,1.0,4/37,6.51%,APOE;MT3;PINK1;LRPAP1
prerank,intracellular sterol transport (GO:0032366),0.5958691741550389,1.2698337435598837,0.17857142857142858,0.45420251797635686,1.0,4/13,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,phagosome maturation (GO:0090382),0.4962357621541906,1.2694610487271212,0.13801169590643275,0.45481717561934515,1.0,18/35,32.21%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;RAB14;CORO1A;ATP6V0D2;RAB20;RAB31;ATP6V1A;ATP6V0A1;ATP6V0B;TCIRG1;MREG;ATP6V0E1;RAB38;RAB34;RAB39A
prerank,positive regulation of double-strand break repair (GO:2000781),-0.35559709298944703,-1.2693501674885173,0.08333333333333333,0.5704966390376222,1.0,14/39,15.12%,ARID2;PARP9;KMT5C;SPIDR;PARP3;KMT5B;SHLD1;MMS19;MRNIP;FUS;KDM4D;FANCB;MGMT;SMCHD1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5873846364442442,1.2692910418322891,0.20665742024965325,0.45479419792511266,1.0,4/12,14.25%,CYBA;GRIN1;ADGRB1;TLR6
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5304220017394541,1.2690648233344064,0.17857142857142858,0.45492351183294294,1.0,7/25,14.18%,AKT1;AGT;GPER1;RTN4;PTK6;HAP1;CCDC88A
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6007915044632175,1.2687982893226428,0.19166666666666668,0.4551855360305725,1.0,3/12,4.23%,APOE;PRNP;FKBP1A
prerank,histone methylation (GO:0016571),-0.40132254828771097,-1.268783363081238,0.13793103448275862,0.5691546220235302,1.0,12/26,20.60%,NSD1;CREBBP;SMYD3;EHMT1;NSD3;EHMT2;CARM1;EZH2;SIRT7;PRMT6;SETD6;PRMT8
prerank,regulation of glycolytic process (GO:0006110),-0.3260456773223865,-1.2686418632478331,0.06578947368421052,0.5666699474120203,1.0,12/68,8.24%,ZBTB20;PRKAG2;ARNT;RANBP2;HDAC4;OGT;PPARA;NUP98;NCOR1;INSR;IGF1;PRKAA2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.487248433981716,-1.2686262190150703,0.1885245901639344,0.5639410298532934,1.0,5/12,21.10%,WEE1;PRCC;CHFR;PLK2;ZWILCH
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5237016852852038,1.268262755525042,0.1581569115815691,0.4561150380163579,1.0,10/25,20.94%,PINK1;GPER1;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PYCARD
prerank,regulation of neurogenesis (GO:0050767),0.4657601296826694,1.2676828181378172,0.13303769401330376,0.4571572781423685,1.0,18/55,19.67%,B2M;SERPINF1;TGM2;GPER1;TNF;SORL1;CTNNB1;HES1;HES6;BHLHE41;SNW1;CX3CR1;HEY1;DLL1;TRIM32;SOX11;NOTCH1;IL6
prerank,establishment of spindle localization (GO:0051293),0.5885554291661492,1.266936862035408,0.17560321715817695,0.45871345972560684,1.0,9/14,32.41%,CFL1;CLASP1;LLGL1;KPNB1;ZBED3;MAP4;ESPL1;CLASP2;DYNC1H1
prerank,regulation of vasculature development (GO:1901342),0.5288147778258208,1.2668029556108973,0.16823529411764707,0.45862581616765663,1.0,7/26,11.61%,GPNMB;HMOX1;EMP2;CTNNB1;VASH1;RNH1;WARS1
prerank,cellular response to interferon-gamma (GO:0071346),0.4469676351281307,1.266362631269634,0.09657320872274143,0.4593893402845223,1.0,28/88,23.81%,B2M;GAPDH;RPL13A;MT2A;CCL19;AQP4;SIRPA;HCK;FCGR1A;IRF8;WNT5A;AIF1;PDE12;CCL2;IRF7;IFNGR1;CCL3;VCAM1;NCAM1;CCL8;OAS3;EPRS1;IFNGR2;IRF9;IRF5;TRIM68;IL12RB1;CAMK2G
prerank,axonal transport (GO:0098930),0.4983763925477153,1.2655640212630674,0.16292798110979928,0.46098346519307754,1.0,10/36,12.87%,SOD1;BLOC1S4;NEFL;AP3B2;MAPT;BLOC1S1;BLOC1S3;HAP1;BLOC1S5;DCTN1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3173900964124089,-1.2650142682928218,0.04411764705882353,0.5701880336912946,1.0,17/69,11.99%,ARHGAP28;FCHSD2;FER;BAIAP2L1;ARFGEF1;SLIT2;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;PLEKHG2;GBA2;KANK1;SNX9;NCK1;ARHGAP18
prerank,secondary alcohol metabolic process (GO:1902652),0.4884815126423496,1.2646273124312004,0.1543778801843318,0.46297158861958077,1.0,10/42,23.09%,APOE;ABCG1;PIP4P1;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;IDH3G;NSDHL
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5138914531140983,1.2646031077679378,0.16113161131611317,0.4625925492684346,1.0,7/29,9.13%,APOE;AKT1;MID1IP1;CTDNEP1;HSD17B13;MFSD2A;MLXIPL
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.559880392839485,1.2644764555879018,0.18485237483953787,0.46248448147988813,1.0,5/18,15.33%,ATF4;MAF1;FLNA;POLR2K;UBTF
prerank,engulfment of apoptotic cell (GO:0043652),0.5640978147553263,1.2644029097603176,0.21130551816958276,0.46219759254825343,1.0,6/15,20.24%,RAC1;RHOG;XKR4;ADGRB1;RAC2;XKR6
prerank,regulation of sodium ion transport (GO:0002028),0.5008654796374843,1.2639681694541482,0.169392523364486,0.46291721732320734,1.0,11/34,15.65%,NKAIN2;ANK3;YWHAH;NKAIN3;P2RX7;SCN4B;FGF12;ATP1A1;CNKSR3;PRSS8;SPTBN4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5116971862797394,1.2636082079337532,0.17560975609756097,0.46345108606754704,1.0,10/27,21.01%,CALM1;FKBP1A;YWHAE;AHNAK;PLN;JPH4;FKBP1B;SELENON;CALM2;CACNB4
prerank,regulation of endothelial cell migration (GO:0010594),0.4495117720052314,1.26288274437275,0.0934873949579832,0.464925580200048,1.0,21/85,11.65%,APOE;SPARC;GRN;CALR;RHOB;AKT1;AGT;EMP2;RAC1;ACVRL1;EMC10;GLUL;VASH1;PROX1;KDR;DCN;ADGRB1;PDCD6;WNT5A;AAMP;FLT4
prerank,regulation of protein catabolic process (GO:0042176),0.4413641060249951,1.2628040254517978,0.08627858627858628,0.46467989648057517,1.0,28/99,18.19%,EEF1A1;GFAP;NDUFA13;OAZ1;TNF;CHEK2;PIN1;SORL1;FLNA;EEF1A2;VCP;TNFAIP3;FMN2;TNFSF12;ATP13A2;ADGRB1;DDB1;CHMP6;WNT5A;CTSA;VPS28;ODC1;EGLN2;RAB26;DAB2IP;TRIM32;FAM83D;AGAP2
prerank,negative regulation of nervous system development (GO:0051961),0.5508013543127163,1.2624613761276906,0.1910569105691057,0.46510209569872857,1.0,9/17,23.04%,B2M;TNF;SORL1;ROBO2;SLIT1;NOTCH1;IL6;REST;WNT7A
prerank,mitochondrion transport along microtubule (GO:0047497),0.5820285480109321,1.2619657302037037,0.20467032967032966,0.465960449116189,1.0,3/13,8.71%,UBB;NEFL;MAPT
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5716755594551728,1.2615837413027702,0.20241286863270777,0.4665518240060315,1.0,5/15,15.47%,C3;CTDNEP1;MFSD2A;FBXW7;NR1H2
prerank,JNK cascade (GO:0007254),0.49031650275588506,1.2613829663930247,0.15753424657534246,0.46667397023313545,1.0,8/40,14.13%,RPS27A;UBC;UBB;UBA52;SH2D3C;RIPK2;UBE2V1;MAPK10
prerank,ephrin receptor signaling pathway (GO:0048013),0.4475335378638674,1.2613381609535352,0.10970464135021098,0.46634796732538925,1.0,30/82,19.88%,ACTB;ACTG1;ANKS1B;RAC1;PSENEN;GRIN1;AP2M1;PAK1;CDK5R1;AP2S1;EPHA5;ARPC1B;ARHGEF7;PAK3;ARPC3;HRAS;ARPC5;RHOA;VAV3;SDCBP;TIAM1;ARPC4;EPHB1;PSEN2;EFNB1;ARPC2;APH1B;GRIN2B;EFNA1;GIT1
prerank,maintenance of protein location in nucleus (GO:0051457),0.532731491405662,1.261287382857726,0.1922110552763819,0.4660235318816759,1.0,10/20,24.60%,CHCHD10;PARK7;ARL2BP;HNRNPU;ARL2;RANGAP1;SYNE1;SKP1;SUN2;BARD1
prerank,regulation of cellular component organization (GO:0051128),0.43499540798964537,1.2609777144905447,0.0751269035532995,0.4664138762894241,1.0,30/135,14.19%,APOE;HSPA8;GFAP;HSP90AA1;PARK7;SNX17;NRG3;PINK1;AGT;LAMTOR2;TNF;LTBP4;PACSIN1;SPOCK1;BAG5;TFRC;FAM107A;KLK8;SGK1;WFDC1;CD22;NET1;AP2S1;WNT5A;ATF5;SSRP1;NCLN;HNRNPU;STK11;EGLN2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5461144864240807,1.2609654490933435,0.18503937007874016,0.46599730804858036,1.0,10/18,28.03%,MDK;HES1;TENM4;CXCR4;PTPRZ1;NOTCH1;SOX1;PTN;TMEM98;TNFRSF1B
prerank,pseudouridine synthesis (GO:0001522),0.5880804051064772,1.260873911056906,0.20352781546811397,0.46579294344681854,1.0,7/13,20.46%,NOP10;NHP2;TRUB2;PUSL1;GAR1;DKC1;PUS7
prerank,aortic valve morphogenesis (GO:0003180),-0.3732590370699389,-1.2601544388460055,0.13793103448275862,0.5801122406011993,1.0,10/30,14.92%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1;ELN;JAG1;BMP4;HEY2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5501335157461227,1.259925300413465,0.1844532279314888,0.4674290621408411,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5501335157461227,1.259925300413465,0.1844532279314888,0.4674290621408411,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,regulation of interleukin-10 production (GO:0032653),0.4770247297716437,1.259750944590157,0.13687782805429866,0.46742631059275824,1.0,15/44,24.49%,TYROBP;CD34;ISG15;HSPD1;VSIR;LILRA5;HMGB1;LILRB1;F2RL1;DLL1;SYK;IL6;PYCARD;CD28;AGER
prerank,mesonephros development (GO:0001823),-0.4924852373913264,-1.2593894675344517,0.21071428571428572,0.5793609246986205,1.0,2/11,2.69%,ZBTB16;FGF1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4993340291430839,1.2591974142592273,0.17411764705882352,0.4684122239804894,1.0,8/32,9.13%,TMSB4X;TREM2;PINK1;ENO1;VCP;P2RX7;NUPR1;MLXIPL
prerank,negative regulation of cell division (GO:0051782),0.6096811729107721,1.2589702039514048,0.2017167381974249,0.46855189860802765,1.0,6/11,28.99%,TXNIP;VPS4A;MYC;BLM;CHMP4C;AURKB
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5281453078739884,1.2588441212456691,0.18695106649937265,0.4684494967292017,1.0,5/22,9.13%,APOE;AKT1;EEF1A2;HSD17B13;MLXIPL
prerank,positive regulation of intracellular protein transport (GO:0090316),0.43206330866344955,1.2587308064669143,0.060142711518858305,0.46828875443701945,1.0,38/144,15.14%,CD81;PRNP;TOMM7;OAZ1;ITGB2;PINK1;ANK3;RAN;TMEM30A;YWHAB;HCLS1;UBL5;SORL1;YWHAH;PRR5L;FLNA;YWHAE;HYAL2;SAR1A;TRIM28;LEPROT;YWHAG;VAMP2;CAMK1;CEP131;PMAIP1;HRAS;B3GAT3;YWHAQ;FBXW7;GAS6;YWHAZ;MTCL1;RHOU;MIEF2;BBC3;BAD;MFF
prerank,regulation of potassium ion transport (GO:0043266),0.48793012458503554,1.2586342273976745,0.1622596153846154,0.4680772649660761,1.0,8/31,15.36%,CD63;KCNIP4;ANK3;DPP10;DPP6;KCNN2;KCNE5;KCNIP1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6188037580607143,1.2585387583033378,0.1949509116409537,0.46789770978359924,1.0,4/10,14.62%,TIRAP;TICAM2;NINJ1;F2RL1
prerank,mucosal immune response (GO:0002385),0.5711069380186594,1.257727531268582,0.2151238591916558,0.4695575775295058,1.0,1/15,0.48%,RPL39
prerank,superoxide metabolic process (GO:0006801),0.5026230239692869,1.2575856030236778,0.16765053128689492,0.46948154808042303,1.0,6/29,9.70%,MT3;SOD1;CYBA;PRDX2;CYBB;PRDX1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.37407635692067914,-1.257517268596587,0.14835164835164835,0.5810881307862583,1.0,10/29,14.87%,STRN3;KANK2;YAP1;AXIN1;CNOT1;UFL1;ESR1;KMT2D;CBFB;CARM1
prerank,regulation of apoptotic process (GO:0042981),0.4160850367991741,1.2575023991005532,0.003,0.4692549329895725,1.0,190/676,20.95%,TPT1;RPS3;MTCH1;RPS27A;CTSD;PTMA;PPIA;ARHGDIA;CD74;CLU;CTSB;UBC;RACK1;UBB;HSP90AA1;HSPB1;CALR;LGALS1;MT3;CFL1;PARK7;SOD1;RPL10;RHOB;HSPA5;ATF4;RPS6;AKT1;NME1;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;TGM2;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;AGT;IGFBP3;GPER1;GRID2;BEX2;MAGED1;TNF;HSP90B1;FZD9;PRDX2;GLO1;NAA38;RTN4;MIF;BNIP2;HSPA1B;PSENEN;CTNNB1;FLNA;IL2RB;VCP;ALPK2;LTK;TMEM14A;BAG1;TFRC;OMA1;UBA52;NDRG1;BNIP3L;ARHGEF4;FOXL2;SGK1;HSPD1;FMN2;KDR;CXCL10;AQP1;IL2;CSRNP3;FAIM2;DHCR24;NUPR1;NET1;TRIM2;RRP1B;JUN;HMGB1;HCK;ARHGEF7;TAF9;TARDBP;SMPD1;GAS1;APBB1;APEX1;WNT5A;ATF5;DNAJA1;BAX;ZBTB7A;FLT4;WFS1;PMAIP1;PNMA2;TCTN3;SOX8;ACTN1;PHLPP1;CTLA4;MCF2L;SOX9;HSPA1A;VAV1;LILRB1;BMP2;SPTLC1;RIPK2;GAS6;WNT10B;YWHAZ;NME2;CLIP3;NLRP2B;CAT;SFRP4;GLS2;VAV3;ABR;CTSH;EGLN2;IKZF3;TIAM1;BAD;IER3IP1;ARF4;LRP8;CDK5;DAB2IP;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;DNM1L;PDCD5;PCID2;SCIN;ASNS;APH1B;CIAPIN1;GRM4;NOP53;KCNMA1;AKT1S1;ANP32A;TNFRSF12A;NSMF;HMGN5;ARHGEF19;ANP32E;CCAR2;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;SOS1;TFAP2B;FLT3;IL6;HGF;KLF11;ING5;CITED2;OSGIN1;MEF2C;SFRP1;SPHK2;CAPN3;TFAP4;MYC;NFKBIA;HSPA9;BAK1;PTPN6;PYCARD;GADD45A
prerank,B cell differentiation (GO:0030183),0.4695158524720131,1.2572406121388293,0.15444444444444444,0.4694842052400342,1.0,20/46,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;IL11;ZBTB7A;SYVN1;IRF2BP2;HDAC5;HDAC9;VCAM1;ADAM17;DNAJB9;FLT3;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.42204684143066834,-1.2568017133727711,0.17272727272727273,0.5801093871146832,1.0,8/19,14.38%,PARD3B;PARD3;DLG1;PATJ;SYNJ2BP;MARK2;PRKCI;CLIC4
prerank,regulation of cell death (GO:0010941),0.4425453649194132,1.2563546047873153,0.11226611226611227,0.4714445328774253,1.0,20/94,15.67%,CLU;UBB;CTSZ;MT3;PARK7;DCC;CRYAB;HSPA1B;LRPAP1;BNIP3L;CCN2;DHCR24;RAMP3;TMEM109;HSPA1A;RIPK2;PDE12;HPR;HP;EPHB1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4012965497747266,-1.2563286665525277,0.14622641509433962,0.5786183353989744,1.0,11/22,15.71%,SCAF8;BRD4;KAT7;CCNT1;CDK12;TCERG1;CCNK;CDK13;ELL;THOC5;CDC73
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.46006321932105676,1.2560926526118363,0.14888888888888888,0.4716694484692207,1.0,20/54,27.61%,CD63;KCNIP4;AKAP6;DPP10;FLNA;YWHAE;KCNJ10;DPP6;KCNN2;KCNE5;KCNIP1;CAV1;KCNMA1;GABBR2;KCNJ3;KCNAB1;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,post-translational protein modification (GO:0043687),0.42261577393440347,1.2559908302343092,0.025025025025025027,0.4715107102306691,1.0,85/332,20.58%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;LGALS1;C3;LAMC1;LAMB2;PSME1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;COPS7A;IGFBP3;MFGE8;COPS6;IGFBP4;FBXO15;HSP90B1;KLHL9;IGFBP5;PSMD1;SHISA5;EPAS1;PSMC3;PDIA6;PSMD6;PENK;FN1;PSMA7;P4HB;FN3KRP;FEM1A;FEM1C;FBXL14;APLP2;UBE2M;VWA1;PSMD5;RBX1;NEDD8;FBXO27;TIMP1;DDB1;ICMT;PSMB9;PSMD13;PSMB3;FBXW5;WFS1;PSMB11;MXRA8;ASB13;FBXW7;FBXO30;FBXO31;GAS6;PSMB10;KBTBD7;SPSB3;COPS8;PSMB1;RNF7;PSMB5;VCAN;VHL;EVA1A;SCG3;RBBP5;NOTUM;STT3A;PSMA6;FBXL16;IL6;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5407194407776743,1.255968568590068,0.20358514724711907,0.4711139026393753,1.0,10/19,27.24%,TREM2;CCT2;TNF;CCT7;CCT8;DKC1;CCT4;CCT3;CHP1;CORO2B
prerank,negative regulation of programmed cell death (GO:0043069),0.418324043790924,1.2558715934813491,0.018018018018018018,0.4709265670884124,1.0,93/355,20.87%,TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;GPX4;UBB;HSPB1;LAPTM5;MT3;CFL1;PARK7;RPL10;HSPA5;AKT1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;HSP90B1;PRDX2;GLO1;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;IL2RB;LTK;TMEM14A;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;ARF4;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;PCID2;ASNS;CIAPIN1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;IL6;HGF;POU4F1;CITED2;SFRP1;CAPN3;MYC;NFKBIA;HSPA9
prerank,microtubule polymerization or depolymerization (GO:0031109),0.51795603557058,1.2557821424726767,0.17164179104477612,0.4707717369376343,1.0,7/25,15.85%,TPPP3;PIN1;STMN3;MAPT;STMN4;STMN1;FGF13
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5846937119041085,1.2555076370019136,0.20698924731182797,0.47107515157884505,1.0,3/12,10.47%,HSPA5;KDELR1;RER1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33327717155498615,-1.25514832839665,0.11818181818181818,0.578825687736859,1.0,8/45,5.77%,EGFR;PLCE1;GAREM1;BRAF;GAB1;SLC30A10;PDPK1;EFEMP1
prerank,neuron projection morphogenesis (GO:0048812),0.4312799221101793,1.2549404704611318,0.0855397148676171,0.4721509189054638,1.0,38/137,16.85%,ACTB;S100A6;UBB;DCC;NBL1;NLGN1;S100B;CTNNA2;ANK3;MAP1A;CNTNAP2;PACSIN1;CNTN4;LRP4;CTNNB1;NEFH;KLK8;SGK1;PAK1;NRCAM;MAP2;PAK3;ADGRB1;DOCK10;APBB1;NYAP2;TMEM106B;SHTN1;CCK;TNN;MAPK8IP2;DSCAML1;SPTBN4;EPHB1;CDK5;EPB41L3;DAB2IP;BRSK2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6142038807347985,1.254679393680438,0.1997126436781609,0.4723700207905096,1.0,3/11,10.24%,AGT;ABCG1;PLA2G7
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.49299271899825936,1.2545066299787304,0.1789838337182448,0.47235534737512985,1.0,9/35,13.41%,ARHGDIA;SEMA3F;RAC1;SEMA7A;FLNA;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,glycerophospholipid catabolic process (GO:0046475),0.5123287730312194,1.2543974499418622,0.1872749099639856,0.47220995854760345,1.0,12/27,26.52%,PRDX6;ENPP2;PLA2G7;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;ABHD16A;GDPD3;ABHD12;PLA2G6
prerank,positive regulation of transferase activity (GO:0051347),0.4324986151022436,1.254054938529215,0.07230142566191446,0.4727179437119638,1.0,48/142,22.31%,CD74;RPS2;DBI;HSP90AA1;HSP90AB1;MAPK3;SERINC1;TREM2;ERBB4;PINK1;CCT2;NTRK2;PIN1;SORL1;CTNNB1;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;PCNA;KLF4;FBXW7;TIE1;RFC2;SERINC5;PTGES3;ARRDC3;IGF2;EPHB1;PARM1;FLT1;TYRO3;DDR2;ERBB3;EPM2AIP1;FLT3;DKC1;MAPK15;TGFB1;RFC4;MAGEC2;MYC;MAP2K7;CCT4;GRHL2;NAF1
prerank,regulation of protein localization (GO:0032880),0.4569868132439159,1.252775696337079,0.13186813186813187,0.47564054738711403,1.0,16/58,18.88%,CTSD;RACK1;HSP90AA1;HSP90AB1;FKBP1A;PARP1;RAB14;SLC26A4;MAP2;CAMK1;FBXW7;MMD2;USP8;ADCYAP1;ATCAY;VPS4A
prerank,regulation of T cell proliferation (GO:0042129),0.45543876191601823,1.2527039569234752,0.14759358288770053,0.4753849036905398,1.0,13/61,19.67%,GPNMB;CCL19;PTPRC;LGALS3;TFRC;CEBPB;SDC4;PNP;AIF1;LILRB1;VCAM1;CD86;IL6
prerank,regulation of biosynthetic process (GO:0009889),0.5983323641826623,1.2523901728041376,0.21787709497206703,0.47582199227946326,1.0,3/11,20.24%,MID1IP1;SNCA;SPHK2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4190098247126965,1.2512531884787899,0.017,0.4784067876542078,1.0,91/348,20.07%,RPL23;RPS3;ACTG1;RPL11;RPS7;RPL5;CD74;CLU;CD63;CLDN5;GSN;RAMP2;TYROBP;LAPTM5;ACTA2;MT3;PARK7;MAPK3;ATF4;AKT1;KLF2;TREM2;CD34;ANK3;GPER1;TNF;PDGFB;LAMTOR5;NTRK2;AMH;HSPA1B;FN1;MUSK;TFRC;MSN;RIMS2;RIMS1;TRIM28;P2RX7;VSIR;VAMP3;EGR1;GATA2;ATP13A2;LRP3;WNT5A;RAMP3;POU3F1;WARS1;WFS1;TMEM119;CAMK2N1;KLF4;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;HEY1;ARRB2;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;AGO1;MAZ;HMGN5;SOX11;SNCA;DDRGK1;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C
prerank,membrane raft organization (GO:0031579),0.5702389035123462,1.2512419779783996,0.21081081081081082,0.4779865349133528,1.0,4/15,6.04%,S100A10;EMP2;FLOT1;MYADM
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5178650393641944,1.2511389584348276,0.18249075215782984,0.47781866832489284,1.0,5/23,15.91%,LAMP1;LILRB1;NCR1;RASGRP1;ARRB2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.26570152604277536,-1.2511070120307066,0.0,0.5866598523948799,1.0,45/138,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;MAML1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;POLR2B;CDK7;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;NR5A2;GTF2H2;MED23
prerank,presynapse assembly (GO:0099054),0.5537157727531608,1.2507777721342381,0.19425444596443228,0.47835257981710927,1.0,8/16,23.04%,NLGN1;LRP4;IL1RAPL1;WNT5A;PTPRD;LRRTM3;FZD1;WNT7A
prerank,histone deacetylation (GO:0016575),-0.34391384081686055,-1.2506813558707084,0.0891089108910891,0.5851276532112434,1.0,12/43,9.37%,PRDM5;MIDEAS;BAZ2A;HDAC4;PER2;MTA3;HDAC8;TBL1X;SMARCAD1;RCOR1;MIER1;TBL1XR1
prerank,positive regulation of lipid storage (GO:0010884),0.53136456467874,1.2499800899385511,0.1707920792079208,0.48001513243121774,1.0,5/21,14.66%,C3;LPL;PLIN3;MSR1;EHD1
prerank,regulation of inflammatory response (GO:0050727),0.421889297724983,1.249745792634649,0.058174523570712136,0.48015561656950717,1.0,45/190,19.67%,TMSB4X;APOE;MDK;GRN;PARK7;AGT;GPER1;TNF;NR1D1;LRFN5;SEMA7A;S100A8;S100A9;SIRPA;DDT;HYAL2;TNFAIP3;FEM1A;CEBPA;OTULIN;IL2;BCL6B;LPL;VAMP3;VAMP2;LILRA5;HCK;NINJ1;PLA2G7;WNT5A;MMP3;KLF4;TNFRSF1A;AKNA;GPSM3;FNDC4;TYRO3;CCL3;CDH5;CCR2;SNCA;PSMA6;CXCL17;NLRP3;IL6
prerank,negative regulation of protein catabolic process (GO:0042177),0.48851871906443356,1.2492524665569087,0.17889908256880735,0.48103244613310453,1.0,16/40,21.37%,CST3;TIMP2;PIN1;FLNA;NELL1;FMN2;TIMP1;ADGRB1;ATRAID;CTSA;TIMP3;DAB2IP;AGAP2;SNCA;TIMP4;SIRT2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.49155242247670466,1.2491254431795238,0.16806722689075632,0.4809240044120533,1.0,7/32,9.13%,APOE;C3;AKT1;GPER1;MID1IP1;HSD17B13;MLXIPL
prerank,stress-activated MAPK cascade (GO:0051403),0.46218857695525334,1.2489792766631767,0.13297297297297297,0.4808356355494973,1.0,12/61,15.22%,RPS27A;UBC;UBB;MAPK3;ZFP36L1;UBA52;ZFP36;SH2D3C;RIPK2;UBE2V1;MAPK10;MAPK11
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5741839333316975,1.2489377148032885,0.1997264021887825,0.4804965630409076,1.0,2/14,3.71%,PARK7;TNF
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5635545755239949,1.2489357688383056,0.22117962466487937,0.4800517349554546,1.0,4/15,10.15%,CD74;MIF;PTTG1IP;TAF9
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4289778986379927,1.2486492797605226,0.09044715447154472,0.48035623744360095,1.0,42/161,16.42%,APOE;IGFBP6;PFDN5;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;TNN;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,regulation of exocytosis (GO:0017157),0.47573049274644225,1.2483565282908131,0.15254237288135594,0.48066737520064096,1.0,13/46,11.11%,ATP6AP1;SYT1;RIMS2;RAB15;IL1RAPL1;CLASP1;RAB3C;VAMP2;CADPS;STXBP5L;RAB3D;CHMP6;HAP1
prerank,negative regulation of protein transport (GO:0051224),0.5277157268546868,1.2482099103134283,0.18270401948842874,0.48060212904538474,1.0,6/25,21.84%,APOE;DPH3;RSC1A1;ERP29;RSAD2;PPM1F
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5546322690910764,1.2478251361973332,0.20418848167539266,0.48117564637842086,1.0,4/16,15.47%,PNPLA2;CTDNEP1;MFSD2A;NR1H2
prerank,negative regulation of developmental process (GO:0051093),0.4505072393177412,1.2477677752884562,0.13978494623655913,0.480874034535694,1.0,24/69,20.17%,CST3;DCC;VAT1;PINK1;SPI1;MIF;ALPK2;SFRP5;GRIN3A;TFRC;OMA1;VASH1;THY1;MAPT;SOX9;BMP2;GAS6;HEY1;DLL1;BCL11A;SPRY3;NOTCH1;TGFB1;SFRP1
prerank,cellular response to chemokine (GO:1990869),0.4714523190822215,1.2472650278121835,0.1583710407239819,0.48179232069898476,1.0,21/46,34.31%,CXCL12;CCL19;CXCL10;RHOA;DOCK8;CCL2;PF4;CCL3;CCL8;CCR2;DUSP1;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3;LRCH1;CCL5;SLC12A2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4767076042826822,-1.2468879257101375,0.1970260223048327,0.5920034825096568,1.0,5/12,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.46488204567703845,1.2466964749811758,0.14923747276688454,0.48284327641626135,1.0,20/54,22.80%,RACK1;LAPTM5;TNF;HSPA1B;TNFAIP3;SPPL2B;OTULIN;RBCK1;HSPA1A;GAS6;TNFRSF1A;CLIP3;NLRP2B;F2RL1;ADAM17;SYK;TRAIP;PYCARD;SPPL2A;PELI3
prerank,eosinophil chemotaxis (GO:0048245),0.5695570329361741,1.246439396739837,0.199203187250996,0.48259684427058325,1.0,7/14,29.90%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,eosinophil migration (GO:0072677),0.5695570329361741,1.246439396739837,0.199203187250996,0.48259684427058325,1.0,7/14,29.90%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,regulation of acrosome reaction (GO:0060046),0.6087450313920466,1.246264599858038,0.22142857142857142,0.4826204656090835,1.0,2/10,11.81%,PRSS37;GLRA1
prerank,negative regulation of cell adhesion (GO:0007162),0.44361417873629555,1.2461798991291813,0.14014752370916755,0.48239237036827126,1.0,29/72,27.79%,ARHGDIA;MDK;PTPRC;ACVRL1;DSCAM;PDE3B;SPOCK1;ARHGDIB;PODXL;ARHGDIG;RHOA;JAM3;DMTN;ERBB3;LPXN;MUC1;NOTCH1;TGFB1;PTPRO;PLXND1;CD164;DUSP1;PLXNB2;TBCD;PLXNB3;CX3CL1;CORO2B;PLXNA3;ADAM22
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3014544684459052,-1.2450938892887748,0.07142857142857142,0.5938194815472464,1.0,25/86,12.69%,AKAP13;NOTCH2;PLCE1;DENND4A;ARHGAP17;KANK2;DENND4C;MAPKAP1;OGT;EPS8;ARHGEF18;RAF1;SHOC2;STARD13;DENND1A;RAPGEF1;BCR;IGF1;KANK1;NGF;EPHB2;OPHN1;MYO9B;DENND3;ARHGEF2
prerank,Golgi organization (GO:0007030),-0.27883087679607055,-1.2450365024061967,0.0,0.5912145726837593,1.0,38/112,16.74%,LRRK2;BCAS3;ARFGEF1;ARHGAP21;CSNK1A1;USP6NL;VTI1A;RAB30;GORASP2;RAB2A;BLZF1;STX16;GOLGB1;HUWE1;UBXN2B;GOLGA2;GBF1;DYNC2H1;OPTN;BET1;UBXN2A;GOLGA5;GOLGA8B;PLEKHM2;MYO18A;OBSL1;ATP8B1;RAB43;PRKD1;TRAPPC11;SEC16A;SEC16B;NPLOC4;TRIP11;FBXW8;ATL2;LMAN2L;GOLPH3L
prerank,camera-type eye morphogenesis (GO:0048593),-0.497855778233524,-1.2449820999081356,0.21069182389937108,0.5886540599300493,1.0,5/10,16.91%,SHROOM2;SKI;LRP6;IFT122;NF1
prerank,vasculature development (GO:0001944),0.5549123044784722,1.2442408925161987,0.2041343669250646,0.4870722767906546,1.0,7/16,16.81%,SOX18;ACVRL1;APLNR;FLT4;FBXW7;STK11;CDH5
prerank,actomyosin structure organization (GO:0031032),-0.3119173516845107,-1.243993439723035,0.109375,0.5885732945883417,1.0,12/75,7.11%,ROCK2;SORBS1;PHACTR1;TMOD3;FRMD6;ROCK1;ACTN2;EPB41L5;EPB41L2;MYH9;CDC42BPB;MYH10
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5851148467145135,1.2438604330339393,0.2222222222222222,0.4876244426600659,1.0,2/12,2.16%,NBL1;AKT1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5661684769744387,1.243755584141177,0.2145748987854251,0.4874582521270828,1.0,5/14,14.67%,AK4;AK3;SMPDL3A;NME2;CMPK2
prerank,telomere maintenance via telomerase (GO:0007004),0.5032930381152196,1.242752019197573,0.20119760479041915,0.4897536493187378,1.0,9/28,19.75%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,axonogenesis (GO:0007409),0.4172457875085296,1.242467426248895,0.04513540621865597,0.4900717598105357,1.0,64/237,17.54%,ACTB;BSG;S100A6;HSP90AA1;HSP90AB1;CXCL12;MAPK3;DCC;NRXN1;S100B;CTNNA2;ANK3;UNC5D;LYPLA2;MAP1A;SEMA3F;DSCAM;CNTN4;SEMA7A;NEFH;SEMA4C;SHC3;LGI1;NRXN3;DAB1;OTX2;TNR;SEMA6D;ROBO4;NRCAM;LGR6;EMB;UNC5C;CDK5R1;EPHA5;KIF5A;PAK3;B4GALT6;ADGRB1;SEMA4A;LRTM2;APBB1;WNT5A;GFRA1;DOK5;SEMA4G;SHTN1;CCK;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;CDK5;SH3KBP1;GFRA2;SPTBN2;BRSK2;PIK3CD;SLIT3;SLIT1;EFNB1;NCAM1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5031338480990916,1.242136810218281,0.16992665036674817,0.4904629574197751,1.0,12/29,20.94%,AGT;GPER1;TNF;HYAL2;TNFSF12;PMAIP1;CAV1;LTBR;TNFRSF12A;INHBA;SFRP1;PYCARD
prerank,cellular response to acid chemical (GO:0071229),0.5015284644550129,1.2420651956636526,0.19393939393939394,0.4902069944798826,1.0,10/27,18.75%,KLF2;LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,protein polymerization (GO:0051258),0.453789517216595,1.2417479448653765,0.14842903575297942,0.4906115307954802,1.0,11/56,13.12%,GPX4;GSN;TPPP3;RAC1;MID1IP1;ANG;PIN1;FAM107A;MAPT;AIF1;MSRB1
prerank,membrane repolarization (GO:0086009),0.5572307599799216,1.2416258468932657,0.21296296296296297,0.4904886702152465,1.0,6/15,17.70%,ATP1B2;KCNE4;ATP1A1;KCNE5;ATP1B1;ATP1B3
prerank,negative regulation of cell communication (GO:0010648),0.5209938989953495,1.2411518447677063,0.2078720787207872,0.49119907915486727,1.0,9/21,23.07%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;BRAP;PTPN1
prerank,regulation of microtubule-based process (GO:0032886),-0.35296668319247,-1.24096112732687,0.1357142857142857,0.5936494361924939,1.0,10/36,14.72%,PHLDB2;EPHA3;MEMO1;MACF1;ROCK1;PRKAA2;DIAPH1;GSK3B;MARK2;TAOK1
prerank,positive regulation of cell cycle (GO:0045787),0.44816026923684055,1.240023159147867,0.15645514223194748,0.4937636169306132,1.0,19/62,20.02%,RPS15A;CALR;LGMN;AKT1;CCND2;PDGFB;DUSP3;CCND1;PTK6;PROX1;NUPR1;MAPRE3;NUDT16;TRIM32;ADAM17;ASNS;USP22;RAD23A;CITED2
prerank,positive regulation of hydrolase activity (GO:0051345),0.4284889046641981,1.2398918088610567,0.0998980632008155,0.4936364627280001,1.0,39/137,20.99%,RPS3;PSAP;RACK1;CALM1;NDUFA13;CCL19;RCN3;S100A10;CALM3;TGM2;PINK1;RHOC;PIN1;CAV2;THY1;NET1;ARHGEF7;RGS10;MTMR9;DOCK10;HRAS;RHOA;BMP2;DOCK8;MTCL1;CTSH;CCL2;F2RL1;RASGRP1;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;CALM2;AGRN;SFRP1;DOCK9;RGS6
prerank,regulation of phospholipase C activity (GO:1900274),-0.4410115903543568,-1.2387468196687403,0.1906779661016949,0.5967384736154725,1.0,8/15,19.26%,ABL1;NTRK3;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,cell projection assembly (GO:0030031),0.5327198525054795,1.2380935659698797,0.20947630922693267,0.4979650499425901,1.0,10/22,17.69%,GSN;RAC1;NEFH;RHOG;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.45980586061123857,-1.2379417379600859,0.20600858369098712,0.5960356585124468,1.0,6/15,9.67%,GPC3;WNT5B;RNF213;RSPO3;NPHP3;SPEF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.44201780445392136,1.2379016776045133,0.1647183846971307,0.49798146599517185,1.0,21/73,21.58%,ACTB;GPX1;H3-3A;POLR2E;POLR2F;SPI1;POLR1B;CREBZF;DEK;WBP2;POLR2K;HDAC5;IGF2;KDM1B;DNMT3B;ERCC6;TBP;POLR1H;SPHK2;POLR2H;PHF1
prerank,regulation of cell growth (GO:0001558),0.4216870264432377,1.237786988396301,0.059356136820925554,0.4978596401284011,1.0,70/204,21.94%,RACK1;H3-3A;MT3;NDUFA13;AKT1;NRG3;AKAP6;EIF4G2;AGT;LAMTOR2;CCDC85B;ADAM15;LTBP4;ACVRL1;ENO1;RTN4;S100A8;S100A9;HSPA1B;PPP2R1A;SPOCK1;HYAL2;BTG1;LGI1;TFRC;FAM107A;CXCL16;SGK1;DDX49;WFDC1;JADE1;IL2;MFSD2A;NET1;DNPH1;EXOSC2;KIF26A;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;EGLN2;SDCBP;IL17RB;ING1;DACT3;ATAD3A;TRIM32;SLIT3;NDUFS3;MMP14;ADAM17;EXOSC9;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;TMEM97;SPHK2;PAK5;RERG;EXOSC4;CCN3;CDA
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.45089498880756257,1.2377560081860255,0.14254859611231102,0.4974917647714808,1.0,24/72,23.70%,CD74;RACK1;HSP90AB1;TNF;PTPRC;TNFAIP3;SPPL2B;OTULIN;CD24;RBCK1;CDC37;GAS6;TNFRSF1A;CLIP3;IFNGR1;SIGIRR;SYK;IFNGR2;PTPN6;PYCARD;SPPL2A;PTPN1;SOCS3;AGPAT2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.48700575814185937,1.2377192315572938,0.20730270906949352,0.49712806961203293,1.0,9/33,17.49%,AKT1;AGT;GPER1;PTK6;HAP1;FBXW7;CCDC88A;NCF1;ADAM17
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.473716887321521,1.2374757583065887,0.18171557562076748,0.49736027935221677,1.0,16/42,24.52%,LARS2;GARS1;SARS1;SARS2;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;PPA1;EPRS1;QARS1;AIMP2;YARS2;MARS2
prerank,lymphocyte chemotaxis (GO:0048247),0.4909911341062606,1.2369212833224201,0.19331742243436753,0.4983420368355473,1.0,10/34,19.50%,CCL19;CXCL16;CXCL10;GAS6;CCL2;CCL3;PIK3CD;CCL8;CH25H;GPR183
prerank,mRNA metabolic process (GO:0016071),0.4395088816328595,1.2366233218037828,0.13550420168067226,0.4987339840032048,1.0,36/90,25.42%,SNRPG;AURKAIP1;RNASE4;LSM6;SNRPE;HSPA1B;ZFP36L2;SNRPF;SRSF9;HNRNPA0;ZFP36;RNH1;PRPF8;SUPT4H1;SRSF2;SF3A2;SF3B2;HSPA1A;NONO;SNRPB;SF3A3;NUDT16;PPARGC1A;NANOS2;SLBP;TBRG4;SNRPD3;SF3A1;SRSF1;SRRM4;PCBP2;LSM5;ALKBH5;METTL3;PRKACA;PNPT1
prerank,protein localization to nucleus (GO:0034504),0.4288290602937895,1.2363908638220904,0.11570247933884298,0.498895824623046,1.0,24/102,18.25%,RPL11;CHCHD10;CALR;COL1A1;AKT1;RAN;ARL2BP;FAM53C;YWHAE;CTDNEP1;PTTG1IP;MSX1;ZBTB7A;IPO4;HNRNPU;NUP85;ARL2;NUP88;LMNA;SPRN;EIF4ENIF1;SYK;NOP53;NUP50
prerank,B cell activation (GO:0042113),0.4483232639057099,1.2363785538709684,0.13782051282051283,0.4984817649041296,1.0,27/68,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;HSPD1;CD22;IL11;ZBTB7A;CHRNA4;HDAC5;RASGRP1;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;CD86;GPR183;FLT3;MEF2C;BANK1;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4797810824374642,-1.2360809138875137,0.2109090909090909,0.5982050307639303,1.0,5/11,22.45%,CAMK2D;SESTD1;NOS1AP;NOS1;CACNB1
prerank,negative regulation of protein secretion (GO:0050709),0.48609934703742524,1.2359537445765256,0.17942857142857144,0.49918367266072655,1.0,10/38,23.19%,APOE;DPH3;CHGA;ERP29;SFRP1;RSAD2;INHBB;CCN3;REST;PSMD9
prerank,negative regulation of protein modification process (GO:0031400),0.44920913391986766,1.235595439905151,0.12606837606837606,0.4996930853125805,1.0,18/79,11.61%,PPIA;DBI;PARK7;FKBP8;PRNP;FXYD1;IGFBP3;PPP1R15B;YWHAB;PRR5L;SIRPA;SH3GL2;MYADM;CORO1C;MAPT;CADM4;TARDBP;WARS1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5415974023641827,1.2354247918751848,0.2072072072072072,0.49971825722793034,1.0,2/20,1.05%,B2M;CD81
prerank,mitotic recombination (GO:0006312),-0.44155414611383514,-1.2349740484310543,0.16929133858267717,0.5986301774530598,1.0,3/15,7.07%,NSMCE2;TEP1;MSH3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4869839457343148,1.234350784954814,0.18461538461538463,0.5021595907628529,1.0,12/34,19.11%,CALM1;PDE4B;CALM3;RGS2;PLN;CHGA;ATP1B1;SLC8A1;RYR2;ADRA1A;SRI;CALM2
prerank,Golgi ribbon formation (GO:0090161),-0.46703525589753886,-1.234345840282339,0.20072992700729927,0.5975289470189995,1.0,6/13,15.81%,VTI1A;STX16;GOLGA2;OPTN;MYO18A;TRIP11
prerank,alanine transport (GO:0032328),0.6125263120604573,1.234044484565102,0.22158273381294963,0.5025082114773062,1.0,3/10,9.01%,SLC1A4;SLC6A6;SLC6A17
prerank,negative regulation of signaling (GO:0023057),0.5032211941113454,1.233829324955756,0.19805589307411908,0.5026526076784786,1.0,11/25,23.07%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;TRAT1;BRAP;AP1AR;PTPN1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.442085044830477,1.2335359699277093,0.14554973821989528,0.5029723458885758,1.0,31/78,27.26%,ACTB;AKT1;CCNI;CCND2;PDGFB;SERTAD1;CDKN1C;CCND1;CEBPA;PROX1;CDK5R1;CDC37;CCNG1;CDK5R2;HEXIM1;MAPRE3;ADAM17;CCNJL;CDC25A;TFAP4;GADD45A;MEN1;BLM;CCNA2;CDKN2B;CCNG2;HHEX;PSMD10;CCNH;CDKN1A;CNPPD1
prerank,mesenchymal cell differentiation (GO:0048762),-0.31820081182909,-1.2330373834705806,0.12380952380952381,0.5982763884569108,1.0,11/51,8.39%,ROCK2;RANBP3L;TGFBR3;FBXL17;ROCK1;LRP6;LIMS1;TGFBR1;DLG5;LOXL3;FGFR2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.606235335097354,1.2327780841878493,0.25148809523809523,0.5045230905150557,1.0,2/10,1.51%,VTN;MT3
prerank,hippo signaling (GO:0035329),-0.367466603577079,-1.2326220007394153,0.18518518518518517,0.5965727694707543,1.0,7/26,13.23%,TEAD1;STK3;YAP1;TEAD2;LATS2;SAV1;CASP3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4409624035212563,1.232467394790131,0.14362272240085744,0.5048709591564359,1.0,19/76,21.15%,TMSB4X;SPI1;TNFAIP3;ADORA3;OTULIN;RBCK1;KLF4;NLRP2B;ERBIN;TRAF3;G3BP2;ARRB2;DAB2IP;TCEAL7;COMMD7;NLRP3;NFKBIA;PYCARD;DDIT3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5977490057655221,1.2323563930934422,0.23272214386459802,0.5047257613309453,1.0,6/10,24.96%,HSPA5;ATF4;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6105739827486962,1.2319548248274699,0.20977011494252873,0.5053508824625926,1.0,4/10,21.65%,FBXW7;NCF1;ADAM17;TGFA
prerank,extracellular matrix assembly (GO:0085029),0.5065125269525732,1.2316577217218985,0.19533169533169534,0.5057057390570939,1.0,8/23,20.17%,RAMP2;LAMB2;GPM6B;MFAP4;MYH11;GAS6;TGFB1;QSOX1
prerank,glycerolipid catabolic process (GO:0046503),0.534102923984512,1.2315465526140195,0.19710906701708278,0.5055377047134416,1.0,10/19,28.07%,PRDX6;LYPLA2;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;GDPD3;ABHD12;MGLL
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4247074409316188,1.2314407434661152,0.10344827586206896,0.5053656496000772,1.0,40/149,20.94%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;NPM1;AGT;TNF;LAMTOR5;S100A8;S100A9;HSPA1B;FLOT1;TIRAP;TFRC;UBA52;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;UBE2V1;CX3CR1;TLR6;CAV1;TRIM32;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;NFKBIA;PYCARD
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5224853598266571,1.2312923276686163,0.21158690176322417,0.5053354537811582,1.0,10/21,21.84%,RACK1;MLXIPL;CNKSR3;INPP5J;NLRP2B;DMTN;CAV1;DDIT4;GADD45A;PPM1F
prerank,phagosome acidification (GO:0090383),0.5053046812844252,1.2312676124718782,0.1997563946406821,0.5049551907936783,1.0,9/26,23.58%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6057939231957296,1.2312610705679992,0.21153846153846154,0.5045221827146817,1.0,7/10,27.39%,JUN;HSPA1A;DNAJB1;VHL;CITED2;SIRT2;HIF1AN
prerank,regulation of stem cell differentiation (GO:2000736),0.4307141500930333,1.2312497315139401,0.13731656184486374,0.5041097409912028,1.0,35/89,25.43%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ZFP36L2;PSMD6;HES1;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;HNRNPU;PSMB1;PSMB5;LMO1;PSMA6;ESRRB;NOTCH1;PSMA4;PUS7;PSMC1;PTN;PSMD9;METTL3;TCF3;PSMB2;PSMD4
prerank,embryonic digestive tract development (GO:0048566),-0.409524636851303,-1.2312089846994236,0.18859649122807018,0.5975395635755122,1.0,6/18,8.39%,RARB;GLI3;GLI2;NIPBL;PCSK5;FGFR2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.41495130289616877,-1.2311219469331875,0.1894273127753304,0.5951475905525743,1.0,2/19,0.28%,BMP6;AFDN
prerank,positive regulation of protein metabolic process (GO:0051247),0.4232175927132147,1.2310774794947252,0.12849740932642487,0.5041426890221219,1.0,32/110,20.79%,APOE;CLU;NDUFA13;AKT1;KLF2;OAZ1;AGT;TNF;SORL1;VCP;TNFAIP3;TNFSF12;DDB1;WNT5A;WFS1;VPS28;KLF4;PRMT1;EGLN2;ABCB10;NR1H2;RASGRP1;ABCA2;DAB2IP;TRIM32;CD86;INHBA;HECW1;TGFB1;OAZ2;SLC25A37;NFKBIA
prerank,regulation of defense response (GO:0031347),0.4445392620939242,1.2309755056519096,0.1298283261802575,0.5039985595975742,1.0,14/76,15.50%,TMSB4X;APOE;GRN;PARK7;TREM2;SEMA7A;TIRAP;BCL6B;HCK;WNT5A;ELMOD2;AKNA;TRAF3;LRP8
prerank,nucleotide catabolic process (GO:0009166),0.5511202314929554,1.230662937795065,0.2325886990801577,0.5043440625093992,1.0,5/16,11.49%,GPX1;VCP;DNPH1;NUDT3;PNP
prerank,negative regulation of defense response (GO:0031348),0.43261363674857295,1.2304382759298642,0.1412133891213389,0.5044976662247722,1.0,21/77,23.80%,APOE;GPER1;NR1D1;LRFN5;SIRPA;TNFAIP3;FEM1A;OTULIN;KLF4;TNFRSF1A;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5259155469292024,1.2300464461984741,0.21571072319201995,0.5050563804401401,1.0,6/22,9.52%,MDK;NES;TAFA1;FZD9;PROX1;GATA2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5824087724659843,1.2296199149335114,0.26019690576652604,0.5056971700767141,1.0,5/12,21.09%,PODXL;BASP1;CD24;PROM1;PTPRO
prerank,neuron projection fasciculation (GO:0106030),0.6048098877210271,1.2294952231316214,0.24057971014492754,0.5056113385075649,1.0,4/10,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5192355704593458,1.2294311629940422,0.2144638403990025,0.5053324772274342,1.0,10/21,19.11%,CALM1;AKAP6;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;SRI;FKBP1B;CALM2
prerank,regulation of cell killing (GO:0031341),0.5576934284662787,1.2293266306807675,0.23342175066312998,0.5051600058427094,1.0,4/16,11.15%,CYBA;RAC1;WNT5A;IL11
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5405498382215524,1.2292762433399618,0.2071611253196931,0.5048419262744833,1.0,6/18,16.24%,HSP90AA1;MSN;NELL1;PTTG1IP;ATRAID;DAB2IP
prerank,snRNA metabolic process (GO:0016073),-0.4079266813459179,-1.2287713107629157,0.17903930131004367,0.5986714645788785,1.0,7/17,18.66%,INTS8;INTS6;ZCCHC8;TUT1;MTREX;INTS3;INTS11
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4211819409229043,-1.2286256624198224,0.20967741935483872,0.5965383867023665,1.0,5/17,7.71%,BMP6;SASH1;CARD16;TRIM5;LY96
prerank,positive regulation of immune effector process (GO:0002699),0.49587281420784923,1.2285130187319742,0.22456575682382135,0.506359054440233,1.0,4/27,8.64%,RPS19;CD81;PTPRC;IL2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.42461046718508244,1.228498929019427,0.12538540596094552,0.5059621173029033,1.0,37/107,21.40%,HSPA5;ATF4;RCN3;PPP1R15B;HSP90B1;FLOT1;VCP;CEBPB;P4HB;PDIA3;TMCO1;UFC1;SELENOK;JUN;BAX;WFS1;SYVN1;BBC3;UBXN6;ERO1A;DAB2IP;HERPUD1;BCAP31;BRSK2;RASGRF1;PPP1R15A;DNAJB9;EIF2B5;DNAJC10;PDIA4;DDRGK1;TMEM259;TMEM33;BAK1;DDIT3;HYOU1;SELENOS
prerank,regulation of dendrite extension (GO:1903859),0.5359254743897968,1.228100837234859,0.21153846153846154,0.5066032922785467,1.0,11/18,25.63%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,collagen fibril organization (GO:0030199),-0.2841978582710347,-1.2278271476403886,0.07142857142857142,0.5959537536781284,1.0,24/88,9.97%,COL5A2;COL22A1;COL4A3;COL5A1;COL8A1;COL4A5;PLOD2;ADAMTS2;COL4A6;COL25A1;COL13A1;LOXL1;COL26A1;TLL1;COL12A1;COL27A1;TGFBR1;PXDN;ATP7A;COL4A4;LOXL3;COL11A1;COL8A2;ITGB4
prerank,response to acidic pH (GO:0010447),0.5726369519082389,1.2267822900050993,0.23949579831932774,0.509601212736802,1.0,2/13,2.14%,CTSS;LGMN
prerank,neuropeptide signaling pathway (GO:0007218),0.45213702199135225,1.2266975644524338,0.18518518518518517,0.509385985589344,1.0,16/58,19.65%,SORL1;CPE;SORCS1;PENK;SSTR4;PDYN;GLRA2;PPY;SORCS3;GLRA1;NTS;SORT1;HCRTR1;ADCYAP1;GLRA3;GPR149
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.47408648435293943,1.2263282662003225,0.1983663943990665,0.5099333653509313,1.0,11/39,16.81%,RAMP2;GPER1;TNF;TNFAIP3;KDR;GATA2;ECSCR;IL11;GAS6;CCL2;CDH5
prerank,protein insertion into membrane (GO:0051205),0.488124461562429,1.2260565605683367,0.1875,0.5102380901976097,1.0,12/32,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;SEC61G;VAMP2;SERP1;SGTA;TRAM1L1;VAPA;TRAM1;CYB5A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.43202134127564884,1.2257364300154128,0.15010351966873706,0.5106981923277046,1.0,36/88,26.28%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;FBXL14;PSMD5;RBX1;FBXO27;PSMB9;PSMD13;PSMB3;FBXW5;PSMB11;FBXW7;FBXO31;PSMB10;PSMB1;PSMB5;PSMA6;FBXL16;SKP1;PSMA4;PSMC1;PSMD9;FBXO2;FBXL3;PSMB2;PSMD4;PSMD10;CUL2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.47982542358548685,1.2256583569264965,0.20398593200468934,0.5104836061348822,1.0,8/34,16.26%,MT1G;RAMP2;HSPB1;KDR;GAS1;FLT4;DAB2IP;FLT1
prerank,positive regulation of protein polymerization (GO:0032273),0.4435662732702556,1.2256052227007486,0.16073354908306364,0.5101721201825106,1.0,13/65,9.84%,RPS3;HSP90AA1;TPPP3;PINK1;RAC1;PFN1;NAV3;PAK1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,positive regulation of dendrite extension (GO:1903861),0.5412272240693973,1.2254810603559818,0.22483660130718955,0.5100580886865633,1.0,11/17,25.63%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,protein ADP-ribosylation (GO:0006471),-0.3681249670177543,-1.2249706033066818,0.14102564102564102,0.6008079556200968,1.0,9/28,15.22%,PARP4;PARP9;PARP12;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.48807638704597006,1.2238399844582033,0.19739952718676124,0.5139457949747579,1.0,11/33,16.76%,APOE;ACVRL1;CORO1C;VASH1;DCN;EPPK1;ADGRB1;PTPRR;DAB2IP;DNAJA4;PFN2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.41210537424207977,1.223684779867045,0.042042042042042045,0.5139206437416328,1.0,68/291,16.24%,ACTB;RPS3;VIM;MT3;NDUFA13;MAPK3;AKT1;PDE4B;AKAP6;TGM2;PRDX5;LAMTOR2;GPER1;LAMTOR4;HSP90B1;PDGFB;LAMTOR5;ROMO1;NR1D1;IGFBP5;ZFP36L1;TIRAP;SIRPA;CD180;VCP;LTK;TNFAIP3;DRD5;BRINP3;CCR5;PTK6;P2RY6;P2RX7;CXCL10;AQP1;MAPT;LPL;P2RY1;EGR1;P2RY12;TICAM2;JUN;CD68;HMGB1;ZFP36;CHMP5;BRINP1;WNT5A;MMP3;GLRA2;RAMP3;GLRA1;BRINP2;SNW1;SOX9;RHOA;LILRB1;LAMTOR3;WNT10B;CX3CR1;CCL2;PF4;RRAGC;HCN1;NCF1;RRAGD;DMTN;DAB2IP
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4600584964938124,-1.2235781445228011,0.19767441860465115,0.601789655427684,1.0,8/12,30.84%,MAD1L1;CENPC;CENPE;NDC80;MIS12;NUF2;RMDN1;KIF2C
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4373360017564705,1.2234460023361817,0.13457556935817805,0.514076763966306,1.0,32/101,21.40%,VIM;PDE4B;TNF;NR1D1;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;HCK;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CCL3;CD14;CD86;NLRP3;IL6;TGFB1;GIT1;MEF2C;PYCARD;SELENOS
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.49448584527440764,-1.223173568707827,0.21671826625386997,0.6002866608483546,1.0,4/10,16.18%,CAMK2D;PRKCE;HECW2;STK39
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5556598130721215,1.2231534377477624,0.23474801061007958,0.5143597842645271,1.0,10/15,31.70%,SRP14;SEC61G;SPCS1;SEC61A1;SPCS2;RYR2;ZFAND2B;SRPRB;SRPRA;SPCS3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4360156836641989,1.2228016090485645,0.1595744680851064,0.5148762405141831,1.0,20/76,16.47%,GRM5;TGM2;AGT;C5AR1;GNA11;DRD5;P2RY6;TACR1;HTR2C;P2RY1;P2RY12;GRM1;GPR18;CHRM2;GRPR;CX3CR1;F2RL1;ADRA1D;ADRA1A;CCKBR
prerank,synapse assembly (GO:0007416),0.4453463151310394,1.2223010708592168,0.17177242888402625,0.515770132925348,1.0,26/67,23.67%,NRXN1;SPOCK2;NLGN1;GRID2;DSCAM;ADGRL3;DNM3;GABRA2;KIRREL3;NRCAM;DNER;WNT5A;GABRB3;NRXN2;ACHE;CDK5;FGF13;GABRB2;PCDHB14;GPM6A;LRRTM3;POU4F1;PLXND1;FZD1;WNT7A;PLXNB2
prerank,negative regulation of cellular senescence (GO:2000773),-0.4550362605352541,-1.2221322994766288,0.2,0.6003339831974449,1.0,7/13,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5598328692149264,1.222028092839775,0.22636484687083888,0.5160433957368296,1.0,5/15,19.84%,CST3;CLASP1;DDR2;IL6;TGFB1
prerank,regulation of cellular component size (GO:0032535),0.48587968708090984,1.2216923093729688,0.2302158273381295,0.5165461494733457,1.0,9/30,14.15%,PPP1CA;LAMTOR4;LAMTOR5;RAC1;AP2M1;MSN;ATP13A2;VAV1;VAV3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5849183402878074,1.2210206336369616,0.23374827109266944,0.5178287316978143,1.0,4/11,18.24%,NCL;PIH1D1;DDX11;NOP53
prerank,lipid droplet formation (GO:0140042),0.6045437023313041,1.2206421456527952,0.23695976154992549,0.5184279438941938,1.0,3/10,5.09%,CDS1;AUP1;BSCL2
prerank,mitochondrion organization (GO:0007005),0.4164618510542093,1.2206115617119917,0.09274193548387097,0.5180651193880553,1.0,38/165,18.30%,CHCHD10;TSPO;ATP5F1B;ATP5F1D;CHCHD2;TIMM8B;TIMM13;PARK7;TOMM5;TOMM7;HIGD2A;PINK1;COX7A2L;SLC25A4;COX7A2;CAV2;PARP1;AIP;TIMM10B;DNM3;OMA1;BNIP3L;HSPD1;HIGD1B;HAP1;BAX;GDAP1;TMEM70;TIMM50;MIEF2;SPG7;MFF;ATAD3A;BCAP31;DNM1L;PPARGC1A;FMC1;ATCAY
prerank,positive regulation of protein localization to membrane (GO:1905477),0.42695424505512475,1.2203840026111679,0.1425598335067638,0.5181905356090526,1.0,28/98,15.14%,CD81;AKT1;PRNP;ITGB2;TREM2;ANK3;GPER1;TNF;YWHAB;LGALS3;DPP10;YWHAH;YWHAE;RHOG;YWHAG;ARF6;ZDHHC5;RAMP3;PMAIP1;HRAS;YWHAQ;YWHAZ;CLIP3;MTCL1;MIEF2;BBC3;BAD;MFF
prerank,arachidonic acid metabolic process (GO:0019369),0.4783575315325347,1.2202656281438853,0.19186046511627908,0.5180708841595548,1.0,3/35,1.19%,GPX4;PTGDS;GPX1
prerank,atrial septum morphogenesis (GO:0060413),-0.49267896936433453,-1.2201081055133713,0.2027491408934708,0.6030308322974602,1.0,2/10,1.44%,NOTCH2;ACVR1
prerank,regulation of protein phosphorylation (GO:0001932),0.40944615426348047,1.2198328262171356,0.056,0.5187296157984005,1.0,62/256,15.65%,PPIA;CD74;RACK1;HSP90AA1;HSPB1;GPNMB;MT3;PARK7;SOD1;C3;MAPK3;ATF4;AKT1;FKBP8;PRNP;ITGB2;CCND2;TREM2;GRM5;ERBB4;NPM1;PINK1;IGFBP3;PPP1R15B;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;PRR5L;KNDC1;SIRPA;SH3GL2;RARRES2;MYADM;FN1;MUSK;TFRC;CCND1;CEBPB;CORO1C;PAK1;KDR;P2RY1;CADM4;TARDBP;CSF1R;PECAM1;WARS1;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;CCDC88A;IGF2;PDGFA;RASGRP1;SPTBN4
prerank,regulation of cellular respiration (GO:0043457),0.5478290518219355,1.2197057626418095,0.2258485639686684,0.5186539216275391,1.0,10/17,30.36%,VCP;NOS2;NOP53;PRELID1;IL10RB;SHMT2;PNPT1;IDE;IFNAR1;IFNLR1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.45939086736105034,1.2195943697282536,0.19116022099447513,0.5185150096026626,1.0,11/48,12.82%,ACTB;POLR2E;ELOF1;POLR2F;SERTAD1;POLR1B;H1-0;DEK;WBP2;ZMIZ2;POLR2K
prerank,proteasome assembly (GO:0043248),0.5828155991806894,1.219560424158688,0.24625850340136055,0.5181747961114302,1.0,7/11,26.19%,POMP;PSMD5;PSMD13;OTUD6B;PSMD9;PSMD4;PSMD10
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4314519835667528,-1.2190465927005434,0.1762114537444934,0.6030332322858926,1.0,6/16,13.42%,PDK1;PRKN;FOXK2;FOXK1;RORA;SIRT1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.35000382867021307,-1.2185374833063662,0.12962962962962962,0.6018979777577006,1.0,9/30,11.01%,GOLGA4;VAMP5;MACF1;SPTBN1;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,apical protein localization (GO:0045176),0.6017998902550279,1.217793079455158,0.23356643356643356,0.522500721663365,1.0,2/10,5.26%,ACTB;MAL
prerank,positive regulation of apoptotic process (GO:0043065),0.40952565599618385,1.2177229862648329,0.042,0.5222183716967492,1.0,89/293,21.46%,RPS3;MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;GRN;SOD1;RHOB;ATF4;RPS6;PRNP;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;TLE5;CTNNB1;BTG1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NUPR1;NET1;CDK5R1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DLC1;CDK5;DAB2IP;CCL3;BACE1;SQSTM1;PSEN2;DNM1L;PDCD5;SCIN;APH1B;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;TFAP2B;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;DDIT3;FOXA1;SIRT2;SUDS3
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5779994003887199,1.2169706009874248,0.24722222222222223,0.5238237924893218,1.0,9/12,25.37%,TUBB4A;MAP2;ARHGEF7;CLIP3;STMN1;CDH5;SNCA;TBCD;MAPRE1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4173792094736098,-1.2169478251239143,0.20647773279352227,0.603506118810168,1.0,11/15,30.75%,ANAPC1;ANAPC7;NEK6;HECW2;CDC27;CENPE;TPR;PLK1;RIOK2;UBE2C;CDC16
prerank,protein import into mitochondrial matrix (GO:0030150),0.5352733140742454,1.2162934889948138,0.222509702457956,0.5252073610281185,1.0,5/18,14.02%,ROMO1;DNLZ;TOMM40L;TIMM50;TOMM20L
prerank,response to ATP (GO:0033198),0.5374169449668171,1.215871855020834,0.23673997412677877,0.5258737506723563,1.0,4/18,9.32%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4269980293450313,-1.2153463980876862,0.20675105485232068,0.6051475906216466,1.0,3/16,3.19%,SOX5;DHX36;HOXB4
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.48384127018640555,1.2148096502082042,0.21027479091995221,0.5278571196806339,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.48384127018640555,1.2148096502082042,0.21027479091995221,0.5278571196806339,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,regulation of cell differentiation (GO:0045595),0.41279663093668095,1.2144272403153633,0.12323232323232323,0.5284178148405532,1.0,28/148,9.69%,MDK;HSP90AB1;UQCC2;ATF4;SPOCK2;NLGN1;TNF;EMP2;LTBP4;NR1D1;LGALS3;ZFP36L1;YWHAH;MCRIP1;PPP2R1A;PLEKHB1;LTK;FADS1;CEBPB;SLC6A6;KLK6;CLASP1;CCN2;YWHAG;BCL6B;CD24;CDK5R1;CAMK1
prerank,glucose import (GO:0046323),0.5691803350831629,1.214112499054697,0.24752475247524752,0.5288296246692832,1.0,3/13,18.04%,SLC2A1;SORT1;SLC2A3
prerank,regulation of angiogenesis (GO:0045765),0.4127604546762394,1.2140139990226892,0.0925553319919517,0.5286420788152633,1.0,53/192,18.31%,SPARC;CLDN5;RAMP2;HSPB1;GRN;GPNMB;HMOX1;RHOB;SERPINF1;CD34;EMP2;ECM1;CTNNB1;APLNR;PDE3B;ADAM12;TNFAIP3;EMC10;BTG1;PGK1;HIPK2;GLUL;VASH1;KDR;CXCL10;AQP1;TNFSF12;SARS1;GATA2;DCN;ADGRB1;ECSCR;NINJ1;STAB1;RNH1;PDCD6;WNT5A;WARS1;KLF4;TIE1;CTSH;RRAS;PF4;DAB2IP;FLT1;GATA4;AMOT;CDH5;PIK3CD;TWIST1;AGO1;ADAMTS1;CCR2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3506382824240487,-1.2140021352547368,0.1527777777777778,0.60612089890555,1.0,5/34,6.44%,AUTS2;PLCE1;FER;SLIT2;NCKAP1
prerank,polyamine metabolic process (GO:0006595),0.5571860138583865,1.2139990177925497,0.21477428180574556,0.52824034322594,1.0,5/13,19.94%,ODC1;SMS;SMOX;SRM;OAZ2
prerank,renal absorption (GO:0070293),0.6069597689216253,1.2136170888435511,0.25176803394625175,0.5288326086654561,1.0,4/10,15.43%,GSN;HYAL2;SGK1;SLC15A2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4752915273251279,1.2133344560778252,0.19489559164733178,0.5291265387575447,1.0,14/38,24.36%,RACK1;AKT1;GPER1;HYAL2;SFRP5;PDCD6;PHLPP1;ARRB2;NOP53;THEM4;DDIT3;BANK1;PHLDA3;PLEKHA1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4503739848298192,1.2128736013518728,0.18421052631578946,0.5298865755600246,1.0,19/57,21.42%,CHCHD10;PARK7;TREM2;PINK1;GPER1;KDR;DCN;BAX;PMAIP1;MIEF2;BBC3;BAD;MFF;DNM1L;PDCD5;PPARGC1A;BAK1;PYCARD;FIS1
prerank,response to calcium ion (GO:0051592),0.4206968267647005,1.2128686803730426,0.15762004175365343,0.5294539015126227,1.0,31/102,20.40%,CALM1;LGMN;NLGN1;CALM3;SLC25A13;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;PDCD6;WNT5A;TRPM2;TRPC1;ALOX5AP;CPNE5;SYT10;CPNE6;RYR2;DMTN;ADCY8;SYT2;CAV1;KCNMA1;PPP3CA;CALM2;CPNE4;D2HGDH;MEF2C;CAPN3
prerank,regulation of cellular component movement (GO:0051270),-0.31253515640754004,-1.2121436879421716,0.12727272727272726,0.6081451032711085,1.0,14/49,11.99%,ROCK2;TGFBR3;EGFR;ABL1;MEMO1;ROCK1;RAF1;TGFBR1;CDK6;SP100;DIAPH1;ABL2;ZSWIM4;ARHGAP18
prerank,protein localization to mitochondrion (GO:0070585),0.5831456758692078,1.212104274883796,0.24759284731774414,0.5310634965699893,1.0,4/11,11.32%,AKT1;PINK1;ISG15;DNAJA1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3097604651908363,-1.2120296714671501,0.16853932584269662,0.6059529953085718,1.0,17/59,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5740688817863369,1.2119493401285675,0.2631578947368421,0.5310196424790338,1.0,3/12,5.31%,APOD;NDRG4;IFT20
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4359085491009057,1.211483909799872,0.1703940362087327,0.5318665537097717,1.0,22/75,17.49%,MDK;HMOX1;AKT1;PDGFB;ANG;ECM1;APLNR;EMC10;PROX1;KDR;TNFSF12;JCAD;GATA2;HMGB1;PDCD6;WNT5A;FLT4;BMP2;IGF2;EGFL7;PIK3CD;ADAM17
prerank,import into nucleus (GO:0051170),0.43389120293990274,1.2113608800194384,0.16881720430107527,0.5317262189114713,1.0,19/73,18.56%,SNRPG;AKT1;GEMIN7;RAN;SNRPD2;SNRPE;FAM53C;SNRPF;PTTG1IP;IPO4;NUP85;HNRNPA1;SNRPB;NUP88;SPRN;EIF4ENIF1;SYK;NUP50;SNRPD3
prerank,regulation of cell size (GO:0008361),0.5047086957814684,1.2111751040724745,0.22358722358722358,0.5317875394228381,1.0,8/23,18.37%,LAMTOR4;LAMTOR5;RAC1;MSN;VAV1;RHOA;VAV3;AKT1S1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5368184208769419,1.2108998812252305,0.23036649214659685,0.5320639134860907,1.0,9/17,20.17%,NELL1;ATRAID;TMEM119;SOX8;RHOA;BMP2;TNN;HPSE;SFRP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5936747576547095,1.2108601399722636,0.25290697674418605,0.5312603434200779,1.0,2/10,15.93%,REEP6;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5936747576547095,1.2108601399722636,0.25290697674418605,0.5312603434200779,1.0,2/10,15.93%,REEP6;CNGB1
prerank,nucleocytoplasmic transport (GO:0006913),0.4558694446923065,1.2106924428522372,0.21354764638346727,0.5312614632271355,1.0,12/40,18.56%,SNRPG;GEMIN7;NPM1;SNRPD2;SNRPE;SNRPF;RBM15B;XPO1;HNRNPA1;SNRPB;ANP32A;SNRPD3
prerank,positive regulation of cell migration (GO:0030335),0.40673063653151403,1.210670738232336,0.07028112449799197,0.5308712172938426,1.0,73/253,19.84%,ACTG1;RACK1;VTN;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;S100A11;HSPA5;GPER1;RHOC;SEMA3F;PDGFB;PTPRC;SEMA7A;RTN4;SEMA4C;MYADM;PFN1;FN1;FAM107A;CXCL16;SEMA6D;ENPP2;PAK1;PODXL;CLASP1;KDR;VSIR;LGR6;LAMC2;ARHGEF7;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SOX9;SEMA4G;SHTN1;BMP2;FBXO5;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;DMTN;DAB2IP;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;F10;MMP14;ADAM17;DDR2;CCR2;MAZ;NSMF;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4697486639367293,-1.2095132317742023,0.24719101123595505,0.6100069201005787,1.0,4/11,15.02%,CLK2;SIK1;C1QTNF3;CRY1
prerank,purine ribonucleotide transport (GO:0015868),0.5360996894809225,1.209511901624051,0.2503311258278146,0.5336449423686069,1.0,3/16,13.31%,LRRC8A;SLC25A4;SLC19A1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5299242380290471,1.2091379673970664,0.23418573351278602,0.5341991936018743,1.0,6/17,16.81%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1
prerank,positive regulation of protein kinase activity (GO:0045860),0.41299439094083695,1.2085820794505808,0.11507128309572301,0.5352250413201689,1.0,44/148,19.76%,CLU;CALM1;HSP90AA1;HSP90AB1;CCL19;PRNP;CALM3;GRM5;AGT;TNF;EMP2;PDGFB;PTPRC;PAK1;EGR1;LILRA5;CAMK1;PAK3;PIH1D1;FCGR1A;CSF1R;DOK7;SLC11A1;RHOA;SRCIN1;GAS6;CCDC88A;STK11;MMD2;LRP8;MAPRE3;DAB2IP;CASS4;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3;MAP2K2;CALM2;SNCA;UNC119;EFNA1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4264019472326836,1.2084495719480954,0.1509433962264151,0.5351310160442853,1.0,31/93,19.99%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;MLXIPL;CAMK1;IL11;RAMP3;SH2D3C;CNKSR3;RIPK2;INPP5J;GAS6;NLRP2B;SPTBN4;DMTN;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1;DDIT4
prerank,stem cell development (GO:0048864),0.5354845722450353,1.2083718018282377,0.2386058981233244,0.5348763846195816,1.0,10/16,32.29%,NRG1;PTPRC;PDCD6;SOX8;SOX11;WNT7A;NOLC1;KBTBD8;CDH2;SHH
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3372904248140742,-1.2077281343643413,0.1864406779661017,0.6121141351759734,1.0,16/44,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;WNT11;TGFB3
prerank,positive regulation of protein modification process (GO:0031401),0.40511773427990755,1.2077142229331614,0.07738693467336684,0.5362536178562703,1.0,56/203,20.04%,PPIA;CD74;RACK1;CALM1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;TXN;CALM3;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;KNDC1;RARRES2;MUSK;TFRC;CCND1;PAK1;KDR;P2RY1;CAMK1;SMPD1;CSF1R;PECAM1;SVIP;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;IGF2;DLC1;RASGRP1;ASPSCR1;CDH5;ADAM17;TERF2IP;NSMF;CALM2;HGF;EFNA1;ERP29;TGFB1;THPO
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.539306673448348,1.207693649921294,0.24705882352941178,0.535872834795222,1.0,3/17,8.53%,CD74;MIF;PTTG1IP
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42143700563693803,1.2076476046100633,0.16095534787123572,0.5355509995879693,1.0,23/100,14.29%,RPL11;CLU;RACK1;GABARAP;ELOB;HSP90AB1;PARK7;UBXN1;MAP1A;HSPA1B;VCP;BAG5;FOXF2;USP5;CEBPA;RBX1;XPO1;TAF9;SUMO2;DNAJB2;HSPA1A;HSPBP1;SDCBP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5037976701651625,1.2075802808014608,0.23345367027677497,0.535308195772818,1.0,11/25,26.22%,AKAP6;GPER1;APLNR;THY1;CXCL10;RAMP3;TRPC1;SNCA;CAPN3;F2RL3;CX3CL1
prerank,negative regulation of hydrolase activity (GO:0051346),0.45044671777221507,1.2073472165054147,0.2052980132450331,0.5354627980197829,1.0,12/49,16.24%,CST3;ECM1;ATP5IF1;CSTB;TMED2;MAP2;RRP1B;NEIL1;HRAS;PPP1R35;ARL2;DAB2IP
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.31151048800856646,-1.206872538062726,0.15584415584415584,0.6117249745035083,1.0,25/61,19.40%,EYA2;EGFR;EYA1;BABAM2;DHX36;OTUD4;UIMC1;PARP3;RNF8;PML;EYA4;PDGFRB;EYA3;SMOC2;ERCC8;SIRT1;SMCHD1;MECP2;RTEL1;TIGAR;USP9X;ZCWPW1;FGF2;WRN;PRKD2
prerank,acute-phase response (GO:0006953),0.5758666076313601,1.2067784994841289,0.23418573351278602,0.5365106652143656,1.0,5/12,24.75%,MBL2;CEBPB;SIGIRR;IL6;LBP
prerank,regulation of ruffle assembly (GO:1900027),0.501453148499999,1.2067701431760494,0.24598269468479605,0.5360795882205066,1.0,7/23,16.76%,NLGN1;PFN1;P2RY12;DEF8;HRAS;CAV1;PFN2
prerank,vacuolar acidification (GO:0007035),0.5239335154309697,1.2067654226065714,0.2265331664580726,0.5356476136168073,1.0,7/21,12.97%,GRN;ATP6V0E2;ATP6V0D2;ATP6AP2;SLC11A1;CLN5;CLN6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4277514280793768,-1.2067218180555903,0.20816326530612245,0.6096488562789943,1.0,6/13,10.33%,TNRC6B;TNRC6A;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,regulation of endocytosis (GO:0030100),0.44772557396063034,1.2065550336480992,0.18945102260495156,0.5357506514334568,1.0,17/61,17.08%,APOE;CD151;CCL19;SNX17;LGALS3;PACSIN1;FLOT1;LRPAP1;SYT11;CD22;AP2S1;SMPD1;LILRB1;CLIP3;DLL1;SNX33;RAB5C
prerank,microtubule anchoring at centrosome (GO:0034454),-0.47896027723844103,-1.2060482266622632,0.2508250825082508,0.6089432260945555,1.0,5/10,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,cellular sodium ion homeostasis (GO:0006883),0.5456337508922645,1.2057203464229131,0.258732212160414,0.5375581453724503,1.0,7/15,17.70%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3
prerank,regulation of cellular protein localization (GO:1903827),0.45909512050971335,1.2054838316407945,0.20454545454545456,0.5377398852461184,1.0,13/45,11.05%,HSP90AA1;HSP90AB1;MAP1A;PIN1;PARP1;CTNNB1;VCP;MAPT;MAP2;LCP1;ATP13A2;SUMO3;GPC5
prerank,chromatin disassembly (GO:0031498),-0.43531407103908204,-1.204811871413595,0.212,0.6072756625265279,1.0,3/14,6.66%,ARID2;ARID1A;SMARCE1
prerank,nucleosome disassembly (GO:0006337),-0.43531407103908204,-1.204811871413595,0.212,0.6072756625265279,1.0,3/14,6.66%,ARID2;ARID1A;SMARCE1
prerank,carboxylic acid transport (GO:0046942),0.4471706083386148,1.2045691100328493,0.20372398685651696,0.5397139695017693,1.0,10/55,12.43%,PSAP;SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC15A4;SLC3A2;SLC1A1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5798321315184758,1.2034956103785797,0.2647482014388489,0.5421337865022664,1.0,3/11,5.66%,NBL1;MIF;DDT
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3344217581163449,-1.2032048975238887,0.14492753623188406,0.608906676710311,1.0,9/34,14.03%,NSMCE2;LRP5;ANAPC5;INSR;ANAPC7;IGF1;PDGFRB;PHIP;CDC27
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5129667438250487,1.2026638927287803,0.24968474148802017,0.5439324468739132,1.0,4/22,12.65%,MDK;IL2;VSIR;CTLA4
prerank,response to estradiol (GO:0032355),-0.3489777899804026,-1.2025525704345505,0.17424242424242425,0.6082772668266847,1.0,7/31,9.87%,STRN3;EGFR;NRIP1;STAT5B;LCOR;STAT3;ESR1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3582976212880646,-1.2025338562386578,0.19607843137254902,0.6059582324025741,1.0,9/32,15.38%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;ATM;TAOK1;CLSPN
prerank,regulation of mitotic cell cycle (GO:0007346),0.4119550723434868,1.2024502666765486,0.1006036217303823,0.5440489879907546,1.0,66/171,26.74%,PSMB4;PSME1;LGMN;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PIN1;CAV2;PSMC3;DUSP3;PSMD6;CDKN1C;BTG1;BRINP3;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;GAS1;BRINP1;BUB3;PSMB3;PSMB11;BRINP2;FBXO5;PSMB10;RNF40;HNRNPU;SDCBP;L3MBTL1;PSMB1;PSMB5;PIM3;ASNS;USP22;BTG4;PSMA6;TGFB1;DYNLT3;SKP1;PSMA4;TFAP4;ASAH2;CDK9;FOXA1;CCDC8;PSMC1;FZR1;PSMD9;MEIS2;CDK10;INTS13;APP;RCC1;CDC20;PSMB2;PRKCA;XPC;KIF20B;PSMD4;PSMD10;CDK11B;ERCC2
prerank,zinc ion transport (GO:0006829),0.5191561335438551,1.2024209782893387,0.2585987261146497,0.5436846014605733,1.0,5/21,11.56%,MT3;SLC30A1;SLC39A1;SLC39A7;TRPM2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.471826399397001,1.202166143213789,0.2346109175377468,0.5439244418766498,1.0,10/33,19.75%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;CTC1;TERF2IP;DKC1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4322033569354708,1.2014087238108375,0.19279661016949154,0.5454837339318879,1.0,12/73,8.71%,MTCH1;RACK1;LAPTM5;RPS27L;HSPE1;TNF;S100A8;S100A9;VCP;BEX3;HSPD1;MAPT
prerank,secretory granule organization (GO:0033363),0.5947036034636232,1.2011977084089265,0.2671232876712329,0.5456090061987863,1.0,6/10,24.34%,BLOC1S1;SRGN;BLOC1S3;BLOC1S2;LYST;F2RL3
prerank,inflammatory response (GO:0006954),0.408686727865091,1.2009989734661632,0.09696969696969697,0.545702128899998,1.0,54/195,20.10%,CCL19;CYBA;ITGB2;PRDX5;NFAM1;TAC1;TNF;RAC1;C5AR1;S100A8;S100A9;CYBB;ADORA3;CEBPB;CCR5;HNRNPA0;CXCL10;TACR1;CRH;SIGLEC1;HMGB1;TUSC2;AOC3;CSF1R;AIF1;SLC11A1;BMP2;RIPK2;CXCR4;TNFRSF1A;HDAC5;KLRG1;TLR6;CCL2;PF4;TLR5;FOLR2;HPR;HP;TLR1;ADCY8;CCL3;HDAC9;PIK3CD;PTGIR;NOS2;CCL8;CCR2;CD14;NLRP3;IL6;HSPG2;TGFB1;IL10RB
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.26355135817898145,-1.2009110650715717,0.0,0.6076369795694528,1.0,38/140,13.41%,ARHGAP29;AKAP13;ARHGAP28;ARHGAP6;ARHGAP20;PLCE1;ARHGAP10;RHOJ;CGNL1;SOS2;ARHGEF11;ARHGAP17;TIAM2;ARHGAP21;SLIT2;ITSN1;ARHGAP23;ARHGEF18;FGD4;RHOT1;STARD13;ARHGAP12;ARHGAP32;ARHGEF12;FAM13B;PLEKHG2;BCR;VAV2;ARHGEF6;SYDE2;ARHGAP31;OPHN1;TRIO;MYO9B;ARHGAP18;ARHGEF2;ARHGEF17;ARHGAP5
prerank,plasma membrane invagination (GO:0099024),0.4845305409904738,1.2009006347887992,0.2407185628742515,0.5455333754468258,1.0,9/29,16.40%,GSN;ITGB2;ARHGAP25;ELMO1;FCGR1A;MSR1;AIF1;RHOA;SNX33
prerank,chemokine-mediated signaling pathway (GO:0070098),0.46223069629707997,1.2005994409331466,0.2113163972286374,0.5459229963601658,1.0,16/42,31.16%,CXCL12;CCL19;CXCL10;CCL2;PF4;CCL3;CCL8;CCR2;THPO;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5283198614127654,1.200119229311926,0.261455525606469,0.5467843793254071,1.0,6/18,18.88%,ACTB;VAMP8;CDK5;ABCA2;MMP14;VPS4A
prerank,somite development (GO:0061053),-0.48288280310783993,-1.1999692555760268,0.2391304347826087,0.6077442089942122,1.0,6/11,25.52%,SMO;MEOX2;LOXL3;PPP2R3A;PTCH1;MTHFD1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5889206559734596,1.1997979136478194,0.274310595065312,0.5472256678702901,1.0,4/10,15.85%,PTPRC;TLE5;KLF4;SIGIRR
prerank,DNA double-strand break processing (GO:0000729),-0.41038302331133775,-1.199778959694568,0.21568627450980393,0.6059396085907437,1.0,5/18,12.01%,SMARCAD1;RBBP8;SLX4;RNF138;ATM
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5659983330410848,1.1997112981673281,0.252387448840382,0.5470100912038014,1.0,7/12,31.39%,FLOT1;PQBP1;IFIT1;CAV1;RALB;DHX9;MAVS
prerank,sulfur amino acid catabolic process (GO:0000098),0.5819088961274461,1.1997079998389013,0.26433566433566436,0.5465747422362105,1.0,4/10,24.30%,MPST;TXN2;TST;ADO
prerank,smooth muscle cell differentiation (GO:0051145),0.5613086748384508,1.1985012434419267,0.26842837273991654,0.5493678173197697,1.0,5/12,20.07%,MRTFA;APLNR;HEY1;TMEM204;MEF2C
prerank,regulation of catecholamine secretion (GO:0050433),0.4916653302047725,1.1984434569224194,0.22572815533980584,0.5490867563592511,1.0,15/29,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;CHGA;KCNA2;CHRNA4;SYT10;SYT2;SNCA;GRK2;SYT3;SYT5;SYT17
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.49817574376320406,1.1980967249650003,0.24411400247831475,0.5495766874140349,1.0,10/24,24.03%,RAMP2;TNFAIP3;KDR;GATA2;IL11;GAS6;CDH5;SCG2;TEK;PAK4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3984189212090617,-1.1980213392948678,0.18518518518518517,0.6079518276540511,1.0,7/22,10.55%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A;SMAD4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4999135347647723,-1.1979991261202805,0.25,0.6056569449545574,1.0,3/10,15.71%,DHX36;CPEB3;CDC73
prerank,cellular response to oxygen levels (GO:0071453),0.5879203572800094,1.19743054425939,0.26358695652173914,0.5509038446318832,1.0,3/10,8.91%,ATP6V1G1;ATP6AP1;NDUFS2
prerank,ear morphogenesis (GO:0042471),-0.3933687918016656,-1.1973985161397482,0.25112107623318386,0.6047542757622779,1.0,5/20,13.03%,NIPBL;FGFR2;EPHB2;ZIC1;SIX1
prerank,lymphocyte migration (GO:0072676),0.47345463793227144,1.197250587423503,0.2158956109134045,0.5509261319888535,1.0,13/32,34.09%,CCL19;S1PR1;MSN;CCL2;CCL3;CCL8;MYO1G;CX3CL1;CCL13;ZAP70;CCL14;ADAM8;CCL5
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4323026252264469,1.1970061213339684,0.19032258064516128,0.5511041696705211,1.0,21/69,21.86%,SEC61B;HSPA5;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;HERPUD1;DNAJB9;DNAJC10;TRIM13;SELENOS;STUB1;AMFR
prerank,cellular response to ionizing radiation (GO:0071479),0.4484960319779376,1.195852694935357,0.22384701912260968,0.5536816093918633,1.0,8/47,12.02%,RPL26;RHOB;CRYAB;EEF1D;NUCKS1;NET1;TMEM109;HRAS
prerank,Notch signaling involved in heart development (GO:0061314),-0.47514446557991685,-1.195805860556924,0.2225705329153605,0.6062355368056969,1.0,5/11,14.92%,NOTCH2;GALNT11;RBPJ;JAG1;HEY2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.43304926869961813,1.1957879277417685,0.1891891891891892,0.5533944664972079,1.0,23/73,19.84%,HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;CAMK1;IL11;RAMP3;SH2D3C;RIPK2;GAS6;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1
prerank,regulation of dopamine secretion (GO:0014059),0.49962970962066616,1.1956973059037193,0.23680981595092024,0.5532008763157544,1.0,13/25,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;KCNA2;CHRNA4;SYT10;SYT2;SNCA;SYT3;SYT5;SYT17
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.51924715540888,1.1955823937099623,0.24327784891165172,0.5530675055880612,1.0,7/20,19.95%,PARK7;LAMTOR5;H1-0;TWIST1;DDRGK1;TGFB1;POU4F1
prerank,protein-DNA complex disassembly (GO:0032986),0.5332352707029702,1.195052249840508,0.24670184696569922,0.5540101999153346,1.0,1/16,0.13%,RPL23
prerank,ventricular septum morphogenesis (GO:0060412),-0.36114895200642544,-1.1949504633821153,0.1807909604519774,0.6061397354412701,1.0,12/27,16.29%,TGFBR3;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;SMAD7;SMAD4;BMP4;HEY2;BMPR2
prerank,positive regulation of viral transcription (GO:0050434),0.49761295903481473,1.1941416314966684,0.25,0.5559547326537463,1.0,10/25,21.24%,POLR2E;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;POLR2K;NELFE;POLR2H;CDK9
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5340023590022763,1.1932290482880021,0.246684350132626,0.5579472294572849,1.0,9/15,27.38%,ARL6IP1;RTN4;REEP2;LNPK;RAB18;TMEM33;RTN3;ZFYVE27;REEP1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3214051618906106,-1.193182914202578,0.13,0.6083053986101397,1.0,12/44,10.33%,ROCK2;FTO;TNRC6B;ROCK1;TNRC6A;DHX36;TNRC6C;CNOT1;YTHDF3;CPEB3;MOV10;CNOT7
prerank,positive regulation of T cell activation (GO:0050870),0.4378818091637031,1.1930781285823222,0.19934640522875818,0.5578756645051383,1.0,17/62,20.94%,CD81;MDK;CCL19;PTPRC;SIRPA;TFRC;HSPD1;THY1;PNP;AIF1;DOCK8;CCL2;VCAM1;CCR2;CD86;IL6;PYCARD
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5104799870530891,1.1929756622508711,0.25561097256857856,0.5577343460746284,1.0,5/22,15.33%,ATF4;NCL;PIH1D1;DDX11;UBTF
prerank,regulation of multicellular organismal development (GO:2000026),-0.36192831180742885,-1.1927618731733995,0.1912568306010929,0.6071423965999073,1.0,7/25,8.98%,TRIP12;NIPBL;DHX36;EHMT1;MYSM1;INSR;TDG
prerank,negative regulation of B cell proliferation (GO:0030889),0.5728266422188868,1.1927060972937593,0.28314917127071826,0.5580293890370709,1.0,4/11,24.11%,TYROBP;CTLA4;CD300A;TNFRSF13B
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.584779405795086,1.192597249252811,0.2757660167130919,0.5578826881096822,1.0,5/10,31.52%,CTNNB1;CX3CR1;CX3CL1;FZD3;DRD2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49804986236176485,1.1925604141155366,0.24843161856963614,0.5575420028511343,1.0,5/23,16.24%,RPS3;TNF;PAK1;TLR6;DAB2IP
prerank,glial cell development (GO:0021782),0.49247683027674954,1.1924660795332918,0.24783147459727387,0.5573528921067518,1.0,15/25,32.54%,MDK;MT3;S100A9;MYRF;MXRA8;DLL1;EIF2B5;SOX11;SOX10;APP;CSPG5;TLR2;EIF2B1;SOX4;PRDM8
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5332675771547103,1.1922787358255846,0.2602921646746348,0.5574119441749008,1.0,1/16,0.71%,VIM
prerank,steroid metabolic process (GO:0008202),0.426625885971686,1.1919809364089216,0.20297555791710944,0.5577388733413946,1.0,10/72,12.81%,TSPO;LGMN;SCP2;RDH5;LSS;HSD17B4;DHCR24;FDX2;GC;HSD3B2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.3966512522167297,-1.1917914465807364,0.2146341463414634,0.6072012010614429,1.0,8/21,15.34%,SMO;DCDC2;TTC23;DLG5;GAS8;EVC;UCHL5;KIF7
prerank,peripheral nervous system development (GO:0007422),0.5007304346395207,1.1913256546957118,0.25346784363177804,0.5590590219410065,1.0,10/23,26.06%,ASIC2;PMP22;ADGRB1;ADGRB2;SOX8;NFASC;ERBB3;SOX10;SCN8A;GPC1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.520569237599602,1.1912718601660617,0.25380710659898476,0.5587538599601326,1.0,6/19,16.24%,CD63;CADM4;JCAD;DCN;DLL1;DAB2IP
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.48475239760061695,1.1909131851139036,0.2518248175182482,0.5592737715062448,1.0,9/26,21.12%,AKT1;CYB5R3;SPR;SPTLC1;ABCA2;DDAH2;NOS2;SPHK2;ASAH2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4571606004728798,1.1906103355006845,0.23847926267281105,0.5596682489732542,1.0,9/39,10.98%,FXYD5;FXYD1;ANK3;YWHAH;FGF14;SCN4B;FGF11;FXYD7;FGF12
prerank,regulation of transposition (GO:0010528),-0.44813052601453773,-1.1902894865181999,0.236,0.608776551915421,1.0,4/13,16.08%,UBR2;MYBL1;TEX15;SIRT7
prerank,female gonad development (GO:0008585),0.514247538127646,1.1902123884884348,0.24739583333333334,0.560283084271413,1.0,9/19,25.31%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;COL9A3;INHA
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.38559304797486393,-1.1899311182955132,0.19469026548672566,0.6074058997508601,1.0,7/19,11.61%,TGFBR3;BMPR1A;VGLL4;TGFBR1;ZFPM2;FGFR2;RBPJ
prerank,regulation of actin nucleation (GO:0051125),0.5652117617369845,1.1897660914682202,0.25608011444921314,0.5610120072447395,1.0,4/12,17.69%,GSN;CORO1A;ARF1;SCIN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.412072270763322,1.1897302460562282,0.1540816326530612,0.5606769820516665,1.0,28/117,19.67%,CD81;RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;KARS1;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5613442871670004,1.1896627417244101,0.27030625832223704,0.5604139086535395,1.0,5/12,19.67%,TREM2;TNF;NUPR1;CCL3;IL6
prerank,diterpenoid metabolic process (GO:0016101),0.4375623677750973,1.1895472602267116,0.22404371584699453,0.5602885448580538,1.0,16/55,19.90%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5408445896645824,1.1885934360723458,0.2691790040376851,0.5624078662744157,1.0,5/14,14.67%,AK4;AK3;PNP;NME2;CMPK2
prerank,regulation of lymphocyte migration (GO:2000401),0.5803844625436684,1.1882634321311365,0.2859259259259259,0.5628456597192487,1.0,2/10,6.44%,AKT1;MSN
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.40403969964559,1.1881769230043375,0.13245702730030334,0.5626141968837628,1.0,51/173,21.86%,CTSZ;DYNLL2;DYNLL1;USE1;ANK3;LMAN2;DCTN3;ERGIC3;KDELR1;TMED7;F9;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;CAPZA2;YKT6;ARFGAP2;TICAM2;TEX261;TMED3;TMED9;PDCD6;GRIA1;BET1L;TMED1;DCTN1;YIF1B;GAS6;MCFD2;DCTN2;IER3IP1;ARF4;SPTBN4;NAPA;SPTBN2;BCAP31;F10;TRAPPC3;CTSC;VAPA;YIF1A;GOLT1A;COL7A1;TMED10;HYOU1;COPB2;TGFA;COPG1
prerank,cardiac muscle contraction (GO:0060048),0.4617653317951286,1.188087447469003,0.23935558112773303,0.5624395444468657,1.0,9/34,19.18%,GSN;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;GRK2
prerank,carnitine shuttle (GO:0006853),-0.46097439493348974,-1.1879883750661693,0.26785714285714285,0.6102354172900781,1.0,3/11,11.96%,PRKAG2;PRKAA2;CPT2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4705820851524825,1.187384889136623,0.2517241379310345,0.5639462713808859,1.0,11/33,21.67%,OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;GLUD1;GOT1;ALDH4A1;MTHFS
prerank,positive regulation of secretion by cell (GO:1903532),0.42476940723174406,1.187346599656289,0.21367521367521367,0.5636010090213426,1.0,24/70,22.13%,PPIA;TREM2;GPER1;ANG;ATP6AP1;ABCG1;CLASP1;ARF6;CADPS;ATP13A2;APBB1;BMP2;IER3IP1;ACHE;DNM1L;NMB;EDN3;SOX11;SNCA;GRK2;TGFB1;TMED10;STX1B;RAB27B
prerank,ERAD pathway (GO:0036503),0.42132289436888437,1.1872838952051465,0.19517313746065057,0.563316459125837,1.0,25/83,21.86%,SEC61B;HSPA5;RCN3;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;UBXN6;HERPUD1;BRSK2;DNAJB9;DNAJC10;TRIM13;USP13;SELENOS;STUB1;AMFR
prerank,regulation of centrosome cycle (GO:0046605),0.5080758330213686,1.1872351580328453,0.24133663366336633,0.5630015314530785,1.0,7/21,15.97%,NPM1;CHMP2B;CHMP5;ATF5;CEP131;FBXW5;CHMP1B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.444184271275878,1.1871148170390706,0.21128318584070796,0.562875781396327,1.0,15/52,15.07%,TOMM7;PINK1;YWHAB;UBL5;YWHAH;YWHAE;LEPROT;YWHAG;PMAIP1;YWHAQ;FBXW7;YWHAZ;RHOU;BBC3;BAD
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.47918555071869606,1.1871057899527098,0.2296037296037296,0.5624470448412221,1.0,15/32,27.25%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4624559177454064,1.1869797193585199,0.24019024970273484,0.5623203946364326,1.0,6/37,6.77%,APOD;TREM2;TNF;PLD3;SIRPA;CUEDC2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5570177522857284,1.1865636481595547,0.2834008097165992,0.5629929663288695,1.0,4/12,12.97%,GRN;ATP6AP2;CLN5;CLN6
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5102581486334589,1.1864957319802454,0.2630922693266833,0.562737114209319,1.0,7/21,18.09%,YWHAB;FKBP1A;PPP1R1B;YWHAE;ARPP19;FKBP1B;PPP1R15A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5436226046167489,1.1863809196217063,0.27041499330655955,0.5625882897034156,1.0,8/14,23.07%,HSPA5;BAX;DAB2IP;DNAJB9;DDRGK1;TMEM33;BAK1;PTPN1
prerank,autophagosome assembly (GO:0000045),0.43815269856590233,1.186290141351276,0.2223463687150838,0.5623967774856369,1.0,7/52,5.66%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A
prerank,peptidyl-threonine modification (GO:0018210),-0.3043473685329093,-1.1861464210204087,0.10606060606060606,0.612504930985913,1.0,19/66,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;GALNT11;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;GALNT1;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4202118906858242,1.1859964098231865,0.2014846235418876,0.5627730755390461,1.0,29/86,21.40%,CD74;VTN;CD81;PRNP;ITGB2;TREM2;IL5;AGT;PDGFB;PTPRC;HCLS1;MIF;CLEC6A;ENPP2;CADM4;PECAM1;IL11;RIPK2;IGF2;PDGFA;LRP8;DMTN;IL6;HGF;EFNA1;TGFB1;SFRP1;PTPN6;BANK1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.29266668145228014,-1.1858573141598179,0.15492957746478872,0.6111023884774209,1.0,18/76,13.04%,FCHSD2;FER;ABL1;BAIAP2L1;BCAS3;PRKCE;NRP1;BAIAP2;SORBS3;NTRK3;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1;KATNBL1;SYNPO2;NUMA1
prerank,response to muramyl dipeptide (GO:0032495),0.5691200510761859,1.1855616126322248,0.28993288590604027,0.5635008030320802,1.0,4/12,14.05%,VIM;CHMP5;RIPK2;ERBIN
prerank,pore complex assembly (GO:0046931),-0.3868083506026188,-1.1853647414172448,0.20425531914893616,0.6101456897401291,1.0,6/19,11.24%,AFDN;ANO6;NUP98;PLEKHA7;AHCTF1;PDZD11
prerank,metal ion homeostasis (GO:0055065),0.45785742242112265,1.1850420096110779,0.22514285714285714,0.5644659603165292,1.0,12/40,19.56%,MT3;ANK3;TMTC2;GRIN1;SLC12A5;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,secondary palate development (GO:0062009),-0.4377621071706235,-1.18501672917003,0.24015748031496062,0.6087661968977225,1.0,5/14,14.11%,TGFBR3;SMAD4;WNT11;SMAD2;TGFB3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4802736408989648,1.1848042217903494,0.24630541871921183,0.5646808192528727,1.0,7/27,19.38%,CD74;MIF;PTTG1IP;MSX1;PMAIP1;TWIST1;HIC1
prerank,positive regulation of chromatin organization (GO:1905269),0.5654529305248344,1.1845883772047576,0.29411764705882354,0.5647960905868438,1.0,2/12,2.96%,H3-3A;TERF1
prerank,inhibitory synapse assembly (GO:1904862),0.5654328736626106,1.1845771130817335,0.26884779516358465,0.5643825171954759,1.0,5/11,16.30%,GABRA2;WNT5A;GABRB3;FGF13;GABRB2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3524978434009133,-1.1840098367347052,0.2085889570552147,0.6091302985854659,1.0,6/26,4.13%,ROCK2;ASAP3;ALMS1;SLC9A1;ROCK1;PRKN
prerank,positive regulation of protein transport (GO:0051222),0.43019630676116316,1.1839947095738907,0.21467098166127294,0.5654979323741047,1.0,21/67,19.94%,PPIA;RACK1;OAZ1;TREM2;TNF;ANG;PRR5L;ABCG1;VAMP2;ARF6;ATP13A2;APBB1;CEP131;VPS28;B3GAT3;IER3IP1;ACHE;DNM1L;ACSL3;TGFB1;OAZ2
prerank,embryonic heart tube development (GO:0035050),0.5419255840151984,1.1839281056624196,0.28396739130434784,0.5652185105527888,1.0,6/14,20.02%,SOX18;NDRG4;HES1;SOX17;RYR2;CITED2
prerank,regulation of myoblast fusion (GO:1901739),0.5751593360344329,1.1833206318497023,0.27540500736377027,0.5664213304558975,1.0,6/11,18.68%,FLOT1;CD53;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,regulation of telomerase activity (GO:0051972),0.4480664149869746,1.1830855507262683,0.21988950276243094,0.5666321296914565,1.0,20/45,25.95%,HSP90AA1;HSP90AB1;MAPK3;TERF1;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MEN1;MAP2K7;CCT4;GRHL2;NAF1;PNKP;PIF1;PRKCQ
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5105803781660769,1.182986956285742,0.2675879396984925,0.566433023805989,1.0,4/20,17.43%,TSPO;FDX2;HSD3B2;STARD3NL
prerank,negative regulation of response to external stimulus (GO:0032102),0.41173462955621765,1.182974799805999,0.17713697219361482,0.5660231473324493,1.0,28/105,23.80%,APOE;CTNNA2;CERS2;GPER1;GRID2;NR1D1;LRFN5;DUSP3;SIRPA;TNFAIP3;KLK8;FEM1A;OTULIN;EPPK1;KLF4;TNFRSF1A;SIGIRR;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4275976760027006,1.1828204897563432,0.20062370062370063,0.5659955338370924,1.0,26/77,19.68%,CLU;GPX1;NDUFA13;PARK7;AKT1;SLC25A5;TMBIM6;PINK1;TNF;FZD9;LGALS3;GHITM;TMEM14A;PIH1D1;ACAA2;HSPA1A;CX3CR1;MAPK8IP2;GATA4;HERPUD1;NDUFS3;MAZ;QARS1;PRELID1;RTKN2;HGF
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5428946166361354,1.1827141572559392,0.28067700987306066,0.5658451508764605,1.0,6/13,20.24%,LAMP1;ITGB2;F2RL1;SYK;STX4;SPHK2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3723259910616613,-1.182662784280411,0.2192513368983957,0.610427159635164,1.0,9/20,19.22%,DICER1;DROSHA;ZC3H7A;ZC3H7B;TERT;PUM2;TARBP2;AGO2;AGO4
prerank,regulation of protein transport (GO:0051223),0.48506793496281025,1.1822053597398894,0.24381625441696114,0.5667835459936189,1.0,6/27,11.32%,HSPA8;TNF;LCP1;ATP13A2;STXBP5L;DNAJA1
prerank,Notch signaling pathway (GO:0007219),-0.3031981031758366,-1.181694449456757,0.16883116883116883,0.6104841955825152,1.0,17/59,15.36%,PBX1;GMDS;NOTCH2;ZNF423;CREBBP;MAML2;MIB1;GALNT11;KAT2B;MAML1;ITCH;PSEN1;RBPJ;JAG1;DTX1;HEY2;NLE1
prerank,tRNA aminoacylation (GO:0043039),0.4630451737028001,1.1809538839146387,0.24943052391799544,0.5696892316837076,1.0,14/37,24.52%,LARS2;GARS1;SARS1;SARS2;KARS1;WARS1;NARS1;CARS1;PPA1;EPRS1;QARS1;AIMP2;YARS2;MARS2
prerank,nervous system development (GO:0007399),0.39157472207272104,1.1809398744700235,0.055,0.5692791723785823,1.0,131/429,22.59%,GSN;SCD5;MBP;MDK;ITM2B;BCAN;LSAMP;MPZ;NBL1;MARCKS;ASIC2;NRXN1;SPOCK2;NLGN1;S100B;SLC2A1;NRG1;ERBB4;NES;KCNQ2;FZD9;MOBP;ADAM23;PMP22;DSCAM;CNTN4;MAL;ECRG4;RBFOX3;ADGRL3;SH3GL2;GPM6B;SPOCK1;TAGLN3;HES1;DNM3;STMN3;HAPLN2;FN1;NINJ2;LGI1;LY6H;CRMP1;LRCH4;APLP1;NELL1;PRDM12;NAV3;KIRREL3;NRCAM;KLK6;PROX1;MOG;NDUFS2;ADGRB1;FGF11;NINJ1;MARCKSL1;SMPD1;DNER;ADGRB2;FGF12;HAP1;CHRM3;POU3F1;ELP3;IRF2BPL;GFRA1;SOX8;CHRM2;NRXN2;NRSN2;DCTN1;CLN5;ST8SIA4;CXCR4;CAPG;PTPRZ1;DCHS1;NAGLU;SPG7;NFASC;PRPS1;DSCAML1;ROBO2;RBFOX1;ACHE;EPHB1;CDK5;CPNE6;COX7B;FGF13;DOC2A;GFRA2;GMFB;TYRO3;VCAN;PRX;GLIS2;PPP2R5D;CLN8;PCDHB14;SCIN;ERCC6;GPM6A;APBA2;MYT1L;ERBB3;FABP7;UNC119;INHBA;DCX;TGFB1;POU4F1;MEF2C;GDF11;BTBD6;SRRM4;SOX10;IGF2BP3;PLXND1;HAPLN4;GRIK1;ROGDI;SDHA;SNTG2;POU6F2;GRHL2;CHRNA3;ACAN;DPYSL2
prerank,chondrocyte differentiation (GO:0002062),-0.35034487294334776,-1.1801885414714188,0.17557251908396945,0.6121578173125234,1.0,12/32,21.54%,SULF1;NFIB;SOX5;WNT5B;EIF2AK3;CREB3L2;BMP4;RUNX2;BMPR2;GPLD1;SULF2;WNT2B
prerank,positive regulation of MAPK cascade (GO:0043410),0.39596047915529076,1.1797977606140064,0.1091091091091091,0.5719456293206546,1.0,68/245,20.94%,APOE;CD74;LAPTM5;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;GPR37L1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;CAV2;NDRG4;TIRAP;ATP6AP1;DDT;SEMA4C;P2RY6;KDR;CCN2;HTR2C;P2RY1;CD24;JCAD;LILRA5;HMGB1;CSF1R;IL11;RAMP3;FLT4;HRAS;FBXW7;NEK10;BMP2;GAS6;CCL2;F2RL1;GDF15;IGF2;PDGFA;RASGRP1;ARRB2;ADRA1D;ADRA1A;DAB2IP;FLT1;CCL3;GATA4;ADCYAP1;CCL8;GRM4;EDN3;GPR183;FLT3;NOTCH1;IL6;TGFB1;THPO;ADRA2B;TMEM106A;PYCARD
prerank,negative regulation of response to wounding (GO:1903035),0.519946071633578,1.1795637540466724,0.27629911280101394,0.5721197006185178,1.0,4/19,9.80%,MDK;CERS2;KLK8;EPPK1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.46512799585175774,1.1793191060916746,0.24701670644391407,0.5723387758548629,1.0,11/35,12.02%,ARHGDIA;MDK;HCLS1;ARHGDIB;IQGAP2;ESAM;HCK;PHPT1;CSF1R;TRPM2;HRAS
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39177092444999645,1.1791749140550254,0.042,0.5722868304894138,1.0,139/509,20.91%,RPL23;RPS3;RPS15;RPL37;CD74;RPS20;RACK1;GAPDH;HSP90AA1;HSP90AB1;LAPTM5;LGALS1;HMOX1;PARK7;CCL19;TXN;NLGN1;S100B;NRG1;TREM2;TGM2;ERBB4;PINK1;AGT;S100A13;LAMTOR2;GPER1;LAMTOR4;GPR37L1;TNF;EEF1D;RHOC;PDGFB;LAMTOR5;PTPRC;HCLS1;RAC1;FKBP1A;NTRK2;SHISA5;ECM1;SCTR;RTN4;S100A8;S100A9;MIF;CAV2;TIRAP;FLNA;FN1;TFRC;RHOG;EPOR;TMEM101;CLEC6A;KDR;NUPR1;P2RY12;TICAM2;JCAD;LILRA5;TMEM9B;DCN;HMGB1;KITLG;MC1R;RBCK1;WNT5A;IL11;BAX;RAMP3;FLT4;PMAIP1;C1QTNF4;HRAS;SOX9;BST2;VAV1;RUNDC3A;RHOA;GJA1;BMP2;LAMTOR3;RIPK2;GAS6;TNFRSF1A;UBE2V1;CX3CR1;TLR6;HEXIM1;BBC3;F2RL1;BAD;GDF15;RRAGC;IGF2;PDGFA;NCF1;ADRA1D;ADRA1A;RRAGD;DAB2IP;HPSE;FLT1;CCL3;CAV1;CASS4;BCAP31;PIK3CD;TRIM32;DNM1L;F10;RAC2;S100A4;GRM4;ERBB3;TERF2IP;LTBR;KLB;MAZ;SOX11;CD14;CD86;RTKN2;FLT3;TRIM13;IL6;HGF;TGFB1;VAPA;THPO;CANT1;TRAT1;SPHK2;GOLT1B;ADRA2B;TMEM106A;PTPN6;THEM4
prerank,cation transmembrane transport (GO:0098655),0.447746607797375,1.1790734974717951,0.2524698133918771,0.5721302429599949,1.0,11/44,15.78%,SLC38A5;ASIC2;SLC7A5;SLC25A29;SLC6A5;ATP13A2;SLC3A2;TRPM2;ABCC8;ATP1B1;SLC25A19
prerank,muscle contraction (GO:0006936),0.4074622086742477,1.1789544022137848,0.15682281059063136,0.5720047635164696,1.0,23/126,16.43%,MYL6;ALDOA;VIM;CALM1;MYL9;ACTA2;MYL12A;FXYD1;TPM2;CRYAB;MYL1;MYL12B;P2RX6;GNAO1;MYL6B;GLRA1;MYH11;TNNI1;DES;SLC8A1;TMOD1;ADRA1A;DTNA
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5747052589017341,1.1780666917666012,0.296448087431694,0.5739548931894662,1.0,1/10,1.89%,MAPK3
prerank,ERBB2 signaling pathway (GO:0038128),0.4649335086653077,1.177887090417115,0.24378698224852072,0.5739837887665528,1.0,14/31,27.02%,HSP90AA1;NRG1;ERBB4;MATK;PTK6;CDC37;PTPRR;ERBIN;ERBB3;SOS1;STUB1;PRKCA;CPNE3;MYOC
prerank,negative regulation of ossification (GO:0030279),0.4866678629548409,1.1778073912259428,0.27994955863808324,0.5737662881289627,1.0,9/23,20.17%,MDK;ECM1;LRP4;SRGN;SOX9;CCL3;NOTCH1;MEF2C;SFRP1
prerank,regulation of dendrite development (GO:0050773),0.4537586825109474,1.1759215638602065,0.23245109321058688,0.578313996042212,1.0,18/37,28.27%,DCC;ADGRB3;PACSIN1;CSMD3;CAMK1D;KNDC1;MFSD2A;LRP8;DAB2IP;BCL11A;NSMF;HECW1;CHRNA3;PTN;VLDLR;ALK;LZTS1;RAP2A
prerank,regulation of cholesterol storage (GO:0010885),0.5299963632738012,1.1750976522022252,0.3064516129032258,0.5801377519981488,1.0,6/15,15.47%,TREM2;ABCG1;LPL;MSR1;EHD1;NR1H2
prerank,endothelial cell proliferation (GO:0001935),0.5215185565218202,1.1750927364821546,0.27058823529411763,0.5797061960022952,1.0,3/17,4.15%,HMOX1;CD34;ACVRL1
prerank,regulation of vasculogenesis (GO:2001212),0.5427808207937264,1.1749901804698932,0.2656042496679947,0.5795059221976402,1.0,5/14,15.74%,CD34;EMP2;KDR;RRAS;HEY1
prerank,blood vessel morphogenesis (GO:0048514),0.43336671975273267,1.1742208243459327,0.22466960352422907,0.5812033433764434,1.0,17/54,18.00%,RAMP2;SOX18;ID1;RASIP1;APLNR;LOX;HES1;PROX1;COL4A1;KDR;SOX17;FLT4;SLC1A1;EGFL7;FLT1;CAV1;SYK
prerank,response to muscle stretch (GO:0035994),0.5340710704982133,1.1738545318213145,0.27123287671232876,0.5817685214917704,1.0,4/15,15.89%,GSN;CTNNB1;SLC8A1;RYR2
prerank,glycolipid biosynthetic process (GO:0009247),-0.31833715139024266,-1.173645833462052,0.17557251908396945,0.626599270504561,1.0,17/38,19.97%,LARGE1;ST3GAL4;A4GALT;PGAP2;PIGM;ST3GAL5;PIGN;ST3GAL2;GBGT1;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIGU;ST6GALNAC5
prerank,negative regulation of transmembrane transport (GO:0034763),0.5718711682992018,1.1736132305961275,0.2972582972582973,0.5819301812308081,1.0,2/10,12.48%,AKT1;RSC1A1
prerank,endoderm development (GO:0007492),0.5467549198455433,1.1735391837514684,0.2677376171352075,0.5816892523594005,1.0,5/13,22.49%,LAMC1;SOX17;GATA4;DUSP2;DUSP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5591321794056211,1.1732865771665828,0.2723521320495186,0.5819268049731636,1.0,7/11,25.54%,LEPROT;CAV1;VHL;ADIPOR1;SOCS3;PTPRT;HGS
prerank,cellular lipid catabolic process (GO:0044242),0.47414148367315184,1.1725924035412867,0.25970873786407767,0.5833505300375944,1.0,12/27,32.50%,MT3;NUDT19;LIPG;ENPP2;PLBD2;FAAH;SIRT2;ABHD12;AOAH;PLBD1;CEL;ACOX1
prerank,vasculogenesis (GO:0001570),0.46239192335249246,1.171702849750745,0.25534441805225655,0.5852844549125011,1.0,10/32,19.84%,RAMP2;SOX18;RASIP1;APLNR;KDR;SOX17;EGFL7;CAV1;NOTCH1;TGFB1
prerank,positive regulation of programmed cell death (GO:0043068),0.3951078681179724,1.1715714479262997,0.099,0.5851838322003853,1.0,78/272,21.46%,MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;LAPTM5;SOD1;RHOB;ATF4;RPS6;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;CTNNB1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NET1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DAB2IP;SQSTM1;PSEN2;DNM1L;PDCD5;NOS2;SCIN;APH1B;SYK;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;FOXA1;SUDS3
prerank,cellular response to organic cyclic compound (GO:0071407),0.40197075941725074,1.1715085428667806,0.1715736040609137,0.5849041555456982,1.0,40/141,20.17%,ACTB;SPP1;GABRB1;AKAP6;TGM2;GPER1;TNF;HSP90B1;PDGFB;IGFBP5;ZFP36L1;CTNNB1;MSN;DRD5;ATP1A3;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GNAI1;RAMP3;TRPM2;ATP1A1;GABRB3;SLC1A1;PDE12;CCL2;HCN1;DMTN;GABRB2;ADCY8;CCL3;HCN3;NCOA4;TGFB1;POU4F1;MEF2C;SFRP1
prerank,regulation of chromosome organization (GO:0033044),-0.3651270785480482,-1.1713073607642912,0.23118279569892472,0.630601134531012,1.0,6/22,11.44%,SMG6;SMG1;HDAC8;WAPL;YLPM1;TERF2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.36402210162173315,-1.171160196672601,0.22839506172839505,0.6287277514162054,1.0,13/30,23.30%,TRIP12;UBR5;SHLD1;RNF169;FBH1;CYREN;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,response to gamma radiation (GO:0010332),0.4847352343960515,1.1705761598546918,0.28,0.5869253361279457,1.0,4/24,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,histone H4-K5 acetylation (GO:0043981),-0.40553428942925884,-1.1705491846171059,0.23846153846153847,0.6259650390420194,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),-0.40553428942925884,-1.1705491846171059,0.23846153846153847,0.6259650390420194,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,regulation of establishment of protein localization (GO:0070201),0.5315424340405873,1.170053085579852,0.29261744966442954,0.5878943252794033,1.0,2/14,2.84%,CTSD;TREM2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4688867937335111,1.1699440308344706,0.2710843373493976,0.5877467617414847,1.0,14/31,25.63%,SYT1;SYT12;SYT11;SYT6;SYT4;SYT10;DOC2A;CBARP;SYT2;DOC2B;REST;SYT3;SYT5;SYT17
prerank,RNA destabilization (GO:0050779),-0.3989224404106417,-1.1692866359840213,0.18055555555555555,0.6270302056163629,1.0,4/18,5.58%,ROCK2;FTO;ROCK1;YTHDF3
prerank,regulation of cell projection organization (GO:0031344),0.5425799467248252,1.1690977493760435,0.29916897506925205,0.5895936077757022,1.0,3/13,8.69%,CCL19;TREM2;MFSD2A
prerank,chromosome organization (GO:0051276),0.40921444836139215,1.1690511130577144,0.2045929018789144,0.5892664490367279,1.0,19/99,14.77%,RPS27A;UBC;UBB;H3-3A;HDAC11;COPS7A;COPS6;PARP1;NUCKS1;HMGN1;UBA52;RBX1;DDB1;SUPT4H1;ZBTB7A;FAM50A;HDAC5;COPS8;L3MBTL1
prerank,negative regulation of translation (GO:0017148),0.4170248882497863,1.168989658218264,0.21812434141201265,0.58898568123963,1.0,9/87,4.59%,MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;IGFBP5;NCL;MEX3D
prerank,sodium ion export across plasma membrane (GO:0036376),0.5324575783759501,1.1689554939308235,0.2924901185770751,0.5886446903131066,1.0,6/13,17.70%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.42827897799225123,1.168696417537092,0.23922413793103448,0.5888629605998114,1.0,13/66,9.89%,PARK7;AKT1;RAN;CCT2;LAMTOR5;HCLS1;ORMDL3;FLNA;HYAL2;TFRC;CCT7;TRIM28;CCT8
prerank,positive regulation of interferon-gamma production (GO:0032729),0.439159641953176,1.168691385003879,0.2516930022573363,0.5884317436938076,1.0,19/48,29.43%,PDE4B;SLC7A5;ISG15;HSPD1;SLC11A1;LILRB1;F2RL1;RASGRP1;CCR2;CD14;PYCARD;IL12RB1;CD276;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5;TXK
prerank,DNA duplex unwinding (GO:0032508),0.4404132666173585,1.1681235813325037,0.24584717607973422,0.5895294867351624,1.0,8/50,12.09%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1;DDX11
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.47899684327571007,-1.168122563863639,0.2528301886792453,0.6276786880754212,1.0,5/11,14.92%,BMPR1A;ZFPM2;JAG1;BMP4;HEY2
prerank,negative regulation of cell growth (GO:0030308),0.40817459549120705,1.1680046948668328,0.19367991845056065,0.5893882147975106,1.0,40/121,21.94%,RACK1;MT3;NDUFA13;DCC;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;MAP2;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;FGF13;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;SPHK2;RERG;CCN3;MAG;CDA
prerank,positive regulation of growth (GO:0045927),0.42796734767434147,1.1674721584937444,0.24126637554585154,0.5903826216253757,1.0,22/64,21.84%,H3-3A;AKT1;AKAP6;EIF4G2;S100A8;S100A9;LGI1;CXCL16;DDX49;IL2;MFSD2A;DNPH1;EXOSC2;WFS1;SDCBP;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;PPM1F
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5510645743424146,1.167441104744987,0.2949061662198391,0.5900141438065127,1.0,6/13,16.12%,NELFCD;SUPT4H1;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,regulation of inclusion body assembly (GO:0090083),0.5632209203576694,1.1672947470355395,0.28473177441540576,0.5899589051229823,1.0,8/11,20.71%,HSPA1B;BAG5;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5143141541565323,1.1671551814784125,0.28793774319066145,0.5898919873824204,1.0,1/16,1.00%,LAMP1
prerank,stress granule assembly (GO:0034063),0.5051625893928346,1.1671339029857077,0.28991060025542786,0.5894894547603913,1.0,7/20,15.81%,RPS23;MAPT;ATXN2L;CSDE1;G3BP1;CIRBP;YTHDF1
prerank,sodium ion homeostasis (GO:0055078),0.49620581354603477,1.1669880502683314,0.2749691738594328,0.5894391418522633,1.0,8/21,19.56%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;TFAP2B
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5762692853414613,1.1668284145235515,0.3012729844413013,0.5894329148620047,1.0,2/10,13.40%,CD24;LILRB1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.47427627640929626,1.166587654319126,0.2898550724637681,0.5896421835046621,1.0,9/29,14.97%,RPS2;PARK7;PINK1;PIN1;BAG5;FEM1A;FBXW7;FBXO5;ARRDC3
prerank,regulation of kinase activity (GO:0043549),0.41422692060763355,1.1665582660626665,0.20523560209424083,0.5892769398001739,1.0,22/89,18.24%,EEF1A1;CD74;SOD1;TREM2;ERBB4;EMP2;NTRK2;LTK;CDKN1C;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;HNRNPU;EPHB1;FLT1;TYRO3;DDR2;ERBB3
prerank,negative regulation of angiogenesis (GO:0016525),0.4148478243711474,1.1657309244720184,0.2168421052631579,0.5910565448689131,1.0,23/84,18.31%,SPARC;CLDN5;KLF2;SERPINF1;TNF;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;EPN1;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,regulation of cellular localization (GO:0060341),0.44549651497418014,1.1650836112439429,0.24157303370786518,0.5924166354485159,1.0,10/46,9.65%,GSN;HSP90AA1;HSP90AB1;PINK1;NR1D1;PARP1;REEP5;REEP6;MAP2;EPHA5
prerank,regulation of cholesterol transport (GO:0032374),0.49989443273037676,1.164956797301155,0.29102564102564105,0.5923022355541724,1.0,6/20,16.01%,TSPO;APOC1;LIPG;OSBPL6;NR1H2;ABCA2
prerank,integrated stress response signaling (GO:0140467),0.5343660052223884,1.1644108796475545,0.2781546811397558,0.5933052028961031,1.0,7/14,24.96%,HSPA5;ATF4;OMA1;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,regulation of interleukin-12 production (GO:0032655),0.4326437217129877,1.1644031829522705,0.2543352601156069,0.592880938269873,1.0,10/47,15.22%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;LILRA5;HMGB1;LILRB1;RIPK2;MAPK11
prerank,response to fatty acid (GO:0070542),-0.40579612758158,-1.1643402895228336,0.2318181818181818,0.6353374553214997,1.0,3/17,5.03%,PID1;IRS1;FOXO3
prerank,regulation of neuron projection development (GO:0010975),0.3974972934173654,1.1637447163324917,0.16683518705763398,0.5942086023139481,1.0,29/163,10.03%,APOE;ITM2C;MDK;MT3;CFL1;DCC;AKT1;CTNNA2;NTRK2;CSMD3;S100A9;CAMK1D;NDRG4;KNDC1;SPOCK1;LRRC4C;TENM3;LTK;BAG5;CRMP1;ATP1B2;PTK6;PAK1;IL1RAPL1;PPFIA2;MFSD2A;CDK5R1;CAMK1;PAK3
prerank,regulation of protein modification process (GO:0031399),0.4344463809551256,1.1633825825894,0.24662162162162163,0.5947561834783348,1.0,16/50,19.00%,HSPB1;MT3;PPIB;GRM5;PIN1;FN1;CORO1C;CADM4;WARS1;CCDC88A;IGF2;ABCA2;ASPSCR1;CDH5;NOP53;CCAR2
prerank,positive regulation of DNA recombination (GO:0045911),-0.3441386266813833,-1.1630206491493251,0.20606060606060606,0.6366466535819717,1.0,12/27,19.20%,ARID2;KMT5C;KMT5B;SHLD1;MMS19;MRNIP;FUS;FANCB;PRDM9;HMCES;ZCWPW1;SHLD2
prerank,positive regulation of protein processing (GO:0010954),0.5022733021329726,1.1628651243831811,0.2873417721518987,0.5956793229773235,1.0,3/19,8.76%,GSN;ENO1;CLEC3B
prerank,positive regulation of protein catabolic process (GO:0045732),0.4095021105015815,1.1625114303166477,0.23422459893048128,0.5961522375434619,1.0,18/84,16.95%,APOE;HSP90AA1;NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;MSN;PTTG1IP;TNFSF12;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;SNX33;TRIM32
prerank,actin crosslink formation (GO:0051764),-0.4372956435643023,-1.1623170158354206,0.2702702702702703,0.6363035186913584,1.0,4/12,4.65%,DPYSL3;BAIAP2L1;BAIAP2;EPS8
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4138703136478928,1.1620632129256585,0.22245762711864406,0.596859965523074,1.0,18/80,16.42%,UBB;RPS2;LAPTM5;PINK1;FKBP1A;PIN1;FAM107A;CENPX;PTTG1IP;RBX1;PDCD6;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1;ARRDC3;CAV1
prerank,anterior/posterior axis specification (GO:0009948),-0.42060089191916483,-1.1619314285056312,0.2616033755274262,0.6350891699283876,1.0,3/15,8.57%,WLS;SKI;TASOR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.42495615987348334,1.1617554456808312,0.24104234527687296,0.5972688227296996,1.0,11/66,9.80%,APOE;SPARC;B2M;ATP5F1A;MAGED1;CAV2;ATP5IF1;CDKN1C;VASH1;NUPR1;EPPK1
prerank,negative regulation of transport (GO:0051051),0.43367742336841375,1.1616534320814385,0.25609756097560976,0.5970775333250162,1.0,15/51,21.84%,RACK1;NRG1;CRYAB;LGALS3;SIRPA;SYT11;RSC1A1;BST2;LILRB1;NR1H2;SNX33;ERBB3;SNCA;TRAT1;PPM1F
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4369347257066626,-1.1615018813991453,0.28125,0.6340276699644923,1.0,5/12,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5508626737355254,1.1614628250223866,0.29324324324324325,0.5971955024336679,1.0,6/12,22.06%,CLTC;PF4;TMEFF2;TGFB1;SELENOS;AP2A1
prerank,epithelial cell morphogenesis (GO:0003382),-0.3832535662981156,-1.1605992831008514,0.22672064777327935,0.6341600801260814,1.0,3/17,7.96%,COL22A1;SIPA1L3;MET
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4246563065906589,1.1601444032563895,0.23903508771929824,0.6003050548969682,1.0,17/64,23.49%,GPX4;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;ACOT1;ACOT4;FAAH;LTC4S;ACSL3;ASAH2;CYP2E1;ELOVL6;ACSL4
prerank,regulation of coagulation (GO:0050818),0.5584952794193947,1.1600744473922908,0.3036935704514364,0.6000279225362615,1.0,5/11,20.14%,HS3ST5;PROCR;F2RL1;CAV1;FOXA2
prerank,polyol biosynthetic process (GO:0046173),-0.4100230805758555,-1.1599866535179353,0.2595419847328244,0.6335316710240205,1.0,6/16,19.26%,ITPKB;ACER3;IP6K2;PPIP5K1;CYP27A1;FGF2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5137762835816269,1.1592008612307056,0.3058510638297872,0.6019844441652016,1.0,2/17,8.66%,VIM;VSIR
prerank,placenta development (GO:0001890),0.5501965020473851,1.158844595220875,0.3075880758807588,0.6024751620085546,1.0,2/12,4.35%,SOD1;ANG
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5749239301474736,1.158842693640702,0.32547864506627394,0.6020301154551584,1.0,5/10,17.76%,FKBP1A;YWHAE;PLN;CBARP;FKBP1B
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.35008942336564713,-1.157913842831601,0.2254335260115607,0.6365202286314231,1.0,7/26,6.67%,LGR4;APPL2;OTUD4;BIRC2;FLOT2;IRAK3;BIRC3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.41922667042166917,-1.1577682575109647,0.26436781609195403,0.634767522564639,1.0,7/14,22.50%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;NECTIN2;SHLD3
prerank,regulation of small molecule metabolic process (GO:0062012),0.4647804346032544,1.1577130765620156,0.27744270205066346,0.6045721524123784,1.0,2/28,1.95%,APOE;ACADVL
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.43704936140917655,1.1576769406725789,0.2713004484304933,0.6042099061453468,1.0,15/46,23.07%,GPER1;PTPRC;PIN1;DUSP3;SIRPA;DUSP26;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1;DAB2IP;SPRY3;TNIP1;PTPN1
prerank,positive regulation of catalytic activity (GO:0043085),0.4469963459920184,1.1576029172074362,0.2835820895522388,0.6039743695993852,1.0,11/37,18.78%,MT3;SOD1;MAPK3;YWHAB;MID1IP1;PSENEN;B3GAT3;IGF2;CAV1;PSEN2;STX4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5440431015996589,1.1575040858036112,0.3004059539918809,0.6038025818468167,1.0,6/13,19.67%,MDK;ITGB2;TNF;RHOA;FUT9;IL6
prerank,sterol transport (GO:0015918),0.49277546170610553,1.157450957196189,0.2964376590330789,0.6034899450117747,1.0,5/19,25.65%,NPC2;MSR1;CAV1;NPC1;ABCG5
prerank,extracellular matrix organization (GO:0030198),0.38830642115877106,1.157148376844506,0.12312312312312312,0.6038115477419042,1.0,45/276,9.85%,BSG;SPARC;GSN;VTN;CTSL;BGN;SPP1;COL1A1;CAPNS1;CD151;PPIB;CTSS;BCAN;LAMC1;LAMB2;TMPRSS6;TIMP2;SERPINH1;A2M;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;PLEC;FLOT1;ADAMTS4;GPM6B;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;P4HB;COL6A1;COL4A1;KDR;COL3A1;LCP1;TIMP1;LAMC2;DCN;COL9A1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.40812734975574294,1.156788857194378,0.20473251028806586,0.6042980105214084,1.0,40/104,27.26%,ACTB;CALM1;AKT1;CCNI;CALM3;CCND2;SERTAD1;CCND1;THY1;CDK5R1;CAMK1;PIH1D1;CSF1R;CDC37;CCNG1;RHOA;CDK5R2;SLC8A1;DAB2IP;CCNJL;CDC25A;MAP2K2;CALM2;SNCA;PYCARD;GADD45A;RALB;BLM;INCENP;TESK1;CCNA2;CDKN2B;CCNG2;HGS;TRIB1;TRIB3;SNF8;CCNH;CDKN1A;CNPPD1
prerank,I-kappaB phosphorylation (GO:0007252),0.5671570121206014,1.1567809758283603,0.29428989751098095,0.6038664596085146,1.0,5/10,29.15%,PRDX4;DAB2IP;TLR7;MAP3K7;TLR2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5428091433201196,1.1565037306957162,0.3020689655172414,0.6041662558072226,1.0,5/11,21.37%,RAC1;PAK1;STMN1;HGF;SIRT2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.45142389224452467,1.1564896778832663,0.2873303167420814,0.603759108676608,1.0,9/38,20.17%,GPX1;HMOX1;LGALS3;TNFAIP3;FAIM2;PMAIP1;TMBIM1;STX4;SFRP1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3858188760629108,1.1562767621557146,0.103,0.6039130455192918,1.0,92/348,20.04%,PPIA;CD74;RACK1;CALM1;VTN;CD81;HSP90AA1;HSP90AB1;GPNMB;MT3;PARK7;C3;MAPK3;AKT1;CCL19;TXN;PRNP;CALM3;CCND2;TREM2;ERBB4;IL5;PINK1;AGT;CSNK2B;GPER1;TNF;PDGFB;PTPRC;HCLS1;RAC1;ACVRL1;NTRK2;PIN1;MIF;FLOT1;KNDC1;APLNR;RARRES2;MUSK;TFRC;LEFTY2;CCND1;CLEC6A;ENPP2;PAK1;KDR;P2RY1;CAMK1;CSF1R;PECAM1;IL11;RAMP3;FLT4;HRAS;TMEM119;SH2D3C;SOX9;NEK10;BMP2;RIPK2;GAS6;LEFTY1;CLIP3;CX3CR1;SDCBP;MMD2;GDF15;IGF2;PDGFA;LRP8;RASGRP1;MAPRE3;CAV1;PFN2;LCP2;ADCYAP1;ADAM17;CAMKK1;AGAP2;DDR2;TERF2IP;CALM2;SNCA;DDRGK1;INHBA;IL6;HGF;EFNA1;ERP29;TGFB1;THPO
prerank,regulation of gastrulation (GO:0010470),0.5292404273806588,1.1561355808218592,0.3005464480874317,0.6038604891361722,1.0,4/14,11.04%,RACK1;OTX2;CLASP1;TENM4
prerank,DNA biosynthetic process (GO:0071897),0.5169642702726244,1.1555335932838446,0.29726205997392435,0.6050368244754372,1.0,1/16,0.39%,PPIA
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3487523071628614,-1.1553721921319438,0.25625,0.6389557169945145,1.0,14/26,32.31%,NSMCE2;ANAPC5;ANAPC7;NEK6;HECW2;CDC27;CENPE;ANAPC4;PLK1;RIOK2;UBE2C;CDC16;CCNB1;RB1
prerank,kidney development (GO:0001822),-0.2855328600550479,-1.1553645873739389,0.1917808219178082,0.6368241860664217,1.0,17/65,13.72%,SULF1;KANK2;ZBTB16;GLI2;NIPBL;AGTR1;TGFBR1;PYGO1;ARL3;PCSK5;CEP290;IFT88;NPHP3;PKD1;GREB1L;SIX1;BMP4
prerank,sensory perception of sound (GO:0007605),0.40740915938370603,1.1542965732366626,0.22316684378320936,0.607879155129639,1.0,19/88,13.56%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4833429952995584,1.1542799233185606,0.28266331658291455,0.6074836379997146,1.0,6/23,7.25%,MAPK3;ATF4;PDE4B;TGM2;DRD5;APLP1
prerank,rRNA modification (GO:0000154),0.49230111785497505,1.154115959392636,0.30456852791878175,0.6075035928288894,1.0,9/21,24.45%,TRMT112;NOP10;FBL;NHP2;ZCCHC4;GAR1;DKC1;FTSJ3;THUMPD1
prerank,protein transport (GO:0015031),0.3845847292172776,1.1532596182267916,0.125,0.6093688190768441,1.0,94/332,22.86%,APOE;CD74;CLU;RAMP2;ATP6V0C;LAPTM5;SNX17;RCN3;ATP6V1F;NPM1;ANK3;LRP1B;TXNIP;CANX;OLFM2;ARF5;HSP90B1;YWHAH;ATP6V1G1;ATP6AP1;ATP6V0E2;ABCG1;CHMP2B;TFRC;TMED7;RD3;ARRDC1;SAR1A;RAB14;RAB15;SCAMP3;TMED2;ARL11;CLTC;RAB3C;SCG5;VAMP2;ARF6;TICAM2;TMED3;RAB3D;ARL4C;TMED9;PDCD6;ATP6V0D2;RAMP3;PPY;CTSA;CMTM6;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;VMP1;SCAMP2;ARF1;EHD1;TBC1D22B;TVP23A;ARRDC3;UNC93B1;RAB26;GOLGA7;ARF4;CHMP1B;RAB20;NAPA;SNX33;TBC1D9;RAB5C;LAMP2;PREPL;STX4;SYS1;RAB18;PDIA4;RAB31;UNC119;TBC1D10C;ERP29;CTTN;RAB6B;IFT27;TMED10;COPB2;SCG2;COPG1;AP2A1;ATP6V1A;STX1B;RAB28;ATP6V0A1;EVI5L
prerank,regulation of wound healing (GO:0061041),0.44807484236312667,1.1531374536765808,0.28018223234624146,0.6092525950952186,1.0,12/42,20.14%,ACTG1;VTN;TNFAIP3;CADM4;EPPK1;HRAS;F2RL1;DMTN;CAV1;PLAU;TNFRSF12A;FOXA2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5059365794043551,1.1530660376838608,0.293733681462141,0.6090111367657721,1.0,1/17,1.00%,LAMP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.536631800253167,1.1528992620424667,0.3004231311706629,0.609029914072542,1.0,2/12,2.21%,CALR;KLF2
prerank,regulation of cell migration (GO:0030334),0.3836930737133448,1.1527195062104727,0.1031031031031031,0.609057913176809,1.0,99/382,20.17%,TMSB4X;ACTG1;CD74;TMSB10;RACK1;CLDN5;IFITM1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;RHOB;HSPA5;AKT1;SERPINE2;ERBB4;CTNNA2;ADAM15;GPER1;RHOC;SEMA3F;PDGFB;RAC1;ACVRL1;IGFBP5;DNAI3;SEMA7A;SORL1;MIF;DUSP3;PRR5L;FLNA;SEMA4C;MYADM;FRMD5;FAM107A;ADORA3;CORO1C;CXCL16;SEMA6D;NAV3;ENPP2;SGK1;PAK1;PODXL;ROBO4;THY1;KDR;VSIR;LGR6;LAMC2;EPPK1;SEMA4A;CSF1R;DOCK10;PECAM1;ELP3;HRAS;AIF1;BST2;RHOA;SRCIN1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;IGSF10;SLURP1;PDGFA;DLC1;FLT1;CCL3;CAV1;AMOT;PLAU;CDH5;CASS4;PIK3CD;TRIM32;LMNA;F10;MMP14;ADAM17;TMEFF2;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;MAPK15;TGFB1;CITED2;OSGIN1;SFRP1
prerank,protein destabilization (GO:0031648),0.45421158043369697,1.152651366165433,0.2845528455284553,0.6088036188600736,1.0,4/32,4.06%,SERF2;GSN;PRNP;NR1D1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.398234123613186,1.1524063462043692,0.2093973442288049,0.6090242726814815,1.0,25/122,16.13%,RPL26;RPS4X;RPL5;EEF2;VIM;AKT1;CCL19;EIF3D;NPM1;RPS27L;PDGFB;EIF3C;NAMPT;KDR;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;CCL2;ABCB10;IGF2;CIRBP;YTHDF1;EIF4A3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5029425193237365,1.152372146580688,0.29112271540469975,0.6086724048320943,1.0,4/18,3.71%,PARK7;RFK;AGT;TNF
prerank,negative regulation of chemotaxis (GO:0050922),0.461287456168452,1.1523180330371545,0.2857142857142857,0.6083813502119962,1.0,9/31,15.46%,SEMA3F;SEMA7A;DUSP3;SEMA4C;SEMA6D;SEMA4A;AIF1;SEMA4G;ROBO2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3101171791303481,-1.1522866282018254,0.20618556701030927,0.6426732941621767,1.0,17/51,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;SYNPO2;WNT11;TGFB3
prerank,regulation of translational initiation (GO:0006446),0.4199683782364734,1.1522319610510636,0.24973089343379978,0.60815806464142,1.0,12/63,10.28%,HSPB1;EIF1;ATF4;EIF4G2;POLR2D;NPM1;EIF1B;PPP1R15B;UHMK1;CEBPB;MIF4GD;POLR2G
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.4078627198251348,-1.1522067243629421,0.25862068965517243,0.6406689590582629,1.0,6/16,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,protein secretion (GO:0009306),0.4215075551944466,1.1512787910771594,0.25436681222707425,0.6102415650703844,1.0,20/56,24.00%,PARK7;RCN3;PTPRN;CANX;OLFM2;RIMS2;RAB15;RAB3C;RAB3D;PPY;ARL4D;MAFA;TVP23A;ADCYAP1;PDIA4;PORCN;SCG2;COPG1;CAMK2G;MTTP
prerank,long-chain fatty acid transport (GO:0015909),0.4553915547097906,1.1509534617852684,0.2685851318944844,0.6106465342926272,1.0,4/30,8.69%,APOE;MID1IP1;FABP5;MFSD2A
prerank,positive regulation of innate immune response (GO:0045089),0.46010658000837024,1.1506488353463942,0.285207100591716,0.6110424259446248,1.0,4/30,11.12%,RPS19;SPI1;SLC15A4;WNT5A
prerank,phosphatidylcholine metabolic process (GO:0046470),0.41317862943508593,1.15061001889296,0.2781954887218045,0.6107040554809569,1.0,20/70,27.03%,DBI;CHKB;CSNK2B;PLAAT3;ENPP2;MFSD2A;PLA2G7;PLA2G4F;CHAT;NR1H2;ACHE;SLC44A5;STARD10;LPCAT2;SLC44A2;PLA2G3;ABCA3;SLC44A1;PLA2G6;MBOAT7
prerank,intracellular cholesterol transport (GO:0032367),0.5209110189458754,1.1498820402654262,0.3159340659340659,0.6122711034557926,1.0,4/15,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5630690065152647,1.1497341031790953,0.3111111111111111,0.6122245334637321,1.0,6/10,32.37%,MID1IP1;MLXIPL;NR1H2;ABCD2;NR1H3;ELOVL5
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5232076366609929,1.149366851628022,0.32297297297297295,0.6127345033279666,1.0,6/15,27.61%,YWHAE;KCNN2;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4068260473074075,1.149274168275273,0.23773987206823027,0.612536842646029,1.0,19/85,13.56%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5564431716275227,1.1491660557649916,0.33099579242636745,0.6123767945208057,1.0,5/11,23.76%,PCBP1;PCBP4;IGF2BP3;ZNF445;PCBP2
prerank,motor neuron axon guidance (GO:0008045),0.5111839367685633,1.1489813768122958,0.308300395256917,0.6124189561298751,1.0,6/15,17.42%,RAC1;RHOG;NTN1;LAMC2;SLIT1;RAC2
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5364187139441351,1.1489615989580064,0.30578512396694213,0.6120398119575404,1.0,3/12,13.02%,MAPK3;CSF1R;BST2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4461586190146905,1.1487202440168995,0.2745995423340961,0.6122515161607599,1.0,9/41,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,aortic valve development (GO:0003176),-0.32253321891900893,-1.1486401519907512,0.2375,0.6478743071877199,1.0,6/34,4.95%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1
prerank,dendritic spine organization (GO:0097061),0.4716983392612573,1.1478382965013942,0.2869352869352869,0.614099813578104,1.0,8/26,18.74%,LGMN;PRNP;TREM2;PAK3;DOCK10;ARF1;EPHB1;CTNND2
prerank,regulation of stem cell proliferation (GO:0072091),0.5057846984397625,1.1477138620001706,0.3153846153846154,0.6139953526178684,1.0,5/17,18.98%,PTPRC;ZFP36L1;GJA1;HNRNPU;SOX11
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4568598344628048,1.14755152307869,0.29308323563892147,0.6139857067055994,1.0,4/33,7.85%,CALR;H3-3A;PARK7;PKN1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4068201463711001,-1.1474872682162711,0.2594142259414226,0.6487903329720032,1.0,4/15,11.61%,EGFR;FER;PTPN12;RBPJ
prerank,lipid translocation (GO:0034204),0.4889710248828269,1.1474558624116893,0.30200501253132833,0.6137875832948624,1.0,6/21,18.30%,TMEM30A;ATP8B4;ATP8A2;ATP8A1;ATP11B;RFT1
prerank,positive regulation of GTPase activity (GO:0043547),-0.24354663902604382,-1.1470922403941441,0.1,0.647654390175258,1.0,51/188,15.32%,ARHGAP29;AFDN;SIPA1L1;DOCK11;ASAP3;RSU1;ARHGAP42;BCAS3;RAPGEF2;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;LIMS1;DOCK7;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;CCL25;RAPGEF1;TBC1D9B;BCR;TBC1D4;MAP4K4;SYDE2;PICALM;PIP5K1A;BCAR3;ALS2;SNX9;PKP4;TBC1D8B;TBCK;RAPGEF3;FERMT2;SIPA1;RIC1;RALGAPA1;DVL3;WNT11;RGS16;GSK3B;RAP1GDS1;TSC1;EZH2;NGEF;NDEL1;LARS1
prerank,ureteric bud development (GO:0001657),-0.4153615863407372,-1.1468592865512877,0.2930232558139535,0.6461586636339749,1.0,6/17,13.72%,GPC3;SLIT2;FGFR2;SIX1;WNT11;BMP4
prerank,cell projection organization (GO:0030030),0.4668447477432684,1.146732536646922,0.30083234244946494,0.6151841160582983,1.0,12/30,17.69%,GSN;RAC1;NEFH;RHOG;ATP1B2;P2RY12;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,import into cell (GO:0098657),0.43852101455686765,1.1463292828798872,0.28325688073394495,0.6158271573743046,1.0,10/41,14.83%,SNAP25;TREM2;LRRC8A;SLC7A5;GLUL;TSPO2;SLC6A6;SLC29A1;SLC19A1;SLC29A2
prerank,sensory perception of pain (GO:0019233),0.48882634250847484,1.146217285663637,0.3175591531755915,0.6157057478973664,1.0,7/21,20.76%,PRDM12;P2RX7;KCNA2;CHRNA4;CCL2;CCR2;SCN9A
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5452417922868245,1.1461477475814081,0.3252840909090909,0.6154692280514223,1.0,2/11,5.80%,AUP1;VCP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.28029349352524147,-1.145446757129339,0.15492957746478872,0.647418706623581,1.0,11/62,10.41%,AUTS2;AKAP13;NOTCH2;ROBO1;LPAR1;SHOC2;RAPGEF1;IGF1;MAP4K4;ALS2;NGF
prerank,membrane depolarization (GO:0051899),0.4580675046508986,1.1451446828470493,0.2872340425531915,0.6177465486949327,1.0,14/32,26.73%,SCN1A;YWHAH;ATP5IF1;CACNA1A;P2RX7;CHRNA4;CAV1;SCN9A;CACNB4;CACNA1E;CACNG2;CACNA1B;SCN8A;SCN2A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3830361884895635,1.1448313029467174,0.15646940822467403,0.6181270597552228,1.0,75/241,23.83%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5
prerank,peptide catabolic process (GO:0043171),-0.35675802411261626,-1.1447429385483965,0.23979591836734693,0.6470581397369553,1.0,3/23,5.90%,CPQ;NPEPPS;ANPEP
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.502875574499714,1.1446101178580805,0.3201058201058201,0.6182497607031829,1.0,6/18,20.52%,FTH1;DAB2IP;TRIM32;CD300A;SFRP1;MYC
prerank,receptor recycling (GO:0001881),0.5711656040694693,1.1445928745398348,0.31305637982195844,0.6178650931338652,1.0,2/10,4.82%,NSG1;SORL1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.43956019310409145,1.1443803546686577,0.2746878547105562,0.6179885021417452,1.0,9/43,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,regulation of chromatin organization (GO:1902275),-0.4137628249077192,-1.144051612995656,0.27450980392156865,0.646707367583653,1.0,5/14,11.57%,MLLT3;SETD5;TLK2;TLK1;PARG
prerank,mitochondrial membrane organization (GO:0007006),0.45165439051304584,1.143509652252882,0.2862190812720848,0.6198474952971252,1.0,11/32,20.90%,SLC25A5;MICOS13;SLC25A4;GHITM;PMAIP1;TIMM50;SPG7;BAD;APOO;HSPA9;BAK1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2913990920471189,-1.1433873075536074,0.2222222222222222,0.6462960104810754,1.0,15/53,13.69%,EYA2;EGFR;EYA1;BABAM2;PLA2R1;UIMC1;RNF8;EYA4;FBH1;FXR2;EYA3;ATM;ERCC8;SIRT1;BCLAF1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.43355835950761784,1.1430562407460545,0.2917139614074915,0.6206478230577606,1.0,15/45,23.81%,B2M;MT2A;HCK;FCGR1A;IRF8;IRF7;IFNGR1;VCAM1;NCAM1;OAS3;IFNGR2;IRF9;IRF5;TRIM68;CAMK2G
prerank,negative regulation of reproductive process (GO:2000242),0.5096568527871095,1.1430043388251394,0.3254901960784314,0.6203466000385257,1.0,5/17,13.23%,CALR;NPPC;ARHGDIB;TIMP1;GJA1
prerank,cellular response to amino acid starvation (GO:0034198),0.41087370405681145,1.1427836474000392,0.275974025974026,0.6205171724953872,1.0,10/71,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,negative regulation of cell migration (GO:0030336),0.3933342688575785,1.1426709127119568,0.2222222222222222,0.6203704762380614,1.0,27/137,9.80%,CD74;CLDN5;IFITM1;CALR;HMOX1;RHOB;IGFBP3;ADAM15;RAC1;ACVRL1;IGFBP5;DNAI3;MIF;NDRG4;DUSP3;HYAL2;ARHGDIB;ADORA3;ADGRG1;CORO1C;ATP1B2;NAV3;CLASP1;THY1;COL3A1;TIMP1;EPPK1
prerank,cGMP biosynthetic process (GO:0006182),0.5609759481231575,1.1426355515546154,0.3117816091954023,0.6200167180710601,1.0,1/10,2.33%,NPPC
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5330842249262766,1.1426097462639182,0.33022636484687085,0.6196433752964869,1.0,6/13,27.80%,UBE2G2;SVIP;BCAP31;BRSK2;OS9;UBE2J1
prerank,positive regulation of cell growth (GO:0030307),0.39985993515807783,1.1425641893919127,0.2577962577962578,0.6193100212969432,1.0,40/96,26.70%,H3-3A;AKT1;AKAP6;EIF4G2;SEMA7A;S100A8;S100A9;SYT1;LGI1;RIMS2;CXCL16;RIMS1;DDX49;IL2;MFSD2A;MAPT;NTN1;DNPH1;SYT4;EXOSC2;SHTN1;SDCBP;CPNE5;CPNE6;SYT2;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27;TAF9B;PSMD10;TGFB2
prerank,autonomic nervous system development (GO:0048483),0.5063563983210909,1.1424186463664625,0.3129161118508655,0.619264211625449,1.0,7/17,21.30%,FN1;KIF26A;PHOX2A;SOX8;SOX11;TFAP2B;SOX10
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2973738714329855,-1.1422611604115478,0.22,0.6471077504298393,1.0,13/52,11.64%,CELF2;RBFOX2;RBM5;RBM25;MBNL2;THRAP3;YTHDC1;TRA2B;RBM4;WTAP;FXR2;HNRNPL;DDX17
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.437972541019551,1.1415658047368498,0.2806004618937644,0.6211027941093984,1.0,11/39,21.84%,MBP;FXYD5;AKT1;MYADM;PODXL;KLF4;BMP2;AKNA;NOTCH1;TGFB1;PPM1F
prerank,T cell activation (GO:0042110),0.41466828944246226,1.1414775981342113,0.27398720682302774,0.6209065731168184,1.0,15/69,16.92%,CD74;MDK;CCL19;PTPRC;FKBP1A;MSN;DDOST;HSPD1;IL2;LCP1;ICOSLG;F2RL1;RASGRP1;JAG2;PIK3CD
prerank,synaptic vesicle exocytosis (GO:0016079),0.4358667190222675,1.1410129780989848,0.3086560364464693,0.6216942522000884,1.0,22/40,31.69%,SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;VAMP2;SYT10;CDK5;SYT2;DOC2B;STX4;SNCA;STX1B;SYT5;UNC13A;STX3;PIP5K1C;CPLX1;PCLO;SNPH;SYT7;RAB3A
prerank,regulation of developmental growth (GO:0048638),0.4617509728045027,1.1409896699281894,0.31176470588235294,0.6213185495779834,1.0,6/29,9.80%,APOE;SOD1;MUSK;NRCAM;MFSD2A;EPPK1
prerank,negative regulation of complement activation (GO:0045916),0.5633015217737419,1.1409686984063958,0.3423913043478261,0.6209364870523446,1.0,2/10,9.66%,A2M;SERPING1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4782924476389452,1.140597889870122,0.3032886723507917,0.6215027452429722,1.0,8/24,22.29%,RPS3;ACVRL1;H1-0;SUB1;TERF2IP;ERCC1;DACH1;BLM
prerank,ether lipid biosynthetic process (GO:0008611),-0.4600529313213738,-1.1404174144819548,0.2679738562091503,0.6496782140196913,1.0,4/10,16.44%,PLA2G4A;FAR1;PEX7;PLA2G4C
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30912100286824695,-1.1400013962498374,0.2074074074074074,0.6486531446340933,1.0,11/39,15.56%,AFDN;EPHA7;FLOT2;DPP4;SMAD7;PTK2;CDH1;NF2;JAG1;MDGA1;SPINT2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39920284371975395,1.1399567072207066,0.2661122661122661,0.6227365457038091,1.0,22/92,14.50%,SPARC;GRN;CALR;RHOB;AKT1;AGT;RAC1;RTN4;EMC10;PFN1;ENPP2;PROX1;CLASP1;KDR;ARF6;PDCD6;WNT5A;AAMP;FLT4;SOX9;CTSH;RRAS
prerank,blood circulation (GO:0008015),0.42705275996245773,1.1398812579203446,0.3005524861878453,0.6225042351531133,1.0,9/49,9.66%,GPX1;CXCL12;SOD1;SGCZ;CYB5R3;ACVRL1;CXCL10;PLN;SERPING1
prerank,establishment of protein localization to membrane (GO:0090150),-0.27550542079016926,-1.1392425676596898,0.18518518518518517,0.6484525873403075,1.0,9/66,6.61%,AFDN;EGFR;PARD3;SYNE3;BRAF;SEC63;ZDHHC1;GORASP2;RAB10
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.47687765041986024,1.1386667458305724,0.3026481715006305,0.6252985743489788,1.0,6/22,19.39%,LGMN;VKORC1;RBP1;GC;LRAT;CBR1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5337208448140057,1.1384345380106846,0.33741496598639453,0.6255091708169591,1.0,3/12,17.43%,TSPO;FDX2;STARD3NL
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5001520415730168,1.138174791970122,0.32729624838292365,0.6257709468938832,1.0,8/17,25.28%,NLGN1;RAB15;RAB3D;SYT4;SYT10;DOC2B;UNC13D;SLC4A8
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.543198003627755,1.1372770536786756,0.3389355742296919,0.6277703644033436,1.0,3/11,20.22%,TREM2;CCL3;TRAT1
prerank,chromatin assembly or disassembly (GO:0006333),-0.4516045040044143,-1.137022050594476,0.2977941176470588,0.6522421720487664,1.0,4/11,16.27%,HDAC8;NOC2L;CDAN1;TP53
prerank,telomere maintenance via recombination (GO:0000722),-0.44107833590821577,-1.137006302877182,0.3050847457627119,0.6501812079128723,1.0,2/11,3.01%,NSMCE2;TEP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5230591403203838,1.1368802735918668,0.3451568894952251,0.6283817831076245,1.0,8/13,27.40%,CADM4;PDCD6;DAB2IP;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.39947710311027185,1.1368008273594437,0.24352331606217617,0.6281478463411045,1.0,21/95,17.73%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;TCTN3;DCTN1;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B;TCTN1
prerank,regulation of centriole replication (GO:0046599),-0.38322564322479896,-1.136766380893955,0.29118773946360155,0.6487554294557765,1.0,3/18,5.53%,ALMS1;CEP295;KAT2B
prerank,hyaluronan catabolic process (GO:0030214),0.5028583729969875,1.1366218055695578,0.3219895287958115,0.6282085428494318,1.0,4/18,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,ncRNA transcription (GO:0098781),0.528816159611632,1.1365242376606863,0.3257676902536716,0.6280352444805097,1.0,2/13,4.35%,CAVIN1;ANG
prerank,regulation of organelle assembly (GO:1902115),-0.29177240161774504,-1.136070986970056,0.1896551724137931,0.648373274982587,1.0,15/73,8.13%,ALMS1;DCDC2;CEP295;PDCD6IP;MTMR3;SENP6;ATXN2;TBC1D19;USP6NL;TBC1D12;STX18;TBC1D2B;RABGAP1;TBC1D9B;IFT88
prerank,protein N-linked glycosylation (GO:0006487),0.4113853947510974,1.1358502328641522,0.27952329360780065,0.6294218564873131,1.0,20/66,18.84%,OST4;KRTCAP2;TMEM258;RPN1;RPN2;DAD1;DDOST;LMAN1;PMM1;GAL3ST1;MGAT2;DPM3;MPDU1;MOGS;MCFD2;ASGR2;ALG3;DPM2;MAGT1;STT3A
prerank,detection of visible light (GO:0009584),0.5028537288841826,1.1358242768967677,0.3104359313077939,0.6290485175714332,1.0,3/16,15.93%,GNA11;REEP6;CNGB1
prerank,positive regulation of vacuole organization (GO:0044090),0.550739034775968,1.1352508876979814,0.3367496339677892,0.6301267083433609,1.0,1/10,1.29%,GRN
prerank,proteasomal protein catabolic process (GO:0010498),0.38586033253581603,1.1351641483887538,0.20241691842900303,0.629923905256705,1.0,60/201,21.78%,PSMB4;UBXN1;PSME1;PSMB6;RCN3;PSME2;PSMB8;PSMD2;KCTD10;NR1D1;PSMD1;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;CDC34;RNF187;PSMA7;KCTD2;FEM1C;NHLRC1;PRPF19;KCTD17;PSMD5;TRIM9;RBX1;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;PMAIP1;SYVN1;PSMB11;ZSWIM8;FBXW7;PSMB10;KBTBD7;SPSB3;UBXN6;PSMB1;ARRB2;ENC1;PSMB5;BRSK2;KCTD13;PSMA6;HECW1;TRIM13;RAD23A;PSMA4;DDIT3;SIRT2;UBXN11;STUB1;IFI27
prerank,vasoconstriction (GO:0042310),0.5434657658721107,1.1348771298735263,0.3328785811732606,0.6302686693545381,1.0,3/11,18.94%,ACTA2;SLC8A1;EDN3
prerank,regulation of neuron differentiation (GO:0045664),0.4011329173673732,1.1347313590322028,0.27906976744186046,0.630226102478107,1.0,27/76,22.12%,CALR;NBL1;NLGN1;CNTN4;YWHAH;HES1;LTK;BRINP3;NRCAM;YWHAG;CDK5R1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;TIAM1;HEY1;BEND6;DLL1;TRIM32;SOX11;MEF2C;ADRA2B;ID2;REST
prerank,negative regulation of cell population proliferation (GO:0008285),0.38062510991530624,1.1345350809872192,0.148,0.6302761558784522,1.0,99/351,22.43%,FTH1;IGFBP6;B2M;APOD;IFITM1;GPNMB;HMOX1;S100A11;NME1;TREM2;RBP4;ERBB4;NPM1;IGFBP3;CSNK2B;GPER1;MAGED1;ACVRL1;IGFBP5;ANG;HSPA1B;NDRG4;CTNNB1;ST18;HES1;SFRP5;TNFAIP3;CDKN1C;BTG1;ADORA3;SSTR4;ADGRG1;ATP8A2;NELL1;PAK1;CEBPA;PROX1;NUPR1;GATA2;CGREF1;EPPK1;ADGRB1;ZBTB49;THAP12;CTBP1;WNT5A;ATF5;ATRAID;WARS1;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;SOX9;HSPA1A;DDAH1;BMP2;TNN;SFRP4;STK11;COPS8;SLURP1;DLC1;DLL1;ADRA1A;DAB2IP;VHL;TRIM32;LMNA;PTGIR;PDCD5;SCIN;CD300A;ADAMTS1;FABP7;BTG4;SOX11;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;SFRP1;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;RERG;CCN3;MEN1;SSTR2;REST;TMEM127;CD164
prerank,rRNA 3'-end processing (GO:0031125),0.5518597066327405,1.134106249053698,0.33528550512445093,0.6309817718306923,1.0,2/10,10.38%,RPS21;EXOSC2
prerank,negative regulation of gene expression (GO:0010629),0.3819557627170582,1.1338779707224431,0.16216216216216217,0.631182786774816,1.0,55/302,13.45%,APOE;MRPL13;RPS3;RPS13;RACK1;CLDN5;GAPDH;RPL13A;RPS26;CALR;H3-3A;GPNMB;PARK7;LGMN;CNPY2;TMBIM6;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;IGFBP5;NCL;SPI1;LSM6;MIF;HSPA1B;ZFP36L2;TLE5;SH3GL2;APLNR;MYADM;CREBZF;KDR;SYT11;MAPT;YBX1;GATA2;ZFP36;TARDBP;LRP3;RNH1;SRGN;PCIF1;HRAS;ATP2B1;MSR1;NCOR2;KLF4;SLC11A1;HSPA1A;FBXW7;BMP2
prerank,regulation of catabolic process (GO:0009894),0.49493416846349414,1.133767947482832,0.3110236220472441,0.631040541812693,1.0,9/18,26.88%,CHEK2;RARRES2;CHMP6;ODC1;FAM83D;HGS;ZDHHC2;ITGB1;SNF8
prerank,icosanoid biosynthetic process (GO:0046456),0.5536402232013602,1.1337225881990014,0.34146341463414637,0.6307281438284562,1.0,4/10,17.03%,FADS1;MGST3;ALOX5AP;LTC4S
prerank,striated muscle tissue development (GO:0014706),0.4612405942793623,1.1333452400198831,0.3013205282112845,0.6313093954416591,1.0,3/29,3.40%,MYL6;RBP4;SGCZ
prerank,L-glutamate transmembrane transport (GO:0015813),0.5553245859627711,1.1331170552699064,0.3438914027149321,0.6314825113897614,1.0,5/10,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;SLC25A18
prerank,peptidyl-tyrosine modification (GO:0018212),-0.30448398820872974,-1.132981256166668,0.22077922077922077,0.6542599164519622,1.0,15/56,10.73%,EGFR;FER;ABL1;EPHA3;EPHA4;EFEMP1;INSR;DYRK1A;FGFR2;PDGFRB;ABI1;ABL2;TPST1;PTK2;EPHB2
prerank,cellular response to inorganic substance (GO:0071241),0.47573636419682963,1.1325216946712124,0.33078880407124683,0.632648945723695,1.0,5/21,12.09%,MT3;AQP1;MMP3;NSMCE3;DDX11
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.46623665854145796,1.1316949522811501,0.3076923076923077,0.6343829455404291,1.0,6/26,13.00%,EEF1A1;ZFP36L1;ZFP36L2;DUSP3;ZFP36;SOX9
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.466823036713154,1.131254110376116,0.3179611650485437,0.6352021621572176,1.0,7/28,16.24%,GABARAP;TNF;SPI1;BAX;TNFRSF1A;SORT1;DAB2IP
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5014931276373572,1.1311875054047327,0.31084656084656087,0.6349429182816717,1.0,5/16,19.97%,LGALS3;CD22;IKZF3;SOX11;LST1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.44723832880505276,1.1308477472339475,0.30434782608695654,0.6353972470802713,1.0,5/31,12.81%,SCP2;PYCR2;GPHN;LSS;HSD3B2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.453240253635132,1.1300114596323079,0.31866825208085614,0.6372129364013435,1.0,7/31,15.80%,ROMO1;DNLZ;HSPD1;TOMM40L;TIMM50;TOMM20L;PEX6
prerank,response to purine-containing compound (GO:0014074),0.49575993417227693,1.1299281672513082,0.33376792698826596,0.6369777916052713,1.0,5/17,15.89%,P2RY6;P2RX7;P2RY1;TRPM2;RYR2
prerank,organophosphate catabolic process (GO:0046434),0.548699233151076,1.1298091041277547,0.3495575221238938,0.6368407008267994,1.0,3/11,14.12%,LIPG;ENPP2;PLBD2
prerank,potassium ion homeostasis (GO:0055075),0.4692675804173472,1.1297091137519073,0.3180693069306931,0.6366627154393698,1.0,9/23,19.56%,ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1;TFAP2B
prerank,chloride transmembrane transport (GO:1902476),0.42554698215891495,1.1296834375996359,0.3009049773755656,0.6362776765883605,1.0,13/48,18.84%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,regulation of protein polymerization (GO:0032271),0.43580817232440855,1.1295836327437554,0.31664726426076834,0.6360868754615259,1.0,12/35,16.76%,HSP90AA1;TPPP3;HCLS1;PFN1;ESAM;MAPT;MAP2;COTL1;PAK3;ARL2;MAPRE3;PFN2
prerank,regulation of MAPK cascade (GO:0043408),0.3837705201715571,1.1295345243229942,0.23535353535353534,0.6357901431233988,1.0,52/157,20.90%,CD74;LAPTM5;MAPK3;PEBP1;GPER1;GPR37L1;PDGFB;PTPRC;NTRK2;CAV2;DUSP3;FN1;PAK1;P2RX7;KDR;CD24;JCAD;LILRA5;HMGB1;PAK3;IL11;ATP6AP2;FLT4;HRAS;PHLPP1;NEK10;BMP2;YWHAZ;RRAS;GDF15;IGF2;PDGFA;RASGRP1;EPHB1;ADRA1D;ADRA1A;DAB2IP;FLT1;CAV1;SYK;GRM4;FAM83D;MAP2K2;LBH;SPRY3;FLT3;IL6;THPO;PAK5;ADRA2B;TMEM106A;PTPN6
prerank,regulation of AMPA receptor activity (GO:2000311),0.4640555556273148,1.129528526626165,0.32922318125770655,0.6353621762502557,1.0,9/25,25.00%,NLGN1;SHISA7;MAPK8IP2;CACNG8;CACNG5;MEF2C;CACNG2;SHISA6;PRRT1
prerank,response to interleukin-6 (GO:0070741),-0.4539139645272617,-1.12904736621836,0.29537366548042704,0.6625232419690033,1.0,3/10,6.32%,PID1;PTGIS;NFKB1
prerank,spinal cord development (GO:0021510),-0.4265403067241532,-1.128793614754202,0.2924187725631769,0.6610764542706805,1.0,6/12,19.40%,GLI2;VIT;LOXL3;PKD1;NF1;PKD2
prerank,peptide metabolic process (GO:0006518),0.406353203707415,1.12842673991025,0.2854077253218884,0.6378598579563687,1.0,19/75,18.39%,GPX1;SOD1;GSTM1;CPXM1;CPD;CPE;SPCS1;GSTM5;AEBP1;CPXM2;GSTM2;CLN5;HPGDS;SPCS2;DNPEP;GLRX2;BACE1;PSEN2;SEC11C
prerank,mRNA stabilization (GO:0048255),0.43357064880086493,1.128098118160102,0.31543624161073824,0.6382949529019408,1.0,12/40,17.32%,TIRAP;HNRNPA0;YBX1;ZFP36;TARDBP;ELAVL4;PABPC1;SLC11A1;HNRNPU;CIRBP;YBX3;EIF4ENIF1
prerank,histone deubiquitination (GO:0016578),-0.3838135606868134,-1.1280781262488822,0.2916666666666667,0.6608773590415614,1.0,5/18,8.94%,USP3;UIMC1;USP49;USP16;USP36
prerank,lymphocyte proliferation (GO:0046651),0.4768581550933656,1.1279680019671716,0.30845771144278605,0.6382361313199408,1.0,6/22,20.07%,PTPRC;MSN;HSPD1;RASGRP1;FLT3;MEF2C
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5209849459436238,1.1278765692196637,0.3236111111111111,0.6380434298334813,1.0,6/13,25.50%,PTPRC;HES1;IL6;CRLF2;DOT1L;PTPRT
prerank,mitotic cytokinesis (GO:0000281),-0.29863917049968297,-1.1275829490670821,0.22413793103448276,0.6600586332753645,1.0,9/47,7.45%,ROCK2;SON;ROCK1;SPTBN1;PDCD6IP;TTC19;ARL3;MYH10;KLHDC8B
prerank,positive regulation of developmental process (GO:0051094),0.38303224187858254,1.1272884220318549,0.2474747474747475,0.6391910196846026,1.0,39/164,17.17%,APOE;MDK;HSP90AB1;CFL1;NRXN1;NLGN1;PINK1;TNF;PDGFB;PACSIN1;RTN4;SORL1;TFRC;OTX2;CEBPB;CORO1C;ENPP2;SLC6A6;BASP1;CLASP1;KDR;CCN2;DCN;CAMK1;ARHGEF7;WNT5A;TMEM119;SOX8;SOX9;GJA1;BMP2;FBXO5;MIEF2;MFF;LRP8;DAB2IP;VHL;LMNA;DNM1L
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3987534208331053,1.1269330862619358,0.28299894403379094,0.6397022600041888,1.0,28/85,21.57%,CLU;RACK1;GABARAP;ELOB;TREM2;HSPA1B;PSMC3;VCP;USP5;CEBPA;RBX1;NUPR1;ECSCR;SUMO2;DNAJB2;HSPA1A;FBXW7;RNFT1;HSPBP1;DAB2IP;NOP53;DDRGK1;RNF144B;RAD23A;TMEM259;USP13;SIRT2;STUB1
prerank,organic hydroxy compound transport (GO:0015850),0.4413062421179013,1.1267972649793865,0.33528722157092616,0.6396366165493702,1.0,11/36,28.12%,NPC2;RBP4;SLCO1C1;SLC10A3;SLC16A1;ABCC3;SLCO1B1;SLC10A6;ABCG5;RALBP1;STRA6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3904093087127297,1.1260801356374932,0.23959390862944163,0.6410973599709923,1.0,36/136,21.72%,TMSB4X;ID3;PRNP;ID1;SPI1;FLNA;HES1;SFRP5;TNFAIP3;ADORA3;HES6;PROX1;OTULIN;NUPR1;RBCK1;WFS1;KLF4;GAS6;FOXS1;NLRP2B;SFRP4;ERBIN;TRAF3;SIGIRR;ARRB2;DAB2IP;TCEAL7;GLIS2;COMMD7;NLRP3;FOXA2;NFKBIA;PYCARD;ID2;DDIT3;MEN1
prerank,positive regulation of exocytosis (GO:0045921),0.44300734030663663,1.1260067494243093,0.3006993006993007,0.6408572972765083,1.0,14/35,26.88%,ATP6AP1;RAB15;CLASP1;CADPS;ATP13A2;RAB3D;SDC4;SDCBP;VPS4A;SNCA;RAB27B;UNC13D;HGS;SNF8
prerank,transcription by RNA polymerase I (GO:0006360),0.4508502583282132,1.1257597160059267,0.29906542056074764,0.6410784933253031,1.0,15/34,27.25%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,positive regulation of multicellular organismal process (GO:0051240),0.37555739530479054,1.1254770733472554,0.1765295887662989,0.6414167056335583,1.0,65/308,17.36%,APOE;RPS19;GAPDH;MDK;COL1A1;PPIB;CFL1;SOD1;GATM;NLGN1;TREM2;AGT;S100A13;NFAM1;UCP2;TNF;PDGFB;EPAS1;FABP5;ENO1;RTN4;SORL1;MIF;FLOT1;BSCL2;CTNNB1;TFRC;LRPAP1;OMA1;OTX2;CEBPB;CLEC6A;IL2;CRH;HAP1;WNT5A;SCD;KDM6B;LCN2;MFAP2;VAMP8;TMEM119;SOX8;THRA;SLC11A1;HCRT;SOX9;GJA1;BMP2;FBXO5;GAS6;NME2;CXCR4;SDCBP;TIAM1;F2RL1;BAD;ACHE;ADRA1D;ADRA1A;CAV1;PIK3CD;TWIST1;ADCYAP1;PPARGC1A
prerank,retinoid metabolic process (GO:0001523),0.40571118552548174,1.12518473429116,0.29014989293361887,0.6417557865841911,1.0,17/71,19.90%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;DHRS13;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,positive regulation of lipid localization (GO:1905954),0.5431685158522479,1.1251127995221701,0.3342503438789546,0.6415119365627405,1.0,2/11,8.93%,C3;LPL
prerank,regulation of Notch signaling pathway (GO:0008593),-0.2724268852234766,-1.1245737750596423,0.16326530612244897,0.6659118694594157,1.0,19/76,14.26%,TSPAN5;EGFR;ZMIZ1;CREBBP;MAML2;NIBAN2;GALNT11;YAP1;KAT2B;STAT3;MAML1;AAK1;SYNJ2BP;RBPJ;CD46;JAG1;DTX1;WWP2;PRKCI
prerank,regulation of protein localization to nucleus (GO:1900180),0.43101552160054196,1.1242645940014613,0.30666666666666664,0.6433412469458739,1.0,9/43,10.87%,PARK7;AKT1;LAMTOR5;ORMDL3;PIN1;TFRC;GLUL;ATP13A2;SUMO3
prerank,ketone body metabolic process (GO:1902224),-0.4541090962759849,-1.1240961024581757,0.32550335570469796,0.6650331677088894,1.0,8/10,29.14%,ACSS3;BDH2;HMGCS2;BDH1;AACS;HMGCLL1;OXCT1;HMGCL
prerank,presynaptic endocytosis (GO:0140238),0.4675340658911587,1.1240518180102714,0.33087330873308735,0.6434343468535615,1.0,9/24,19.11%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4688087486835788,1.1235444985613212,0.3341772151898734,0.6443703300866482,1.0,9/22,30.38%,RPS21;EXOSC2;EXOSC9;FTSJ3;ERI1;NOP14;NOL9;URB1;PES1
prerank,regulation of protein kinase A signaling (GO:0010738),0.48386859320645,1.1234653109066979,0.3589420654911839,0.6441485954332828,1.0,6/20,11.35%,AKAP6;MIF;PRKAR1A;MC1R;PRKAR1B;RAMP3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4518147362618029,1.123457993072422,0.3234597156398104,0.643730132488636,1.0,14/33,26.93%,AKT1;ZFP36L1;LTK;PIK3C2G;NYAP2;TYRO3;PIK3CD;ERBB3;SIRT2;C1QBP;NYAP1;PLEKHA1;PIK3R5;HTR2B
prerank,RNA transport (GO:0050658),0.4039206807873749,1.1228274951502217,0.2890792291220557,0.6449570231463393,1.0,22/71,22.07%,MAGOHB;MAGOH;DDX39B;ZFP36L1;FLOT1;SRSF9;YBX1;ZFP36;RTRAF;SRSF2;HNRNPA1;RBFOX1;THOC3;TST;EIF4A3;SLBP;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;DHX38
prerank,myeloid leukocyte differentiation (GO:0002573),0.4056026524747306,1.1225758538158892,0.284789644012945,0.6452010792343105,1.0,18/65,20.16%,MT1G;TYROBP;CCL19;TREM2;GLO1;SPI1;PARP1;CEBPA;DEK;CSF1R;F2RL1;OSTM1;BATF3;OSCAR;PIK3CD;GPR183;BATF2;PDE1B
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4482337776713022,1.1223290395760175,0.31393939393939396,0.6454500992072992,1.0,12/28,21.15%,ATF4;CEBPB;SELENOK;BAX;BBC3;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;BAK1;DDIT3
prerank,negative regulation of response to stimulus (GO:0048585),0.4093426372769019,1.1220554962653422,0.2923408845738943,0.645759647129192,1.0,20/60,20.68%,CLU;CD34;IGFBP3;TLE5;PTK6;THY1;COL3A1;YBX1;KIF26A;WFS1;KLF4;DDAH1;FBXO5;NR1H2;PIM3;TWIST1;ERBB3;SRMS;FOXA2;BRAP
prerank,oxoacid metabolic process (GO:0043436),0.4638011645625166,1.1220509182380682,0.316747572815534,0.6453315943608628,1.0,5/27,8.82%,AGXT;MIF;SULT4A1;BPNT2;GRHPR
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5274835481605256,1.1218232723161743,0.3365921787709497,0.6454994125802065,1.0,6/12,22.12%,ZFP36L2;HES1;HNRNPU;ESRRB;NOTCH1;REST
prerank,regulation of neuroinflammatory response (GO:0150077),0.49214063387856266,1.1218199223735301,0.35868187579214195,0.6450674964502109,1.0,5/19,11.31%,TREM2;TNF;NR1D1;NUPR1;MMP3
prerank,regulation of osteoblast differentiation (GO:0045667),-0.27812133422949975,-1.121642348766378,0.21666666666666667,0.6694004228996181,1.0,28/82,16.73%,BMP6;RANBP3L;SMAD6;ACVR1;BMPR1A;SMOC1;CRIM1;SUFU;LRP5;SKI;YAP1;CDK6;IGF1;FGFR2;PPARG;IL6R;TRPM4;PTK2;FERMT2;ZHX3;PRKD1;BMP4;RUNX2;ACVR2A;LIMD1;WNT4;BMPR2;ACVR2B
prerank,positive regulation of cell adhesion (GO:0045785),0.40385551759164057,1.1212069462141732,0.29108485499462944,0.6462111118318818,1.0,20/74,20.02%,MDK;CXCL12;TGM2;TNF;PDGFB;RAC1;FRMD5;ADGRG1;P4HB;DUSP26;P2RY12;MAGI1;ARL2;EPB41L4B;TMEM102;FBLN2;SYK;STX4;PPP3CA;CITED2
prerank,microtubule nucleation (GO:0007020),-0.36837670939615047,-1.1210926760595663,0.26126126126126126,0.6686950401291157,1.0,10/20,27.27%,AKAP9;GOLGA2;CCDC57;TUBGCP6;NDEL1;TUBGCP5;TPX2;TUBG1;SLAIN2;TUBG2
prerank,covalent chromatin modification (GO:0016569),0.5142753642894672,1.12083428156156,0.3497191011235955,0.6467788786786726,1.0,2/14,1.76%,MT3;PARK7
prerank,positive regulation of viral process (GO:0048524),0.4098170330059992,1.1207725722791977,0.3081140350877193,0.6465163125293,1.0,18/60,21.24%,PPIA;POLR2E;POLR2D;POLR2F;IFIT1;NELFCD;DDB1;POLR2G;SUPT4H1;PABPC1;POLR2K;PDE12;NELFE;TYRO3;VPS4A;RAD23A;POLR2H;CDK9
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.44104846909383966,1.120738142322596,0.3263157894736842,0.646166526983981,1.0,9/33,13.55%,RAMP2;MDK;TNFAIP3;KDR;NUPR1;GATA2;IL11;WFS1;GAS6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.38659188342361306,1.1199876921071112,0.26557711950970375,0.6477017676523593,1.0,49/150,21.84%,PPIA;RACK1;CALM1;HSPB1;PARK7;AKT1;FKBP8;PRNP;CALM3;IGFBP3;PPP1R15B;CAMK2N2;PTPRC;PRR5L;SIRPA;SH3GL2;MYADM;DBNDD2;CORO1C;THY1;YWHAG;MLXIPL;CADM4;RTRAF;TARDBP;WARS1;CAMK2N1;CNKSR3;INPP5J;NLRP2B;DMTN;DAB2IP;CAV1;TWIST1;PRKRIP1;AKT1S1;TERF2IP;QARS1;DNAJC10;TAB1;CALM2;SNCA;TGFB1;DDIT4;SFRP1;PTPN6;SIRT2;MEN1;PPM1F
prerank,positive regulation of DNA binding (GO:0043388),0.4496436033838091,1.1195402556764416,0.3138424821002387,0.6483991607158281,1.0,11/31,21.37%,PARK7;TXN;NME1;HES1;EDF1;HMGB1;H1-0;TWIST1;TGFB1;POU4F1;SIRT2
prerank,response to amino acid starvation (GO:1990928),0.40197650571662047,1.1190075703735807,0.30885529157667385,0.649397230798486,1.0,10/72,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,positive regulation of TOR signaling (GO:0032008),0.4305869424151228,1.1188575597152737,0.3208868144690782,0.6493537704583857,1.0,12/40,16.15%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;LAMTOR3;GAS6;RRAGC;RRAGD
prerank,regulation of autophagy (GO:0010506),0.38092572599855645,1.1180051297053601,0.23470411233701102,0.6512193620958283,1.0,44/216,16.49%,EEF1A1;PSAP;GFAP;GAPDH;ATP6V0C;HSPB1;MT3;CAPNS1;AKT1;EIF4G2;TREM2;PINK1;LAMTOR2;LAMTOR4;RASIP1;LAMTOR5;TMEM59;ORMDL3;ATP6V1G1;UCHL1;ATP6V0E2;EEF1A2;DEPP1;MAPT;NUPR1;GPR137B;CDK5R1;ATP13A2;DCN;HMGB1;MTMR9;ATP6V0D2;SVIP;CTSA;FBXW7;UBQLN2;LAMTOR3;STK11;ATG101;BAD;RRAGC;CDK5;RRAGD;RAB39B
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.48902412807961104,1.1178836682370445,0.3574193548387097,0.6510966913951239,1.0,7/18,23.15%,MDK;CAMK1D;F2RL1;ADAM17;EDN3;IL6;PTN
prerank,apoptotic nuclear changes (GO:0030262),0.4653294132616471,1.1175561032421177,0.32234432234432236,0.6515836634317688,1.0,5/24,10.22%,GPER1;ENDOG;FOXL2;HMGB1;H1-0
prerank,regulation of dephosphorylation (GO:0035303),-0.4064364010357967,-1.116885258350309,0.2627118644067797,0.6778092991892986,1.0,4/15,11.65%,SMG6;MTMR3;SMG7;PPP1R16A
prerank,positive regulation of endopeptidase activity (GO:0010950),0.44455798923438905,1.116855268177479,0.3362282878411911,0.6530012616543772,1.0,13/26,24.87%,MBP;PSME1;PSME2;PSENEN;GRIN1;VSIR;APH1B;GRIN2B;PRELID1;EFNA1;PYCARD;AGER;APH1A
prerank,cellular component assembly (GO:0022607),0.37311608531209944,1.1165179409894161,0.2062062062062062,0.6534980757450796,1.0,63/253,20.50%,ACTB;ACTG1;CD74;GSN;CHCHD10;ELOB;LAMC1;NLGN1;SLC2A1;ARL6IP1;ANK3;RAC1;SYCP2;TAPBP;RTN4;PPP2R1A;NEFH;FLNA;GPM6B;IL2RB;HES1;ADD2;RHOG;FAM107A;OTX2;RIMS1;CAPZA2;MYO7B;LCP1;VAMP3;VAMP2;RHOV;MICAL1;EPPK1;WNT5A;AIF1;SOX9;RHOA;MAGI1;GAS6;YWHAZ;VMP1;RHOU;TSPAN4;CAPG;SPG7;PDGFA;YTHDF1;DMTN;DNM1L;PPARGC1A;RAC2;SCIN;EPRS1;FBLIM1;LPXN;LRRTM3;DCX;TGFB1;QSOX1;IL1RAP;CAPN3;TFAP4
prerank,cellular response to retinoic acid (GO:0071300),0.4257947266466315,1.1164943339559197,0.322435174746336,0.6531191305284333,1.0,11/42,13.56%,NDUFA13;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B
prerank,intracellular pH reduction (GO:0051452),0.4454238257564044,1.116460529729799,0.32435597189695553,0.6527537667703525,1.0,10/33,23.58%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;SLC11A1;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.437771407700805,1.1164101952219936,0.31949250288350634,0.6524385334784272,1.0,5/36,5.31%,PPIA;TREM2;PINK1;DUSP3;SIRPA
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5164887995923064,1.1163918548815293,0.35,0.6520493145299532,1.0,5/13,19.84%,SOX8;SOX9;DLL1;NOTCH1;TGFB1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4824023307484027,1.1159882358435207,0.34777070063694265,0.6526944708904296,1.0,5/20,14.26%,GSN;GPER1;ECSCR;SFRP4;CCL2
prerank,midbody abscission (GO:0061952),0.49733976992794077,1.1155874425213936,0.34822601839684625,0.6533498430557114,1.0,10/17,32.42%,CHMP2B;CHMP5;CHMP6;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C;CHMP4A;CHMP4B
prerank,neural tube closure (GO:0001843),-0.3065911812814964,-1.1150953270214454,0.2624113475177305,0.6806550538103393,1.0,8/34,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;DVL3;IFT122;CELSR1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3642184491382049,-1.1149946380061782,0.25,0.6788245634169876,1.0,6/20,16.08%,CLK2;NCOR1;SIK1;C1QTNF3;CRY1;WNT4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3813678734677861,1.114940275388482,0.25529767911200807,0.654664203631408,1.0,43/186,16.42%,APOE;IGFBP6;PFDN5;RACK1;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;ALPK2;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.540542331525597,1.1148221954805657,0.3512396694214876,0.6545310159308741,1.0,5/11,27.61%,YWHAE;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,negative regulation of lyase activity (GO:0051350),0.4950359433892937,1.1143844529054092,0.35667107001321,0.6552716639147802,1.0,5/16,20.07%,GNAI2;RD3;PHPT1;CCR2;GABBR2
prerank,regulation of protein kinase activity (GO:0045859),0.3898174740083889,1.114120114527902,0.29927760577915374,0.6555757597019238,1.0,29/106,19.11%,PPIA;HSPB1;PARK7;SOD1;AKT1;CCL19;CAMK2N2;TNF;PTPRC;C5AR1;DBNDD2;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;GAS6;MMD2;MAPRE3;LCP2;ADCYAP1;CAMKK1;PRKRIP1;AGAP2;DDR2;AKT1S1;QARS1;TAB1;SNCA
prerank,regulation of secretion by cell (GO:1903530),0.41520762574573655,1.1139558687039857,0.31520532741398444,0.6555539707699269,1.0,23/54,27.74%,SYT1;RIMS2;RIMS1;RAB15;RAB3C;SCG5;VAMP3;VAMP2;STXBP5L;RAB3D;HAP1;VAMP8;SYN1;HCRT;RAB26;STX4;MEF2C;LLGL1;ARFIP1;KCNMB4;RAB8A;LGI3;CPLX1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3784673275226171,1.1139378609093638,0.24748490945674045,0.6551628030262145,1.0,68/193,26.27%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;CCL19;RCN3;TXN;NRG1;ERBB4;PINK1;GPER1;TNF;PDGFB;HCLS1;RAC1;NTRK2;RTN4;HYAL2;SFRP5;RHOG;P2RY12;KITLG;MC1R;PDCD6;RAMP3;PHLPP1;VAV1;GAS6;CX3CR1;RRAS;GDF15;IGF2;PDGFA;ARRB2;HPSE;CCL3;GATA4;CASS4;PIK3CD;F10;RAC2;ERBB3;NOP53;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;DDIT3;BANK1;TGFA;MYDGF;PHLDA3;C1QBP;TEK;CD28;PLEKHA1;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1
prerank,negative regulation of phosphorylation (GO:0042326),0.4003650059866564,1.113797129699011,0.30979978925184404,0.655074493521123,1.0,26/85,19.88%,PPIA;PARK7;DYNLL1;FKBP8;PRNP;IGFBP3;PPP1R15B;PRR5L;SIRPA;SH3GL2;MYADM;CDKN1C;CORO1C;MAPT;NUPR1;CADM4;TARDBP;WARS1;HNRNPU;DAB2IP;PRKRIP1;TERF2IP;DNAJC10;INHBA;TGFB1;GIT1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4293388548360803,1.1131738763606358,0.31746031746031744,0.6562875540445959,1.0,15/42,21.84%,EMP2;PDGFB;RAC1;SPOCK1;MYADM;CORO1C;THY1;RHOA;ARL2;DMTN;FBLN2;RAC2;NOTCH1;PTPRO;PPM1F
prerank,cellular response to interleukin-6 (GO:0071354),-0.34329801676620814,-1.112963326585496,0.2840909090909091,0.6822484697638631,1.0,15/26,22.76%,PID1;FER;PTGIS;YAP1;NFKB1;STAT3;IL6R;SMAD4;JAK1;SBNO2;ST3GAL6;CBL;PTPN11;SRC;CTR9
prerank,odontogenesis (GO:0042476),-0.30653394132332884,-1.1125245425103465,0.2689655172413793,0.6812213105340647,1.0,6/35,8.39%,EDA;ANKRD11;GLI2;LRP6;BCOR;FGFR2
prerank,negative regulation of glycolytic process (GO:0045820),-0.44715546726164346,-1.1125234257007448,0.31654676258992803,0.6770801475520947,1.0,3/10,5.50%,HDAC4;PPARA;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.44715546726164346,-1.1125234257007448,0.31654676258992803,0.6770801475520947,1.0,3/10,5.50%,HDAC4;PPARA;NCOR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4129412736719537,-1.1124495925842532,0.29259259259259257,0.6751924960860918,1.0,7/13,19.69%,NR3C2;ESR1;AR;PLPP1;BMP4;NR3C1;MED1
prerank,negative regulation of DNA replication (GO:0008156),0.5292951170445923,1.1122411520904805,0.3658210947930574,0.6584106270875064,1.0,3/13,7.11%,S100A11;TERF1;GMNN
prerank,pancreas development (GO:0031016),-0.4288390232773318,-1.1122188794645358,0.2883895131086142,0.673766179977499,1.0,3/12,8.85%,TCF7L2;MET;NPHP3
prerank,ion transport (GO:0006811),0.3858621784104466,1.1120007970666443,0.28335056876938985,0.6586550841670096,1.0,32/111,19.70%,TSPO;SLC17A8;GABRB1;SLC39A1;LRRC8A;SLC24A4;SLC24A2;SLC1A2;GRIN1;SLC12A5;CNGA3;SLC26A4;TMEM63C;SLC15A4;SLC17A7;LASP1;SLC17A6;KCNN2;GLRA1;ATP1A4;SLC1A1;CHRNA4;SLC25A22;SLC8A1;SLC15A2;CNGB1;ATP11B;SLC9A9;SLC4A2;VDAC2;SLC25A18;PKD2L1
prerank,negative regulation of T cell differentiation (GO:0045581),0.5483041940013742,1.111759182277239,0.36773255813953487,0.6588610390876601,1.0,3/10,14.00%,MDK;CTLA4;ZC3H8
prerank,regulation of cell population proliferation (GO:0042127),0.3684949638942935,1.1111854904722016,0.098,0.6599946359405773,1.0,167/691,21.15%,FTH1;RPL23;RPS9;RPS4X;RPS15A;CLU;IGFBP6;CLDN5;IFITM1;TSPO;CD81;CALR;GPNMB;GNAI2;CAPNS1;JUND;S100A11;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;IGFBP3;S100A13;CSNK2B;GPER1;COX17;EMP2;PDGFB;ROMO1;HCLS1;ACVRL1;NTRK2;ZFP36L1;JUNB;HSPA1B;SSR1;ECRG4;CTNNB1;ST18;SERTAD1;HES1;LTK;SFRP5;EID2;FN1;BTG1;MATK;TFRC;RHOG;RNF187;ADORA3;SSTR4;ADGRG1;ATP8A2;NAMPT;SGK1;PAK1;CEBPA;PROX1;KDR;CXCL10;IL2;BCL6B;VIPR1;NUPR1;MLXIPL;TIMP1;CADM4;LAMC2;JUN;CGREF1;HCK;ADGRB1;ZBTB49;KITLG;CSF1R;THAP12;CTBP1;IL11;ATF5;CEP131;WARS1;FLT4;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;PRMT1;SOX9;HSPA1A;RHOA;DDAH1;BMP2;FBXO5;SFRP4;CTSH;CCDC88A;STK11;SDCBP;TIAM1;PF4;COPS8;SLURP1;PDF;FOLR2;IGF2;PDGFA;DLC1;DLL1;IER5;ADRA1D;ADRA1A;JAG2;DAB2IP;FLT1;CCKBR;VHL;CIAO1;LMNA;PDCD5;ADAM17;SCIN;CNBP;ADAMTS1;TBRG4;ERBB3;FABP7;BTG4;MAZ;SCGB3A1;STX4;HMGN5;EDN3;SOX11;DDRGK1;CD86;INHBA;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;KLF11;MAPK15;TGFB1;ING5;OSGIN1;THPO;SFRP1;TFAP4;MYC;CRLF1;PTPN6;CRLF2;SST;PTPRU;ID2
prerank,regulation of cell junction assembly (GO:1901888),-0.3454058152825693,-1.1111258112887985,0.28823529411764703,0.67447238794668,1.0,5/27,2.53%,ROCK2;PDLIM5;SETD5;ROCK1;RAPGEF2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.513022456675708,1.1110511858182404,0.3535762483130904,0.6594895313529224,1.0,3/14,19.97%,HMOX1;BLVRA;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.513022456675708,1.1110511858182404,0.3535762483130904,0.6594895313529224,1.0,3/14,19.97%,HMOX1;BLVRA;SLCO1B1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4367096223729609,1.110372690226011,0.3423529411764706,0.6608217998107868,1.0,9/35,15.01%,APOE;AKAP6;RIMS2;AQP1;HTR2C;EPHA5;SOX9;NUDT4;CAP1
prerank,negative regulation of heart contraction (GO:0045822),0.5392828467944946,1.1095266221447773,0.36754507628294036,0.6626263126954928,1.0,5/11,19.18%,PLN;SPTBN4;SRI;FKBP1B;GRK2
prerank,synaptic vesicle localization (GO:0097479),0.5129403576257098,1.109389363216988,0.3647214854111406,0.6625561965774537,1.0,5/13,18.48%,NLGN1;KIF5A;SYNDIG1;CDK5;KIF5C
prerank,clathrin coat assembly (GO:0048268),0.49676533713400306,1.1092530568334653,0.3527080581241744,0.6624578347388304,1.0,6/15,14.97%,NSG1;CLTC;AP2S1;FCHO1;NSG2;CLTA
prerank,neuromuscular process controlling balance (GO:0050885),0.519463243517637,1.109204888878087,0.33620689655172414,0.6621420549822026,1.0,2/12,5.93%,NRXN1;PCDH15
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.39463266142712333,1.1091871966357865,0.3230277185501066,0.6617443626070512,1.0,22/72,20.90%,TREM2;AGT;GPER1;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;SOX9;F2RL1;PDGFA;NCF1;FLT1;PIK3CD;ERBB3;MAZ;FLT3;HGF;PTPN6
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5067074525416589,1.1089564256242865,0.3682758620689655,0.6619334137889301,1.0,3/13,8.38%,CTNNB1;COL4A1;KDR
prerank,negative regulation of cell cycle (GO:0045786),0.4024140140792336,1.10874984167462,0.32150537634408605,0.6620721111820895,1.0,26/73,25.82%,RHOB;NPPC;GPER1;CDKN1C;BTG1;BRINP3;GMNN;CEBPA;NUPR1;GAS1;BRINP1;CAMK2N1;BRINP2;LILRB1;BMP2;NLRP2B;HEXIM1;BTG4;INHBA;TGFB1;TFAP4;MEN1;DUSP1;CHMP1A;INHA;HHEX
prerank,protein depolymerization (GO:0051261),0.45144419809128455,1.1084724776021146,0.3561811505507956,0.6623717505982378,1.0,7/27,13.97%,GSN;CFL1;STMN3;STMN4;MICAL1;DSTN;STMN1
prerank,hepaticobiliary system development (GO:0061008),-0.35915419117680714,-1.1084333683774856,0.29949238578680204,0.6794670591624217,1.0,5/20,7.96%,TGFBR3;NIPBL;COBL;ARID5B;MET
prerank,Rac protein signal transduction (GO:0016601),0.48794292533311434,1.1084262689423863,0.3436293436293436,0.6620699000306378,1.0,6/18,17.42%,RAC1;ELMO1;RHOG;AIF1;TIAM1;RAC2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.48258805566946,1.1081384124676041,0.34517766497461927,0.6623826084162421,1.0,11/20,22.55%,TGM2;TMCO1;KCTD17;SELENOK;BAX;WFS1;HERPUD1;BCAP31;BAK1;FIS1;ATP2A2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3279786019647483,-1.1080396696562411,0.30405405405405406,0.6783616606592576,1.0,9/31,11.61%,TGFBR3;BMPR1A;TGFBR1;ZFPM2;FGFR2;SMAD7;SMAD4;TPM1;RBPJ
prerank,regulation of trophoblast cell migration (GO:1901163),0.513620608296987,1.107696841898542,0.3708165997322624,0.663083787431571,1.0,4/14,13.23%,CALR;ARHGDIB;TIMP1;GJA1
prerank,iron-sulfur cluster assembly (GO:0016226),0.46444661295227,1.107612321381737,0.3401442307692308,0.6628723384258728,1.0,8/24,21.18%,BOLA2;GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2396803431353905,-1.1074347349502582,0.16666666666666666,0.678003790407708,1.0,41/153,14.26%,ROCK2;LRRK2;ROCK1;CAMK2D;PRKCE;CSNK1A1;MAP3K13;MARK1;SMG1;PDPK1;RICTOR;TLK2;TGFBR1;EIF2AK3;TLK1;MAST2;DYRK1A;MARK3;MAPKAPK3;TOP1;NEK6;MAPK9;HIPK3;RIPK1;DMPK;PKD1;MORC3;TBK1;DGKQ;LATS2;STK38;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;GSK3B;MARK2;PRKCI
prerank,response to peptide hormone (GO:0043434),-0.2964062617780308,-1.1070284196749964,0.2857142857142857,0.6771343015727729,1.0,14/43,15.19%,ROCK2;TGFBR3;STAT5B;ROCK1;OGT;IRS1;EIF2B3;STAT3;STAT2;SIRT1;EIF2B2;TSC1;CRY1;STAT5A
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3205555575658466,-1.106668782572888,0.272108843537415,0.6760791442532433,1.0,11/28,18.00%,FOXP1;APPL2;BIRC2;RNF135;BIRC3;TRIM5;CASP8;PTPN22;APPL1;CD55;DHX58
prerank,myelin assembly (GO:0032288),0.5298911352823729,1.1062529448125669,0.37052932761087265,0.666038138976388,1.0,7/10,31.35%,PMP22;TENM4;EPB41L3;ABCA2;GPC1;CD9;CNTNAP1
prerank,regulation of heart contraction (GO:0008016),0.3900705993071812,1.1053819369720947,0.31917098445595854,0.6678864478556698,1.0,23/90,17.76%,CALM1;S100A1;NPPC;FXYD1;CALM3;AGT;ADORA3;ATP1A3;ATP1B2;PLN;FXYD7;ATP1A4;ATP1A1;ATP2B1;DES;TRPC1;KCNE5;ATP1B1;SLC8A1;RYR2;SRI;ATP1B3;FKBP1B
prerank,negative regulation of cellular process (GO:0048523),0.368638785026673,1.1051684704054097,0.153,0.6680038883959681,1.0,141/521,22.49%,FTH1;ARHGDIA;CLU;IGFBP6;RACK1;IFITM1;MDK;GPNMB;MT3;NDUFA13;PARK7;RHOB;S100A11;NME1;TMBIM6;TREM2;CRYAB;ERBB4;CD34;NPM1;IGFBP3;TXNIP;CCDC85B;CSNK2B;ADAM15;GPER1;ACVRL1;DSCAM;ENO1;RTN4;MIF;HSPA1B;PPP2R1A;SIRPA;CTNNB1;ST18;PDE3B;HYAL2;SFRP5;ARHGDIB;BTG1;LRPAP1;ADORA3;SSTR4;ADGRG1;ATP8A2;GMNN;BNIP3L;KLK8;PODXL;CEBPA;WFDC1;PROX1;CCN2;SYT11;JADE1;NUPR1;VAMP3;CGREF1;ADGRB1;ZBTB49;ARHGDIG;APBB1;THAP12;BRINP1;CTBP1;SOX17;ATF5;MSX1;TMEM109;WARS1;WFS1;VAMP8;HRAS;DNAJB2;CAMK2N1;ACTN1;KLF4;BST2;HSPA1A;GJA1;DDAH1;LILRB1;BMP2;FBXO5;NLRP2B;PDE12;SFRP4;STK11;COPS8;SLURP1;NR1H2;DLC1;DLL1;ING1;ADRA1A;DACT3;DAB2IP;VHL;SLIT3;LMNA;NDUFS3;PDCD5;SCIN;ADAMTS1;ERBB3;FABP7;BTG4;ANXA6;SCGB3A1;SOX11;CCAR2;LPXN;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;OSGIN1;SFRP1;SPHK2;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;PLXND1;RERG;CCN3;MEN1;TDRD9;CDA;SSTR2;REST;TMEM127;BLM;CD164;DUSP1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4560448013444102,1.1050709323443753,0.3520097442143727,0.6678216904028798,1.0,9/25,19.38%,APOC1;RAC1;LRPAP1;ARF6;UBQLN2;SDCBP;ANKRD13D;ABCA2;UNC119
prerank,cyclooxygenase pathway (GO:0019371),0.5494031954584561,1.1049562662876897,0.3756983240223464,0.6677022693726332,1.0,5/10,23.33%,PTGDS;HPGDS;PTGES3;CBR1;TBXAS1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4313862456557429,1.1049345761824163,0.3539518900343643,0.6673157999312709,1.0,10/37,16.62%,NLGN1;GRID2;TENM2;TENM3;IL1RAPL1;TENM4;CADM3;PTPRD;DCHS1;VCAM1
prerank,cellular response to interleukin-15 (GO:0071350),-0.40487715352188464,-1.104691325039784,0.29457364341085274,0.6775485930448117,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.40487715352188464,-1.104691325039784,0.29457364341085274,0.6775485930448117,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5142758618759097,1.104211197851472,0.37017310252996005,0.6688149793136166,1.0,4/13,17.49%,MDK;HMGB1;IGF2;ADAM17
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4415899604542691,1.103592357740791,0.34360189573459715,0.6699657282603791,1.0,10/30,23.89%,CD34;ISG15;HSPD1;LILRA5;HMGB1;F2RL1;SYK;IL6;PYCARD;CD28
prerank,regulation of viral life cycle (GO:1903900),0.4685622093234363,1.1033204895260842,0.32142857142857145,0.6702996542563627,1.0,5/21,22.66%,PPIA;HS3ST5;TYRO3;VPS4A;TRIM68
prerank,cellular component maintenance (GO:0043954),0.5256785641456394,1.1032253129048606,0.3578231292517007,0.6700956795313695,1.0,2/12,2.84%,PRNP;TREM2
prerank,zinc ion transmembrane transport (GO:0071577),0.4698682640025906,1.1031462000896903,0.36795994993742176,0.6698379425833697,1.0,5/22,11.56%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TRPM2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.386598474883817,-1.1027078004371937,0.3269230769230769,0.6810808243691279,1.0,6/16,19.40%,FOXD1;FGF1;SIX1;BMP4;FGF2;PKD2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5103263343568377,1.1024694436853992,0.36495388669301715,0.671213058488422,1.0,5/13,15.30%,SHISA7;GRIK2;SYNGR1;SYP;PPFIA3
prerank,cellular response to sterol (GO:0036315),-0.39752753108760197,-1.102373887135828,0.3140794223826715,0.6798808924836888,1.0,7/13,23.75%,SMO;LRP6;GRAMD1C;RORA;GPLD1;PTCH1;RORC
prerank,cellular response to hormone stimulus (GO:0032870),0.3960161874861189,1.10229327111837,0.3375796178343949,0.6712253554555094,1.0,18/69,20.17%,CTSB;CTSL;RAMP2;CTSS;GPER1;ZFP36L1;ATP1A3;RAMP3;WBP2;ATP1A1;CTSH;ROBO2;CAV1;SLIT3;NCOA4;NSMF;MEF2C;SFRP1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3606385166773331,-1.1019885193959187,0.35555555555555557,0.678856222952863,1.0,5/20,6.44%,ROCK2;FMNL2;ROCK1;DLG1;NCKAP1
prerank,response to exogenous dsRNA (GO:0043330),0.479847906163346,1.1019552894766593,0.3579617834394904,0.6717020105384347,1.0,9/18,31.39%,FLOT1;PQBP1;IFIT1;SLC3A2;CAV1;RALB;RFTN1;DHX9;MAVS
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.42694057927882645,1.1018956085127658,0.339041095890411,0.6714109314487557,1.0,13/39,23.49%,RBP4;TRH;LRRC8A;GPER1;CRH;RASL10B;BAD;ADCYAP1;DOC2B;GLUD1;NNAT;PSMD9;ACSL4
prerank,protein localization to cell periphery (GO:1990778),0.3792782920562775,1.1017242876144624,0.30403309203722856,0.6714382809075525,1.0,34/133,18.18%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;EHD1;LIN7C;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1;CRB3;ATP1B3;EHD2
prerank,vitamin D metabolic process (GO:0042359),0.50596643082065,1.1011742453408049,0.3804945054945055,0.6724121556109626,1.0,2/13,12.74%,LGMN;GC
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4216374667474405,1.1006760584557764,0.32721010332950634,0.6733411032654978,1.0,4/42,6.08%,ACTB;VPS72;MBD3;ZNHIT1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.44785771902204385,1.1004628974575212,0.34238488783943327,0.673436067203396,1.0,14/30,27.25%,CAVIN1;POLR2E;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,purine nucleotide metabolic process (GO:0006163),0.46003584941854436,1.100180461667247,0.3617283950617284,0.6737451272004039,1.0,11/24,26.00%,GPX1;GART;DNPH1;PNP;PRPS1L1;PRPS1;NT5C;GUK1;GDA;PRPSAP1;ADSL
prerank,cardiac muscle cell contraction (GO:0086003),0.4757163674089191,1.0996007720546597,0.37051282051282053,0.6748286427751425,1.0,5/19,11.97%,GSN;SCN1A;SCN4B;FGF12;ATP1A1
prerank,response to histamine (GO:0034776),0.5363636153698975,1.0992178672889594,0.3802008608321377,0.6754083992449471,1.0,3/10,16.30%,GABRB1;GABRB3;GABRB2
prerank,cellular amide metabolic process (GO:0043603),0.38715607621899994,1.0991723259835333,0.3048907388137357,0.675077954251133,1.0,32/102,24.25%,DBI;ATF4;CPXM1;CPD;ORMDL3;PPP2R1A;CPE;PLAAT3;SMPD1;AEBP1;OXSM;CPXM2;ACOT1;ACOT7;SLC19A1;GLYAT;DNPEP;NAAA;FOLR2;ABCA2;NIT1;ACOT4;CLN8;SHMT2;THEM4;ASAH2;MTHFS;SGPL1;ACSM5;ORMDL2;CPZ;THOP1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3925668356206967,1.098908570784992,0.32872340425531915,0.6753479614235797,1.0,6/76,4.50%,TMSB4X;RPS3;LAPTM5;CCL19;TNF;SPI1
prerank,hemopoiesis (GO:0030097),0.3901762992479769,1.098728886947055,0.3196635120925342,0.675394645209784,1.0,30/87,20.17%,ATF4;CD34;LYL1;GLRX5;PDGFB;PTPRC;ZFP36L2;TIRAP;SBDS;KIRREL3;CEBPA;KDR;KITLG;CSF1R;WNT5A;FLT4;ARMC6;SELPLG;WNT10B;RRAS;L3MBTL1;DLL1;FLT1;TOX;INHBA;RTKN2;FLT3;TGFB1;TPO;SFRP1
prerank,carnitine metabolic process (GO:0009437),-0.4263985895175833,-1.0984119732495565,0.31448763250883394,0.6864028857067233,1.0,8/12,28.56%,TMLHE;CPT1C;CPT2;ACADM;SHMT1;BBOX1;ALDH9A1;CPT1A
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4693657545640787,1.0983850520151404,0.3547979797979798,0.6758315339988936,1.0,1/19,0.71%,VIM
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.48845804628554823,1.0979258449589087,0.36,0.6766320789372915,1.0,8/16,19.11%,CALM1;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;FKBP1B;CALM2
prerank,protein acetylation (GO:0006473),-0.3288655769642842,-1.09788443980882,0.2624113475177305,0.6858178192040392,1.0,11/30,16.20%,CREBBP;NAA40;KAT2B;NAA16;NAA15;ESCO1;KAT6A;SIRT1;NAA35;SPHK1;FOXO1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3932217745603783,1.0978275552528374,0.33192389006342493,0.6764559294423985,1.0,20/75,18.31%,SPARC;CLDN5;SERPINF1;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,response to chemokine (GO:1990868),0.510102129639044,1.0975234159135605,0.3622159090909091,0.6768184091599956,1.0,5/13,26.20%,CXCL12;RHOA;DOCK8;DUSP1;OXSR1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4368198670964715,1.0972593940053443,0.34088200238379024,0.6770925238074312,1.0,7/32,13.19%,PGAM1;RPL10;GRM5;METAP1;PCIF1;RBM4B;METTL18
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.49403072046653296,1.0971593339819807,0.37317397078353254,0.6769170456427752,1.0,4/15,14.67%,ENTPD3;AK4;NME2;CMPK2
prerank,negative regulation of hormone secretion (GO:0046888),0.5382337436784222,1.0968594780496415,0.37660485021398005,0.6772684939112651,1.0,2/10,13.23%,IL11;GJA1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5147936591002606,1.0968312847702562,0.3721244925575101,0.6769038894639383,1.0,2/13,1.76%,APOD;PARK7
prerank,second-messenger-mediated signaling (GO:0019932),0.3887145116928814,1.0967821135576712,0.33192834562697576,0.6765967405055667,1.0,18/82,18.94%,APOE;RCAN3;AGT;PPP2R1A;CCR5;P2RY12;CHRM3;DDAH1;CXCR4;MAFA;CX3CR1;NUDT4;RYR2;CCL3;DDAH2;NOS2;CCR2;EDN3
prerank,protein autophosphorylation (GO:0046777),-0.23292460921486208,-1.0967593770584114,0.15384615384615385,0.6867895080863525,1.0,33/157,11.17%,GRK5;EGFR;FER;ABL1;DAPK1;LRRK2;CAMK2D;SIK2;MAP3K3;MAP3K13;CLK2;SMG1;EIF2AK4;PDPK1;EPHA4;STK24;CDK12;EIF2AK3;INSR;DYRK1A;MARK3;MAPKAPK3;SIK1;TAOK3;FGFR2;NEK6;AAK1;STK10;PDGFRB;RIPK1;PTK2;SLK;DAPK2
prerank,blood vessel endothelial cell migration (GO:0043534),0.4635997906343342,1.0963800103216281,0.36079900124843944,0.6772180671455488,1.0,5/22,8.38%,AKT1;SOX18;ID1;EMP2;KDR
prerank,regulation of epithelial cell differentiation (GO:0030856),0.48721679582817456,1.096377316876303,0.366751269035533,0.6767885309821517,1.0,5/17,16.42%,CEBPB;CD24;SOX9;DLL1;CAV1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3815775926675209,1.0962765433510333,0.3360910031023785,0.6766289255814555,1.0,25/110,17.30%,RAMP2;GPER1;ADGRB3;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;ADGRG1;RXFP1;CXCL10;ADGRB1;MC1R;ADGRB2;CALCB;RAMP3;ADCY4;PF4;ADGRL4;ADRA1D;ADRA1A;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,cholesterol biosynthetic process (GO:0006695),0.4335265248613317,1.0959845226746403,0.35005973715651134,0.677014806359613,1.0,12/31,28.44%,LSS;DHCR24;ACAA2;SC5D;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.45956380266099556,1.0955934883823943,0.36770186335403726,0.6776099242889989,1.0,6/23,16.92%,MDK;AGT;SOX8;SOX9;GJA1;PIK3CD
prerank,muscle cell differentiation (GO:0042692),0.43430443245338607,1.0955533897665517,0.3474178403755869,0.6772766814418274,1.0,8/32,20.07%,SGCZ;MRTFA;SEMA4C;MTLN;NINJ1;SYNE1;TMEM204;MEF2C
prerank,telomere organization (GO:0032200),0.42132615631689896,1.0954076938977741,0.35051546391752575,0.6772256447362489,1.0,15/43,25.10%,H3-3A;TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;DOT1L
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5156186124104455,1.0951550959428253,0.3760330578512397,0.6774531564459567,1.0,6/14,16.81%,PARK7;TMBIM6;CREB3;SYVN1;HSPA1A;HERPUD1
prerank,mRNA destabilization (GO:0061157),-0.29588123908609887,-1.0950994248370967,0.2644628099173554,0.6891772837504294,1.0,10/38,10.06%,ROCK2;FTO;ROCK1;DHX36;CNOT1;YTHDF3;TUT7;CPEB3;MOV10;RC3H2
prerank,regulation of mast cell activation (GO:0033003),0.5305468808340874,1.0950561640053107,0.391304347826087,0.6772887579072457,1.0,5/10,33.35%,CD84;CD300LF;CRLF2;PLSCR1;MILR1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4561872070389591,1.0948968232501224,0.35802469135802467,0.6772633219683005,1.0,3/21,3.08%,MT3;PARK7;PINK1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.44318029604031267,1.0944895587104724,0.3614163614163614,0.677944293205322,1.0,12/27,34.99%,CHKB;PLAAT3;PCYT2;NAAA;ETNPPL;PLA2G3;PLA2G6;CEPT1;PNPLA8;PISD;PLAAT1;PLA2G15
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48147884777450556,1.0943652441153608,0.3709043250327654,0.677845144145983,1.0,7/17,17.49%,AKT1;CCND2;PDGFB;CCND1;PROX1;MAPRE3;ADAM17
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4240012263732608,1.0943108321543658,0.36363636363636365,0.677558575564261,1.0,14/36,25.54%,ERBB4;TNF;PTPRC;HES1;LEPROT;CAV1;VHL;NOTCH1;IL6;IL10RB;ADIPOR1;SOCS3;DOT1L;HGS
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43132413068828934,1.0941592771595359,0.3632183908045977,0.6775231024192722,1.0,13/35,25.41%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,regulation of protein processing (GO:0070613),0.4672771726200784,1.0940152642513183,0.3635220125786163,0.6775000789773745,1.0,5/21,10.76%,PRNP;SERPINE2;TMEM59;PRSS37;GAS1
prerank,dopaminergic neuron differentiation (GO:0071542),0.48139823596679254,1.0939145719996868,0.36118251928020567,0.6773326654805663,1.0,6/19,21.30%,CTNNB1;MANF;OTX2;PHOX2A;FOXA2;FOXA1
prerank,negative regulation of cell development (GO:0010721),0.44220458288568326,1.0937559820496427,0.36691542288557216,0.6773079344689134,1.0,10/25,23.04%,B2M;TNF;SORL1;RFLNB;FBXW7;LILRB1;NOTCH1;IL6;REST;WNT7A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4078258667897377,1.0937373515348876,0.346782988004362,0.6769204797154362,1.0,13/59,15.46%,BSG;CD84;DSCAM;CNTN4;TENM3;KIRREL3;ROBO4;EMB;PECAM1;CADM3;IGSF9;DSCAML1;ROBO2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4202701926929351,1.093082122558473,0.35571260306242636,0.6781803438019762,1.0,9/39,14.60%,FXYD5;FXYD1;YWHAH;YWHAE;SCN4B;FXYD7;FGF12;CHRM3;KCNE5
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4340632774220014,1.092830885385712,0.3696172248803828,0.6783980924820059,1.0,9/31,19.67%,RBP4;PTPRC;TFRC;IL2;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4288894192325523,1.0925036211862842,0.3569767441860465,0.678783003182814,1.0,12/34,19.32%,TREM2;NR1D1;TNFAIP3;TICAM2;NLRP2B;TLR6;F2RL1;CD300LF;DAB2IP;TYRO3;CD300A;CD14
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5319451550681539,1.0922693231621705,0.3802612481857765,0.6789710715311368,1.0,1/10,2.61%,SERPINE2
prerank,positive regulation of neuron differentiation (GO:0045666),0.42075914013416793,1.0922078056853233,0.3649122807017544,0.6787121416136098,1.0,18/40,24.63%,NBL1;BRINP3;NRCAM;PROX1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;BEND6;TRIM32;SOX11;MEF2C;ADRA2B;REST;ECT2;TCF3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.45074330754520886,1.0921571765711073,0.35678391959798994,0.6784251730294534,1.0,5/25,7.46%,CTSS;NDUFA4;ANK3;COX17;ATP1B2
prerank,response to ionizing radiation (GO:0010212),-0.27118618778948234,-1.092075863350256,0.21875,0.6952611338260786,1.0,22/70,18.08%,EYA1;BABAM2;DCUN1D3;COP1;CLK2;BRAT1;SPIDR;UIMC1;RNF8;NHEJ1;INO80;MRNIP;EYA3;ATM;TNKS1BP1;USP28;SIRT1;KDM4D;TP53;INIP;MAPK14;INTS3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3680829514740556,1.0919384778715986,0.2625250501002004,0.6785422373378275,1.0,60/234,21.50%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;PARK7;AKT1;NPM1;AGT;NFAM1;BEX1;TNF;LAMTOR5;HCLS1;S100A8;S100A9;CAMK1D;HSPA1B;FLOT1;TIRAP;CTNNB1;TFRC;HIPK2;UBA52;EPHA5;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;HDAC5;UBE2V1;CX3CR1;TLR6;TSSK4;LRP8;ADCY8;CAV1;TRIM32;PPARGC1A;DDR2;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;BUD31;NFKBIA;PYCARD;FZD2;DDIT3;FOXA1;FZD1
prerank,nucleic acid-templated transcription (GO:0097659),0.418301920684725,1.0916797309281903,0.35785953177257523,0.6788174390419622,1.0,8/42,15.37%,PTMA;POLR2E;POLR2D;POLR2F;XAB2;POLR2G;POLR2K;RRAGC
prerank,sulfation (GO:0051923),-0.428940600000157,-1.0916004908607828,0.32653061224489793,0.694605464727516,1.0,1/11,0.07%,UST
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.38210098658577646,1.0912850389273665,0.3358050847457627,0.6794178958307624,1.0,20/87,13.63%,RPS27A;UBC;CLDN5;UBB;FMOD;ID1;ACVRL1;FKBP1A;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;AMHR2;ZMIZ2;COL1A2;RHOA;LEFTY1
prerank,hyaluronan metabolic process (GO:0030212),0.46068214699224547,1.0910466861751413,0.3702290076335878,0.679602387691472,1.0,4/23,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,steroid hormone biosynthetic process (GO:0120178),0.4368728628091725,1.0908392201209651,0.3546099290780142,0.6797350089100399,1.0,6/29,20.74%,TSPO;HSD17B6;FDX2;HSD3B2;STARD3NL;HSD17B11
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3222604941936222,-1.0906567942167835,0.32748538011695905,0.6951173459627095,1.0,8/29,10.55%,PLEKHH2;LIMA1;ARFGEF1;SLIT2;PRKN;ARPIN;KANK1;SMAD4
prerank,regulation of protein kinase C signaling (GO:0090036),0.4979256998565254,1.0905837162329044,0.37582128777923784,0.6800222763119688,1.0,6/14,20.24%,MYADM;MC1R;WNT5A;FLT4;ADRA1A;SPHK2
prerank,protein localization to cell junction (GO:1902414),-0.355566585467447,-1.090471983525656,0.2894736842105263,0.6936438363456502,1.0,11/22,21.96%,CGNL1;ARHGEF18;HEG1;DLG4;FERMT2;JAK1;NECTIN1;NLGN2;BSN;PAK2;MPP4
prerank,regulation of JUN kinase activity (GO:0043506),0.4286392292027119,1.090176827497697,0.36666666666666664,0.6806781662696295,1.0,7/33,16.24%,RPS3;TNF;PAK1;DNAJA1;MAPK8IP1;TLR6;DAB2IP
prerank,oligodendrocyte development (GO:0014003),0.48302111398728786,1.0901026723559177,0.38666666666666666,0.6804361960878547,1.0,9/15,33.08%,PLP1;B4GALT6;MYRF;EIF2B5;SOX10;EIF2B1;CNTNAP1;PRDM8;B4GALT5
prerank,regulation of organelle organization (GO:0033043),0.3881557430840581,1.090072582483789,0.3336886993603412,0.6800859987483829,1.0,21/80,17.17%,MAPK3;ARL6IP1;PINK1;S100A8;S100A9;STMN3;MSN;LMAN1;SAR1A;SURF4;MYO5A;SYT11;MAPT;ATP13A2;TMED9;PJVK;MIEF2;MFF;PDE4DIP;SQSTM1;DNM1L
prerank,phospholipid metabolic process (GO:0006644),0.3913090339656624,1.0899136910336924,0.3311965811965812,0.6800640863384885,1.0,21/71,25.29%,GPX4;PLAAT3;FADS1;LIPG;ENPP2;LPL;PIP4P1;PCYT2;SMPD1;PLA2G4F;GDE1;PLBD2;ABCA2;CLN8;AGPAT5;PLPPR2;PGP;AGPAT2;PLA2G3;PLPPR4;ABHD12
prerank,cellular response to starvation (GO:0009267),0.3706673134851604,1.0889431336603586,0.32016210739615,0.6821586736321756,1.0,18/147,7.08%,HSPA8;GABARAP;ATP6V0C;MAPK3;HSPA5;ATF4;ATP6V1F;MAP1LC3B;MAP1LC3A;LAMTOR2;LAMTOR4;GABARAPL2;LAMTOR5;ATP6V1G1;GABARAPL1;ATP6V0E2;FADS1;CEBPB
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5449459035759073,1.0888901527035544,0.3900414937759336,0.6818594628266955,1.0,4/10,19.11%,APOD;NDRG4;PTGIR;SNCA
prerank,bone development (GO:0060348),0.42259613736182583,1.0887354125091058,0.35141242937853107,0.6818328058929592,1.0,6/39,6.69%,RPL13;PPIB;VKORC1;TGM2;PTPRC;SBDS
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.31925904892511725,-1.0886347377790675,0.3116883116883117,0.696572722609314,1.0,10/31,14.40%,PARD3B;PARD3;PDCD6IP;DLG1;SYNJ2BP;OPHN1;PDZD11;MARK2;PRKCI;MYO9A
prerank,regulation of T cell chemotaxis (GO:0010819),0.5230055077005837,1.0885525538476282,0.39714285714285713,0.6818624174565523,1.0,5/11,26.20%,CXCL10;WNT5A;ADAM17;CCR2;OXSR1
prerank,pentose-phosphate shunt (GO:0006098),0.5368454606339507,1.0878696265594336,0.39316239316239315,0.6832413935638671,1.0,5/11,18.22%,TALDO1;PGLS;RPIA;PGD;TKT
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4281827712205184,1.087805252504427,0.36483253588516745,0.6829752204575797,1.0,8/34,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;ARHGEF7
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.40287863149412406,-1.0872181617017214,0.31316725978647686,0.6984689171118051,1.0,5/13,11.61%,TGFBR3;BMPR1A;ZFPM2;FGFR2;RBPJ
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38469073805583426,1.0870258655908773,0.35541535226077814,0.6845964162138442,1.0,24/87,16.20%,ARHGDIA;MDK;RHOB;RHOC;RAC1;GPM6B;ARHGDIB;IQGAP2;RHOG;FAM107A;ESAM;CORO1A;PAK1;EPHA5;PHPT1;PAK3;CSF1R;TRPM2;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,positive regulation of phosphorylation (GO:0042327),0.3636325102406453,1.0868835752123123,0.27354709418837675,0.6845327623477155,1.0,51/240,16.32%,PPIA;CD74;RACK1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;ANG;DSCAM;PIN1;MIF;FLOT1;KNDC1;RARRES2;LTK;MUSK;TFRC;CCND1;PAK1;P2RX7;KDR;MLXIPL;P2RY1;EPHA5;CSF1R;PECAM1;FLT4;HRAS;TMEM119;SOX9;TIE1;BMP2;GAS6;CLIP3;SDCBP;PTGES3;IGF2;RASGRP1;EPHB1;FLT1;TYRO3
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4155906673192582,1.0867156820383583,0.36621315192743764,0.6845331683152002,1.0,15/41,28.86%,CTSS;AKAP6;ANK3;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1;STAC
prerank,lipid transport (GO:0006869),0.38021923515204126,1.0860791296102048,0.33195449844881075,0.6857685278335928,1.0,13/97,12.54%,APOE;PLTP;GM2A;NPC2;SLCO1C1;SCP2;FABP5;ABCG1;MFSD2A;ATP8A1;SLC10A3;NME4;GLTP
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4580428445304422,1.0852445886273123,0.37092731829573933,0.6874660708936521,1.0,2/22,7.89%,B2M;HSPD1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4778984084228046,1.0851141418489771,0.3794466403162055,0.6874269327336934,1.0,5/17,16.39%,APOC1;LPL;SORT1;NR1H2;HDAC9
prerank,negative regulation of cell differentiation (GO:0045596),-0.23195689422622034,-1.0849991744772336,0.14285714285714285,0.7024861845346889,1.0,45/181,16.53%,LDLRAD4;RANBP3L;SMAD3;COL5A2;EGFR;ADAMTS12;SMAD6;COL5A1;CRIM1;ZBTB16;SUFU;LRP5;SKI;YAP1;EIF2AK4;PPARA;ADGRV1;TGFBR1;EFEMP1;ASXL1;ZFPM2;CDK6;RUNX1T1;TRIB2;NPHP3;SMAD7;ENPP1;PPARG;PTEN;TRPM4;PDCD4;FERMT2;TRIO;JAG1;RORA;SIRT1;BMP4;DTX1;CHADL;IL17RD;CDC73;LIMD1;FOXO1;ANKRD26;WNT9A
prerank,macroautophagy (GO:0016236),0.37551711507654467,1.0848467626965494,0.34698055271238487,0.687656495196713,1.0,19/118,12.05%,GABARAP;DYNLL2;DYNLL1;TOMM6;TOMM5;TOMM7;MAP1LC3B;PINK1;MAP1LC3A;CSNK2B;GABARAPL2;GABARAPL1;CHMP2B;VCP;ATP13A2;CHMP6;ULK3;VAMP8;VPS28
prerank,axonal fasciculation (GO:0007413),0.5092234464512654,1.0848159780753244,0.3958333333333333,0.6873178242862159,1.0,4/12,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.41724344750296555,-1.0847606864631125,0.35185185185185186,0.7011933604810564,1.0,4/12,15.55%,GMDS;FUT8;PARG;GFPT2
prerank,regulation of neuron projection arborization (GO:0150011),-0.37982841840172554,-1.0844879133119645,0.32061068702290074,0.6998887512235814,1.0,6/15,14.40%,MACF1;MAP3K13;MOV10;DLG4;DVL3;MYO9A
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4014373067396599,-1.0828291647221016,0.36981132075471695,0.7023659796615754,1.0,2/13,2.98%,KCNK5;KCNT2
prerank,lysosome organization (GO:0007040),0.4221221323324041,1.0827013990131993,0.37986270022883295,0.6924211719370408,1.0,8/36,13.30%,GRN;CORO1A;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,synaptic vesicle recycling (GO:0036465),0.4327810257887963,1.0823374050643981,0.38822115384615385,0.6929462758022368,1.0,18/31,32.94%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA;WNT7A;SYT5;TBC1D24;PIP5K1C;SYT7;RAB3A;CEL;SNCG;SNCB
prerank,thyroid hormone generation (GO:0006590),-0.4442299974096917,-1.0822261227547776,0.34285714285714286,0.7020482525645161,1.0,1/10,0.40%,CPQ
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.36087229913954644,1.0821752031144896,0.27927927927927926,0.6929620450848657,1.0,69/264,21.41%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;STRAP;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200
prerank,nucleoside salvage (GO:0043174),0.5276021959724364,1.0815261455079273,0.39492242595204513,0.6942708163340924,1.0,7/10,31.96%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;DCK
prerank,regulation of synapse maturation (GO:0090128),0.5276809705244063,1.0812565769841092,0.37985611510791367,0.6945721597197295,1.0,6/10,32.76%,NRXN1;YWHAZ;DAB2IP;CDC20;CAMK2B;RELN
prerank,calcium ion import across plasma membrane (GO:0098703),0.48994217665720124,1.0807477750952315,0.3714670255720054,0.6954807084500703,1.0,5/14,28.26%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4754851385391603,1.080712910317124,0.38461538461538464,0.6951319913211356,1.0,5/19,17.17%,PARK7;PINK1;ATP13A2;FBXW7;DNM1L
prerank,base conversion or substitution editing (GO:0016553),0.5203390666712115,1.0807027799823694,0.398884239888424,0.6947293112638532,1.0,4/11,24.57%,APOBEC2;NUDT16;APOBEC1;METTL3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5038372664045525,1.0803876722711583,0.4111888111888112,0.6950930438716211,1.0,2/13,6.02%,SULT4A1;BPNT2
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3528914154064654,-1.0802214881059782,0.33513513513513515,0.705589721362314,1.0,10/22,19.26%,NTRK3;PDPK1;AGTR1;FGFR2;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.27093681928674007,-1.0801784164371315,0.2903225806451613,0.7036934299845038,1.0,17/67,10.73%,EGFR;FER;ABL1;GHR;EPHA3;IL15;EPHA4;EFEMP1;INSR;DYRK1A;PIBF1;FGFR2;PDGFRB;ABI1;ABL2;PTK2;EPHB2
prerank,regulation of muscle contraction (GO:0006937),0.43955352800300385,1.0801620002451437,0.36848484848484847,0.6952378009941569,1.0,8/26,18.67%,MYL9;ENO1;CHRM2;TNNI1;KCNA1;CAV1;SRI;ANXA6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.48375738598430684,1.0799952469810004,0.408,0.6952653417434811,1.0,3/16,3.71%,MDK;ITGB2;TNF
prerank,chloride transport (GO:0006821),0.38895883421175736,1.0797769060144944,0.373134328358209,0.6954104152895939,1.0,14/74,12.51%,GABRB1;FXYD1;LRRC8A;GABRG3;GABRA2;SLC12A5;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;CLIC1;TTYH3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.39670537214949697,1.0785658661904947,0.3682539682539683,0.6981913940679505,1.0,10/63,13.46%,RPL26;RPS27L;CHEK2;PCBP4;RPA2;CCND1;BAX;PCNA;PRMT1;FBXO31
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4927202467392783,1.0782741463056886,0.3768707482993197,0.6985000690417699,1.0,2/14,10.09%,CHKB;PCYT2
prerank,macrophage differentiation (GO:0030225),-0.39580632040491065,-1.0782270272312375,0.33093525179856115,0.7067907007807921,1.0,5/13,13.72%,IL31RA;IL15;SIRT1;CASP8;BMP4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.39552823439395834,-1.0777999851504239,0.37398373983739835,0.706004818554148,1.0,6/14,22.93%,SEC24D;SCAP;SEC24A;SEC24C;SEC31B;RAB1A
prerank,cellular response to light stimulus (GO:0071482),0.38857760369975136,1.077550029284432,0.35965848452508004,0.6999782367881787,1.0,9/66,12.08%,RPL26;ATF4;NPM1;COPS9;PARP1;AQP1;SMPD1;PCNA;NSMCE3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.42083634829141364,-1.0773910279615329,0.3516483516483517,0.7051578282620435,1.0,4/11,8.19%,GHR;IRS1;EIF2AK3;IGF1
prerank,RNA splicing (GO:0008380),0.3744299232411396,1.0771253037353636,0.3596673596673597,0.7006330419901158,1.0,25/95,19.04%,SNRPG;MAGOHB;MAGOH;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;TARDBP;PRPF8;SRSF2;SF3B2;IVNS1ABP;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;TXNL4A;SNRPD3;CCAR2;USB1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.36771840122239624,1.0766472395513202,0.34712411705348134,0.7014342928850965,1.0,58/151,31.64%,APOE;CHKB;GSTM1;CERS2;CSNK2B;GPHN;MGST1;GSTO1;ELOVL1;ELOVL2;MFSD2A;GSTM5;MGST3;GSTM2;ELOVL7;CHAT;GCNT1;HPGDS;SPTLC1;DEGS1;ACHE;FA2H;CSNK1G2;SPTSSA;AKR1A1;INHBA;VAPA;ESD;SGPP1;SPHK2;SGPP2;SLC44A5;SGPL1;TNIP1;STARD10;LPCAT2;MOCS2;ELOVL6;ALDH3B1;VAPB;SLC44A2;INHA;LCMT2;ASL;HACD4;SLC44A1;SAMD8;CERT1;GSTM4;ALAS2;ASS1;ARG2;CEPT1;SPNS2;ALDH3A2;PCSK1;ELOVL4;ALAS1
prerank,response to tumor necrosis factor (GO:0034612),0.38117639745161125,1.0762648140154762,0.36506276150627615,0.7020074994299159,1.0,18/91,17.62%,RPS3;AKT1;CCL19;GPER1;NR1D1;ZFP36L1;ZFP36L2;HYAL2;CXCL16;ZFP36;SMPD1;ERBIN;CCL2;YBX3;DAB2IP;CCL3;TRIM32;CCL8
prerank,erythrocyte development (GO:0048821),0.5140575751499852,1.0762597999012755,0.38920454545454547,0.7015889013283945,1.0,5/10,31.64%,ZBTB7A;ABCB10;DMTN;ALAS2;ALAS1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.31777796710060474,-1.0761462777226036,0.3148148148148148,0.7064849435358432,1.0,6/31,8.39%,HOXB3;HOXA3;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,positive regulation of protein acetylation (GO:1901985),-0.40745909526814805,-1.076065290418768,0.3475177304964539,0.7047796158776981,1.0,5/12,14.72%,CEP295;FAM161A;PRKAA2;RAPGEF3;TAOK1
prerank,protein localization to membrane (GO:0072657),0.36331765476384503,1.0757482300614578,0.32926829268292684,0.7024408722463208,1.0,41/187,16.42%,BSG;CD81;RAMP2;KCNIP4;NRXN1;NLGN1;S100A10;ITGB2;ANK3;TNF;EMP2;DPP10;DLG2;PACSIN1;FLOT1;FLNA;CPE;MYADM;RAB15;DPP6;TMED2;MYO5A;THY1;RAB3C;P2RY1;ABHD17A;RAB3D;RAMP3;NRXN2;GAS6;TNFRSF1A;MAP7;LRRC7;EHD1;LIN7C;FRMPD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1
prerank,cellular response to calcium ion (GO:0071277),0.38979784351118496,1.0755997999306781,0.37431991294885747,0.7023972483274389,1.0,25/67,25.93%,LGMN;NLGN1;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;WNT5A;TRPM2;ALOX5AP;CPNE5;SYT10;CPNE6;DMTN;ADCY8;SYT2;CPNE4;MEF2C;CAPN3;SYT3;SYT5;ECT2;SYT17;CPNE3
prerank,inorganic cation transmembrane transport (GO:0098662),0.3588892989117685,1.075353460806995,0.297,0.7025657916209271,1.0,61/268,19.70%,ATP5MF;ATP6V0C;ATP5F1B;SLC30A1;ASIC2;ATP6V1F;SLC39A1;UCP2;SLC24A4;SLC24A2;KCNQ3;SCN1A;KCNQ2;KCNC3;FKBP1A;KCND2;ATP6V0E2;KCNJ10;CACNA1A;ATP1A3;SLC39A7;TMCO1;SLC6A6;P2RX7;HVCN1;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;KCNC1;KCNA2;TRPM2;TRPC7;KCNN2;SLC40A1;ATP1A4;ATP1A1;KCNK9;SLC11A1;SLC25A27;ABCC8;GAS6;TRPC1;KCNF1;ATP1B1;SLC8A1;HCN1;KCNK3;KCNA1;ORAI1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,protein-containing complex subunit organization (GO:0043933),0.37059634767488514,1.074697962663392,0.36119711042311664,0.7038605100314604,1.0,28/109,20.50%,CD74;CHCHD10;ELOB;LAMC1;SLC2A1;TAPBP;PPP2R1A;IL2RB;HES1;ADD2;OTX2;RIMS1;CAPZA2;VAMP3;VAMP2;SOX9;MAGI1;TSPAN4;CAPG;SPG7;DMTN;DNM1L;PPARGC1A;EPRS1;LPXN;IL1RAP;CAPN3;TFAP4
prerank,regulation of neuron migration (GO:2001222),0.43671468416424875,1.0746891889559296,0.38545454545454544,0.7034552256566662,1.0,12/26,26.22%,MDK;CTNNA2;ADGRG1;COL3A1;SHTN1;TNN;IGSF10;DAB2IP;NSMF;PLXNB2;KIF20B;CX3CL1
prerank,ion homeostasis (GO:0050801),-0.31348263529557296,-1.0743871659333721,0.32571428571428573,0.7074296461942928,1.0,20/30,34.49%,SLC4A10;CAMK2D;FHL1;WNK4;KLHL3;SLC4A3;HCN4;RANGRF;NEDD4L;SLC4A9;SLC4A5;SLC4A4;SLC4A11;AP3D1;SLC4A7;SLC30A2;SLC30A3;SLC30A8;WNK1;RHAG
prerank,cellular defense response (GO:0006968),0.4110547709051443,1.0741783110998264,0.4034090909090909,0.7043512733591442,1.0,15/40,26.69%,TYROBP;CD5L;LGALS3BP;C5AR1;CCR5;KLRG1;CX3CR1;NCR1;NCF1;TRAT1;NCF2;RELA;LBP;ITGB1;ITK
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4835893526698796,1.074097805580621,0.3905635648754915,0.7041087645368649,1.0,4/15,11.24%,PNPLA2;TREM2;LPL;PLIN3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.47040786871156615,1.0738449110547095,0.3944954128440367,0.7043277072953784,1.0,8/19,23.97%,RPS27L;HIPK2;TMEM109;SNW1;DDIT4;PYCARD;PHLDA3;DYRK2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4478206131893702,1.0738281163299737,0.37453646477132263,0.7039505929074873,1.0,6/27,10.98%,FXYD5;FXYD1;YWHAH;SCN4B;FXYD7;FGF12
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3849140924114902,1.0732532049816634,0.36792452830188677,0.7050010461978121,1.0,21/85,16.57%,B2M;GPX1;GRN;LAMC1;NME1;MAGED1;NR1D1;ACVRL1;ZFP36L1;C5AR1;CDKN1C;NUPR1;EPPK1;ZFP36;HRAS;SOX9;TIE1;NME2;BAD;DAB2IP;EPB41L4B
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.39363456172350003,-1.0732301698400324,0.37362637362637363,0.7087705023479615,1.0,6/13,13.72%,NFIB;PPARA;NFATC4;PPARG;NFATC3;BMP4
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.43663013428463116,1.0720319361977868,0.39805825242718446,0.7077364045867524,1.0,5/26,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,response to retinoic acid (GO:0032526),0.39433607044160746,1.0719705287399712,0.35706462212486306,0.7074431053281163,1.0,13/59,14.17%,NDUFA13;RBP4;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B;CTSH
prerank,aorta development (GO:0035904),-0.388146897140253,-1.0718968965318385,0.35564853556485354,0.7103838038758595,1.0,6/14,12.82%,HECTD1;ROBO1;ADAMTS9;PDGFRB;LRP1;JAG1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3842132462996468,1.071588731281874,0.38160676532769555,0.7079791278800688,1.0,15/80,10.72%,USE1;ARF5;LMAN2;TAPBP;ERGIC3;KDELR1;TMED7;SURF4;TMED2;ARFGAP2;KIF5A;TMED3;RER1;KIF26A;TMED9
prerank,negative regulation of interleukin-6 production (GO:0032715),0.43574255685674257,1.0711567112365488,0.4152334152334152,0.7086323344893302,1.0,7/27,21.40%,TNF;SIRPA;TNFAIP3;SYT11;GAS6;PTPN6;SELENOS
prerank,protein localization to synapse (GO:0035418),0.5060070859904187,1.0708425945169178,0.3991825613079019,0.7090158964827608,1.0,3/12,12.53%,NRXN1;NLGN1;NRXN2
prerank,regulation of macroautophagy (GO:0016241),0.3762609296951188,1.0703710137041422,0.3658280922431866,0.7098174653688984,1.0,24/105,16.15%,GAPDH;ATP6V0C;CAPNS1;AKT1;PINK1;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;UCHL1;ATP6V0E2;BNIP3L;SCOC;KDR;CDK5R1;ATP13A2;DCN;ATP6V0D2;UBQLN2;LAMTOR3;ATG101;RRAGC;CDK5;RRAGD
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3319704061404637,-1.0695798391062827,0.3463687150837989,0.7149683430757965,1.0,5/25,6.88%,EXT1;B3GNT2;HS2ST1;B3GALT1;NDST1
prerank,granulocyte differentiation (GO:0030851),0.470023096905982,1.0691564679988703,0.4091503267973856,0.7124875703234256,1.0,3/18,10.36%,SPI1;CEBPA;DEK
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.45811268672023797,1.069035545669246,0.3987421383647799,0.7123776781201895,1.0,6/21,18.08%,PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1
prerank,neuron projection regeneration (GO:0031102),0.5331389511045439,1.068878007649688,0.41917024320457796,0.7123551407167333,1.0,7/10,40.34%,GAP43;PTN;DHFR;NREP;MTR;OMG;RTN4RL1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.38440150287760416,1.0687732989575285,0.3820704375667022,0.7121855728788558,1.0,25/78,19.84%,ACTB;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;TMEM59;AP2M1;RHOG;CLTC;ARF6;ZDHHC5;RAMP3;VAMP8;RSC1A1;CLIP3;CDK5;SQSTM1;MMP14;TMBIM1;STX4;VPS4A;STAC3;TGFB1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3591432449781285,1.0687623331098262,0.30930930930930933,0.7117767957842193,1.0,59/314,13.85%,RPS27A;UBC;UBB;PSMB4;SEC61B;UBXN1;HSPA5;PSME1;PSMB6;PSME2;PSMB8;PSMD2;KCTD10;HSP90B1;PSMD1;AUP1;UBE2G2;PSMC3;UCHL1;ECRG4;CTNNB1;PSMD6;VCP;CDC34;RNF187;UBA52;PSMA7;KCTD2;FEM1A;FEM1C;FBXL14;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;SEL1L2;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;WFS1;SYVN1;DNAJB2;MAN1B1;PSMB11;ZSWIM8;FBXW7;UBQLN2;FBXO5;FBXO31;PSMB10;KBTBD7
prerank,TOR signaling (GO:0031929),0.4353496596714226,1.0686911325100963,0.3823884197828709,0.7115242793933322,1.0,7/26,14.27%,RPS6;AKT1;PINK1;PRR5L;RHEBL1;CCDC88A;PRR5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.46146479812695185,1.0679203222067346,0.41415465268676277,0.7130737903017165,1.0,6/18,18.77%,NRXN1;NLGN1;CCL2;CACNG8;CCR2;CACNG5
prerank,centromere complex assembly (GO:0034508),-0.29328915394698696,-1.0676807028038942,0.36054421768707484,0.7182194063352833,1.0,18/36,26.05%,SMARCA5;POGZ;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPE;CENPU;CENPI;CENPH;MIS18BP1;MIS12;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,sensory perception of chemical stimulus (GO:0007606),0.49049281384560284,1.067438835665804,0.41304347826086957,0.7139044783421161,1.0,3/15,15.44%,SLC24A4;C5AR1;SYT10
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4868084607362303,1.0666418373743352,0.3970976253298153,0.7155801230797584,1.0,5/14,17.36%,AKT1;DDB1;PMAIP1;ARPP19;PPARGC1A
prerank,positive regulation of cell cycle process (GO:0090068),-0.24817389380159588,-1.0664313904916847,0.37142857142857144,0.7197392024713293,1.0,26/91,21.61%,SVIL;CEP295;LRP5;PRKCE;INSR;CDC14A;UBXN2B;IGF1;PDGFRB;CSPP1;CDC25B;INO80;PKP4;GIPC1;NUMA1;PHIP;DYNC1LI1;MAD2L1;CDC14B;RACGAP1;NUP62;PKN2;NDC80;KIF23;XRCC3;TPR
prerank,protein localization to plasma membrane (GO:0072659),0.366997469959211,1.0660923876365929,0.38193018480492813,0.7165553899255607,1.0,33/129,18.18%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;CCDC88A;EHD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CRB3;ATP1B3;EHD2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.505981358531447,1.066002739129714,0.4157458563535912,0.7163143178767358,1.0,3/12,14.54%,SERINC3;PHGDH;SERINC5
prerank,axonal transport of mitochondrion (GO:0019896),0.4989167583111681,1.06567921976731,0.41217150760719223,0.7166783862285421,1.0,3/11,11.11%,NEFL;MAPT;HAP1
prerank,brain development (GO:0007420),0.3678864660666191,1.0656189232126776,0.3718079673135853,0.7163933018184273,1.0,37/136,19.99%,APOD;CTNNA2;NES;CNTNAP2;CNTN4;SCTR;NDRG4;ABCB6;ADGRL3;GRIN1;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;SLC6A17;CDK5R1;DNAJC30;AATK;HAP1;CLN5;CXCR4;CX3CR1;IER3IP1;DSCAML1;ROBO2;GRIN2B;QARS1;RAB18;NNAT;HSPG2;DDIT4
prerank,mitotic cytokinetic process (GO:1902410),0.46319504258590083,1.0651777078695397,0.4117647058823529,0.7171081509375281,1.0,9/20,25.88%,CHMP2B;CHMP5;CHMP6;RHOA;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4076403517773027,1.0650898499604076,0.3950892857142857,0.7169073818207792,1.0,10/45,12.33%,AURKAIP1;ZFP36L1;ZFP36L2;CTNNB1;CDKN1C;BTG1;BRINP3;GAS1;BRINP1;BRINP2
prerank,thymus development (GO:0048538),0.4989419710452261,1.0650058856601419,0.41534391534391535,0.7166891959448257,1.0,2/13,5.71%,SOD1;HES1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5276334455500296,1.0642288646942688,0.4027972027972028,0.718269147361515,1.0,3/10,16.24%,CADM4;DCN;DAB2IP
prerank,regulation of biomineral tissue development (GO:0070167),0.4334352218643555,1.0641583878277057,0.38881987577639754,0.7180016015288944,1.0,12/26,19.84%,ECM1;S1PR1;CEBPB;SOX9;FBXO5;GAS6;HEY1;TWIST1;DDR2;NOTUM;NOTCH1;TGFB1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4367897365889443,1.0639748426539968,0.3966547192353644,0.7180710728053171,1.0,3/23,8.79%,CALM1;METAP1;METAP2
prerank,cellular response to glucose starvation (GO:0042149),-0.2976303787148654,-1.0638988303159158,0.2978723404255319,0.7245260252781124,1.0,12/41,16.27%,PRKAG2;SIK2;MTMR3;FOXO3;EIF2AK3;SIK1;PRKAA2;SESN1;NUAK1;PRKAG1;ITFG2;TP53
prerank,acidic amino acid transport (GO:0015800),0.4700749927788904,1.0637932576360642,0.39594594594594595,0.7181058128001746,1.0,6/17,13.23%,SLC1A2;SLC25A13;SLC6A6;SLC1A1;SLC25A22;GJA1
prerank,amino acid import across plasma membrane (GO:0089718),0.44676112652602534,1.0634609113317084,0.4167709637046308,0.7184996864403745,1.0,8/24,12.43%,SLC7A5;SLC1A4;SLC1A2;TSPO2;SLC6A6;SLC6A5;SLC3A2;SLC1A1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5115261529346962,1.0629574815180625,0.4103641456582633,0.7194209653208443,1.0,3/11,15.47%,CTDNEP1;MFSD2A;NR1H2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.40786106683681844,-1.062911602905534,0.36363636363636365,0.7252867394377395,1.0,5/12,14.89%,PARP12;PARP16;PARP3;TNKS2;PARP10
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4261356431882031,1.0628298043264308,0.41169305724725946,0.7193018352316738,1.0,10/28,17.34%,AKT1;ARRDC1;GATA2;ZBTB7A;FBXW7;HEY1;BEND6;DLL1;EGFL7;MMP14
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3686891940232425,1.0628258691768817,0.37743589743589745,0.718881733703036,1.0,26/116,19.67%,RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36198785476396783,1.0623953285321315,0.3413897280966767,0.7195552183718023,1.0,53/208,20.94%,CD74;GAPDH;HSPB1;LGALS1;HMOX1;CCL19;S100B;TREM2;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;NR1D1;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TNFAIP3;TFRC;TMEM101;CLEC6A;OTUD7A;TICAM2;TMEM9B;TRIM59;RBCK1;WNT5A;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1;TRAF3;DAB2IP;SQSTM1;TRIM32;S100A4;TERF2IP;LTBR;TRIM13;VAPA;CANT1;SPHK2;GOLT1B;CAPN3;TMEM106A;PYCARD
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2955299246116059,-1.0621760710946508,0.3120567375886525,0.7253991024779194,1.0,7/39,12.93%,PI4KA;TTC7B;SMG1;ITPKB;IP6K2;PIP4K2C;SOCS5
prerank,negative regulation of immune response (GO:0050777),0.36210029288900714,1.061749061367509,0.3643724696356275,0.7208100880608719,1.0,33/154,18.71%,RAMP2;TREM2;POMC;LGALS3;SPI1;SCTR;TNFAIP3;DRD5;CD163;RXFP1;PRKAR1A;COL3A1;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;LILRB1;ADCY4;TYRO3;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;CD300A;SYK;CCR2;GPR83
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.41067562154125703,-1.0614852299736501,0.35789473684210527,0.725269531474341,1.0,2/12,1.09%,NOTCH2;DOCK11
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.42868812108015925,-1.0614591017977342,0.3862815884476534,0.723386625933971,1.0,6/10,20.46%,SETD2;EHMT1;SETD7;SETD4;SETD3;SETD6
prerank,carbohydrate transport (GO:0008643),0.5040216348988207,1.0610002644734489,0.4166666666666667,0.722285075321732,1.0,3/11,16.52%,AQP1;SLC50A1;SLC2A2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4594814724138285,1.060956409173638,0.3979591836734694,0.7219775674365237,1.0,3/18,14.43%,FCER1G;C5AR1;SH2B2
prerank,apoptotic DNA fragmentation (GO:0006309),0.47846503142749347,1.0607400140287517,0.4065359477124183,0.7221102313473158,1.0,4/16,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,lipid biosynthetic process (GO:0008610),0.3769165323614057,1.0605384033130212,0.37671957671957673,0.7221884503261976,1.0,17/77,23.49%,SCD5;SCP2;FADS1;LIPG;LSS;LPL;PCYT2;OXSM;SCD;HSD3B2;CLN8;AGPAT5;PDSS1;ACSM5;NDUFAB1;PRLR;ACLY
prerank,neurotransmitter uptake (GO:0001504),0.4946068479746512,1.0604014826982187,0.4081081081081081,0.7221084833542977,1.0,4/12,14.83%,SNAP25;GLUL;SLC29A1;SLC29A2
prerank,ganglion development (GO:0061548),0.5091079503453317,1.0599526379859487,0.40027137042062416,0.7228460001253694,1.0,3/11,9.29%,SEMA3F;CTNNB1;UNC5C
prerank,regulation of neurotransmitter secretion (GO:0046928),0.4198639184763059,1.0597239089814205,0.4058479532163743,0.7230069585552272,1.0,11/32,22.37%,SLC30A1;GPER1;RIMS2;RIMS1;SYT11;SYN1;HCRT;PREPL;MEF2C;STX1B;CHRNA3
prerank,positive regulation of lipid kinase activity (GO:0090218),0.42083919269270453,1.0595076914707047,0.4046172539489672,0.7231589893513524,1.0,5/29,9.32%,CD81;CCL19;PDGFB;EEF1A2;P2RY12
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.387645791225926,-1.0594603489244585,0.40408163265306124,0.7269028467823915,1.0,6/15,19.25%,NIPBL;TGFBR1;FGFR2;SIX1;PDGFRA;MTHFD1L
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3595461975600721,1.0591797879017542,0.3780241935483871,0.7235622483444852,1.0,32/170,15.65%,APOE;CRIP1;PCBP1;HNRNPAB;TREM2;HNRNPK;PTPRC;TAPBP;ZFP36L1;PIN1;FLOT1;SIRPA;APLNR;PCBP4;ALPK2;RNF187;NELL1;PRDM12;PROX1;YBX1;TARDBP;MTMR9;KDM6B;ATRAID;AIF1;RO60;SORT1;ARF1;ATP1B1;DHH;SLC8A1;YBX3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36628462619308744,1.0585670492234245,0.3586626139817629,0.724651917832946,1.0,31/158,14.62%,CD74;GAPDH;LGALS1;HMOX1;CCL19;S100B;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TFRC;TMEM101;CLEC6A;TICAM2;TMEM9B;RBCK1;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4146075219154578,1.0585281720367667,0.4131455399061033,0.724323723822881,1.0,4/36,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,transport across blood-brain barrier (GO:0150104),0.3773211284850815,1.0583426407675607,0.3983050847457627,0.7243543526575921,1.0,22/83,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;FABP5;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,protein homotetramerization (GO:0051289),0.3960439383221005,1.0576529887318489,0.4149286498353458,0.7257423353558299,1.0,3/49,2.27%,ALDOA;B2M;AQP4
prerank,establishment of skin barrier (GO:0061436),0.46965573564418045,1.0575277003963353,0.40498034076015726,0.72520624883333,1.0,4/15,16.90%,HRNR;LSR;STMN1;FA2H
prerank,regulation of water loss via skin (GO:0033561),0.46965573564418045,1.0575277003963353,0.40498034076015726,0.72520624883333,1.0,4/15,16.90%,HRNR;LSR;STMN1;FA2H
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.32210902273435704,-1.0575180174449155,0.3945578231292517,0.7303734800050721,1.0,11/26,16.96%,SORBS1;OSBPL8;BRAF;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,neuron differentiation (GO:0030182),0.35932219970822227,1.057341449687479,0.3773965691220989,0.7252617780760604,1.0,57/165,29.19%,ITM2C;NTRK2;PIN1;CTNNB1;SPOCK1;TENM2;TENM3;MANF;OTX2;ATP8A2;IL1RAPL1;CDK5R1;EPHA5;PHOX2A;TENM4;WNT5A;PTPRD;IRX3;WNT10B;UGDH;CDK5;OLIG1;MYEF2;FUT9;BRSK2;ERCC6;MYT1L;BTG4;ACSL3;SOX11;INHBA;DDIT4;MEF2C;FOXA2;FZD2;ID2;FOXA1;HS6ST1;FZD1;USH2A;IER2;WNT7A;ACSL4;OLIG2;SRF;RORB;FZD3;ALK;TGFB2;ERCC2;XBP1;TENM1;ATP2B2;FZD5;MTPN;SNPH;IRX5
prerank,regulation of protein secretion (GO:0050708),0.36843312517023624,1.05706187706313,0.3961105424769703,0.7255720863339823,1.0,29/119,21.29%,APOE;PPIA;UQCC2;MTNR1B;SLC2A1;SNAP25;TREM2;TNF;ANG;ABCG1;CACNA1A;ARF6;ATP13A2;DPH3;STXBP5L;APBB1;ABCC8;IER3IP1;ACHE;SLC2A2;DNM1L;NOS2;TFAP2B;IL6;ERP29;TGFB1;KCNC2;RSAD2;TMED10
prerank,regulation of receptor internalization (GO:0002090),0.41351566020144637,1.0565980085221736,0.39952718676122934,0.7263271595871519,1.0,8/35,15.91%,CD63;FLOT1;LRPAP1;SFRP4;SDCBP;ARF1;ANKRD13D;ARRB2
prerank,positive chemotaxis (GO:0050918),0.47072846215522307,1.0561798250319872,0.4205128205128205,0.7269187742856917,1.0,3/17,7.45%,GPNMB;LGALS3;CORO1A
prerank,regulation of platelet aggregation (GO:0090330),0.47211247575794235,1.0561095697178258,0.4243208279430789,0.7266574772927269,1.0,6/17,26.81%,SERPINE2;DMTN;SYK;PRKCA;PRKCQ;CD9
prerank,mRNA processing (GO:0006397),0.3522993356159229,1.0558882634961708,0.344,0.7267691824752145,1.0,98/287,26.91%,HSPA8;PCBP1;SNRPG;AURKAIP1;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SUPT4H1;SRSF2;SF3A2;PABPC1;CMTR1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;THOC3;PDCD7;EIF4A3;PRPF31;SF3B6;PPARGC1A;TXNL4A;TBRG4;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;SRRM4;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;RAMAC;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5;ALKBH5;METTL3;METTL14;PRPF40B;PRKACA;PPIE;DNAJC8;GTF2H5;RPRD1A;SART1;HNRNPC;SYMPK;ERCC2;USP39;CCNH
prerank,miRNA metabolic process (GO:0010586),-0.33954778010118347,-1.055879607643031,0.34782608695652173,0.7330437476139176,1.0,9/20,16.50%,TENT4B;DICER1;PARN;DROSHA;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4837843220938348,1.0553701536389244,0.4141145139813582,0.7276666955551444,1.0,2/14,3.41%,PPP1CA;PPP1R15B
prerank,icosanoid metabolic process (GO:0006690),0.40651795251246803,1.055169261564687,0.4190585533869116,0.7277672804328603,1.0,7/40,17.03%,GPX4;GPX1;FADS1;DPEP2;ALOX5AP;FAAH;LTC4S
prerank,regulation of mitotic spindle organization (GO:0060236),0.4132454283747961,1.0540498464625856,0.4107551487414188,0.7301535547496292,1.0,10/35,15.97%,HSPA1B;CHMP2B;CLTC;TACC3;CHMP5;GNAI1;DCTN1;HSPA1A;HNRNPU;CHMP1B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.42471199300648627,1.0537638648530065,0.40714285714285714,0.7304427722818722,1.0,8/27,16.29%,RNASE1;RNASE4;NHP2;POP7;RNASEH1;TOE1;PDE12;NUDT16
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.27663658216474096,-1.053711229021544,0.38271604938271603,0.7370127224310214,1.0,14/56,14.03%,EGFR;UBE2E2;NSMCE2;BRD4;ANAPC5;ANAPC7;TFDP1;CDC25B;RAD51B;EIF4G1;ANKRD17;KLHL18;CCND3;CDC27
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2638037049806191,-1.0529837390739534,0.3283582089552239,0.7370179319482048,1.0,18/63,13.92%,WWOX;TCF7L2;ACVR1;BIRC6;CFLAR;ZMYND11;SH3RF1;TGFBR1;PML;IGF1;SP100;RIPK1;BCL2L12;AR;DEPTOR;CASP8;BMP4;PHIP
prerank,histone H4 acetylation (GO:0043967),-0.29388697733611,-1.0528165248564865,0.2871287128712871,0.7355158427737231,1.0,11/47,13.78%,OGT;ZZZ3;KMT2A;NAA40;EPC1;KAT7;ATF2;EP400;KANSL3;BRD8;JADE2
prerank,protein modification by small protein removal (GO:0070646),0.3527590994960143,1.0523536729004508,0.34839357429718876,0.7336784173033959,1.0,63/252,21.46%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;COPS7A;RCE1;COPS6;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;COPS8;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;DESI1;WDR48;NLRP3;RAD23A;PSMA4;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,cortical cytoskeleton organization (GO:0030865),0.40423264612581444,1.051831608238331,0.4180602006688963,0.7345392390798858,1.0,14/41,17.42%,RHOB;NLGN1;TNF;RHOC;RAC1;RHOG;LCP1;ARF6;FMNL1;RHOA;EPB41L3;FMNL3;FHOD3;RAC2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4410904441798089,1.0517221490447397,0.43510506798516685,0.7343903276302051,1.0,7/22,19.25%,APOD;PARK7;LMAN1;GDI1;DMTN;RANGAP1;CABP1
prerank,axon guidance (GO:0007411),0.35398556356559646,1.0516746460288144,0.3766364551863041,0.7340782693976012,1.0,52/201,17.54%,BSG;CXCL12;MAPK3;DCC;NRXN1;UNC5D;LYPLA2;SEMA3F;RAC1;DSCAM;CNTN4;SEMA7A;SEMA4C;SHC3;LGI1;NRXN3;RHOG;DAB1;OTX2;TNR;SEMA6D;ROBO4;NTN1;LGR6;EMB;UNC5C;CDK5R1;LAMC2;EPHA5;KIF5A;SEMA4A;LRTM2;WNT5A;GFRA1;DOK5;SEMA4G;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;GAP43;SH3KBP1;GFRA2;SPTBN2;PIK3CD;SLIT3;SLIT1;EFNB1;RAC2;NCAM1
prerank,glucan biosynthetic process (GO:0009250),0.4998294686610468,1.0514790174148922,0.42370572207084467,0.7336873176287032,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,glycogen biosynthetic process (GO:0005978),0.4998294686610468,1.0514790174148922,0.42370572207084467,0.7336873176287032,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.5164006434638406,1.0514736839561858,0.4441176470588235,0.7332683039579639,1.0,5/10,19.28%,C3;TREM2;F2RL1;CD300A;RAB31
prerank,oogenesis (GO:0048477),0.480224994724747,1.051381894597191,0.4075520833333333,0.7330666523203488,1.0,6/15,24.57%,MDK;FMN2;NANOS2;IHO1;PTN;METTL3
prerank,embryonic axis specification (GO:0000578),-0.38026296122850056,-1.0512221946536784,0.3436293436293436,0.7380058738265564,1.0,4/15,13.79%,SMAD6;COBL;TASOR;SMAD2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5057024168264921,1.0507499040484516,0.44776119402985076,0.7342952598499465,1.0,5/12,16.12%,NELFCD;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.228452122875016,-1.0506223849042804,0.2857142857142857,0.7377433295264603,1.0,52/166,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;TAF1D;SMARCA5;MAML1;TAF1A;GTF3C1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;CRCP;POLR2B;CDK7;RSF1;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;RRN3;NR5A2;GTF2H2;MED23
prerank,sensory perception of taste (GO:0050909),0.5165499087258505,1.0506025880505951,0.4324712643678161,0.7342382212658808,1.0,5/10,33.39%,ASIC2;PKD2L1;TAS1R1;PKD1L3;CD36
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4367802299984339,1.050519278086111,0.43552311435523117,0.7340071464135035,1.0,12/24,34.38%,ITGB2;MSN;PECAM1;VCAM1;SYK;CERCAM;TNIP1;ITGB1;SEMA4D;ITGAL;CCL5;FERMT3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4189930102769541,1.050480756174136,0.41454545454545455,0.7336750339665393,1.0,13/32,25.95%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5013461099858724,1.0499932789122224,0.4281842818428184,0.7344753691033696,1.0,2/11,9.42%,KLF2;EPN1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3779994475694899,1.0495946610306592,0.40496760259179265,0.7350666645283603,1.0,15/68,16.69%,DBI;HINT1;RAN;SULT4A1;BPNT2;ADSS1;AK4;AK3;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;BAD;ACOT4
prerank,response to lipopolysaccharide (GO:0032496),0.36447564574367725,1.049575295179279,0.4092741935483871,0.7346853777979603,1.0,52/138,29.84%,VIM;PDE4B;NR1D1;S100A8;S100A9;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;HNRNPA0;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;SLC11A1;RHOA;LILRB1;ERBIN;CX3CR1;CCL2;PF4;DAB2IP;ADAM17;NOS2;SNCA;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SELENOS;NUGGC;RELA;TNFRSF11A;LBP;CASP1;TRIB1;SCARB1;XBP1;TNFRSF1B;GGT5;PPBP;GGT7;NOD2;ACOD1;IFNAR1
prerank,positive regulation of neurogenesis (GO:0050769),0.3786343526760846,1.0492631736440383,0.4036796536796537,0.7350497285573084,1.0,24/68,26.32%,ARHGDIA;SERPINF1;TGM2;GPER1;NTRK2;CTNNB1;IL1RAPL1;SS18L2;PTPRD;SOX8;SNW1;RHOA;CX3CR1;TIAM1;ROBO2;TRIM32;SOX11;PLXND1;SS18L1;PLXNB2;NAP1L1;PLXNB3;CX3CL1;FZD3
prerank,protein deubiquitination (GO:0016579),0.351852864203378,1.049097251507961,0.3597989949748744,0.7350455556721213,1.0,61/242,21.46%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RCE1;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;OTULIN;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;WDR48;NLRP3;RAD23A;PSMA4;SHMT2;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3619938739436287,1.0483156222238594,0.41260162601626016,0.7366406664001677,1.0,37/142,18.31%,CD52;CHRNA9;GPER1;TAC1;FZD9;C5AR1;CAV2;YWHAE;CACNA1A;CCR5;CALB1;PLN;TACR1;P2RY1;CD24;HMGB1;CALCB;WNT5A;TRPC7;ATP2B1;CXCR4;TRPC1;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;HCRTR1;PTGIR;ADCYAP1;FKBP1B;CCR2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.285042213194053,-1.047990803792779,0.35,0.7429440910913494,1.0,18/42,23.30%,ARID2;SETD2;SPIDR;SHLD1;MMS19;PPP4R2;FBH1;MRNIP;FUS;FANCB;CGAS;SMCHD1;RTEL1;RMI2;SHLD2;SIRT6;SHLD3;POLQ
prerank,establishment of protein localization to organelle (GO:0072594),0.37819109384659233,1.0475820600091206,0.40816326530612246,0.7380577693390278,1.0,16/72,18.28%,LAMP1;AKT1;PINK1;RAN;FAM53C;PTTG1IP;CD68;IPO4;NUP85;NUP88;RYR2;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4178783359328847,1.0475199018102581,0.4050480769230769,0.7377914933789351,1.0,13/32,24.89%,HINT1;RPS27L;HIPK2;TMEM109;PMAIP1;SNW1;STK11;POU4F1;DDIT4;PYCARD;PHLDA3;DYRK2;BOK
prerank,regulation of DNA damage checkpoint (GO:2000001),0.5018877071211819,1.0471403462445308,0.42158273381294964,0.7383135150479591,1.0,2/10,5.95%,DDX39B;RPA2
prerank,ceramide biosynthetic process (GO:0046513),0.3969791265116576,1.0468471423311982,0.4184476940382452,0.738607886292226,1.0,12/40,21.12%,CERS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA4;SPTLC1;ST6GALNAC3;DEGS1;FA2H;CLN8;SPTSSA;ASAH2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.38732522713985984,1.0467323019811905,0.4106753812636166,0.7384589054854381,1.0,16/55,22.68%,MT3;PINK1;AGT;PDGFB;ROMO1;RAC1;DCXR;ARF4;RAC2;BCO2;SNCA;CBR1;SPHK2;GADD45A;SIRT2;MPV17
prerank,regulation of protein localization to membrane (GO:1905475),0.42659410617834737,1.0465936753672955,0.4117647058823529,0.7383669344177621,1.0,2/28,0.88%,ACTB;GSN
prerank,primary neural tube formation (GO:0014020),-0.30132141611497687,-1.0463513574354408,0.3767123287671233,0.7457588039578609,1.0,7/30,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,mRNA splice site selection (GO:0006376),-0.3150696791005594,-1.046283032821313,0.35333333333333333,0.7439992363883726,1.0,7/30,10.92%,CELF2;LUC7L2;SFSWAP;YTHDC1;KHDC4;PRPF39;SETX
prerank,Rho protein signal transduction (GO:0007266),0.3879404557302605,1.0462728820044525,0.43344334433443343,0.7387414175322318,1.0,13/53,13.96%,ARHGDIA;CFL1;RHOB;ARHGDIB;RHOG;ADGRG1;NTN1;RHOV;ARHGDIG;COL1A2;RHOA;SHTN1;RHOU
prerank,nucleic acid metabolic process (GO:0090304),0.38028793073782136,1.0448749372245636,0.42021276595744683,0.7418755766115469,1.0,23/69,25.03%,PCBP1;POLR2E;POLR2D;HNRNPK;POLR2F;RAN;LSM8;HNRNPA0;POLR2G;POLR2K;HNRNPU;PDE12;HNRNPA1;RECQL5;WDR74;HNRNPA3;POLR2H;HNRNPF;POLG;HNRNPH2;PCBP2;METTL3;METTL14
prerank,metal ion export (GO:0070839),0.41186203641696295,1.0447817301526268,0.43160377358490565,0.7416841862160115,1.0,10/31,17.70%,ATP1A3;ATP1B2;KCNE4;SLC40A1;ATP1A4;ATP1A1;SLC11A1;KCNE5;ATP1B1;ATP1B3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.33014479638841454,-1.0445502675609817,0.3894736842105263,0.7466917245937511,1.0,3/24,6.44%,AUTS2;PLCE1;NCKAP1
prerank,protein O-linked mannosylation (GO:0035269),-0.34675038815498116,-1.0441587998441144,0.3656387665198238,0.745784996959484,1.0,3/18,1.53%,TMTC1;LARGE1;TMTC4
prerank,T cell mediated immunity (GO:0002456),0.4909548992127899,1.0436086489203473,0.4283783783783784,0.7442998104342631,1.0,5/13,26.74%,EMP2;BTN3A3;CTSH;MYO1G;GNL1
prerank,negative regulation of cyclase activity (GO:0031280),0.47816044934080043,1.0435828613298122,0.4256480218281037,0.7439275864483372,1.0,4/14,20.07%,GNAI2;RD3;CCR2;GABBR2
prerank,pre-miRNA processing (GO:0031054),-0.36413070138513687,-1.0435160690035319,0.4008810572687225,0.745622518072782,1.0,8/14,19.58%,DICER1;DROSHA;TUT7;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,actin filament polymerization (GO:0030041),0.41951329837911777,1.0434445836036212,0.4297719087635054,0.743833882816144,1.0,6/29,13.12%,GSN;RAC1;ANG;FAM107A;AIF1;MSRB1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5053564972769047,1.0430595733648962,0.43706777316735823,0.7443991563448464,1.0,3/10,11.32%,TERF1;MAPT;DNAJA1
prerank,regulation of cell morphogenesis (GO:0022604),0.41439266991905543,1.0427900497339029,0.4226190476190476,0.7446356609782004,1.0,2/30,1.57%,SPARC;CFL1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3869891553097428,-1.0427608478521417,0.3639705882352941,0.7457588415280433,1.0,4/13,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,cell-substrate junction assembly (GO:0007044),0.41477047594813704,1.0425344409850124,0.4224037339556593,0.7448283562442986,1.0,12/33,22.31%,CD151;LAMC1;PLEC;FN1;THY1;LAMC2;ARHGEF7;ACTN1;DLC1;CTTN;THSD1;RCC2
prerank,cellular response to growth factor stimulus (GO:0071363),0.3550366049315888,1.042105667440992,0.40447154471544716,0.745502815553716,1.0,28/151,14.66%,EEF1A1;MT1G;RACK1;RAMP2;HSPB1;LGMN;AKT1;PDGFB;ACVRL1;NTRK2;ZFP36L1;ZFP36L2;DUSP3;CTNNB1;HYAL2;KDR;MAPT;CLEC3B;ZFP36;GAS1;WNT5A;FLT4;AMHR2;KLF4;SOX9;BMP2;CCL2;EHD1
prerank,positive regulation of type I interferon production (GO:0032481),0.3759705748241549,1.042101510031178,0.4244984160506864,0.7450803652550391,1.0,19/73,22.13%,GAPDH;HSP90AA1;POLR2E;POLR2F;FLOT1;CTNNB1;ISG15;PQBP1;HSPD1;POLR2K;RIPK2;IRF7;G3BP1;OAS3;CD14;POLR2H;POLR3K;IRF5;POLR3D
prerank,regulation of Rho protein signal transduction (GO:0035023),0.37788771468439414,1.0420764013797919,0.44385026737967914,0.7447154094277835,1.0,11/72,10.83%,APOE;ARHGDIA;KCTD10;RASIP1;RAC1;ARHGDIB;ADGRG1;COL3A1;NET1;TNFAIP1;GPR18
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35625222573600657,1.0418392874696396,0.4084507042253521,0.7448856124596982,1.0,50/182,20.22%,APOE;RACK1;CLDN5;HSP90AB1;PARK7;LGMN;CNPY2;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;SPI1;MIF;TLE5;SH3GL2;APLNR;MYADM;LRPAP1;KDR;MAPT;GATA2;TARDBP;LRP3;HRAS;MSR1;KLF4;FBXW7;BMP2;SDCBP;ANKRD13D;SUB1;CCL3;VHL;NOS2;AGO1;MAP2K2;APOBEC1;SOX11;DDRGK1;NOTCH1;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SFRP1;TRAT1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.2714655035756899,-1.0417665810335066,0.38738738738738737,0.7466418135534787,1.0,10/49,8.46%,GPC6;EXT1;GPC4;GPC3;HS3ST3A1;B3GNT2;HS2ST1;B3GALT1;NDST1;SLC35D2
prerank,tube closure (GO:0060606),-0.2967896074872823,-1.0410213715641132,0.3698630136986301,0.7467662068043346,1.0,7/31,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,protein sumoylation (GO:0016925),-0.26919646423254,-1.040977431898346,0.3584905660377358,0.7450009669172818,1.0,13/49,16.30%,EYA1;RANBP2;NSMCE2;PIAS1;PIAS2;NUP98;SAE1;TOPORS;TRPM4;STX1A;AAAS;NUP214;NUP35
prerank,glycine metabolic process (GO:0006544),0.48839285976848906,1.0406142528698568,0.4353099730458221,0.7475896271571342,1.0,7/12,34.77%,SDS;GLYAT;SHMT2;DLD;RIDA;GCAT;GCSH
prerank,response to organonitrogen compound (GO:0010243),0.403489575342564,1.0402079528849961,0.43463302752293576,0.7482284162508691,1.0,12/38,21.91%,RCN3;VCP;GLRA2;TRPM2;SYVN1;GLRA1;RRAGC;UBXN6;BRSK2;GLRA3;IL6;IRF5
prerank,myotube differentiation (GO:0014902),0.45047753918368777,1.04009971352621,0.4266487213997308,0.7480595625066084,1.0,6/17,20.07%,PLD3;ADGRB3;ADAM12;SORT1;MYEF2;MEF2C
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4172992440054414,1.039984831313582,0.438489646772229,0.7479083498753134,1.0,11/29,31.74%,DBI;PLAAT3;PLA2G4F;NR1H2;LPCAT2;PLA2G3;PLA2G6;MBOAT7;PLBD1;PNPLA8;NR1H3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.4104500337642,-1.0399582108930028,0.3927272727272727,0.7460079983959403,1.0,4/11,16.27%,EGFR;RIPK1;BMP4;TP53
prerank,tight junction assembly (GO:0120192),0.3865068331672604,1.0399245790010567,0.41294642857142855,0.7476296396131246,1.0,15/49,24.28%,ACTG1;CLDN5;RAMP2;CLDN11;ESAM;PECAM1;LSR;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,focal adhesion assembly (GO:0048041),-0.33249053792450745,-1.0398883037165654,0.405,0.7443707236326944,1.0,6/21,11.07%,SORBS1;ACTN2;BCR;PIP5K1A;TESK2;FERMT2
prerank,lipid oxidation (GO:0034440),0.49224826223366286,1.039608624569891,0.45391061452513964,0.7479605781911345,1.0,5/12,34.12%,PLA2G7;PPARGC1A;ADIPOR1;ACOX1;ADIPOR2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3079654742141248,-1.0395822412537268,0.36486486486486486,0.7434027026769076,1.0,9/30,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.37133543683292813,-1.0395775362831448,0.39776951672862454,0.7415386774755443,1.0,7/14,21.57%,ADAMTS12;TGFBR1;EFEMP1;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42317397646728083,1.0393941003487737,0.42427884615384615,0.7480731618540265,1.0,7/27,18.29%,AKT1;TREM2;CTNNA2;IL1RAPL1;CCDC88A;BRSK2;NCS1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4251621947007822,-1.0392231805086996,0.41403508771929826,0.7406478360106514,1.0,3/10,15.22%,SMAD7;RC3H2;NFKBIZ
prerank,positive regulation of heart contraction (GO:0045823),0.44840206849784014,1.0391505575390627,0.43929912390488113,0.7482647812701082,1.0,8/19,27.61%,RGS2;CHGA;RYR2;ADRA1A;EDN3;ATP2A2;TGFB2;KCNQ1
prerank,skeletal muscle tissue development (GO:0007519),0.41554038399405985,1.0389834961023114,0.4310747663551402,0.748252487180553,1.0,8/32,21.04%,MYL6;CAV2;FOXL2;MYL6B;CAV1;SELENON;MEF2C;MYH14
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3977371631899641,-1.0388637573140354,0.3992932862190813,0.7397953917233838,1.0,3/12,6.72%,DPYSL3;DPYD;CTPS2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3969234209263144,1.0387991341136487,0.4417249417249417,0.7483063830766039,1.0,11/41,18.27%,CCL19;SLC24A2;PTPRC;GRIN1;GRIN2A;HTR2C;TRPM2;SLC8A1;RYR2;ERO1A;GRIN2B
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.46893012907001885,1.038676591083244,0.43483870967741933,0.7481797395373064,1.0,4/16,10.25%,ZFP36L1;ZFP36L2;ZFP36;TARDBP
prerank,protein tetramerization (GO:0051262),0.37547332397763195,1.0386727218636362,0.434549356223176,0.7477574746676958,1.0,13/67,20.45%,ALDOA;B2M;AQP4;KCNC3;GRIN1;KCNC1;TRPM2;GLS;HCN1;GRIN2B;SNCA;PKD2L1;SHMT2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4143935871931223,1.0376049802801843,0.4369047619047619,0.7500738869113,1.0,9/32,26.26%,CHKB;CSNK2B;MFSD2A;CHAT;ACHE;SLC44A5;STARD10;SLC44A2;SLC44A1
prerank,regulation of synapse assembly (GO:0051963),0.39216683219698156,1.0373468707879288,0.4346846846846847,0.750280478213465,1.0,22/46,24.38%,NRXN1;NLGN1;GRID2;LRFN5;LHFPL4;MUSK;IL1RAPL1;PTPRD;SYNDIG1;LRRC4B;ROBO2;EPHB1;CLSTN2;CLSTN1;SLIT1;SNCA;MEF2C;IL1RAP;CLSTN3;SLITRK3;WNT7A;APP
prerank,positive regulation of metabolic process (GO:0009893),0.36041771662452765,1.037061897039535,0.45208333333333334,0.750583573114605,1.0,31/103,23.49%,GATM;UCP2;TNF;EPAS1;FABP5;CAMK1D;BSCL2;OMA1;CEBPB;FASN;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6;ACLY
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.24696655355071745,-1.0368359394598445,0.45454545454545453,0.7435362956708695,1.0,9/86,1.92%,BMP6;SULF1;RBPMS;ZNF423;ACVR1;BMPR1A;CREBBP;FOXD1;DAB2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4768655168809388,1.0363882539282927,0.45964432284541723,0.7518352924003907,1.0,5/13,20.90%,LGMN;GRIN2A;RIPK2;BAD;BAK1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4273249262424348,1.0360819228953766,0.423500611995104,0.752119271562729,1.0,8/24,22.85%,MT3;ACADVL;SLC25A13;MTLN;PPARGC1A;MYC;CYCS;COQ10A
prerank,regulation of histone acetylation (GO:0035065),0.41096421508025355,1.036060338178318,0.4396248534583822,0.7517430908738746,1.0,9/33,19.11%,PARK7;MAPK3;SPI1;SET;CAMK1;CTBP1;HDAC5;PPARGC1A;SNCA
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.35006170593064995,-1.036016048499454,0.3791469194312796,0.7439104201261149,1.0,7/19,16.29%,SMAD6;ACVR1;BMPR1A;MDM4;SMAD4;HEY2;BMPR2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4663165058411407,1.0359388928873894,0.4336870026525199,0.7516050136238477,1.0,2/16,2.92%,ACADVL;APOC1
prerank,positive regulation of reproductive process (GO:2000243),0.41442141702302027,1.0354942726597403,0.42822966507177035,0.7522795097535323,1.0,8/31,23.52%,PGAM4;PRSS37;TACR1;GLRA1;INHBA;SIRT2;INHBB;C1QBP
prerank,apoptotic process (GO:0006915),0.34864821227574344,1.035170455675503,0.4321608040201005,0.7526684650519403,1.0,51/203,20.95%,PPIA;GAPDH;RHOB;DCC;AKT1;NSG1;ITGB2;RFK;ADAM15;IER3;RTN4;BNIP2;PPP2R1A;PARP1;MAL;ELMO1;SFRP5;MAGEH1;HSPD1;TNFSF12;JADE1;DHCR24;TNFAIP1;BAX;PMAIP1;PAX3;CXCR4;STK11;BBC3;BAD;RRAGC;DLC1;CDK5;GLRX2;ADRA1A;PRUNE2;PPP1R15A;ERBB3;ATCAY;TRAIP;CD14;NLRP3;DDIT4;PDE1B;CAPN3;MYC;NFKBIA;PAK5;BAK1;PYCARD;GADD45A
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.42638106456404923,1.0351027248323579,0.4238329238329238,0.7524393111767992,1.0,6/24,9.69%,NRG1;CTNNA2;OLFM2;BNIP2;CTNNB1;CAMK1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4260138680210586,1.0350877406750794,0.44360902255639095,0.7520489952742668,1.0,11/24,27.40%,VTN;MT3;CADM4;PDCD6;DAB2IP;TMEM204;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,regulation of secretion (GO:0051046),0.48479867645242203,1.034995278454799,0.42645074224021595,0.7518404857647494,1.0,5/13,18.55%,NRG1;SGK1;SCIN;ERBB3;ACSL3
prerank,regulation of cell communication (GO:0010646),0.40235009733199184,1.0348965912913504,0.42857142857142855,0.751673914778241,1.0,11/35,19.69%,MTCH1;KAZALD1;YWHAG;SCG5;NCLN;SLC8A1;GLRX2;RYR2;SRI;GRK2;IGFBPL1
prerank,heterocycle biosynthetic process (GO:0018130),0.472995353115206,1.0348789794091304,0.4380952380952381,0.7512947082574777,1.0,2/14,6.40%,PYCR2;GPHN
prerank,positive regulation of chromosome organization (GO:2001252),-0.37522993780273234,-1.034754144035242,0.3858267716535433,0.7453323324805471,1.0,4/15,20.89%,DHX36;PML;RTEL1;SIRT6
prerank,early endosome to Golgi transport (GO:0034498),0.4898386231666233,1.034647013144488,0.43989071038251365,0.7514363111421931,1.0,3/11,10.72%,LMAN1;SURF4;TMED9
prerank,regulation of MAP kinase activity (GO:0043405),0.36326400667087705,1.0344175520173289,0.4174454828660436,0.7515871880828286,1.0,22/92,19.84%,APOE;AGT;TNF;PDGFB;SORL1;UCHL1;RGS2;HYAL2;CD24;SMPD1;HRAS;SPRY1;NEK10;PDGFA;RASGRP1;DAB2IP;FLT1;CD300A;EDN3;SPRY3;FLT3;TGFB1
prerank,phospholipid translocation (GO:0045332),0.41867118107487716,1.0342719959679427,0.43200962695547535,0.7515498393267358,1.0,6/28,10.95%,TMEM30A;ATP8B4;ATP8A2;P2RX7;MFSD2A;ATP8A1
prerank,calcium ion import into cytosol (GO:1902656),0.4640293639327831,1.0339870935121007,0.4358974358974359,0.7518579328127074,1.0,5/15,28.26%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,peptidyl-lysine modification (GO:0018205),-0.2380153443898892,-1.0339450282925389,0.30303030303030304,0.7456973439871604,1.0,28/99,18.54%,EYA1;PLOD2;RANBP2;NSMCE2;HDAC4;SENP6;PIAS1;PIAS2;LOXL1;NUP98;SAE1;KAT2B;ATP7A;SENP7;LOXL3;TOPORS;SENP1;TRPM4;ESCO1;STX1A;SIRT1;AAAS;SIRT7;NUP214;NUP35;NDC1;VCPKMT;METTL21A
prerank,positive regulation of behavior (GO:0048520),0.5057211909857909,1.0339338227036325,0.4444444444444444,0.7515600464848502,1.0,3/10,9.16%,NLGN1;INSL5;CRH
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5099831443068275,1.0335728120209564,0.45179856115107914,0.7520333637860637,1.0,3/10,19.36%,PDE3B;JAM3;MUC1
prerank,regulation of protein import into nucleus (GO:0042306),0.40658952686238514,1.0333998058379668,0.4536082474226804,0.7520451045262345,1.0,6/36,7.50%,APOD;RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,regulation of membrane repolarization (GO:0060306),0.4755659362341958,1.0327137649337568,0.453551912568306,0.7533290800078236,1.0,4/13,16.42%,AKAP6;YWHAE;KCNE5;CAV1
prerank,cellular response to lipid (GO:0071396),0.3536645908438221,1.0323639362911516,0.421105527638191,0.7538132985683061,1.0,51/191,20.24%,VIM;SPP1;NDUFA13;PDE4B;ADAM15;GPER1;NR1D1;SIRPA;CD180;LTK;TNFAIP3;MSN;BRINP3;MGST1;ATP1A3;CCR5;PTK6;CXCL10;AQP1;LPL;TICAM2;CD68;HMGB1;ZFP36;CHMP5;GNAI1;BRINP1;WNT5A;RAMP3;ATP1A1;BRINP2;SNW1;SOX9;RHOA;LILRB1;WNT10B;CX3CR1;CCL2;PF4;DAB2IP;ADCY8;NCOA4;CD14;CD86;NLRP3;IL6;GIT1;POU4F1;MEF2C;SFRP1;SPHK2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3922816497401267,1.0322355509723988,0.437570303712036,0.7536925070488982,1.0,14/48,24.89%,CRIP1;RPS27L;CHEK2;HIPK2;BAX;TMEM109;SNW1;HIC1;DDIT4;BAK1;PYCARD;PHLDA3;DYRK2;BOK
prerank,positive regulation of protein secretion (GO:0050714),0.374136589318925,1.0311211199694568,0.4386339381003202,0.756031389357122,1.0,20/69,19.84%,PPIA;TREM2;RBP4;TRH;LRRC8A;GPER1;ANG;ABCG1;ARF6;ATP13A2;APBB1;F2RL1;BAD;IER3IP1;ACHE;DNM1L;DOC2B;GLUD1;NNAT;TGFB1
prerank,regulation of monocyte differentiation (GO:0045655),0.47211702797895716,1.0309190984783834,0.4389261744966443,0.7561048462550207,1.0,2/14,4.40%,CD74;ZFP36L1
prerank,response to UV (GO:0009411),0.35795279946682323,1.0309173402485414,0.4444444444444444,0.7556784867705475,1.0,25/95,21.84%,RPL26;GPX1;ATF4;AKT1;NPM1;COPS9;PARP1;MFAP4;CCND1;AQP1;SDF4;SMPD1;MC1R;PCNA;NSMCE3;CAT;CIRBP;TRIM32;ERCC6;CDC25A;CCAR2;MYC;BAK1;MEN1;MAP2K7
prerank,histone H2A ubiquitination (GO:0033522),-0.35923756398384865,-1.0306529897450694,0.4043478260869565,0.75272382309141,1.0,5/17,11.00%,BCOR;RNF8;UBR2;DDB2;CUL4B
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3914171904201809,1.03044997725603,0.43665158371040724,0.7564102754747222,1.0,12/41,21.30%,MDK;ANK3;TNF;FLOT1;PODXL;THY1;MAGI1;SKAP1;CITED2;FOXA2;PTPRU;FOXA1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4778122820075542,1.0303064191263542,0.4564032697547684,0.7563428988000055,1.0,6/13,23.63%,BNIP3L;BAX;PMAIP1;BAD;VDAC2;BLOC1S2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4891084892772915,1.0301248534207073,0.45267489711934156,0.7563752650637329,1.0,8/12,31.96%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;CAD;DCK
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4921377721627447,1.0298511028550794,0.4531886024423338,0.7566189222933601,1.0,5/12,25.95%,CLEC6A;SLC11A1;CCR2;IL12RB1;PRKCQ
prerank,organic anion transport (GO:0015711),0.3682603716164056,1.0296318584274802,0.43112513144058884,0.7567170982201888,1.0,20/76,20.85%,LRRC8A;SLCO1C1;CA2;SLC25A4;MGST1;AQP1;SLCO4C1;CA4;SLC19A1;SLC35A3;SLC25A19;SLC2A2;MFSD10;SLC52A1;SLC4A2;SLC35A1;SLC35B4;SLCO1B1;CYB5R1;CA3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5066046220320394,1.029627020265137,0.46153846153846156,0.7563022838468428,1.0,4/10,27.80%,UBE2G2;SVIP;OS9;UBE2J1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2843215400876025,-1.0296094748353921,0.3548387096774194,0.7537373637467435,1.0,10/44,10.85%,FCHSD2;FER;BAIAP2L1;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1
prerank,regulation of intracellular protein transport (GO:0033157),0.40943954358414836,1.0292048849209914,0.4515752625437573,0.7569252038651058,1.0,16/32,28.06%,OAZ1;PRR5L;UHMK1;LCP1;VAMP2;ATP13A2;CEP131;B3GAT3;TGFB1;OAZ2;IFI27;PTPN1;KIF20B;ICE1;PCNT;TENM1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39323991520784574,1.0291189316996756,0.44994246260069043,0.7567100598172017,1.0,9/47,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;CORO1C;P4HB;ARHGEF7
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3973046521823375,1.029011683980832,0.45454545454545453,0.7565566219372455,1.0,9/36,21.65%,PARK7;FBXW7;CCL2;NCF1;ADAM17;CCR2;BUD31;ADRA2B;TGFA
prerank,histone H2B ubiquitination (GO:0033523),-0.4185186247028427,-1.0289060965441625,0.37809187279151946,0.7537510661152856,1.0,6/10,22.76%,RNF8;CDC73;UBE2E1;WAC;RNF20;CTR9
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.27712810708807406,-1.0288433264886214,0.42016806722689076,0.7520737383175814,1.0,10/43,11.42%,SMAD3;TEAD1;NFIB;PPARA;FOXO3;NFATC4;STAT3;PPARG;TERT;NFATC3
prerank,negative regulation of synaptic transmission (GO:0050805),0.4367354983617514,1.0285768396336454,0.44114002478314746,0.757251838653868,1.0,5/23,15.63%,SLC30A1;SLC24A2;SYT11;ARF1;ACHE
prerank,secondary alcohol biosynthetic process (GO:1902653),0.40734758858215436,1.0283783985934183,0.42857142857142855,0.7573021836459696,1.0,11/30,28.44%,LSS;DHCR24;ACAA2;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.47785487614892663,1.0277248179385574,0.4672897196261682,0.7585078887451379,1.0,4/13,17.59%,SYT1;SYT4;SYT10;DOC2B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.39497861208321705,1.0271051405297416,0.4575087310826543,0.7596328417237506,1.0,13/39,24.00%,RCN3;CANX;OLFM2;RAB15;RAB3C;RAB3D;PPY;ARL4D;TVP23A;PDIA4;SCG2;COPG1;MTTP
prerank,vascular transport (GO:0010232),0.36611523631747434,1.0269756740562268,0.458377239199157,0.7595247049676235,1.0,21/81,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,striated muscle contraction (GO:0006941),0.3800211134436185,1.0269277823344252,0.453125,0.7592110458651747,1.0,12/53,21.04%,ALDOA;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;DTNA;GRK2;STAC3;MYH14
prerank,protein maturation (GO:0051604),0.35864426554544615,1.0268973112320785,0.46506777893639206,0.7588567432301077,1.0,35/95,25.56%,BOLA2;CTSS;CPXM1;CPD;SORL1;PSENEN;CPE;PRSS37;HSPD1;METAP2;PCSK2;SRGN;NAA10;AEBP1;CPXM2;BACE1;DNAJB11;CIAO1;PSEN2;MMP14;ADAM17;APH1B;NNAT;LMF2;CIAO2A;CIAO2B;STUB1;TSPAN32;ECE2;NDUFAB1;AANAT;CPZ;APH1A;PCSK6;LIPT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3587427900668875,-1.026773595087711,0.40816326530612246,0.7559849595373809,1.0,9/16,17.18%,SMG6;DHX36;SLX4;TNKS2;TERF2;ATM;TINF2;PINX1;RTEL1
prerank,keratan sulfate metabolic process (GO:0042339),0.4138791076415062,1.0265664884133485,0.4679113185530922,0.7592616646202598,1.0,6/31,10.09%,HEXB;FMOD;LUM;HEXA;CHST1;B4GALT6
prerank,embryonic hemopoiesis (GO:0035162),0.4804640949222439,1.0262761998742391,0.44537815126050423,0.7595585682763968,1.0,3/12,10.12%,ATF4;KDR;KITLG
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3957643095398208,-1.0261790674942737,0.39492753623188404,0.755725490113705,1.0,4/12,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,electron transport chain (GO:0022900),0.46385958686099116,1.0260879000694816,0.4576719576719577,0.7596155773977967,1.0,6/15,22.11%,ETFB;NDUFA5;SDHB;UQCRFS1;PPARGC1A;SDHA
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4591341986981408,1.0256726979974398,0.448,0.7602402746607576,1.0,8/15,25.44%,BGN;BCAN;DCN;B3GAT3;VCAN;CSGALNACT2;CHST14;CSPG5
prerank,response to UV-A (GO:0070141),0.46452766132346973,1.0254795420958271,0.46029609690444145,0.7602837554530655,1.0,4/14,11.31%,AKT1;CCND1;TIMP1;MMP3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.34961346519808606,-1.0252045932963598,0.42386831275720166,0.7565597457450001,1.0,4/17,5.66%,ROBO1;SLIT2;NRP1;EFNB2
prerank,regulation of ossification (GO:0030278),0.39613077540719915,1.0251603498490751,0.4481132075471698,0.7606202789599553,1.0,14/36,20.17%,MDK;ECM1;LRP4;S1PR1;WNT5A;SOX9;BMP2;TWIST1;DDR2;NOTUM;SOX11;NOTCH1;MEF2C;SFRP1
prerank,positive regulation of myelination (GO:0031643),-0.3963564594924063,-1.0248956173444026,0.4230769230769231,0.7555946519416364,1.0,2/11,5.39%,PARD3;DICER1
prerank,calcium ion transport (GO:0006816),0.35407324969031484,1.0247601107380864,0.4600409836065574,0.7611589699112268,1.0,26/113,17.62%,TPT1;RAMP2;SLC24A4;SLC24A2;FKBP1A;CACNA1A;GRIN3A;CCR5;TMCO1;P2RX7;SELENOK;SLC3A2;RAMP3;TRPM2;TRPC7;CHRNA4;GAS6;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;ORAI1;PSEN2;CCL8
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3649515025414067,1.0246636358839853,0.4483493077742279,0.7610059622210092,1.0,24/78,21.57%,CLU;RACK1;GABARAP;ELOB;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;UBQLN2;HSPBP1;SGTA;CAV1;HERPUD1;BCAP31;NOP53;DDRGK1;RNF144B;RAD23A;SIRT2;STUB1
prerank,ganglioside biosynthetic process (GO:0001574),0.464038842948131,1.024645609047288,0.4489795918367347,0.7606203515159486,1.0,4/15,15.57%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.43209360719681345,1.0246358062209557,0.4351851851851852,0.7602243009243987,1.0,4/20,13.45%,MT3;ATF4;CREB3;BMP2
prerank,regulation of fibrinolysis (GO:0051917),0.47157067734932706,1.0245263430206302,0.44951590594744123,0.7600525150132986,1.0,1/13,1.91%,THBD
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4518062275610663,1.0244889422040662,0.44021024967148487,0.7597104336151049,1.0,8/17,17.76%,ATP1A3;ATP1B2;ATP1A1;GJA1;ATP1B1;SLC8A1;RYR2;FKBP1B
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4390789679302729,1.0236384791743445,0.4480946123521682,0.761376540813613,1.0,6/18,23.49%,ELOVL1;ELOVL2;ELOVL7;ACSL3;ELOVL6;ACSL4
prerank,O-glycan processing (GO:0016266),-0.25811023400415994,-1.0234831798796429,0.4065934065934066,0.7574630397918295,1.0,7/54,7.17%,GXYLT2;ST3GAL4;ST3GAL3;GALNT11;B3GNT2;ST6GAL1;GALNT12
prerank,regulation of T cell cytokine production (GO:0002724),0.47178224692484677,1.0231881423131552,0.4606141522029373,0.7620607663806085,1.0,1/15,0.77%,B2M
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4987444861603373,1.0228663882352604,0.4596100278551532,0.7624059925661859,1.0,3/11,10.02%,CORO1C;ENPP2;ARHGEF7
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.35593228425852663,-1.0228621374248688,0.43902439024390244,0.7573964621611765,1.0,4/16,9.11%,FER;ABL1;NRP1;PDGFRB
prerank,protein palmitoylation (GO:0018345),0.4138896528875389,1.0225859576440166,0.46208530805687204,0.7626321921695798,1.0,12/30,29.54%,GLUL;SELENOK;ZDHHC5;GOLGA7B;CLIP3;GOLGA7;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,modulation by host of symbiont process (GO:0051851),0.4080302482972018,1.022424366117636,0.4519230769230769,0.7625787560897944,1.0,11/31,22.12%,NUCKS1;AQP1;RRP1B;JUN;TARDBP;SNW1;CX3CR1;CCL3;TFAP4;SAP30BP;REST
prerank,regulation of fibroblast migration (GO:0010762),0.4382071644714072,1.0217857171814573,0.4755784061696658,0.7637039818083081,1.0,8/20,19.84%,RAC1;PRR5L;HYAL2;CORO1C;ARHGEF7;DMTN;DDR2;TGFB1
prerank,calcium ion transport into cytosol (GO:0060402),0.43497736948352694,1.0217652135887452,0.46446700507614214,0.7633217197521495,1.0,10/21,24.69%,GRIN1;GRIN2A;TRPM2;JPH4;SLC8A1;RYR2;ADRA1A;GRIN2B;CACNA2D1;ITPR3
prerank,carboxylic acid metabolic process (GO:0019752),0.40638520882141294,1.020781260082329,0.4423529411764706,0.7653052762153106,1.0,10/33,18.04%,SLC2A1;AGXT;CYB5R3;MIF;GSTO1;GRHPR;GLYAT;ACOT4;GLUD1;SLC2A3
prerank,lytic vacuole organization (GO:0080171),0.40351505978774516,1.0206630917684996,0.4539170506912442,0.7651661960556676,1.0,7/32,13.30%,GRN;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3556959703987166,1.0205132558554104,0.46016771488469604,0.7651007018859152,1.0,27/100,19.68%,MAPK3;TREM2;AGT;GPER1;IER3;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;PIK3IP1;SOX9;F2RL1;PDGFA;NCF1;DAB2IP;FLT1;PIK3CD;TWIST1;ERBB3;NOP53;MAZ;FLT3;HGF
prerank,negative regulation of lipid storage (GO:0010888),0.4353679920061879,1.0203104712333275,0.45710627400768244,0.7651523817586725,1.0,4/19,5.55%,PNPLA2;TREM2;TNF;ABCG1
prerank,defense response to tumor cell (GO:0002357),0.4956213530944119,1.02030068469379,0.4552023121387283,0.7647585111553615,1.0,3/10,4.50%,LAPTM5;PRDX2;SPI1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.43474777988229313,1.0200793239806423,0.4479297365119197,0.7648917183472032,1.0,9/20,19.11%,CALM1;CALM3;GSTO1;GSTM2;ATP1B1;SLC8A1;RYR2;FKBP1B;CALM2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5033690780763308,1.0199452277246412,0.4592274678111588,0.764814130527321,1.0,5/10,18.77%,DLGAP2;DLGAP1;BEGAIN;NPTXR;CACNG5
prerank,histone ubiquitination (GO:0016574),-0.330029486438301,-1.0195897014187347,0.3925233644859813,0.7643503199837777,1.0,9/21,25.10%,HUWE1;RNF8;UBR2;CDC73;UBE2E1;WAC;RNF20;CTR9;PHC1
prerank,amino acid transport (GO:0006865),0.3843799740184203,1.0195658641453311,0.4707865168539326,0.7653052229102002,1.0,8/49,11.29%,SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC3A2;SLC7A14
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26781676715709385,-1.0195625759621183,0.4065934065934066,0.7625737591690832,1.0,12/52,10.33%,SAMD4A;CNOT4;PAN3;CNOT1;DCP1A;PARN;DDX6;TUT7;PATL1;CNOT10;RC3H2;CNOT7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3715165269673028,1.019516303996523,0.4522019334049409,0.7649987811196315,1.0,25/68,27.25%,CAVIN1;SNRPG;POLR2E;POLR2F;SNRPE;POLR1B;SNRPF;POLR2K;CPSF2;SNRPB;UBTF;SLBP;SNRPD3;MAZ;TBP;POLR1H;CPSF4;POLR2H;POLR3K;POLR1G;GTF2H5;SYMPK;ERCC2;CCNH;POLR1F
prerank,acute inflammatory response (GO:0002526),0.4283055965420819,1.0194344808447555,0.4445812807881773,0.7647819608635092,1.0,6/23,19.67%,MBL2;CEBPB;HPR;HP;SIGIRR;IL6
prerank,response to iron ion (GO:0010039),0.48437647761351615,1.0194105672708562,0.4701086956521739,0.7644186298278641,1.0,1/12,0.77%,B2M
prerank,regulation of DNA binding (GO:0051101),0.3852802681673177,1.0192061674033455,0.45871559633027525,0.7644935599884882,1.0,9/44,11.56%,TXN;NME1;CSNK2B;HES1;EDF1;JUN;HMGB1;SUMO3;ZBTB7A
prerank,protein prenylation (GO:0018342),0.49616045032870104,1.0191068941250199,0.4765957446808511,0.7643181867423235,1.0,1/10,3.04%,RCE1
prerank,muscle cell development (GO:0055001),0.4023175482180535,1.0189552980781829,0.4574468085106383,0.7642524853231704,1.0,6/30,15.38%,RAMP2;SGCZ;HES1;ALPK2;MYH11;SLC8A1
prerank,positive regulation of interferon-beta production (GO:0032728),0.4022922726176332,1.0187996099015908,0.4639905548996458,0.7642077745181577,1.0,15/33,32.14%,HSP90AA1;FLOT1;ISG15;RIPK2;IRF7;OAS3;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3466906894715195,-1.01850808102683,0.4269230769230769,0.763593775788031,1.0,3/17,10.62%,SLC9A1;SLC9A2;TRPM4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4488718633692045,1.0182952987280427,0.475,0.7650149212651254,1.0,5/19,15.15%,GMPPB;PMM1;AMDHD2;NANS;UGDH
prerank,positive regulation of vasculogenesis (GO:2001214),0.5019201059744685,1.0173624430049015,0.4745762711864407,0.7667480603399502,1.0,3/10,14.50%,CD34;KDR;RRAS
prerank,mitochondrial genome maintenance (GO:0000002),0.49372499041947715,1.0172306736634107,0.47547683923705725,0.7666356495784564,1.0,6/11,30.85%,SLC25A4;PARP1;MPV17;LONP1;SLC25A36;MGME1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.49343958369114255,1.0171141964960257,0.457182320441989,0.7665137293769377,1.0,5/11,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3724791930900267,-1.0169498822004146,0.40756302521008403,0.7659400523480258,1.0,3/14,4.69%,ACTN2;ANK2;AKAP9
prerank,autophagy of peroxisome (GO:0030242),0.4720632465573159,1.0168341927383118,0.44755244755244755,0.7667540608468851,1.0,3/12,16.87%,MAP1LC3B;PJVK;SQSTM1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.34831469100270596,1.0165982347160842,0.45951417004048584,0.7669101970969205,1.0,53/150,27.02%,HSP90AA1;HSP90AB1;PARK7;CCL19;TXN;NRG1;ERBB4;PINK1;TNF;PDGFB;HCLS1;RAC1;RTN4;RHOG;P2RY12;KITLG;MC1R;RAMP3;VAV1;GAS6;CX3CR1;GDF15;IGF2;PDGFA;HPSE;CCL3;CASS4;PIK3CD;F10;RAC2;ERBB3;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;TGFA;MYDGF;C1QBP;TEK;CD28;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1;TRIB3;MYOC
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4385119979065901,1.0163957717880352,0.4726810673443456,0.7669929629341432,1.0,9/21,21.40%,PARK7;TMBIM6;CREB3;PMAIP1;SYVN1;HSPA1A;HERPUD1;DDIT3;SELENOS
prerank,purine-containing compound catabolic process (GO:0072523),0.47477042996736024,1.0162339046785058,0.45816186556927296,0.7669795171352363,1.0,4/13,17.45%,GPX1;DNPH1;PNP;NT5C
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.33569010304542357,-1.016119856496112,0.4020100502512563,0.7663425320674147,1.0,3/21,2.23%,ADCY9;ADCY1;ADCY5
prerank,negative regulation of bone mineralization (GO:0030502),0.4651858268364384,1.0159668489853582,0.4444444444444444,0.7672115929596286,1.0,4/13,16.37%,ECM1;RFLNB;SRGN;CCL3
prerank,synaptonemal complex assembly (GO:0007130),0.4626506850619955,1.0157698647422768,0.4691689008042895,0.7668491701168231,1.0,1/15,4.13%,SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.4626506850619955,1.0157698647422768,0.4691689008042895,0.7668491701168231,1.0,1/15,4.13%,SYCP2
prerank,positive regulation of wound healing (GO:0090303),0.39631325605483325,1.0156896851482298,0.46498277841561425,0.7666418815197579,1.0,2/36,0.90%,ACTG1;VTN
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.374910383991098,-1.015526542345669,0.4136690647482014,0.766204554805534,1.0,8/12,21.61%,PTPN14;RBM4;BMP4;AAAS;SIRT7;NUP214;KHDRBS1;TPR
prerank,positive regulation of JNK cascade (GO:0046330),0.36409479262683064,1.0153656151806392,0.46659597030752914,0.7669897275805672,1.0,25/70,25.38%,CCL19;TIRAP;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;MAPK8IP1;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.3592075565107274,-1.014883695392412,0.4069767441860465,0.7661263324752062,1.0,6/15,19.30%,LARGE1;OGA;MGAT3;RENBP;CHST3;NAGK
prerank,cell-matrix adhesion (GO:0007160),0.35780647723845793,1.0145706434083013,0.47406639004149376,0.7685139954890832,1.0,22/95,16.62%,CD63;VTN;ITGB2;CD34;ADAM15;EMP2;RAC1;TIMM10B;FN1;BCAM;PPFIA2;ZYX;THY1;COL3A1;SIGLEC1;ARHGEF7;ACTN1;TNN;TIAM1;DLC1;HPSE;VCAM1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3465285336573593,1.0145026427619206,0.4676767676767677,0.768267835070445,1.0,54/190,25.02%,TMSB4X;RACK1;NDUFA13;AKT1;TREM2;PINK1;PEBP1;GPER1;ARHGAP25;NR1D1;SPI1;DUSP3;APLNR;PDE3B;HYAL2;SFRP5;MYADM;TNFAIP3;CDC34;P2RX7;CD22;OTUD7A;TRIM59;PIK3IP1;PDCD6;PHLPP1;ARRB2;DAB2IP;CAV1;HERPUD1;NDUFS3;TWIST1;NOP53;AKT1S1;SPRY3;RTKN2;NLRP3;DDIT4;PDE11A;THEM4;PYCARD;DDIT3;BANK1;CCN3;TMEM127;TNIP1;ADIPOR1;DUSP1;PHLDA3;RELA;PLEKHA1;EPM2A;PDE2A;RNF157
prerank,regulation of cardiac conduction (GO:1903779),0.37253846967890186,1.0141322969655635,0.46806167400881055,0.7687519224995475,1.0,15/54,17.76%,NPPC;FXYD1;AGT;ATP1A3;ATP1B2;FXYD7;ATP1A4;ATP1A1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ATP1B3;FKBP1B
prerank,cellular response to increased oxygen levels (GO:0036295),0.48762480026692034,1.014074161092002,0.47651006711409394,0.7684724244744021,1.0,4/11,22.08%,ATP6V1G1;ATP6AP1;CAV1;ATP6V1A
prerank,negative regulation of histone acetylation (GO:0035067),0.49145195085218896,1.0140122295089764,0.4663923182441701,0.76819694951183,1.0,4/11,19.11%,SPI1;SET;CTBP1;SNCA
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3557879290380668,1.0137261945431504,0.46446961894953653,0.7685035275351546,1.0,28/101,19.84%,CALM1;AKT1;CALM3;CCND2;TNF;PDGFB;CCND1;PROX1;CD24;CAMK1;PIH1D1;CSF1R;WNT5A;HRAS;RHOA;NEK10;PDGFA;RASGRP1;MAPRE3;DAB2IP;FLT1;ADAM17;MAP2K2;EDN3;CALM2;SNCA;FLT3;TGFB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.49087273127182474,1.0135747840066232,0.46518105849582175,0.768439477704727,1.0,2/11,13.40%,PTPRC;LILRB1
prerank,regulation of interferon-beta production (GO:0032648),0.38538084208003465,1.0135426057011843,0.4585698070374574,0.7680987247242859,1.0,20/46,32.14%,HSP90AA1;FLOT1;TIRAP;SIRPA;ISG15;LILRB1;RIPK2;IRF7;TRAF3;OAS3;PYCARD;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,activation of protein kinase activity (GO:0032147),0.35104689514377496,1.012988951172649,0.468944099378882,0.7689745268111833,1.0,24/106,14.73%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;EMP2;PDGFB;ANG;TIRAP;PAK1;PRKAR1A;PAK3;PRKAR1B;WNT5A;SLC11A1;GAS6;ADCY4;CCDC88A;STK11;TLR6;PRR5;COPS8
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38178832619463937,1.012775109132772,0.4598870056497175,0.7690533274545093,1.0,11/48,11.85%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;IL1RAPL1;ARHGEF7;SS18L2;PTPRD
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.415761806512724,1.0124699002573676,0.4579780755176614,0.7694004227974589,1.0,4/26,3.99%,PRNP;AKAP6;TNF;HOMER2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34158786795188817,1.012126060442776,0.4763819095477387,0.7697968720761983,1.0,54/199,21.30%,RPS19;MDK;GRN;CALR;GPNMB;ATF4;ID1;TNF;NR1D1;SPI1;LRP4;RGS2;ALPK2;ARHGDIB;LRPAP1;CORO1C;SYT11;TIMP1;HS3ST5;PROCR;SRGN;ATP2B1;PTPRR;SLC11A1;SOX9;GJA1;SPRY1;BMP2;GAS6;WNT10B;STK11;ARRDC3;IFNGR1;GDF15;NR1H2;PLCL2;HEY1;DAB2IP;HDAC9;PFN2;BRCA2;ADAM17;IP6K1;VASN;NOTCH1;EFNA1;TGFB1;MEF2C;FOXA2;SFRP1;TWSG1;PTPRO;DDIT3;FOXA1
prerank,development of primary male sexual characteristics (GO:0046546),0.39927099845295044,1.0120532179557258,0.45670225385527874,0.7695657637984363,1.0,13/34,28.28%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5008595576185684,1.011924316286794,0.47464788732394364,0.7694680854940672,1.0,6/10,35.57%,PIH1D1;TAF9;NAF1;RUVBL2;ZNHIT3;NUFIP1
prerank,protein glycosylation (GO:0006486),-0.22272264213430057,-1.0115833625554251,0.47619047619047616,0.7733404552539962,1.0,27/125,13.25%,LARGE1;ST3GAL4;B4GALT1;MAN1C1;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;TET3;B3GNT2;PGM3;FUT8;B3GALT1;TUSC3;PMM2;GOLGA2;ALG5;MGAT3;STT3B;ENTPD5;GALNT1;GCNT2;FUT10;ST3GAL5;MGAT5
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.349246607330674,1.0113132302902035,0.46288659793814435,0.7705283264783456,1.0,24/112,13.63%,RPS27A;UBC;CLDN5;UBB;ID1;ACVRL1;FKBP1A;ZFP36L1;ZFP36L2;HYAL2;LEFTY2;WFIKKN2;UBA52;ZYX;CLEC3B;COL3A1;JUN;WNT5A;AMHR2;ZMIZ2;COL1A2;SOX9;RHOA;LEFTY1
prerank,regulation of interleukin-17 production (GO:0032660),0.4028001404807733,1.0109813605477702,0.4636471990464839,0.7709048247831092,1.0,9/31,25.95%,PRNP;SLC7A5;IL2;VSIR;IL6;TGFB1;DDIT3;RFTN1;PRKCQ
prerank,protein dephosphorylation (GO:0006470),-0.23317868235099354,-1.0107263874501178,0.36363636363636365,0.7739434870639953,1.0,47/135,19.88%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PPP1R12A;PTPN14;TNS2;PPM1E;MTMR3;PPM1D;PTPN3;DUSP16;PPP4R1;DUSP10;EYA4;PPEF2;PPP2R5E;PTPN12;DAPP1;PPP4R2;BTRC;PTEN;FBXW11;NCK1;DUSP7;EYA3;PTPN2;PPP2CB;LHPP;RPAP2;PPP6C;PPP2R2A;PTPN22;DUSP11;SSH1;PPP3CB;PPP3CC;PPP2R1B;SDHAF2;PPTC7;CTTNBP2NL;PTPRM;PPP2R3A;CDC14B;PTPRK;PPM1H
prerank,regulation of myoblast differentiation (GO:0045661),0.3971812697526251,1.0106929536676303,0.48448687350835323,0.7711848863796554,1.0,10/32,20.07%,LRRC8A;IGFBP3;ZFP36L1;BTG1;SOX8;SOX9;DLL1;NOTCH1;TGFB1;MEF2C
prerank,positive regulation of protein depolymerization (GO:1901881),0.48372807384429833,1.0101592990438855,0.4713467048710602,0.77203417084831,1.0,6/11,33.96%,NES;F2RL1;WDR1;STMN2;KATNB1;SEMA5A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.33494738348735764,1.0094138393780248,0.46346346346346345,0.7734296158683739,1.0,96/390,19.99%,ACTB;ACTG1;ATP6V0C;HSP90AA1;COL1A1;POLR2E;MAPK3;AKT1;ATP6V1F;CYBA;NRG1;POLR2D;ERBB4;ANKS1B;POLR2F;PDGFB;RAC1;GRB14;NTRK2;ATP6V1G1;CAV2;PSENEN;ATP6AP1;ATP6V0E2;GRIN1;RARRES2;ELMO1;AP2M1;LTK;CYBB;SHC3;MUSK;RAB14;NAMPT;PTK6;PAK1;KDR;MPZL1;CDK5R1;AP2S1;EPHA5;ARPC1B;HCK;ARHGEF7;PAK3;POLR2G;CSF1R;HAP1;ATP6V0D2;FGFRL1;AAMP;ARPC3;PLAT;FLT4;HRAS;ARPC5;POLR2K;VAV1;RHOA;TIE1;STMN1;VAV3;SDCBP;HNRNPA1;SORT1;SH2B2;TIAM1;ARPC4;MAPK11;GDF15;IGF2;PDGFA;EPHB1;NCF1;GFRA2;FLT1;TYRO3;CASS4;PSEN2;LCP2;EFNB1;ARPC2;APH1B;SYK;DDR2;ERBB3;GRIN2B;SRMS;SLA;KLB;SOS1;FLT3;HGF;EFNA1;GIT1;DDIT4
prerank,regulation of nuclear division (GO:0051783),0.4439803268980571,1.0093759151443176,0.47788697788697787,0.773096802773225,1.0,8/20,28.88%,PIN1;CAV2;FBXO5;L3MBTL1;CCDC8;RCC1;KIF20B;MKI67
prerank,fatty acid transmembrane transport (GO:1902001),-0.3280714521561066,-1.0092667801869895,0.4423963133640553,0.7760213055995393,1.0,4/19,11.96%,PRKAG2;ABCD3;PRKAA2;CPT2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.36711829439605537,1.0087190705391684,0.4772727272727273,0.7742843055892095,1.0,16/59,23.49%,PARK7;GATM;SCP2;LIPG;SDS;LPL;HSD17B4;OXSM;OSBPL6;OSBPL3;CH25H;GAMT;ACSM5;OSBPL1A;NDUFAB1;ACLY
prerank,cell differentiation in spinal cord (GO:0021515),0.5004563230288219,1.0086732376076375,0.49235048678720444,0.7739682284539928,1.0,1/10,3.02%,MDGA2
prerank,cardiac cell development (GO:0055006),0.47915974246873555,1.0077981577796373,0.4623044096728307,0.7757035534576843,1.0,4/11,19.64%,ALPK2;MYH11;SLC8A1;NOTCH1
prerank,superoxide anion generation (GO:0042554),0.45747262085971696,1.0076647596646386,0.46070460704607047,0.7756020326544179,1.0,3/13,15.91%,CYBA;CYBB;NCF1
prerank,receptor catabolic process (GO:0032801),0.41077746970658063,1.0074998096687229,0.46220570012391576,0.7755925568528134,1.0,9/24,24.95%,LGMN;AP2M1;CLTC;AP2S1;CLTA;TGFB1;AP2A1;VLDLR;GPRASP1
prerank,neuron projection extension (GO:1990138),0.3981945089959091,1.0074012906478875,0.4579326923076923,0.7754124466383153,1.0,5/32,5.39%,HSP90AA1;HSP90AB1;SEMA3F;CTNNB1;SH3GL2
prerank,protein mannosylation (GO:0035268),-0.3144981196275796,-1.0073290884931383,0.39215686274509803,0.779475665494427,1.0,3/22,1.53%,TMTC1;LARGE1;TMTC4
prerank,regulation of signal transduction (GO:0009966),0.3435260777118376,1.007221155180774,0.4934673366834171,0.7754151533080074,1.0,56/190,24.62%,MTCH1;PPIA;CLU;IGFBP6;CD63;RGS5;PRNP;TREM2;IGFBP3;IGFBP4;IGFBP5;PPP2R1A;RGS2;NUCKS1;OTX2;PTK6;KAZALD1;YWHAG;TIMP1;CD24;KIF26A;RGS12;GAS1;DOK5;SNW1;IGFBP2;NCLN;FRMPD1;MAPK8IP2;UBTF;GLRX2;DLL1;ADCYAP1;NCAM1;TMEM108;ERBB3;SRMS;TMEM204;RFNG;GRK2;IGFBPL1;TGFB1;GIT1;BRAP;RGS6;AMFR;FRRS1L;LLGL1;LFNG;PTPN1;ZFAND2B;KCTD8;ANKRD54;APP;RGS4;TCF7L1
prerank,regulation of striated muscle contraction (GO:0006942),0.4139595075857491,1.0071888143212149,0.49370277078085645,0.775083230042456,1.0,7/27,19.18%,CALM1;CALM3;TNNI1;RYR2;SRI;CALM2;GRK2
prerank,respiratory tube development (GO:0030323),-0.2959830616144322,-1.007053439167736,0.43023255813953487,0.7783132353223865,1.0,8/28,13.72%,GLI2;FGF1;PCSK5;LOXL3;FGFR2;NPHP3;ITGA3;BMP4
prerank,positive regulation of developmental growth (GO:0048639),0.37938953137352976,1.0069912561805008,0.4801812004530011,0.7751186124362376,1.0,20/49,25.85%,PPIB;SEMA7A;SYT1;RIMS2;RIMS1;MAPT;NTN1;SYT4;SHTN1;CPNE5;CPNE6;DLL1;SYT2;AGRN;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4472268828916154,1.0069724854177462,0.49224806201550386,0.7747489601367497,1.0,9/18,27.82%,BAX;PMAIP1;RNFT1;TMEM259;BAK1;DDIT3;USP13;BOK;XBP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.3736286934829321,1.0069189059401031,0.4796926454445664,0.7744791989040221,1.0,12/54,8.38%,ACTG1;APOD;S100A10;RAC1;ACVRL1;DUSP3;GPM6B;FAM107A;CORO1C;CLASP1;THY1;KDR
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.27228934851325254,-1.0067006250621857,0.43434343434343436,0.7774661292631073,1.0,5/45,1.92%,BMP6;RBPMS;ACVR1;BMPR1A;DAB2
prerank,positive regulation of organelle organization (GO:0010638),0.39866723903445744,1.0064102768465963,0.4750593824228028,0.7752711103700826,1.0,9/32,20.86%,TREM2;LMAN1;SURF4;P2RX7;TMED9;LNPK;PPARGC1A;DOC2B;C2CD5
prerank,proteolysis (GO:0006508),0.33747756742684354,1.006355990771637,0.485,0.7749856660181688,1.0,72/252,25.64%,CTSD;CTSB;CTSL;CTSZ;CTSS;TMPRSS6;LGMN;CPXM1;CPD;PSENEN;PSMD6;CPE;SPPL2B;F9;SPCS1;VASH1;METAP2;TINAGL1;NEDD8;PGPEP1L;TMPRSS5;PCSK2;SRGN;AEBP1;CPXM2;MMP3;PLAT;CTSA;ERMP1;PSMB11;LAP3;CTSH;SPG7;LRP8;RNPEPL1;PSMB5;NAPSA;VHL;BACE1;PLAU;PSEN2;MMP14;ADAM17;APH1B;CTSC;PSMA6;DESI2;DESI1;HGF;PGPEP1;CAPN3;ATG4D;FAM111A;SPPL2A;CTSE;ACAN;ECE2;ST14;DPP7;ERAP1;LONP1;PRCP;CAPN11;CPZ;FBXO3;THOP1;FBXO2;APH1A;PCSK6;MMP1;CASP1;MMP24
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.474516746812494,1.0062148103224764,0.4868238557558946,0.7748751442702769,1.0,7/12,24.11%,SYT1;RIMS2;RIMS1;SYT2;DOC2B;SYT5;UNC13A
prerank,regulation of cell cycle (GO:0051726),0.34027665192771417,1.0060883680810855,0.4854854854854855,0.7747746692401414,1.0,85/271,25.60%,RPL23;RPS15A;RACK1;HSP90AB1;CALR;JUND;RHOB;EIF4G2;GPER1;BEX2;FZD9;PTPRC;JUNB;MIF;UHMK1;HIPK2;USP51;SPATA22;CCND1;GMNN;PTK6;PROX1;DHCR24;NUPR1;MLXIPL;JUN;ZBTB49;TARDBP;APBB1;BRINP1;CTBP1;HRAS;CAMK2N1;SOX9;LILRB1;BMP2;FBXO5;RNF40;HNRNPU;NLRP2B;SND1;STK11;SDCBP;L3MBTL1;CDK5;DAB2IP;PIM3;TRIM32;PPP1R15A;TBRG4;NOP53;CDC25A;BTG4;INHBA;NOTCH1;RAD23A;MLF1;TGFB1;POU4F1;CITED2;DYNLT3;SFRP1;TFAP4;MYC;GADD45A;ASAH2;ID2;CDK9;SIRT2;MEN1;DUSP1;CDK10;INTS13;FOXM1;METTL3;BARD1;CHMP1A;BAP1;CDKN2B;FBXL3;PRKACA;INHA;KIF20B;PNPT1;WDR6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3603633928465497,1.006072403954453,0.4860215053763441,0.7743912486097752,1.0,15/76,14.27%,CLU;RACK1;GABARAP;ELOB;LAPTM5;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;FBXW7;HSPBP1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4202754688413416,1.0054772927145046,0.49635036496350365,0.7753298390049045,1.0,4/25,11.35%,CNRIP1;TNF;CHMP6;RAMP3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.38806871508733953,1.0054717501846462,0.47586980920314254,0.7749261865342333,1.0,9/43,13.23%,HMOX1;AKT1;TNF;PDGFB;IGFBP5;P2RY6;JUN;AIF1;GJA1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4448666276599041,1.0049985134472121,0.47162673392181587,0.7756471024703366,1.0,7/17,21.37%,CALM1;CALM3;CADM4;DMTN;CALM2;DDIT4;SIRT2
prerank,positive regulation of cartilage development (GO:0061036),0.44165498088525307,1.0049233517642224,0.4680306905370844,0.7754042174064533,1.0,4/17,13.45%,MDK;ACVRL1;SOX9;BMP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4882695226324944,1.0048229311385888,0.5076708507670851,0.7752324268718366,1.0,6/11,34.09%,ANK3;SYK;PRKCA;PRKCQ;PLAUR;CCL5
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.322550278636227,-1.0046693199542347,0.42424242424242425,0.7811094989193398,1.0,5/21,10.73%,CGNL1;SLIT2;MAPKAP1;ARHGAP12;EPHB2
prerank,external encapsulating structure organization (GO:0045229),0.33907648896925896,1.004604097690285,0.5070281124497992,0.7753476493396103,1.0,33/205,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;HRNR;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36071465979266243,1.004328071888843,0.49730312837108953,0.7755714873972683,1.0,18/67,16.26%,HSP90AA1;HSPB1;CYBA;RAC1;ELMO1;CYBB;KDR;CLEC14A;PDCD6;AAMP;FLT4;VAV1;RHOA;VAV3;MAPK11;NCF1;DAB2IP;FLT1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.38888748877361906,-1.0042572373741607,0.4772727272727273,0.7803652602704909,1.0,3/12,8.04%,FOXP1;FNIP1;NOC2L
prerank,positive regulation of histone methylation (GO:0031062),-0.3096842319253633,-1.0039967172772526,0.405,0.7792457838267334,1.0,4/24,5.59%,AUTS2;OGT;KMT2A;JARID2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.39544171957236185,-1.0039297985751718,0.43492063492063493,0.7775936359278166,1.0,3/10,15.98%,DNMT3A;PCGF5;MECP2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4062424089243463,1.003873100146475,0.47624703087885983,0.7762412491058303,1.0,11/28,21.64%,MAP1A;STMN3;CLASP1;MAPT;MAP2;STMN4;STMN1;ARL2;MAPRE3;MAP1B;FKBP4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.49566036066263236,1.0037676511375286,0.4783216783216783,0.7760724967808259,1.0,5/10,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.34773271724189986,1.003664791154582,0.48357289527720737,0.7759143138000778,1.0,36/113,23.83%,MDK;GRN;LAMC1;AKT1;NME1;PTPRN;PDGFB;ANG;C5AR1;ECM1;RTN4;EMC10;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;HRAS;SOX9;BMP2;NME2;BAD;EGFL7;PIK3CD;SOX11;SFRP1;MYC;TGFA;SCG2;MYDGF;AGGF1;WNT7A;PTN;TEK;OSR2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.34720387756261245,-1.0033707464300166,0.42323651452282157,0.7772737153619677,1.0,4/18,2.52%,ROCK2;BCAS3;ARFGEF1;ROCK1
prerank,aminoglycan catabolic process (GO:0006026),0.4027443727841437,1.0025797996611434,0.4720873786407767,0.7780878939260036,1.0,13/28,19.90%,HYAL2;OVGP1;GUSB;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;SDC3;HPSE2;HSPG2;AGRN
prerank,negative regulation of cell motility (GO:2000146),0.35064017485209764,1.0023223372945578,0.500515995872033,0.7782956613046511,1.0,17/108,9.80%,CD74;CLDN5;IFITM1;RHOB;ADAM15;ACVRL1;IGFBP5;DNAI3;PIN1;MIF;DUSP3;FRMD5;ADORA3;NAV3;THY1;SPOCK3;EPPK1
prerank,response to hexose (GO:0009746),0.4057768779632138,1.0018385501112126,0.46707317073170734,0.779055533292632,1.0,8/25,21.40%,PFKL;GYS2;LPL;VAMP2;MAFA;EIF2B5;KHK;SELENOS
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4128118653172457,1.0017726935986806,0.47853535353535354,0.7788033140112186,1.0,9/23,26.54%,ELOVL1;ELOVL2;ELOVL7;ACOT7;ACSL3;DGAT1;ELOVL6;ACSL4;FAR2
prerank,NAD biosynthetic process (GO:0009435),-0.3362988017146509,-1.0017676909750848,0.4304932735426009,0.7797027311706165,1.0,8/20,21.13%,PTGIS;PARP9;PARP16;PARP10;NADSYN1;NUDT12;NMNAT2;NMNAT3
prerank,regulation of gene expression (GO:0010468),0.33084256751495905,1.001294156879283,0.497,0.77950667251444,1.0,191/903,20.17%,APOE;RPL23;RPS3;ACTG1;CRIP1;RPL11;RPS7;RPL5;CD74;CLU;PFDN5;RACK1;CLDN5;RPL6;GSN;RAMP2;TYROBP;PCBP1;GPX1;CALR;CXXC1;ACTA2;MT3;PARK7;MAPK3;HNRNPAB;ATF4;LGMN;AKT1;CNPY2;SOX18;TREM2;HINT1;CD34;LYL1;HNRNPK;PINK1;ANK3;SLC7A5;GPER1;MAGED1;TNF;PDGFB;DRAP1;LAMTOR5;PTPRC;HCLS1;ACVRL1;BTN3A3;TAPBP;NTRK2;CHEK2;ZFP36L1;SPI1;PIN1;AMH;MIF;HSPA1B;PPP2R1A;TLE5;SIRPA;SH3GL2;APLNR;AHNAK;PCBP4;ALPK2;MYADM;FN1;BTG1;MUSK;FADS1;TFRC;MSN;RIMS2;RNF187;TBX22;CEBPB;PQBP1;HES6;NELL1;RIMS1;PRDM12;EDF1;CEBPA;P2RX7;PROX1;KDR;VSIR;MAPT;BCL6B;MOG;YBX1;MLXIPL;MLX;EGR1;RRP1B;GATA2;ATP13A2;ICOSLG;TAF5L;TARDBP;HOXB7;LRP3;APBB1;SUPT4H1;WNT5A;SOX17;ATF5;RAMP3;POU3F1;KDM6B;ATRAID;WARS1;FAM50A;HRAS;TMEM119;CAMK2N1;MSR1;AIF1;KLF4;SLC11A1;SOX9;HSPA1A;FBXW7;METTL18;GJA1;LILRB1;BMP2;GAS6;HDAC5;SFRP4;UBE2V1;RO60;MAFA;CTSH;TLR6;SORT1;NONO;PF4;SPIN4;IFNGR1;TRAF3;MAPK11;ATP1B1;DHH;SLC8A1;IGF2;YBX3;GLRX2;HEY1;DNAJA4;CCL3;DNMT3B;EPB41L4B;VHL;GATA4;PRX;CDH5;PIK3CD;TWIST1;PDCD5;BRCA2;PPARGC1A;NOS2;RLIM;AGO1;MLF2;CNBP;ZNF22;TERF2IP;MAP2K2;MAZ;HMGN5;EDN3;SOX11;CCAR2;DDRGK1;ANKRA2;HIC1;INHBA;ESRRB;NOTCH1;IL6;ERP29;MLF1;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1
prerank,actin filament organization (GO:0007015),0.34060915272436587,1.0007539107788155,0.49848024316109424,0.7803749735313797,1.0,34/151,17.69%,ALDOA;GSN;RHOB;MARCKS;TPM2;RHOC;ARHGAP25;EMP2;RAC1;FLNA;ELMO1;RFLNB;RHOG;CORO1C;CORO1A;MYO5A;PROX1;MYO7B;LCP1;MYO1F;MARCKSL1;ACTN1;AIF1;DSTN;RHOA;FLII;CAPG;ARPC4;TMOD1;DMTN;CASS4;FHOD3;RAC2;SCIN
prerank,SNARE complex assembly (GO:0035493),0.48531253291718357,1.0005357318236603,0.47075208913649025,0.7804588371665501,1.0,4/10,19.11%,VAMP3;VAMP2;VAMP8;SNCA
prerank,intracellular protein transport (GO:0006886),0.3336228184040226,1.0003548602326953,0.503,0.7804795087145268,1.0,77/304,22.47%,RPL11;CD74;GABARAP;CALR;LAPTM5;AKT1;SNX17;NLGN1;AKAP6;NPM1;RAN;ARF5;SORL1;YWHAH;FAM53C;TMED7;LMAN1;SAR1A;RAB14;SURF4;TMED2;ARL11;CLTC;PTTG1IP;SCG5;XPO1;ARF6;TICAM2;TMED3;ARL4C;TMED9;PDCD6;HAP1;CDC37;CTSA;SGSM1;ARL4D;ARL1;VPS28;TMED1;SYNDIG1;IPO4;CLIP3;NUP85;ARF1;EHD1;TBC1D22B;NUP88;UNC93B1;ARF4;RAB20;NAPA;TBC1D9;RAB5C;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2;STX4;RAB18;RAB31;DESI1;TBC1D10C;ERP29;TGFB1;CTTN;RAB6B;C2CD5;IFT27;TMED10;HEATR3;COPB2;AP2A1;STX1B;VPS36;RAB28
prerank,calcium ion import (GO:0070509),-0.30335606304692897,-1.0001318459468649,0.4801980198019802,0.7824801027857892,1.0,8/28,14.17%,MCU;CACNA1C;MICU1;MICU2;TRPC4;CACNA1G;AFG3L2;CACNA1D
prerank,phospholipid dephosphorylation (GO:0046839),-0.2824405026640186,-1.0000781501489473,0.45689655172413796,0.7808513273940336,1.0,18/37,24.14%,PLPP3;MTMR3;MTMR11;PTEN;SACM1L;PLPP5;EPHX2;MTMR10;PLPP1;PIP4P2;PLPP2;INPP5B;PLPPR1;TPTE;PLPPR3;MTMR1;SYNJ2;MTMR7
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2228203591038568,-1.0,1.0,0.7722559249843376,1.0,381/1645,16.30%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;WWC2;MLLT3;GLIS3;EGFR;HIVEP2;BNC2;BAZ2B;ZNF148;ATXN1;NR3C2;RBFOX2;ARID1B;TCF4;TCF7L2;PKNOX2;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;SCMH1;ZNF423;KDM3B;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;SETD5;KAT6B;DENND4A;ZMIZ1;CREBBP;FOXD1;PBX3;KDM2A;ZHX2;ARHGEF11;STAT5B;MED13;MXI1;SSBP2;VGLL4;FOXN3;SNX6;ATF7IP;CUX1;IL31RA;TRAK1;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;BICRA;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;NIPBL;BAZ2A;DHX36;LRP5;CCAR1;WWP1;ARNT2;JMJD1C;USP47;MGA;LRP6;DPF3;ZMYND11;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;CHD2;TAF15;DKK3;NFXL1;PIAS1;HMG20A;OGT;YAF2;MED13L;HOXA5;PARP9;PIAS2;CBFA2T2;HIVEP3;ZKSCAN2;NIBAN2;PRDM11;MTA3;YAP1;KLF3;THRAP3;NRF1;EHMT1;URI1;ZNF292;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;ELP4;EPC1;NFATC1;AXIN1;FOXO3;LIMS1;KDM5B;PHC3;ARID1A;KAT7;APBB2;NFATC4;L3MBTL3;ZNF182;SMAD9;NCOR1;BICRAL;TGFBR1;CCNT1;JARID2;KDM3A;TBX15;TFCP2;FOXP4;EFEMP1;TBL1X;LCOR;TLE1;VGLL3;MEOX2;UIMC1;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;MDM4;ELF2;INSR;STAT3;HDGFL3;HIF3A;MTDH;VSX1;NEK4;RCOR1;CRLF3;NAA16;DYRK1A;CHD1;ARID5B;MDFIC;PML;SMARCA5;SMAD1;CCNL1;ZIC2;RUNX1T1;ZFHX3;MBTD1;ZBTB38;CCNL2;BAZ1B;ZFP30;CEP290;RBBP8;ZBTB1;SPEN;MYNN;USP16;ZFHX4;EBF4;IGF1;ZFX;LOXL3;MEF2A;JMY;STAT2;NSD3;RBAK;PRDM15;MMS19;BTAF1;ZBTB26;SMAD7;EBF1;TFDP1;NFX1;TADA1;BTRC;MYBL1;ATF2;SPINDOC;TBL1XR1;SP100;TEAD2;CBX4;PPARG;PICALM;CREBRF;ETV6;KDM5C;SP4;KLF8;NAA15;ESR1;NR2C2;PCGF5;FOXK1;CCNK;IFRD1;HOXC6;ZFP91;ASCC1;CNOT7;ZNF23;SMAD4;MED26;FBXW11;ZKSCAN3;PDCD4;ZIC1;ATF6;ELF4;TULP3;CDH1;HOXA6;CREB3L2;GMEB1;DGKQ;BRD7;ACTR8;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;DNM2;RBPJ;DDX17;ZHX3;ILF2;KDM4C;CD80;RCOR3;ZBTB34;NLK;GPBP1;SLTM;QRICH1;RNF14;AR;POLR2A;HOXC5;TIAL1;PHF20L1;HIVEP1;ATP8B1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;FUS;NR2F1;HSF2;APBB3;KLF7;SIX5;ZKSCAN7;DVL3;TGFB1I1;TASP1;KAT6A;RORA;CBFB;PHF8;SIRT1;PCBD2;WNT11;NFIC;SCML4;BCLAF1;BMP4;PPARGC1B;SMAD2;ORC1;PHIP;ZBTB21;RLF;TGFB3;WWP2;ZFP62;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;RSF1;CREBL2;EDRF1;GMEB2;GON4L;CARM1;RUNX2;HEY2;EZH2;GATAD2A;SRRT;CRY1;FOXN2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ZBTB46;LDB1;NFYB;ZSCAN12;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;LIMD1;ING2;HINFP;WNT4;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NUP35
prerank,phosphorylation (GO:0016310),-0.2731595639326426,-1.0,1.0,0.7722559249843376,1.0,114/385,16.84%,PRKAG2;ROCK2;GRK5;EPHA7;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;PDK1;PI4KA;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;EIF2AK4;PDPK1;TLK2;TGFBR1;CCNT1;AGK;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;STAT3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;DGKA;TYK2;TRIB2;TOP1;SIK1;MAML1;TAOK3;GK5;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;FRK;HIPK3;NEK7;MAP4K4;CDC25B;NRK;FGGY;MAP4K3;TESK2;DMPK;MORC3;EPHB2;CDK13;GRK4;TBCK;NUAK1;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;NLK;COQ8B;PRKD1;WNT11;SRPK2;GSK3B;MARK2;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;PRKCB;PANK2;ACVR2A;SPHK1;DCLK1;LIMD1;PASK;STK39;BMPR2;JAK1;RYK;PPP3CB;ULK1;ACVR2B;COQ8A
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.23048109908522538,-1.0,1.0,0.7722559249843376,1.0,396/1667,16.29%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;AUTS2;NFAT5;BMP6;PRDM6;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;PID1;PHF21A;WWOX;WWC2;GLIS3;EGFR;HIVEP2;BAZ2B;ZNF148;ATXN1;MLLT10;NR3C2;DNMT3A;ARID1B;FHL2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;KDM3B;KLF12;HOXB3;KMT2C;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;KAT6B;TNRC6B;SLC9A1;ZMIZ1;BMPR1A;CREBBP;FOXD1;MAML2;PBX3;KDM2A;GABPB2;ZHX2;NRIP1;STAT5B;DAB2;MED13;BCAS3;MXI1;SSBP2;KANK2;CUX1;TRAK1;TET2;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;ZFP64;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;FGF1;NIPBL;TNRC6A;ZMYM5;DHX36;PPP1R12A;LRP5;ARNT2;JMJD1C;MGA;SKI;LRP6;DPF3;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;THRB;CHD2;PIAS1;OGT;MED13L;HOXA5;PARP9;ASXL2;PIAS2;HIVEP3;ZKSCAN2;MCPH1;CRTC3;PRKN;MTA3;YAP1;PER3;PPM1D;KLF3;THRAP3;TET3;NRF1;ATAD2B;URI1;ZNF292;KMT2A;TEF;PPARA;DCAF6;NFIX;HOXC4;CREB5;OTUD7B;ZFP90;RARG;ELP4;SSBP3;IL18;EPC1;NFATC1;TNRC6C;FOXO3;FNIP1;KDM5B;HDAC8;MED15;DLG1;ARID1A;KAT7;CNOT1;NFATC4;DICER1;ZNF182;SMAD9;NCOR1;KAT2B;CCNT1;KDM3A;TBX15;TFCP2;FOXP4;MYSM1;TBL1X;ASXL1;LCOR;VGLL3;MEOX2;BCLAF3;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;CDK12;MDM4;BCL9L;ELF2;TCERG1;STAT3;HDGFL3;HIF3A;MTDH;RCOR1;CRLF3;CHD1;ARID5B;SMARCA5;SMAD1;CCNL1;ZIC2;ZNF462;ZFHX3;ZBTB38;KCNIP3;CCNL2;BAZ1B;ZFP30;RBBP8;MAML1;ZBTB1;MET;SPEN;DNAJA3;MYNN;NOC2L;USP16;CPEB3;ZFHX4;EBF4;IGF1;POGZ;ZFX;MEF2A;JMY;FGFR2;STAT2;RBAK;PRDM15;MOV10;ZBTB26;MIER1;SMAD7;FRK;EBF1;TFDP1;NFX1;TADA1;MYBL1;ATF2;INO80;TBL1XR1;SP100;TEAD2;CBX4;PPARG;CREBRF;ETV6;PTEN;RIPK1;DCAF1;SP4;KLF8;ESR1;NR2C2;PCGF5;PPID;FOXK1;SENP1;CCNK;ECD;IFRD1;HOXC6;ZFP91;RGMA;PKD1;ZNF23;SMAD4;MED26;BCL2L12;ZKSCAN3;CDK13;ZIC1;ATF6;NCK1;ELF4;SETX;HOXA6;CREB3L2;GMEB1;TBK1;DGKQ;BRD7;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;RBPJ;DDX17;ZHX3;KDM4C;SAP130;KANSL3;RCOR3;ATM;ZBTB34;CAPRIN2;AKAP8L;BRD8;SLTM;RNF14;AR;HOXC5;TIAL1;PHF20L1;HIVEP1;ARHGEF2;IKZF2;ZNF507;JAG1;ZBTB8A;ZNF8;RREB1;CXXC5;RPAP2;MKX;PRKD1;SIX1;FUS;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;DVL3;KAT6A;RORA;CBFB;PHF8;SIRT1;NFIC;BCLAF1;BMP4;PPARGC1B;SMAD2;PHIP;ZBTB21;EHMT2;RLF;TGFB3;WWP2;ZFP62;GTF2H4;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;METTL23;CDK7;RSF1;GMEB2;RUNX2;HEY2;EZH2;GATAD2A;EZH1;CRY1;N4BP2L2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ACVR2A;ZBTB46;LDB2;LDB1;NFYB;CDC73;ZSCAN12;RHOQ;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;HINFP;SIRT7;ZNF483;ESRRA;FOXO1;FOXL1;TP53;BMPR2
prerank,transcription by RNA polymerase II (GO:0006366),-0.23390728321904222,-1.0,1.0,0.7722559249843376,1.0,96/305,18.69%,TEAD1;NOTCH2;MLLT3;GLIS3;NR3C2;RARB;PRRX1;SCAF8;SOX5;CREBBP;MAML2;INTS8;NR6A1;SETD2;MNAT1;THRB;TAF15;AFF4;YAP1;PPARA;NFIX;RARG;ELP4;INTS6;NCOR1;KAT2B;CCNT1;TFCP2;TBL1X;SP1;WDR33;NFKB1;NR1D2;CDK12;MAML1;ZBTB1;RNGTT;TAF1A;CSTF3;TFDP1;NFX1;TBL1XR1;IWS1;PABPN1;TEAD2;PPARG;ESR1;TRIM24;NR2C2;CCNK;MED26;CDK13;PIR;SETX;GTF2E2;PMF1;RBPJ;TAF2;ELL;AR;POLR2A;PHAX;RREB1;RPAP2;NR2F1;RORA;CBFB;FIP1L1;NFIC;DTX1;GTF2H4;POLR2B;CDK7;GMEB2;SRRT;POLR2J;CDC73;TRIP11;GTF2A2;ESRRA;ADRM1;NR3C1;RTF1;ICE2;SNAPC3;TAF8;RPRD2;CPSF1;ERCC3;TAF7;TAF4B;INTS3;NR5A2;INTS11;GTF2H2;MED23
prerank,protein phosphorylation (GO:0006468),-0.23675265774159118,-1.0,1.0,0.7722559249843376,1.0,140/479,17.68%,PRKAG2;ROCK2;GRK5;TGFBR3;EGFR;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;EPHA3;PDK1;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K3;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RICTOR;TLK2;TGFBR1;CCNT1;EPHA4;EFEMP1;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;MAPKAPK3;TYK2;TRIB2;BAZ1B;TOP1;SIK1;MAML1;TAOK3;BCR;PRKAA2;FGFR2;NEK6;AAK1;STK10;SMAD7;MAPK9;FRK;PDGFRB;HIPK3;NEK7;MAP4K4;CDC25B;ABI1;NRK;RIPK1;MAP4K3;ABL2;TESK2;DMPK;PKD1;MORC3;PTK2;EPHB2;CDK13;GRK4;TBCK;NUAK1;SLK;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;CSNK2A2;NLK;COQ8B;ULK2;PRKD1;WNT11;SRPK2;GSK3B;BMP4;SMAD2;MARK2;GTF2H4;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;CRY1;KIT;PRKCB;CLSPN;ACVR2A;DCLK1;PASK;STK39;BMPR2;ABI3;JAK1;RYK;PPP3CB;ULK1;ACVR2B;PKDCC;COQ8A;STRADB;MAPK14;STK26;ABI2;PDGFRA;VRK3;EPHA8
prerank,epithelial cell-cell adhesion (GO:0090136),-0.40070606623993593,-0.9999816574890775,0.4392857142857143,0.7705418245213213,1.0,5/11,21.36%,VCL;PLEKHA7;KIT;ITGB5;THBS4
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4748411660041729,0.9988053770616344,0.4951590594744122,0.7837616660348751,1.0,2/11,4.81%,ARL6IP1;RTN4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4102694261819402,0.9985260903021796,0.49002493765586036,0.7839582997994577,1.0,7/23,20.96%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;CRLF2
prerank,cardiolipin metabolic process (GO:0032048),-0.3782029111274,-0.9983132339885001,0.4664310954063604,0.7731539934314233,1.0,6/13,26.19%,PLA2G4A;CRLS1;PLSCR3;HADHB;PLA2G5;PGS1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34502531853260116,0.9978521062302245,0.5030487804878049,0.7851013073481709,1.0,31/140,18.31%,CD52;CHRNA9;GPER1;TAC1;C5AR1;GRIN1;CACNA1A;CCR5;P2RX7;TACR1;HTR2C;P2RY1;CD24;HMGB1;GRM1;GPR18;JPH4;CXCR4;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;PTGIR;ADCYAP1;CCR2
prerank,negative regulation of ATPase activity (GO:0032780),0.4466105835598201,0.997355175529438,0.47587131367292224,0.7858529009146007,1.0,3/16,8.67%,ATP5IF1;PLN;IFIT1
prerank,histone lysine methylation (GO:0034968),-0.28358419111288946,-0.997265173137552,0.4838709677419355,0.7744244575649348,1.0,18/33,25.60%,PRDM5;SMYD3;KMT2A;ASH2L;SETDB1;KMT2D;WDR82;EHMT2;EZH2;PRDM9;SETD1B;WDR5B;SETD3;SETD6;KDM6A;SMYD1;DYDC2;N6AMT1
prerank,regulation of lipid storage (GO:0010883),0.4219350174131528,0.9969878913333704,0.4888888888888889,0.7862962419369505,1.0,7/22,20.79%,C3;TNF;LPL;ALKBH7;FBXW7;IL6;NFKBIA
prerank,insulin receptor signaling pathway (GO:0008286),0.3620045769554012,0.9964868455772602,0.5058697972251868,0.7870623874253332,1.0,10/69,7.57%,ATP6V0C;AKT1;ATP6V1F;GRB14;ATP6V1G1;CAV2;ATP6AP1;ATP6V0E2;RARRES2;NAMPT
prerank,positive regulation of neuron projection development (GO:0010976),0.3549362179805839,0.9959722747855287,0.502606882168926,0.7878740989434422,1.0,13/85,11.12%,APOE;MDK;PACSIN1;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;CAMK1;WNT5A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3511392334098375,0.9959368241744003,0.508994708994709,0.7875358882848034,1.0,27/90,23.36%,GATM;UCP2;EPAS1;FABP5;BSCL2;OMA1;CEBPB;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6
prerank,mammary gland development (GO:0030879),0.42754262442275087,0.9950613352799412,0.4681933842239186,0.7892030674487998,1.0,2/21,2.95%,NRG1;ERBB4
prerank,proteoglycan metabolic process (GO:0006029),-0.3022678431217186,-0.9948618191663571,0.42134831460674155,0.7791604749181267,1.0,4/26,8.26%,SULF1;ADAMTS12;IGF1;CHST11
prerank,long-term synaptic potentiation (GO:0060291),0.4158029690994081,0.9946758720093392,0.49625935162094764,0.7896717588730028,1.0,6/21,18.78%,SLC24A2;MPP2;GRIN2A;VAMP2;GRIN2B;STX4
prerank,regulation of response to external stimulus (GO:0032101),0.3444889562631927,0.9946360806416289,0.5,0.7893336481397444,1.0,21/121,16.42%,TMSB4X;CALM1;GRN;PARK7;TREM2;METAP1;SEMA7A;TIRAP;BCL6B;METAP2;P2RY12;HCK;WNT5A;ELMOD2;CXCR4;F2RL1;AKNA;TRAF3;LRP8;CNGB1;CAV1
prerank,regulation of p38MAPK cascade (GO:1900744),0.3909714598473894,0.9944561568803821,0.48881036513545345,0.7893654278976914,1.0,13/35,25.38%,TREM2;SPI1;EMC10;PHLPP1;PRMT1;BMP2;RASGRP1;NCF1;DAB2IP;GADD45A;DUSP1;AGER;MFHAS1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.45886141731911356,0.994360414369536,0.4932795698924731,0.78916601702418,1.0,6/14,17.77%,PSENEN;ABCG1;BACE1;PSEN2;ADAM17;APH1B
prerank,protein targeting to membrane (GO:0006612),0.35366798471540317,0.9943172214960841,0.5078369905956113,0.7888441116167161,1.0,32/83,32.42%,NACA;SSR2;ARL6IP1;SRP14;PXMP2;SSR1;ICMT;GDAP1;GOLGA7B;SEC61A1;YIF1B;SDCBP;SGTA;GOLGA7;NCF1;VPS37C;ZDHHC12;TRAM1;FIS1;NACAD;PEX11B;ZDHHC2;ARL6;RTP3;SRP19;ZDHHC14;SRPRA;ABCD2;ALDH3A2;PEX14;CHMP4A;CHMP4B
prerank,diacylglycerol metabolic process (GO:0046339),0.41888325341232574,0.9939337686088583,0.48427672955974843,0.7893194523558882,1.0,10/23,22.75%,PNPLA2;ANG;DGKH;LIPE;DGKI;MOGAT2;DGAT1;DGKK;DGKB;MOGAT1
prerank,skin development (GO:0043588),0.3603648007444296,0.9939236610274789,0.5120087336244541,0.7889208753584938,1.0,15/65,16.90%,COL1A1;TXNIP;HRNR;ABCB6;COL3A1;DHCR24;KRT9;WNT5A;LSR;COL1A2;EVPL;STMN1;PDGFA;DLL1;FA2H
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.308155837392603,-0.993600846795419,0.47093023255813954,0.7807496496894658,1.0,9/27,16.27%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.38980954874908824,-0.993436908059354,0.43272727272727274,0.7794591258966304,1.0,9/11,31.29%,GRK3;ADM;GTF2H2;SAG;ARRB1;ADRB2;DRD3;ADRB3;ARR3
prerank,organophosphate ester transport (GO:0015748),0.40794218578257974,0.9933382062714686,0.4939613526570048,0.7898708530871696,1.0,3/24,4.13%,PLTP;NPC2;SCP2
prerank,striated muscle cell differentiation (GO:0051146),0.44158323315764975,0.992700472743749,0.494750656167979,0.7909894099491865,1.0,8/16,20.07%,NRG1;PLD3;MTLN;KDM6B;BMP2;SORT1;MYEF2;MEF2C
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4474772758309408,0.9922807392400804,0.4913907284768212,0.7915599097263034,1.0,6/16,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;RRAGD
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.43827330435810197,0.9922414710232685,0.4942528735632184,0.7912428786784863,1.0,7/18,20.07%,MDK;HMGB1;CCL2;IGF2;FLT1;ADAM17;MEF2C
prerank,regulation of actin filament-based movement (GO:1903115),0.4925753863011454,0.9920156811629639,0.5128571428571429,0.7913563691907034,1.0,3/10,17.63%,PDE4B;PLN;SRI
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4219683299529119,0.9913110986154687,0.5054945054945055,0.7925791535699271,1.0,7/23,16.42%,PTPRC;HYAL2;PTK6;THY1;CHMP6;SRCIN1;CAV1
prerank,heterochromatin organization (GO:0070828),-0.37335533205874455,-0.9911436482947557,0.4907749077490775,0.7839142092077224,1.0,5/14,15.12%,SETDB1;SETD7;SIRT1;EZH1;SMCHD1
prerank,response to growth factor (GO:0070848),0.37749734573120186,0.9909655882056406,0.46871444823663255,0.7929462909967478,1.0,5/41,5.33%,RACK1;AKT1;PDGFB;ACVRL1;CTNNB1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.19762457046288606,-0.9907273994476952,1.0,0.7832584306002692,1.0,89/336,18.12%,FOXP1;UBE2E2;ABL1;SUSD6;BABAM2;USP3;PDS5A;TRIP12;NIPBL;STXBP4;PARP4;USP47;UBR5;MNAT1;YAP1;KMT5C;BRAT1;UVRAG;TLK2;SPIDR;PDS5B;PARP3;KMT5B;NEK4;MSH3;RNF8;UFL1;PML;ASH2L;ZBTB38;BAZ1B;RBBP8;ZBTB1;RNF169;TAOK3;USP16;DDB2;SLX4;MMS19;ALKBH8;PSME4;ATF2;INO80;FBH1;TOPORS;CCNK;XPA;MRNIP;SETX;CUL4B;BCL2L11;RAD51B;PSEN1;CUL4A;ATM;RAD17;BCL2;MTREX;USP28;SETD7;ERCC8;SIRT1;GTF2H4;BOD1L1;CGAS;TAOK1;MGMT;CRY1;TDP1;FANCC;ETAA1;BATF;HINFP;SIRT7;FOXO1;ALKBH3;TP53;USP45;FANCG;INIP;CEP63;RTEL1;MAPK14;RMI2;WAC;FMR1;ERCC3;INTS3;TIGAR
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33329526102212353,0.9906997641617462,0.5275827482447342,0.7931235680330453,1.0,52/248,16.72%,APOE;IGFBP6;PFDN5;PSMB4;MDK;COL1A1;PPP1CA;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;FZD9;PSMD1;PIN1;LRP4;PSMC3;TLE5;CTNNB1;PSMD6;ANKRD6;VCP;SFRP5;PSMA7;OTULIN;JADE1;PSMD5;RBX1;LGR6;PSMB9;PSMD13;GPC5;WNT5A;SOX17;PSMB3;ATP6AP2;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1;USP8
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3448712698725542,0.9905621065398641,0.5108359133126935,0.7930474782270531,1.0,31/118,20.17%,SPARC;GPNMB;CFL1;HMOX1;EMP2;ADGRB3;KNDC1;CTNNB1;LRRC4C;TNFAIP3;VASH1;PAK1;PPFIA2;CLASP1;MAPT;CDK5R1;PAK3;RNH1;WARS1;FLT4;SRCIN1;ZMYM3;CDK5;DLL1;BRSK2;NSMF;HECW1;IL6;TGFB1;MEF2C;SFRP1
prerank,regulation of store-operated calcium entry (GO:2001256),0.48119058289479694,0.9904288593839427,0.5028490028490028,0.7929224913265914,1.0,2/10,3.99%,CD84;HOMER2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.34566751776047916,0.9903604149406197,0.5082815734989649,0.7926767870982843,1.0,26/95,20.02%,RPS27A;UBC;UBB;HSP90AB1;LTBP4;FKBP1A;PIN1;EID2;CDKN1C;HIPK2;WFIKKN2;UBA52;STRAP;ZBTB7A;SNW1;HSPA1A;SPRY1;STK11;SDCBP;CAV1;ADAM17;PEG10;SOX11;VASN;TGFB1;CITED2
prerank,synaptic vesicle membrane organization (GO:0048499),0.43414495495151584,0.9898777125109592,0.49933598937583,0.7933680621947452,1.0,6/17,22.10%,SNAP25;SYNGR2;SYNGR1;SYP;STX4;STX1B
prerank,inorganic ion transmembrane transport (GO:0098660),0.47405332053273896,0.9898485062871808,0.4900568181818182,0.7930143945544788,1.0,3/12,19.70%,ASIC2;ABCC8;PKD2L1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4259996769337867,0.9895874697930412,0.5012722646310432,0.7931926060564612,1.0,4/19,14.00%,MAF1;PRDX5;CEBPA;ZC3H8
prerank,RNA metabolic process (GO:0016070),-0.2230222681718766,-0.9895465964247468,0.5,0.7847915301968565,1.0,38/127,16.85%,CELF2;RBMS1;RBPMS;ATXN1;RBFOX2;RBM5;FTO;RBM39;DHX36;ATXN2;RNASE3;DICER1;PARN;HNRNPUL1;MPHOSPH10;RBM6;DROSHA;SIDT2;RNGTT;RBM4;WTAP;PABPN1;HNRNPR;SETX;HNRNPL;DDX17;POLR2A;MTREX;PRPF4;POLR2B;PABPC4;RBMS2;DUSP11;POLR2J;ADARB1;NOVA1;AGO2;HNRNPH3
prerank,regulation of cell division (GO:0051302),0.35626888735940665,0.9894770810487147,0.5154749199573105,0.7930302161059443,1.0,17/72,22.29%,RACK1;CALM1;CALM3;TXNIP;KLHL9;PIN1;CDK2AP2;DLL1;CETN2;INSC;CALM2;ESRRB;GIT1;MYC;SIRT2;CCP110;BLM
prerank,regulation of calcium ion transport (GO:0051924),0.36469717655507705,0.9893285749727179,0.4967032967032967,0.7929620824927355,1.0,13/54,17.63%,CD84;HOMER2;CTNNB1;PLN;LILRA5;WFS1;ATP2B1;LILRB1;EPB41;CCL3;SARAF;ORAI1;SRI
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.42273944901771676,0.9886608064829134,0.49682337992376113,0.7941043040208003,1.0,6/22,21.01%,PDE4B;AHNAK;CBARP;SRI;STAC3;CACNB4
prerank,regulation of mitotic spindle assembly (GO:1901673),0.43938694569631237,0.9885340805422175,0.512853470437018,0.793986908010694,1.0,6/19,15.97%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B
prerank,male gonad development (GO:0008584),0.38989675142531743,0.9880630438021303,0.49524940617577196,0.794631809316656,1.0,13/34,28.28%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.45632799829281717,0.9876613600778957,0.5074224021592443,0.7951253058087037,1.0,7/14,26.00%,RFK;ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,actin filament depolymerization (GO:0030042),0.47781254282231916,0.9874810039505906,0.5160390516039052,0.7951531408701265,1.0,4/11,12.83%,GSN;CFL1;MICAL1;DSTN
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4324513388639704,0.9874209469487402,0.5082592121982211,0.7948661102825646,1.0,8/18,19.76%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3824876624885809,-0.9873931026993578,0.460431654676259,0.7887275448127126,1.0,1/11,2.16%,MOXD1
prerank,regulation of glycogen metabolic process (GO:0070873),0.47134890337328206,0.9873323532998453,0.4979536152796726,0.7946472793346345,1.0,3/12,21.22%,AKT1;PPP1R3D;KHK
prerank,inorganic anion transmembrane transport (GO:0098661),0.36073792275320804,0.9869732754420869,0.5265438786565547,0.7951007420856543,1.0,14/63,18.84%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;SLC25A11;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.37770733643454907,0.9869068103540498,0.5155350978135789,0.7948227925232136,1.0,13/40,27.82%,SLC38A5;SLC7A5;SLC25A11;SLC25A21;SLC19A1;SLC16A1;SLC38A10;SLC7A10;SLC25A14;SLC7A6;SLC38A3;ABCC5;SLC16A7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.24666096121168174,-0.9869037484295258,0.44086021505376344,0.7883713181492649,1.0,11/58,13.42%,BABAM2;KDM2A;NSMCE2;UVRAG;MDC1;UIMC1;RNF8;NHEJ1;ATM;ERCC8;CYREN
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4634358689195308,0.9863666480740331,0.4943977591036415,0.7956429952363215,1.0,3/12,9.64%,BGN;BCAN;DCN
prerank,T cell differentiation (GO:0030217),0.3785743835866932,0.9860733253988478,0.5090702947845805,0.7959162269390679,1.0,9/40,17.49%,PTPRC;FCER1G;ZFP36L1;SPI1;ZFP36L2;IL2;JAG2;PIK3CD;ADAM17
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.23959640774811566,-0.9852725885159771,0.47692307692307695,0.7911161837655735,1.0,19/67,18.10%,PLD1;FER;DCDC2;TBC1D19;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;SDCCAG8;FXR2;IFT140;ATP8B1;MYO10;DYNC2LI1;SGSM3;ABITRAM;FMR1;CDKL1
prerank,dermatan sulfate metabolic process (GO:0030205),0.4587483440561242,0.9852687133926327,0.48622589531680444,0.7974253863326396,1.0,3/13,9.64%,BGN;BCAN;DCN
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.39378821217536564,-0.985045179851565,0.4281150159744409,0.7898801212156155,1.0,4/10,21.30%,SEC14L1;NPLOC4;DHX58;GPATCH3
prerank,cellular response to glucose stimulus (GO:0071333),0.3935461197460993,0.9849106502099485,0.505521472392638,0.7978550108968063,1.0,7/30,16.35%,RACK1;PTPRN;GPER1;MLXIPL;PTPRN2;GAS6;ADCY8
prerank,glucose transmembrane transport (GO:1904659),0.4338142179575713,0.9849092845497576,0.5040106951871658,0.7974450846481866,1.0,9/18,36.99%,SLC2A1;SORT1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,RNA catabolic process (GO:0006401),0.37474423536763857,0.9848767853220657,0.5044943820224719,0.7971011839200473,1.0,15/46,25.42%,LSM6;RNASEH2A;HSPA1B;ZFP36L2;ZFP36;RNASEH1;RNH1;HSPA1A;SND1;NUDT16;NANOS2;ISG20;LSM5;METTL3;PNPT1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4336166374777376,0.9846464159987979,0.494910941475827,0.7972408096441023,1.0,4/17,15.07%,BTG1;SOX9;SFRP4;BAD
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4128014965044946,0.9844933116577214,0.509090909090909,0.7971867196888239,1.0,7/24,19.08%,VKORC1;PARP1;AGBL4;NAA10;TTLL7;TTLL10;TTLL5
prerank,potassium ion import across plasma membrane (GO:1990573),0.374512264544694,0.9839596495088127,0.5045662100456622,0.798026479179235,1.0,9/41,17.70%,KCNJ10;ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;KCNK9;ATP1B1;ATP1B3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4058303971574422,0.9839181997652547,0.5199004975124378,0.7977152183326669,1.0,10/26,19.84%,C3;ATF4;SARS1;FLT4;HPSE;GATA4;CCR2;CXCL17;IL6;TGFB1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28100587430300644,-0.9838086882208077,0.4819277108433735,0.7914688520520516,1.0,8/34,11.93%,PTPN13;PTPN9;TNS2;DUSP16;DUSP10;PTPN12;DUSP7;PTPN2
prerank,potassium ion transmembrane transport (GO:0071805),0.3348386675748286,0.983719442895058,0.5350253807106599,0.7978109523878153,1.0,34/135,19.70%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;ATP1A3;ATP1B2;SLC12A5;KCNC1;KCNE4;KCNA2;KCNN2;ATP1A4;ATP1A1;KCNK9;ABCC8;KCNE5;KCNF1;ATP1B1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.30681369048420537,-0.9833587545404969,0.4558139534883721,0.7910053518888567,1.0,2/21,3.64%,OSBPL8;PLA2G4A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3475286454114659,-0.9830640703420302,0.4658119658119658,0.7900752386333042,1.0,7/16,14.98%,DPYSL3;TET2;DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3030108349440168,-0.982950418087191,0.4444444444444444,0.7886518917773556,1.0,10/25,16.98%,SCAF8;SETD5;ZMYND11;KAT7;CCNT1;CCNK;ELL;THOC5;LDB1;WDR43
prerank,positive regulation of protein import into nucleus (GO:0042307),0.40029404439737265,0.9828368741169945,0.5326991676575505,0.7994821307357725,1.0,5/28,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,protein localization to chromosome (GO:0034502),-0.28880100772722117,-0.9823801502595981,0.4764705882352941,0.7884494138981385,1.0,9/34,16.49%,WAPL;PARP3;ESR1;MRNIP;TNKS2;TERF2;TINF2;PINX1;IFFO1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2840389745851744,-0.9820513606029468,0.4838709677419355,0.7875777781464073,1.0,7/35,10.19%,ADCY9;ADCY1;LGR4;ADCY5;RAF1;EDNRA;ADCY7
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.41653937169524896,0.9820151333026088,0.5122850122850123,0.8004830554908379,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.41653937169524896,0.9820151333026088,0.5122850122850123,0.8004830554908379,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,positive regulation of insulin secretion (GO:0032024),0.3891660850436168,0.9819842120722088,0.5129716981132075,0.8001371752216236,1.0,14/36,26.57%,RBP4;TRH;LRRC8A;GPER1;BAD;ADCY8;DOC2B;GLUD1;STX4;NNAT;PSMD9;ACSL4;PLA2G6;TM7SF3
prerank,cytoskeleton organization (GO:0007010),0.3400557513142922,0.9819068429793133,0.533678756476684,0.7998945638468754,1.0,26/114,17.42%,APOE;MDK;CFL1;RHOB;CNN2;RHOC;MAST3;RAC1;PACSIN1;TNFAIP3;RHOG;MAST1;THY1;MICAL1;ARAP3;RHOA;DES;RHOU;CCL2;ZMYM3;EPB41L3;SH3KBP1;DMTN;CCL3;FMNL3;RAC2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4122383670764628,0.9819029341479248,0.5,0.7994911416928661,1.0,6/22,17.58%,AKT1;NTRK2;SH3GL2;MAPT;EHD1;TMEM108
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3386678489621734,0.9812999639732067,0.5456410256410257,0.8004642234398514,1.0,26/117,21.69%,BSG;CKB;GATM;AGXT;SCP2;GLO1;LDHA;CKMT1A;GRHPR;LPL;ALKBH7;FASN;ACOT1;ACOT7;GLYAT;NAAA;SLC16A1;ACOT4;FA2H;BCO2;ACSL3;GAMT;THEM4;ALDH4A1;MTHFS;SGPL1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.45237421673458117,0.9808994702217081,0.5136612021857924,0.8009676505008154,1.0,4/13,16.38%,CD2BP2;PRPF19;PRPF8;PRPF31
prerank,skeletal muscle organ development (GO:0060538),0.4054065360346534,0.9799849088420616,0.5201958384332925,0.8027139726586644,1.0,4/26,11.07%,MYL6;FOXL2;BASP1;MYL6B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.46192481340913494,0.9799326544477929,0.5236167341430499,0.8024180836602977,1.0,3/14,18.31%,CD81;SYK;CCR2
prerank,histone mRNA metabolic process (GO:0008334),0.39764534492976145,0.9796694013799954,0.49760191846522783,0.8026174510700265,1.0,9/27,23.65%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;EXOSC4;ERI1
prerank,cell proliferation in forebrain (GO:0021846),-0.40286992900994734,-0.9796321700366698,0.45794392523364486,0.7921225071212681,1.0,4/10,15.27%,DOCK7;PCM1;NUMBL;NUMB
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2544936740672886,-0.9793885509187326,0.4774774774774775,0.791077441218144,1.0,11/46,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,regulation of ion transmembrane transport (GO:0034765),0.38027374369699374,0.9792374037600557,0.5099882491186839,0.8031532472827101,1.0,6/33,14.60%,AKAP6;YWHAE;KCNJ10;P2RX7;CHRM3;KCNE5
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.48279388284394753,0.9791793302210013,0.5092724679029957,0.8028700874846711,1.0,7/10,34.74%,SYNGR1;SYP;APP;NETO1;CAMK2B;DRD2;NPTN
prerank,cytosolic calcium ion transport (GO:0060401),-0.2953358759954871,-0.978813126877441,0.5120481927710844,0.7907882484894798,1.0,6/28,8.41%,MCU;CACNA1C;MICU1;MICU2;SLC35G1;JPH1
prerank,sterol metabolic process (GO:0016125),0.3571113573115313,0.9786406177761213,0.5408942202835333,0.8037055134205873,1.0,12/60,23.23%,APOE;ABCG1;PIP4P1;FDX2;SC5D;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;NSDHL;PMVK
prerank,extracellular structure organization (GO:0043062),0.3302065257176409,0.978611289409863,0.559679037111334,0.8033659254782505,1.0,32/204,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,positive regulation of lyase activity (GO:0051349),0.44605789856741485,0.9785368276705468,0.517426273458445,0.8031255223261418,1.0,5/14,17.56%,PARK7;DRD5;ISCU;ORAI1;NOS2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.39677262705679783,0.978381148668801,0.50920245398773,0.8030669711484469,1.0,9/26,25.11%,LGMN;DUSP3;HES1;ASNS;USP22;FOXA1;MEIS2;APP;PRKCA
prerank,positive regulation of kinase activity (GO:0033674),0.3391494720818785,0.9782284828711197,0.5356037151702786,0.8030024961427803,1.0,28/107,18.24%,CD74;CCL19;TREM2;ERBB4;TNF;PTPRC;NTRK2;EEF1A2;LTK;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;GAS6;MMD2;EPHB1;MAPRE3;FLT1;TYRO3;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3
prerank,positive regulation of intracellular transport (GO:0032388),0.37606571807776457,0.9780228084089913,0.5251141552511416,0.8030711610131986,1.0,16/38,28.06%,OAZ1;SORL1;PRR5L;MLC1;VAMP2;CEP131;B3GAT3;STK11;EHD1;EHD2;OAZ2;KIF20B;ICE1;PCNT;PGAP1;TENM1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.400233450167357,-0.977898761760275,0.4863013698630137,0.7916309823178141,1.0,2/10,5.34%,ACTN2;CARMIL1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.41434975487630765,0.9776808737691476,0.5260545905707196,0.8034386443479243,1.0,4/22,4.63%,TNF;LGALS3;FKBP1A;PPP1R1B
prerank,regulation of gluconeogenesis (GO:0006111),-0.30779829612696996,-0.9776031897850566,0.5,0.7908008764399407,1.0,9/27,16.08%,OGT;CLK2;SIK1;C1QTNF3;DGKQ;PTPN2;SIRT1;CRY1;SIRT7
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3287192558149043,0.9771866305968675,0.574167507568113,0.8041423267569628,1.0,54/198,25.58%,ALDOA;GPX4;CALM1;ALDOC;PPP1CA;MAPK3;AKT1;PFKL;TOLLIP;PTPRC;DUSP3;PLAAT3;PGK1;PAK1;DUSP28;LPL;PIP4P1;BCKDK;NUDT3;PLA2G4F;PTPRD;GDE1;PTPRB;INPP5J;NUDT4;CDK5;PPA1;PIK3CD;NT5C;CLN8;G6PC3;CERKL;IP6K1;PPP3CA;PLPPR2;NUDT10;PGP;TGFB1;SPHK2;PLCH1;DUSP23;DUSP12;INPP5D;DUSP15;AGPAT2;PNKP;NUDT11;ACP2;PLA2G3;PLPPR4;GPD2;TNK2;INPP4B;DUSP8
prerank,cGMP metabolic process (GO:0046068),0.45896691509096765,0.9769956962310278,0.5101214574898786,0.804172482036317,1.0,1/12,2.33%,NPPC
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.351694045556505,0.9768699118403084,0.5167567567567568,0.8040464281016081,1.0,9/65,7.22%,RPS27A;UBC;UBB;FKBP1A;PIN1;EID2;WFIKKN2;UBA52;STRAP
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4151813474933061,0.9768477005564713,0.5157629255989912,0.8036903324598256,1.0,9/21,24.94%,HINT1;NUDT3;ACAT1;PNP;NUDT4;NUDT16;NUDT10;NUDT11;PDE2A
prerank,photoperiodism (GO:0009648),-0.299433436338694,-0.9767953827426494,0.5149700598802395,0.7912703571485571,1.0,9/28,16.27%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,intestinal lipid absorption (GO:0098856),-0.3848822680676442,-0.975856617857107,0.4788732394366197,0.791910086355369,1.0,1/11,1.11%,LIMA1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.30329520766459866,-0.9758529103035669,0.46285714285714286,0.7902300772872856,1.0,10/25,16.98%,BRD4;ZMYND11;CDK12;TCERG1;RNF8;CDK13;ELL;LDB1;CDC73;WDR43
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3230443471446974,-0.9750070894185412,0.4840182648401826,0.787422143377944,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3230443471446974,-0.9750070894185412,0.4840182648401826,0.787422143377944,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3230443471446974,-0.9750070894185412,0.4840182648401826,0.787422143377944,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,regulation of lipase activity (GO:0060191),0.4589120272533117,0.9749221751791004,0.5296495956873315,0.8076892108372684,1.0,5/13,25.26%,RHOC;LPL;RHOA;SNCA;PCSK6
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4221241233126652,0.9745086972284704,0.5149544863459038,0.808202193981381,1.0,7/18,28.69%,ZFP36L1;ZFP36L2;IKZF3;CCR2;PRELID1;METTL3;XRCC6
prerank,determination of heart left/right asymmetry (GO:0061371),0.3661052814085794,0.9743349442024076,0.5329608938547487,0.8081984312797991,1.0,10/43,20.07%,SOX18;NDRG4;APLNR;MMP21;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.39277380824342467,-0.9736629977471961,0.48464163822525597,0.7892418976141441,1.0,5/10,19.30%,ST6GAL1;GNE;RENBP;NPL;NAGK
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.38238413125179915,0.9735960944279184,0.5207100591715976,0.8095024283809602,1.0,18/32,33.03%,MID1IP1;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;FGF13;CDH5;SNCA;FKBP4;TBCD;MAPRE1;CAMSAP3;CLASP2;STMN2;KATNB1;APC
prerank,vesicle transport along actin filament (GO:0030050),0.42407378500878684,0.9735046458809601,0.5316455696202531,0.8092966866999892,1.0,4/19,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.42721836817117165,0.973408621068989,0.5188067444876784,0.8091075099103036,1.0,13/18,38.37%,PCNA;RFC4;GINS3;LIG1;MCM7;POLE3;POLD3;GINS1;RFC3;POLD2;MCM4;LIG3;MCM3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42826972428175253,0.9729876589220235,0.5233022636484687,0.8096362956611555,1.0,4/16,24.49%,PTPRC;LILRB1;IL12RB1;AGER
prerank,synaptic vesicle endocytosis (GO:0048488),0.3836257687931257,0.9729634719097096,0.5205640423031728,0.8092763281207289,1.0,8/33,9.25%,NLGN1;CANX;PACSIN1;DNM3;SNAP91;SYT1;AMPH;VAMP2
prerank,negative regulation of protein polymerization (GO:0032272),0.3961182496179644,0.972827246624945,0.525748502994012,0.8091834517139084,1.0,14/27,25.37%,MYADM;PFN1;TUBB4A;MAP2;CLIP3;STMN1;PFN2;CDH5;SNCA;TWF1;SSH2;TWF2;TBCD;MAPRE1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3396338303104054,-0.9723983459975709,0.47950819672131145,0.7891198080393106,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,stress fiber assembly (GO:0043149),-0.3396338303104054,-0.9723983459975709,0.47950819672131145,0.7891198080393106,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3513649686277039,0.9721161511748728,0.5302375809935205,0.8103514025430731,1.0,17/67,17.09%,MDK;CALR;S100A10;EMP2;PDGFB;RAC1;FLNA;MYADM;FN1;P4HB;ARHGEF7;ARL2;DMTN;CCL28;CASS4;SKAP1;FBLN2
prerank,cation transport (GO:0006812),0.33004168772063885,0.9710823905424928,0.5593561368209256,0.8122888527673509,1.0,30/167,16.10%,SLC38A5;SLC39A1;SCN1A;GRIN1;KCNJ10;SLC25A29;SLC6A6;SGK1;CNGA3;AQP1;TMEM63C;SLC6A17;SCN4B;SLC3A2;KCNC1;KCNA2;TRPM2;KCNN2;ATP1A4;SLC1A1;KCNK9;ABCC8;NDUFA9;KCNF1;ATP1B1;SLC8A1;KCNK3;FGF13;CNGB1;KCNA1
prerank,monocyte differentiation (GO:0030224),0.4744154395204044,0.9708614431235413,0.531437125748503,0.8123690023840573,1.0,1/10,0.41%,MT1G
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4562330656035151,0.9705841525938793,0.5213204951856947,0.8126090763217566,1.0,6/12,26.00%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,regulation of axonogenesis (GO:0050770),0.3579298899633254,0.9703104195959872,0.5288888888888889,0.8127995469886874,1.0,13/51,16.85%,ARHGDIA;NTRK2;RTN4;LRP4;LRRC4C;PAK1;THY1;PAK3;GDI1;RHOA;TIAM1;ROBO2;BRSK2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.42923411787829047,0.9700048268310149,0.5166666666666667,0.8130904663819591,1.0,4/18,9.52%,HMOX1;KDR;JCAD;GATA2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2513985814422883,-0.9697780718607022,0.4594594594594595,0.7943449081323684,1.0,13/62,8.78%,KMT2C;CNOT4;TNRC6B;CREBBP;ZBTB16;TNRC6A;HOXA5;KMT2A;TNRC6C;KAT2B;CDK6;ASH2L;MOV10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4152507420356126,0.969541480006806,0.5491183879093199,0.8137346384818627,1.0,8/23,28.56%,TNFAIP3;GAS6;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,phagolysosome assembly (GO:0001845),0.4586224035869791,0.9694744608835186,0.5159500693481276,0.8134801968305931,1.0,7/12,34.89%,RAB14;CORO1A;RAB20;SYT7;RAB34;RAB39A;ARL8B
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3405663939702032,0.9693632204712934,0.5535900104058272,0.8133191132693837,1.0,30/93,25.38%,CCL19;SPI1;TIRAP;ANKRD6;SEMA4C;EMC10;HIPK2;CCN2;HMGB1;FLT4;HRAS;PRMT1;MAPK8IP1;BMP2;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,positive regulation of transmembrane transport (GO:0034764),0.4514568326744962,0.9688733182130634,0.5254691689008043,0.8140202871391395,1.0,4/13,13.79%,C3;CA2;P2RX7;CLIP3
prerank,cellular glucose homeostasis (GO:0001678),0.3692598983669173,0.96817828879051,0.5327963176064442,0.8151754464108255,1.0,5/41,5.90%,RACK1;LRRC8A;GPER1;NR1D1;NUCKS1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.35215041893158927,-0.9676423495604115,0.4943820224719101,0.7982721540855579,1.0,5/14,14.22%,TNKS2;TERT;TERF2;TINF2;PINX1
prerank,negative regulation of myotube differentiation (GO:0010832),0.45237185458448215,0.9665228792011066,0.5216178521617852,0.8184271580138192,1.0,6/12,27.82%,BHLHE41;TMEM119;HDAC5;NOTCH1;CCN3;XBP1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4476487791775507,0.966510933215842,0.5252387448840382,0.8180407131527448,1.0,4/13,19.01%,SOD1;CLPTM1;ZC3H8;TOX
prerank,ERBB signaling pathway (GO:0038127),0.3497203753353188,0.966367657744227,0.5392051557465092,0.8179538901448713,1.0,18/64,21.65%,HSP90AA1;AKT1;NRG1;ERBB4;SHC3;MATK;PTK6;CDC37;AAMP;PTPRR;SOX9;ERBIN;ADAM17;ERBB3;SOS1;TGFB1;STUB1;TGFA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3737591095255356,0.9658440605658726,0.53125,0.8187167579011426,1.0,6/37,12.08%,DYNLL2;DYNLL1;IFT20;DYNLRB1;CEP131;DYNLRB2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.46081619018683057,0.9658346489674611,0.5240715268225584,0.8183238803722797,1.0,3/11,13.56%,CD34;WNT5A;WNT10B
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.36285808692092647,0.965687787271954,0.5440180586907449,0.8182385177190611,1.0,13/47,20.52%,PPIA;MAPK3;SEMA4C;PHLPP1;MAPK8IP1;F2RL1;MAPK8IP2;RASGRP1;EPHB1;DAB2IP;MAP2K2;QARS1;MYC
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3254997423442698,-0.9650563378282957,0.5067264573991032,0.8034393590748634,1.0,7/18,16.27%,EGFR;NCOR1;RIPK1;ESR1;TERT;BMP4;TP53
prerank,regulation of isotype switching (GO:0045191),-0.3405342879869324,-0.9649270444652734,0.49612403100775193,0.8020667027174566,1.0,4/14,7.38%,KMT5C;PARP3;KMT5B;SHLD1
prerank,regulation of lymphocyte activation (GO:0051249),0.4576102641808848,0.9648979822794792,0.5121255349500713,0.8195963608876077,1.0,2/12,14.37%,DCAF15;IKZF3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36204709927385353,0.964885562205007,0.5422612513721186,0.8192149066713125,1.0,16/52,19.60%,RACK1;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;RAMP3;CLIP3;SQSTM1;ACSL3;STX4;STAC3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.34254791863058565,-0.9646973965340006,0.4851063829787234,0.8010167475722987,1.0,5/14,14.18%,ARID2;MMS19;MRNIP;FUS;FANCB
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4529816815060552,0.9646408503717675,0.5276243093922652,0.8193305574187392,1.0,3/12,13.00%,AGT;SOX8;SOX9
prerank,snRNA processing (GO:0016180),-0.3360320512263111,-0.9645525014306825,0.470873786407767,0.7996879472406603,1.0,5/16,18.66%,INTS8;INTS6;TUT1;INTS3;INTS11
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4205476244830348,0.9645173909123771,0.5268542199488491,0.8191694588398153,1.0,5/19,12.78%,TLE5;CD24;TAF9;WNT5A;KLF4
prerank,regulation of necroptotic process (GO:0060544),0.40558949594141486,0.9644085873695907,0.5388409371146733,0.8190046075427525,1.0,7/23,15.65%,HSP90AA1;FZD9;SLC25A4;FLOT1;CDC37;SDCBP;YBX3
prerank,regulation of viral release from host cell (GO:1902186),0.41645957995298655,0.9643634971695577,0.5329192546583851,0.8186824246470451,1.0,6/21,19.65%,CHMP2B;TRIM28;DDB1;TRIM32;VPS4A;TRIM13
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3676024707426483,-0.9642091015353532,0.5068493150684932,0.7988852366804757,1.0,8/12,28.99%,GOLGA2;BTRC;PTEN;CDC14B;GORASP1;RAB1A;PLK1;UBE2C
prerank,vesicle transport along microtubule (GO:0047496),-0.2962501606610523,-0.9637611201431716,0.52046783625731,0.798410237613963,1.0,6/23,15.21%,TRAK1;PAFAH1B1;FBXW11;KIF13A;CLN3;NDEL1
prerank,regulation of multicellular organism growth (GO:0040014),0.4419158923037219,0.9637503476546496,0.5176470588235295,0.8196233344510662,1.0,3/15,8.69%,PPIB;SOD1;MFSD2A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.35652198645543637,-0.9631580279947209,0.44664031620553357,0.7983758403984376,1.0,6/15,15.83%,PIEZO2;ADGRV1;COL11A1;TMEM120A;KIT;PDZD7
prerank,cochlea morphogenesis (GO:0090103),0.47230017876124303,0.9628107661890695,0.5122655122655123,0.8212801197181119,1.0,2/10,13.00%,MYO3A;SOX9
prerank,protein modification process (GO:0036211),0.34533784651776694,0.9627142054324309,0.5705196182396607,0.8210837708673715,1.0,15/76,13.09%,RPN1;RPN2;UBL5;PARP1;CPE;LOX;CDC34;UBA52;UBE2M;NEDD8;ICMT;CHRM3;PLAT;SERP1;ST8SIA4
prerank,protein deacetylation (GO:0006476),-0.2636907048191484,-0.9624626712767188,0.5663716814159292,0.7985218222347392,1.0,11/41,13.42%,PRDM5;MIDEAS;BAZ2A;HDAC4;MTA3;TBL1X;RCOR1;MIER1;TBL1XR1;RCOR3;SIRT1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.40552896911498104,0.9621386706721337,0.5358490566037736,0.8219341916097582,1.0,10/22,24.49%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1;RELA;AGER
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2391898674550585,-0.9619657023287648,0.45,0.7982957938357101,1.0,18/60,16.27%,TCF7L2;TNRC6B;MED13;ATF7IP;TNRC6A;DHX36;PPM1D;TNRC6C;MED15;NFKB1;MOV10;PTEN;MED26;CBFB;RUNX2;HEY2;MECP2;TP53
prerank,regulation of cell adhesion (GO:0030155),0.3320372423785583,0.9615195255294212,0.5752032520325203,0.822887192264857,1.0,28/129,19.76%,ARHGDIA;MDK;CXCL12;TGM2;TNF;ACVRL1;DSCAM;PPP2R1A;PDE3B;MYADM;ARHGDIB;FRMD5;ADGRG1;P4HB;PODXL;DUSP26;ARHGDIG;CXCR4;DLL1;EPB41L4B;TMEM102;PLAU;RAC2;ERBB3;STX4;PPP3CA;LPXN;EFNA1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4133560186107832,0.961460888796868,0.5360824742268041,0.8226171850777414,1.0,6/21,18.22%,TALDO1;PGLS;RPIA;PGD;G6PC3;TKT
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.37660290110741446,-0.961037133918891,0.4791666666666667,0.7973161476407065,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.37660290110741446,-0.961037133918891,0.4791666666666667,0.7973161476407065,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,P-body assembly (GO:0033962),-0.36989154907747573,-0.9608667786461758,0.4416058394160584,0.7961189794819932,1.0,4/12,8.40%,ATXN2;LSM14A;DDX6;PATL1
prerank,multivesicular body assembly (GO:0036258),0.38717504879398834,0.9607877822776967,0.5415676959619953,0.8236883017314748,1.0,16/30,32.42%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,cytoplasmic translational initiation (GO:0002183),0.4295784663565093,0.960675005146445,0.5263157894736842,0.8235316722676127,1.0,5/17,20.29%,EIF3D;EIF3I;EIF4A1;EIF4H;EIF3M
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.39135305085400257,0.9601952199523581,0.5374233128834356,0.8241912731350787,1.0,7/26,20.24%,PARK7;CYBA;GRIN1;ADGRB1;TLR6;SNCA;SPHK2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.33100348293113235,-0.9601254871561128,0.5142857142857142,0.7964279489972599,1.0,4/17,5.50%,PID1;HDAC4;PPARA;NCOR1
prerank,cellular protein localization (GO:0034613),0.3203099780458413,0.9600956525622472,0.614,0.824016055080562,1.0,72/285,22.10%,CD74;CD63;LAPTM5;SNX17;ID1;NPM1;LAMTOR2;GRID2;EMP2;CNTNAP2;ARF5;PACSIN1;YWHAH;CTNNB1;FLNA;CPE;ATG9A;TMED7;SAR1A;RAB14;ESAM;TMED2;ARL11;CLTC;PRPF19;SCG5;ARF6;TICAM2;ABHD17A;TMED3;ARL4C;TMED9;PDCD6;WNT5A;CTSA;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;GJA1;LAMTOR3;ARF1;EHD1;TBC1D22B;JAM3;UNC93B1;RRAGC;ARF4;EPB41L3;RRAGD;RAB20;NAPA;TBC1D9;AMOT;RAB5C;STX4;WDR45;RAB18;RAB31;HPS6;TBC1D10C;ERP29;CTTN;CAPN3;RAB6B;PTPRU;IFT27;TMED10;COPB2;AP2A1;STX1B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3581704953592491,0.9600759690129859,0.545755237045204,0.823234411228153,1.0,23/51,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane organization (GO:0101024),0.3581704953592491,0.9600759690129859,0.545755237045204,0.823234411228153,1.0,23/51,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,negative regulation of anoikis (GO:2000811),-0.34896794649296664,-0.9593494185493872,0.4965034965034965,0.7968350661802474,1.0,4/14,12.48%,ITGA5;TLE1;PTK2;BCL2
prerank,regulation of ATP metabolic process (GO:1903578),0.35098519736739753,0.958956532786519,0.5489548954895489,0.8252675755765271,1.0,15/54,21.42%,UQCC2;PGAM1;PINK1;COX7A2L;COX7A2;ATP5IF1;AK4;ZBTB7A;NUP85;NUP88;NUP50;SPHK2;SHMT2;RAE1;FIS1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.31199796457057577,-0.9580883531718761,0.5168067226890757,0.7985856299050302,1.0,3/20,3.29%,CAMK2D;ACTN2;PRKCE
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.2928760036310345,-0.9578431493676948,0.4918918918918919,0.7975360972109355,1.0,5/24,5.77%,ADAMTS12;SOX5;ZBTB16;TGFBR1;EFEMP1
prerank,regulation of macrophage differentiation (GO:0045649),0.44117130929476894,0.9576919329008252,0.526246719160105,0.827649869318403,1.0,6/15,25.31%,C1QC;PF4;INHBA;ID2;PRKCA;INHA
prerank,alpha-amino acid metabolic process (GO:1901605),0.36586547198821084,0.957655659238451,0.5560588901472253,0.8273228693198603,1.0,12/45,20.39%,SLC25A13;OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;NAT8L;ASNS;GLUD1;GOT1
prerank,regulation of lipid metabolic process (GO:0019216),0.3380521985947635,0.9576154612565546,0.575,0.8270059001443086,1.0,14/88,12.48%,PSAP;NPC2;APOC1;CERS2;NR1D1;MID1IP1;RARRES2;EDF1;LSS;SIN3B;FASN;SCD;SC5D;NCOR2
prerank,regulation of type I interferon production (GO:0032479),0.341295394407965,0.9572544999415211,0.570675105485232,0.8274036132918361,1.0,30/84,30.39%,GAPDH;POLR2E;POLR2F;PIN1;TIRAP;CTNNB1;TNFAIP3;ISG15;PQBP1;IRF8;POLR2K;IRF7;TRAF3;G3BP1;TRIM32;CD14;POLR2H;POLR3K;IRF5;POLR3D;PCBP2;RELA;NLRP4;DHX9;XRCC6;TRIM25;TRIM56;ACOD1;POLR3C;POLR3E
prerank,synaptic membrane adhesion (GO:0099560),-0.3432692148469408,-0.9571539971957247,0.5161290322580645,0.7976190721776639,1.0,2/14,1.97%,GPC6;GPC4
prerank,mesenchymal cell development (GO:0014031),0.4177428179083407,0.9568164587996564,0.5283783783783784,0.8279395629648448,1.0,11/18,37.13%,NRG1;PDCD6;SOX8;SOX11;NOTCH1;NOLC1;KBTBD8;CDH2;TBX20;TCOF1;KLHL12
prerank,regulation of neuroblast proliferation (GO:1902692),0.43360215624558796,0.9567897835642373,0.5644090305444888,0.8275757648672502,1.0,6/15,26.32%,TAFA1;CTNNB1;CX3CR1;PTN;CX3CL1;FZD3
prerank,transcription by RNA polymerase III (GO:0006383),0.3945468949318774,0.9566375339095483,0.5405078597339782,0.827489319493106,1.0,10/27,26.43%,GTF3C6;POLR2K;IVNS1ABP;ZC3H8;RO60;TBP;GTF3A;POLR3K;ICE1;GTF3C2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.46141533300395376,0.955551110474168,0.5537414965986395,0.8294735440123638,1.0,4/11,25.95%,CLEC6A;NFKBID;IL12RB1;PRKCQ
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3365240262248367,-0.9555239869909716,0.5020408163265306,0.8001278685228257,1.0,6/16,11.61%,TGFBR3;BMPR1A;ZFPM2;IGF1;FGFR2;RBPJ
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.36923982366686037,-0.9554643839625538,0.5323741007194245,0.7986444898590724,1.0,2/10,2.44%,SOX5;ZBTB16
prerank,neurogenesis (GO:0022008),0.36277362225056947,0.954824985817636,0.5593607305936074,0.830625166094951,1.0,16/43,26.70%,SPOCK1;PRDM12;MAPT;NDUFS2;HAP1;CLN5;CXCR4;DCHS1;EPHB1;ERCC6;BTBD6;ROGDI;METTL3;METTL14;NTN5;TGFB2
prerank,oligodendrocyte differentiation (GO:0048709),0.40976573808344924,0.9545614392274198,0.5373711340206185,0.8307969860005934,1.0,7/19,21.30%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;EIF2B5;SOX10
prerank,visual system development (GO:0150063),0.3678850394472882,0.9544645902835013,0.5446009389671361,0.8306105205509334,1.0,7/37,13.25%,C1QA;C3;RBP4;HIPK2;SALL2;BLOC1S3;MAB21L1
prerank,positive regulation of catabolic process (GO:0009896),0.3447867425507248,0.9540435227737798,0.551762114537445,0.8311265881611484,1.0,16/65,19.94%,NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;TNFSF12;VSIR;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;TRIM32;HECW1;OAZ2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.39261021188462086,0.9539856744508401,0.5647921760391198,0.8308300646441109,1.0,6/28,10.03%,CXCL12;HCLS1;PFN1;ESAM;COTL1;PAK3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.42736864166542005,0.9539737266998761,0.5487646293888166,0.8304455261023388,1.0,6/16,17.98%,GABARAP;STMN3;CADM4;ARF6;KBTBD7;RASGRF1
prerank,membrane lipid catabolic process (GO:0046466),0.4684806565669037,0.9536920100149727,0.5307262569832403,0.8306247260234787,1.0,4/10,24.79%,ENPP2;FUCA1;SGPL1;NAGA
prerank,neuron apoptotic process (GO:0051402),0.41605741649403893,0.9533508118182649,0.541507024265645,0.8309932082664285,1.0,5/19,26.73%,GAPDH;CDK5;ERBB3;APP;SCN2A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4428592668955328,0.9532893596798383,0.5477792732166891,0.8307084214242468,1.0,4/13,12.73%,ELOF1;SPI1;SERTAD1;ZMIZ2
prerank,sodium ion transmembrane transport (GO:0035725),0.3373941668652493,0.9531892510654032,0.5844700944386149,0.8305149409260049,1.0,20/84,17.77%,ASIC2;SLC24A4;SLC24A2;SCN1A;ATP1A3;ATP1B2;SLC6A6;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;ATP1A1;ATP1B1;SLC8A1;HCN1;HCN3;ATP1B3;SLC9A9
prerank,lamellipodium assembly (GO:0030032),0.3928308336458795,0.9530988740893516,0.5472636815920398,0.8303038413811343,1.0,7/26,16.20%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN
prerank,positive regulation of cell differentiation (GO:0045597),0.3219853796593045,0.9530071066126121,0.614070351758794,0.8301083470741922,1.0,62/237,20.17%,IFITM1;MDK;HSP90AB1;COL1A1;NBL1;AKT1;CD34;CTNNA2;LRRC8A;AGT;IGFBP3;ACVRL1;CDS1;ZFP36L1;DNAI3;BNIP2;ATP6AP1;CTNNB1;RARRES2;BTG1;BRINP3;CEBPB;NELL1;SLC6A6;NRCAM;KDR;CCN2;LPL;CAMK1;ZFP36;KITLG;LRP3;BRINP1;ATRAID;TMEM119;MSR1;BRINP2;BLOC1S5;SOX9;RHOA;GJA1;BMP2;FBXO5;SDCBP;MMD2;PCP4;RRAS;TIAM1;PF4;MAPK11;BEND6;VHL;TRIM32;TWIST1;DDR2;EDN3;SOX11;IL6;HGF;TGFB1;MEF2C;SFRP1
prerank,positive regulation of cell projection organization (GO:0031346),0.3303587145154761,0.9530026711363092,0.5948979591836735,0.8297052999904162,1.0,22/115,16.54%,APOE;ARHGDIA;MDK;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;IL1RAPL1;CAMK1;WNT5A;SS18L2;PTPRD;RHOA;LRRC7;TIAM1;ROBO2;DAB2IP;FUT9
prerank,embryonic digit morphogenesis (GO:0042733),-0.3321961578594178,-0.952918626964201,0.5330578512396694,0.8036830024989148,1.0,3/18,5.80%,CREBBP;GLI3;WDPCP
prerank,response to cytokine (GO:0034097),0.3299480200723608,0.9523746366069376,0.6032388663967612,0.8306451244542158,1.0,37/141,22.40%,IFITM3;CD74;IFITM2;IFITM1;TIMP2;AKAP6;SHFL;HCLS1;TLE5;DDOST;ISG15;CXCL16;IL1RAPL1;COL3A1;TIMP1;TAF9;SMPD1;CSF1R;TIMP3;SLC11A1;BST2;RHOA;CXCR4;SIGIRR;TMEM102;TRIM32;SNCA;FLT3;POU4F1;FOXA2;TIMP4;SHMT2;PTPN6;ASAH2;CDK9;MAP2K7;PTPN5
prerank,negative regulation of leukocyte migration (GO:0002686),0.47230120260496733,0.9522426326409861,0.5399129172714079,0.8305112449401311,1.0,1/10,1.73%,HMOX1
prerank,positive regulation of macroautophagy (GO:0016239),0.356332707781795,0.9520957805897131,0.5665137614678899,0.8304375203787945,1.0,8/48,9.64%,SLC25A5;PINK1;SLC25A4;BNIP3L;SCOC;KDR;HSPB8;DCN
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.40104974382521374,0.9519096665421068,0.5272952853598015,0.8304416195856534,1.0,8/22,25.38%,SPI1;EMC10;PRMT1;BMP2;NCF1;GADD45A;AGER;MFHAS1
prerank,pharyngeal system development (GO:0060037),-0.3423960497406486,-0.9517304184136479,0.5141700404858299,0.8053005049720903,1.0,6/15,21.22%,BMPR1A;TGFBR1;BMP4;BMPR2;BMP5;PTCH1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3262763235817544,0.9516494425779866,0.5893223819301848,0.8305910660477724,1.0,23/128,13.63%,RPS27A;UBC;CLDN5;UBB;MAPK3;ID1;ACVRL1;FKBP1A;AMH;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;SLC33A1;AMHR2;ZMIZ2;COL1A2;RHOA;BMP2;LEFTY1
prerank,ceramide metabolic process (GO:0006672),0.3539699054575519,0.9506791686923589,0.5592469545957918,0.8323705651217165,1.0,15/49,22.53%,CERS2;ORMDL3;PPP2R1A;SMPD1;CLN6;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;FA2H;CLN8;SPTSSA;ASAH2;SGPL1;ORMDL2
prerank,coenzyme A metabolic process (GO:0015936),0.440589867035245,0.9506690170947034,0.5732044198895028,0.831984566930363,1.0,6/14,23.84%,ACAT1;ACOT7;COASY;PPCS;ACLY;SLC25A16
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3205067522652095,-0.9505067417191514,0.5345622119815668,0.8052833807298759,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3205067522652095,-0.9505067417191514,0.5345622119815668,0.8052833807298759,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.43845812324761785,0.9504652603359607,0.5599455040871935,0.8320022655282033,1.0,6/13,21.67%,GLUL;ACOT4;GLUD1;GOT1;GAD1;MTHFS
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32718488177585237,-0.9501829798003371,0.5263157894736842,0.804427562990254,1.0,4/16,10.55%,AUTS2;KMT2A;BCOR;SMAD4
prerank,embryonic skeletal system development (GO:0048706),-0.2723779333814554,-0.9501574047812729,0.5234899328859061,0.8028742693711206,1.0,7/35,7.67%,SULF1;HOXB3;HOXA3;HOXB4;HOXC4;KIAA1217;PCSK5
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.451281016800378,0.9497542350998438,0.5357142857142857,0.833156527750297,1.0,4/11,18.57%,NT5C3A;SLC19A3;SLC25A19;SLC19A2
prerank,modulation by host of viral genome replication (GO:0044827),0.4459498908365461,0.9497163572161871,0.5741239892183289,0.8328257432605942,1.0,5/13,21.78%,PPIB;NUCKS1;CCL8;VAPA;IFI27
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3575750797055246,0.9496526875689622,0.5614430665163472,0.8325426351362084,1.0,11/44,20.07%,SOX18;NDRG4;APLNR;HES1;TBX22;SOX17;RYR2;DLL1;GATA4;NOTCH1;MEF2C
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.46211171703396325,0.9495993922932311,0.5285118219749653,0.8322607616355778,1.0,1/10,1.79%,SOD1
prerank,cellular senescence (GO:0090398),0.3872243344712851,0.9491476990439344,0.5670731707317073,0.8328120064501996,1.0,5/27,12.02%,CALR;SPI1;ECRG4;ULK3;HRAS
prerank,sensory perception of smell (GO:0007608),0.46118563213310737,0.9491242484029715,0.5480225988700564,0.8324476552778561,1.0,2/11,15.44%,SLC24A4;SYT10
prerank,positive regulation of dendrite development (GO:1900006),0.4586592821829619,0.948593447669065,0.5471167369901547,0.8331600888368369,1.0,6/10,26.38%,PACSIN1;LRP8;DAB2IP;PTN;VLDLR;ALK
prerank,negative regulation of developmental growth (GO:0048640),0.3809639668779796,0.9473597215066565,0.5686746987951807,0.8354525108630261,1.0,6/30,15.85%,MT3;DCC;RTN4;MAP2;GDF15;FGF13
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23234718302904858,-0.9473062734602584,0.6140350877192983,0.8087013170599708,1.0,12/69,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;PTEN;NGF
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2868732224308289,-0.9471721935710405,0.5301204819277109,0.8074407006882641,1.0,12/27,20.34%,SMG6;PARP4;NIBAN2;PDGFRB;TERF2;ATM;SMOC2;PINX1;BMPR2;FGF2;PRKD2;TOM1L1
prerank,positive regulation of response to stimulus (GO:0048584),0.36267590028950153,0.9471532062673632,0.5578231292517006,0.8354827361421064,1.0,9/40,21.22%,B2M;YPEL3;TAF9;WNT5A;NSMCE1;IER5;SELENON;MYC;RSAD2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.30357209725106993,-0.9471110282011942,0.5414364640883977,0.8060187935235881,1.0,9/24,19.49%,SORBS1;IRS1;INSR;IGF1;ENPP1;GSK3B;PASK;PPP1R3B;PPP1R3F
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4308793442175857,0.9467235990531112,0.5509933774834437,0.836023899297866,1.0,3/15,14.41%,VCP;GSTO1;HNRNPA1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.45310715553071695,0.9466170579633146,0.5746478873239437,0.8358508619945678,1.0,5/11,35.81%,PKD2L1;LPO;RTP3;PKD1L3;RTP4
prerank,regulation of glucose metabolic process (GO:0010906),-0.26980895224751855,-0.9459208369621721,0.5323741007194245,0.8074646171433646,1.0,9/34,13.42%,PDK1;OGT;PRKN;IRS1;FOXK2;FOXK1;DGKQ;RORA;SIRT1
prerank,regulation of establishment of cell polarity (GO:2000114),0.4224534402189205,0.9448960433889992,0.557510148849797,0.8391412640167079,1.0,2/16,0.88%,RACK1;GSN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.40267547815073546,0.9448018086607382,0.5556930693069307,0.8389449759354686,1.0,9/20,27.73%,YWHAB;RGS2;APLP1;STMN1;SNCA;GRK2;GPRASP1;RNF157;ADA
prerank,negative regulation of cell aging (GO:0090344),-0.3303418291786001,-0.9446583666024743,0.47346938775510206,0.8089763371823364,1.0,7/16,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,cellular response to cAMP (GO:0071320),0.38118820580692375,0.9446234768333946,0.5617577197149644,0.8389144290315439,1.0,11/30,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,activation of protein kinase A activity (GO:0034199),-0.3434932628390328,-0.9445367337839777,0.4980237154150198,0.8076603717028794,1.0,3/16,2.23%,ADCY9;ADCY1;ADCY5
prerank,sodium ion transport (GO:0006814),0.3347359991237625,0.9440407537570792,0.5927083333333333,0.8397735404085056,1.0,19/85,17.70%,ASIC2;SLC24A4;SLC24A2;SCN1A;SLC6A6;SGK1;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;NDUFA9;ATP1B1;SLC8A1;HCN1;FGF13;HCN3;ATP1B3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.38422916911921323,-0.9430854765270444,0.5,0.8097722104508088,1.0,5/10,31.62%,IL18;LGALS9;PRKCZ;GATA3;IL4
prerank,positive regulation of nervous system process (GO:0031646),0.4044355844253502,0.9422541374553127,0.5549872122762148,0.8431843810954585,1.0,5/18,12.91%,RIMS2;RIMS1;MYRF;TENM4;HCRT
prerank,gonad development (GO:0008406),0.3625525743740119,0.9421009764122592,0.5652173913043478,0.8430886295360284,1.0,15/41,29.19%,BASP1;KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK;IRX5
prerank,peptidyl-lysine methylation (GO:0018022),-0.2856226915677567,-0.941998510998267,0.5159574468085106,0.8108810045436793,1.0,14/26,27.56%,SETD2;SMYD3;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6;SMYD1;N6AMT1;ETFBKMT;SUV39H1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.27114351211634075,-0.9419833592585178,0.5696969696969697,0.8093292006992455,1.0,6/31,8.06%,BABAM2;OTUD4;OTUD7B;USP50;UIMC1;USP16
prerank,positive regulation of protein import (GO:1904591),0.37911035146212985,0.9419828550622434,0.5896834701055099,0.8429255519190012,1.0,5/30,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,melanocyte differentiation (GO:0030318),-0.3663500778572425,-0.9419460913211498,0.5,0.8078455581905459,1.0,4/11,16.61%,LRMDA;ENPP1;KIT;MITF
prerank,replication fork processing (GO:0031297),0.36582066522008455,0.9418855661437678,0.5774971297359357,0.8427222964537353,1.0,11/38,22.29%,NUCKS1;CENPX;PCNA;DDX11;BRCA2;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM
prerank,meiosis I (GO:0007127),-0.2926894983953622,-0.941253707490509,0.5277777777777778,0.8080401727689311,1.0,9/23,25.97%,MYBL1;BCL2L11;ING2;ZCWPW1;ZSCAN21;SYCP3;SGO1;FOXJ3;MEIOB
prerank,regulation of T cell differentiation (GO:0045580),0.37431967142174744,0.9411325170645193,0.5686046511627907,0.8439554880908555,1.0,7/33,19.12%,MDK;SOD1;CLPTM1;IL2;CTLA4;CCR2;PRELID1
prerank,endoderm formation (GO:0001706),0.3717030359177453,0.940779696235985,0.5596658711217184,0.8442848070040505,1.0,10/35,22.49%,VTN;ITGB2;FN1;COL6A1;SOX17;MMP14;INHBA;COL7A1;DUSP2;DUSP1
prerank,lymphocyte differentiation (GO:0030098),0.3408028694599838,0.9402965538120331,0.5891141942369263,0.8449341341678069,1.0,24/68,26.79%,SLC25A5;LYL1;NFAM1;PTPRC;IL2;IKZF1;IL11;ZBTB7A;HDAC5;JAG2;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;TOX;FLT3;LFNG;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,negative regulation of organelle assembly (GO:1902116),-0.27744249818860234,-0.9401499755395126,0.5144927536231884,0.8093247240687544,1.0,7/35,10.55%,LRRK2;NBDY;YAP1;KAT2B;SCFD1;CEP97;SMAD4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3412751922668162,0.9400044618948121,0.5949098621420997,0.8451792964619502,1.0,9/72,12.90%,RPL26;RPS27L;CHEK2;PCBP4;HIPK2;NDRG1;BAX;PCNA;PRMT1
prerank,regulation of mast cell degranulation (GO:0043304),-0.3482781482669215,-0.9395415217838873,0.5132075471698113,0.8091873561290903,1.0,2/14,1.00%,GAB2;FER
prerank,cell-cell junction maintenance (GO:0045217),0.4612572294889071,0.9394728388127659,0.5836972343522562,0.8459037725057679,1.0,4/11,22.93%,MYADM;CSF1R;F2RL1;PARD6A
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.40441579946068407,0.9392545519732604,0.5956632653061225,0.8459740982125349,1.0,5/21,8.21%,ACTG1;DUSP3;GPM6B;CORO1C;CLASP1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.45251020373871553,0.9389313206538543,0.5646067415730337,0.8454424023799909,1.0,5/11,23.84%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.45251020373871553,0.9389313206538543,0.5646067415730337,0.8454424023799909,1.0,5/11,23.84%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.45251020373871553,0.9389313206538543,0.5646067415730337,0.8454424023799909,1.0,5/11,23.84%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,negative regulation of interferon-beta production (GO:0032688),0.4649533297450375,0.938774849759194,0.5657142857142857,0.8453678353666598,1.0,3/10,20.94%,SIRPA;LILRB1;PYCARD
prerank,smooth muscle contraction (GO:0006939),-0.3434420356226346,-0.9383739055079243,0.5333333333333333,0.8105614316930403,1.0,4/14,7.39%,ROCK2;ROCK1;MYLK;EDNRA
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3245084907642228,-0.9379528933363208,0.5234375,0.8100556263752331,1.0,8/17,22.76%,CCNT1;CPEB3;VIRMA;ZC3H14;CPSF6;ZC3H3;RNF20;CTR9
prerank,osteoclast differentiation (GO:0030316),0.39031519470987847,0.9377470945617594,0.5621156211562116,0.8471007011658336,1.0,7/22,19.50%,TYROBP;TREM2;GLO1;CSF1R;OSTM1;OSCAR;GPR183
prerank,sulfur compound biosynthetic process (GO:0044272),0.3276549692822341,0.9375854300023928,0.6128364389233955,0.8470187964914944,1.0,32/104,25.44%,BGN;BCAN;FMOD;GSTM1;LUM;MPST;MGST1;GSTO1;DCN;CHST1;B4GALT6;GSTM5;MGST3;GSTM2;CHPF2;CHPF;HPGDS;UGDH;VCAN;MAT2A;B3GNT3;AKR1A1;ESD;OPLAH;CSGALNACT2;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3705226889663708,-0.9362615541947653,0.519163763066202,0.8128006570276182,1.0,4/11,6.10%,SLC30A10;PPARA;COA8;ABCB7
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.33220959910319997,-0.9356673491654415,0.5217391304347826,0.8126357526790666,1.0,5/15,12.34%,PRKCE;IRS1;PPARA;PPARG;ADM
prerank,diol biosynthetic process (GO:0034312),0.4191523781580852,0.9355577759015282,0.564276048714479,0.8508419667400166,1.0,6/15,21.12%,SPR;QDPR;SPTLC1;ABCA2;SPHK2;ASAH2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4481432786659528,0.9354588954756762,0.5766016713091922,0.8506272967791938,1.0,7/12,27.82%,BAX;DAB2IP;TMEM33;BAK1;PTPN1;BOK;XBP1
prerank,stabilization of membrane potential (GO:0030322),0.4213168667165693,0.9354297677404456,0.569390402075227,0.8502766859648899,1.0,5/16,19.26%,CHCHD10;KCNK9;KCNK3;KCNK10;KCNK13
prerank,inner dynein arm assembly (GO:0036159),0.45277880676440185,0.9346147463158425,0.5614754098360656,0.8516262752535341,1.0,2/11,11.99%,DNAI3;DNAH1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.38103791364873085,0.9342493212317639,0.594306049822064,0.8519490167053327,1.0,8/30,17.42%,TOMM7;PINK1;UBL5;LEPROT;FBXW7;RHOU;PDCD5;RAC2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.41583686842588974,0.934043179851137,0.5766129032258065,0.8519661433963766,1.0,3/16,6.32%,LRRC8A;IGFBP3;BTG1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3002586064927594,-0.9335705182488276,0.5174418604651163,0.8162402631697424,1.0,11/23,24.14%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10;PIP4P2;INPP5B;TPTE;MTMR1;SYNJ2;MTMR7
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4432695152606956,0.9334411939707473,0.564673157162726,0.8527980963010698,1.0,6/12,27.73%,GART;PRPS1L1;PRPS1;PRPSAP1;ADSL;ADA
prerank,response to organic cyclic compound (GO:0014070),0.3500820451212398,0.9334220758420095,0.586767895878525,0.8524275449663584,1.0,14/52,21.30%,SPP1;TNF;IGFBP5;CTNNB1;TRPM2;PMAIP1;SLC1A1;PAQR7;CCL2;ABCA2;CCL3;TGFB1;SFRP1;FOXA1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.373773401842603,0.93329772709737,0.5870348139255702,0.8522828258334613,1.0,12/30,20.17%,PTPRC;SBDS;KDR;CSF1R;FLT4;ARMC6;FLT1;INHBA;FLT3;MLF1;TGFB1;SFRP1
prerank,renal water homeostasis (GO:0003091),0.3969006164886908,0.9331507160106332,0.5823899371069182,0.8521913012225582,1.0,9/23,19.56%,AQP4;AQP1;PRKAR1A;PRKAR1B;WFS1;ADCY4;ADCY8;PRKAR2B;TFAP2B
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4476049177337599,0.9330949295121151,0.5720279720279721,0.8519102743096083,1.0,5/12,28.23%,MCM5;MUS81;CDC45;MCM7;MCM2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4107520841911416,0.9327355506549694,0.5561290322580645,0.8522744725764383,1.0,5/16,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,dicarboxylic acid transport (GO:0006835),0.3777092115627646,0.9324576884549024,0.5827250608272506,0.8524268766326266,1.0,8/28,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;GJA1;SLC19A1;FOLR2;SLC25A18
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3306198111993728,0.9320035681029719,0.6201469045120671,0.852995255027881,1.0,14/87,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;ZFP36L1;ZFP36L2;HYAL2;RAB14;ZFP36;POLR2G;FGFRL1;POLR2K;CCL2;HNRNPA1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.43189597610289465,0.9317190867851534,0.5815899581589958,0.8531785462326262,1.0,7/14,32.50%,SCP2;HSD17B4;CRAT;ACOX3;EHHADH;DECR2;ACOX1
prerank,nucleoside catabolic process (GO:0009164),-0.3705677140834715,-0.9316146917789639,0.5110294117647058,0.8195215727972178,1.0,6/11,14.98%,DPYD;UPP2;UPB1;DERA;NT5C1A;NT5M
prerank,positive regulation of cellular catabolic process (GO:0031331),0.32222909482908246,0.931206711663736,0.6371951219512195,0.853853690314694,1.0,16/132,9.82%,APOE;HSP90AA1;LAPTM5;PNPLA2;TNF;TMEM59;ORMDL3;PRR5L;MSN;LIN28B;P2RX7;MTLN;PTTG1IP;MLXIPL;DCN;HMGB1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.34559396805047626,-0.931041946902168,0.5508474576271186,0.8193685843554879,1.0,4/13,13.42%,SORBS1;IRS1;ECHDC3;SIRT1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3246388786498336,-0.9308193941493923,0.5443037974683544,0.8183504827945953,1.0,5/15,18.43%,RICTOR;UBR3;RAI2;CELF1;NR5A2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33502536780923986,0.9308044039141988,0.6089266737513284,0.8542974956673237,1.0,22/75,25.02%,CALM1;RGS5;C3;GPER1;METAP1;YWHAB;RGS2;KLK6;METAP2;RGS12;RAMP3;SYP;FRMPD1;CNGB1;ADCYAP1;GIT1;PPEF1;RGS6;KCTD8;RGS4;PDE6G;RNF157
prerank,membrane protein proteolysis (GO:0033619),0.36390066787255126,0.9305682328256591,0.5821596244131455,0.8543765332030772,1.0,15/37,25.95%,TMPRSS6;PSENEN;SPPL2B;CTSH;NAPSA;BACE1;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;ERAP1;RELA;APH1A;PRKCQ
prerank,regulation of nervous system development (GO:0051960),0.363549682147865,0.9304957830338568,0.5833333333333334,0.8541212478793869,1.0,9/37,15.99%,CTNNB1;HES1;HES6;BHLHE41;TENM4;CX3CR1;PTPRZ1;HEY1;DLL1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3489194013714516,0.9298808528629149,0.5864745011086474,0.854953506517096,1.0,4/50,3.71%,RPS3;LAPTM5;CCL19;TNF
prerank,negative regulation of centrosome duplication (GO:0010826),0.4450130024558573,0.9294456925930027,0.5605187319884726,0.8554473034717831,1.0,1/11,3.04%,NPM1
prerank,7-methylguanosine RNA capping (GO:0009452),0.37888728983549047,0.9290151911819008,0.5932203389830508,0.855472319444317,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,7-methylguanosine mRNA capping (GO:0006370),0.37888728983549047,0.9290151911819008,0.5932203389830508,0.855472319444317,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,sensory organ development (GO:0007423),-0.24127169246852456,-0.9289254441042616,0.6442307692307693,0.8215157307149967,1.0,4/51,2.84%,PBX1;SMOC1;PBX3;SHROOM2
prerank,epidermis development (GO:0008544),0.3411335383664964,0.9284434175652372,0.6087912087912087,0.8561922722183667,1.0,17/56,31.95%,GJB5;FABP5;CCN2;YBX1;LAMC2;KRT9;EVPL;DLL1;COL7A1;GRHL2;ATP2A2;PLOD1;PTHLH;POU2F3;ATP2C1;ALDH3A2;EMP1
prerank,cardiac muscle cell differentiation (GO:0055007),0.3973706549081911,0.9278652992795462,0.5669291338582677,0.856960478335981,1.0,7/21,15.38%,NRG1;ALPK2;KDM6B;MYH11;IRX3;BMP2;SLC8A1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40858845161188106,0.9275697302366659,0.5584415584415584,0.8571436975824211,1.0,4/18,12.34%,NLGN1;RIMS2;RIMS1;SYN1
prerank,positive regulation of receptor internalization (GO:0002092),0.3896421691167625,0.927479741180552,0.5804020100502513,0.856918800210387,1.0,3/22,15.91%,CD63;SFRP4;ARRB2
prerank,heart looping (GO:0001947),0.3531570079548795,0.9272318242568508,0.5995449374288965,0.8570325099205026,1.0,13/40,28.22%,SOX18;NDRG4;APLNR;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C;SRF;VANGL2;ENG;TBX2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.45738752044565495,0.92722252623075,0.5718475073313783,0.8566431860342412,1.0,4/10,26.20%,WNT5A;ADAM17;CCR2;OXSR1
prerank,regulation of RNA splicing (GO:0043484),0.33700911744676243,0.9270094465808839,0.6162915326902465,0.8566764707477699,1.0,11/69,13.09%,RPS13;RPS26;TMBIM6;HNRNPK;QKI;AHNAK;PQBP1;RRP1B;KHDRBS3;FAM50A;HSPA1A
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3384940029451323,-0.9263755845370668,0.5614754098360656,0.8264346865297422,1.0,3/17,2.23%,ADCY9;ADCY1;ADCY5
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.38089023396425015,0.9262851741171869,0.579874213836478,0.8577434283195486,1.0,4/26,9.13%,ACADVL;APOC1;MID1IP1;MLXIPL
prerank,macromolecule catabolic process (GO:0009057),0.3760321356517631,0.9262459727526475,0.5990220048899756,0.8574082133894487,1.0,7/26,20.40%,LGMN;USE1;CLN5;CLN6;CLN8;TGFB1;CAPN3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3202307734062776,0.9259968237413394,0.6306584362139918,0.8575047009825333,1.0,12/104,7.22%,RPS27A;UBC;UBB;NBL1;FKBP1A;PIN1;SORL1;EID2;HIPK2;WFIKKN2;UBA52;STRAP
prerank,positive regulation of filopodium assembly (GO:0051491),-0.29596966452553064,-0.9258407141264409,0.5989847715736041,0.8262027757746254,1.0,4/24,3.56%,DPYSL3;DOCK11;BCAS3;NRP1
prerank,amino acid transmembrane transport (GO:0003333),0.35050022906926426,0.925593111941425,0.5968109339407744,0.8579334130557751,1.0,14/45,25.63%,SLC38A5;SLC7A5;SLC25A13;TSPO2;SLC6A6;SLC3A2;SLC25A22;SLC38A10;SLC25A18;MFSD12;SLC7A10;SFXN1;SLC7A6;SLC38A3
prerank,cellular response to estradiol stimulus (GO:0071392),-0.31442976083282936,-0.9254111220706319,0.5514018691588785,0.8256939982616373,1.0,4/18,9.87%,EGFR;NRIP1;LCOR;ESR1
prerank,regulation of actin filament-based process (GO:0032970),0.3342889210298236,0.9253338292534046,0.617363344051447,0.8580448668033206,1.0,19/70,17.42%,RHOB;CNN2;RHOC;RAC1;GPM6B;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN;RAC2
prerank,neuron migration (GO:0001764),0.3497791369088634,0.9251498019830474,0.608167770419426,0.8580222088007954,1.0,18/48,20.37%,RAC1;NTRK2;ADGRL3;SPOCK1;NRCAM;TUBB2B;CDK5R1;DNER;ELP3;CCK;CDK5;FGF13;TUBB2A;GPM6A;DCX;DDIT4;MEF2C;MAP1B
prerank,negative regulation of signal transduction (GO:0009968),0.3132374674407178,0.9248049941318313,0.7048192771084337,0.8583105576848319,1.0,64/249,20.17%,RACK1;APOD;CALR;DCC;LGMN;AKT1;TMBIM6;AGT;IGFBP3;TNF;YWHAB;PTPRC;IGFBP5;GRB14;NDRG4;RGS2;VCP;SFRP5;TNFAIP3;LRPAP1;ARRDC1;PTK6;LEPROT;NTN1;CADM4;GATA2;DCN;SMPD1;KIF26A;PDCD6;ULK3;ZBTB7A;FBXW7;SPRY1;BMP2;NLRP2B;SFRP4;CX3CR1;GDF15;MAPK8IP2;HEY1;SIGIRR;BEND6;DLL1;EGFL7;DACT3;DAB2IP;TYRO3;GATA4;GLIS2;PTGIR;APCDD1;MMP14;TMBIM1;ERBB3;NOTUM;SRMS;MAZ;QARS1;SNCA;HIC1;SPRY3;DDIT4;SFRP1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.42458762232855074,0.924783166759233,0.5885558583106267,0.857951942392595,1.0,4/13,21.55%,CPE;RYR2;NOTCH1;NPY5R
prerank,canonical Wnt signaling pathway (GO:0060070),-0.23592274819035103,-0.9247397318434196,0.5833333333333334,0.8257931810194707,1.0,19/68,16.63%,TCF7L2;LRRK2;PLPP3;LRP5;LRP6;CSNK1A1;FZD6;RARG;AXIN1;WNT5B;BCL9L;PTEN;WNT16;DVL3;WNT11;GSK3B;WNT4;WNT9A;RYK
prerank,positive regulation of organelle assembly (GO:1902117),0.3516763598261661,0.9247064332573015,0.5993189557321226,0.8576987752004206,1.0,10/44,15.60%,IL5;TNF;KCTD17;LCP1;SDC4;CAPG;CCDC88A;SDCBP;G3BP1;G3BP2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.36756738951116075,-0.9246147955807006,0.5052631578947369,0.8245063626151955,1.0,3/10,13.24%,PARD3;PRKD3;PLPP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.30648468241172455,0.9239960239679974,0.763,0.8587532684325035,1.0,103/420,20.94%,TMSB4X;RPL11;RPL5;ARHGDIA;HSPB1;RHOB;MAPK3;AKT1;A2M;RCN3;NLGN1;AKAP6;TREM2;CSNK2B;IER3;TNF;RHOC;MBD3;ARHGAP25;RAC1;NTRK2;CHEK2;PEX5L;PIN1;ARHGAP9;RPA2;ARHGDIB;RHOG;HIPK2;TTC5;BRPF1;CLEC6A;ARHGEF4;SGK1;PAK1;ARHGAP15;TAF10;PRKAR1A;MAPT;NET1;SLC15A4;CD24;CDK5R1;RHOV;PIP4P1;ARHGEF7;PAK3;TAF9;ARAP3;ARHGDIG;GNAI1;PRKAR1B;WNT5A;ATP6AP2;SSRP1;TAGAP;PHLPP1;CCNG1;MCF2L;VAV1;RHOA;RFC2;ARHGAP45;DEPDC7;RHOU;VAV3;ABR;STK11;PRR5;RRAS;TIAM1;F2RL1;L3MBTL1;TRAF3;MAPK11;RRAGC;SLC15A2;DLC1;CDK5;DAB2IP;GATA4;SQSTM1;PRKAR2B;RAC2;FAM83D;NOP53;MTA2;ARHGEF19;TBP;LBH;SOS1;ING5;CHD3;POU4F1;DDIT4;RFC4;SPHK2;ARHGAP33;CAPN3;ARAP2;NFKBIA;PAK5;PYCARD
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.408716846186983,0.9234572419110958,0.5839793281653747,0.8594473308576459,1.0,7/19,28.56%,TNFAIP3;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,positive regulation of translational initiation (GO:0045948),0.40779697192382297,0.9232023462133563,0.5821474773609314,0.859582198455271,1.0,5/18,18.63%,POLR2D;UHMK1;POLR2G;YTHDF1;EIF2B5
prerank,generation of neurons (GO:0048699),0.3147847251666786,0.9230258013146538,0.7022132796780685,0.8595191405473799,1.0,49/190,23.67%,ITM2C;TAFA1;RAC1;NTRK2;PIN1;CTNNB1;ADGRL3;SPOCK1;HES1;HES6;NRCAM;IL1RAPL1;MAPT;TUBB2B;CDK5R1;BHLHE41;DNER;WNT5A;ELP3;PTPRD;IRX3;CCK;WNT10B;CX3CR1;CDK5;HEY1;FGF13;OLIG1;DLL1;MYEF2;FUT9;BRSK2;TUBB2A;ERCC6;GPM6A;MYT1L;BTG4;ACSL3;SOX11;DCX;DDIT4;MEF2C;MAP1B;FZD2;FZD1;IER2;WNT7A;ACSL4;PLXNB2
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2673502066647012,-0.9228882202588247,0.6229508196721312,0.8255606845202448,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2673502066647012,-0.9228882202588247,0.6229508196721312,0.8255606845202448,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.36492959079997056,0.9225514522021658,0.5901442307692307,0.8600423234287905,1.0,12/30,32.50%,ELOVL1;ELOVL2;TECRL;ELOVL7;ACOT1;ACOT4;ELOVL6;HACD4;ABCD2;ELOVL4;ELOVL5;ACOX1
prerank,B cell homeostasis (GO:0001782),0.45332118154031975,0.9220540578725056,0.5967078189300411,0.8606564266165793,1.0,5/10,24.11%,TNFAIP3;DOCK10;MEF2C;PPP2R3C;TNFRSF13B
prerank,substrate-dependent cell migration (GO:0006929),0.4216051542848951,0.9214160229706623,0.5837837837837838,0.8615297625351803,1.0,5/14,14.29%,PTPRC;NTN1;P2RY12;SHTN1;SDCBP
prerank,cellular response to insulin stimulus (GO:0032869),0.3199862994459846,0.921351173831992,0.6571136131013307,0.8612518727029564,1.0,31/124,22.65%,ATP6V0C;AKT1;ATP6V1F;PKM;GRB14;ZFP36L1;ATP6V1G1;CAV2;PARP1;ATP6AP1;ATP6V0E2;PDE3B;RARRES2;RAB15;NAMPT;MYO5A;VAMP2;ATP6V0D2;HDAC5;SH2B2;IGF2;HDAC9;EPRS1;RAB31;SOS1;GOT1;C2CD5;SELENOS;INHBB;ATP6V1A;ATP6V0A1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2920152377315929,-0.9211771718720504,0.5641025641025641,0.8279947467794769,1.0,6/26,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,protein import into nucleus (GO:0006606),0.3336629732934826,0.9210832627997383,0.639186295503212,0.8613937992271361,1.0,12/66,18.25%,RPL23;AKT1;RAN;FAM53C;PTTG1IP;IPO4;NUP85;NUP88;SPRN;EIF4ENIF1;SYK;NUP50
prerank,regulation of blood circulation (GO:1903522),0.361375443872839,0.9205211502819187,0.5997638724911453,0.862118078153977,1.0,7/34,14.60%,S100A1;FXYD1;AGT;ADORA3;PLN;DES;KCNE5
prerank,negative regulation of cholesterol transport (GO:0032375),0.4545801156021469,0.9203526204244944,0.5844155844155844,0.8620526457744693,1.0,3/10,25.65%,APOC1;ABCA2;ABCG5
prerank,response to interleukin-1 (GO:0070555),0.3304889682877767,0.9202241613009621,0.6407249466950959,0.8618938158674655,1.0,21/73,26.22%,CCL19;NR1D1;TLE5;SIRPA;HYAL2;TAF9;SMPD1;SOX9;CCL2;MAPK11;DAB2IP;CCL3;CCL8;SNCA;SFRP1;PYCARD;RELA;TNFRSF11A;APP;PRKCA;CX3CL1
prerank,regulation of fat cell differentiation (GO:0045598),0.3321757585839832,0.9200981832670044,0.6292016806722689,0.8617641273127072,1.0,17/74,13.56%,AKT1;CCDC85B;GPER1;TNF;NR1D1;CDS1;ZFP36L1;ZFP36L2;RARRES2;CEBPB;LPL;GATA2;ZFP36;LRP3;WNT5A;BMP2;WNT10B
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.36293385000298045,0.9198347204463985,0.5906921241050119,0.8618921368430449,1.0,18/35,33.19%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ;AURKB;HNRNPA2B1;ACD;PKIB;CCT6A
prerank,negative regulation of cell cycle process (GO:0010948),-0.23480007350421694,-0.9196437682356866,0.6764705882352942,0.8301322439016809,1.0,15/61,14.96%,TOM1L2;MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;WAPL;RBBP8;TFDP1;TERF2;BMP4;NME6;EHMT2;EZH2
prerank,negative regulation of protein depolymerization (GO:1901880),-0.29157741939726206,-0.9194381566401829,0.5902439024390244,0.8290490957262652,1.0,7/24,14.72%,PLEKHH2;LIMA1;HDGFL3;CAMSAP1;SPEF1;ARHGEF2;TAOK1
prerank,regulation of cytoskeleton organization (GO:0051493),0.31877468981865104,0.9193000533002168,0.6363636363636364,0.862508267420128,1.0,25/108,16.20%,RHOB;MAPK3;RHOC;RAC1;S100A8;S100A9;GPM6B;STMN3;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;P2RX7;CLASP1;MAPT;CDK2AP2;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,retinoic acid metabolic process (GO:0042573),-0.32573372531945444,-0.9188169134955366,0.5680933852140078,0.8290961313771076,1.0,1/14,2.19%,ALDH1A2
prerank,cell-cell junction organization (GO:0045216),0.32945292723508024,0.9187695081376389,0.6369426751592356,0.8631844721403026,1.0,20/79,19.85%,CLDN5;GJA4;CADM2;ANG;CDH20;MYADM;CDH18;CSF1R;CADM3;CDH12;CDH19;DCHS1;F2RL1;CDH7;CDH24;CDH10;CDH5;CTNND2;TGFB1;MARVELD2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24097835373890086,-0.9187340937847271,0.5726495726495726,0.8277374625186265,1.0,14/48,17.35%,ADCY9;ADCY1;ADCY5;AMPD3;PANK1;ADCY7;PAPSS2;PAPSS1;ADSS2;SLC26A2;AMPD2;PANK2;GUCY2C;PANK4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3999833333869441,0.9184705018538541,0.6209476309226932,0.8633878733794046,1.0,4/21,9.00%,CD81;NFAM1;SLC39A10;CD22
prerank,potassium ion transport (GO:0006813),0.3156601684648853,0.918197980957377,0.6546762589928058,0.8635295648168453,1.0,29/120,19.70%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;AQP1;KCNC1;KCNA2;KCNN2;ATP1A4;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3140019981157284,0.9178544328073248,0.6724667349027635,0.8638055714032326,1.0,34/129,20.35%,PSMB4;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.34502994911013307,0.9178136570677287,0.6167800453514739,0.8634749774587336,1.0,9/49,13.76%,ERBB4;TNF;HCLS1;ARL2BP;HES1;PTK6;IL2;CSF1R;TNFRSF1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.41982055129759177,0.9176603800304804,0.594222833562586,0.8633693296368755,1.0,5/14,26.20%,WNT5A;CCL3;ADAM17;CCR2;OXSR1
prerank,negative regulation of DNA recombination (GO:0045910),0.3498605018535396,0.9175782989321272,0.6124293785310735,0.8631341048685428,1.0,11/43,22.29%,POLR2E;POLR2D;TERF1;POLR2F;H1-0;POLR2G;POLR2K;TERF2IP;POLR2H;RADX;BLM
prerank,serine family amino acid catabolic process (GO:0009071),0.4563423415448507,0.9169350332982664,0.5869565217391305,0.8639726658666029,1.0,5/10,34.77%,SDS;SHMT2;DLD;THNSL2;GCSH
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3431443190529689,0.9166712944566138,0.6221973094170403,0.8641113924544324,1.0,19/51,26.23%,MAPK3;TERF1;CCT2;CTNNB1;CCT7;CCT8;HNRNPU;HNRNPA1;CTC1;MAPK15;GNL3L;MAP2K7;CCT4;NAF1;PNKP;CCT3;PIF1;PRKCQ;HNRNPC
prerank,regulation of cellular metabolic process (GO:0031323),0.3405990986489864,0.916567599562308,0.6084474885844748,0.8639036049868755,1.0,17/45,28.39%,NPC2;PINK1;FLOT1;ABCG1;FASN;NCOR2;ARF1;ARF4;ABCA2;BCO2;STUB1;MPV17;ACLY;FOXM1;EIF6;MBOAT7;PDK2
prerank,neuromuscular synaptic transmission (GO:0007274),0.4006265546792213,0.9165226551711573,0.5833333333333334,0.8635853323144469,1.0,8/18,24.53%,ERC2;CHAT;DTNA;STAC3;RIMBP2;CHRNA3;SLC5A7;TBC1D24
prerank,body fluid secretion (GO:0007589),0.41446569193140803,0.9164806150902802,0.5930851063829787,0.8632609590439128,1.0,1/15,2.95%,ERBB4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.33893738352741937,0.9162886673435212,0.6212624584717608,0.8632434898033059,1.0,12/51,17.89%,UBB;NBL1;CNTNAP2;PACSIN1;KLK8;SGK1;PAK1;NYAP2;SHTN1;EPB41L3;DAB2IP;GPM6A
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.37361688258182346,0.9162100645776959,0.6136087484811664,0.8629940263811966,1.0,6/27,18.09%,NME1;AK4;NME4;NME2;NME3;GUK1
prerank,regulation of bone mineralization (GO:0030500),0.3354082731146276,0.9160349110738898,0.6149614961496149,0.8629251145144189,1.0,19/55,20.07%,FZD9;ECM1;GPM6B;S1PR1;ISG15;NELL1;P2RX7;SRGN;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;CCL3;TWIST1;DDR2;NOTUM;TGFB1;MEF2C
prerank,clathrin-dependent endocytosis (GO:0072583),0.37154432975850477,0.9159267093659801,0.5990037359900373,0.8627444775432648,1.0,10/26,15.99%,CANX;SNAP91;AP2M1;CLTC;SIGLEC1;AP2S1;FNBP1L;FCHO1;CLTA;DLL1
prerank,calcium import into the mitochondrion (GO:0036444),-0.3799144593401027,-0.91568856027562,0.5623003194888179,0.8334701970425932,1.0,3/10,6.11%,MCU;MICU1;MICU2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.34073049259231286,-0.9156690315279608,0.5610687022900763,0.8319671388182942,1.0,2/13,3.19%,CACNA1C;ANK2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3637068080300117,0.9146207757767908,0.6011904761904762,0.8649510847894833,1.0,8/30,15.89%,SCN1A;SCN4B;KCNE4;FGF12;ATP1A1;GJA1;KCNE5;RYR2
prerank,fatty acid metabolic process (GO:0006631),0.3190133467638676,0.9144293419342782,0.6728395061728395,0.8649333196330138,1.0,46/115,34.99%,GPX4;GPX1;NUDT19;LIPG;LPL;ALKBH7;FASN;OXSM;ACOT1;ACOT7;CRAT;ALOX5AP;NAAA;ACOT4;FA2H;FAAH;LTC4S;PPARGC1A;ACSL3;THEM4;SGPL1;ACSM5;ADIPOR1;NDUFAB1;ACSL4;ACLY;PON2;ACAD9;GPAM;XBP1;HSD17B8;GGT5;CYP4B1;AOAH;ABCD2;PNPLA8;ELOVL4;GNPAT;CEL;ACOX1;ACSF3;CD36;ADIPOR2;CPT1B;PEX2;PLA2G15
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.40945268770437004,0.914336784706891,0.5963777490297542,0.8647082534828713,1.0,7/16,19.87%,HSPA5;GABARAPL2;RYR2;BCAP31;PPP1R15A;DDRGK1;VAPA
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.24374119451681528,-0.9139260305195033,0.5955056179775281,0.8346521482247028,1.0,18/45,22.36%,EGFR;NFKB1;DYRK1A;RIPK1;HEATR1;SETX;POLR2A;BMP4;ZC3H18;DIMT1;SIRT7;TP53;WDR43;SUPV3L1;BUD23;RBM20;DXO;PIK3R1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.42981552903569625,0.9131391622683036,0.5741758241758241,0.8662703547695655,1.0,2/12,3.71%,AKAP6;TNF
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.42981552903569625,0.9131391622683036,0.5741758241758241,0.8662703547695655,1.0,2/12,3.71%,AKAP6;TNF
prerank,regulation of intracellular pH (GO:0051453),-0.27134884730690195,-0.9127778098872658,0.5882352941176471,0.8359363010467099,1.0,6/34,6.83%,SLC9A1;LRRK2;SLC4A10;SLC9A2;NOX1;TM9SF4
prerank,regulation of insulin secretion (GO:0050796),0.32164661242076253,0.9126646489557845,0.6618106139438086,0.866794824111877,1.0,32/101,23.49%,UQCC2;MTNR1B;SLC2A1;SNAP25;RBP4;TRH;LRRC8A;GPER1;TNF;NR1D1;CACNA1A;EPHA5;CHGA;ABCC8;BAD;SLC2A2;BRSK2;NOS2;DOC2B;GLUD1;TFAP2B;IL6;NNAT;FOXA2;SFRP1;KCNC2;INHBB;CCN3;REST;CACNA1E;PSMD9;ACSL4
prerank,cellular response to nutrient levels (GO:0031669),0.3338568222064788,0.9125593847880927,0.6329386437029063,0.8665993243150422,1.0,15/62,21.55%,HSPA8;MAP1LC3B;MAP1LC3A;FADS1;FAM107A;MFSD2A;LPL;CD68;RRAGC;RRAGD;LAMP2;WDR45;SFRP1;RALB;INHBB
prerank,metallo-sulfur cluster assembly (GO:0031163),0.38607471581233266,0.9124334721020769,0.5876662636033857,0.8664581021343867,1.0,9/22,28.68%,GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B;HSCB;CIAO3
prerank,peptidyl-methionine modification (GO:0018206),0.4398448978232735,0.9123657828457507,0.5977961432506887,0.8661852461233369,1.0,4/12,20.00%,METAP1;METAP2;PDF;NAA25
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.41569269351881655,0.9123545976021261,0.5924426450742241,0.8658036484536793,1.0,3/14,14.26%,GPER1;ECSCR;CCL2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.29076090819386247,-0.9121006209865538,0.5980392156862745,0.8360161465442122,1.0,5/23,11.02%,TGFBR3;ADAMTS9;FGFR2;SMAD7;TPM1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.32521367479385477,-0.9119285577498385,0.5565610859728507,0.8333355650442977,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.32521367479385477,-0.9119285577498385,0.5565610859728507,0.8333355650442977,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,rRNA methylation (GO:0031167),0.37883150972235635,0.9115846140347801,0.5984752223634053,0.8669730684968645,1.0,4/22,12.72%,TRMT112;EMG1;FBL;ZCCHC4
prerank,C-terminal protein amino acid modification (GO:0018410),0.43430580340032476,0.9112516557273486,0.5959885386819485,0.8672343929291659,1.0,2/11,10.21%,AGBL4;ICMT
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4476371287922464,0.9111618587633799,0.5983606557377049,0.8670224552479748,1.0,4/11,15.65%,FZD9;SLC25A4;NUPR1;YBX3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.43317828387525037,0.9110372137266421,0.600828729281768,0.866446026900149,1.0,2/12,3.99%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.43317828387525037,0.9110372137266421,0.600828729281768,0.866446026900149,1.0,2/12,3.99%,PRNP;HOMER2
prerank,mRNA catabolic process (GO:0006402),0.34855234853069106,0.9110331317330278,0.6281908990011099,0.8660508823636301,1.0,15/44,25.42%,LSM6;HSPA1B;ZFP36L2;ZFP36;RNH1;HSPA1A;PDE12;NUDT16;NANOS2;AGO1;EXOSC9;EXOSC4;LSM5;METTL3;PNPT1
prerank,nuclear body organization (GO:0030575),-0.3458209903007019,-0.9106110406282824,0.5601374570446735,0.8348358007827539,1.0,4/12,13.51%,USP50;PML;AFF2;SRPK2
prerank,heart trabecula morphogenesis (GO:0061384),0.3985364816342097,0.9105952514239215,0.5896414342629482,0.8665193515442114,1.0,4/18,5.77%,NRG1;RBP4;FKBP1A;S1PR1
prerank,response to glucagon (GO:0033762),-0.31863753346233203,-0.9105433925664224,0.5663716814159292,0.8334724501709372,1.0,3/19,2.23%,ADCY9;ADCY1;ADCY5
prerank,regulation of neurotransmitter transport (GO:0051588),0.4028584445715262,0.9097734697447054,0.5933333333333334,0.8677276112588402,1.0,8/16,31.23%,FLOT1;RIMS1;SYN1;HCRT;MEF2C;KCNMB4;CPLX1;MCTP1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4120146626401108,0.9094738477154173,0.5855354659248957,0.8679108507257426,1.0,3/14,8.69%,AKT1;MTLN;MFSD2A
prerank,phosphatidylserine metabolic process (GO:0006658),0.3574726830375938,0.9094111984618805,0.5988235294117648,0.86761837320586,1.0,8/32,25.29%,SERINC1;PLAAT3;PLA2G4F;PTDSS1;SERINC5;ABHD16A;PLA2G3;ABHD12
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.35599173844682763,-0.9093525900376458,0.5748299319727891,0.834775752661085,1.0,5/10,16.50%,DICER1;DROSHA;TERT;TARBP2;AGO2
prerank,negative regulation of GTPase activity (GO:0034260),-0.2820407042683063,-0.9092722517347621,0.57,0.8334548559752968,1.0,3/22,2.28%,LRRK2;BCAS3;ARFGEF1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.39371072083464426,0.9088536796448999,0.6042713567839196,0.8683459485634838,1.0,9/18,26.10%,PINK1;KDR;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1;RALBP1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.4217573191558003,0.9088220447592517,0.6189224704336399,0.8680047656855867,1.0,4/14,12.35%,IGFBP3;IGFBP5;NDRG4;AIF1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4039125804061333,0.9085243928503063,0.5973509933774834,0.8678088425602781,1.0,4/16,7.15%,APOD;ACVRL1;FAM107A;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4039125804061333,0.9085243928503063,0.5973509933774834,0.8678088425602781,1.0,4/16,7.15%,APOD;ACVRL1;FAM107A;CORO1C
prerank,multivesicular body organization (GO:0036257),0.36398954936806566,0.9083025834400027,0.6052009456264775,0.8678467658460752,1.0,16/31,32.42%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,cellular response to misfolded protein (GO:0071218),0.3889804145469583,0.9080032744990861,0.6005089058524173,0.8680613606657855,1.0,2/20,5.80%,AUP1;VCP
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.40689502077652934,0.9077903789840319,0.6008064516129032,0.8680396560246147,1.0,3/15,13.00%,AGT;SOX8;SOX9
prerank,protein export from nucleus (GO:0006611),-0.2776548826164617,-0.9074580266338871,0.6107784431137725,0.8363991784455823,1.0,12/27,17.19%,RANBP3L;SMURF1;DUSP16;NUTF2;PKD1;RANBP17;XPO4;XPO7;CCHCR1;CSE1L;NUP214;STRADB
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3366077676820189,0.9071322309280055,0.6448390677025527,0.8689619358131047,1.0,9/57,10.71%,ERBB4;TNF;HCLS1;ARL2BP;PPP2R1A;HES1;PTK6;IL2;CSF1R
prerank,regulation of mitochondrial fusion (GO:0010635),0.4455539925920544,0.9069779673776771,0.6149584487534626,0.8688624073106254,1.0,3/11,6.54%,VAT1;TFRC;OMA1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3296976407079113,0.9064889409036052,0.619625137816979,0.8694113455269328,1.0,25/54,26.06%,HEXA;HYAL2;GUSB;HS3ST6;HS3ST5;SDC4;FUCA1;GPC5;B3GAT3;CLN6;SGSH;NAGLU;UGDH;XYLT1;HPSE;SDC3;HPSE2;HS3ST2;HSPG2;AGRN;HS6ST1;B3GAT1;CHST9;HS6ST2;GPC1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3527445925998641,0.9050054552229312,0.6194379391100703,0.8719440260969689,1.0,7/35,17.03%,SCD5;FASN;SCD;ACAT1;ALOX5AP;SLC25A1;LTC4S
prerank,cellular response to drug (GO:0035690),0.3784802113014766,0.9048143277143847,0.5942928039702233,0.8719039431216793,1.0,9/25,28.27%,PDE4B;TFRC;GAS6;MEF2C;MYC;PPM1F;REST;KCNQ1;RAP2A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.37218814404389866,0.9047957767597975,0.6111111111111112,0.8715327457238005,1.0,3/25,3.34%,CALM1;CALM3;CTNNA3
prerank,cAMP-mediated signaling (GO:0019933),-0.2926482818500553,-0.9044081192525452,0.6174863387978142,0.8420148511760109,1.0,7/24,11.31%,PDE7B;ADCY1;RAPGEF2;KSR1;PDE7A;RAPGEF3;DGKQ
prerank,cellular response to mechanical stimulus (GO:0071260),0.341180601815717,0.9037054160099881,0.6357541899441341,0.8732112074862547,1.0,14/46,25.86%,MAPK3;CNN2;AQP1;TMEM150C;SOX9;TNFRSF1A;BAD;TLR5;LTBR;BAK1;GADD45A;PDE2A;CASP1;TLR7
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.40917368246064334,0.9035838217929388,0.60546875,0.873035024380198,1.0,8/16,29.08%,PPP2R1A;LEPROT;CAV1;VHL;ADIPOR1;SOCS3;HGS;PPP2CA
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.35999619386863874,-0.9034689546771736,0.5774193548387097,0.8426804193210038,1.0,4/11,19.26%,ITPKB;IP6K2;PPIP5K1;FGF2
prerank,regulation of postsynapse organization (GO:0099175),0.3589405299452657,0.9034556943137556,0.6248506571087217,0.8728818877188635,1.0,8/28,15.70%,CFL1;IL1RAPL1;PPFIA2;CDK5R1;ABHD17A;WNT5A;SRCIN1;CDK5
prerank,monoacylglycerol metabolic process (GO:0046462),0.41479061660219774,0.9033422548098959,0.6081632653061224,0.872683145984714,1.0,7/13,28.07%,MOGAT2;DGAT2L6;FAAH;DGAT1;ABHD16A;ABHD12;MGLL
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4093467206549059,0.9031971602689822,0.6096904441453567,0.8725908316878995,1.0,2/14,7.06%,PCBP4;SRSF9
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3284171000483783,-0.9030031541199472,0.5740072202166066,0.8422400316294976,1.0,2/14,5.55%,MOXD1;DAGLA
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.35424982909165303,0.9025609567961497,0.6192714453584018,0.8733961080479368,1.0,5/32,7.15%,APOD;ADAM15;ACVRL1;FAM107A;CORO1C
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3832924752068899,0.9022228411012952,0.608641975308642,0.8736430388911763,1.0,4/22,10.02%,MDK;ZFP36L1;EPPK1;ZFP36
prerank,lamellipodium organization (GO:0097581),0.3656589344085827,0.9021982400779439,0.610909090909091,0.8732894196538113,1.0,9/29,21.09%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN;CTTN;PTPRO
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.35702859850055996,0.901826859085878,0.6504739336492891,0.873605976273591,1.0,10/35,19.48%,KCTD10;RASIP1;STMN3;TNFAIP1;SPRY1;STMN1;DLC1;DAB2IP;KCTD13;SPRY3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32835602150310433,0.9015070436681363,0.681283422459893,0.8738184781859156,1.0,21/70,24.57%,LAMC1;LAMB2;ATF4;RAC1;SPI1;FN1;PROX1;VAMP3;ACTN1;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1;MEF2C;GRHL2;USH2A;TEK;TBCD;METTL3
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.42322288217174003,0.9014790144823877,0.6182336182336182,0.8734697367257559,1.0,3/12,16.01%,RAN;SEC14L2;ABCA2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4416181955530786,0.9012829065202949,0.5986013986013986,0.8734229360268492,1.0,6/10,40.56%,SMOX;SLC44A1;DMGDH;CHDH;SARDH;COMT
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3972705451179295,0.9012737003379033,0.6227848101265823,0.8730416455744106,1.0,2/19,3.71%,CLDN5;TNF
prerank,aorta morphogenesis (GO:0035909),-0.3207098820215175,-0.9010753812782214,0.6123348017621145,0.8454489947619215,1.0,8/17,14.92%,BMPR1A;ADAMTS9;MYLK;PDGFRB;LRP1;RBPJ;JAG1;HEY2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29995318034135177,0.9008385987587212,0.842,0.8734700903409495,1.0,121/497,22.16%,MRPL13;RPS3;HSPA8;PFDN5;RACK1;GAPDH;DBI;RPL13A;CALR;MT3;NDUFA13;TMPRSS6;S100A11;ID3;SOX18;NRG1;ID1;CRYAB;TERF1;EID1;CCDC85B;TNF;PDGFB;NR1D1;ACVRL1;IGFBP5;NCL;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;YBX1;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;PCIF1;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;ENC1;EIF4A3;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;EIF4ENIF1;NANOS2;RLIM;ZHX1;COMMD7;CIR1;EPRS1;QARS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;PUS7;CBX3;TFAP4;ID2;DDIT3;SIRT2;SELENOS;IGF2BP3;SUDS3;DACH1;MEN1;PPM1F;REST;EIF4E2
prerank,cellular response to alkaloid (GO:0071312),0.40353781078243295,0.9007630281331964,0.6057441253263708,0.8732225508602603,1.0,6/17,25.76%,TGM2;GSTM2;SLC8A1;RYR2;BLM;RAD51
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4312197564052736,0.9006885653527871,0.6016483516483516,0.8729805908756858,1.0,5/12,19.84%,TNF;LIN28B;NCOR2;IL6;TGFB1
prerank,telomere capping (GO:0016233),0.4088142321173049,0.9005051721257861,0.5873655913978495,0.8729305553391474,1.0,4/16,18.54%,TERF1;DCLRE1C;CTC1;TERF2IP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.442353016244271,0.9004412126024451,0.5962910128388017,0.8726510738172335,1.0,4/10,19.76%,NELL1;ATRAID;DAB2IP;EFNA1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3602660036864942,0.9001449758428693,0.6185446009389671,0.8728435387729347,1.0,7/33,15.99%,S100A1;KLF2;PKM;GLUL;EPN1;KLF4;DLL1
prerank,positive regulation of histone acetylation (GO:0035066),0.3759751487129969,0.9000291891597834,0.6172839506172839,0.8726756549194947,1.0,8/23,27.18%,MAPK3;PIH1D1;WBP2;PPARGC1A;MUC1;SPHK2;PAXIP1;RUVBL2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3261340358097472,-0.8997565452701627,0.6,0.8471549706018321,1.0,1/14,0.28%,SULF1
prerank,regulation of response to oxidative stress (GO:1902882),0.4308444971944311,0.8995407896886806,0.6055172413793104,0.8732234899027617,1.0,5/11,31.23%,PINK1;SELENON;HEBP2;GGT7;MCTP1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3159061281863696,0.8995397299587671,0.6707946336429309,0.8728256244829851,1.0,33/94,29.04%,CRIP1;ATF4;HINT1;CHEK2;HIPK2;CEBPB;SELENOK;CD24;BAX;PMAIP1;STK11;BBC3;BAD;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;HIC1;POU4F1;BAK1;PYCARD;DDIT3;PPM1F;C1QBP;BOK;CUL2;SCN2A;TRIB3;CDKN1A;TNFRSF1B;PDK2;MCL1
prerank,histone H3 acetylation (GO:0043966),0.3415205511611074,0.8995162295290692,0.634902411021814,0.8724783624269329,1.0,7/40,10.15%,SPI1;BRD1;BRPF1;TAF10;JADE1;TAF5L;TAF9
prerank,cardiac myofibril assembly (GO:0055003),-0.3267951760125588,-0.8994310942904687,0.5958333333333333,0.8463198141659813,1.0,5/15,17.51%,NEBL;MEF2A;PDGFRB;OBSL1;PDGFRA
prerank,COPII-coated vesicle budding (GO:0090114),0.3238655349580937,0.8985356824914065,0.6595289079229122,0.8739307641450104,1.0,17/68,21.65%,CTSZ;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;VAPA;COL7A1;TMED10;TGFA
prerank,fatty acid beta-oxidation (GO:0006635),0.33399229835502275,0.8983359761311885,0.664804469273743,0.8739208985449377,1.0,8/51,13.88%,ACADVL;SCP2;ETFB;MTLN;HSD17B4;ACAT1;ACAA2;CRAT
prerank,smoothened signaling pathway (GO:0007224),-0.2572598154598868,-0.8982398453927932,0.6496815286624203,0.8476010758444585,1.0,4/32,2.67%,SMO;CC2D2A;GLI3;GLI2
prerank,regulation of cytoplasmic transport (GO:1903649),0.43238682128530354,0.8976677745556944,0.6127717391304348,0.8747737081490482,1.0,1/11,1.89%,MAPK3
prerank,urogenital system development (GO:0001655),0.4318952765331681,0.8972050768292045,0.5997248968363136,0.875241422002362,1.0,8/11,40.05%,AMH;SOX9;OSR2;SHH;PAX2;EPHB3;LHX1;OSR1
prerank,sphingolipid catabolic process (GO:0030149),0.4068621742503089,0.8972007630786848,0.6171052631578947,0.8748512660020762,1.0,5/15,21.69%,ENPP2;SMPD1;SMPDL3A;ASAH2;SGPL1
prerank,positive regulation of integrin activation (GO:0033625),0.42830027221026706,0.8970674480587157,0.5972027972027972,0.8747337007328683,1.0,3/11,17.01%,RASIP1;P2RY12;SKAP1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.37645802080160967,0.8969138399119418,0.6356877323420075,0.8746317538735244,1.0,6/24,9.28%,S100A10;RAC1;DUSP3;THY1;KDR;ARF6
prerank,tyrosine metabolic process (GO:0006570),-0.34121191594636485,-0.8968637849020795,0.5944055944055944,0.8493306288594358,1.0,3/11,24.99%,THAP4;GSTZ1;HGD
prerank,positive regulation of neuron migration (GO:2001224),0.4337452385149325,0.8967860167523031,0.6276150627615062,0.8744603528878631,1.0,4/11,18.75%,MDK;SHTN1;DAB2IP;NSMF
prerank,cellular response to nitrogen compound (GO:1901699),-0.29554485684585624,-0.8967803462170962,0.64,0.8479950836090052,1.0,2/20,5.78%,ROCK2;SPIDR
prerank,regulation of cell cycle process (GO:0010564),0.3184948101308776,0.8967419399846486,0.6907216494845361,0.8741505201004586,1.0,27/104,26.14%,CALM1;CALM3;GPER1;KLHL9;PIN1;CAV2;CTNNB1;USP51;ATF5;SOX9;FBXO5;SND1;L3MBTL1;NUDT16;CETN2;CALM2;GIT1;SFRP1;CCP110;IHO1;CCDC8;NUGGC;ECT2;RCC1;CDKN2B;KIF20B;KLHL21
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4272951073107307,0.8965901105879276,0.6055944055944056,0.8740520760779403,1.0,1/10,1.76%,PARK7
prerank,regulation of vesicle-mediated transport (GO:0060627),0.318749922083957,0.8961955890515066,0.6749740394600208,0.8744177678177941,1.0,23/91,19.62%,MAPK3;SNX17;PTPRC;PACSIN1;SYT1;RIMS2;RAB15;RAB3C;CD22;VAMP2;AP2S1;HCK;STXBP5L;RAB3D;GAS1;HAP1;BET1L;RAB26;RAB5C;SYK;MAP2K2;STX4;RAB4A
prerank,positive regulation of exosomal secretion (GO:1903543),0.410015184326928,0.8961684103530697,0.6092105263157894,0.8740791941507425,1.0,6/15,26.88%,ATP13A2;SDC4;SDCBP;VPS4A;HGS;SNF8
prerank,response to sterol (GO:0036314),0.42434450415282216,0.8960460127573917,0.6183644189383071,0.8739093181030058,1.0,5/11,23.23%,CCR5;ABCA2;CCL3;TGFB1;PMVK
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3265032915689936,0.8954154534680976,0.6510869565217391,0.8739073033566178,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,vesicle coating (GO:0006901),0.3265032915689936,0.8954154534680976,0.6510869565217391,0.8739073033566178,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,COPII vesicle coating (GO:0048208),0.3265032915689936,0.8954154534680976,0.6510869565217391,0.8739073033566178,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,T-helper cell differentiation (GO:0042093),-0.31555231381790266,-0.8953697292675056,0.5756457564575646,0.8498193366512506,1.0,2/14,6.77%,FOXP1;ATP7A
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.38694743528889586,0.8951893515866312,0.609254498714653,0.8739394262733146,1.0,5/19,19.32%,ITGB2;TIRAP;TICAM2;TRIL;CD14
prerank,nucleus organization (GO:0006997),0.334927467420913,0.8945566708776392,0.6238636363636364,0.8747542329658347,1.0,13/47,25.88%,RPS19;CHMP2B;CTDNEP1;CHMP5;CHMP6;CHMP1B;SYNE1;VPS4A;CHMP7;SUN2;SPAG4;CHMP1A;CHMP4C
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2756557784468418,-0.8941546062301448,0.624390243902439,0.8511479915684623,1.0,5/26,5.23%,ACTN2;ANK2;FHL1;AKAP9;DLG1
prerank,actin polymerization or depolymerization (GO:0008154),0.33581933557984045,0.8939962624695909,0.6530147895335608,0.8753968430024338,1.0,11/50,13.99%,GSN;CFL1;RAC1;ANG;FAM107A;MICAL1;AIF1;DSTN;MSRB1;FLII;CAPG
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4175034188834012,0.8935370987135361,0.6101231190150479,0.875878945254353,1.0,1/13,1.43%,GNAI2
prerank,positive regulation of actin nucleation (GO:0051127),0.4371302557268007,0.8935126551309484,0.6063218390804598,0.8755296406972141,1.0,1/11,0.88%,GSN
prerank,nuclear transport (GO:0051169),0.3948304723319094,0.8935085087556608,0.6211512717536813,0.8751436785801158,1.0,4/16,11.38%,NPM1;RBM15B;XPO1;BANF1
prerank,regulation of metal ion transport (GO:0010959),-0.31203695578417023,-0.8934272979248528,0.6099585062240664,0.8513233876313087,1.0,6/16,14.27%,ANK2;SLC30A10;DLG1;IL16;BCL2;STIM1
prerank,regulation of response to interferon-gamma (GO:0060330),0.41550120497175824,0.8930684463445985,0.6276881720430108,0.8755838838138978,1.0,5/14,23.59%,HSP90AB1;CDC37;IFNGR1;IFNGR2;SOCS3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3524487117343877,0.8929256596627639,0.6386946386946387,0.8754748604096864,1.0,9/33,21.12%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;MAZ;CPSF4
prerank,heterotypic cell-cell adhesion (GO:0034113),0.36642030876921894,0.8923788995003832,0.6093366093366094,0.8760960596311514,1.0,5/25,16.62%,ITGB2;CTNNA3;NINJ1;JAM3;VCAM1
prerank,triglyceride biosynthetic process (GO:0019432),-0.3014029447662772,-0.8920228209637766,0.5829787234042553,0.8530247062832083,1.0,8/18,26.39%,AGMO;MOGAT3;GPAT3;GK;PNPLA3;LPIN2;DGAT2;LPIN3
prerank,protein homotrimerization (GO:0070207),0.41179291369880006,0.8917140024383241,0.6405835543766578,0.8765849119344759,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,protein trimerization (GO:0070206),0.41179291369880006,0.8917140024383241,0.6405835543766578,0.8765849119344759,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,negative regulation of biosynthetic process (GO:0009890),0.3977970999510484,0.8915962066662891,0.6192959582790091,0.8764097873681576,1.0,2/16,3.43%,PARK7;GPER1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3432150831253583,-0.891231668182845,0.6214285714285714,0.8532687765249239,1.0,5/13,17.26%,PTGIS;PARP9;PARP16;PARP10;NUDT12
prerank,nucleotide biosynthetic process (GO:0009165),0.3895494373304721,0.8912258346734885,0.6074168797953964,0.8767161572502845,1.0,7/18,27.36%,GART;PNP;PRPS1L1;PRPS1;PRPSAP1;ADSL;RRM2B
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3571186979531696,-0.891058081509514,0.6111111111111112,0.850631053165284,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3571186979531696,-0.891058081509514,0.6111111111111112,0.850631053165284,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.35514927327710205,0.8905653573577135,0.6235565819861432,0.8775555604168016,1.0,9/32,19.64%,HMOX1;KDR;JCAD;GATA2;KLF4;RHOA;HDAC5;HDAC9;NOTCH1
prerank,positive regulation of signal transduction (GO:0009967),0.29915837301375026,0.8904319031318887,0.7675350701402806,0.8773951399012668,1.0,38/238,13.55%,RPS3;CD74;CD63;VTN;ATP6V0C;MT3;C3;KLF2;NRXN1;NLGN1;TREM2;GPER1;EMP2;PTPRC;SORL1;CAV2;LY86;FLNA;CD180;GRIN1;TNFAIP3;RIMS2;RIMS1;CLEC6A;P2RY6;KLK6;LGR6;JCAD;ZDHHC5;PIH1D1;HAP1;ULK3;BAX;ATP6AP2;SNW1;BMP2;PDCL;GAS6
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33363046154907694,0.8902354506612264,0.6692392502756339,0.8773628130838619,1.0,16/52,19.60%,AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;GNAI1;RAMP3;CLIP3;EPB41;SQSTM1;STX4;STAC3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.40958518565450724,0.8901676048740452,0.6363636363636364,0.8770931279706236,1.0,4/15,20.57%,NLGN1;HAP1;ADRA1A;ZDHHC12
prerank,regulation of extracellular matrix organization (GO:1903053),0.40110412194367756,0.8899674912054453,0.6266666666666667,0.8770745377118531,1.0,5/15,19.64%,AGT;AEBP1;TIE1;DDR2;NOTCH1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.28404580246212924,-0.889836698580562,0.6312849162011173,0.8520585081019989,1.0,7/23,21.10%,WEE1;PRCC;PABIR1;CHFR;INTS3;PLK2;ZWILCH
prerank,sister chromatid segregation (GO:0000819),-0.25951476121729344,-0.8897127537195575,0.6527777777777778,0.8508957766511055,1.0,16/31,28.90%,TOP2B;INO80;CENPK;DSN1;KLHL22;SMC4;KIF18B;NDC80;TUBG1;SMC1A;MIS12;SGO1;PLK1;TUBG2;CDCA8;KIFC1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.3109872750109719,-0.8896255034977624,0.6438356164383562,0.8495691337220247,1.0,6/18,14.01%,SMAD3;ITGB8;LTBP1;SMAD4;CD46;LGALS9
prerank,regulation of axon guidance (GO:1902667),0.4352698209252843,0.8894261558817949,0.5988700564971752,0.8776664019499979,1.0,3/10,15.81%,TUBB2B;ZSWIM8;YTHDF1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.31103793429774274,-0.889212592609043,0.6440677966101694,0.8490619105768608,1.0,5/16,15.38%,TIPIN;RAD17;ORC1;NAE1;CLSPN
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.39337288084149785,0.889004034907667,0.6246753246753247,0.8780644058153709,1.0,13/18,35.51%,CLASP1;BMP2;IER3IP1;DDR2;IL6;TGFB1;COLGALT1;EFEMP2;CLASP2;RGCC;FSCN1;RUNX1;MELTF
prerank,axon extension (GO:0048675),0.3708803669537052,0.8884941381606035,0.6177944862155389,0.8786137586481024,1.0,3/23,3.78%,HSP90AA1;HSP90AB1;SEMA3F
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3085366998003321,0.888480647212281,0.698170731707317,0.8782436074772142,1.0,23/129,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.331977339614859,0.8884725009041055,0.6695464362850972,0.8778615585393627,1.0,6/54,12.90%,RPL26;CHEK2;PCBP4;BAX;PCNA;PRMT1
prerank,tRNA methylation (GO:0030488),-0.25318912667465293,-0.8883953168438677,0.6838709677419355,0.8494853779403577,1.0,10/34,14.42%,TRMT13;NSUN6;ALKBH8;THADA;THUMPD3;TRMT5;FTSJ1;TRMO;PRORP;TRMT1L
prerank,nuclear membrane reassembly (GO:0031468),0.3290665783296706,0.8881806528736801,0.6644808743169399,0.8780155695080688,1.0,24/54,32.42%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NSFL1C;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,positive regulation of biomineral tissue development (GO:0070169),0.34127812932293633,0.8880672734480481,0.6601382488479263,0.8778299145370451,1.0,17/40,24.73%,FZD9;GPM6B;ISG15;CEBPB;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;FBXO5;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,circulatory system development (GO:0072359),0.3098712404263875,0.887654605325385,0.7206931702344547,0.8782106332354891,1.0,32/118,21.15%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;PDGFB;ACVRL1;APLNR;FN1;COL3A1;FGF12;SOX17;KDM6B;FLT4;SOX9;FBXW7;BMP2;STK11;HEY1;HDAC9;CDH5;TCF25;ERBB3;NOTCH1;HSPG2;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.20277747368885904,-0.8874214811568655,0.7741935483870968,0.8502157749598525,1.0,30/119,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;TTC7B;PLEKHA4;SMG1;PLEKHA2;PGAP2;ITPKB;PIP5K1A;PTEN;SACM1L;VAC14;PIGM;IP6K2;PIP4K2C;SOCS5;PIGN;PLEKHA8;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIP4K2A;PIGU;PLCG2;FGF2
prerank,cellular response to alcohol (GO:0097306),-0.24571635879939996,-0.8872011639277707,0.7163120567375887,0.8492591965908562,1.0,7/42,5.78%,ADCY1;SMO;ADCY5;LRP6;GRAMD1C;LARP1;SPIDR
prerank,inorganic cation import across plasma membrane (GO:0098659),0.31590825728281263,0.8870936872763655,0.6937697993664202,0.8788691906146284,1.0,14/75,17.77%,SLC24A2;SLC39A10;KCNJ10;ATP1A3;ATP1B2;SLC12A5;TRPM2;ATP1A4;ATP1A1;KCNK9;ATP1B1;SLC8A1;ATP1B3;SLC9A9
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.43896628279310224,0.8870632859324447,0.6099290780141844,0.8785282493652794,1.0,6/10,35.64%,SIRT2;RCC2;ECT2;SPAG5;APC;KNSTRN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3243182547673059,-0.8864721483192183,0.6153846153846154,0.8493905907652931,1.0,1/14,0.47%,ZEB1
prerank,organelle organization (GO:0006996),0.2938870339176932,0.8853009793809185,0.852,0.8813951455404719,1.0,81/388,20.80%,APOE;PPIA;CHCHD10;ATP5F1B;MDK;CHCHD2;CFL1;PARK7;PINK1;CNN2;MAST3;LMAN2;PACSIN1;AUP1;ATP8B4;CAV2;BSCL2;PARP1;CHMP2B;PLAAT3;REEP5;BAG5;TNFAIP3;TMED7;LMAN1;SAR1A;RAB14;TSPO2;SURF4;REEP6;HSD17B13;TMED2;CLASP1;MAST1;THY1;TICAM2;MICAL1;TMED3;ARHGEF7;ARAP3;CHMP5;CHMP6;CHGA;TMED9;FNBP1L;ARL1;TMED1;SEC61A1;SNX11;VMP1;DES;RHOU;CCL2;MIEF2;SORT1;ZMYM3;PEX6;YTHDF1;CHMP1B;SH3KBP1;DMTN;ATAD3A;CCL3;CAV1;DNM1L;SYNE1;LNPK;PPARGC1A;FMNL3;KIF5C;STX4;VPS4A;RAB18;RAB31;HPS6;MAPK15;VAPA;CFAP410;MYC;CHMP7;PAK5
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.31446870260357074,-0.8852188963733941,0.5957446808510638,0.8507487242561549,1.0,4/14,15.20%,AUTS2;KMT2A;SMAD4;PRDM9
prerank,positive regulation of MAP kinase activity (GO:0043406),0.32035164457858717,0.8851803398173438,0.6795284030010718,0.8812157946807873,1.0,15/66,19.84%,RPS3;TNF;PDGFB;PAK1;CD24;HRAS;NEK10;TLR6;PDGFA;RASGRP1;DAB2IP;FLT1;EDN3;FLT3;TGFB1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.34556976874887335,0.885037068612346,0.6682027649769585,0.8810892682811842,1.0,5/38,9.10%,GRN;CYBA;LY86;CD180;SLC15A4
prerank,regulation of cilium assembly (GO:1902017),-0.21688407554748768,-0.8849926691588669,0.7738095238095238,0.8497646241087936,1.0,11/62,12.10%,DCDC2;TBC1D19;YAP1;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;CEP97;SDCCAG8;IFT140
prerank,response to cholesterol (GO:0070723),-0.2959714094812822,-0.8849081448987336,0.6367521367521367,0.8484506234273712,1.0,4/17,5.54%,SMO;LRP6;GRAMD1C;TGFBR1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.35330358307140486,-0.8846891940136553,0.6285714285714286,0.8474818448008438,1.0,2/10,10.54%,INO80;SSBP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3946418629737589,0.8843438207764424,0.6386010362694301,0.8819556241601594,1.0,3/16,7.19%,PUF60;SRSF9;PQBP1
prerank,regulation of synapse organization (GO:0050807),0.3578589979705169,0.884101562635487,0.6402439024390244,0.8819771633820115,1.0,7/26,13.60%,CTNNA2;TNF;KLK8;IL1RAPL1;ABHD17A;WNT5A;YWHAZ
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31648780089585155,0.8836544035989496,0.7014925373134329,0.8824107355753537,1.0,12/76,14.27%,UBB;LAPTM5;PINK1;FKBP1A;FAM107A;CENPX;PTTG1IP;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.33505280935253423,-0.8834287742217926,0.5856573705179283,0.8487709413047486,1.0,2/12,4.54%,SORBS1;IRS1
prerank,melanosome organization (GO:0032438),0.36640074502993925,0.8832979680904194,0.6488456865127582,0.8826544955904784,1.0,5/26,12.70%,BLOC1S4;ABCB6;BLOC1S1;BLOC1S3;BLOC1S5
prerank,mismatch repair (GO:0006298),-0.2703482819800828,-0.8830114013315337,0.7169811320754716,0.8483229811827727,1.0,6/27,8.98%,ABL1;SETD2;MLH3;MLH1;MSH3;TDG
prerank,positive regulation of hemostasis (GO:1900048),-0.3403330022189655,-0.8826469109025825,0.6111111111111112,0.8462546029638384,1.0,1/10,1.41%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.3403330022189655,-0.8826469109025825,0.6111111111111112,0.8462546029638384,1.0,1/10,1.41%,ST3GAL4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2139681722007008,-0.8820517855389373,0.9111111111111111,0.8461646741270676,1.0,20/80,16.17%,SNX6;DENND2A;VPS54;SGSM2;VTI1A;SNX12;DENND5A;SPAG9;STX16;ANKFY1;GBF1;TRAPPC10;TBC1D23;TMEM87B;RIC1;SNX2;WASHC1;VPS50;SNX1;HEATR5B
prerank,phosphatidic acid metabolic process (GO:0046473),-0.227038388589623,-0.8819208019979919,0.7524752475247525,0.8450189211108338,1.0,11/48,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,endodermal cell differentiation (GO:0035987),0.3555455538732237,0.8813409133572234,0.6594982078853047,0.8858341090301666,1.0,4/31,8.22%,VTN;ITGB2;FN1;COL6A1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.42355120209114777,0.8806107624725639,0.6461748633879781,0.886787132058179,1.0,2/11,6.44%,SORL1;MSN
prerank,regulation of osteoclast differentiation (GO:0045670),0.347893718070876,0.8796626706587116,0.6546091015169195,0.8881454140654629,1.0,7/33,19.95%,TNF;CEBPB;GPR137B;PRXL2A;LILRB3;CCL3;POU4F1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.38345540410723455,0.879571919602193,0.6553966189856957,0.8879355818310516,1.0,9/20,24.87%,PSENEN;SPPL2B;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;RELA;APH1A
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3716214282709128,0.8794202192051528,0.6380832282471627,0.887821304809601,1.0,2/21,4.78%,AGXT;NUDT19
prerank,replicative senescence (GO:0090399),0.4132770681475757,0.8793796486864199,0.6278755074424899,0.8875026131321273,1.0,2/12,4.36%,ROMO1;CHEK2
prerank,cilium organization (GO:0044782),-0.19955440413547876,-0.8789367508191925,1.0,0.850057110177594,1.0,78/210,26.76%,PARVA;ASAP1;DCDC2;CC2D2A;EXOC4;CYS1;GALNT11;BBS9;ATP6V0D1;EXOC2;WDPCP;PCM1;ARL3;TTLL3;CCDC66;CDC14A;DZIP1L;PIBF1;CEP290;OFD1;IFT88;CCDC57;FAM161A;GBF1;DYNC2H1;NPHP3;ABLIM1;PKD1;CFAP44;WDR35;CEP162;CEP89;PDE6D;IFT140;INTU;IFT122;WDR11;CLUAP1;WDR19;DYNC2I2;CEP78;AVIL;TTC17;CEP41;RFX3;CEP19;TCTN2;POC1B;RAB8B;PKD2;CDC14B;CFAP70;CPLANE2;RTTN;RFX2;TMEM138;IFT80;IFT81;RAB1A;TMEM231;FOXJ1;RILPL2;CFAP61;CCDC65;MNS1;IFT52;RAB3IP;TEKT2;MAK;PTPDC1;EXOC1;RILPL1;CFAP43;BBS5;ARL13B;CFAP52;KIF3B;SNX10
prerank,cellular response to amino acid stimulus (GO:0071230),0.3432889303008063,0.8789072793466098,0.6513872135102533,0.8880023402515732,1.0,9/33,18.75%,LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3280429032890336,-0.8788716986075622,0.6105263157894737,0.8487260649197023,1.0,3/13,8.79%,PLXNA2;NRP1;NRP2
prerank,leukotriene metabolic process (GO:0006691),0.3801344852851754,0.8787319927634422,0.6362467866323908,0.887905935584899,1.0,4/19,17.03%,DPEP2;MGST3;ALOX5AP;LTC4S
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3456275024307612,0.8785792809435942,0.6512455516014235,0.8877931734410529,1.0,13/35,24.37%,ZFP36L1;SPI1;HSPA1B;BRD1;ZFP36;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA;HSPA9;MAFB;ANKRD54
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.2945537027124457,-0.8784678891445334,0.6029411764705882,0.8481517487528747,1.0,6/18,13.89%,OGA;ADAMTS9;NGLY1;STT3B;DERA;MANBA
prerank,microtubule depolymerization (GO:0007019),0.38255465289185914,0.8783903725954759,0.6228868660598179,0.8877363075754947,1.0,7/17,32.85%,STMN3;STMN4;STMN1;NCKAP5;CCSAP;STMN2;KATNB1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3433926852935555,0.8780549602175087,0.659477866061294,0.8879393250605853,1.0,8/38,13.96%,TOMM7;PINK1;UBL5;ATP5IF1;LMAN1;LEPROT;FBXW7;RHOU
prerank,response to glucose (GO:0009749),0.32845524600280057,0.8778739445364117,0.671201814058957,0.8878591091222334,1.0,12/46,21.40%,RACK1;GPER1;PFKL;GYS2;LPL;VAMP2;GAS6;MAFA;ADCY8;EIF2B5;KHK;SELENOS
prerank,positive regulation of cilium assembly (GO:0045724),0.3847896965358567,0.8777503147997225,0.6361355081555834,0.8876809118951835,1.0,5/18,24.77%,KCTD17;HAP1;CCDC88A;CCP110;WRAP73
prerank,mitochondrial fission (GO:0000266),0.39227341725249526,0.8774005709545203,0.6293888166449935,0.8879048395546125,1.0,7/16,23.35%,DNM3;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3874362491863995,0.8772483458204045,0.6454891994917408,0.8877755472504242,1.0,2/18,3.97%,COX17;COA3
prerank,lysosome localization (GO:0032418),0.3465951821684202,0.8768569393383191,0.6778290993071594,0.8880949992800972,1.0,17/37,34.89%,S100A13;PIP4P1;BLOC1S1;CHGA;DEF8;TMEM106B;PIK3CD;BORCS5;HPS6;BLOC1S2;BORCS6;RAB3A;RAB34;LAMTOR1;MILR1;KLC2;ARL8B
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.35857723023741395,0.8768406991982688,0.6552132701421801,0.8877242747435155,1.0,8/29,24.57%,HSP90AB1;ISG15;WNT5A;CDC37;OAS3;PTPN6;PTPN1;METTL3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.32770896633054325,0.8766304186378109,0.6759156492785794,0.8873008811323675,1.0,12/50,21.13%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,regulation of gene silencing by RNA (GO:0060966),0.32770896633054325,0.8766304186378109,0.6759156492785794,0.8873008811323675,1.0,12/50,21.13%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,protein-containing complex assembly (GO:0065003),0.29383537885458993,0.8764477989994207,0.8044132397191575,0.8872233854448124,1.0,61/259,21.72%,CD74;CHCHD10;CTSZ;ELOB;CXCL12;LAMC1;SLC2A1;CSNK2B;TNF;TAPBP;PPP2R1A;CTNNB1;IL2RB;HES1;AP2M1;ADD2;FN1;OTX2;TRAPPC2L;LMAN1;TRAPPC5;RIMS1;TRAPPC1;TMED2;P2RX7;CAPZA2;RBX1;VAMP3;VAMP2;PDCD6;GRIA1;SOX9;MAGI1;TNFRSF1A;TSPAN4;CAPG;MCFD2;TIAM1;SPG7;BAD;PDE4DIP;DMTN;NAPA;ADCY8;DNM1L;PPARGC1A;RBBP5;TRAPPC3;CTSC;EPRS1;LPXN;SKP1;IL1RAP;CAPN3;TFAP4;MYC;COL7A1;TMED10;COL16A1;TGFA;MEN1
prerank,cell cycle G2/M phase transition (GO:0044839),0.30487275210382203,0.8763489152776979,0.7240325865580448,0.8870043504276803,1.0,23/130,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,endothelial cell development (GO:0001885),0.365964817720108,0.8762822378601042,0.6517412935323383,0.8867313005003123,1.0,11/25,27.35%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1;MARVELD2;CNMD;PDE2A;STC1;RAP1B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4240463490936771,0.8761056421151797,0.6491477272727273,0.8866472790945857,1.0,3/11,21.03%,VSIR;HMGB1;TWSG1
prerank,chromatin remodeling at centromere (GO:0031055),-0.25500286640661407,-0.8760658882029281,0.7142857142857143,0.8521929644893659,1.0,15/31,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,regulation of mitochondrion organization (GO:0010821),0.3325278374942574,0.875916767701752,0.6921348314606741,0.8866024482031334,1.0,12/47,17.36%,TREM2;PINK1;OMA1;MAPT;ATP13A2;FBXW7;MIEF2;MFF;TMEM102;SQSTM1;DNM1L;PPARGC1A
prerank,determination of left/right symmetry (GO:0007368),-0.2465198251850418,-0.8751407784958013,0.7248322147651006,0.8527912088929336,1.0,20/37,32.02%,SMO;GALNT11;OFD1;NPHP3;CCDC39;RFX3;CFAP53;PKD2;DAND5;ODAD2;ODAD3;FOXJ1;ODAD4;KIF3B;MKKS;CCDC40;DNAAF4;STIL;PKD1L1;BBS7
prerank,cognition (GO:0050890),0.33303593908493007,0.8746767168668329,0.6644370122630993,0.8884245219716301,1.0,13/42,20.75%,GRM5;SLC1A4;TNF;C5AR1;CHMP2B;FAM107A;MFSD2A;CHRNA4;MAGT1;CBR3;PTCHD1;JAKMIP1;GPR155
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3585888136254331,0.8741417073687514,0.6348808030112923,0.8890162764147581,1.0,7/24,23.30%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;PRLR
prerank,cell part morphogenesis (GO:0032990),-0.32756052820016945,-0.8741046574278882,0.6239669421487604,0.8535108385891865,1.0,2/13,3.98%,PID1;PACSIN2
prerank,negative regulation of autophagy (GO:0010507),0.3265460977183466,0.8737291567430185,0.6829533116178067,0.8893688291627037,1.0,9/54,11.66%,MT3;AKT1;EIF4G2;TREM2;PINK1;RASIP1;NUPR1;MTMR9;CTSA
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2762839423354313,-0.8736725288427959,0.6683417085427136,0.8529727090693686,1.0,8/23,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;NDC80
prerank,organelle disassembly (GO:1903008),-0.24809922064162537,-0.8735317788194006,0.656441717791411,0.8518559594819405,1.0,8/33,12.61%,UFL1;ATG2B;GOLGA2;RB1CC1;GBF1;ATG2A;KLC1;ULK2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3647361955355008,0.8725022223996566,0.6703703703703704,0.8911443593133053,1.0,9/24,21.19%,TMEM59;AP2M1;CLTC;GDI1;RSC1A1;DMTN;TMBIM1;TGFB1;PPP2R5A
prerank,microtubule polymerization (GO:0046785),0.3486497621105649,0.8720939652250979,0.6485507246376812,0.8914557740770479,1.0,4/29,8.71%,TPPP3;PIN1;CLASP1;MAPT
prerank,glycogen metabolic process (GO:0005977),0.35600556908836395,0.8716770165200778,0.6546329723225031,0.8917806328425544,1.0,5/27,10.43%,CALM1;NR1D1;GYS2;NHLRC1;GAA
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.33170069766668686,0.8713320169625411,0.6659064994298746,0.8919882187476458,1.0,7/45,13.19%,RPL10;GRM5;METAP1;MEX3D;PCIF1;RBM4B;METTL18
prerank,hexose transmembrane transport (GO:0008645),0.3713628659740697,0.8705191213528714,0.6512820512820513,0.8929957471823742,1.0,4/21,18.04%,SLC2A1;SLC50A1;SLC2A2;SLC2A3
prerank,Golgi localization (GO:0051645),-0.3533850124486041,-0.8704489983817045,0.6059602649006622,0.8570672508437098,1.0,2/11,5.32%,ARHGAP21;UVRAG
prerank,nucleotide metabolic process (GO:0009117),0.3689926016042997,0.8702671686547405,0.67,0.8930467704768913,1.0,6/23,18.09%,PARK7;AK4;PNP;NME2;CMPK2;GUK1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3630579576131706,0.8698932339381693,0.6716232961586122,0.8933224254701382,1.0,8/24,19.84%,C3;ATF4;FLT4;HPSE;GATA4;CXCL17;IL6;TGFB1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.351884576947162,-0.8683846460611275,0.6375838926174496,0.8601039879335122,1.0,2/10,9.45%,ATP7A;THAP4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3987127822152716,0.8678080142577682,0.6594594594594595,0.8965477199478825,1.0,4/15,19.84%,TNF;CUEDC2;LILRB1;TGFB1
prerank,DNA modification (GO:0006304),0.3656048752164755,0.8674843014716932,0.6637168141592921,0.8967463382680769,1.0,6/22,21.53%,TERF1;PARP1;NEIL1;NEIL2;TERF2IP;EXOSC4
prerank,chromosome condensation (GO:0030261),0.3430199483508747,0.867381834880256,0.6946039035591275,0.8965302127221171,1.0,6/36,13.98%,CSNK2B;GPER1;SET;H1-0;BANF1;NCAPG
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3838495324706805,0.867104645537095,0.6333333333333333,0.8966043480427893,1.0,2/17,3.71%,CLDN5;TNF
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.37866421434594927,0.8665188279204655,0.6571798188874515,0.8972335381652348,1.0,6/18,18.76%,KCTD10;RASIP1;TNFAIP1;STMN1;DLC1;KCTD13
prerank,nuclear membrane organization (GO:0071763),0.3783354476698294,0.866234631144779,0.6572164948453608,0.8973388847446655,1.0,6/19,22.41%,GPER1;TARDBP;DCTN1;VPS4A;CHMP7;TMEM43
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3348669414545447,-0.8655647969863769,0.6474820143884892,0.8646372907821792,1.0,3/11,14.01%,RAPGEF2;SIRT1;LGALS9
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3808138946853124,0.8648764149309753,0.6626826029216467,0.899347381837219,1.0,5/17,20.04%,PTPRC;GJA1;HNRNPU;SOX11;THPO
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3809424360462429,0.8648305424052788,0.6644823066841415,0.8990397546105356,1.0,7/18,23.19%,CRH;CHGA;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,myeloid cell development (GO:0061515),-0.2874598705971949,-0.8647940374587609,0.6739130434782609,0.8648618598323824,1.0,1/18,0.16%,FOXP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.34939531982287153,-0.8644621433612111,0.6187290969899666,0.8640717855212724,1.0,3/10,16.08%,OGT;DGKQ;SIRT7
prerank,cardiac muscle cell action potential (GO:0086001),0.34803961026412894,0.864261465868067,0.670263788968825,0.8996437543554012,1.0,7/30,15.38%,SCN1A;YWHAE;SCN4B;FGF12;ATP1A1;ATP1B1;SLC8A1
prerank,protein hydroxylation (GO:0018126),-0.307657449603108,-0.8642013772662593,0.6496062992125984,0.863166415643132,1.0,2/15,5.98%,PLOD2;ASPH
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.36579447127312703,0.8638573065124474,0.650375939849624,0.8999481168274884,1.0,9/22,27.11%,DYNLL1;CDKN1C;PRKRIP1;INHBA;CDA;TESK1;CDKN2B;INHA;CDKN1A
prerank,regulation of pH (GO:0006885),0.41131290227719675,0.8634328266159302,0.6410256410256411,0.9002769143199837,1.0,3/11,11.96%,ATP6AP1;SLC26A4;ATP1A4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.31870603433335604,0.8627235202688209,0.702819956616052,0.9011077569170654,1.0,13/65,16.24%,AKT1;AGT;GPER1;DUSP3;SH3GL2;PTK6;EPN1;ARHGEF7;HAP1;SPRY1;CCDC88A;SH3KBP1;DAB2IP
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.30486711754792317,-0.8624481348608299,0.6322314049586777,0.865405671059107,1.0,4/15,11.93%,YTHDF3;STAT2;CNOT7;PTPN2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.41625840033391304,0.8622534691353212,0.6680613668061367,0.9015259689421932,1.0,3/11,19.64%,RGS2;LMNA;NOTCH1
prerank,glycerophospholipid metabolic process (GO:0006650),0.3119464323382626,0.8615965521011126,0.7377919320594479,0.90227174700379,1.0,22/75,26.52%,SERINC1;PRDX6;PIGZ;PIGQ;DGKH;PLA2G7;PLA2G4F;CSF1R;GDE1;SERINC5;GPCPD1;CPNE6;GDPD1;DPM2;ENPP6;PGP;GDPD3;PLA2G3;ABCA3;ABHD12;CPNE3;PLA2G6
prerank,embryonic organ development (GO:0048568),0.31806648957676636,0.8612867340034669,0.7133550488599348,0.9024365464102799,1.0,12/61,11.29%,RPL10;ATF4;SOX18;RBP4;NES;TNF;NDRG4;RARRES2;KDR;MFSD2A;KITLG;SOX17
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3601314834429762,0.8607110721670614,0.6638141809290954,0.9029985406894799,1.0,2/23,2.58%,CALM1;CALM3
prerank,neurotrophin signaling pathway (GO:0038179),-0.2793897583093837,-0.8604414685617022,0.6682027649769585,0.8682252182204995,1.0,7/21,15.41%,RAPGEF2;FRS2;RAPGEF1;NGF;KIDINS220;CASP3;BDNF
prerank,negative regulation of receptor internalization (GO:0002091),0.41399848894108005,0.860371487855728,0.684931506849315,0.9031684004707496,1.0,4/12,15.36%,LRPAP1;UBQLN2;SDCBP;ANKRD13D
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.29233293350774703,0.8595923142041555,0.7722672064777328,0.9041155364581597,1.0,37/152,20.35%,PSMB4;ATP6V0C;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;TNFAIP3;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;BMP2;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,positive regulation of cyclase activity (GO:0031281),0.3902385288503223,0.8595293323656177,0.6530054644808743,0.9038336178489776,1.0,4/14,17.56%,MAPK3;DRD5;ORAI1;NOS2
prerank,negative regulation of defense response to virus (GO:0050687),-0.3521661902834229,-0.8593463038064607,0.621160409556314,0.8691366171090322,1.0,3/10,15.47%,ITCH;ILRUN;TARBP2
prerank,modified amino acid transport (GO:0072337),0.3919192875089952,0.8592686699454141,0.6457800511508951,0.9038879272101042,1.0,4/15,15.31%,SLC1A4;MGST1;SLC19A1;FOLR2
prerank,regulation of JNK cascade (GO:0046328),0.30053224313324084,0.8592536336150773,0.734504132231405,0.9035245152633962,1.0,33/101,25.75%,CCL19;PINK1;DUSP3;TIRAP;SIRPA;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;PHLPP1;MAPK8IP1;SDCBP;F2RL1;TRAF3;MAPK8IP2;RASGRP1;EPHB1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;MEN1;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1;FKTN
prerank,protein homooligomerization (GO:0051260),0.29991386871880205,0.8589730876357008,0.7489754098360656,0.9036602911631256,1.0,23/114,21.10%,ALDOA;B2M;AQP4;SLC1A2;MPP2;MIF;STEAP4;ALAD;NINJ1;TRPM2;RS1;PRMT1;GLS;ALOX5AP;EHD1;G3BP2;HCN1;ADCY8;GLRA3;PKD2L1;SHMT2;PYCARD;KCNC2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2303236506742195,-0.8589039234935756,0.7368421052631579,0.8685293136093121,1.0,12/43,16.93%,EGFR;SNX6;CBLB;ERRFI1;PTPN3;STAM2;RNF115;PTPN2;SOCS5;GPRC5A;STAM;EPS15L1
prerank,cellular response to interleukin-2 (GO:0071352),0.4125414565477441,0.8589036246212168,0.6591230551626591,0.9029820455176896,1.0,4/11,18.00%,IL2RB;IL2;IL2RG;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4125414565477441,0.8589036246212168,0.6591230551626591,0.9029820455176896,1.0,4/11,18.00%,IL2RB;IL2;IL2RG;SYK
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.30122741844700357,-0.8581939346779,0.6607142857142857,0.8685994714308731,1.0,3/17,5.82%,SULF1;SLIT2;CASK
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3655728330564493,0.8578429148774311,0.6980645161290323,0.9044004662422235,1.0,5/20,21.67%,GATM;PTDSS1;GAMT;OPLAH;MTHFS
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.331249218267204,0.8575167877777446,0.7032332563510393,0.9045813203888277,1.0,13/39,27.24%,ADAM15;SPOCK1;CORO1C;RHOA;DMTN;NOTCH1;PTPRO;RCC2;AP1AR;TBCD;CX3CL1;MYOC;CORO2B
prerank,positive regulation by host of viral transcription (GO:0043923),0.3877770900006013,0.8574981566970664,0.6573705179282868,0.9042181326334072,1.0,4/15,12.40%,NUCKS1;RRP1B;JUN;SNW1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.38788771947604334,0.8570996931810461,0.6521145975443383,0.9045003671570266,1.0,4/15,17.36%,MID1IP1;MLXIPL;NR1H2;PPARGC1A
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3759128519001485,0.8570746923203925,0.67375,0.904157390712088,1.0,2/18,6.44%,MAPK3;MSN
prerank,positive regulation of viral genome replication (GO:0045070),0.34969476456695275,0.8569712117914722,0.6674876847290641,0.9039431146484544,1.0,5/29,13.84%,PPIA;IFIT1;DDB1;PABPC1;PDE12
prerank,gland development (GO:0048732),0.31584286424929353,0.8569312321717353,0.7100977198697068,0.9036238988404166,1.0,9/59,13.00%,MDK;SOD1;NRG1;HES1;MSN;CEBPA;PROX1;LSR;SOX9
prerank,negative regulation of cell junction assembly (GO:1901889),0.3536418009846774,0.8562734668901512,0.6802973977695167,0.9043895235981148,1.0,9/25,16.96%,APOD;TNF;ACVRL1;FAM107A;CORO1C;ROBO2;DLC1;DMTN;SLIT1
prerank,lipid phosphorylation (GO:0046834),0.4235660406408266,0.8556577225751925,0.6543385490753911,0.9050587292668536,1.0,6/10,30.98%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,regulation of protein export from nucleus (GO:0046825),0.3581017063253015,0.8555445027573441,0.6926889714993805,0.9048541317997152,1.0,9/23,24.60%,PARK7;YWHAE;UHMK1;CAMK1;GAS6;RANGAP1;IFI27;ANP32B;BARD1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36611210894336405,0.8552193207030728,0.6701434159061278,0.905030711684282,1.0,3/19,17.06%,PNPLA2;MTLN;TWIST1
prerank,sodium-independent organic anion transport (GO:0043252),0.42302899447907644,0.8549293965983438,0.6576319543509273,0.905109823411542,1.0,4/10,19.97%,SLCO1C1;SLCO4C1;MFSD10;SLCO1B1
prerank,tRNA processing (GO:0008033),0.3136125049787373,0.854877890069275,0.7334047109207709,0.9048098812159849,1.0,19/61,25.97%,METTL1;ELAC2;SARS1;KARS1;AARS2;POP7;RTRAF;TSEN15;RTCB;CTU1;TSEN54;CPSF4;ADAT2;URM1;TRNT1;THUMPD1;TRMT10C;CTU2;LCMT2
prerank,organophosphate biosynthetic process (GO:0090407),0.33294764423304063,0.8541248571893004,0.70267131242741,0.9056975929369528,1.0,8/37,18.57%,TPI1;FADS1;GPHN;PCYT2;PNPO;AGPAT5;TKT;IP6K1
prerank,wound healing (GO:0042060),0.3121155450172509,0.8540985221917281,0.7242489270386266,0.9053492720049273,1.0,18/62,19.09%,HMOX1;NRG1;PLEC;PAK1;SYT11;COL3A1;EPPK1;SMPD1;WNT5A;SLC11A1;EVPL;PDGFA;HPSE;EPB41L4B;GATA4;ERBB3;ANXA6;PPP3CA
prerank,reticulophagy (GO:0061709),-0.323992369441654,-0.8538751093171727,0.6524822695035462,0.8762242211672667,1.0,6/12,16.72%,UFL1;ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,positive regulation of axonogenesis (GO:0050772),0.3218321762600735,0.8537120835965334,0.7037457434733257,0.9056017953686369,1.0,9/43,15.46%,ARHGDIA;NTRK2;SEMA7A;MAPT;NTN1;RHOA;SHTN1;TIAM1;ROBO2
prerank,acyl-CoA metabolic process (GO:0006637),0.33360363671655935,0.8536449054167011,0.6915887850467289,0.9053135092041081,1.0,8/35,22.00%,DBI;OXSM;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5
prerank,double-strand break repair (GO:0006302),-0.19254952431368152,-0.8535314884393352,0.9411764705882353,0.8754520693382466,1.0,32/158,15.13%,EYA1;BABAM2;KDM2A;NSMCE2;DDX1;PARP9;MDC1;SPIDR;UIMC1;SMARCAD1;PARP3;RNF8;SMARCA5;BAZ1B;RBBP8;NHEJ1;SLX4;INO80;FBH1;RNF138;ERCC5;SETX;RAD51B;ACTR8;EYA3;ATM;TNKS1BP1;CYREN;KDM4D;PALB2;KPNA2;TDP1
prerank,Golgi to endosome transport (GO:0006895),-0.2974410728845522,-0.8532439741131327,0.67578125,0.874573606051824,1.0,4/16,10.18%,VPS13A;MON2;GBF1;KIF16B
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.31120983574573086,0.8519668818532827,0.7334801762114538,0.9077604537149008,1.0,12/66,14.26%,GPNMB;PSME1;AKT1;PSME2;CCND2;FAM107A;CCND1;JADE1;CDK2AP2;AIF1;KLF4;CCL2
prerank,nucleosome assembly (GO:0006334),0.3395940193454361,0.8516234921414341,0.6926770708283313,0.9079612073368116,1.0,6/31,16.60%,H3-3A;NPM1;BRD2;SOX9;IPO4;NAP1L2
prerank,DNA replication initiation (GO:0006270),0.33524901640094074,0.8512441343869659,0.7021276595744681,0.9082142652170769,1.0,5/37,12.19%,MCM5;RPA2;CDC34;GMNN;POLE4
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3535045023721885,0.8506995778447287,0.6816431322207959,0.9087176298231956,1.0,6/23,20.07%,AKAP6;NRG1;PROX1;MMP14;TGFB1;MEF2C
prerank,respiratory chain complex IV assembly (GO:0008535),0.3661987085849326,0.8506038353810513,0.6787954830614805,0.9084923787940204,1.0,2/21,3.97%,COX17;COA3
prerank,negative regulation of cellular component movement (GO:0051271),0.387852295596684,0.8505692276772514,0.6737400530503979,0.9081650182277123,1.0,4/15,12.28%,PIN1;FRMD5;SPOCK3;ACTN1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3473971075924527,0.8501168708110087,0.6846733668341709,0.9085566920699942,1.0,4/25,8.21%,MAP1A;MID1IP1;NAV3;CLASP1
prerank,Ras protein signal transduction (GO:0007265),0.291040398757247,0.8501104594197167,0.7686034658511722,0.9081801538101434,1.0,28/137,15.62%,ARHGDIA;CFL1;PARK7;RHOB;RAC1;ELMO1;ARHGDIB;SHC3;RHOG;ADGRG1;TRIM28;NTN1;JUN;GRAP;ARHGDIG;RASGRP3;GDI1;HRAS;AIF1;COL1A2;RHOA;SHTN1;RRAS;TIAM1;G3BP1;MAPK11;G3BP2;RASGRP1
prerank,prostanoid metabolic process (GO:0006692),0.3983556135636965,0.8493924009318863,0.6631158455392809,0.9090011070575941,1.0,2/13,13.37%,GSTM1;HPGDS
prerank,histone exchange (GO:0043486),0.32720850476368135,0.8493859832324356,0.7005847953216374,0.9086205161673839,1.0,4/37,7.60%,VPS72;NPM1;ZNHIT1;CENPX
prerank,mesenchyme development (GO:0060485),-0.2969223462998437,-0.849253865225087,0.7226890756302521,0.8813632958765435,1.0,6/15,19.40%,TGFBR1;FGFR2;WNT11;BMP4;BMPR2;PKD2
prerank,cellular response to organic substance (GO:0071310),0.29497418828516947,0.8487971232215844,0.7752808988764045,0.9092037723562526,1.0,31/116,21.24%,RACK1;RAMP2;PARK7;AKAP6;TNF;PDGFB;HCLS1;ACVRL1;IGFBP5;CTNNB1;IL1RAPL1;CLEC3B;CSF1R;RAMP3;SLC1A1;AMHR2;KLF4;RHOA;CXCR4;CCL2;ROBO2;SIGIRR;CCL3;SLIT3;FLT3;TGFB1;POU4F1;SFRP1;PTPN6;ASAH2;CDK9
prerank,regulation of sequestering of calcium ion (GO:0051282),0.39168481724891024,0.8485339894258517,0.6680384087791496,0.9092478904776589,1.0,4/12,18.67%,MTLN;RYR2;FKBP1B;ANXA6
prerank,apical junction assembly (GO:0043297),0.31167560178871,0.8484219259759725,0.712253829321663,0.9090386530242764,1.0,15/53,24.28%,CLDN5;RAMP2;RHOC;CLDN11;ESAM;PECAM1;RHOA;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.40876519462310734,0.8483481957512726,0.6819407008086253,0.9083843239819235,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.40876519462310734,0.8483481957512726,0.6819407008086253,0.9083843239819235,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3475033430429431,-0.8482104603349544,0.6538461538461539,0.8820402553150583,1.0,4/10,14.99%,DUSP10;HIPK3;PDCD4;PTPN22
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.41295200750301786,0.8479631574454205,0.667590027700831,0.9086412141907566,1.0,3/10,19.11%,SET;CTBP1;SNCA
prerank,myelination in peripheral nervous system (GO:0022011),-0.32363301333312017,-0.8477827572231037,0.6717557251908397,0.8814167585267842,1.0,3/13,5.39%,PARD3;SKI;DICER1
prerank,establishment of endothelial barrier (GO:0061028),0.3425544664708086,0.8472215774613959,0.6861143523920653,0.9095338458722128,1.0,6/29,14.62%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.24894811851434062,-0.8471898044578117,0.7161290322580646,0.8811906704992252,1.0,4/32,6.44%,AUTS2;PLCE1;CARMIL1;NCKAP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.32319595419893704,0.8464909834569437,0.710079275198188,0.9103543840227074,1.0,15/44,27.61%,AKAP6;FLNA;KCNJ10;ATP1B2;KCNN2;KCNE5;ATP1B1;ATP1B3;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.37855016242942535,0.8464445126188699,0.6649145860709592,0.9100343044456629,1.0,3/16,13.34%,GPR37L1;KLK1;DDAH1
prerank,negative regulation of ion transport (GO:0043271),0.3497395012444387,0.8463627130531378,0.6923076923076923,0.9097920169469939,1.0,5/24,19.11%,GPM6B;SYT11;PLN;LILRB1;SNCA
prerank,positive regulation of ion transport (GO:0043270),0.31871359616814227,0.8461670938228695,0.7228381374722838,0.9097307339487268,1.0,11/48,16.89%,ANK3;P2RX7;LILRA5;SCN4B;WFS1;VAMP8;ATP2B1;CNKSR3;PRSS8;CCL3;ORAI1
prerank,neuron fate commitment (GO:0048663),0.38557486803975427,0.8460524484044301,0.6825396825396826,0.9095158503898472,1.0,7/14,32.29%,DLL1;MYT1L;POU4F1;ID2;DLL4;POU3F2;SHH
prerank,mitotic nuclear division (GO:0140014),-0.21171231748717256,-0.8459139414852418,0.8518518518518519,0.8823467619260407,1.0,30/71,23.71%,EPS8;STAG1;LSM14A;KLHDC8B;PIBF1;OFD1;GOLGA2;INO80;CENPK;AAAS;NDEL1;DSN1;KIF2A;KLHL22;CCDC61;SMC4;MISP;TPX2;KIF18B;CEP192;ARHGEF10;ABRAXAS1;NUP62;NDC80;TUBG1;SMC1A;MIS12;MAP9;SGO1;SMC3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3562648173833807,0.845752145599375,0.70062893081761,0.9096407910262653,1.0,6/21,21.50%,PPP1CA;CTNNB1;FRAT2;CAV1;FZD2;FZD1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3896520053058668,0.8449906691579656,0.6853625170998632,0.9105278236836881,1.0,4/15,15.99%,S100A1;PKM;KLF4;DLL1
prerank,extracellular transport (GO:0006858),-0.31377166314184307,-0.8446841451840081,0.6395348837209303,0.8833652175562987,1.0,9/13,30.04%,WWP2;SPAG17;TSG101;SPA17;DNAAF2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,mitotic DNA replication (GO:1902969),0.4112682575338449,0.8446286516454615,0.6546546546546547,0.9107528647825454,1.0,7/10,38.37%,GINS3;CDC45;LIG1;MCM2;GINS1;MCM4;MCM3
prerank,positive regulation of isotype switching (GO:0045830),-0.2953356012226131,-0.8445686557329829,0.6987951807228916,0.8821349917205613,1.0,6/15,22.50%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;SHLD3
prerank,cranial nerve development (GO:0021545),0.4167800361411701,0.8443981689001284,0.6909090909090909,0.9107532399188525,1.0,3/11,19.95%,TMEM126A;ERBB3;POU4F1
prerank,regulation of cellular senescence (GO:2000772),0.34823422530837567,0.8443813282789512,0.7108140947752126,0.9103904556192084,1.0,4/28,8.92%,B2M;YPEL3;VASH1;YBX1
prerank,atrioventricular valve development (GO:0003171),-0.3046399107298483,-0.8443164663701411,0.6743295019157088,0.8812293056020051,1.0,3/14,6.73%,ACVR1;BMPR1A;MDM4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.33401292251570036,0.8440890030963883,0.7075812274368231,0.9104906660206151,1.0,7/33,12.78%,TNF;PDGFB;SPI1;EGR1;GATA2;JUN;KLF4
prerank,heart development (GO:0007507),0.2898506474160921,0.84314787328849,0.8102926337033299,0.9116315941043552,1.0,36/150,21.15%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;SGCZ;PDGFB;ACVRL1;FKBP1A;NDRG4;APLNR;ALPK2;FN1;MMP21;COL3A1;FGF12;SOX17;KDM6B;SOX9;BMP2;LEFTY1;DLC1;HDAC9;GATA4;SGCG;CRELD1;TCF25;ERBB3;NOTCH1;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,nucleosome organization (GO:0034728),0.3130661450023153,0.842273647960519,0.7386990077177509,0.9126976811426625,1.0,8/55,13.00%,H3-3A;VPS72;NPM1;ZNHIT1;BRD2;SET;H1-0;SOX9
prerank,RNA biosynthetic process (GO:0032774),-0.2412988336096656,-0.8418760028719522,0.75,0.8848395192603964,1.0,9/31,23.43%,TTF1;SMARCA5;SETX;TERT;POLR2A;RSF1;TAF7;NCOA6;BRF1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2777255964895592,-0.8418523751481618,0.6622222222222223,0.8834615050520904,1.0,5/19,14.40%,PARD3;SIPA1L3;OPHN1;MYO18A;MYO9A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.39333570387632,0.8413713890075829,0.6919889502762431,0.9137935536945,1.0,7/13,27.92%,LGMN;SHISA7;ADCY8;SQSTM1;APP;ZDHHC2;CHRNA7
prerank,positive regulation of blood coagulation (GO:0030194),-0.2889200992386699,-0.8399204755715418,0.6926406926406926,0.885845082385507,1.0,3/17,7.65%,ST3GAL4;ANO6;F3
prerank,regulation of chromatin binding (GO:0035561),-0.3395461385846292,-0.8393679935423182,0.6621160409556314,0.885498768791736,1.0,4/10,14.05%,PARP9;WAPL;BTAF1;KDM4D
prerank,"phototransduction, visible light (GO:0007603)",0.38230916564842254,0.8392316856626242,0.6935270805812418,0.9168592158360858,1.0,3/14,24.45%,GNA11;CNGB1;PDE6G
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3597335679966862,0.8391527226611563,0.6931216931216931,0.9166137032962232,1.0,7/21,20.94%,MT3;GRIN1;BEX3;PSMB9;PCID2;GRIN2B;PYCARD
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.39243708026835844,0.8385130761535439,0.6844319775596073,0.917243761128352,1.0,6/13,32.61%,CCL19;ABCA2;IL33;CHP1;ALG10B;RAMP1
prerank,glucose homeostasis (GO:0042593),0.2998750069466171,0.8382707388957436,0.7595338983050848,0.9172504793578532,1.0,16/83,19.67%,PARK7;MTNR1B;RPS6;RBP4;LRRC8A;NR1D1;NUCKS1;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;PPARGC1A;TFAP2B;IL6
prerank,barbed-end actin filament capping (GO:0051016),0.3672906531950194,0.8378787552049384,0.6719160104986877,0.9170851608317674,1.0,8/18,22.97%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,actin filament capping (GO:0051693),0.3672906531950194,0.8378787552049384,0.6719160104986877,0.9170851608317674,1.0,8/18,22.97%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,regulation of nervous system process (GO:0031644),0.3660216695845149,0.8378318905741696,0.6666666666666666,0.9167813477279406,1.0,9/18,24.59%,DLGAP2;DLGAP1;HTR2C;BEGAIN;TMEM108;NPTXR;CACNG5;APP;NPTX1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.33047414061665104,0.8376264688671228,0.7171361502347418,0.9167150806555147,1.0,8/37,20.07%,GPER1;PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1;MEF2C
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.26199433375143555,-0.8376015699486,0.745945945945946,0.8876140122824719,1.0,9/23,23.02%,CAMK2D;ANK2;ATP1A2;DIAPH1;NOS1AP;NOS1;PTK2B;CACNB1;CASQ1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4136294063410177,0.8373015772288073,0.6680851063829787,0.9168810980153539,1.0,1/10,3.60%,PFKL
prerank,glycoprotein metabolic process (GO:0009100),-0.2181756541357359,-0.8369772842779474,0.8023255813953488,0.8873521712553403,1.0,12/53,16.22%,LARGE1;ST3GAL4;MAN1C1;OGA;ADAMTS9;FUT8;NGLY1;STT3B;MANBA;ST6GALNAC6;MAN2A1;ST3GAL2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3841465144342193,0.8369291300451971,0.690179806362379,0.9171167782970854,1.0,2/15,12.50%,IDO2;QDPR
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3462126188721111,0.8366430945345853,0.7042944785276074,0.9172061037227462,1.0,4/23,11.19%,RACK1;VCP;RFX4;ULK3
prerank,ether lipid metabolic process (GO:0046485),-0.3037630341079769,-0.836457259357961,0.7023809523809523,0.8869593090210616,1.0,4/14,10.78%,AGMO;PAFAH1B1;FAR1;PEX7
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4036141326671919,0.8362577426578315,0.688293370944993,0.9174146209402548,1.0,5/10,31.37%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.36646805602328913,0.8362008825502606,0.6884816753926701,0.9171209295757048,1.0,6/18,21.71%,BHLHE41;TMEM119;BMP2;HDAC5;NOTCH1;CCN3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32515540480618277,0.8361229702396271,0.7029239766081872,0.916861299352601,1.0,5/38,9.75%,TREM2;NR1D1;TNFAIP3;OTUD7A;TRIM59
prerank,regulation of transferase activity (GO:0051338),0.37286812664557184,0.836044402137456,0.7079530638852672,0.9165948825233735,1.0,3/17,7.78%,EMP2;BAG5;FEM1A
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.41327984775374216,0.835794050145942,0.6862170087976539,0.9166117294285827,1.0,3/10,12.78%,PSMC3;HMGB1;THRA
prerank,regulation of endocytic recycling (GO:2001135),0.4077664122762471,0.8350593259639091,0.6676258992805756,0.9174159551907172,1.0,4/11,24.66%,SORL1;EHD1;EHD2;PLA2G3
prerank,signal peptide processing (GO:0006465),0.3994300881345078,0.8347885690147068,0.6904422253922967,0.9174542570897528,1.0,4/11,18.39%,SPCS1;CLN5;SPCS2;SEC11C
prerank,dendritic spine morphogenesis (GO:0060997),0.37747203778852684,0.8346454707148161,0.6990679094540613,0.917274860095523,1.0,5/15,23.04%,PAK3;DOCK10;EPHB1;CTNND2;WNT7A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.30438522058604306,0.8344571208686725,0.7602150537634409,0.9171893898945042,1.0,20/70,26.70%,GABARAP;DCC;TNF;P2RX7;TNFSF12;BAX;TNFRSF1A;SORT1;BAD;DAB2IP;SIVA1;ERBB3;INHBA;TGFB1;BAK1;IFI27;BLOC1S2;BOK;FGFR3;TGFB2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.37991366147905153,0.8341745214922018,0.6890982503364738,0.9172503506092532,1.0,5/15,19.99%,NTRK2;HAP1;SORT1;SOS1;DDIT4
prerank,pyroptosis (GO:0070269),0.3776031909998178,0.8341238092547982,0.7013333333333334,0.9169525040491925,1.0,1/15,2.84%,TREM2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.21409863245845343,-0.8327429932395203,0.8307692307692308,0.8927044277562092,1.0,18/61,19.26%,ACVR1;MNAT1;CDK6;CRLF3;NASP;CUL4B;CUL4A;LATS2;PHF8;PPP6C;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,negative regulation of mRNA processing (GO:0050686),0.37274760666207496,0.8324116110218606,0.6972111553784861,0.9192932988236455,1.0,2/15,7.06%,PCBP4;SRSF9
prerank,axoneme assembly (GO:0035082),-0.24793640190969266,-0.8323479233788523,0.7419354838709677,0.8920777995481854,1.0,11/31,24.62%,DNAI4;TTLL3;SPEF1;GAS8;CCDC39;LRGUK;SPAG17;RP1;FOXJ1;CCDC65;DNAAF2
prerank,negative regulation of blood pressure (GO:0045776),0.39013080180675974,0.8316586434740477,0.7021276595744681,0.9201092054756868,1.0,3/13,23.56%,GPR37L1;NOS2;PRCP
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.32037014430021427,0.8311786733895307,0.7502837684449489,0.9204918348347364,1.0,14/43,20.07%,IFITM1;DNAI3;ATP6AP1;NELL1;LRP3;ATRAID;TMEM119;BMP2;FBXO5;DDR2;SOX11;IL6;HGF;MEF2C
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.39824682635975445,0.8311483735740833,0.6934812760055479,0.9201479951723207,1.0,1/11,1.37%,H3-3A
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.37834111705105355,0.8293351395108643,0.6875834445927904,0.922652853503248,1.0,4/15,14.72%,AGT;LPL;MSR1;PF4
prerank,cytoplasmic sequestering of protein (GO:0051220),0.38065553648549155,0.8288252052881112,0.6979591836734694,0.9230794254655504,1.0,2/13,5.34%,YWHAB;FLNA
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.30575999049024144,0.8284589290531826,0.7694805194805194,0.9232675828216141,1.0,10/62,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,mitochondrial protein processing (GO:0034982),0.3943567534160882,0.8281478259935791,0.6926345609065155,0.9233908710464116,1.0,3/11,14.65%,OMA1;PMPCB;SPG7
prerank,cellular response to fluid shear stress (GO:0071498),0.38959394540868775,0.8281332723111373,0.691771269177127,0.9230203335739914,1.0,3/12,20.07%,KLF2;KLF4;MEF2C
prerank,bicellular tight junction assembly (GO:0070830),0.3103949489208444,0.8280718982795248,0.7477578475336323,0.922740953984425,1.0,13/46,24.28%,CLDN5;RAMP2;CLDN11;ESAM;PECAM1;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3589371787752575,0.8280594155450001,0.7063389391979301,0.9223705929030332,1.0,6/20,19.84%,TNF;HCK;CCL2;CCL3;CD14;TGFB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3220422677612582,0.8278201175798995,0.7392290249433107,0.9223754783636086,1.0,7/39,11.11%,MYO5A;PPFIA2;MYO7B;MYO1F;SYT4;FNBP1L;HAP1
prerank,glycerol metabolic process (GO:0006071),0.402791412551461,0.8275089219565553,0.6995645863570392,0.9224792649446067,1.0,4/10,26.80%,TPI1;PGP;GOT1;COQ2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.32739429347676113,0.8271561984711004,0.7249712313003452,0.9226609930258444,1.0,8/34,13.56%,CCDC85B;GPER1;TNF;ZFP36L2;GATA2;LRP3;WNT5A;WNT10B
prerank,DNA packaging (GO:0006323),0.3727137799705996,0.8267522271912348,0.6781456953642384,0.922906680262837,1.0,3/16,11.38%,H1-0;NAA10;BANF1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3466116960096335,0.8263906853408466,0.711217183770883,0.9230644014927532,1.0,4/23,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,N-terminal protein amino acid modification (GO:0031365),0.38794384006082844,0.8263752457468736,0.7086720867208672,0.9227038138082041,1.0,4/14,15.29%,METAP1;METAP2;NAA10;PDF
prerank,bile acid and bile salt transport (GO:0015721),0.3465597485465088,0.8263598131337986,0.7035670356703567,0.9223435287570451,1.0,5/24,20.83%,SLCO1C1;SLC10A3;ABCC3;SLCO1B1;SLC10A6
prerank,cellular amino acid catabolic process (GO:0009063),0.29148293572201744,0.8262593072334173,0.7924528301886793,0.9221152235910064,1.0,19/87,21.20%,BCAT2;GLUL;SDS;BCKDK;IDO2;ACAT1;QDPR;SLC25A21;DDAH1;CRYM;GLS2;GLS;ECHS1;NOS2;GLUD1;GOT1;SHMT2;GAD1;ALDH4A1
prerank,glial cell differentiation (GO:0010001),0.33061509615390017,0.8260072598922451,0.7108433734939759,0.9221246822347164,1.0,16/28,32.85%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;ERBB3;EIF2B5;SOX11;SOX10;MMP24;GPC1;SOX4;CDH2;SHH;RELN;PAX2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.221034723031727,-0.8255558533947568,0.8273381294964028,0.9037179407708342,1.0,4/41,5.13%,PRKAG2;RANBP2;OGT;NUP98
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.38456540003910566,0.8253943373685741,0.7103174603174603,0.9227263892725094,1.0,3/13,9.45%,RAN;AK4;AK3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.29822516418592115,0.8253522998595043,0.7776606954689147,0.9223956067501525,1.0,8/74,6.09%,GPX1;HMOX1;PARK7;AKT1;TNF;LGALS3;HSPA1B;TNFAIP3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.30297927595239726,0.8252298264639399,0.7707212055974165,0.9221941164051543,1.0,10/64,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,inorganic anion transport (GO:0015698),0.30766130322589536,0.8249413098752696,0.7505592841163311,0.9222698374352216,1.0,8/53,12.89%,FXYD1;TTYH1;SLC26A4;SLC25A11;GLRA1;CLIC1;TTYH3;SLC11A1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3631009920665842,0.8245691650915545,0.7063389391979301,0.9224735889835239,1.0,2/17,10.56%,PLAAT3;PLA2G4F
prerank,regulation of anoikis (GO:2000209),-0.27363927361813073,-0.8242226427689457,0.7520661157024794,0.9048043136806154,1.0,5/19,12.48%,ITGA5;TLE1;SIK1;PTK2;BCL2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.39829275775900996,0.8240083108867166,0.7048951048951049,0.9229552004866626,1.0,2/10,10.24%,ENPP2;PLA2G7
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.329959543797637,0.8238541184803296,0.7094430992736077,0.9228009447782335,1.0,5/30,12.48%,H3-3A;PARK7;PKN1;ZBTB7A;NCOR2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3750751893958473,0.8238307855514675,0.72,0.9224494351905722,1.0,3/15,14.25%,TREM2;NLRP2B;TLR6
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.34481546018108766,0.8237834359417691,0.7207872078720787,0.9221290728148153,1.0,10/26,30.02%,C1QC;GPR137B;LILRB3;CCL3;INHBA;MYC;MAFB;INHA;ZFPM1;TMEM178A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.2790727938079459,-0.8236517473205138,0.7086956521739131,0.9044428320883362,1.0,5/17,17.44%,IL18;STAT3;CD46;JAG1;CD55
prerank,negative regulation of nuclear division (GO:0051784),0.4039016861781233,0.8233131165241689,0.7030812324929971,0.9224838205339054,1.0,3/11,17.56%,AURKAIP1;FBXO5;NANOS2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.22268335554754287,-0.8222649924694475,0.8321167883211679,0.9055771489010779,1.0,4/41,5.13%,PRKAG2;RANBP2;OGT;NUP98
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3101768102060021,-0.8222634092833064,0.7034220532319392,0.9041271959576687,1.0,4/13,15.43%,RREB1;SIX1;NAPEPLD;SOX13
prerank,skeletal system development (GO:0001501),0.28395080824758306,0.8218856327543546,0.8442871587462083,0.9243650594389344,1.0,13/148,6.12%,RPL13;COL1A1;PPIB;BCAN;VKORC1;RBP4;TGM2;ETS2;ADAMTS4;HYAL2;BPNT2;HAPLN2;RFLNB
prerank,negative regulation of histone methylation (GO:0031061),-0.3310823461930732,-0.8216822909833212,0.7013888888888888,0.9037269518865317,1.0,2/10,6.41%,JARID2;BCOR
prerank,amino sugar biosynthetic process (GO:0046349),-0.3139109513341354,-0.8215610804725737,0.7103448275862069,0.9025228818283578,1.0,4/12,19.30%,PGM3;GFPT2;RENBP;NAGK
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.38965979725804556,0.8215305559169636,0.6979020979020979,0.9245182812415191,1.0,4/11,21.53%,FBL;EXOSC2;DKC1;EXOSC4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2762659343454289,0.8211001249949691,0.92992992992993,0.924770266165675,1.0,82/341,21.86%,PSMB4;UBXN1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCTD10;TOLLIP;PSMD1;UBE2G2;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;TNFAIP3;CDC34;RNF187;ARRDC1;PSMA7;KCTD2;FEM1A;FEM1C;FBXL14;UBAP1L;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;NEDD8;TRIM2;OTUD7A;TNFAIP1;RNF128;DDB1;PSMB9;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;SYVN1;VPS28;PSMB11;ZSWIM8;FBXW7;UBQLN2;PSMB10;RNF40;KBTBD7;RNF150;SPSB3;PSMB1;ARRB2;RNF7;PSMB5;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM;KCTD13;VPS4A;VPS37C;PSMA6;RNF144B;HECW1;TRIM13;RAD23A;RNF11;PSMA4;KLHL25;DDIT3;SIRT2;UBXN11;STUB1;ELOC;IFI27;AMFR
prerank,regulation of exosomal secretion (GO:1903541),0.3605071611519133,0.8205975423627532,0.7200504413619168,0.9251739616467942,1.0,7/19,26.88%,ATP13A2;SDC4;CHMP6;SDCBP;VPS4A;HGS;SNF8
prerank,regulation of protein sumoylation (GO:0033233),0.361947572127331,0.8204818373277297,0.7031847133757961,0.9249808251162207,1.0,3/17,9.30%,PARK7;CTNNB1;EGR1
prerank,early endosome to late endosome transport (GO:0045022),-0.26794033150792196,-0.8203238305784208,0.722488038277512,0.9033916857962384,1.0,4/20,10.18%,STX8;EEA1;ANKRD27;KIF16B
prerank,regulation of cell aging (GO:0090342),0.3940638746676215,0.8202890098607736,0.6827309236947792,0.9248922837956062,1.0,5/11,25.42%,MIF;VASH1;LMNA;FOXM1;PNPT1
prerank,cellular protein modification process (GO:0006464),0.2709451673397928,0.8201380750953023,0.993,0.924754048466312,1.0,248/983,25.12%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;F13A1;LGALS1;PPP1CA;MT3;PARK7;C3;LAMC1;LAMB2;MAPK3;PSME1;AKT1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;RPN1;COPS7A;TGM2;RCE1;PINK1;IGFBP3;MFGE8;COPS6;IGFBP4;METAP1;FBXO15;HSP90B1;PDGFB;KLHL9;PTPRC;CTDSP2;ACVRL1;IGFBP5;CHEK2;PSMD1;RPN2;SHISA5;EPAS1;UBL5;PSMC3;PDIA6;PPP2R1A;DAD1;PARP1;PSMD6;CPE;LOX;CTDNEP1;LTK;CDC34;PENK;FN1;MATK;HIPK2;CDK8;DDOST;UBA52;BRD2;PSMA7;ISG15;P4HB;EPB42;PTK6;SGK1;FN3KRP;FEM1A;FEM1C;PKN1;PAK1;FBXL14;DUSP26;APLP2;MAST1;UBE2M;VWA1;LIPE;METAP2;PSMD5;COL3A1;RBX1;NEDD8;FBXO27;TIMP1;PTPRN2;HS3ST5;CAMK1;CTDSP1;HCK;PHPT1;BCKDK;PAK3;DDB1;ICMT;PSMB9;PSMD13;PRKAR1B;AATK;CTBP1;CHRM3;B3GNT9;PSMB3;PLAT;FBXW5;WFS1;PTPRD;SERP1;CDK19;MAP3K21;PSMB11;PTPRB;MXRA8;PTPRR;AMHR2;CDKL4;ASB13;ST8SIA4;FBXW7;FBXO30;NEK10;BMP2;FBXO31;GAS6;PSMB10;YWHAZ;EVPL;KBTBD7;TIMM50;CDC42BPA;MAPK10;STK11;CCL2;SPSB3;PTPRZ1;COPS8;PIGS;TSSK6;TSSK4;ALG3;PDF;ARF4;CDK5;PSMB1;RNF7;ERO1A;GMFB;PSMB5;VCAN;FUT9;VHL;PDP2;PIM3;BRSK2;PIK3CD;EVA1A;SCG3;CSNK1G2;PPP2R5D;B3GNT3;PPM1J;MAP4K2;RBBP5;SYK;PDP1;NOTUM;ST6GALNAC2;STT3A;WDR45;TAB1;SLC35A1;PPP3CA;MKNK1;PSMA6;ST8SIA5;GRK2;FBXL16;IL6;TGFB1;PPEF1;NEK1;PORCN;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6;GAD1;SSH2;PAK5;PTPN6;PTPRU;PTPRO;PPP2R5A;CDK9;SIRT2;DUSP2;QPCT;ELOC;MEN1;SCG2;PPM1F;ENGASE;PTPN5;DUSP12;DUSP1;B3GALT5;MGAT1;CCDC8;CDK18;PSMC1;KCTD7;PTPN1;PSMD9;NUS1;B3GALT2;TGM7;PTPRE;SOCS3;CDK10;SBF1;DYRK2;PAK4;NPC1;DYRK1B;RCN1;APP;FBXO2;LMTK3;CCN1;BAP1;WSB2;PPP1CB;PRRT1;MACROD2;VRK1;FBXL3;DNAJC3;PSMB2;PRKCA;PRKACA
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21435794565204305,-0.8199849843316744,0.8764044943820225,0.9025932605087611,1.0,13/49,14.83%,OGA;PRKN;RNASE3;ADAMTS9;SIDT2;NGLY1;RIPK1;STT3B;DNASE1L1;DENND3;MTREX;MANBA;PABPC4
prerank,regulation of programmed necrotic cell death (GO:0062098),0.35625111996341713,0.8198429847628694,0.7191867852604829,0.9248306897190401,1.0,5/20,14.29%,HSP90AA1;FLOT1;NUPR1;CDC37;SDCBP
prerank,long-chain fatty acid import into cell (GO:0044539),0.39470117015780376,0.8195371002225591,0.6986706056129985,0.9249226298155937,1.0,1/10,2.52%,SLC2A1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.34158934519442974,0.8194885302413399,0.7078651685393258,0.9246063413582616,1.0,7/24,18.67%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A;ANXA6
prerank,regulation of phosphorylation (GO:0042325),0.2846752446043363,0.8193592682401974,0.8249227600411947,0.9244195775859546,1.0,42/120,29.08%,HSPB1;PGAM1;DYNLL1;GRM5;EMP2;ANG;DSCAM;PIN1;MIF;CDKN1C;FN1;CORO1C;CD24;CADM4;ZBTB7A;CCDC88A;NUP85;SDCBP;NUP88;PTGES3;CDH5;PRKRIP1;NOP53;NUP50;INHBA;RAE1;SIRT2;TESK1;PLXNB2;APP;BARD1;CDKN2B;INHA;EIF6;SLC2A6;CDKN1A;ITGA6;MCM7;CCDC88C;NUP205;NUP188;PPP2CA
prerank,negative regulation of histone modification (GO:0031057),0.37815725533586536,0.8188592270386736,0.7320954907161804,0.9248039071398658,1.0,5/14,20.24%,SET;CTBP1;TWIST1;SNCA;SPHK2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2972539872483931,0.817946301810839,0.7648327939590076,0.9258211776915213,1.0,8/64,8.34%,ACTG1;ADAM15;EMP2;DUSP3;GPM6B;CORO1C;CLASP1;THY1
prerank,response to cAMP (GO:0051591),0.3205867096527602,0.8173391186802249,0.7409568261376897,0.9263869612221182,1.0,11/37,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,regulation of double-strand break repair (GO:2000779),-0.2285235088901284,-0.8168764492216076,0.8085106382978723,0.907018148475882,1.0,13/39,19.20%,TRIP12;SETD2;UBR5;SPIDR;PML;RNF169;PPP4R2;MRNIP;MGMT;SIRT7;RTEL1;ZCWPW1;SHLD2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3997333008923428,0.8168561245429548,0.6866096866096866,0.9267599142011891,1.0,3/10,18.54%,APEX1;DCLRE1C;TERF2IP
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3562010658331768,0.8163221110314189,0.7107329842931938,0.9271910080752536,1.0,5/18,16.35%,CAMK1D;EPHA5;TSSK4;LRP8;ADCY8
prerank,toxin transport (GO:1901998),-0.33017387483522687,-0.8162667578720862,0.685064935064935,0.9067366672832846,1.0,10/10,67.01%,ANTXR2;RAB29;ANTXR1;ANTXRL;SLC22A1;SLC22A3;SLC22A2;ADAM10;RAB40B;SLC29A4
prerank,magnesium ion transport (GO:0015693),0.3794367572773011,0.8160670277381291,0.6959459459459459,0.9271918094392675,1.0,6/12,31.06%,NIPAL4;MAGT1;NIPA1;NIPAL1;NIPAL3;MMGT1
prerank,pinocytosis (GO:0006907),0.4004692173879464,0.8155207547029645,0.6887608069164265,0.9276598247392843,1.0,4/10,24.63%,DOCK2;SNX33;PYCARD;SNX5
prerank,regulation of spindle assembly (GO:0090169),0.34403749549147145,0.81493785506627,0.7348668280871671,0.9281938820076695,1.0,12/25,32.42%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B;CHMP1A;CHMP4C;CCSAP;SPAG5;DYNC1H1;CHMP4B
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.33685121788903394,0.8147046394299672,0.7180124223602484,0.9281391331495589,1.0,8/25,19.95%,PARK7;H1-0;ZBTB7A;HEY1;TWIST1;SOX11;TGFB1;POU4F1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3187534382521231,-0.8143325467693049,0.7152542372881356,0.9088486490864799,1.0,4/11,19.30%,PGM3;GFPT2;RENBP;NAGK
prerank,muscle tissue morphogenesis (GO:0060415),-0.28353223643165304,-0.8142442760113693,0.6944444444444444,0.9075781791116422,1.0,4/16,14.92%,TGFBR3;MYLK;BMP4;HEY2
prerank,protein import into peroxisome matrix (GO:0016558),0.39301777386271586,0.8140209241604467,0.7066115702479339,0.9288157584318202,1.0,6/12,35.64%,PEX5L;PEX6;PEX1;PEX14;PEX2;PEX13
prerank,primary alcohol metabolic process (GO:0034308),0.3352542583491443,0.8135182733726697,0.7220843672456576,0.929199091645289,1.0,9/25,30.92%,RBP4;GDE1;NAAA;LRAT;GDPD1;GDPD3;GPD2;ALDH3A2;ADH1A
prerank,RNA interference (GO:0016246),-0.27353118368390145,-0.8132731721019675,0.7397260273972602,0.9079933674104731,1.0,8/17,21.82%,DICER1;DROSHA;TERT;TARBP2;AGO2;CELF1;AGO4;CLP1
prerank,activation of phospholipase C activity (GO:0007202),0.32772130842034436,0.8129646790799544,0.7518072289156627,0.9296717400437576,1.0,5/29,9.32%,NTRK2;ANG;C5AR1;P2RY6;P2RY12
prerank,homocysteine metabolic process (GO:0050667),0.3841403733265024,0.812469945200805,0.7112970711297071,0.9300447599318099,1.0,2/11,15.82%,MPST;TST
prerank,positive regulation of protein maturation (GO:1903319),-0.3145946595140414,-0.8117122534503511,0.7490909090909091,0.9094089290624738,1.0,4/11,24.20%,RHBDD1;CCBE1;BAG2;NLRC4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4018695975653719,0.8112877607906029,0.7185289957567186,0.9315026114005607,1.0,3/10,21.50%,CTNNB1;WNT5A;FZD1
prerank,plasma membrane tubulation (GO:0097320),0.37818395781997,0.8108348590634917,0.708843537414966,0.9318087306828914,1.0,5/13,24.62%,PACSIN1;FNBP1L;SNX33;EHD2;CAVIN2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2966820885096787,0.8108067070337113,0.7859459459459459,0.9314721566531795,1.0,16/62,23.94%,H3-3A;POLR2E;POLR2D;POLR2F;ZFP36;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;TGFB1;RAE1;POLR2H;ELAVL1;DND1
prerank,calcium-mediated signaling (GO:0019722),0.283116540179674,0.8099026659471257,0.8113207547169812,0.9324302389369348,1.0,23/93,19.09%,RCAN3;PRNP;GRM5;PTPRC;CCR5;P2RX7;KDR;P2RY12;CHRM3;TRPM2;CXCR4;CX3CR1;NUDT4;ATP1B1;SLC8A1;RYR2;DMTN;CCL3;VCAM1;BCAP31;FKBP1B;CCR2;PPP3CA
prerank,serine family amino acid metabolic process (GO:0009069),0.3549862207005814,0.8089724993411402,0.6958762886597938,0.933420408086652,1.0,4/16,20.45%,SARS1;GLYAT;SEPSECS;SHMT2
prerank,sympathetic nervous system development (GO:0048485),0.3647576129367176,0.8087888614746783,0.7052489905787349,0.9333044145679008,1.0,4/15,19.56%,SEMA3F;CTNNB1;SOX11;TFAP2B
prerank,programmed necrotic cell death (GO:0097300),0.35854774999234174,0.8084841070320907,0.7259740259740259,0.9333792084202256,1.0,9/18,36.23%,ALKBH7;TICAM2;DNM1L;CD14;PGAM5;MLKL;PPIF;IPMK;ITPK1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.30130794702732555,-0.8082054982560499,0.7093023255813954,0.9144075912745454,1.0,4/13,11.86%,FBN1;LTBP1;CHRDL1;CD46
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.34889036453741523,0.8081245234483224,0.7105263157894737,0.9335055984098888,1.0,9/19,31.74%,MDK;GAS6;MMP14;SYK;PPP2R3C;XBP1;XRCC6;ZAP70;BTK
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3275156378541012,-0.8079346722250844,0.7084745762711865,0.9134739514219734,1.0,5/10,14.98%,DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3082974665060346,0.807854582896636,0.7702552719200888,0.9335101982823887,1.0,9/47,13.74%,AKT1;CDS1;ZFP36L1;RARRES2;CEBPB;LPL;ZFP36;BMP2;HNRNPU
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4009984126587009,0.8077704344754332,0.7097701149425287,0.9332603192406994,1.0,3/10,19.11%,AKT1;PMAIP1;SNCA
prerank,regulation of response to stress (GO:0080134),0.403875051946139,0.8077056451659852,0.7190201729106628,0.9329746500488216,1.0,3/10,27.24%,MLC1;ADCY8;CORO2B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.30540905678737496,0.8069551758624648,0.7586980920314254,0.9337582515149513,1.0,7/46,9.69%,RAN;HCLS1;FLNA;YWHAE;HYAL2;TRIM28;CAMK1
prerank,pigment granule transport (GO:0051904),0.361468491741319,0.8067016678994574,0.737467018469657,0.9333665659790724,1.0,7/18,30.83%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,melanosome transport (GO:0032402),0.361468491741319,0.8067016678994574,0.737467018469657,0.9333665659790724,1.0,7/18,30.83%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,positive regulation of bone mineralization (GO:0030501),0.3128310290417242,0.8063825125170082,0.7488479262672811,0.9334666434225319,1.0,15/35,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3221059483480352,0.8063099532842484,0.7345454545454545,0.9331926517894273,1.0,15/31,34.73%,LSM4;LSM6;POLR2G;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,ethanol metabolic process (GO:0006067),-0.31595850867827935,-0.8063024031588996,0.7065217391304348,0.9148848623294835,1.0,1/12,1.42%,ALDH1A1
prerank,glucan catabolic process (GO:0009251),0.36319352443760816,0.8060854237293869,0.7269076305220884,0.9331598619972757,1.0,2/15,10.43%,CALM1;GAA
prerank,gliogenesis (GO:0042063),-0.2889913996708371,-0.80578445457135,0.759493670886076,0.9143908825327294,1.0,2/15,6.80%,NFIB;CDK6
prerank,regulation of hemopoiesis (GO:1903706),-0.32486309526637824,-0.8054033128353211,0.7093425605536332,0.9135748359612352,1.0,5/10,16.59%,CREBBP;MYSM1;CBFB;PRKCB;IL17D
prerank,heterochromatin assembly (GO:0031507),0.34488089673768707,0.8053572296031178,0.7334183673469388,0.9338581080314874,1.0,1/20,1.37%,H3-3A
prerank,mitotic cell cycle phase transition (GO:0044772),0.2747771139939765,0.8045741765175309,0.8894472361809045,0.9346024222682768,1.0,32/204,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;CCNI;CCND2;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CDC34;GPR132;CCND1;CLASP1;YWHAG;TUBB4A;TACC3;CEP131;USP29;CCNG1;DCTN1;SSNA1;HAUS2;USP26;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3027393053242039,-0.8045403351397056,0.7580071174377224,0.9136017796879264,1.0,4/11,17.61%,STAT3;PUM2;LIMD1;FMR1
prerank,response to molecule of bacterial origin (GO:0002237),0.2903163002130624,0.8045247277585336,0.7882978723404256,0.9342909574153916,1.0,24/69,29.84%,C4B;S100A8;S100A9;TIRAP;TNFAIP3;HNRNPA0;CD24;SLC11A1;ERBIN;ADAM17;NOS2;SNCA;CD14;IL6;SIRT2;IRF5;TNFRSF11A;LBP;TRIB1;FZD5;GGT5;GGT7;ACOD1;IFNAR1
prerank,organelle assembly (GO:0070925),0.26748880979246537,0.8044587898005171,0.952,0.9340167910926355,1.0,69/385,20.65%,RPS23;RPS3;GABARAP;GSN;DYNLL2;DYNLL1;MAP1LC3B;CD34;NPM1;MAP1LC3A;EMC6;GABARAPL2;CDS1;AUP1;LSM4;GABARAPL1;BSCL2;IFT20;ABCB6;FLNA;CHMP2B;ATG9A;CORO1A;CNGA4;MAPT;CHMP5;CHMP6;FNBP1L;CEP131;FHDC1;TCTN3;VPS28;SAC3D1;ANLN;ATXN2L;UBQLN2;FLII;VMP1;HAUS2;EHD1;CSDE1;ATG101;G3BP1;ARF4;CIRBP;MAPRE3;YTHDF1;TMOD1;CNGB1;CHMP1B;TMEM17;E2F4;CCDC28B;EIF4ENIF1;TCTN1;EXOC7;EHD2;VPS4A;WDR45;VPS37C;NOTCH1;BBIP1;NEK1;EXOC5;CAPN3;CFAP410;CFAP54;CHMP7;EXOC8
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3704422025379094,0.8042588569054098,0.7180851063829787,0.9339279896824926,1.0,5/14,21.12%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,sterol biosynthetic process (GO:0016126),0.3136945092046295,0.8040901914331167,0.7641509433962265,0.9337942883462883,1.0,13/33,28.44%,LSS;DHCR24;ACAA2;SC5D;CH25H;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of integrin activation (GO:0033623),0.3650385772688196,0.8036216822532947,0.7272727272727273,0.9341098410986524,1.0,4/15,19.08%,RASIP1;JAM3;SKAP1;FBLIM1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.36192549108421784,0.8028997631204657,0.7252311756935271,0.9348037102359923,1.0,5/15,21.12%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3952450976566545,0.8027805174548904,0.7169540229885057,0.9346189348128158,1.0,4/10,20.24%,CAMK1;PIH1D1;HDAC5;SPHK2
prerank,protein localization to centrosome (GO:0071539),-0.2735535501567798,-0.8026396806876519,0.75,0.9153826883024611,1.0,6/17,20.57%,PCM1;GOLGB1;PIBF1;C2CD3;CCDC14;CEP192
prerank,positive regulation of axon extension (GO:0045773),0.3399981975177456,0.8025952947454233,0.7324675324675325,0.934520135320197,1.0,5/22,13.44%,DSCAM;SEMA7A;MAPT;NTN1;SHTN1
prerank,regulation of receptor recycling (GO:0001919),0.3635273208626564,0.8025303679852204,0.7378378378378379,0.9342275952393966,1.0,9/16,35.30%,VAMP3;RAMP3;SNCA;TRAT1;AP1AR;ECE1;ANXA2;LAMTOR1;NSF
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.30772663119972415,0.8024413198801177,0.7583046964490263,0.9339642760840524,1.0,12/40,25.76%,NUCKS1;CENPX;PCNA;DDX11;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM;POLD1;RAD51
prerank,regulation of dendrite morphogenesis (GO:0048814),0.31746243713131383,0.8024329631571524,0.7570422535211268,0.9335987845368181,1.0,10/32,22.37%,ADGRB3;YWHAH;KNDC1;IL1RAPL1;SS18L2;PTPRD;NSMF;HECW1;SS18L1;CHRNA3
prerank,liver development (GO:0001889),-0.23065006826568624,-0.8018956507186874,0.8356164383561644,0.9152412769555487,1.0,5/32,8.85%,TGFBR3;COBL;ARID5B;MET;NPHP3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.34149215361835594,0.8016928609196098,0.7322335025380711,0.9342987000795738,1.0,9/21,25.95%,PSENEN;SPPL2B;BACE1;PSEN2;ADAM17;SPPL2A;ERAP1;APH1A;PRKCQ
prerank,Wnt signaling pathway (GO:0016055),0.28270608306529904,0.801528524633783,0.8269430051813471,0.9341470982142737,1.0,10/92,9.27%,RPS27A;UBC;UBB;FZD9;CTNNB1;CPE;SFRP5;UBA52;RBX1;CD24
prerank,protein polyubiquitination (GO:0000209),0.26886175438604853,0.8010377939658934,0.929,0.9344970217000803,1.0,45/297,14.04%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FBXO15;PSMD1;UBE2G2;ANAPC13;PSMC3;CTNNB1;PSMD6;IRF2BP1;UBE2Q1;MAGEL2;TNFAIP3;CDC34;DCAF15;RNF187;UBA52;PSMA7;FBXL14;NHLRC1;PRPF19;PSMD5;RBX1;FBXO27;TRIM2;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;SYVN1;PSMB11;FBXW7;FBXO30;FBXO31;PSMB10;KBTBD7;UBE2V1
prerank,spliceosomal complex assembly (GO:0000245),0.3018575471633608,0.8008796956399336,0.7660753880266076,0.9343561600830566,1.0,17/46,25.46%,SNRPG;DDX39B;SNRPD2;SNRPE;PUF60;SRSF9;PRPF19;SF3A2;SF3A3;CELF3;TXNL4A;SF3A1;SRSF1;SNRNP200;LUC7L3;CELF4;CELF5
prerank,histone H2A monoubiquitination (GO:0035518),-0.2753614668680312,-0.8006447147928218,0.7763157894736842,0.9160071098971627,1.0,4/17,11.00%,BCOR;DDB2;PCGF5;CUL4B
prerank,indolalkylamine catabolic process (GO:0046218),0.3956363827054683,0.7999482237694867,0.7118402282453637,0.9353290832051506,1.0,1/10,11.01%,IDO2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3242909108499313,0.7998636213699856,0.7496902106567535,0.9350621073805174,1.0,9/27,25.73%,CCL19;PDGFB;P2RY12;FLT1;AGAP2;FLT3;TGFB1;TEK;FGFR3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3458126721304981,0.799757258866333,0.7285353535353535,0.9348325465894266,1.0,6/20,29.04%,DCC;BAX;ERBB3;BAK1;BOK;MCL1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.36531922597188793,0.7995945722708481,0.7532299741602068,0.9347123467719787,1.0,2/16,3.71%,SHFL;TNF
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3400438653845825,0.7994249034078779,0.7484035759897829,0.9345736610775045,1.0,8/20,26.00%,ADSS1;GART;AK4;AK3;IMPDH1;PAICS;IMPDH2;ADSL
prerank,regulation of peptide hormone secretion (GO:0090276),0.2897320088926064,0.799372062034234,0.8004314994606256,0.9342706697350254,1.0,14/67,21.10%,UQCC2;MTNR1B;SLC2A1;SNAP25;TNF;CACNA1A;HTR2C;RASL10B;ABCC8;SLC2A2;NOS2;TFAP2B;IL6;KCNC2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.252600682216665,-0.7990427815324969,0.7736842105263158,0.9174531151672043,1.0,3/23,3.64%,PLCE1;AGMO;PLA2G4A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3213226221489786,0.7974541347252131,0.7529002320185615,0.9367231846451556,1.0,6/30,14.62%,RAC1;ADGRG1;COL3A1;NET1;GPR18;F2RL1
prerank,cellular response to hexose stimulus (GO:0071331),0.3387149357967979,0.797287124248512,0.7567917205692108,0.9365929339845828,1.0,2/23,3.43%,RACK1;GPER1
prerank,regulation of spindle organization (GO:0090224),0.34559688026713176,0.7972476115397941,0.7402269861286255,0.9362654116099498,1.0,4/18,12.87%,CLTC;TACC3;GNAI1;DCTN1
prerank,AMP metabolic process (GO:0046033),0.3685025049909406,0.7963200765272515,0.7300944669365722,0.9371913881842265,1.0,3/13,9.45%,ADSS1;AK4;AK3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.17790674904122017,-0.7959757798884718,1.0,0.9214594317485508,1.0,24/109,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;PLA2G4A;PLEKHA4;PLEKHA2;MTMR11;PDGFRB;PIP5K1A;PTEN;SACM1L;VAC14;PIP4K2C;MTMR10;PLCD1;PIP4P2;PLEKHA8;PLA2G4C;PGAP3;PIGW;PIP4K2A;PLCG2;FGF2
prerank,protein methylation (GO:0006479),-0.22605990932580355,-0.7958782877525561,0.8333333333333334,0.9201917386717751,1.0,12/40,18.54%,NSD1;EHMT1;NSD3;CAMKMT;EHMT2;CARM1;EZH2;PRMT6;METTL22;SETD3;VCPKMT;METTL21A
prerank,filopodium assembly (GO:0046847),0.35933005399285,0.7951980674757374,0.7381275440976933,0.9384238777291259,1.0,2/16,7.71%,DNM3;ARHGEF4
prerank,regulation of defense response to virus (GO:0050688),0.3634874361265027,0.7951794418641884,0.74640522875817,0.9380688062371362,1.0,7/14,30.36%,TNFAIP3;ELMOD2;TRAF3;C1QBP;PCBP2;DHX9;IFNLR1
prerank,chromatin assembly (GO:0031497),0.30772280506840266,0.7949305191049889,0.7664739884393064,0.9380525672713268,1.0,6/38,16.60%,H3-3A;NPM1;BRD2;H1-0;SOX9;NAP1L2
prerank,cellular response to ketone (GO:1901655),0.3119252058704056,0.794404932839591,0.7596618357487923,0.9384267508504314,1.0,9/35,20.24%,SPP1;ADAM15;MSN;AQP1;GNAI1;ADCY8;NCOA4;SFRP1;SPHK2
prerank,retinol metabolic process (GO:0042572),0.3672651350004994,0.7942263860019443,0.7475728155339806,0.938310749786519,1.0,2/14,16.23%,RBP4;LRAT
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.39152430776585945,0.7936661319866667,0.7395543175487466,0.9387616783178999,1.0,2/11,11.44%,CD34;ATP6AP2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.25749347084362983,-0.7929669307725536,0.7983193277310925,0.9236504794627945,1.0,6/20,14.92%,TGFBR3;TGFBR1;PDCD4;RBPJ;BMP4;HEY2
prerank,regulation of muscle cell differentiation (GO:0051147),0.31672689857392133,0.792579842049716,0.7571428571428571,0.9399189254954595,1.0,12/31,24.84%,CTNNA2;BNIP2;CTNNB1;CAMK1;MAPK11;IGF2;HDAC9;MEF2C;ID2;CDK9;TCF3;SRF
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.35238284681624776,0.7924082701689126,0.7375504710632571,0.9397843687982423,1.0,7/17,33.59%,MPDU1;DOLK;ALG3;NUS1;DPAGT1;ALG6;ALG2
prerank,positive regulation of ossification (GO:0045778),0.30416903110775995,0.7922641287895013,0.7949599083619702,0.9396137504167646,1.0,17/39,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;WNT5A;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;SOX11;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,protein monoubiquitination (GO:0006513),-0.225488712031245,-0.7921420984472031,0.7916666666666666,0.9236248975674378,1.0,9/36,18.97%,PRKN;UBE2R2;HUWE1;TOPORS;CDC73;UBE2E1;KLHL22;WAC;RNF20
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.36649383176156464,0.7917936019397084,0.7306176084099869,0.939913297015587,1.0,5/14,22.80%,GAS6;NLRP2B;F2RL1;TRAIP;PELI3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.36362315097562825,0.7910981834933666,0.7442799461641992,0.9405194097394746,1.0,6/14,32.09%,RASL10B;EDN3;CORIN;ECE1;ENPEP;ACE
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.31451260535754805,0.7910795000694104,0.7586618876941458,0.9401668896081,1.0,9/29,28.00%,FKBP1A;S1PR1;PROX1;BMP2;NOTCH1;TGFB1;TCAP;ZFPM1;ENG
prerank,regulation of centrosome duplication (GO:0010824),0.322285719990304,0.7908548041764801,0.7785888077858881,0.9400968782560735,1.0,6/30,15.97%,NPM1;CHMP2B;CHMP5;CEP131;FBXW5;CHMP1B
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3827780324149187,0.7904464322707049,0.7437037037037038,0.940271758895348,1.0,4/10,22.51%,B3GAT3;XYLT1;CSGALNACT2;B3GAT1
prerank,myoblast differentiation (GO:0045445),0.3637426756509756,0.790022759505515,0.7448275862068966,0.940489248862021,1.0,2/14,4.55%,NRG1;EPAS1
prerank,regulation of phosphatase activity (GO:0010921),-0.2495608759941006,-0.7899787837373053,0.7878787878787878,0.9258105911945648,1.0,8/24,17.56%,PPP6R3;URI1;GPATCH2;PPP6R2;SH3RF2;TSC1;ZCCHC9;SH2D4A
prerank,regulation of DNA replication (GO:0006275),0.2993038688510895,0.7898730890981115,0.7932900432900433,0.9403086346711916,1.0,9/49,14.18%,S100A11;TERF1;ACVRL1;PPP2R1A;NUCKS1;GMNN;PCNA;FBXO5;CCDC88A
prerank,organic acid transport (GO:0015849),0.27919367960285274,0.7896489201277164,0.8287815126050421,0.9402316250674461,1.0,22/94,25.80%,SLC38A5;SLC1A4;SLCO1C1;SLC25A29;SLC6A6;MFSD2A;SLC25A11;SLC3A2;SLC10A3;SLC7A14;SLC19A1;FOLR2;SLC16A1;ABCC3;SLCO1B1;SLC10A6;SLC7A10;SLC25A14;SLC7A6;SLC43A2;SLC38A3;SFXN5
prerank,ncRNA metabolic process (GO:0034660),-0.21390349479211473,-0.7895877364682873,0.8671875,0.9249820879832121,1.0,10/37,16.50%,TENT4B;DICER1;PARN;DROSHA;ZCCHC8;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.33213341538411295,0.7890005733955833,0.7657213316892725,0.940775964386945,1.0,8/22,27.11%,CDKN1C;CEBPA;CAMK2N1;HEXIM1;TFAP4;MEN1;HHEX;CDKN1A
prerank,smooth muscle tissue development (GO:0048745),-0.31832888406761556,-0.7889674664546329,0.7188498402555911,0.9246317274379361,1.0,5/10,21.22%,SMO;MYLK;BMP4;NF1;PTCH1
prerank,tRNA wobble base modification (GO:0002097),0.367489509629346,0.7886668377494425,0.7466307277628033,0.940864855969624,1.0,6/14,24.68%,DPH3;ELP3;CTU1;ADAT2;URM1;CTU2
prerank,mitochondrial fusion (GO:0008053),0.3424828914680785,0.7884603509196823,0.7448186528497409,0.9407857583163011,1.0,6/18,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;FIS1
prerank,DNA metabolic process (GO:0006259),0.26658589280462414,0.7883234983010804,0.9409409409409409,0.9406065620893477,1.0,59/270,25.76%,RPS27A;UBC;UBB;PARK7;TERF1;NPM1;ENDOG;RAN;RNASEH2A;LTO1;MCM5;PARP1;HMGB3;VCP;RPA2;CDC34;UBA52;GMNN;TRIM28;HMGB1;DDB1;NEIL1;RNASEH1;APEX1;PCNA;NSMCE3;POLE4;CHRNA4;RFC2;TSN;PTGES3;GLRX2;RECQL5;POLD4;MUS81;CNBP;CTC1;NOP53;TERF2IP;RFC4;ERCC1;GADD45A;POLG;MEN1;ZNF445;BLM;CDC45;LONP1;POLD1;PNKP;BARD1;ATRIP;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;RAD51
prerank,chordate embryonic development (GO:0043009),0.2939121948723031,0.7876811535314627,0.8039647577092511,0.9411393145914575,1.0,10/55,15.42%,COL1A1;RBP4;FOXD3;PROX1;WNT5A;SOX8;PTPRR;BMP2;XYLT1;IGF2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.36251778740475166,0.78755744201375,0.7410832232496698,0.9409214168483472,1.0,4/14,20.76%,CCL19;CD86;NLRP3;NFKBID
prerank,membrane lipid biosynthetic process (GO:0046467),0.28871920224152897,0.7872938862542069,0.8076502732240437,0.9409069035022121,1.0,27/58,32.49%,CERS2;ELOVL1;ELOVL2;ELOVL7;SPTLC1;DEGS1;SCCPDH;FA2H;CSNK1G2;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;SGPL1;ELOVL6;ALDH3B1;VAPB;HACD4;SAMD8;CERT1;SPNS2;ALDH3A2;ST8SIA6;ELOVL4;ELOVL5;CERS6
prerank,DNA recombination (GO:0006310),0.3059760570437837,0.7871086292069569,0.7881548974943052,0.9407924005959833,1.0,9/37,25.76%,ENDOG;HMGB3;HMGB1;TSN;RECQL5;ERCC1;BLM;RPAIN;RAD51
prerank,glycogen catabolic process (GO:0005980),0.35181191092076836,0.7870941860858395,0.7355263157894737,0.9404355060573045,1.0,1/15,0.80%,CALM1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3000125627251317,0.78704445900245,0.8011363636363636,0.9401319811614215,1.0,11/46,19.76%,LAMC1;LAMB2;RAC1;FN1;VAMP3;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21620727215479318,-0.7865901318953429,0.823943661971831,0.9271333535483152,1.0,5/36,7.93%,ZMIZ1;GLI3;GLI2;DUSP10;ZBTB1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2618530455298953,0.7861143804732887,0.971,0.9410592625296521,1.0,98/417,21.84%,HSPA8;PFDN5;CALR;MT3;NDUFA13;TMPRSS6;ID3;SOX18;NRG1;ID1;CRYAB;EID1;CCDC85B;TNF;PDGFB;NR1D1;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;RLIM;ZHX1;COMMD7;CIR1;QARS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;ID2;DDIT3;SIRT2;SUDS3;DACH1;MEN1;PPM1F
prerank,protein O-linked glycosylation via serine (GO:0018242),0.3875989674595066,0.785545709687366,0.7446504992867332,0.9414846461216495,1.0,4/10,30.95%,POGLUT3;GALNT13;GALNT2;POGLUT1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.26158444482597876,-0.7849194815133068,0.7677725118483413,0.9284610041829671,1.0,4/20,7.42%,MCU;MICU1;MICU2;SLC8B1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3497012338350686,0.7848597782135741,0.7542932628797886,0.942082780225674,1.0,1/16,0.80%,CALM1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2602875491654624,0.7848203441488653,0.98,0.9417599868318774,1.0,108/476,22.29%,APOE;CD74;CXXC1;SPP1;COL1A1;ACTA2;MT3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;ERBB4;LYL1;NPM1;AGT;ETS2;TNF;PDGFB;NR1D1;ACVRL1;CHEK2;YWHAH;CTNNB1;HES1;CDKN1C;RHOG;HIPK2;RNF187;OTX2;FOXF2;CEBPB;BRPF1;TRIM28;EDF1;FOXL2;SEC14L2;MLXIPL;EGR1;JUN;KARS1;NPAS3;APBB1;MYRF;WNT5A;SOX17;ATF5;POU3F1;WBP2;SOX8;KLF4;SOX9;PAX3;BMP2;RAI1;NME2;UBE2V1;ATMIN;NUP85;IRF7;MED30;NR1H2;MAPRE3;EBF3;HEY1;NCF1;ING1;VHL;GATA4;SKAP1;GLIS2;PCID2;BRCA2;PPARGC1A;MRPL12;CNBP;USP22;MAP2K2;MAZ;HMGN5;SOX11;CD86;INHBA;LBH;ESRRB;TFAP2B;NOTCH1;IL6;TGFB1;ING5;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;FZD2;ID2;DDIT3;SOX10;FZD1;ZXDC;SS18L1;MAP2K7;REST;ESRRG;BLM
prerank,regulation of cellular pH (GO:0030641),0.31899206105626676,0.7846910604888979,0.788391777509069,0.9415624925518952,1.0,3/29,5.28%,ATP5F1B;CA2;ATP6AP1
prerank,regulation of stem cell population maintenance (GO:2000036),0.33946335996881555,0.7843175935117387,0.74640522875817,0.94170547269458,1.0,6/18,23.64%,TAF5L;ESRRB;MYC;REST;PTN;ELAVL1
prerank,male meiosis I (GO:0007141),-0.2708671224972604,-0.784285305032962,0.782258064516129,0.9281829474644795,1.0,12/16,43.17%,MYBL1;ING2;ZSCAN21;SYCP3;FOXJ3;SLC25A31;BRDT;MOV10L1;CCNA1;DNMT3L;MEIOC;BTBD18
prerank,defense response to protozoan (GO:0042832),0.3707875765585328,0.7838558999936763,0.7513888888888889,0.9419853444017406,1.0,4/12,23.94%,SLC11A1;PF4;BATF2;LYST
prerank,base-excision repair (GO:0006284),0.29428204467269736,0.783633702583575,0.8137472283813747,0.9418949902454594,1.0,15/48,25.41%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;NEIL2;ERCC6;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.2874798955789304,-0.7827771365182006,0.7743055555555556,0.9292375385504109,1.0,2/13,13.39%,GLI3;CBFB
prerank,positive regulation of potassium ion transport (GO:0043268),0.30432938852228175,0.7827746261847692,0.772093023255814,0.9427054247331266,1.0,12/38,27.61%,AKAP6;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,amino sugar metabolic process (GO:0006040),-0.3175894335153293,-0.7823349967375172,0.7275862068965517,0.9286215367840923,1.0,3/10,15.55%,ST6GAL1;GNE;GFPT2
prerank,keratinocyte differentiation (GO:0030216),-0.22903872559288352,-0.780932099273879,0.8636363636363636,0.9294280229955605,1.0,7/29,14.38%,ADAM9;BCR;PIP5K1A;WNT16;JAG1;CASP3;CLIC4
prerank,blood vessel diameter maintenance (GO:0097746),0.304829801899564,0.7804313508711291,0.7814726840855107,0.9456315918360202,1.0,3/34,3.43%,KLF2;AGT;GPER1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3195999655750964,0.7800821342442671,0.7754601226993865,0.9457442913927984,1.0,6/27,15.47%,AGT;ABCG1;LPL;MSR1;PF4;NR1H2
prerank,regulation of vasoconstriction (GO:0019229),0.31647702102022746,0.7797329093412918,0.7765830346475507,0.9458223293447676,1.0,6/27,16.42%,AGT;CHRM3;ATP2B1;ADRA1D;ADRA1A;CAV1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.34824437708374784,0.7793477548763076,0.7716216216216216,0.9459535005098823,1.0,5/18,16.37%,GPR137B;FBXW7;LILRB3;LILRB1;CCL3
prerank,myofibril assembly (GO:0030239),-0.2149051977161047,-0.7791328787150428,0.9343065693430657,0.9309756229575554,1.0,7/42,14.99%,TMOD3;CFLAR;ACTN2;PDGFRB;TPM1;OBSL1;TNNT3
prerank,dephosphorylation (GO:0016311),0.2693895383869645,0.7790021667381585,0.9009193054136875,0.9460539043390456,1.0,52/147,25.90%,PPP1CA;PTPRC;CTDSP2;PPP2R1A;DUSP3;CTDNEP1;DUSP28;DUSP26;PTPRN2;CTDSP1;PHPT1;PTPRD;PTPRB;PTPRR;TIMM50;STK11;PTPRZ1;PDP2;NT5C;PPP2R5D;PPM1J;PDP1;PLPP6;TAB1;PPP3CA;PLPPR2;PGP;PPEF1;SGPP1;SSH2;SGPP2;PTPN6;PTPRU;PTPRO;PPP2R5A;DUSP2;DUSP23;PPM1F;PTPN5;DUSP12;DUSP1;PTPN1;PTPRE;DUSP15;SBF1;PNKP;ACP2;PPP1CB;PLPPR4;PTPRT;DUSP8;DUSP6
prerank,positive regulation of histone modification (GO:0031058),0.3061929959914399,0.7787053792248582,0.7841306884480747,0.9460739163915018,1.0,8/33,27.18%,MAPK3;APLNR;CTBP1;PPARGC1A;SAP30BP;CDK9;PAXIP1;RUVBL2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.30392433555457077,0.7784701471171641,0.7932203389830509,0.9460334119299746,1.0,8/39,16.24%,LGMN;DUSP3;SH3GL2;EPN1;ARHGEF7;SPRY1;SH3KBP1;DAB2IP
prerank,regulation of mitochondrial fission (GO:0090140),0.32302703358520385,0.7776006705391312,0.7781908302354399,0.9468764381049446,1.0,9/24,22.93%,PINK1;KDR;MAPT;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.31147940810481217,0.7771396488895813,0.7739975698663426,0.94713984501563,1.0,14/29,34.73%,LSM4;LSM6;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,establishment of vesicle localization (GO:0051650),0.3428399588254525,0.7770946229665552,0.7710219922380336,0.946830523474528,1.0,7/18,31.29%,SYT11;KIF5A;CDK5;KIF5C;TESK1;IKBKG;SPG11
prerank,neuromuscular junction development (GO:0007528),0.3230279062542377,0.7770408517593246,0.7843373493975904,0.9465202867869378,1.0,6/24,12.87%,ANK3;LRP4;MUSK;GPHN;DOK7;DCTN1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.34419706233024305,0.7768504720945631,0.744,0.9464069194860832,1.0,6/17,27.90%,PODXL;P2RY12;SKAP1;SYK;TGFB2;CD3E
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.29780565807380144,-0.7767989428502965,0.7342657342657343,0.9332078039175132,1.0,3/12,10.62%,CACNA1C;DLG1;TRPM4
prerank,amino acid import (GO:0043090),0.33331457892694005,0.7764091462174918,0.7715736040609137,0.9466627428137453,1.0,4/21,12.43%,SLC7A5;TSPO2;SLC6A6;SLC1A1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.2999840691870409,-0.7764038723956779,0.756,0.9324148886742364,1.0,4/12,14.99%,ELF1;ELF2;CBFB;PTPN22
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2720465041603468,0.7763878348969007,0.8547544409613375,0.9463235507280651,1.0,35/95,26.25%,BGN;BCAN;FMOD;LUM;HEXA;HS3ST6;HS3ST5;DCN;CHST1;B4GALT6;SDC4;GPC5;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;B3GNT3;SDC3;HS3ST2;HSPG2;AGRN;CSGALNACT2;HS6ST1;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5;HS6ST2;GPC1;ABCC5
prerank,regulation of chromosome segregation (GO:0051983),-0.2835765517301188,-0.7763274924979023,0.7657657657657657,0.93111838098737,1.0,5/16,17.49%,CSNK2A1;CSNK2A2;NUMA1;PUM2;RMI2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3075825217623894,0.775977926470962,0.7761904761904762,0.9465111638821837,1.0,3/31,4.81%,RPS2;PINK1;PIN1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.37391994709568044,0.7753790970516611,0.7378917378917379,0.9469374453829843,1.0,4/11,20.07%,GPER1;GATA4;TGFB1;MEF2C
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.30699155482564233,-0.7751518369939933,0.7188612099644128,0.9315121710357486,1.0,2/11,5.66%,FRS2;EFNB2
prerank,protein localization to phagophore assembly site (GO:0034497),0.3736611997051951,0.775074399446013,0.7447698744769874,0.946950838252458,1.0,4/11,32.46%,ATG9A;WDR45;WIPI2;ATG13
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.2385104435555943,-0.774971446650564,0.8520710059171598,0.9303828504002055,1.0,3/26,4.62%,SNX6;CBLB;ERRFI1
prerank,neuromuscular process (GO:0050905),0.3511722788093419,0.7749636156443902,0.7783711615487316,0.9467302262507041,1.0,3/16,16.10%,NRXN1;DCTN1;KCNA1
prerank,tRNA 5'-leader removal (GO:0001682),0.3610354404156725,0.7749239872987856,0.753120665742025,0.9464063479775945,1.0,2/13,13.83%,POP7;POP4
prerank,positive regulation of vasoconstriction (GO:0045907),0.3591519281775766,0.7744756787017719,0.752895752895753,0.9466410120362264,1.0,3/13,16.42%,ADRA1D;ADRA1A;CAV1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3029300317893001,0.7743984099751748,0.798358733880422,0.9463629352026552,1.0,8/34,19.84%,CCL19;PDGFB;P2RY12;PIK3IP1;DAB2IP;FLT1;FLT3;TGFB1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.26727297073839607,-0.7741676514757151,0.7854406130268199,0.930131614510747,1.0,3/15,8.51%,DAB2;SMAP1;AAK1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.35054181853949246,0.773791087392863,0.738562091503268,0.9467944292105709,1.0,5/13,23.31%,B3GNT9;B3GNT3;B3GALT5;GAL3ST3;B3GALT2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.22155686404697403,-0.7736759571326883,0.8705035971223022,0.9294835353206776,1.0,8/38,14.17%,CACNA1C;CAMK2D;ANK2;AKAP9;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.299334980750753,-0.773333586747576,0.7929824561403509,0.9285744337376796,1.0,3/12,16.59%,IL18;CD80;IL17D
prerank,purine-containing compound biosynthetic process (GO:0072522),0.31909117855787095,0.7731744347611393,0.7751552795031056,0.947265273482174,1.0,12/25,31.96%,APRT;GART;PNP;PRPS1L1;PRPS1;PAICS;SHMT2;PRPSAP1;ADSL;ADA;DGUOK;DCK
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.3704383610070785,0.7731201519481704,0.75,0.946964937642475,1.0,3/11,16.40%,GPM6B;LEPROT;SNX33
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.29084777167881387,-0.7731188638026849,0.8022388059701493,0.9275206804562292,1.0,4/12,15.12%,YTHDC1;CDYL;PCGF5;SMCHD1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.29687346735147535,0.7730000355947707,0.8112994350282486,0.9467514778841076,1.0,8/47,16.42%,ACADVL;APOC1;CD34;SIRPA;PROX1;FBXW7;ABCA2;CAV1
prerank,regulation of TORC1 signaling (GO:1903432),0.30472062482633044,0.7726830186665422,0.7857142857142857,0.946815704221093,1.0,8/33,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;STK11;RRAGC;RRAGD
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3282261483953435,0.7724483378591223,0.7814407814407814,0.9463828714268385,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3282261483953435,0.7724483378591223,0.7814407814407814,0.9463828714268385,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,iron ion transmembrane transport (GO:0034755),0.3787243261456306,0.7718622273990737,0.7359550561797753,0.9467777934445779,1.0,4/10,26.25%,ABCB6;SLC40A1;SLC25A37;ABCC5
prerank,negative regulation by host of viral process (GO:0044793),-0.3128218340078453,-0.7717204927273797,0.7793594306049823,0.9282241755863767,1.0,3/10,10.17%,PRKN;EIF2AK4;CCNK
prerank,microvillus organization (GO:0032528),0.3563066987747376,0.7712751533826011,0.748641304347826,0.9471950766661142,1.0,1/13,1.80%,FXYD5
prerank,regulation of histone deacetylation (GO:0031063),-0.28360804838871245,-0.7710703731600154,0.7867132867132867,0.9278615127603016,1.0,5/13,16.75%,CAMK2D;NIPBL;AKAP8L;ING2;PRMT6
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3062910795190592,0.7710625837828343,0.7757575757575758,0.9471091841768899,1.0,8/30,19.64%,TGM2;EPOR;VAV1;ERBIN;MMD2;RASGRP1;RASGRF1;NOTCH1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3156409594813705,0.7708434570052058,0.7906698564593302,0.9470360313373799,1.0,11/27,31.52%,HTR2C;GRM1;GPR18;F2RL1;F2RL3;C3AR1;GPR17;OPRL1;F2RL2;GPR35;DRD2
prerank,nuclear export (GO:0051168),0.271892796510288,0.7705567081363527,0.8479408658922915,0.9470600482044716,1.0,17/80,20.62%,CALR;MAGOHB;MAGOH;DDX39B;RAN;SRSF9;XPO1;SRSF2;HNRNPA1;THOC3;EIF4A3;U2AF1L4;DESI1;TGFB1;ALYREF;RAE1;SRSF1
prerank,V(D)J recombination (GO:0033151),0.3740178092162817,0.770177284489994,0.7607449856733525,0.9472198723897208,1.0,3/11,25.41%,HMGB1;TCF3;LIG1
prerank,regulation of vacuole organization (GO:0044088),0.3337839643221491,0.7700930783284844,0.7726161369193154,0.9469496236117935,1.0,4/20,16.28%,ENO1;IFT20;UBQLN2;ENO3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.29542236759181756,-0.7697332585746627,0.7445255474452555,0.9285016832336588,1.0,5/12,19.10%,SDK2;STAT3;CEP290;NKD1;AGTPBP1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.31541846956837916,0.7695596939208924,0.7716049382716049,0.9472707713357679,1.0,6/26,16.17%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.31942946699152425,0.7692863254800495,0.7866831072749692,0.9472705138796753,1.0,3/24,7.94%,H3-3A;SPI1;CREBZF
prerank,organic cation transport (GO:0015695),-0.2500997195167841,-0.7692053336179693,0.8465116279069768,0.9278803636925174,1.0,5/20,16.82%,SLC47A1;SLC22A4;SEC14L1;SLC25A26;SLC22A18
prerank,negative regulation of insulin secretion (GO:0046676),0.3445236417878945,0.7691565973313313,0.7839586028460543,0.947073733965396,1.0,7/17,23.19%,CHGA;PIM3;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,negative regulation of cellular protein localization (GO:1903828),0.3015545172201097,0.7691493465591018,0.7701283547257877,0.9467120644908943,1.0,6/34,11.32%,MAP1A;SPI1;GPM6B;LEPROT;MAPT;DNAJA1
prerank,protein deacylation (GO:0035601),0.321853467126228,0.7688884344417505,0.779639175257732,0.9466986299717531,1.0,5/23,21.37%,LYPLA2;ABHD17A;HDAC5;NOTUM;SIRT2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.33355614017549706,0.768834315431343,0.7668393782383419,0.9463951704847581,1.0,4/17,18.54%,TERF1;NEIL1;NEIL2;TERF2IP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.18681249177248285,-0.7688082842756943,0.9285714285714286,0.927126382501297,1.0,22/83,19.26%,ACVR1;BRD4;MNAT1;CDK6;CRLF3;NASP;TFDP1;CUL4B;CUL4A;LATS2;PHF8;PPP6C;ORC1;NPAT;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3830476592499728,0.7685363743091281,0.7668539325842697,0.9456933662376671,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,t-circle formation (GO:0090656),0.3830476592499728,0.7685363743091281,0.7668539325842697,0.9456933662376671,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3830476592499728,0.7685363743091281,0.7668539325842697,0.9456933662376671,1.0,3/10,22.29%,TERF1;ERCC1;BLM
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33132502566320526,0.7679943758279787,0.7636138613861386,0.9460253325683783,1.0,5/21,15.99%,CTSL;ZFP36L1;ZFP36;SFRP4;DLL1
prerank,protein import into peroxisome membrane (GO:0045046),0.3238433459154712,0.7679807808775656,0.7964824120603015,0.9456749987118367,1.0,10/22,35.64%,PXMP2;GDAP1;FIS1;PEX11B;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3243443924239613,0.7678343559084371,0.7569974554707379,0.9454963372417812,1.0,6/22,20.07%,GNAI2;DRD5;CAP1;ORAI1;CCR2;GABBR2
prerank,mitochondrion distribution (GO:0048311),0.3636771340244259,0.7675929180646143,0.7418032786885246,0.945447172037814,1.0,5/12,18.83%,MAPT;HAP1;DNM1L;ATCAY;ARMC1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.311288693001261,0.7675075404554554,0.7894117647058824,0.9451886396477635,1.0,8/29,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;ELAVL1;DND1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.33957808689040253,0.7673200745796017,0.7399219765929779,0.9450759596975881,1.0,1/18,0.84%,APOD
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.35634119328019587,0.7670366896431683,0.7545076282940361,0.9450647492695037,1.0,6/13,33.59%,MPDU1;ALG3;ALG11;DPAGT1;ALG6;ALG2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.2725162450832692,-0.7668200994143517,0.7704280155642024,0.9286999460774819,1.0,5/14,17.16%,GAB1;NRP1;VEGFB;VEGFC;VEGFD
prerank,transcription preinitiation complex assembly (GO:0070897),-0.2979999356622368,-0.7664501714084805,0.7896678966789668,0.92784807879096,1.0,7/12,34.63%,BDP1;GTF2A2;TAF7;TAF1;POLR1E;GTF2B;TAF7L
prerank,response to peptide (GO:1901652),0.30159517108811335,0.7663094257937642,0.7937427578215527,0.9456768353629214,1.0,15/33,29.85%,PRNP;CACNA1A;GNAI1;MMP3;RAMP3;ERBIN;EIF2B5;IRF5;AGER;CACNA1B;STAT4;CHRNA7;NOD2;EIF2B1;MMP2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.330163757017061,0.765929185738964,0.7661498708010336,0.9458108766392462,1.0,2/19,6.02%,SULT4A1;BPNT2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.36475390172320626,0.7657699994212137,0.7728571428571429,0.9456642486070853,1.0,1/11,3.61%,CANX
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.25312191696228387,0.765236218478582,0.996,0.9459895990558098,1.0,164/807,20.52%,RPL23;RPS27A;HSPA8;RPS14;UBC;PFDN5;UBB;CALR;MT3;HSBP1;VPS72;NDUFA13;RPL10;TMPRSS6;ATF4;KLF2;MAF1;ID3;SOX18;NRG1;ID1;CRYAB;PRDX5;EID1;CCDC85B;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;CTNNB1;FLNA;HES1;TENM2;IRF2BP1;MAGEL2;EID2;CDKN1C;TBX22;UBA52;CCND1;CEBPB;GMNN;ARID4A;FOXD3;PRDM12;TRIM28;FOXL2;CREBZF;DUSP26;CEBPA;CBX6;PROX1;BASP1;NR2F6;RBM15B;BCL6B;IKZF1;MLXIPL;MLX;CDK5R1;SARS1;SET;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;WFS1;IRF2BPL;BCL7A;SOX8;MAEL;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;YWHAQ;IRF2BP2;CRYM;BMP2;GAS6;LEFTY1;FOXS1;HNRNPU;HDAC5;ZC3H8;HEXIM1;SDCBP;IRF7;IKZF5;NONO;L3MBTL1;DNAJB1;SAMD11;IGF2;NR1H2;KDM1B;CDK5;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;TCEAL7;VHL;PAX9;GLIS2;TWIST1;RIPPLY2;BCL11A;RLIM;ZHX1;TCF25;CNBP;MYT1L;COMMD7;NOP53;CIR1;MAZ;MTA2;QARS1;SOX11;CCAR2;SNCA;MUC1;HIC1;ZBTB14;LBH;TFAP2B;NOTCH1;KLF11;EFNA1;BEND5;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;MYC
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.33447627697518134,0.7648891784008632,0.7777777777777778,0.9460780945664518,1.0,4/17,16.21%,CTNNA2;DNAI3;ARF1;GMFB
prerank,mRNA modification (GO:0016556),0.32754781277423056,0.7646498321210304,0.7799227799227799,0.9460197491760084,1.0,8/22,25.03%,PCIF1;CMTR1;TRUB2;DKC1;PUS7;TRMT10C;METTL3;METTL14
prerank,cardiac atrium morphogenesis (GO:0003209),0.3374186416774163,0.7644459693065393,0.7519685039370079,0.9459055763757674,1.0,8/16,28.00%,PROX1;BMP2;GATA4;NOTCH1;TGFB2;ZFPM1;DLL4;ENG
prerank,negative regulation of JNK cascade (GO:0046329),0.304803476981552,0.7642235458401895,0.7869822485207101,0.9458222679955176,1.0,6/31,14.62%,PINK1;DUSP3;SIRPA;DNAJA1;MAPK8IP1;F2RL1
prerank,secretion (GO:0046903),-0.2789153302019998,-0.7641833811699382,0.7755102040816326,0.9298394079738735,1.0,3/14,14.26%,SLC22A4;SLC22A6;PRKCI
prerank,plasma membrane repair (GO:0001778),-0.2778646137886381,-0.7637959751517628,0.7564575645756457,0.9290218057603116,1.0,2/13,5.20%,MYOF;MYH9
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24887764159258183,-0.7636858352671057,0.8169014084507042,0.9278244253573052,1.0,10/21,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,heart morphogenesis (GO:0003007),0.28638321898999475,0.7635570801261001,0.8153503893214683,0.9463406147548837,1.0,11/50,15.89%,ACVRL1;FKBP1A;HES1;ALPK2;SOX17;SOX9;BMP2;LEFTY1;DLC1;HEY1;RYR2
prerank,dendrite morphogenesis (GO:0048813),0.29770399334763464,0.7628200181346274,0.828505214368482,0.9469546063181241,1.0,11/35,23.15%,CTNNA2;LRP4;MAP2;PAK3;DOCK10;TMEM106B;MAPK8IP2;EPHB1;CTNND2;WNT7A;PTN
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3680571635973834,0.7627576559905554,0.7307692307692307,0.9466634020958186,1.0,3/11,12.73%,ELOF1;SERTAD1;ZMIZ2
prerank,organelle fission (GO:0048285),0.31633483981561444,0.7622467051307338,0.7869458128078818,0.9469683792802134,1.0,9/24,26.04%,DNM3;CORO1C;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L;PEX11B
prerank,bile acid biosynthetic process (GO:0006699),0.31329074766787857,0.7618488126168907,0.7647058823529411,0.9471187845052258,1.0,6/24,22.20%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A
prerank,positive regulation of mRNA processing (GO:0050685),0.32052776510950576,0.7616305583949089,0.7818627450980392,0.9470317864447295,1.0,5/21,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3241688553339982,0.7614468137627817,0.8037974683544303,0.9469020401479209,1.0,6/23,23.59%,HSP90AB1;CDC37;IFNGR1;NR1H2;IFNGR2;SOCS3
prerank,regulation of cartilage development (GO:0061035),0.33364928179520414,0.761371080421199,0.7847133757961784,0.9466360429549433,1.0,4/18,17.69%,MDK;SOX9;BMP2;SCIN
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3122899119206691,0.761329323116795,0.8,0.9463164906592645,1.0,3/28,5.31%,C3;RAC1;SIRPA
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3412358109030797,0.7611421815527433,0.7747625508819539,0.9461796052644117,1.0,2/15,4.23%,CSNK2B;FKBP1A
prerank,negative regulation of metabolic process (GO:0009892),0.282613370044515,0.761129594894177,0.8424581005586592,0.9458260529034618,1.0,14/54,21.42%,ATF4;ID1;APOC1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3;FIS1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.17648989842156682,-0.7602161701355563,1.0,0.9314151549895556,1.0,30/98,23.42%,EML4;PDS5A;NIPBL;PDCD6IP;MCPH1;PDS5B;PIBF1;POGZ;INO80;CSNK2A1;CSNK2A2;AKAP8L;CENPK;PHF8;PINX1;DSN1;CENPE;KLHL22;SMC4;KIF18B;NUP62;NDC80;KIF23;DIS3L2;TUBG1;KIF22;SMC1A;NCAPD3;MIS12;SGO1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.31646141450174686,0.7599493257491103,0.7860635696821516,0.9470069956203382,1.0,6/25,19.11%,ANG;DSCAM;MIF;SDCBP;PTGES3;SNCA
prerank,regulation of glucose transmembrane transport (GO:0010827),0.34001907172285023,0.7597834388629886,0.7922077922077922,0.9468760496817226,1.0,4/18,13.79%,C3;SLC2A1;RSC1A1;CLIP3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3123426860825681,0.7593436521340006,0.7985074626865671,0.9470958708333556,1.0,6/26,18.08%,AKT1;CCND2;CCND1;AIF1;ADAM17;ADAMTS1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.28751154829995423,-0.7591920828136722,0.8040540540540541,0.931507423052575,1.0,2/13,7.68%,ADHFE1;DLST
prerank,respiratory system development (GO:0060541),0.3058800443793821,0.7591097251046042,0.7992874109263658,0.9470326049475277,1.0,4/32,8.19%,RBP4;CEBPA;PROX1;BASP1
prerank,cellular response to radiation (GO:0071478),0.2915720779530083,0.7587409348645968,0.8227272727272728,0.9471102249800873,1.0,14/40,33.42%,RHOB;EEF1D;NET1;NSMCE3;GADD45A;BLM;ECT2;RAD51;RAD9A;CDKN1A;RHNO1;GRB2;CLOCK;SWI5
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3447655605825546,0.7585915122801005,0.7598425196850394,0.9469420766139185,1.0,2/16,5.85%,PIGZ;PIGQ
prerank,regulation of DNA recombination (GO:0000018),-0.2201607811493171,-0.7585389989231204,0.8924050632911392,0.9309979168452452,1.0,10/32,20.89%,SETD2;SPIDR;SMARCAD1;MSH3;PPP4R2;KPNA2;RTEL1;ZCWPW1;SHLD2;SIRT6
prerank,sphingolipid biosynthetic process (GO:0030148),0.26989478296007946,0.7583150681935974,0.8491978609625669,0.9469389324721056,1.0,22/71,23.79%,CERS2;ELOVL1;ELOVL2;B4GALT6;SMPD1;ELOVL7;SPTLC1;DEGS1;FA2H;CSNK1G2;CLN8;ST8SIA5;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ELOVL6;ALDH3B1;VAPB
prerank,positive regulation of telomere capping (GO:1904355),0.3393063439879346,0.7582540715528705,0.7700258397932817,0.9466491652131217,1.0,8/17,33.05%,MAPK3;MAPK15;MAP2K7;PNKP;PRKCQ;AURKB;HNRNPD;PKIB
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.29356723441191335,0.7574441730620863,0.8180764774044033,0.9472998422984624,1.0,8/37,15.68%,STMN3;FAM107A;CLASP1;MAPT;STMN4;CDK2AP2;STMN1;MAPRE3
prerank,ruffle organization (GO:0031529),0.34544942564482345,0.7574140416891476,0.7787958115183246,0.9469702140898425,1.0,4/16,12.35%,RAC1;ARF6;CSF1R;AIF1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2937082470061842,0.7572232622335549,0.8394919168591224,0.9468548072100972,1.0,10/40,19.84%,MDK;COL1A1;CTNNB1;BMP2;SDCBP;TIAM1;TWIST1;NOTCH1;IL6;TGFB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2867731935090595,0.7568927775866188,0.8245810055865922,0.946896889500223,1.0,12/48,19.67%,TREM2;PTPRC;ISG15;GAS6;NLRP2B;F2RL1;NR1H2;SIGIRR;SLIT3;OAS3;TRAIP;IL6
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2915301097057241,-0.7567771177653267,0.7896678966789668,0.9321789397223196,1.0,5/12,25.75%,BDH2;GGCT;GGT1;GCLC;MGST2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3620845125384927,0.7562584616104934,0.7799174690508941,0.9473563762956414,1.0,2/12,4.18%,PDGFB;IGFBP5
prerank,protein neddylation (GO:0045116),0.35510165351430323,0.7559205883623141,0.786723163841808,0.9474230651685124,1.0,4/13,16.09%,UBE2M;RBX1;NEDD8;RNF7
prerank,fat cell differentiation (GO:0045444),0.2760351189248592,0.7556206665147454,0.8369330453563715,0.9474377982468496,1.0,14/57,17.36%,PSMB8;BSCL2;CEBPA;STEAP4;SDF4;CTBP1;IL11;ATF5;ZBTB7A;SOX8;KLF4;CLIP3;TRIM32;PPARGC1A
prerank,metanephros development (GO:0001656),-0.23149502960143825,-0.7555482035298484,0.9075144508670521,0.9324651737990671,1.0,10/26,24.71%,FOXD1;NIPBL;PKD1;SIX1;BMP4;NF1;PKD2;PTCH1;GDNF;FGF10
prerank,regulation of GTPase activity (GO:0043087),0.2569669715814991,0.7555002315067839,0.9208121827411168,0.947229944661984,1.0,40/177,21.45%,RACK1;SOD1;CCL19;S100A10;TGM2;RASIP1;NTRK2;PIN1;CAV2;STMN3;ARHGAP9;TMED2;ARHGAP15;THY1;NET1;GPR137B;RRP1B;EPHA5;ARHGEF7;RGS10;DOCK10;HRAS;VAV1;DOCK8;VAV3;CCL2;ARL2;F2RL1;RASGRP1;DAB2IP;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;AGRN;SFRP1;DOCK9;RGS6;PLXND1
prerank,renal system development (GO:0072001),0.283842874206839,0.7546797758202727,0.8366445916114791,0.9479249867056696,1.0,8/52,11.69%,RBP4;AGT;LRP4;HYAL2;PROX1;C1GALT1;SOX17;WFS1
prerank,histone H2A acetylation (GO:0043968),-0.26898426197965486,-0.754367889101271,0.825531914893617,0.9327654571794124,1.0,4/16,12.30%,NAA40;EPC1;EP400;BRD8
prerank,regulation of hydrolase activity (GO:0051336),0.2693051202978175,0.7542733052998911,0.8654467168998924,0.9480852729363942,1.0,13/71,16.42%,SOD1;RASIP1;NTRK2;ATP5IF1;STMN3;ARHGAP9;ARHGAP15;GPR137B;EPHA5;VAV1;VAV3;DAB2IP;CAV1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3011595622160946,0.7541178040994435,0.7928994082840237,0.9479224744198382,1.0,6/31,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,"transcription, DNA-templated (GO:0006351)",0.25784720142021816,0.7540527108346797,0.9508032128514057,0.94764267971833,1.0,39/207,21.89%,PTMA;ELOB;TSC22D1;POLR2E;ATF4;POLR2D;POLR2F;DRAP1;BTF3;GTF3C6;PARP1;XAB2;TAF10;NELFCD;TAF5L;TAF9;POLR2G;DEK;SUPT4H1;SSRP1;THRA;POLR2K;IVNS1ABP;RO60;UBTF;RRAGC;ARRB2;NELFE;MRPL12;ERCC6;KLF13;TBP;MLF1;GTF3A;POLR2H;IRF9;CDK9;ELOC;POLR3K
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3182078489767067,0.7539135860061438,0.7967781908302355,0.94745203435662,1.0,8/22,31.76%,SLC7A5;IL2;IL6;TGFB1;RFTN1;PRKCQ;NOD2;LY9
prerank,actin filament-based transport (GO:0099515),0.31955449785571965,0.7535853792906549,0.7864197530864198,0.9475282330291611,1.0,4/21,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,regulation of interleukin-1 production (GO:0032652),0.34013412262704923,0.7534836627910534,0.7976031957390146,0.9473006582430944,1.0,4/15,21.29%,SIRPA;HMGB1;GAS6;TMED10
prerank,calcium ion transmembrane transport (GO:0070588),0.2648934541769865,0.7527370022671708,0.8777660695468915,0.9478821027893469,1.0,17/86,15.38%,SMDT1;SLC24A4;SLC24A2;FKBP1A;GRIN1;CACNA1A;TMCO1;P2RX7;GRIN2A;PMPCB;TRPM2;TRPC7;ATP2B1;GAS6;TRPC1;SPG7;SLC8A1
prerank,endomembrane system organization (GO:0010256),0.2556483600607261,0.752734133672196,0.9393939393939394,0.9475196868265837,1.0,34/178,17.51%,ANK3;LMAN2;ATP8B4;SYNGR2;CAV2;CHMP2B;CTDNEP1;REEP5;BAG5;TMED7;SYNGR1;LMAN1;SURF4;REEP6;TMED2;CLASP1;TICAM2;TMED3;ARHGEF7;SRGN;TMED9;SERP1;ARL1;TMED1;SEC61A1;VMP1;SYP;SNX33;USP8;SQSTM1;DNM1L;SYNE1;LNPK;HOOK1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.34317549801536584,0.7524359203766106,0.7760989010989011,0.9475159685967397,1.0,3/14,14.73%,TIRAP;TLR6;COPS8
prerank,epithelial to mesenchymal transition (GO:0001837),0.28437561487431584,0.7523381730688768,0.8521444695259593,0.9472793897238123,1.0,14/47,19.84%,HNRNPAB;CTNNB1;FOXF2;TRIM28;WNT5A;SOX9;BMP2;AKNA;HEY1;S100A4;FAM83D;NOTCH1;HGF;TGFB1
prerank,intestinal absorption (GO:0050892),0.35554984585921645,0.7522769593938117,0.7917241379310345,0.9469947167980244,1.0,7/13,43.32%,SLC2A2;KCNQ1;CD36;SLC26A6;F11R;ADRA2A;UGCG
prerank,ncRNA 3'-end processing (GO:0043628),0.3472942967632886,0.7520808678725552,0.7791005291005291,0.9468853373386195,1.0,7/14,32.11%,ELAC2;TOE1;TRNT1;ERI1;INTS12;INTS5;INTS6L
prerank,tRNA metabolic process (GO:0006399),0.3317191464916472,0.7520363675209591,0.7992177314211213,0.9465857032871705,1.0,3/17,10.06%,SARS1;KARS1;POP7
prerank,microvillus assembly (GO:0030033),0.34391151938279785,0.7511405620199421,0.7884097035040432,0.9473434136531935,1.0,1/14,1.80%,FXYD5
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2636670266818794,0.7510798072749784,0.881126173096976,0.9470557909717228,1.0,18/84,16.07%,MAGOH;HNRNPK;PRDX6;QKI;NCL;PUF60;RBFOX3;PCBP4;SRSF9;RBM15B;KHDRBS3;ZBTB7A;SNW1;HNRNPU;HNRNPA1;RBFOX1;CIRBP;CELF3
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.28757367228132585,-0.7506982824482561,0.8013937282229965,0.9364313883318757,1.0,6/11,17.85%,P4HTM;EGLN1;P4HA1;EGLN3;P4HA2;P4HA3
prerank,regulation of mitotic nuclear division (GO:0007088),0.28328246146811337,0.7503651166177897,0.858397365532382,0.9475774236015038,1.0,14/55,25.39%,AURKAIP1;PDGFB;PIN1;CAV2;FBXO5;L3MBTL1;IGF2;EDN3;TGFA;DUSP1;CCDC8;CD28;RCC1;KIF20B
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3577472943260788,0.7498309335670755,0.7820689655172414,0.9478787394188701,1.0,5/12,23.94%,TNF;NCOR2;TGFB1;ELAVL1;DND1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.33733029836789713,0.7495122585938491,0.7855263157894737,0.947915578057708,1.0,3/15,14.62%,CXCL12;KDR;F2RL1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.320973127578026,0.7494514400580335,0.8118686868686869,0.9476322813196044,1.0,7/20,21.19%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,eye photoreceptor cell development (GO:0042462),-0.26580292118598714,-0.7489309540208388,0.8421052631578947,0.9374458103899106,1.0,3/15,9.39%,CEP290;RPGRIP1L;TOPORS
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.26925630501920245,0.7488946693859363,0.8842887473460722,0.9479604539827825,1.0,19/80,20.53%,CCL19;NLGN1;RAC1;TENM2;PFN1;P2RX7;KCTD17;P2RY12;DEF8;FNBP1L;HRAS;ANLN;CCDC88A;F2RL1;RAC2;ARPC2;GPM6A;AGRN;CDC42EP2
prerank,epithelial cell development (GO:0002064),0.326049701434483,0.7488421263652565,0.7969151670951157,0.9476680373921602,1.0,1/20,1.46%,ACTA2
prerank,endocrine system development (GO:0035270),0.3243874538409188,0.7483827787508778,0.8030495552731893,0.9478778127179583,1.0,1/21,1.22%,MDK
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2971925108030732,0.7482008355620113,0.8080568720379147,0.9477324221610579,1.0,6/33,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.307636886685352,0.7477986741168039,0.7777777777777778,0.9478850393893121,1.0,7/25,19.44%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3164138680096984,0.7476853248835416,0.7861635220125787,0.9476630784947524,1.0,1/20,1.89%,MAPK3
prerank,isotype switching (GO:0045190),0.3640258740534925,0.7470798190914095,0.7945402298850575,0.9480511354363538,1.0,1/10,7.89%,HSPD1
prerank,lymphocyte mediated immunity (GO:0002449),0.35005307344052783,0.7463010470928204,0.7880886426592798,0.9486430920360741,1.0,1/12,4.16%,BTN3A3
prerank,protein ubiquitination (GO:0016567),0.24889594281321753,0.7460745896849319,0.985,0.9485527133146834,1.0,86/471,20.68%,RPS27A;UBC;RACK1;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;UBE2Z;PINK1;KCTD10;FBXO15;KLHL9;PSMD1;EPAS1;UBE2G2;PSMC3;CTNNB1;PSMD6;VCP;IRF2BP1;UBE2Q1;CDC34;DCAF15;RNF187;UBA52;ARRDC1;PSMA7;ISG15;USP5;FBXL14;OTULIN;NHLRC1;PRPF19;PSMD5;RBX1;NEDD8;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;KLHL7;PSMB3;FBXW5;SYVN1;PCNA;PSMB11;ZSWIM8;FBXW7;FBXO30;FBXO31;PSMB10;RNF40;UBE2V1;RNFT1;PSMB1;ARRB2;RNF7;ENC1;PSMB5;VHL;TRIM32;RUSC1;RNF181;RLIM;USP22;TRAIP;RNF208;KCTD13;PSMA6;RNF144B;FBXL16;HECW1;TRIM13;RNF11;SKP1;PSMA4;UBE2QL1;KLHL25;BRAP
prerank,telomere maintenance (GO:0000723),0.27999028937416787,0.745616777297745,0.8470982142857143,0.9487515540132865,1.0,14/50,25.76%,TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;RAD51
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2460157431958184,0.7450190241766941,1.0,0.9491040504858153,1.0,231/1082,22.30%,APOE;RPS27A;CD74;UBC;UBB;CHCHD10;CD81;PCBP1;CXXC1;SPP1;COL1A1;ACTA2;MT3;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;PTPRN;ELOF1;ERBB4;LYL1;POMC;NPM1;AGT;DDX39B;GPER1;EIF5A;ETS2;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;CHEK2;SPI1;EPAS1;GLMP;JUNB;PIN1;YWHAH;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;SERTAD1;HES1;HYAL2;CDKN1C;HMGN1;RHOG;HIPK2;CDK8;RNF187;OTX2;UBA52;FOXF2;CEBPB;FOXD3;BRPF1;TRIM28;EDF1;NAMPT;SALL2;FOXL2;CEBPA;PROX1;SEC14L2;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;KARS1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;H1-0;HOXB7;PHOX2A;MC1R;NPAS3;IRF8;APBB1;SUPT4H1;MYRF;APEX1;WNT5A;IL11;SOX17;ATF5;POU3F1;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;RAI1;NME2;HNRNPU;TNFRSF1A;HDAC5;ZC3H8;UBE2V1;ATMIN;NUP85;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;UBTF;IGF2;ARF4;NR1H2;KDM1B;MAPRE3;EBF3;HEY1;NCF1;DLL1;IER5;ING1;DAB2IP;E2F4;VHL;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;PCID2;ADCYAP1;BRCA2;PPARGC1A;MED21;MRPL12;ERCC6;AGO1;CNBP;TOX2;LMO1;USP22;MAP2K2;MAZ;HMGN5;NRL;SOX11;PPP3CA;DDRGK1;CD86;INHBA;LBH;NLRP3;ESRRB;TFAP2B;NOTCH1;IL6;HGF;TGFB1;AGRN;ING5;ALYREF;POU4F1;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;NFKBIA;FOSL2;FZD2;CDC5L;ID2;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;CKAP2;SIRT2;FZD1;ZXDC;MEN1;SS18L1;MAP2K7;IRF5;REST;ESRRG;BLM;GRHL2;TNIP1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3168658498475461,0.7449653195364541,0.8053777208706786,0.9488034012942221,1.0,4/21,14.60%,FLNA;SCN4B;KCNE4;KCNE5
prerank,spindle assembly (GO:0051225),0.271699816523353,0.7446872543748198,0.865301724137931,0.9487828911546076,1.0,11/67,18.89%,RPS3;CHEK2;FLNA;ABRAXAS2;CLASP1;SAC3D1;RHOA;HAUS2;MAPRE3;TOGARAM2;KIFC2
prerank,regulation of innate immune response (GO:0045088),0.2773377315664072,0.7444994958607882,0.8529411764705882,0.948642905425523,1.0,13/57,23.07%,HSP90AB1;TREM2;TIRAP;TNFAIP3;SLC15A4;CDC37;LRP8;TYRO3;PTPN6;POLR3D;AKIRIN2;ERAP1;PTPN1
prerank,membrane lipid metabolic process (GO:0006643),0.3150113615574293,0.7440753586591256,0.8034610630407911,0.948817591483418,1.0,5/22,20.24%,SERINC1;GAL3ST1;SPTLC1;CERKL;SPHK2
prerank,mitochondrion morphogenesis (GO:0070584),-0.2949399651236587,-0.7436901509467619,0.816793893129771,0.9430887888958454,1.0,1/11,0.51%,PID1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.27354856595343413,-0.7435231819587801,0.8277310924369747,0.9419426307901964,1.0,6/14,19.18%,DPYD;UPP2;UPB1;NT5C1A;NT5M;DHODH
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3492140431979362,0.7429676213209395,0.7851458885941645,0.949819786980189,1.0,8/12,38.65%,GLUD1;IDH3G;ACLY;IDH1;ASS1;IDH3A;SIRT4;IDH3B
prerank,endocardial cushion development (GO:0003197),0.31450658427493766,0.7428391806436568,0.78625,0.9496195180245173,1.0,10/21,28.22%,ACVRL1;SOX9;BMP2;HEY1;GATA4;CRELD1;NOTCH1;TGFB2;ENG;TBX2
prerank,lung development (GO:0030324),0.29406480151594583,0.7424842939981382,0.815347721822542,0.9496720997814552,1.0,4/33,8.17%,RCN3;RBP4;CEBPA;PROX1
prerank,cardiocyte differentiation (GO:0035051),0.36709996526707256,0.7414773309574321,0.7916666666666666,0.950540226447012,1.0,3/10,13.45%,NRG1;KDM6B;BMP2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.35900229412306395,0.7410636205574996,0.7918424753867792,0.9506509157322727,1.0,3/11,21.50%,CTNNB1;WNT5A;FZD1
prerank,lipid modification (GO:0030258),0.2903675354115203,0.7407224087537231,0.8402366863905325,0.9507208095338829,1.0,18/37,33.28%,DGKH;DGKI;PLA2G7;PLPP6;PLPPR2;PORCN;SGPP1;SGPP2;DGKK;DGKB;CYP2E1;PLPPR4;MBOAT7;PLPP4;DGKZ;DGKG;PLPPR5;MBOAT1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2733870911403101,-0.7405718510843194,0.8162393162393162,0.9445146013729426,1.0,4/13,15.22%,CNOT1;MOV10;CNOT7;ZC3HAV1
prerank,small GTPase mediated signal transduction (GO:0007264),0.25617950009772184,0.74031144460247,0.9036885245901639,0.9508383750619578,1.0,37/103,27.11%,PARK7;RAC1;SHC3;TRIM28;RGS19;NTN1;JUN;GRAP;RASGRP3;HRAS;RHEBL1;RUNDC3A;SHTN1;ABR;CCDC88A;RRAS;TIAM1;G3BP1;MAPK11;RRAGC;G3BP2;RASGRP1;USP8;RAB18;SOS1;ARHGAP33;BRAP;RALB;RERG;CCNA2;RAB42;TNK2;KSR2;RGL2;RALBP1;CHP1;CDKN1A
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.36036664986170863,0.7397432207203051,0.8038147138964578,0.9511392818315054,1.0,2/10,24.45%,CNGB1;PDE6G
prerank,response to laminar fluid shear stress (GO:0034616),0.36038160619541404,0.7396755991599708,0.7784256559766763,0.9508506908573168,1.0,2/10,12.78%,KLF2;KLF4
prerank,organonitrogen compound catabolic process (GO:1901565),0.2715328524602109,0.7391087272538006,0.8525852585258525,0.9511624502802278,1.0,15/57,24.30%,USE1;MPST;ENPP2;AMDHD2;BCKDK;PLA2G7;CLN5;CLN6;TXN2;TST;CLN8;CAPN3;SGPL1;ERAP1;ADO
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.2490345689800625,-0.7390164969374312,0.8669527896995708,0.9452309585004428,1.0,5/17,14.11%,PPARG;PTEN;PDCD4;TPM1;TGFB3
prerank,negative regulation of cilium assembly (GO:1902018),0.3462513324650758,0.7389886126611994,0.7883310719131614,0.950955337503108,1.0,7/12,30.11%,CCP110;EVI5L;TESK1;CDK10;TCHP;TBC1D7;MAP4
prerank,response to prostaglandin E (GO:0034695),0.36101822254648647,0.7385172057503401,0.7841726618705036,0.9511512425292528,1.0,1/10,2.23%,CCL19
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3086972334072946,0.7382981777223359,0.8122699386503067,0.9510498589937547,1.0,3/25,6.54%,AUP1;VCP;OMA1
prerank,megakaryocyte differentiation (GO:0030219),0.3533375188019191,0.7377149925244958,0.7779349363507779,0.9513688178925761,1.0,4/11,27.86%,IL11;THPO;CDKN2B;ZFPM1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3222460978329451,0.7376810209806546,0.8124191461836999,0.9510531341254402,1.0,4/19,8.38%,S100A10;RAC1;THY1;KDR
prerank,natural killer cell activation (GO:0030101),0.3076181014962741,0.7365816909917404,0.8048780487804879,0.9519746703860384,1.0,7/23,19.01%,PTPRC;IL2;PRDX1;NCR1;RASGRP1;PIK3CD;TOX
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.32089788070570247,0.7364180303758482,0.7795698924731183,0.9518134220135331,1.0,3/17,11.97%,GPER1;ATP1A3;ATP1A1
prerank,sphingosine metabolic process (GO:0006670),0.3218557024124176,0.736235017932926,0.7984395318595578,0.951665558942757,1.0,7/17,21.12%,SPTLC1;NAAA;ABCA2;SGPP1;SPHK2;SGPP2;ASAH2
prerank,vitamin transport (GO:0051180),0.2994542439949921,0.7357452437728199,0.8298906439854192,0.9518960299362962,1.0,10/29,32.19%,GC;SLC19A1;FOLR2;SLC2A2;SLC52A1;SLC19A2;TCN2;SLC2A6;SLC52A3;SLC52A2
prerank,fibrinolysis (GO:0042730),0.34391987632436805,0.7352157729574853,0.8161865569272977,0.9521646127851277,1.0,2/13,16.75%,PLAT;PLAU
prerank,negative regulation of DNA binding (GO:0043392),-0.2256071836329096,-0.7351652563486228,0.8505747126436781,0.9486994992025334,1.0,6/28,14.92%,SMO;PER2;SP100;ILRUN;RSF1;HEY2
prerank,organelle fusion (GO:0048284),0.3075584485275367,0.7351176624344993,0.82125,0.9519119048167666,1.0,7/22,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;STX4;FIS1
prerank,regulation of epithelial cell migration (GO:0010632),0.2748986661937781,0.7349797524824889,0.8469162995594713,0.9517130957532682,1.0,12/51,16.76%,EMP2;RTN4;PFN1;GLUL;CORO1C;ENPP2;CLASP1;PTPRR;SOX9;CTSH;DAB2IP;PFN2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.19232387648216784,-0.7349311423627656,0.96,0.9476139885752923,1.0,15/57,17.55%,BABAM2;FOXN3;RINT1;MDC1;UIMC1;TAOK3;ATF2;MRNIP;TIPIN;ATM;RAD17;TAOK1;CLSPN;TP53;WAC
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2802622844637034,0.7348861370943132,0.8494868871151653,0.9514629561748068,1.0,10/40,22.22%,IER3;RPA2;USP51;MAPT;NSMCE1;FBXO5;UBE2V1;MYC;CDK9;RADX
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3519358696095301,0.7346542565984682,0.7939972714870396,0.9513839314595075,1.0,2/13,9.04%,PINK1;NUPR1
prerank,endothelial cell migration (GO:0043542),0.2858697110450704,0.7336446296280671,0.8368055555555556,0.9521824205516857,1.0,11/37,22.56%,SOX18;ID1;EMP2;TNFSF12;RHOA;CDH5;LPXN;PLXND1;CCN3;SCG2;LGALS8
prerank,regulation of lipid kinase activity (GO:0043550),0.35249508356776954,0.7334019076497273,0.8138888888888889,0.9521171412211615,1.0,1/11,5.39%,EEF1A2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2637066175397079,0.7331236292724661,0.875531914893617,0.9520893620888898,1.0,9/72,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;RAB14;POLR2G;FGFRL1;POLR2K;HNRNPA1
prerank,dorsal/ventral pattern formation (GO:0009953),0.3208544293081075,0.7331150394363906,0.8107769423558897,0.9517404555022844,1.0,2/20,4.15%,NBL1;ACVRL1
prerank,bicarbonate transport (GO:0015701),0.3022180740742349,0.7330217517416877,0.8371810449574727,0.9514949079335893,1.0,6/25,20.85%,CA2;AQP1;CA4;SLC4A2;CYB5R1;CA3
prerank,cell chemotaxis (GO:0060326),0.2704796729723039,0.7327931706171902,0.8657205240174672,0.9513977125957992,1.0,16/60,26.78%,CXCL12;PDGFB;RHOG;CCR5;CXCR4;CX3CR1;EPHB1;ARRB2;CCL28;CCR2;HGF;CCN3;PRKCQ;PLXNB3;CX3CL1;LEF1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3035521147176842,0.7319350665794957,0.843937575030012,0.9520756071656704,1.0,4/26,10.09%,FMOD;LUM;CHST1;B4GALT6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.31223160205167877,0.7315313230407903,0.8286066584463625,0.9521823917326213,1.0,4/24,13.68%,CTSL;ZFP36L1;ZFP36;NME2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3462544578943926,0.7314117125176208,0.8037135278514589,0.9519623249222032,1.0,2/12,12.09%,CTNNB1;DDX11
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.19503093714662523,-0.7313998024184599,0.9491525423728814,0.9507800440706029,1.0,16/48,23.07%,PRKAG2;RANBP2;OGT;NUP98;PRKAG1;AAAS;NUP214;NUP35;NDC1;TIGAR;NOA1;JMJD8;NUP62;TPR;NUP93;NUP160
prerank,carboxylic acid catabolic process (GO:0046395),0.34730935132493385,0.7313960685674357,0.7924528301886793,0.9516164521706476,1.0,3/12,16.69%,AMDHD2;BCKDK;ACOT4
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3066494333390708,0.7313807271417171,0.8043758043758044,0.9512788932638385,1.0,8/21,19.84%,ECM1;SRGN;SOX9;GAS6;HEY1;CCL3;NOTCH1;TGFB1
prerank,genitalia development (GO:0048806),0.3527203993582893,0.73114962517937,0.8243430152143845,0.9511717530287824,1.0,2/12,11.12%,FOXF2;WNT5A
prerank,histone monoubiquitination (GO:0010390),-0.23491612532015363,-0.730820670118445,0.8944444444444445,0.9501218273912962,1.0,9/24,23.84%,BCOR;DDB2;CUL4B;CDC73;UBE2E1;WAC;RNF20;CTR9;RYBP
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.23860767798645716,-0.7304699113318808,0.8666666666666667,0.9491887433166107,1.0,6/20,21.04%,SULF1;SMOC2;FGF2;PRKD2;SULF2;CREB3L1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2313285294962832,-0.7299728982067419,0.9011627906976745,0.9484079122179733,1.0,4/25,9.77%,SLIT2;YAP1;CEP97;KANK1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24455495877035077,0.7294454350525909,0.986986986986987,0.9528120415141205,1.0,87/366,25.25%,PFDN5;RPL6;CALR;CXXC1;RPL10;ATF4;SOX18;HINT1;GRM5;LYL1;MAGED1;METAP1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;NUCKS1;BTG1;FADS1;TBX22;CEBPB;GMNN;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;PCIF1;SOX17;ATF5;RBM4B;METTL18;BMP2;FBXO5;UBE2V1;MAFA;CCDC88A;NONO;SPIN4;IGF2;PDGFA;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1;TAF5;SP3;RELA;MAFB;APP;TCF7L1;TCF3;CCNA2;EIF2A;PPIE;RORB;MYCBP
prerank,DNA conformation change (GO:0071103),0.32044184147823007,0.729174778206572,0.8146718146718147,0.9527746091125382,1.0,3/17,10.81%,HMGB3;HMGB1;NAA10
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.22358887394494975,-0.7290594058990948,0.8791208791208791,0.9481715290955062,1.0,2/26,1.41%,LARGE1;ST3GAL4
prerank,positive regulation of RNA splicing (GO:0033120),0.2924023964067353,0.7288233351011564,0.836662749706228,0.9528234648563316,1.0,6/29,16.07%,PRDX6;NCL;SNW1;HSPA1A;CIRBP;CELF3
prerank,adipose tissue development (GO:0060612),0.35155843022079414,0.7286954376098975,0.8022130013831259,0.9526190817471549,1.0,3/11,12.21%,NAMPT;PGRMC2;SOX8
prerank,positive regulation of DNA repair (GO:0045739),0.27803961762414503,0.7283951395282019,0.8744343891402715,0.9526055042523541,1.0,7/46,12.09%,RPS3;PARP1;TRIM28;FMN2;HMGB1;PCNA;DDX11
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24173190955663879,0.7283213403414629,0.996,0.9523367344946081,1.0,119/572,21.78%,RPL23;RPS27A;RPS14;UBC;UBB;CALR;HSBP1;VPS72;RPL10;TMPRSS6;ATF4;KLF2;ID3;SOX18;ID1;EID1;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;HES1;TENM2;IRF2BP1;TBX22;UBA52;CCND1;CEBPB;FOXD3;PRDM12;DUSP26;CBX6;PROX1;NR2F6;BCL6B;MLX;SARS1;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;ZBTB7A;WFS1;IRF2BPL;SOX8;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;HSPA1A;IRF2BP2;CRYM;BMP2;LEFTY1;HNRNPU;HDAC5;HEXIM1;SDCBP;IRF7;IKZF5;DNAJB1;IGF2;NR1H2;KDM1B;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;VHL;GLIS2;TWIST1;RIPPLY2;BCL11A;ZHX1;TCF25;CNBP;MYT1L;NOP53;CIR1;MAZ;MTA2;SOX11;SNCA;HIC1;TFAP2B;NOTCH1;KLF11;EFNA1;CHD3;POU4F1;CITED2;MEF2C;MYC;GADD45A;ID2;DDIT3;SOX10;SIRT2;SUDS3;DACH1;MEN1;IFI27
prerank,GTP metabolic process (GO:0046039),0.3287155421599114,0.7278533811760742,0.8073979591836735,0.9525075777276304,1.0,3/15,9.45%,RAN;AK4;AK3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3055643016146423,0.7278125119983264,0.824967824967825,0.952189795481701,1.0,3/21,8.21%,MID1IP1;NAV3;CLASP1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2833887936924285,0.7277806045593629,0.8534583821805393,0.9518675108096917,1.0,7/39,13.45%,RASIP1;CTNNB1;PAK1;COL4A1;KDR;TIE1;BMP2
prerank,carbohydrate homeostasis (GO:0033500),0.2637762259248244,0.7266373731714955,0.8823529411764706,0.95285091692517,1.0,14/67,22.34%,PARK7;MTNR1B;RPS6;RBP4;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;TFAP2B;IL6;PYGL;ADIPOR1
prerank,regulation of TOR signaling (GO:0032006),0.26418168578632895,0.72656483677083,0.8831168831168831,0.9525712622561053,1.0,13/67,19.99%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;PIH1D1;PDCD6;LAMTOR3;GAS6;RRAGC;RRAGD;FAM83D;AKT1S1;DDIT4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3538665357170925,0.7251959616683108,0.8041095890410959,0.9537419978226126,1.0,4/11,20.52%,WNT5A;SOX9;PDGFA;MYC
prerank,brain morphogenesis (GO:0048854),0.3417255220432745,0.7250609146560588,0.8247282608695652,0.9535416011443998,1.0,1/12,3.11%,CTNNA2
prerank,regulation of oxidoreductase activity (GO:0051341),0.3371753769099321,0.7248293310224455,0.8193103448275862,0.9534378152631404,1.0,1/13,1.51%,MT3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.28844355405321875,-0.7247780760249082,0.8113207547169812,0.9521213087375537,1.0,2/10,6.10%,LRP6;ARHGAP12
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2603575125514479,0.7243093824243934,0.8900747065101388,0.9536408463970728,1.0,28/68,33.86%,SLC2A1;RFK;CYB5R3;GSTO1;SLC19A1;PNPO;SLC19A3;FOLR2;SLC25A19;SLC2A3;SLC52A1;SLC19A2;SHMT2;MTHFS;CYB5A;TCN2;DHFR;ACP5;AASDHPPT;SLC52A3;ALDH1L1;SLC52A2;PCCB;MTHFD2L;MTRR;LMBRD1;MTR;NNMT
prerank,sphingosine biosynthetic process (GO:0046512),0.3415696391871921,0.7241616304438969,0.813986013986014,0.9530978360244353,1.0,4/11,21.12%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.3415696391871921,0.7241616304438969,0.813986013986014,0.9530978360244353,1.0,4/11,21.12%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,fatty acid oxidation (GO:0019395),0.26509155579672145,0.7233665769603582,0.8793103448275862,0.9536442344088405,1.0,8/57,17.38%,ACADVL;SCP2;MTLN;HSD17B4;ACAT1;ACAA2;PPARGC1A;ECHS1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.30993093557685825,0.7228976634368574,0.8245838668373879,0.9538116425240137,1.0,7/20,21.19%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,lung epithelium development (GO:0060428),0.3575895285273155,0.7228829968946517,0.8065433854907539,0.9534730068052869,1.0,1/10,2.36%,RCN3
prerank,cellular response to UV-A (GO:0071492),0.3481481221221654,0.7227915600085548,0.8152777777777778,0.9532192149133888,1.0,2/11,11.31%,TIMP1;MMP3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2915118557005391,0.7212418081170586,0.835909631391201,0.9545929243452611,1.0,7/27,17.63%,PDE4B;CTNNA3;PLN;FGF13;RYR2;CAV1;SRI
prerank,amyloid-beta metabolic process (GO:0050435),0.3207704905010142,0.7208030730736718,0.8114209827357237,0.9547212737309827,1.0,8/16,32.12%,PSENEN;BACE1;PSEN2;APH1B;APH1A;IDE;ACE;NCSTN
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2526817438491048,-0.7206737146259445,0.8765432098765432,0.955583857479483,1.0,3/15,12.42%,GGACT;PRODH;HOGA1
prerank,phosphate ion homeostasis (GO:0055062),0.3511218840063822,0.7199244974089477,0.8137535816618912,0.955338371949911,1.0,2/10,19.56%,SFRP4;TFAP2B
prerank,proteoglycan biosynthetic process (GO:0030166),-0.21138309544647682,-0.7186526944368636,0.8909090909090909,0.9565731232024748,1.0,9/31,20.76%,EXT1;IGF1;CHST11;GLCE;EXT2;FOXL1;BMPR2;B3GALT6;PXYLP1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.30396006520787344,0.718193864302595,0.8343711083437111,0.9565523444096571,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.30396006520787344,0.718193864302595,0.8343711083437111,0.9565523444096571,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,plasma membrane organization (GO:0007009),0.26364386077548835,0.7177461709934926,0.896328293736501,0.9566765119840066,1.0,15/61,18.78%,ANK3;PACSIN1;P2RX7;SYT11;SMPD1;FNBP1L;SERP1;CXCR4;DEGS1;EPB41L3;SNX33;FA2H;EHD2;ANXA6;STX4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.28911494667770876,0.7177020271721527,0.8403361344537815,0.9563711317843466,1.0,11/30,27.11%,TERF1;ACVRL1;HNRNPU;HNRNPA1;CTC1;DACH1;MEN1;GNL3L;PIF1;HNRNPC;CDKN1A
prerank,RNA processing (GO:0006396),0.24270328410129083,0.7174832079239314,0.9535353535353536,0.9562744732337968,1.0,42/176,21.23%,SNRPG;AURKAIP1;MAGOHB;MAGOH;HNRNPK;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;SRSF9;LIN28B;HNRNPA0;TARDBP;PRPF8;SUPT4H1;SRSF2;SF3A2;ELAVL4;SF3B2;IVNS1ABP;HNRNPU;MRPL44;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;SNRPD3;APOBEC1;CCAR2;USB1;SF3A1;DKC1;TSEN54;SRSF1;SRRM4;SNRNP35;HNRNPF
prerank,axonemal dynein complex assembly (GO:0070286),0.2937715691526408,0.7173275953954198,0.8686746987951808,0.9560943029326748,1.0,4/28,13.36%,DNAI3;DNAAF3;DNAH1;LRRC49
prerank,response to lipid (GO:0033993),0.2521959015758514,0.7172711544283544,0.9092783505154639,0.955803586648026,1.0,20/105,19.84%,SPP1;RBP4;S100A8;S100A9;TIRAP;CTNNB1;ABCG1;HNRNPA0;GPX3;SCD;SLC11A1;SOX9;PAQR7;ERBIN;CTSH;ABCA2;ADAM17;NOS2;SNCA;TGFB1
prerank,visual perception (GO:0007601),0.2512687769576091,0.7171257557732477,0.8998935037273695,0.9556099861103438,1.0,9/84,13.24%,COL1A1;OAT;SFRP5;RD3;GRM8;REEP6;WFS1;RS1;CRYBA1
prerank,B cell activation involved in immune response (GO:0002312),0.3346958767331608,0.7169436415824403,0.8313253012048193,0.9554552026428741,1.0,2/13,19.50%,CD180;GPR183
prerank,autophagy of nucleus (GO:0044804),-0.25131614881656705,-0.7168944358500849,0.849802371541502,0.9571996215485478,1.0,5/16,16.72%,ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.30802749170614246,0.7165976871363983,0.8252184769038702,0.9554746790503725,1.0,8/20,24.15%,ZFP36L1;ZFP36;PRMT1;PF4;HSPA9;HOXB8;MEIS2;MAFB
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28436865704799424,0.7149017748815938,0.8703481392557023,0.9569788779351287,1.0,7/31,15.70%,CFL1;NLGN1;PPFIA2;CDK5R1;SRCIN1;LRP8;CDK5
prerank,protein complex oligomerization (GO:0051259),0.25344469530841196,0.7148441206259998,0.9136842105263158,0.9566909002146997,1.0,26/85,26.37%,LRRC8A;KCNC3;MPP2;ALAD;NINJ1;KCNC1;RS1;PRMT1;EHD1;UGDH;G3BP2;ADCY8;MAT2A;DNM1L;GLRA3;SNCA;SHMT2;PYCARD;KCNC2;BLM;ELAVL1;ECT2;BOK;PNPT1;EHD3;STOML2
prerank,motile cilium assembly (GO:0044458),0.3352525583924801,0.7144872531961406,0.8272980501392758,0.9567106178576422,1.0,3/12,20.36%,DNAAF3;E2F4;BBOF1
prerank,mRNA 3'-end processing (GO:0031124),0.2517904380410337,0.7141494692221259,0.9232386961093586,0.9567227449064266,1.0,16/78,22.07%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;SRSF2;PABPC1;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2739278356499567,0.714140130111139,0.8854166666666666,0.9563771220177748,1.0,5/38,15.49%,H3-3A;NPM1;CENPX;IPO4;CENPL
prerank,modification-dependent protein catabolic process (GO:0019941),0.24293050451261716,0.7130904712302797,0.9678068410462777,0.9571918193676039,1.0,30/193,17.67%,RPS27A;UBC;UBB;PINK1;KCTD10;TOLLIP;UBE2G2;CDC34;UBA52;ARRDC1;ISG15;FEM1A;FEM1C;FBXL14;RBX1;NEDD8;RNF128;DDB1;PSMD13;BUB3;SYVN1;UBQLN2;RNF40;RNF150;RNF7;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32163769685027743,0.7126511983947993,0.8291390728476821,0.9572970873620005,1.0,3/15,16.29%,POP7;RNASEH1;NUDT16
prerank,cardiac muscle cell development (GO:0055013),0.30430320116475185,0.7102784796957984,0.8462549277266754,0.9595164375703293,1.0,5/20,17.41%,ALPK2;MYH11;SORBS2;SLC8A1;FHOD3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.32598753293019556,0.7102204191751526,0.8362183754993342,0.9592325876481514,1.0,6/14,28.00%,KLF4;RHOA;HDAC5;NOTCH1;MMRN2;DLL4
prerank,mesenchymal to epithelial transition (GO:0060231),0.3463286398100086,0.7099589314719362,0.8,0.9591577236944906,1.0,1/10,8.19%,BASP1
prerank,oligosaccharide metabolic process (GO:0009311),0.2697066589211497,0.708790035862156,0.8756936736958935,0.9600789103627737,1.0,20/46,32.56%,MAN2B2;MAN1B1;MPDU1;ST8SIA4;ST6GALNAC3;MAN2C1;NEU1;ST6GAL2;FUT9;ST8SIA5;B3GALT5;GAL3ST3;B3GALT2;NAGA;NEU3;MAN2B1;ST8SIA6;AMY1B;AMY1C;AMY1A
prerank,peroxisomal membrane transport (GO:0015919),0.2935046298046867,0.7080047106066372,0.8684863523573201,0.960555555641006,1.0,12/27,35.64%,PXMP2;GDAP1;PEX6;FIS1;PEX11B;PEX1;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,tRNA 5'-end processing (GO:0099116),0.3190602958331254,0.7079291514388859,0.8355795148247979,0.9602789325113075,1.0,5/15,33.23%,POP7;POP4;TRMT10C;POP5;HSD17B10
prerank,regulation of defense response to virus by host (GO:0050691),0.2851500327317883,0.7077543843602129,0.8556461001164144,0.9601056691423584,1.0,3/30,7.19%,HSP90AA1;TNFAIP3;PQBP1
prerank,response to organophosphorus (GO:0046683),-0.24517848809267528,-0.7072318065004937,0.881578947368421,0.9665649088615793,1.0,6/16,26.29%,DGKQ;TRPC3;VGF;ABCC9;NDUFS4;TYMS
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2763650264086696,0.7071711760126674,0.854066985645933,0.9603884763950776,1.0,9/33,20.04%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;SCIN;INHBA;THPO
prerank,cilium movement (GO:0003341),-0.18631890259595368,-0.7069784760961655,0.970873786407767,0.9654677273956557,1.0,24/48,30.30%,DNAI4;CFAP251;SPEF1;GAS8;ODAD1;CCDC39;CFAP53;CFAP70;DNAAF5;ODAD2;SPAG17;ODAD3;CFAP61;SPA17;DNAAF2;ODAD4;TEKT2;ROPN1L;CCDC40;DNAAF4;CCDC63;TTC29;ADCY10;TEKT5
prerank,negative regulation of type I interferon production (GO:0032480),0.27268111974979325,0.706190494792499,0.8704128440366973,0.9610693830501399,1.0,4/40,6.97%,PIN1;SIRPA;TNFAIP3;ISG15
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.24534691004460385,-0.7061655627842407,0.8728070175438597,0.9649860031595973,1.0,4/17,14.72%,TAOK3;MID1;KLHDC10;TAOK1
prerank,methylguanosine-cap decapping (GO:0110156),0.33677606991205733,0.7046680997438737,0.8435277382645804,0.962377366368492,1.0,2/10,11.69%,PNRC2;EDC4
prerank,regulation of cellular catabolic process (GO:0031329),0.25608838478330687,0.7042332316443023,0.894962486602358,0.9624688072297776,1.0,6/62,9.11%,PSAP;HSPB1;DEPP1;MAPT;NUPR1;GPR137B
prerank,sensory perception of light stimulus (GO:0050953),0.24473762282633765,0.7038930242849515,0.913135593220339,0.962466184873838,1.0,9/87,13.24%,COL1A1;OAT;PCDH15;SFRP5;RD3;GRM8;WFS1;RS1;CRYBA1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.2543728825630127,0.7031775753490714,0.9155227032734953,0.9628591331896409,1.0,19/74,22.34%,MDK;COL1A1;MCRIP1;CTNNB1;CLASP1;SPRY1;BMP2;SDCBP;TIAM1;DAB2IP;TWIST1;VASN;IL6;EFNA1;TGFB1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,regulation of T cell mediated immunity (GO:0002709),0.3433488286043365,0.7021896896375729,0.8289473684210527,0.9635730054398165,1.0,4/10,28.03%,HMGB1;CCR2;AGER;TNFRSF1B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3024063723577468,0.7002721514244571,0.8435114503816794,0.965210575562071,1.0,7/19,26.23%,TERF1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,positive regulation of autophagy (GO:0010508),0.2516617267283444,0.6998057536461466,0.9070010449320794,0.9653570462181815,1.0,12/81,15.07%,PARK7;PINK1;TMEM59;ORMDL3;BNIP3L;SCOC;KDR;DCN;HMGB1;SVIP;STK11;BAD
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3015697238008628,0.6996541078405272,0.8580323785803238,0.9651470981457092,1.0,5/21,22.31%,NPM1;CCND1;FBXO5;CDC25A;RCC2
prerank,cobalamin metabolic process (GO:0009235),-0.22990454659633255,-0.6988251666726988,0.8911290322580645,0.9715607140072486,1.0,17/17,77.04%,CUBN;MMADHC;MMAA;TCN1;AMN;ABCD4;ABCC1;CTRC;CBLIF;MMACHC;CD320;MMUT;MMAB;MTR;LMBRD1;MTRR;TCN2
prerank,phosphate ion transmembrane transport (GO:0035435),0.33075164198512313,0.6987531901169005,0.8335644937586685,0.9657155302080583,1.0,8/12,40.29%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.27892151715385843,-0.6983599942975317,0.8557377049180328,0.9706518214846508,1.0,4/11,20.93%,PTGIS;FAP;TP53;DFFA
prerank,regulation of keratinocyte migration (GO:0051547),0.33207327341146253,0.6983186377497189,0.8356164383561644,0.9658104823823733,1.0,3/12,16.57%,ARF6;EPPK1;EPB41L4B
prerank,DNA damage checkpoint signaling (GO:0000077),0.2841531706690281,0.6982417503792006,0.8385922330097088,0.9655376429995081,1.0,11/28,33.33%,CHEK2;PRPF19;ERCC6;CDC5L;STK33;ATRIP;DOT1L;RAD9A;RHNO1;CLOCK;DONSON
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3458320120040304,0.697979205332092,0.8326055312954876,0.965454876329927,1.0,2/10,16.48%,PRDM12;DNMT3B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.30578329912662344,0.6978739292742087,0.8402597402597403,0.9652070319755587,1.0,3/17,15.89%,KCNE4;KCNE5;RYR2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.23595001966957901,-0.6977318979217535,0.9068627450980392,0.9699055403704244,1.0,7/19,17.93%,CUX1;DHX36;CAPRIN2;OBSL1;CDKL3;FBXW8;CUX2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.31135118417824303,0.6973984957409839,0.8490813648293963,0.9653374052876973,1.0,5/16,19.17%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3;ST8SIA5
prerank,glycoprotein catabolic process (GO:0006516),0.3141931142721959,0.6970787646307481,0.8702983138780804,0.9653062373886364,1.0,2/17,9.13%,CTSL;FBXO27
prerank,regulation of phosphate metabolic process (GO:0019220),0.3186402936066151,0.696428208365353,0.8478543563068921,0.9656139317325647,1.0,2/16,9.27%,PGAM1;CD24
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.312295007469382,0.6962026496200938,0.8355263157894737,0.9654923849932235,1.0,3/15,10.90%,MAPK3;KDR;AATK
prerank,negative regulation of phosphatase activity (GO:0010923),0.2854149654855453,0.696172640903555,0.8435619735258725,0.9651725540998705,1.0,11/25,33.08%,FKBP1A;PPP1R1B;PPP1R35;FKBP1B;PPP1R15A;CHP1;TGFB2;PPP1R11;BOD1;PTPA;SEMA4D
prerank,protein localization to cell surface (GO:0034394),0.28548515793241797,0.6956291237933303,0.8753086419753087,0.9653522759968042,1.0,9/26,25.83%,EMP2;CTNNB1;FLNA;ARF6;JAM3;PTPRU;UNC50;PRRT1;MESD
prerank,response to insulin (GO:0032868),0.24963906833670318,0.6953747800827711,0.9148029818956337,0.9652662549732732,1.0,26/80,28.30%,AKT1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;VAMP2;HDAC5;SORT1;HDAC9;EPRS1;RAB31;EPM2AIP1;GOT1;C2CD5;KHK;SELENOS;INHBB;ZBED3;EIF6;INSIG2;TRIB3;RAB8A;XBP1;USF1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.25048771927639923,-0.6948783092226695,0.9020408163265307,0.9713651024404343,1.0,1/15,2.16%,MOXD1
prerank,regulation of cilium movement (GO:0003352),-0.2864854685832653,-0.6944969035890203,0.8552631578947368,0.9703757657346265,1.0,10/10,71.38%,CCDC39;ODAD2;CCDC65;CFAP43;CCDC40;DNAAF1;CFAP298;DNAH11;DRC1;CFAP206
prerank,bile acid metabolic process (GO:0008206),0.28010680669902677,0.6942421000852224,0.8525564803804994,0.9660855382495738,1.0,7/27,24.21%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A;NPC1
prerank,purine-containing compound salvage (GO:0043101),-0.2608535707725688,-0.6942177038306576,0.8653198653198653,0.9693063592256073,1.0,4/12,16.79%,AMPD3;ADK;AMPD2;GMPR
prerank,fatty acid catabolic process (GO:0009062),0.25201328693184116,0.6938749645322847,0.9094781682641108,0.9661108219865235,1.0,7/67,11.50%,ACADVL;SCP2;NUDT19;MTLN;HSD17B4;ACAT1;ACAA2
prerank,regulation of smooth muscle contraction (GO:0006940),0.29771418398703847,0.6927129627559785,0.8734177215189873,0.9669316882877024,1.0,9/20,31.79%,CHRM3;ATP2B1;CHRM2;CAV1;CTTN;CHRNA3;SRF;NMUR2;NMU
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2723098885192179,0.6922805002032443,0.8726415094339622,0.9670217920207466,1.0,7/33,19.76%,PDE3B;P2RY12;JAM3;PLAU;SYK;MUC1;EFNA1
prerank,regulation of protein acetylation (GO:1901983),0.32688408808560726,0.6914501353930762,0.8734353268428373,0.9675171681805429,1.0,2/12,9.69%,PARK7;CAMK1
prerank,arachidonate transport (GO:1903963),-0.28818027744648794,-0.6912944803048686,0.8373702422145328,0.9695013781815068,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,arachidonic acid secretion (GO:0050482),-0.28818027744648794,-0.6912944803048686,0.8373702422145328,0.9695013781815068,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3217879532803992,0.691001820987652,0.8437067773167358,0.9675980980993755,1.0,2/13,13.49%,ENTPD3;SMPDL3A
prerank,cilium assembly (GO:0060271),0.23039990235336727,0.6903268792315734,0.9909729187562688,0.9679108276573395,1.0,48/297,20.65%,TUBB;GSN;TUBA1A;HSP90AA1;TUBB4B;DYNLL2;DYNLL1;TUBA4A;DCTN3;PPP2R1A;IFT20;FLNA;YWHAE;DNAAF3;DYNLRB1;CLASP1;CNGA4;YWHAG;TUBB4A;FNBP1L;CEP131;FHDC1;TCTN3;DYNLRB2;DCTN1;SSNA1;HAUS2;EHD1;DCTN2;ARF4;CNGB1;TMEM17;E2F4;CETN2;PRKAR2B;CCDC28B;TCTN1;EXOC7;EHD2;DCX;NOTCH1;BBIP1;NEK1;EXOC5;BBOF1;CFAP410;CFAP54;EXOC8
prerank,negative regulation of telomere maintenance (GO:0032205),0.31673626682461786,0.6903149837713546,0.8492063492063492,0.967569242146965,1.0,2/15,5.17%,TERF1;PARP1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2785179648852705,0.6902856535910242,0.875,0.9672396330312776,1.0,8/33,19.20%,AKT1;CCND2;CCND1;AIF1;ADAM17;FAM83D;ADAMTS1;DDRGK1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2549836894962764,0.6896422821893624,0.9067702552719201,0.9675052614206018,1.0,16/56,24.04%,RHOB;ANK3;RHOC;DCTN3;ANLN;RHOA;STMN1;SNX33;USP8;VPS4A;UNC119;CKAP2;SPIRE1;INCENP;RTKN;ECT2
prerank,signal transduction by p53 class mediator (GO:0072331),0.27272710833677044,0.6891908026732814,0.8930669800235017,0.9676062880919949,1.0,9/30,28.39%,HINT1;NDRG1;PMAIP1;STK11;POU4F1;PYCARD;BOK;PAXIP1;PDK2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.29625534184507585,0.6886925407966417,0.8589743589743589,0.967759775395679,1.0,10/21,26.06%,HS6ST3;HS3ST5;B3GAT3;SGSH;UGDH;XYLT1;HPSE;HS6ST1;HS6ST2;GPC1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.293331821515709,0.6880861681530411,0.8676092544987146,0.9680121489632622,1.0,2/21,2.94%,SMDT1;TGM2
prerank,in utero embryonic development (GO:0001701),0.2855826229369227,0.6875519464269555,0.8730350665054414,0.9681753077991933,1.0,5/25,15.42%,FOXD3;SOX8;PTPRR;BMP2;IGF2
prerank,cilium-dependent cell motility (GO:0060285),0.2898999838890567,0.686719410002328,0.8729559748427673,0.9686528545894258,1.0,3/22,11.99%,DNAI3;DNAH2;DNAH1
prerank,folic acid metabolic process (GO:0046655),0.2985928260415449,0.6853347163428742,0.8470290771175727,0.9696326554142217,1.0,8/18,32.91%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.2636402797292817,0.6851417725202238,0.8906426155580609,0.9694545480031059,1.0,16/42,27.90%,S100A10;EMP2;RAC1;THY1;KDR;RRAS;CCL28;SKAP1;SFRP1;COL16A1;PPM1F;TEK;EFEMP2;CX3CL1;MYOC;CD3E
prerank,sulfur amino acid metabolic process (GO:0000096),0.28104617211916916,0.6850817224017546,0.8868388683886839,0.9691596889631052,1.0,4/24,15.82%,MPST;SMS;TXN2;TST
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3380775068680176,0.6849134896532492,0.8425655976676385,0.9689818836216703,1.0,2/10,10.44%,MFSD2A;MTMR9
prerank,RNA 3'-end processing (GO:0031123),0.24508413523183134,0.6839104004183403,0.9300106044538706,0.9695715241866597,1.0,14/69,22.07%,MAGOHB;MAGOH;DDX39B;SRSF9;LIN28B;SRSF2;CPSF2;THOC3;EIF4A3;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,amide biosynthetic process (GO:0043604),0.2550887574110563,0.6830484285038825,0.9115646258503401,0.970048934846773,1.0,15/47,32.49%,CERS2;SMPD1;SPTLC1;DEGS1;FA2H;CLN8;SPTSSA;ASAH2;AANAT;ASL;SAMD8;ASS1;ARG2;PCSK1;CERS6
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.25225113235855884,0.6829835131898783,0.9055201698513801,0.9697588864251533,1.0,23/59,27.56%,CTNNB1;CDK8;CCND1;CEBPB;TRIM28;JUN;CSF1R;BAX;THRA;SOX9;MED31;MED30;TWIST1;AGO1;IL6;RELA;CCNC;MED7;LEF1;CDKN1A;MED16;MED25;MED12
prerank,icosanoid secretion (GO:0032309),0.3252361343263463,0.6823445478530843,0.8614958448753463,0.9700467366315779,1.0,5/12,32.09%,NOS2;NMUR2;PNPLA8;DRD2;ACE
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.28139934890639107,-0.6822888761031832,0.85,0.9766717486869163,1.0,2/10,9.43%,ERRFI1;ENPP1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.28938612033942845,0.681783071394623,0.8745247148288974,0.9702347149061455,1.0,8/22,28.79%,UBAP1L;VPS28;VPS4A;VPS37C;VPS36;RNF126;SNF8;MVB12A
prerank,phospholipid biosynthetic process (GO:0008654),0.26244468545954125,0.6816906102725551,0.888509670079636,0.9699777707553418,1.0,14/36,33.28%,FADS1;PCYT2;DOLK;CPNE6;AGPAT5;SPHK2;FDPS;NUS1;CPNE3;GPAM;SAMD8;DPAGT1;GNPAT;MBOAT1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.24693179650333108,-0.6812258429408992,0.9047619047619048,0.9762602840716411,1.0,4/15,12.43%,MDC1;ATF2;TIPIN;RAD17
prerank,inositol phosphate catabolic process (GO:0071545),0.3240112695911681,0.6811254803784049,0.861731843575419,0.9701907115956203,1.0,2/12,13.53%,NUDT3;INPP5J
prerank,mRNA transport (GO:0051028),0.23564713297881518,0.6809410161057002,0.9449064449064449,0.970010930263834,1.0,22/101,22.07%,MAGOHB;MAGOH;DDX39B;ZFP36L1;SRSF9;RBM15B;ZFP36;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,negative regulation of macroautophagy (GO:0016242),0.28668596491840354,0.680755267639476,0.8884803921568627,0.969842925196068,1.0,3/26,9.04%,AKT1;PINK1;NUPR1
prerank,neural crest cell differentiation (GO:0014033),0.2988153749708275,0.6806777409797284,0.8708827404479579,0.9695695632572515,1.0,9/18,32.04%,NRG1;PDCD6;SOX8;SOX11;MEF2C;HTR2B;NOLC1;KBTBD8;CDH2
prerank,positive regulation of rRNA processing (GO:2000234),0.3329330065220849,0.680015251359028,0.8368495077355836,0.9698419399952329,1.0,1/10,4.39%,TRMT112
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2792539293580255,0.6796405382158781,0.874390243902439,0.9698370414794246,1.0,7/26,20.14%,NR1D1;EPHA5;ADCY8;PIM3;BRSK2;STX4;FOXA2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2851284244531782,0.6792342155044495,0.8957816377171216,0.9698716140050853,1.0,3/24,13.40%,HSP90AA1;PQBP1;LILRB1
prerank,cardiac muscle tissue development (GO:0048738),0.2532582244241316,0.6786398379296729,0.8974358974358975,0.9700847575799466,1.0,10/50,17.13%,NRG1;RBP4;SGCZ;MSX1;KDM6B;GJA1;BMP2;HEY1;GATA4;SGCG
prerank,protein acylation (GO:0043543),0.26549487866452476,0.6776472746584951,0.8925714285714286,0.9706755853507791,1.0,12/38,29.54%,GLUL;SELENOK;ZDHHC5;NAA10;NAT9;ING5;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29780721423182743,0.6774988708465557,0.8634590377113134,0.9704574287257675,1.0,3/18,8.00%,SPI1;ST18;CEBPA
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2519623807783847,-0.677446114295353,0.89568345323741,0.9783074002750805,1.0,5/13,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,mesoderm formation (GO:0001707),-0.23130149130359778,-0.6765113491673481,0.9120370370370371,0.9777889268291028,1.0,4/17,16.29%,ITGB4;ITGA3;SMAD2;BMPR2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2880594869563072,0.6763972938351648,0.8706338939197931,0.9711525533743224,1.0,8/18,29.26%,SLC25A13;SMS;NAT8L;ASNS;GOT1;SLC25A12;ADI1;ASS1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28688865319003237,0.6762165226529011,0.8794587945879458,0.9709783508609868,1.0,6/20,25.82%,CDKN1C;CEBPA;HEXIM1;TFAP4;MEN1;HHEX
prerank,mitotic spindle organization (GO:0007052),0.23333847310273814,0.6762021303524779,0.9706180344478217,0.97063830818033,1.0,20/153,17.39%,RPS27;DYNLL2;DYNLL1;RAN;CHEK2;FLNA;VCP;SBDS;ABRAXAS2;CLASP1;XPO1;BUB3;RHOA;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1;TOGARAM2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.28923658397806773,0.6752486619729069,0.8652392947103275,0.9711937722184485,1.0,8/19,32.91%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2603964249046843,0.6743655109366327,0.9146482122260668,0.9716985888386283,1.0,8/40,16.26%,NTRK2;ANG;C5AR1;P2RY6;P2RY12;HRAS;ADRA1A;FLT1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.28058151289469035,0.672707552952055,0.8875305623471883,0.9728865577241801,1.0,8/24,26.23%,TERF1;PARP1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,synaptic vesicle transport (GO:0048489),0.32303497586923446,0.672144561005864,0.86468200270636,0.9730607008475615,1.0,3/11,18.48%,KIF5A;CDK5;KIF5C
prerank,phagosome-lysosome fusion (GO:0090385),0.33239324791381963,0.6709977250930319,0.8609077598828697,0.9737440023813995,1.0,7/10,39.87%,RAB20;SYT7;RAB34;RAB39A;ARL8B;RAB7A;RAB7B
prerank,protein kinase A signaling (GO:0010737),0.3135038910103371,0.6708366785463489,0.8649732620320856,0.9735514106029123,1.0,3/12,30.61%,LCP1;PRKACA;PRKACB
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2251682203735622,0.6704149587832297,0.993,0.9735802716688005,1.0,65/327,22.44%,PFDN5;RPL6;CALR;CXXC1;ATF4;SOX18;HINT1;LYL1;RALY;MAGED1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;BTG1;FADS1;TBX22;CEBPB;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;SOX17;ATF5;BMP2;UBE2V1;MAFA;NONO;SPIN4;IGF2;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2696147998734461,0.6698774663695403,0.9045346062052506,0.973742343163435,1.0,11/33,29.26%,PSME1;PSME2;FBXW7;FAM83D;DDRGK1;PTPN6;ID2;CDKN1A;TRIM39;ATP2B4;PSME3
prerank,renal filtration (GO:0097205),0.3390623013426178,0.6692454962855169,0.8618233618233618,0.9739565196016287,1.0,3/10,11.09%,CD34;TMEM63C;MCAM
prerank,mRNA methylation (GO:0080009),0.3043288920878593,0.6692446599129099,0.8690958164642375,0.9736061184676141,1.0,5/15,25.03%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,xenobiotic transport (GO:0042908),0.2964100394228018,0.6689046196362185,0.8620236530880421,0.9735603193293014,1.0,6/17,26.25%,SLC7A5;GJA1;SLC15A2;ABCC3;ABCA3;ABCC5
prerank,striated muscle cell development (GO:0055002),0.3021439140741847,0.6674977505409134,0.8671232876712329,0.9744864401101606,1.0,7/14,35.92%,FLII;TMOD1;CAPN3;KLHL41;LMOD1;LMOD3;SDC1
prerank,chemical homeostasis (GO:0048878),0.2411864250831124,0.667384666799064,0.9362637362637363,0.9742436697172893,1.0,8/61,13.10%,AQP4;PNPLA2;TREM2;RBP1;CEBPA;ATP13A2;ABHD8;FBXW7
prerank,detection of mechanical stimulus (GO:0050982),-0.22446425600267053,-0.667102505864507,0.927710843373494,0.9845162613762556,1.0,4/19,10.70%,PIEZO2;PIEZO1;PKD1;PTK2
prerank,myotube cell development (GO:0014904),-0.27402904148056484,-0.6670603216307994,0.8774834437086093,0.9831759050289821,1.0,3/10,13.03%,SKI;IGF1;SIX1
prerank,DNA replication (GO:0006260),0.2341437857996977,0.666995592398432,0.957688338493292,0.9742564655570811,1.0,33/105,32.27%,PTMS;RNASEH2A;MCM5;RPA2;SET;RFC2;RECQL5;POLD4;ING5;RFC4;FAM111A;POLG;BLM;CDC45;POLD1;PNKP;BARD1;NAP1L1;ATRIP;RPA3;RPAIN;PIF1;RAD9A;RMI1;MCM7;MCM2;POLE3;KAT5;DNA2;RHNO1;UPF1;TOPBP1;TBRG1
prerank,RNA export from nucleus (GO:0006405),0.22921818383388612,0.666503587794919,0.9443872296601442,0.9743521371107968,1.0,35/100,32.55%,MAGOHB;MAGOH;DDX39B;RAN;SRSF9;RBM15B;SRSF2;NUP85;HNRNPA1;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;XPO5;UPF1;POLDIP3;U2AF1
prerank,acetyl-CoA metabolic process (GO:0006084),0.2973688516325244,0.666355396659292,0.8819538670284939,0.9741296041887062,1.0,5/15,28.44%,ACAT1;PPCS;PMVK;ACLY;HMGCS1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.29895689825998834,0.6662795264169661,0.881491344873502,0.9738478207412613,1.0,3/15,19.67%,TNF;TLR6;IL6
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.276080085521843,-0.6656783566347348,0.8675496688741722,0.9829832555119904,1.0,2/10,13.39%,SH3RF1;CBFB
prerank,protein localization to Golgi apparatus (GO:0034067),-0.20195166806525605,-0.6656214775356085,0.9414893617021277,0.9816597673354811,1.0,7/27,17.06%,VPS13A;VPS13D;GBF1;OPTN;OBSL1;ARL5B;GBP5
prerank,cellular response to interleukin-4 (GO:0071353),-0.26790534178645403,-0.665577139959835,0.8838028169014085,0.9803305456136058,1.0,10/10,73.23%,STAT6;JAK3;GATA3;TCF7;RUFY4;XCL1;DCSTAMP;SHPK;XBP1;LEF1
prerank,RNA modification (GO:0009451),0.24813181851965121,0.6653328922845536,0.9258028792912514,0.9743068582294616,1.0,14/54,25.97%,METTL1;NOP10;RBM15B;AARS2;CTU1;MEPCE;PUS7;FTSJ3;ADAT2;URM1;THUMPD1;METTL3;CTU2;LCMT2
prerank,transport along microtubule (GO:0010970),0.3103053212714919,0.6649105447014857,0.8610354223433242,0.9743248467160838,1.0,6/13,31.29%,CLIP3;BORCS5;COPG1;APP;CAMSAP3;SPG11
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2739082064176152,0.6647832053972212,0.9063260340632603,0.9740893776298486,1.0,5/25,20.22%,TREM2;MAPT;CD22;CCL3;TRAT1
prerank,sulfur compound transport (GO:0072348),0.2720143950371114,0.6645484513623022,0.9057071960297767,0.9739427165208241,1.0,6/27,18.57%,MGST1;SLC6A6;SLC26A4;SLC25A11;SLC25A19;SLC19A2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3050609803120625,0.6644457543066494,0.8846675712347354,0.9736942974580297,1.0,3/14,23.84%,CD84;RASGRP1;PAEP
prerank,intracellular lipid transport (GO:0032365),0.2778716336378948,0.6644235229673469,0.8967254408060453,0.9733693379270392,1.0,2/21,4.19%,NPC2;MID1IP1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.251094490121877,0.664196923191077,0.9271070615034168,0.9732140293872543,1.0,12/46,21.15%,ATF4;ID1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.240654329258619,-0.6641521139183906,0.922509225092251,0.980095641000238,1.0,5/14,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,protein alkylation (GO:0008213),0.27841002042668517,0.6639683416929433,0.8845686512758202,0.9730755588501113,1.0,5/22,22.90%,EEF1AKMT2;PRMT1;SNRPB;SNRPD3;ETF1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3078569306292032,0.6639640238460603,0.8706666666666667,0.9727302697140457,1.0,4/12,23.31%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.31458171413188096,0.6638436206423309,0.8625850340136054,0.9724903909788829,1.0,3/12,16.24%,CADM4;DCN;DAB2IP
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.24908306271121233,0.6626461229486842,0.9131905298759865,0.9732079509238152,1.0,8/44,18.11%,PARK7;SCP2;HSD17B4;OSBPL6;SC5D;PNPO;OSBPL3;CH25H
prerank,estrogen metabolic process (GO:0008210),0.29864846534565676,0.662600139002386,0.8604026845637583,0.9729036980374047,1.0,4/15,33.23%,HSD17B4;HSD17B11;HSD17B8;HSD17B10
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.23756888402533655,-0.66247289486741,0.9369747899159664,0.9801039345268211,1.0,3/14,16.01%,FOXO3;EARS2;MTERF2
prerank,establishment of spindle orientation (GO:0051294),-0.1999548419463289,-0.6615618157952158,0.9593023255813954,0.9794324527643054,1.0,9/28,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;LLGL2;NDC80
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2735190209588013,0.6613312816774062,0.8926767676767676,0.9736832090271235,1.0,7/23,33.28%,PLAAT3;PLA2G4F;PLA2G3;PLA2G6;PLBD1;PNPLA8;MBOAT1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.23938133813510182,-0.6612980937758066,0.9212598425196851,0.9782619119503447,1.0,3/14,12.45%,BCAS3;TRIM24;AR
prerank,chromatin remodeling (GO:0006338),0.2275304740874674,0.6597463734586025,0.9553941908713693,0.9747125230802934,1.0,17/100,21.30%,ACTB;NPM1;MBD3;PAK1;NPM3;PIH1D1;KDM6B;ZBTB7A;SOX9;HDAC5;ERCC6;MTA2;CHD3;CBX3;MYC;ACTR5;FOXA1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.23093155711265323,0.6593108254622757,0.9650205761316872,0.9747257640543363,1.0,24/102,22.38%,AKT1;GPER1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;PRKAR1A;VAMP2;PRKAR1B;ADCY4;HDAC5;ADCY8;HDAC9;CAV1;PRKAR2B;EPRS1;RAB31;GOT1;C2CD5;SELENOS;INHBB;TSHR
prerank,membrane fusion (GO:0061025),0.25884075429129094,0.6592255311528832,0.917550058892815,0.9744495490796714,1.0,9/33,22.53%,DNM3;RIMS1;VAMP3;VAMP2;NAPA;DNM1L;GCA;VAPA;DNM1
prerank,mesenchyme morphogenesis (GO:0072132),0.28784149878325016,0.6578513354105463,0.8801546391752577,0.9752920004098532,1.0,8/17,28.22%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,positive regulation of heart rate (GO:0010460),0.28801574008356845,0.6573493044018582,0.8863636363636364,0.9753772432701644,1.0,6/17,27.61%,RYR2;ADRA1D;ADRA1A;EDN3;ATP2A2;KCNQ1
prerank,leukotriene biosynthetic process (GO:0019370),0.3009925170025072,0.6571121100988723,0.8674698795180723,0.9752198006145218,1.0,5/14,29.46%,MGST3;ALOX5AP;LTC4S;GGT5;GGT7
prerank,regulation of presynapse organization (GO:0099174),0.28448407975515144,0.6566229861986463,0.9085051546391752,0.9749451407322309,1.0,8/18,24.38%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,regulation of presynapse assembly (GO:1905606),0.28448407975515144,0.6566229861986463,0.9085051546391752,0.9749451407322309,1.0,8/18,24.38%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,endocardial cushion morphogenesis (GO:0003203),0.28480496554689205,0.6550303765400749,0.8910256410256411,0.9759575443201441,1.0,8/18,28.22%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,regulation of cytokinesis (GO:0032465),0.23650267399921934,0.6530621274972237,0.9518716577540107,0.9773182593645328,1.0,4/78,4.81%,CALM1;CALM3;KLHL9;PIN1
prerank,protein lipidation (GO:0006497),0.24192117878800112,0.653044738813371,0.9420765027322404,0.9769805803040119,1.0,16/59,29.54%,PIGZ;PIGQ;GLUL;SELENOK;ZDHHC5;DPM3;DPM2;WDR45;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;WIPI2;PGAP4;ZDHHC14;ZDHHC16
prerank,actin filament network formation (GO:0051639),0.31131932306139265,0.652851283683682,0.8887362637362637,0.9767851496385077,1.0,4/11,22.93%,LCP1;ACTN1;FHOD3;SPIRE1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.2225441918510364,0.6527146038218002,0.9733606557377049,0.9765434624762784,1.0,26/138,18.49%,NPPC;ERBB4;NTRK2;LTK;SHC3;MUSK;PTK6;KDR;MPZL1;EPHA5;HCK;CSF1R;FLT4;PTPRD;TIE1;EPHB1;GFRA2;FLT1;TYRO3;CASS4;LCP2;SYK;DDR2;ERBB3;SRMS;SLA
prerank,nuclear pore organization (GO:0006999),-0.23683517668948575,-0.6525876245999954,0.9266666666666666,0.9834385754305415,1.0,6/14,22.28%,NUP98;AHCTF1;NUP35;NDC1;TPR;NUP93
prerank,RNA methylation (GO:0001510),0.23876366008240854,0.6525267407875399,0.9501084598698482,0.9763465961072649,1.0,15/60,26.12%,METTL1;TRMT112;FBL;RBM15B;PCIF1;CMTR1;ZCCHC4;MEPCE;FTSJ3;TRMT10C;METTL3;METTL14;WDR6;LCMT2;TYW3
prerank,sprouting angiogenesis (GO:0002040),0.242005549124017,0.6519080470508779,0.9448123620309051,0.9765128137947211,1.0,5/51,8.38%,RAMP2;AKT1;ACVRL1;OTULIN;KDR
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.257564236543884,0.6515645650670033,0.9164705882352941,0.9764572122818894,1.0,9/37,21.37%,CALM1;CALM3;CADM4;RIPK2;DMTN;CALM2;TGFB1;DDIT4;SIRT2
prerank,negative regulation of viral release from host cell (GO:1902187),0.30443475431852896,0.6515057131005215,0.8844621513944223,0.9761582464181017,1.0,3/13,19.65%,TRIM28;TRIM32;TRIM13
prerank,protein targeting to peroxisome (GO:0006625),-0.19930968004027436,-0.6503404121375896,0.96045197740113,0.9836896453315458,1.0,3/29,4.26%,LONP2;ZFAND6;ABCD3
prerank,glycoprotein biosynthetic process (GO:0009101),0.2331213426721735,0.6503234470558303,0.9585547290116897,0.9767926705340255,1.0,23/79,25.19%,DAD1;DDOST;B3GNT9;SERP1;ST8SIA4;GCNT1;ALG3;XYLT1;FUT9;B3GNT3;ST6GALNAC2;ST8SIA5;CANT1;TMEM106A;CSGALNACT2;TNIP1;B3GALT5;MGAT1;GAL3ST3;NUS1;B3GALT2;NPC1;CHST9
prerank,regulation of Golgi organization (GO:1903358),0.28624891850621176,0.6500920191520392,0.8922686945500634,0.9766233598673506,1.0,4/17,18.60%,MAPK3;MYO5A;PDE4DIP;MAP2K2
prerank,tRNA transport (GO:0051031),0.25236642764596207,0.6496800644962681,0.9251461988304094,0.9766019902896017,1.0,14/35,31.92%,RAN;YBX1;TOMM20L;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L;TOMM20
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.31007124658522406,0.6496342530867496,0.8865836791147994,0.9763027073073778,1.0,1/12,3.71%,TNF
prerank,integrin-mediated signaling pathway (GO:0007229),0.23503187278724827,0.6479049255845104,0.9447453954496208,0.9773720785205976,1.0,11/73,14.05%,ITGB2;ADAM15;SEMA7A;FN1;ISG15;ZYX;THY1;COL3A1;HCK;NME2;ERBIN
prerank,regulation of cytoplasmic translation (GO:2000765),0.29702016331864134,0.6471971402521902,0.8958051420838972,0.9776023215958954,1.0,3/14,17.91%,PKM;YBX3;CNBP
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.28172483518816266,0.6469404753982242,0.8919270833333334,0.9774664779035893,1.0,2/19,13.44%,AQP4;NEK10
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2585904265593256,-0.6467159221399182,0.8857142857142857,0.9849905541902753,1.0,3/10,21.07%,UBXN2B;GSK3B;NUP62
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2499559802070502,-0.646322557438655,0.9101123595505618,0.9839150264185443,1.0,3/11,13.51%,IWS1;SLTM;SRPK2
prerank,response to estrogen (GO:0043627),0.2599805442792211,0.6459793609350851,0.9215219976218787,0.977863389437575,1.0,9/31,23.99%,CD24;WBP2;CAV1;RBBP5;NCOA4;CITED2;SFRP1;SFR1;KRT19
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22540054481620517,0.6437992717145763,0.9743062692702981,0.9792805007428272,1.0,15/125,17.28%,RPS27;DYNLL2;DYNLL1;RAN;SBDS;CLASP1;XPO1;TACC3;BUB3;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1
prerank,endocytic recycling (GO:0032456),0.24493213282340062,0.6437985623696821,0.9284928492849285,0.9789333612530213,1.0,8/50,18.18%,SNX17;RAB14;ARF6;ARL4C;CMTM6;EHD1;DENND1C;EHD2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2322821989854366,0.6424205097811347,0.9533898305084746,0.9796668396070883,1.0,18/69,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2770123464399793,0.6413416256542241,0.91005291005291,0.9801987420066567,1.0,5/19,15.24%,HS6ST3;HS3ST5;B3GAT3;UGDH;XYLT1
prerank,regulation of phospholipase activity (GO:0010517),0.3149650771878382,0.6409675324728029,0.8976486860304288,0.9801372927870438,1.0,4/10,25.73%,RGS2;RASGRP1;SNCA;FGFR3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2933592738261057,0.6407733542030348,0.9014844804318488,0.9799334583329007,1.0,3/14,16.89%,PRKAR1A;PRKAR1B;PRKAR2B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2929595390751967,0.639354309619921,0.8891820580474934,0.9807061258753542,1.0,3/14,19.21%,ENTPD3;NUDT16;NUDT9
prerank,necroptotic process (GO:0070266),0.28874729104324703,0.6390779076582392,0.8893229166666666,0.980570304313503,1.0,7/16,36.23%,TICAM2;DNM1L;CD14;PGAM5;MLKL;IPMK;ITPK1
prerank,regulation of mRNA processing (GO:0050684),0.2525500267959237,0.6390185896090402,0.9237089201877934,0.9802713375447399,1.0,3/32,4.40%,HNRNPK;QKI;ZFP36L1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2332998493219488,-0.6388792493124262,0.9076923076923077,0.9876885842631858,1.0,13/13,76.70%,PVR;NECTIN2;IL12A;IL23A;IL23R;IL12B;XCL1;SLC22A13;MR1;FADD;STX7;CYRIB;IL12RB1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.21094800234572395,0.6387775540022314,1.0,0.9801247722748396,1.0,175/834,22.83%,RPS27A;UBC;UBB;CD81;PCBP1;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;ATF4;KLF2;SOX18;PTPRN;POMC;NPM1;GPER1;EIF5A;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;SPI1;EPAS1;GLMP;JUNB;PIN1;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;HES1;HYAL2;HIPK2;CDK8;OTX2;UBA52;FOXF2;CEBPB;FOXD3;NAMPT;SALL2;CEBPA;PROX1;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;HOXB7;PHOX2A;MC1R;IRF8;APBB1;SUPT4H1;APEX1;WNT5A;IL11;SOX17;ATF5;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;NME2;HNRNPU;TNFRSF1A;HDAC5;ATMIN;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;IGF2;ARF4;NR1H2;KDM1B;SUB1;HEY1;DLL1;IER5;MEPCE;DAB2IP;E2F4;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;ADCYAP1;PPARGC1A;MED21;AGO1;CNBP;TOX2;LMO1;NRL;SOX11;PPP3CA;DDRGK1;MUC1;INHBA;NLRP3;ESRRB;TFAP2B;NOTCH1;IL6;HGF;TGFB1;AGRN;POU4F1;CITED2;MEF2C;FOXA2;MYC;NFKBIA;FOSL2;CDC5L;DDIT3;CEBPZ;CDK9;FOXA1;CKAP2;SIRT2;PLXND1;MEN1;SS18L1;IRF5;REST;GRHL2;TNIP1;SOX1;MYDGF;CSRNP1;IER2;AKIRIN2;PPP3R1
prerank,peroxisome organization (GO:0007031),-0.20356233270025778,-0.6385456804183753,0.9774011299435028,0.9865720674358005,1.0,7/25,16.54%,LONP2;ABCD3;ACOT8;PEX7;TMEM135;SEC16B;PEX11A
prerank,polyol metabolic process (GO:0019751),0.24205917733819304,0.6384935176492426,0.9461009174311926,0.980011966032841,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of RNA metabolic process (GO:0051252),0.23360773858284123,0.6379314190469125,0.9532608695652174,0.9800702036975808,1.0,15/59,23.76%,PCBP1;AHNAK;PCBP4;PQBP1;RRP1B;FAM50A;METTL18;PRX;OAS3;SRRM4;HNRNPF;IGF2BP3;HNRNPLL;HNRNPH2;PCBP2
prerank,regulation of histone modification (GO:0031056),0.2968951035238236,0.6374822197732776,0.9021164021164021,0.9800638823168428,1.0,1/13,1.76%,PARK7
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3063400688794452,0.6373385946862679,0.879382889200561,0.9798301171002518,1.0,2/11,13.45%,EGR1;BMP2
prerank,histone acetylation (GO:0016573),0.23137048379879716,0.6372517133603596,0.9635193133047211,0.9795515919484326,1.0,9/69,10.80%,SPI1;BRD1;BRPF1;TAF10;JADE1;MORF4L2;TAF5L;TAF9;APBB1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2411392281639274,0.6370222541074205,0.9492671927846674,0.9793836504436695,1.0,10/49,20.07%,MYL9;H3-3A;PRMT1;PF4;L3MBTL1;SCIN;RBBP5;AGO1;THPO;MEF2C
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.28359078621271655,0.637021047327333,0.8887399463806971,0.979039338740681,1.0,6/16,26.00%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,snRNA transcription (GO:0009301),0.23005013580590825,0.6368394271367099,0.9566137566137566,0.9788322999994393,1.0,18/70,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,N-glycan processing (GO:0006491),-0.22178716004455823,-0.6363327182856154,0.9699570815450643,0.9867197572080924,1.0,2/18,5.77%,MAN1C1;FUT8
prerank,tRNA wobble uridine modification (GO:0002098),0.2941533171370122,0.63619035414489,0.8909574468085106,0.9789825875928811,1.0,5/14,24.68%,DPH3;ELP3;CTU1;URM1;CTU2
prerank,regulation of filopodium assembly (GO:0051489),0.24567888155543602,0.6351655987196619,0.9243986254295533,0.9794151950651606,1.0,9/38,19.90%,NLGN1;TENM2;ARF6;FNBP1L;TRPM2;GAP43;DMTN;GPM6A;AGRN
prerank,RNA stabilization (GO:0043489),0.2525454040136882,0.6348797889472799,0.9333333333333333,0.9792931116819197,1.0,10/33,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;DKC1;NAF1;ELAVL1;DND1
prerank,modulation by symbiont of entry into host (GO:0052372),0.2875214279049935,0.6339027252396748,0.9050131926121372,0.9796753596928321,1.0,9/16,37.84%,HS3ST5;CAV1;EXOC7;TRIM68;TRIM25;TRIM27;TRIM21;TRIM14;TRIM6
prerank,protein K48-linked deubiquitination (GO:0071108),0.2658337469361836,0.6325530750556572,0.9170854271356784,0.9803220257129381,1.0,5/23,16.72%,TNFAIP3;USP5;OTUD7A;OTUB1;USP8
prerank,cardiac ventricle morphogenesis (GO:0003208),0.24298473720325753,0.6325412427603687,0.9480968858131488,0.9799864361671059,1.0,10/41,21.55%,FKBP1A;CPE;PROX1;HEY1;GATA4;SOX11;NOTCH1;TGFB1;MEF2C;NPY5R
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.29851041600690575,0.6320767334129881,0.9026425591098748,0.9799740197299304,1.0,3/12,17.36%,MTLN;TWIST1;PPARGC1A
prerank,artery development (GO:0060840),0.26440511682294715,0.6319229813277618,0.9221105527638191,0.9797481043494165,1.0,3/23,5.71%,ACVRL1;APLNR;HES1
prerank,ureteric bud morphogenesis (GO:0060675),-0.22665972454107175,-0.6316749165437053,0.9578544061302682,0.9882360474149171,1.0,7/16,27.15%,SIX1;WNT11;BMP4;FGF2;PKD2;GDNF;NPNT
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.29294555665113475,0.6304169146457032,0.8951724137931034,0.9805215540309222,1.0,4/12,26.54%,SNAP25;STX4;STX1B;STX3
prerank,regulation of myotube differentiation (GO:0010830),0.2615405081958695,0.6303670054579041,0.910761154855643,0.9802146998010182,1.0,7/24,21.71%,BHLHE41;TMEM119;HDAC5;HDAC9;MMP14;NOTCH1;CCN3
prerank,tryptophan catabolic process (GO:0006569),0.3048736545166766,0.6300209987224706,0.896358543417367,0.9801268038667231,1.0,1/11,11.01%,IDO2
prerank,inositol phosphate metabolic process (GO:0043647),0.23850870118612683,0.6295158058906538,0.9450171821305842,0.9801331222471091,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of myelination (GO:0031641),0.25856843719920625,0.6283298713520856,0.9265255292652553,0.9806144672403112,1.0,8/25,28.03%,KLK8;MYRF;TENM4;PTPRZ1;SIRT2;PTN;TMEM98;TNFRSF1B
prerank,digestive tract morphogenesis (GO:0048546),-0.23017550581184265,-0.6281363495456911,0.9418604651162791,0.9891147199028836,1.0,2/14,8.39%,NIPBL;FGFR2
prerank,response to ketone (GO:1901654),0.2615885298726089,0.623797883902095,0.9344059405940595,0.9834336620099563,1.0,6/24,19.84%,CCL19;WBP2;HSD3B2;CAV1;SLIT3;TGFB1
prerank,epidermal cell differentiation (GO:0009913),0.24071544801410522,0.6235742885077159,0.9523809523809523,0.9832374169315118,1.0,4/41,13.69%,TXNIP;CTNNB1;WNT5A;EVPL
prerank,peptidyl-serine modification (GO:0018209),0.21351872423177357,0.6232403457696197,0.9919028340080972,0.9831479342424658,1.0,29/166,19.18%,AKT1;PNCK;PINK1;MAST3;PDGFB;CAMK1D;PARP1;UHMK1;HIPK2;SGK1;PKN1;MAST1;CDK5R1;CAMK1;NAA10;POGLUT3;ULK3;GAS6;DCLK3;SBK1;STK32C;CAMKV;CDK5;HIPK4;GALNT13;CSNK1G2;STK32A;MKNK1;GRK2
prerank,sphingoid metabolic process (GO:0046519),0.2960221856669262,0.6224377330512946,0.9074074074074074,0.9833871305463278,1.0,5/12,21.12%,NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.26135733541627665,0.6223972145954535,0.925,0.9830709412237482,1.0,10/22,32.38%,PSMC3;MED30;SUB1;SRF;PAXIP1;MED16;MED12;PSMC5;PSMC2;MED4
prerank,regulation of autophagosome assembly (GO:2000785),0.24414928717953419,0.622239912447262,0.9421296296296297,0.9828305191544878,1.0,4/33,13.21%,PINK1;IFT20;NUPR1;UBQLN2
prerank,phosphate ion transport (GO:0006817),0.27604159418058316,0.6221465872825742,0.906578947368421,0.9825511449844331,1.0,8/16,40.29%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,endodermal cell fate commitment (GO:0001711),-0.25078875006087065,-0.6220821657703545,0.9184397163120568,0.9915271151308676,1.0,4/10,22.76%,CDC73;RTF1;SOX2;CTR9
prerank,establishment of melanosome localization (GO:0032401),0.27575573776640105,0.6218595514428014,0.918954248366013,0.9824090098550284,1.0,7/19,30.83%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2795145142239869,0.6208808414533765,0.9090909090909091,0.9827408497660112,1.0,3/15,13.55%,YWHAE;CAMK1;GAS6
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2478073618562365,0.6204820276807909,0.9435957696827262,0.9826724887721652,1.0,8/32,22.85%,PCNA;FBXO5;CDK5;ESRRB;KLF11;ID2;CDC45;CDK18
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.27944544303013064,0.6202920788598073,0.9067017082785808,0.9824642184144066,1.0,4/15,23.89%,PNP;SYK;CCR2;HSPH1
prerank,regulation of lamellipodium organization (GO:1902743),0.28581829278949544,0.6196406988951629,0.9228687415426252,0.9825715663277451,1.0,4/14,22.97%,RAC1;DMTN;TWF1;TWF2
prerank,organelle transport along microtubule (GO:0072384),0.2495891419355523,0.6192730317158276,0.9388235294117647,0.9824707475001034,1.0,3/31,11.11%,UBB;MAPT;HAP1
prerank,cellular response to pH (GO:0071467),-0.21288201134951476,-0.6190384340907452,0.964,0.9919700583244039,1.0,2/17,10.93%,SLC9A1;RAB11B
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.30508263178050476,0.6188286567378164,0.9029957203994294,0.9824290452793754,1.0,6/10,34.38%,PODXL;SKAP1;ADA;CD3E;CCL5;FERMT3
prerank,response to progesterone (GO:0032570),0.27473352323850186,0.6188240156423243,0.9214659685863874,0.9820908872939088,1.0,8/18,32.88%,WBP2;CAV1;TGFB1;TGFB2;UBE3A;ACOD1;NR1H3;CATSPER2
prerank,cytosolic transport (GO:0016482),0.21373702274324557,0.6184428230001299,0.9825641025641025,0.9819879679523307,1.0,18/108,19.62%,LAMP1;LAPTM5;EMP2;MAGEL2;RAB14;CLTC;YKT6;VAMP3;BET1L;ARL1;DCTN1;CLN5;SORT1;HOOK1;PREPL;SYS1;SNX16;TBC1D10C
prerank,mRNA export from nucleus (GO:0006406),0.21308557877790865,0.618405230214073,0.9804123711340206,0.981672912100494,1.0,21/102,22.07%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;PCID2;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,response to steroid hormone (GO:0048545),0.2459852513461267,0.6180972037022017,0.941747572815534,0.9815288677970296,1.0,7/31,19.84%,ATP1A3;WBP2;ATP1A1;PAQR7;ABCA2;CAV1;TGFB1
prerank,cellular response to hydroxyurea (GO:0072711),0.30576674839118884,0.6177263676614931,0.9097421203438395,0.9814215094037275,1.0,3/10,22.29%,NSMCE3;DDX11;BLM
prerank,protein oxidation (GO:0018158),0.29617818155076187,0.6172175457600803,0.9186206896551724,0.9814134463362549,1.0,1/11,5.58%,LOX
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2074502953056194,0.6169739064872,0.9989969909729187,0.9812324058771585,1.0,44/260,21.09%,GSN;DYNLL2;DYNLL1;FXYD5;EMP3;EMP2;RAC1;PMP22;IFT20;FLNA;S1PR1;DNM3;ARHGEF4;P2RX7;CNGA4;NTN1;ARF6;P2RY12;ARHGEF7;FNBP1L;CEP131;FHDC1;TCTN3;AIF1;SHTN1;CCDC88A;SDCBP;EHD1;ARF4;CNGB1;DMTN;TMEM17;CCDC28B;TCTN1;EXOC7;EHD2;NOTCH1;BBIP1;NEK1;EXOC5;CFAP410;CFAP54;EXOC8;PTPRO
prerank,response to hydroxyurea (GO:0072710),-0.23606993185990344,-0.6169357759950532,0.9475524475524476,0.9918238872812355,1.0,2/11,5.78%,KAT7;SPIDR
prerank,cardiac ventricle development (GO:0003231),0.2621752175848864,0.6168230724923243,0.9092071611253197,0.9809932865636812,1.0,8/20,28.12%,HES1;HEY1;GATA4;NOTCH1;PDE2A;DLL4;ENG;STRA6
prerank,Golgi inheritance (GO:0048313),-0.2468286285214062,-0.6168117914997925,0.9209621993127147,0.9905544796375204,1.0,2/11,8.20%,GOLGA2;GBF1
prerank,protein heterooligomerization (GO:0051291),0.2686962072156812,0.6156281420899663,0.9152317880794701,0.9814464606307886,1.0,4/17,21.10%,GRIN1;MAT2A;GRIN2B;KCNC2
prerank,microtubule bundle formation (GO:0001578),-0.16620699894509752,-0.6143715142115211,0.990909090909091,0.9905606487754547,1.0,17/42,29.03%,NAV1;TTLL3;CCDC66;SPEF1;NUMA1;GAS8;AAAS;MAP1S;LRGUK;CAPN6;RP1;FOXJ1;PLK1;NCKAP5L;PSRC1;CCDC40;SPAST
prerank,lipoprotein transport (GO:0042953),-0.2503763715636551,-0.6134431790097251,0.9283276450511946,0.9896801143444947,1.0,3/10,15.34%,PPARG;LRP1;PRKCB
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.28517806286353037,0.6133369077291284,0.9144021739130435,0.9826334760900296,1.0,1/13,3.61%,CANX
prerank,mitochondrial transcription (GO:0006390),-0.242945548032987,-0.613232495763144,0.9295302013422819,0.9884584550673703,1.0,2/10,16.01%,FOXO3;MTERF2
prerank,transepithelial transport (GO:0070633),0.2789404229885369,0.6130281787608206,0.9264305177111717,0.9824951952035462,1.0,2/15,12.43%,SLC1A2;SLC1A1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2398677067205977,0.6105064162638204,0.9577142857142857,0.9837746271829854,1.0,13/36,28.40%,CALM1;CTNNB1;GNAO1;WNT5A;AGO1;PPP3CA;FZD2;PPP3R1;PDE6G;FZD3;LEF1;FZD5;MAP3K7
prerank,positive regulation of histone deacetylation (GO:0031065),0.2872289318436916,0.6094407080333626,0.8957475994513031,0.9841312790873679,1.0,2/12,10.93%,APLNR;CTBP1
prerank,DNA strand elongation (GO:0022616),0.26929788234208935,0.6094088177807476,0.9254901960784314,0.9838079026112245,1.0,10/18,39.78%,RFC4;GINS3;MCM7;POLD3;GINS1;RFC3;POLD2;MCM4;MCM3;DCLRE1B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.25916955093163185,0.6086622929087012,0.9300791556728232,0.983926640318733,1.0,7/22,25.90%,PPP1CA;PDP1;DUSP2;PPM1F;DUSP1;DUSP8;DUSP6
prerank,photoreceptor cell development (GO:0042461),0.27928466395593887,0.6066727323962315,0.921015514809591,0.9848086317566843,1.0,4/14,25.22%,MFSD2A;CDHR1;DCX;RORB
prerank,membrane depolarization during action potential (GO:0086010),0.24774974840657576,0.6061407669482015,0.931899641577061,0.9848098814507502,1.0,4/26,15.38%,SCN1A;YWHAH;SCN4B;SLC8A1
prerank,nuclear envelope organization (GO:0006998),0.2580554235675411,0.6060103502013034,0.9363057324840764,0.9845443840749951,1.0,5/20,23.69%,CTDNEP1;VPS4A;TMEM43;SUN2;SPAG4
prerank,determination of bilateral symmetry (GO:0009855),0.2502053406744283,0.6056578301403043,0.9309045226130653,0.9844078467405902,1.0,5/25,20.02%,MMP21;LEFTY1;DLL1;NOTCH1;CITED2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.29464114603890673,0.6055301652580736,0.9106382978723404,0.984145368825599,1.0,1/11,4.40%,ZFP36L1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.22532667903353948,-0.6049533568752149,0.9571428571428572,0.9915426277568233,1.0,5/13,21.61%,DYNC1LI1;MAD2L1;NDC80;XRCC3;TPR
prerank,GPI anchor biosynthetic process (GO:0006506),0.24368367017817943,0.6045103023713958,0.9406175771971497,0.9844345386916298,1.0,5/30,16.86%,PIGZ;PIGQ;DPM3;PIGS;DPM2
prerank,piRNA metabolic process (GO:0034587),0.2615702426532819,0.6042038402700519,0.9434447300771208,0.9842826904282382,1.0,3/19,21.87%,ASZ1;MAEL;TDRD9
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.207120213873832,-0.6038659150454118,0.9637096774193549,0.9907800491966899,1.0,4/16,15.58%,TOP2B;SLX4;HFM1;FANCM
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.2663291671670706,0.6033693779226955,0.9298701298701298,0.9844578272353154,1.0,6/17,29.42%,SCN4B;KCNE4;KCNE5;CACNA2D1;KCNQ1;SCN1B
prerank,protein modification by small protein conjugation (GO:0032446),0.2009577239846015,0.6028507781080427,1.0,0.9844366481318894,1.0,61/361,21.86%,RPS27A;UBC;RACK1;UBB;ELOB;UBE2Z;PINK1;KCTD10;KLHL9;EPAS1;UBE2G2;VCP;CDC34;DCAF15;RNF187;UBA52;ARRDC1;ISG15;USP5;TRIM28;UFC1;UBE2M;OTULIN;RBX1;NEDD8;TNFAIP1;DDB1;SUMO2;SUMO3;KLHL7;FBXW5;SYVN1;PCNA;ZSWIM8;FBXW7;RNF40;NUP85;NUP88;ARRB2;RNF7;ENC1;VHL;TRIM32;BCL11A;RANGAP1;RNF181;RLIM;NUP50;TRAIP;KCTD13;DDRGK1;HECW1;TRIM13;SKP1;KLHL25;RAE1;BRAP;SELENOS;STUB1;ELOC;AMFR
prerank,DNA repair (GO:0006281),0.2027193253637581,0.6025163865224633,0.996996996996997,0.9843064870261303,1.0,63/284,25.98%,RPS27A;UBC;UBB;PARK7;UBXN1;NPM1;CHEK2;RNASEH2A;PARP1;VCP;NUCKS1;RPA2;UBA52;TRIM28;CENPX;DDB1;NEIL1;MC1R;APBB1;APEX1;PCNA;NSMCE1;NSMCE3;CHRNA4;RFC2;TEX264;UBE2V1;BABAM1;RECQL5;POLD4;CETN2;MUS81;BRCA2;DCLRE1C;NEIL2;ERCC6;NOP53;TRAIP;WDR48;RAD23A;RFC4;ERCC1;ACTR5;FAM111A;GADD45A;MEN1;FAAP20;BLM;POLD1;PNKP;ALKBH5;BARD1;ATRIP;BAP1;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;GTF2H5;RAD51;ALKBH2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.2855595759408952,0.6016678211268406,0.9141274238227147,0.9844740353490146,1.0,3/12,20.79%,ABCG1;NR1H2;NFKBIA
prerank,skeletal muscle contraction (GO:0003009),0.25761246170416624,0.6004120432253736,0.9350811485642946,0.9848603188119941,1.0,5/19,28.86%,TNNI1;STAC3;MYH14;TCAP;STAC
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2575177864936239,0.6000342042655827,0.951188986232791,0.984383715497567,1.0,4/20,17.38%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2575177864936239,0.6000342042655827,0.951188986232791,0.984383715497567,1.0,4/20,17.38%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2355302870837402,0.5993180111844277,0.941656942823804,0.9844667126665623,1.0,15/36,36.97%,CHEK2;PRPF19;ERCC6;CDC5L;CDC45;ATRIP;DOT1L;RAD9A;DNA2;RHNO1;CLOCK;DONSON;TIMELESS;SETMAR;RAD1
prerank,nuclear membrane disassembly (GO:0051081),0.2829446123601528,0.5991401433683214,0.9207397622192867,0.9842243473407701,1.0,4/14,25.11%,CTDNEP1;DCTN1;VRK1;PRKCA
prerank,muscle tissue development (GO:0060537),-0.2171582663519646,-0.5972051381513002,0.9397163120567376,0.992800573794666,1.0,4/13,21.22%,SMO;BMP4;NF1;PTCH1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.22246087063537026,-0.5965102774501159,0.9739776951672863,0.9917498431768677,1.0,4/13,20.58%,ACTN2;STK39;NOS1;PTK2B
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2833788903582227,0.5955013358466156,0.9277929155313351,0.986019554611045,1.0,3/12,23.21%,GMNN;BLM;NUGGC
prerank,quinone biosynthetic process (GO:1901663),-0.21757449733055267,-0.5946818019556168,0.9488188976377953,0.9912690862762994,1.0,7/14,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,inner ear morphogenesis (GO:0042472),-0.19220286345693205,-0.5935300518266509,0.9800995024875622,0.9904761379261176,1.0,4/22,13.03%,FGFR2;EPHB2;ZIC1;SIX1
prerank,female gamete generation (GO:0007292),0.2410958150850867,0.5925544801369924,0.9524940617577197,0.9873539142808347,1.0,2/29,8.16%,MDK;FMN2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2762672937961896,0.5919726655041807,0.9410977242302544,0.9873495832487995,1.0,3/13,17.55%,NEIL1;NT5C;NEIL2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.2843723991427939,0.5913613623152552,0.939106901217862,0.9873499486910593,1.0,3/12,23.32%,SLC11A1;CCR2;IL12RB1
prerank,melanosome localization (GO:0032400),0.2560904096752729,0.5897861066300971,0.9483627204030227,0.9879006029595768,1.0,7/21,30.83%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.27094520205645495,0.589780371187042,0.925414364640884,0.9875644202388032,1.0,2/14,15.24%,ANK3;ATP1B1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21198315948939667,-0.5897586029356934,0.9510204081632653,0.9908619440569342,1.0,5/15,20.57%,PCM1;PIBF1;C2CD3;CCDC14;CEP192
prerank,cellular response to osmotic stress (GO:0071470),0.2503443879570931,0.5888571872541679,0.9408805031446541,0.9877375209390862,1.0,6/21,26.73%,ZFP36L1;AQP1;YBX3;CAPN3;OXSR1;SCN2A
prerank,regulation of acute inflammatory response (GO:0002673),-0.19544055768385354,-0.5886534916049301,0.9683794466403162,0.9900036979462227,1.0,18/18,80.48%,OSMR;PTGES;KLKB1;IL4;GSTP1;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;F12;DNASE1L3;C2CD4A;ADAM8;IL6;NLRP3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2686150405658381,0.5884408541282222,0.9333333333333333,0.9876162245307122,1.0,6/14,33.26%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1;FSCN1
prerank,protein polyglutamylation (GO:0018095),0.28879488314809704,0.5882045860956915,0.9405255878284924,0.9874063236313972,1.0,4/11,27.01%,TTLL7;TTLL5;TPGS1;TTLL1
prerank,homeostasis of number of cells (GO:0048872),0.2773432336919135,0.5871344215999178,0.9243697478991597,0.9876368437276206,1.0,4/12,27.83%,CX3CR1;NOTCH1;CCN3;OCIAD2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.25192810033716606,0.5866846676533631,0.9474358974358974,0.9875341014648709,1.0,4/19,20.39%,SDS;SLC25A21;CRYM;GOT1
prerank,lipoprotein localization (GO:0044872),-0.23316787216232937,-0.586276022390948,0.9644128113879004,0.9897148795651397,1.0,3/11,15.34%,PPARG;LRP1;PRKCB
prerank,UV-damage excision repair (GO:0070914),0.2754495844604048,0.5862124499282663,0.9322033898305084,0.9874371134374876,1.0,5/12,25.37%,DDB1;MC1R;ERCC1;ACTR5;XPC
prerank,DNA geometric change (GO:0032392),0.24744574450899298,0.5839141881707955,0.95125,0.9882719736619859,1.0,9/24,31.45%,HMGB3;HMGB1;DDX11;RECQL5;BLM;PIF1;DHX9;HNRNPA2B1;DNA2
prerank,response to interleukin-4 (GO:0070670),0.28912183792605606,0.581664510735144,0.9310829817158931,0.9890865482045019,1.0,10/10,71.11%,LEF1;XBP1;SHPK;DCSTAMP;XCL1;CITED1;RUFY4;TCF7;GATA3;JAK3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.20041459538067485,0.5806746520720466,0.989648033126294,0.9892469605969287,1.0,32/96,32.55%,MAGOHB;MAGOH;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;UPF1;POLDIP3;U2AF1
prerank,polarized epithelial cell differentiation (GO:0030859),0.26963383757931003,0.5805930348820525,0.93296853625171,0.9889501988148705,1.0,5/13,31.37%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2527791515855406,0.5800934223050639,0.9575289575289575,0.9888478847363014,1.0,8/19,32.14%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,DNA catabolic process (GO:0006308),-0.22312363681642797,-0.5794625968774392,0.9527272727272728,0.9912931610526889,1.0,2/11,9.96%,FBH1;DNASE1L1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.28248110787541325,0.579387681014797,0.9382716049382716,0.9888433967808016,1.0,3/11,22.29%,GMNN;FBXO5;BLM
prerank,regulation of rRNA processing (GO:2000232),0.2592754329807046,0.5766124343826811,0.9408602150537635,0.9898991825051555,1.0,3/16,16.29%,TRMT112;METTL18;NUDT16
prerank,regulation of adaptive immune response (GO:0002819),-0.19613575425064245,-0.5747338550071807,0.9655172413793104,0.9917495313817719,1.0,3/18,13.42%,EIF2AK4;ADCY7;SIRT1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2717668183508065,0.5747197012377436,0.9349930843706777,0.9904728014069397,1.0,4/12,30.14%,ADCY8;STX4;PLA2G6;C2CD2L
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.22247544695831917,-0.5725713468760546,0.9700996677740864,0.9912432098454217,1.0,1/11,2.94%,ACTN2
prerank,nuclear pore complex assembly (GO:0051292),0.2810584770892807,0.5724928089308893,0.9357664233576642,0.9912023420264643,1.0,1/10,4.81%,RTN4
prerank,steroid biosynthetic process (GO:0006694),0.2096585955210789,0.57173631839779,0.9835706462212487,0.9912147116305919,1.0,11/56,23.30%,SCP2;LSS;HSD17B4;OSBPL6;SC5D;HSD3B2;OSBPL3;CH25H;OSBPL1A;PMVK;PRLR
prerank,mitotic spindle assembly (GO:0090307),0.22079105560485301,0.5716424710105613,0.982837528604119,0.9909209849971782,1.0,7/42,18.89%,CHEK2;FLNA;ABRAXAS2;CLASP1;RHOA;TOGARAM2;KIFC2
prerank,negative regulation of dephosphorylation (GO:0035305),0.25100844203591754,0.5710087257037331,0.9451697127937336,0.990868516871912,1.0,8/18,32.34%,YWHAB;PPP1R35;ARPP19;PPP1R15A;MFHAS1;CHP1;PTPA;PPP1R16B
prerank,positive regulation of protein deacetylation (GO:0090312),0.2624033771259761,0.570956288763433,0.943758573388203,0.9905518113218675,1.0,2/14,10.93%,APLNR;CTBP1
prerank,positive regulation of nuclear division (GO:0051785),0.23660969192646958,0.5707982396045485,0.9573690621193667,0.9902898893618329,1.0,6/25,23.89%,PDGFB;IGF2;EDN3;SIRT2;TGFA;CD28
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.27274665826883615,0.57065968289501,0.9419889502762431,0.9900188335927924,1.0,1/12,4.36%,CHEK2
prerank,ubiquinone metabolic process (GO:0006743),-0.20426221213722137,-0.5696669028745384,0.9795918367346939,0.9909302744967432,1.0,7/15,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25899866616451417,0.5672195991806812,0.9485488126649076,0.9912664742614508,1.0,9/16,39.02%,RECQL5;BLM;RAD51;MCM7;MCM2;TWNK;RECQL;MCM4;PURA
prerank,endosome organization (GO:0007032),0.21754252947664784,0.5668226402928835,0.975609756097561,0.9910976437656053,1.0,10/41,27.58%,CHMP2B;CORO1C;SNX33;USP8;SQSTM1;HOOK1;EXOC8;DNM1;LAPTM4B;AKTIP
prerank,GPI anchor metabolic process (GO:0006505),0.23328337615279504,0.5664695406230792,0.9646341463414634,0.9909099893745117,1.0,4/26,16.86%,PIGZ;PIGQ;DPM3;DPM2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2285063031052785,0.565047176153943,0.965435041716329,0.9911741946975741,1.0,1/29,4.13%,SYCP2
prerank,ncRNA export from nucleus (GO:0097064),0.21869676851872025,0.5647530769993582,0.9893992932862191,0.9909653916883729,1.0,12/36,30.81%,NPM1;RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24044188005021302,0.5636368583143341,0.9597989949748744,0.9911152141854924,1.0,8/21,27.56%,JUN;MED30;SUB1;TWIST1;SRF;PAXIP1;MED16;MED12
prerank,protein heterotetramerization (GO:0051290),0.25992457291793647,0.5634279668726849,0.943342776203966,0.9908684151334175,1.0,2/13,18.27%,GRIN1;GRIN2B
prerank,manganese ion transport (GO:0006828),0.26410884196676543,0.5620160315658661,0.9448818897637795,0.9911166839607742,1.0,3/14,14.00%,TRPC7;SLC11A1;TRPC1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2511710786148976,0.5616456227167913,0.9626038781163435,0.9909221122629093,1.0,2/14,15.16%,ZDHHC5;TLR5
prerank,positive regulation of transporter activity (GO:0032411),-0.20336919157798705,-0.5612100035705333,0.9757085020242915,0.992510544483292,1.0,3/13,16.18%,KMT2A;TRPC6;STK39
prerank,regulation of urine volume (GO:0035809),0.27887203212287925,0.5611880378115093,0.9423631123919308,0.9907807094091858,1.0,2/10,19.56%,HYAL2;TFAP2B
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.22619363516269572,-0.5602900830264382,0.96,0.9914800164700596,1.0,5/10,31.27%,NUMA1;MED1;NCOA3;PRKCH;VDR
prerank,snRNA 3'-end processing (GO:0034472),0.24160201736249987,0.560069472580736,0.951885565669701,0.9909220553964954,1.0,9/19,33.90%,EXOSC2;TOE1;EXOSC9;USB1;EXOSC4;INTS12;INTS5;INTS6L;EXOSC3
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2743972939374866,0.5599388071687171,0.952247191011236,0.9906426177833372,1.0,4/11,25.11%,PF4;TGFB1;ID2;PRKCA
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.19040141306863637,0.5594186610160917,1.0,0.9905249654149804,1.0,38/172,27.26%,CHKB;CSNK2B;CDIPT;CDS1;RAB14;DGKH;MFSD2A;PIK3C2G;PCYT2;MTMR9;CHAT;ABHD8;INPP5J;PTDSS1;ARF1;ACHE;CPNE6;PIK3CD;AGPAT5;RAB4A;SLC44A5;DGKB;STARD10;LPCAT2;INPP5D;ETNPPL;AGPAT2;SBF1;PLEKHA1;SLC44A2;PIK3R5;INPP4B;CPNE3;SLC44A1;MTMR6;MBOAT7;GPAM;PIP5K1C
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24218966976884412,0.5588748832086574,0.970360824742268,0.9904027588531016,1.0,10/18,37.03%,KCNE5;CBARP;CAV1;SLC43A2;COMMD1;PPIF;CAB39;BIN1;KCNH2;SLC43A1
prerank,regulation of DNA metabolic process (GO:0051052),0.21459823402765554,0.5579585038386473,0.9718785151856018,0.9904202801408966,1.0,12/44,22.68%,NUCKS1;UBE2V1;KDM1B;PDGFA;SUB1;TERF2IP;ALYREF;MYC;CDK9;RADX;GRHL2;MPV17
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22618357306443435,0.5575901878262306,0.9671532846715328,0.9902383178150264,1.0,9/26,31.00%,TNFAIP3;SIGIRR;TYRO3;SIRT2;C1QBP;PCBP2;TRIB1;ACOD1;TRAFD1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.2515924427479865,0.5564403338983629,0.9656121045392022,0.9903716233224196,1.0,2/14,13.40%,LILRA5;LILRB1
prerank,cytoplasmic microtubule organization (GO:0031122),0.20176870077221076,0.551848772419352,0.986827661909989,0.9918605212307903,1.0,14/54,28.63%,STMN3;CLASP1;MAPT;DCTN1;RHOA;CLIP3;CCDC88A;HOOK1;KATNA1;KPNB1;CHP1;KATNAL1;CCDC88C;CAMSAP3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.27201534664332583,0.5515111430474787,0.9478138222849083,0.9916564443551042,1.0,2/10,16.57%,ARF6;EPB41L4B
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2735365113739283,0.5510166314636267,0.9486111111111111,0.9915208884674348,1.0,1/10,5.11%,PPP2R1A
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.2517899239811294,0.5507379408223909,0.9528301886792453,0.9912893257898492,1.0,2/15,13.95%,NME2;SFRP4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22111825318931702,0.5506264163284087,0.9805352798053528,0.9909948666187596,1.0,8/29,26.40%,GABARAPL2;NAPA;TRAPPC3;RAB6B;COPB2;COPG1;COG8;COPE
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.1868616115618862,-0.5502739715118865,0.9777777777777777,0.9932167617367921,1.0,4/17,25.41%,PLA2G4A;CRLS1;SERAC1;PLA2G5
prerank,microtubule anchoring (GO:0034453),0.25952504827376266,0.5497658839208422,0.9583911234396671,0.9909764979012179,1.0,6/12,36.50%,CLASP1;CAMSAP3;CLASP2;PEX14;GCC2;BICD2
prerank,endochondral bone morphogenesis (GO:0060350),-0.22323618446121232,-0.5495582004111799,0.9583333333333334,0.9921104225392839,1.0,3/11,16.29%,COL13A1;BMP4;BMPR2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2165132109700076,-0.5494623981578048,0.948905109489051,0.9908326295329289,1.0,5/11,28.66%,RIPK1;CASP8;COLEC12;SCARA3;TLR3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.20137488173418921,0.5492907988784183,0.9891186071817193,0.9908232123425564,1.0,17/52,32.91%,MDH1;SLC19A1;FOLR2;ACOT4;D2HGDH;GOT1;SHMT2;MTHFS;SDHA;ACLY;IDH1;DHFR;ASS1;L2HGDH;ALDH1L1;MTHFD2L;MTRR
prerank,sulfate transport (GO:0008272),0.2522345814808832,0.5485788781605547,0.9570637119113573,0.9907336800065599,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.21598894272855126,0.5479402314656321,0.9792147806004619,0.9906211310423695,1.0,7/37,22.14%,RNASEH2A;ENTPD3;RNASEH1;SND1;NUDT16;NUDT9;ISG20
prerank,ncRNA catabolic process (GO:0034661),0.2222662660573367,0.5454725442718387,0.9741060419235512,0.9911750386585715,1.0,7/28,21.53%,LIN28B;EXOSC2;SND1;NUDT16;EXOSC9;RBM7;EXOSC4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.2701915526473765,0.5444864778477954,0.9562146892655368,0.9912136354017654,1.0,5/10,32.29%,SOX9;PDGFA;MYC;CHRD;SHH
prerank,mitotic chromosome condensation (GO:0007076),0.22648299791500914,0.5425715994478171,0.9627403846153846,0.9915604696800789,1.0,3/26,13.98%,CSNK2B;SET;NCAPG
prerank,homologous chromosome segregation (GO:0045143),-0.17573757178028454,-0.5412617569133745,0.9907834101382489,0.99190695604503,1.0,7/20,25.97%,CENPC;PRDM9;SIRT7;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,outer dynein arm assembly (GO:0036158),-0.18978350870011274,-0.541112522566669,0.9954545454545455,0.990646176405887,1.0,7/15,29.09%,ODAD1;DNAAF5;ODAD2;ODAD3;ODAD4;DNAAF4;CCDC63
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.24757950298716264,0.5404736863117534,0.9568627450980393,0.9919271520050477,1.0,3/15,19.20%,NPM1;FAM83D;DDRGK1
prerank,tryptophan metabolic process (GO:0006568),0.2622026034448367,0.5395802962954671,0.9588652482269504,0.9919062135130038,1.0,1/11,11.01%,IDO2
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.21494467079145868,-0.53520518749426,0.9828178694158075,0.9909266737544712,1.0,5/10,26.29%,MTHFR;MTHFD1L;SHMT1;MTHFD1;TYMS
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2511142652946533,0.533996347825485,0.9593837535014006,0.9934441247557659,1.0,2/13,15.19%,AMDHD2;SLC35A3
prerank,metanephric mesenchyme development (GO:0072075),0.26134314646401463,0.5327724739760166,0.9722222222222222,0.9935039243260347,1.0,1/10,8.19%,BASP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.2306005173389075,0.5253728776628543,0.9674902470741222,0.9953496407314961,1.0,1/18,5.32%,ABCB6
prerank,ubiquinone biosynthetic process (GO:0006744),0.2317629083890434,0.5224077298073218,0.9708994708994709,0.9958560797967408,1.0,5/15,26.80%,COQ6;NDUFA9;PDSS1;COQ10A;COQ2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.2507632676549708,0.5198589158340113,0.9544846050870147,0.9962346943169796,1.0,3/12,25.11%,CTDNEP1;VRK1;PRKCA
prerank,response to X-ray (GO:0010165),0.234186848028197,0.5194914997765756,0.9749009247027741,0.9959981923964316,1.0,4/14,28.69%,NUCKS1;BLM;IKBIP;XRCC6
prerank,maturation of 5.8S rRNA (GO:0000460),0.2314819089843967,0.519213015253212,0.9809523809523809,0.9957349263799993,1.0,8/17,33.67%,EXOSC4;FTSJ3;RRP15;EIF6;NOL9;URB1;PES1;LAS1L
prerank,regulation of telomere capping (GO:1904353),0.21872222797104263,0.5188721136992336,0.9789343246592317,0.995487593191774,1.0,1/23,1.89%,MAPK3
prerank,rRNA catabolic process (GO:0016075),0.2301041589372823,0.5185397486460862,0.9863201094391245,0.9952315678089045,1.0,7/16,35.61%,EXOSC2;EXOSC9;EXOSC4;TRIR;PELO;EXOSC3;DEDD2
prerank,glutathione biosynthetic process (GO:0006750),-0.20483364720652855,-0.5177622567172996,0.9715302491103203,0.993446590855376,1.0,11/11,79.54%,GGCT;GGT1;GCLC;MGST2;GCLM;GSS;CHAC1;CNDP2;HAGH;CHAC2;OPLAH
prerank,muscle cell migration (GO:0014812),0.2546223598276494,0.5170518914200408,0.9696531791907514,0.9952984748535335,1.0,3/10,21.71%,AAMP;PLAT;CCN3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.2082551417417202,0.5155149282117033,0.9894117647058823,0.9953522208688116,1.0,8/29,22.34%,SPRY1;DAB2IP;VASN;EFNA1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,lysine metabolic process (GO:0006553),0.23898508129250032,0.5112563671489128,0.9738651994497937,0.9957545125468106,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,lysine catabolic process (GO:0006554),0.23898508129250032,0.5112563671489128,0.9738651994497937,0.9957545125468106,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2423339544959563,0.5050358587261881,0.9690576652601969,0.9968549499436621,1.0,3/11,27.82%,PF4;TMEM106A;XBP1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2225676427922499,0.5041236420526345,0.982367758186398,0.9967171927463153,1.0,4/18,22.31%,CCND1;FBXO5;CDC25A;RCC2
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.2483840305994509,0.5027314848575966,0.967930029154519,0.9963781458914406,1.0,4/10,33.97%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.2483840305994509,0.5027314848575966,0.967930029154519,0.9963781458914406,1.0,4/10,33.97%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.15132308306509526,-0.5015808541234488,0.9884393063583815,0.9948331420422513,1.0,5/29,18.75%,DDO;PRODH;HOGA1;ACADSB;GSTZ1
prerank,positive regulation of immune system process (GO:0002684),-0.1720067551942056,-0.5008352988851811,1.0,0.9936165399191754,1.0,2/16,14.01%,IL15;LGALS9
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17628204435497977,0.49925082007070437,0.9969199178644764,0.9967833878460163,1.0,23/95,29.99%,SEM1;MCM5;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;MUS81;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;CDC45;SFR1;RPA3;RAD51;RMI1;MCM7;MCM2;SMC6;AP5Z1;POLN
prerank,recombinational repair (GO:0000725),0.17814527737182978,0.49610265835282,0.9989572471324296,0.997093522905745,1.0,22/77,33.42%,SEM1;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;SFR1;RPA3;RAD51;RMI1;SMC6;AP5Z1;POLN;PSMD14;RHNO1;RAD51C;SWI5
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21149973960831137,0.4955942584012268,0.9874529485570891,0.9968699412725962,1.0,8/19,31.96%,APRT;PNP;CDA;POLD1;ADA;POLD3;DGUOK;DCK
prerank,establishment of mitotic spindle localization (GO:0040001),0.20006009312928774,0.4921781528841773,0.9939393939393939,0.9972138252954763,1.0,9/28,30.50%,CLASP1;DCTN1;GJA1;INSC;KPNB1;ITGB1;ESPL1;CLASP2;NSFL1C
prerank,glycerolipid metabolic process (GO:0046486),0.2358720956409754,0.49125866586612693,0.977110157367668,0.9970494834585901,1.0,6/11,34.99%,GAL3ST1;PGP;DGKB;DGKZ;DGKG;PLA2G15
prerank,tRNA export from nucleus (GO:0006409),0.19217145806767086,0.48972279243641625,0.9964028776978417,0.9966666113182185,1.0,11/32,30.81%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.19217145806767086,0.48972279243641625,0.9964028776978417,0.9966666113182185,1.0,11/32,30.81%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.20205086278276427,0.489414948419903,0.9854191980558931,0.9963900261136913,1.0,9/24,38.03%,PLA2G4F;PLA2G3;ABCA3;GPAM;CDS2;PNPLA8;PLA2G15;LPCAT1;LPGAT1
prerank,regulation of interferon-alpha production (GO:0032647),0.20513478801330692,0.4861380574724602,0.9851851851851852,0.9966104993024647,1.0,8/23,32.14%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2158743430815538,0.4856938788342935,0.9895424836601308,0.9963686890295577,1.0,8/16,35.68%,SRSF1;SNRNP200;SART1;WBP4;WBP11;CWC15;DCPS;PSIP1
prerank,exit from mitosis (GO:0010458),0.23042382823790225,0.48445928724278264,0.9808481532147743,0.9962590819851744,1.0,4/12,32.42%,CLASP1;CHMP7;CLASP2;CHMP4B
prerank,tRNA modification (GO:0006400),0.17703242564612243,0.48421252233200923,0.9957671957671957,0.9959683381483974,1.0,13/62,26.12%,METTL1;TRMT112;AARS2;CTU1;PUSL1;PUS7;ADAT2;URM1;THUMPD1;CTU2;WDR6;LCMT2;TYW3
prerank,positive regulation of telomere maintenance (GO:0032206),0.1938214578648525,0.4836237808903,0.9859976662777129,0.9957315476572167,1.0,11/31,33.05%,MAPK3;MAPK15;ERCC1;MAP2K7;NAF1;PNKP;PRKCQ;AURKB;HNRNPA2B1;HNRNPD;PKIB
prerank,regulation of interleukin-13 production (GO:0032656),0.22457678235978468,0.4834464999272289,0.9778085991678225,0.9954314044954803,1.0,3/13,26.78%,LILRA5;SPHK2;LEF1
prerank,retinal metabolic process (GO:0042574),0.2288538314723222,0.4778905641093245,0.9811066126855601,0.9959946022109076,1.0,2/12,18.14%,DHRS13;BCO2
prerank,mitotic metaphase plate congression (GO:0007080),0.1796894681341098,0.4769117797218234,0.9977802441731409,0.9958094668574343,1.0,11/51,25.88%,CHMP2B;CHMP5;CHMP6;DCTN2;CHMP1B;NUDC;VPS4A;CHMP7;CHMP1A;KPNB1;CHMP4C
prerank,regulation of sensory perception of pain (GO:0051930),0.2283351945885566,0.46982136161567856,0.9887482419127989,0.9965299664475535,1.0,3/11,28.07%,CCL3;CCN3;MGLL
prerank,sarcomere organization (GO:0045214),0.19224362574618334,0.4655234092437336,0.9962779156327544,0.9967734729516958,1.0,7/27,30.26%,CSRP1;FHOD3;CAPN3;KRT19;TCAP;WDR1;SYNPO2L
prerank,neural tube development (GO:0021915),0.208271498392331,0.4612561148730685,0.990909090909091,0.9969836507575708,1.0,4/15,22.29%,PROX1;SOX11;TGFB1;GRHL2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.19122396570984737,0.457484809369635,0.9949238578680203,0.9971280287259903,1.0,10/23,35.71%,SLC12A5;SLC26A4;TFAP2B;PDK2;SLC12A9;SLC12A6;SLC9A7;CLCN3;SLC12A2;KCNH2
prerank,monosaccharide transmembrane transport (GO:0015749),0.20751918916744655,0.4556406199387228,0.9946380697050938,0.9970032622183445,1.0,2/16,16.52%,SLC50A1;SLC2A2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.20417375093754977,0.443989842499385,0.9959839357429718,0.9978904199410285,1.0,5/13,36.06%,UNC93B1;TLR7;IRAK2;PIK3AP1;MYD88
prerank,signal transduction in response to DNA damage (GO:0042770),0.16569209697698717,0.44118091960010414,1.0,0.9978180867188063,1.0,11/49,26.95%,CHEK2;NDRG1;PRPF19;ERCC6;GADD45A;CDC5L;STK33;ATRIP;DOT1L;PAXIP1;RAD9A
prerank,phasic smooth muscle contraction (GO:0014821),0.21668327174615065,0.43863738276189845,0.9912790697674418,0.9976971100857771,1.0,3/10,31.52%,EDN3;HTR2B;DRD2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.1931047475508666,0.43190668566605495,0.9961928934010152,0.9978935783153995,1.0,17/17,80.71%,BUB3;AURKB;BOD1;IK;CENPA;ZW10;MTBP;HASPIN;CHAMP1;CTCF;RB1;SPDL1;KNL1;CDK1;MIS12;ZWILCH;TTK
prerank,protein localization to condensed chromosome (GO:1903083),0.2017697551045607,0.4177307786818266,1.0,0.9985051407788553,1.0,1/12,11.18%,BUB3
prerank,response to light stimulus (GO:0009416),0.1479404864229669,0.4012590439671842,1.0,0.9989693932987347,1.0,20/55,35.35%,MAPK10;CIRBP;TRIM32;ERCC6;CCAR2;MEN1;MAP2K7;AANAT;POLD1;UBE2A;ERCC2;USF1;FECH;DRD2;CLOCK;TYR;CPT1B;ERCC4;DTL;GPR88
prerank,protein localization to kinetochore (GO:0034501),0.16017153121417357,0.3461446269835824,1.0,0.9998113281557717,1.0,3/14,28.99%,BUB3;RCC2;AURKB
